{
   "data": [
      {
         "claim": "Recognition of start codons depends on the translation initiation factor IF3.",
         "label": 1,
         "prediction": 1,
         "rationale": "Translation initiation factor IF3 functions as a fidelity factor during the assembly of the ternary initiation complex in bacterial protein biosynthesis, enhancing the fidelity and speed of mRNA translation initiation, stimulating the formation of the 30S initiation complex, and is essential for cell viability. The function of translation initiation factor IF3 involves recognition of start codons, preventing initiation from non-canonical start codons and favoring initiation from canonical start codons such as AUG, GUG, and UUG. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of translation initiation factor IF3?",
               "answer": "Translation initiation factor IF3 functions as a fidelity factor during the assembly of the ternary initiation complex in bacterial protein biosynthesis. It enhances the fidelity and speed of mRNA translation initiation, stimulates the formation of the 30S initiation complex, and is essential for cell viability.",
               "rationale": "1. In molecular biology, translation initiation factor IF-3 ( gene infC) is one of the three factors required for the initiation of protein biosynthesis in bacteria. IF-3 is thought to function as a fidelity factor during the assembly of the ternary initiation complex which consists of the 30S ribosomal subunit, the initiator tRNA and the ...\n2. Translation initiation factor IF3 performs several functions, at least one of which is essential for cell viability ( Olsson et al ., 1996 ). In particular, IF3 stimulates on and off rates of '30S initiation complex' formation ( Gualerzi et al ., 1977 ), ensuring translational efficiency and, at the same time, fidelity.\n3. Abstract. Initiation factor IF3 is an essential protein that enhances the fidelity and speed of bacterial mRNA translation initiation. Here, we describe the dynamic interplay between IF3 domains and their alternative binding sites using pre-steady state kinetics combined with molecular modelling of available structures of initiation complexes.\n4. Indeed, many translation factors are phosphoproteins whose function can be regulated by extracellular signals. We will describe here the mechanism of translation initiation in eukaryotes, with a particular emphasis on translation factors and their function.\n5. Protein synthesis is regulated at the initiation stage. Determining the structures and activities of initiation factors, and mapping their interactions in ribosomal initiation complexes, has ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the function of translation initiation factor IF3 involve recognition of start codons?",
               "answer": "Yes, the function of translation initiation factor IF3 involves recognition of start codons. Specifically, it is known to prevent initiation from non-canonical start codons and favor initiation from canonical start codons such as AUG, GUG, and UUG. This indicates that IF3 plays a role in ensuring that the correct",
               "rationale": "1. IF3 is one of the three factors required for initiation of protein synthesis in bacteria (for review see Gualerzi and Pon, 1990; Gualerzi et al ., 2000 ). In Escherichia coli, IF3 is a protein of 180 amino acids encoded by infC, an essential gene ( Olsson et al ., 1996) mapped at 37.5 min ( Sacerdot et al ., 1982 ).\n2. Initiation of translation in eukaryotic protein synthesis is a rather complex process. In order to start the translational machinery, the correct codon for initiation must be found. This process is orchestrated by at least 12 proteins, the eukaryotic initiation factors (eIF) ( 1, 2 ). The small 40S ribosomal subunit, in complex with eIF1, eIF1A ...\n3. IF3 is the stand-alone fidelity factor in bacterial translation initiation. As shown in Table 1, there are three bacterial initiation factors, IF1, IF2 and IF3.After ribosome dissociation into the 30S small subunit (SSU) and 50S large subunit (LSU), the former binds GTP-bound IF2 and IF3, priming the subsequent loading of IF1 and formyl-methionyl initiator tRNA (fMet-tRNA i fMet) onto the SSU ...\n4. Further, IF3 is known to prevent initiation from non-canonical start codons and favour initiation from AUG, GUG, and UUG start codons (43, 44). IF3 is also required for accurate i-tRNA selection at the P-site over elongator tRNAs . Notably, based on the biochemical studies, it was shown that all of these functions of IF3 could be carried by the ...\n5. Initiation factor IF3 contains two domains separated by a flexible linker. While the isolated N‐domain displayed neither affinity for ribosomes nor a detectable function, the isolated C‐domain, added in amounts compensating for its reduced affinity for 30S subunits, performed all activities of intact IF3, namely: (i) dissociation of 70S ...",
               "predicate": null
            }
         ],
         "row": 366,
         "id": 197912182993133712
      },
      {
         "claim": "Reduced responsiveness to interleukin-2 in regulatory T cells is associated with autoimmune diseases such as Type 1 Diabetes.",
         "label": 1,
         "prediction": 1,
         "rationale": "Type 1 Diabetes is an autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells due to an autoimmune response. Reduced responsiveness to interleukin-2 in regulatory T cells is associated with autoimmune diseases. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is Type 1 Diabetes an autoimmune disease?",
               "answer": "Yes, Type 1 Diabetes is an autoimmune disease. The evidence clearly states that Type 1 diabetes is characterized by the destruction of insulin-producing pancreatic beta cells due to an autoimmune response.",
               "rationale": "1. Type 1 diabetes is a chronic (life-long) autoimmune disease that prevents your pancreas from making insulin. It requires daily management with insulin injections and blood sugar monitoring. Both children and adults can be diagnosed with Type 1 diabetes.\n2. Type 1 diabetes is an autoimmune disease. Testing, coupled with education about diabetes symptoms and close follow-up, has been shown to enable earlier diagnosis and to prevent diabetes ketoacidosis. ... People with type 1 diabetes who also have the classic risk factors for type 2 diabetes—such as overweight/obesity, not being physically ...\n3. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition. In this condition, the pancreas makes little or no insulin. ... Heart and blood vessel disease. Diabetes increases the risk of some problems with the heart and blood vessels. These include coronary artery disease with chest pain (angina ...\n4. Type 1 diabetes mellitus (T1D) is an autoimmune disease that leads to the destruction of insulin-producing pancreatic beta cells. There is heterogeneity in the metabolic, genetic, and immunogenetic characteristics of T1D and age-related differences, requiring a personalized approach for each individual. Loss of insulin secretion can occur quickly or gradually.\n5. Core Tip: Type 1 diabetes (T1D) often occurs in combination with several other endocrine and non-endocrine autoimmune disorders.Recent studies have revealed a strong clustering of T1D + autoimmune diseases in patients and their first-degree relatives. Therefore, regular screening for autoantibodies in patients with T1D and first-degree relatives is of upmost importance for diagnostic and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is reduced responsiveness to interleukin-2 in regulatory T cells associated with autoimmune diseases?",
               "answer": "Yes, reduced responsiveness to interleukin-2 (IL-2) in regulatory T cells (Tregs) is associated with autoimmune diseases. The evidence indicates that disturbances in Treg biology, including decreased numbers or impaired function of Tregs, are observed in many autoimmune diseases. Since IL-2 is essential for the",
               "rationale": "1. The immunosuppressive capacity and number of T reg cells in patients with RA is controversial, as there are reports that these are decreased, normal or increased 62. RA, like SLE and type 1 ...\n2. The cytokine interleukin-2 (IL-2) is essentially required for the growth and survival of Treg in the peripheral lymphatic tissues and thus plays a vital role in the biology of Treg. Most autoimmune and rheumatic diseases exhibit disturbances in Treg biology either at a numerical or functional level resulting in an imbalance between protective ...\n3. Failure of regulatory T (T reg) cells to properly control immune responses leads invariably to autoimmunity and organ damage.Decreased numbers or impaired function of T reg cells, especially in the context of inflammation, has been documented in many human autoimmune diseases. Restoration of T reg cell fitness and/or expansion of their numbers using low-dose natural IL-2, the main cytokine ...\n4. Low-dose interleukin-2 (IL-2) is a potential treatment for autoimmune diseases. IL-2 is a protein that helps regulate the immune system, and low doses of it can activate regulatory T cells (Tregs), which help control the immune response. This can be beneficial in autoimmune diseases where the immune system attacks healthy tissues.\n5. The maintenance of immune homeostasis is of para-mount importance in the prevention of autoimmun-ity and the development of excessive effector immune response and host tissue injury1. In this ...",
               "predicate": null
            }
         ],
         "row": 367,
         "id": 237700021910451357
      },
      {
         "claim": "Reducing H3k4me3 methylation induces mouse epiblast stem cells to naive pluripotency efficiently.",
         "label": 1,
         "prediction": 1,
         "rationale": "H3K4me3 methylation is the tri-methylation of the fourth lysine residue on the histone H3 protein, commonly found at the promoters of actively transcribed genes and associated with regions of open chromatin. Reducing H3K4me3 methylation in mouse epiblast stem cells does not completely inhibit transcription or gene activation in response to differentiation signals. Reducing H3K4me3 methylation induces mouse epiblast stem cells to naive pluripotency efficiently. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is H3k4me3 methylation?",
               "answer": "H3K4me3 methylation refers to the tri-methylation of the fourth lysine residue on the histone H3 protein. This epigenetic modification is significant in the regulation of gene expression, as it is commonly found at the promoters of actively transcribed genes and is associated with regions of open chrom",
               "rationale": "1. H3K4me3. H3K4me3 is an epigenetic modification to the DNA packaging protein Histone H3 that indicates tri- methylation at the 4th lysine residue of the histone H3 protein and is often involved in the regulation of gene expression. [1] The name denotes the addition of three methyl groups ( trimethylation) to the lysine 4 on the histone H3 protein.\n2. The roles of tri-methylated H3 lysine 4 (H3K4me3) in transcriptional initiation and pause-release steps. H3K4me3 is enriched at the promoters of actively transcribed genes and is associated with regions of open chromatin. It serves as a recognition signal for transcriptional initiation complexes.\n3. Epigenetic modifications, including posttranslational modifications of histones, are closely linked to transcriptional regulation. Trimethylated H3 lysine 4 (H3K4me3) is one of the most studied histone modifications owing to its enrichment at the start sites of transcription and its association with gene expression and processes determining cell fate, development, and disease.\n4. Gene expression is associated with the position of histone methyl-lysine residues within genes and their degree of methylation. H3K4me1, H3K4me2 and H3K4me3 have been shown to differentially mark ...\n5. Highlights. The protein complexes catalyzing the mono-, di-, and trimethylation and demethylation of H3 lysine 4 (H3K4), as well as those that read these modifications, are essential for differentiation and development. More specifically, trimethylated H3K4 (H3K4me3) plays critical roles in regulating gene expression, as well as transcriptional ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of reducing H3k4me3 methylation on mouse epiblast stem cells?",
               "answer": "The evidence suggests that reducing H3K4me3 methylation in mouse embryonic stem cells (mESCs) does not completely inhibit transcription or gene activation in response to differentiation signals. Specifically, studies indicate that transcription can still be maintained and genes can be activated even in cells that have lost most of the H3",
               "rationale": "1. However, whether this is the case has been intensively debated, partly because of studies in Saccharomyces cerevisiae, Drosophila melanogaster, and mouse embryonic stem cells (mESCs) have shown that transcription can be maintained and genes can be activated in response to differentiation signals in cells, which have lost most of the H3K4me3 [17 ...\n2. Epigenetic modifications, including posttranslational modifications of histones, are closely linked to transcriptional regulation. Trimethylated H3 lysine 4 (H3K4me3) is one of the most studied histone modifications owing to its enrichment at the start sites of transcription and its association with gene expression and processes determining cell fate, development, and disease. In this review ...\n3. The molecular effect of histone methylation depends on which residue is methylated or the level of methylation. ... H3K4me3 and associated chromatin environment can affect transcription in a more nuanced way. The effect of H3K4me3 may be on the induction, transcriptional memory, or sustainability of transcription on a more limited gene, rather ...\n4. Transcriptionally active chromatin is marked by tri-methylation of histone H3 at lysine 4 (H3K4me3) located after first exons and around transcription start sites. This epigenetic mark is typically restricted to narrow regions at the 5`end of the gene body, though a small subset of genes have a broad H3K4me3 domain which extensively covers the coding region. Although most studies focus on the ...\n5. e CpG methylation heterogeneity was measured in E4.5, E5.5, and E6.5 epiblast cells for all covered CpGs in the mouse genome as well as within EpiLC, EpiSC, and PGCLC enhancers. The horizontal ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does reducing H3k4me3 methylation induce mouse epiblast stem cells to naive pluripotency efficiently?",
               "answer": "Yes, reducing H3K4me3 methylation by inhibiting the histone H3K4 methyltransferase MLL1 activity with the small-molecule inhibitor MM-401 induces mouse epiblast stem cells (EpiSCs) to naive pluripotency efficiently. The evidence indicates that this reversion",
               "rationale": "1. Yamaji, M. et al. PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell 12 , 368-382 (2013).\n2. Here, we show that blocking histone H3K4 methyltransferase MLL1 activity with the small-molecule inhibitor MM-401 reprograms mouse epiblast stem cells (EpiSCs) to naive pluripotency. This reversion is highly efficient and synchronized, with more than 50% of treated EpiSCs exhibiting features of naive embryonic stem cells (ESCs) within 3 days.\n3. These models were initially classified dichotomously with mouse embryonic stem cells (ESCs) reflecting the naïve epiblast 9, and epiblast stem cells (EpiSCs) resembling the primed epiblast of the ...\n4. Interestingly, reducing H3K4me3 methylation by inhibiting the histone H3K4 methyltransferase MLL1 activity with small-molecule inhibitor MM-401 induces mouse epiblast stem cells to naïve pluripotency efficiently . In the case, blocking MLL1 redistributes globally the repressive H3K4 monomethylation (H3K4me1) at enhancers of lineage determinant ...\n5. Histone acetylation is a prerequisite for H3K4me3 methylation by MLL1 ... Kalkan T, Smith A (2014) Mapping the route from naive pluripotency to lineage specification. Philos Trans R Soc B Biol Sci 369(1657):20130540. ... Histone proteomics implicates H3K36me2 and its regulators in mouse embryonic stem cell pluripotency exit and lineage choice ...",
               "predicate": null
            }
         ],
         "row": 368,
         "id": 159329911937093924
      },
      {
         "claim": "Reduction of Rpl38 alters the composition of the Hox gene mRNAs translation in mice without lowering overall protein synthesis.",
         "label": 1,
         "prediction": 1,
         "rationale": "RPL38 (Ribosomal Protein L38) is a protein-coding gene located on the long arm of chromosome 17 at 17q25.1. Reducing Rpl38 does not affect global protein synthesis in mice, but specifically decreases the translation of a small subset of Hox genes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Rpl38?",
               "answer": "RPL38 (Ribosomal Protein L38) is a protein-coding gene located on the long arm of chromosome 17 at 17q25.1. It consists of five exons and encodes a 70 amino acid protein with a 213 nucleotide open reading frame. RPL38 is associated with",
               "rationale": "1. The human RPL38 gene resides on the long arm of chromosome 17 at 17q25.1. It consists of five exons spread out over a distance of 6223 bp. The 213 nucleotide open reading frame encodes a 70 amino acid protein. Alternative splice variants have been identified, both encoding the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this ...\n2. RPL38 (Ribosomal Protein L38) is a Protein Coding gene. Diseases associated with RPL38 include Klippel-Feil Syndrome 2 and Dyskeratosis Congenita, X-Linked.Among its related pathways are Peptide chain elongation and rRNA processing in the nucleus and cytosol.Gene Ontology (GO) annotations related to this gene include RNA binding and structural constituent of ribosome.\n3. Primary sequence of the human, lysine-rich, ribosomal protein RPL38 and detection of an unusual RPL38 processed pseudogene in the promoter region of the type-1 angiotensin II receptor gene. Espinosa L, et al. Biochim Biophys Acta, 1997 Oct 9. PMID 9375793. Characterization of the proteome, diseases and evolution of the human postsynaptic density.\n4. Background: Ribosomal protein L38 (RPL38) was found upregulated in osteoarthritic peripheral blood mononuclear cells, however, its role in progression of osteoarthritis has not been characterized. Methods: The protein levels of RPL38 and SOCS2 in cartilage tissues from OA patients and controls were detected with Western blotting. IL-1β was used to stimulate primary chondrocytes to establish ...\n5. RPL38 belongs to the L38E family of ribosomal proteins. It is located in the cytoplasm. Alternative splice variants have been identified, both encoding the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome, including one located in the promoter ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of reducing Rpl38 on the overall protein synthesis in mice?",
               "answer": "Reducing Rpl38 does not affect global protein synthesis in mice. Instead, it specifically decreases the translation of a small subset of Hox genes, which are important for body plan formation.",
               "rationale": "1. Accordingly, decreased expression of certain RPs can lead to defects in ribosome assembly, nucleolar stress and decreased global protein synthesis 5,16,17,18, whose effects in turn may mask any ...\n2. Dynamic protein synthesis among embryonic cells. Cellular function depends upon proteostasis - appropriate regulation of protein synthesis, protein folding, and protein degradation. Each of these are likely to exhibit cell type-specific differences in regulation that influence stem cell function, tissue development, and homeostasis ( Vilchez et ...\n3. Nude mice were purchased from Beijing Charles river. ... Effects of RPL38 knockdown on the size of MKN-45 xenograft tumors in nude mice. (B and C) ... Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 ...\n4. RPL38/eL38 haploinsufficiency decreases the translation of a small subset of Hox genes, which are master regulators of body plan formation, without affecting global protein synthesis 13.\n5. Once the global tissue-dependent effect on expression levels was removed, the standard score-normalized expression of each RP was very consistent across tissues, with some notable exceptions (Fig. 2a).Tissue-specific patterns of RP expression are also evident at the protein level (Additional file 1: Figure S1c-f).For example, the expression of RPL3L, a paralog of the canonical ribosomal ...",
               "predicate": null
            }
         ],
         "row": 369,
         "id": 300240100777064879
      },
      {
         "claim": "Removal of H3K9me3 by ectopic expression of other H3K9 demethylases decreases reprogramming efficiency in SCNT experiments.",
         "label": 0,
         "prediction": 0,
         "rationale": "Somatic cell nuclear transfer (SCNT) is a laboratory technique in which the nucleus of a somatic cell is transferred to the cytoplasm of an enucleated egg, allowing the somatic nucleus to be reprogrammed by the egg's cytoplasm. The removal of H3K9me3 in SCNT experiments improves reprogramming efficiency. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is SCNT?",
               "answer": "Somatic cell nuclear transfer (SCNT) is a laboratory technique in which the nucleus of a somatic (body) cell is transferred to the cytoplasm of an enucleated egg (an egg that has had its own nucleus removed). This process allows the somatic nucleus to be reprogrammed by the egg's",
               "rationale": "1. somatic cell nuclear transfer (SCNT), technique in which the nucleus of a somatic (body) cell is transferred to the cytoplasm of an enucleated egg (an egg that has had its own nucleus removed). Once inside the egg, the somatic nucleus is reprogrammed by egg cytoplasmic factors to become a zygote (fertilized egg) nucleus.\n2. Somatic cell nuclear transfer can create clones for both reproductive and therapeutic purposes. In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory strategy for creating a viable embryo from a body cell and an egg cell.The technique consists of taking a denucleated oocyte (egg cell) and implanting a donor nucleus from a somatic (body) cell.\n3. Somatic cell nuclear transfer (SCNT) is a procedure by which a nucleus from a fully differentiated cell (e.g., fibroblast) undergoes complete genetic reprogramming when it is introduced into an enucleated oocyte. The prime advantage of SCNT is the possibility of creating multiple genetically identical animals.\n4. Abstract. Somatic cell nuclear transfer (SCNT) has been an area of interest in the field of stem cell research and regenerative medicine for the past 20 years. The main biological goal of SCNT is to reverse the differentiated state of a somatic cell, for the purpose of creating blastocysts from which embryonic stem cells (ESCs) can be derived ...\n5. These dyes can have a detrimental effect on egg quality, especially from primates. This new technology uses birefringence to visualize the chromosomes, and the successful generation of primate and human somatic cell nuclear transfer (SCNT) embryos has been attributed, at least in part, to this technological breakthrough (see below).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What happens to reprogramming efficiency in SCNT experiments when H3K9me3 is removed?",
               "answer": "When H3K9me3 is removed in SCNT experiments, the reprogramming efficiency improves. Specifically, the removal of H3K9me1/2 by Kdm3a leads to a loss of H3K9me3, which is identified as a major epigenetic barrier for reprogram",
               "rationale": "1. Successful cloning of monkeys, the first non-human primate species, by somatic cell nuclear transfer (SCNT) attracted world-wide attention earlier this year. Remarkably, it has taken more than 20 years since the cloning of Dolly the Sheep in 1997 to achieve this feat. This success was largely due to recent understanding of epigenetic barriers ...\n2. Somatic cell nuclear transfer (SCNT) can be used to reprogram differentiated somatic cells to a totipotent state but has poor efficiency in supporting full-term development. H3K9me3 is considered ...\n3. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n4. Somatic cell nuclear transfer (SCNT) has broad applications but is limited by low cloning efficiency. ... H3K9me3 can be removed in donor somatic cells, but incomplete H3K9me3 demethylation in cloned embryos inhibits their development. ... Z., Meissner, A., Pollard, S., Smith, A., and Jaenisch, R. (2006). Reprogramming efficiency following ...\n5. Abstract. Mammalian oocytes can reprogram differentiated somatic cells into a totipotent state through somatic cell nuclear transfer (SCNT), which is known as cloning. Although many mammalian species have been successfully cloned, the majority of cloned embryos failed to develop to term, resulting in the overall cloning efficiency being still low.",
               "predicate": null
            }
         ],
         "row": 370,
         "id": 190480664778514188
      },
      {
         "claim": "Removal of H3K9me3 by ectopic expression of other H3K9 demethylases improves reprogramming efficiency in SCNT experiments.",
         "label": 1,
         "prediction": 1,
         "rationale": "Somatic cell nuclear transfer (SCNT) is a laboratory technique in which the nucleus of a somatic cell is transferred to the cytoplasm of an enucleated egg, allowing the somatic nucleus to be reprogrammed by the egg's cytoplasm. The provided evidence does not directly address whether the removal of H3K9me3 by ectopic expression of other H3K9 demethylases improves reprogramming efficiency in SCNT experiments. Reducing H3K9me3 levels improves reprogramming efficiency in SCNT experiments. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is SCNT?",
               "answer": "Somatic cell nuclear transfer (SCNT) is a laboratory technique in which the nucleus of a somatic (body) cell is transferred to the cytoplasm of an enucleated egg (an egg that has had its own nucleus removed). This process allows the somatic nucleus to be reprogrammed by the egg's",
               "rationale": "1. somatic cell nuclear transfer (SCNT), technique in which the nucleus of a somatic (body) cell is transferred to the cytoplasm of an enucleated egg (an egg that has had its own nucleus removed). Once inside the egg, the somatic nucleus is reprogrammed by egg cytoplasmic factors to become a zygote (fertilized egg) nucleus.\n2. Somatic cell nuclear transfer can create clones for both reproductive and therapeutic purposes. In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory strategy for creating a viable embryo from a body cell and an egg cell.The technique consists of taking a denucleated oocyte (egg cell) and implanting a donor nucleus from a somatic (body) cell.\n3. Somatic cell nuclear transfer (SCNT) is a procedure by which a nucleus from a fully differentiated cell (e.g., fibroblast) undergoes complete genetic reprogramming when it is introduced into an enucleated oocyte. The prime advantage of SCNT is the possibility of creating multiple genetically identical animals.\n4. Abstract. Somatic cell nuclear transfer (SCNT) has been an area of interest in the field of stem cell research and regenerative medicine for the past 20 years. The main biological goal of SCNT is to reverse the differentiated state of a somatic cell, for the purpose of creating blastocysts from which embryonic stem cells (ESCs) can be derived ...\n5. These dyes can have a detrimental effect on egg quality, especially from primates. This new technology uses birefringence to visualize the chromosomes, and the successful generation of primate and human somatic cell nuclear transfer (SCNT) embryos has been attributed, at least in part, to this technological breakthrough (see below).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does removal of H3K9me3 by ectopic expression of other H3K9 demethylases improve reprogramming efficiency in SCNT experiments?",
               "answer": "The provided evidence does not directly address whether the removal of H3K9me3 by ectopic expression of other H3K9 demethylases improves reprogramming efficiency in SCNT experiments. However, it does suggest that the reduction of H3K9me3 levels, particularly through the removal of H3",
               "rationale": "1. H3K9me3-dependent heterochromatin is a major barrier of cell fate changes that must be reprogrammed after fertilization. However, the molecular details of these events are lacking in early embryos.\n2. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n3. Derivation of iPSCs requires ectopic expression of defined ... can significantly improve developmental efficiency of SCNT ... a negative impact on NT reprogramming 41. H3K9me3, on the other hand ...\n4. Xu et al. profiled the genome-wide H3K9me3 distribution in human oocytes and early embryos. They found the function and mechanism of H3K9me3 modification on long terminal repeat (LTR) regulation and provide a detailed map of the sequential reprogramming of histone modifications in human pre-implantation embryo development.\n5. Upon cell activation Suv39h1 represses a set of stem cell-related memory genes, via deposition of H3K9me3, contributing to the generation of T cell effectors. Loss of Suv39h1 leads to defects in silencing of stem/memory genes suggesting that Suv39h1 establishes a reprogramming barrier on stem/memory genes expression.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the reduction of H3K9me3 levels improve reprogramming efficiency in SCNT experiments?",
               "answer": "Yes, the reduction of H3K9me3 levels improves reprogramming efficiency in SCNT experiments. Evidence from the snippets indicates that reducing H3K9me3, either through the removal of H3K9me1/2 or by knocking down specific methyltransferases, enhances the efficiency of reprogram",
               "rationale": "1. This is a ~5-fold greater increase than previously observed with ESCs using the same approach 26, suggesting that a greater reduction in H3K9me3 levels is beneficial for NT-mediated reprogramming ...\n2. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n3. Since H3K9me3 is normally erased by the 8-cell stage (Fig. 1A,B), the observed increase in H3K9me3 in both Chk1 and CHX experiments must not be caused by incomplete erasure of H3K9me3, but by precocious re-accumulation of H3K9me3. These experiments demonstrated that the slowing of the cell cycle is sufficient to induce H3K9me3 re-accumulation ...\n4. These findings suggested that H3K9me3 removal might be an effective strategy to enhance the efficiency of reprogramming. Indeed, knockdown of the SUV39H1/H2 methyltransferases, thereby reducing H3K9me3, causes a dramatic increase in the number and rate of appearance of human iPS colonies [32].\n5. The H3K9me3 level and RNA-seq read counts of all KD experiments were first normalized by the sequence depth and then compared with control experiments to identify LTRs with differential H3K9me3 ...",
               "predicate": null
            }
         ],
         "row": 371,
         "id": 920114876870885543
      },
      {
         "claim": "Removal of H3K9me3 improves reprogramming efficiency in human somatic cell nuclear transfer experiments.",
         "label": 1,
         "prediction": 1,
         "rationale": "H3K9me3 is an epigenetic modification of the histone protein H3, specifically indicating the tri-methylation at the 9th lysine residue, commonly associated with heterochromatin. The removal of H3K9me3 improves reprogramming efficiency in mouse SCNT embryos, suggesting it may also be a barrier to successful reprogramming in human somatic cells. Removal of H3K9me3 improves reprogramming efficiency in mouse somatic cell nuclear transfer experiments. Kdm3a removes H3K9me1/2. KDM3A improves reprogramming efficiency in mouse somatic cell nuclear transfer experiments. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is H3K9me3?",
               "answer": "H3K9me3 is an epigenetic modification of the histone protein H3, specifically indicating the tri-methylation at the 9th lysine residue. It is commonly associated with heterochromatin, which is a form of tightly packed DNA that is generally transcriptionally inactive. H3K",
               "rationale": "1. H3K9me3 is an epigenetic modification to the DNA packaging protein Histone H3. It is a mark that indicates the tri- methylation at the 9th lysine residue of the histone H3 protein and is often associated with heterochromatin .\n2. Whereas much of the cellular H3K9me2 and H3K9me3 marks repetitive or 'constitutive' heterochromatin, detailed analyses of tissue-specific H3K9 methylation patterns and transcriptomics in both ...\n3. The role of H3K9me3 within cells is still being explored and has proved to be multi-faceted and intricate in a wide-range of cellular processes, which consequently highlight an extended network of mechanisms which contribute to its accumulation and subsequent genomic stability.\n4. Trinucleotide-repeat-containing 18 (TNRC18), which has poorly understood functions, is now identified as an H3K9me3-specific reader that silences endogenous retroviruses.\n5. McCarthy, Kaeding et al. identify H3K9me3-heterochromatin proteins that repress heterochromatic genes with implications in hepatic reprogramming and show that ERH is key to global H3K9me3 ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does removal of H3K9me3 improve reprogramming efficiency in human somatic cell nuclear transfer experiments?",
               "answer": "The provided evidence does not specifically mention human somatic cell nuclear transfer (SCNT) experiments. However, it does indicate that the removal of H3K9me3 improves reprogramming efficiency in mouse SCNT embryos and suggests that H3K9me3 is a barrier to successful reprogramming in somatic",
               "rationale": "1. Developmental success following somatic cell nuclear transfer is greatly improved by ... These results demonstrate that H3K9me3 in somatic cells is a barrier for oocyte-mediated genomic reprogramming and removal of H3K9me3 by Kdm4d injection at very early stages of SCNT embryo development can significantly improve the overall efficiency of ...\n2. Somatic cell nuclear transfer (SCNT) can be used to reprogram differentiated somatic cells to a totipotent state but has poor efficiency in supporting full-term development. H3K9me3 is considered ...\n3. Successful cloning of monkeys, the first non-human primate species, by somatic cell nuclear transfer (SCNT) attracted world-wide attention earlier this year. Remarkably, it has taken more than 20 years since the cloning of Dolly the Sheep in 1997 to achieve this feat. This success was largely due to recent understanding of epigenetic barriers ...\n4. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n5. In addition to the natural reprogramming process through fertilization, totipotency can also be acquired through somatic cell nuclear transfer (SCNT). The low efficiency of SCNT is closely linked with the failure to remove H3K9me3 of the repetitive elements in the reprogramming-resistant regions (",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does removal of H3K9me3 improve reprogramming efficiency in mouse somatic cell nuclear transfer experiments?",
               "answer": "Yes, the removal of H3K9me3 improves reprogramming efficiency in mouse somatic cell nuclear transfer (SCNT) experiments. Evidence 1 indicates that the reduction of H3K9me3 levels, achieved through the removal of H3K9me1/2 by Kdm3a and",
               "rationale": "1. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n2. Removal of somatic histone H3 lysine 9 trimethylation (H3K9me3) from the embryonic genome can improve the efficiency of mammalian cloning using somatic cell nuclear transfer (SCNT). However, this strategy involves the injection of histone demethylase mRNA into embryos, which is limiting because of its invasive and labor-consuming nature.\n3. Somatic cell nuclear transfer (SCNT) can be used to reprogram differentiated somatic cells to a totipotent state but has poor efficiency in supporting full-term development. H3K9me3 is considered ...\n4. In addition to the natural reprogramming process through fertilization, totipotency can also be acquired through somatic cell nuclear transfer (SCNT). The low efficiency of SCNT is closely linked with the failure to remove H3K9me3 of the repetitive elements in the reprogramming-resistant regions (\n5. We also find that cell cycle slowing, toward the mid-blastula transition, permits increasing nuclear accumulation of H3K9me3 histone methyltransferase Setdb1, leading to the onset of H3K9me3 re-accumulation. We further demonstrate that cell cycle length in early development also governs H3K9me3 reprogramming in zebrafish and Xenopus laevis.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does Kdm3a remove H3K9me1/2?",
               "answer": "Yes, Kdm3a removes H3K9me1/2. Evidence 1 states that KDM3 subfamily members, including KDM3A, are involved in removing H3K9me1/2. Additionally, Evidence 2 indicates that KDM3A removes H3K9me",
               "rationale": "1. In addition, the KDM3 subfamily members, KDM3A and KDM3B, remove H3K9me1/2. Moreover, the KDM4 subfamily members, KDM4A-D, are involved in removing H3K9me2/3 and H3K36me2/3.\n2. KDM3A directly upregulates the expression of krüppel-like factor 2 (KLF2) and interferon regulatory factor 4 (IRF4), which are essential transcription factors for MM cell survival, by removing H3K9me1/me2 from their promoters.\n3. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n4. Importantly, KDM3A depletion elevated the basal level of H3K9me2 at both pS2 and GREB1 EREs and abrogated H3K9me1/2 demethylation following hormone stimulation at pS2 EREs, demonstrating that KDM3A is required to remove transcriptionally repressive marks at these loci (Figure 2C and D; Supplementary Figure S4B and C).\n5. Here we use a systematic approach to compare KDM3 subfamily members. We show that full-length KDM3A and KDM3B are H3K9me1/2 histone demethylases whereas we fail to observe histone demethylase activity for JMJD1C using immunocytochemical and biochemical approaches.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does KDM3A improve reprogramming efficiency in mouse somatic cell nuclear transfer experiments?",
               "answer": "Yes, KDM3A improves reprogramming efficiency in mouse somatic cell nuclear transfer (SCNT) experiments. The evidence indicates that the removal of H3K9me1/2 by Kdm3a can lead to a reduction in H3K9me3, which is a significant epigenetic",
               "rationale": "1. Matoba and colleagues revealed that the removal of H3K9me1/2 by Kdm3a could induce a loss of H3K9me3, a major epigenetic barrier for reprogramming, in mouse SCNT embryos. Simple treatment of SCNT embryos with inhibitors for H3K9me1/2 methyltransferase G9a, combined with HDAC inhibitor TSA, greatly reduced the H3K9me3 level, boosted ZGA, and improved the mouse cloning efficiency to >14%.\n2. Abstract. Mammalian oocytes can reprogram differentiated somatic cells into a totipotent state through somatic cell nuclear transfer (SCNT), which is known as cloning. Although many mammalian species have been successfully cloned, the majority of cloned embryos failed to develop to term, resulting in the overall cloning efficiency being still low.\n3. Radical manipulations, such as induced pluripotent stem cell (iPSC) derivation or somatic cell nuclear transfer (SCNT) cloning can artificially reprogram somatic cells 6.\n4. The expression pattern was similar to SOX2, suggesting that a similar interaction mechanism might exist in Epiblast. 51 Our results also reveal that the overexpression of KDM3A can significantly improve the proliferation and anti-apoptosis ability of pluripotent stem cells, but that of KDM3B leads to a decline in cell proliferation. The results ...\n5. Successful cloning of monkeys, the first non-human primate species, by somatic cell nuclear transfer (SCNT) attracted world-wide attention earlier this year. Remarkably, it has taken more than 20 years since the cloning of Dolly the Sheep in 1997 to achieve this feat. This success was largely due to recent understanding of epigenetic barriers ...",
               "predicate": null
            }
         ],
         "row": 372,
         "id": 251574259733507576
      },
      {
         "claim": "Replacement of histone H2A with H2A.Z accelerates gene activation in yeasts by destabilizing +1 nucleosomes.",
         "label": 1,
         "prediction": 1,
         "rationale": "Histone H2A in yeasts functions as a core component of nucleosomes, playing a critical role in the structural organization of chromatin and the regulation of gene expression. When histone H2A is replaced with H2A.Z in +1 nucleosomes in yeasts, this incorporation is mediated by the conserved SWR1 complex in an ATP-dependent manner. The replacement of histone H2A with H2A.Z may play a role in transcriptional control and gene regulation, but it is unclear if it accelerates gene activation in yeasts. The destabilization of +1 nucleosomes accelerates gene activation in yeasts. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of histone H2A in yeasts?",
               "answer": "Histone H2A in yeasts functions as a core component of nucleosomes, which are essential for the packaging of DNA into chromatin. It plays a critical role in the structural organization of chromatin and is involved in the regulation of gene expression. The variant H2A.Z, which is closely related to canonical",
               "rationale": "1. Histone H2A is one of the five main histone proteins involved in the structure of chromatin in eukaryotic ... Different functions of H2A.Z compared to H2A are correlated with genetic differences between H2A and the variant. Resistance to nucleosomes occurs in H2A.Z by binding to H1 factor. ... H2A.Z gene is an essential gene in yeast and it is ...\n2. Abstract. We discuss the regulation of the histone genes of the budding yeast Saccharomyces cerevisiae. These include genes encoding the major core histones (H3, H4, H2A, and H2B), histone H1 ( HHO1 ), H2AZ ( HTZ1 ), and centromeric H3 ( CSE4 ). Histone production is regulated during the cell cycle because the cell must replicate both its DNA ...\n3. The H2A.Z histone variant. H2A.Z has a protein sequence that is highly conserved across species, and it is expressed alongside canonical H2A in all organisms, including yeast and ciliates 5 ...\n4. Epigenetic changes involve histone proteins that function in the packaging of DNA and a series of DNA modifications [Citation 42]. Nucleosomes comprise four core histone proteins, H2A, H2B, H3 and H4, wrapped by 147 base pairs of genomic DNA. They are further packaged into higher-order chromatin structures to compact the genomic DNA into the ...\n5. In yeast, the Chz1 protein (chaperone for H2A.Z) has been identified as an H2A.Z-preferring histone chaperone, and was shown to deliver H2A.Z to SWR1 for H2A replacement in chromatin (Luk et al., 2007). Interestingly, although it does not have a preference for H2A.Z, NAP1 is also an important H2A.Z-binding chaperone.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What happens to +1 nucleosomes when histone H2A is replaced with H2A.Z in yeasts?",
               "answer": "When histone H2A is replaced with H2A.Z in +1 nucleosomes in yeasts, this incorporation is mediated by the conserved SWR1 complex in an ATP-dependent manner. The presence of H2A.Z at the +1 nucleosome is significant as it is commonly found at most eukary",
               "rationale": "1. Although canonical H2A is replaced by H2A.Z in the first nucleosome over the coding region (+1), the remaining nucleosomes may undergo H2A-H2B exchange, in which the existing dimer is replaced ...\n2. Histone variant H2A.Z-containing nucleosomes are incorporated at most eukaryotic promoters. This incorporation is mediated by the conserved SWR1 complex, which replaces histone H2A in canonical nucleosomes with H2A.Z in an ATP-dependent manner. Here, we show that promoter-proximal nucleosomes are highly heterogeneous for H2A.Z in Saccharomyces cerevisiae, with substantial representation of ...\n3. Tandem and divergent genes had equivalent incorporation of H2A.Z at the +1 nucleosome but divergent genes showed significantly more H2A.Z at the −1 nucleosome (Supplementary Figure S7B). Moreover, the −1 nucleosome at tandem genes was primarily a single peak and was not followed by a regularly spaced array of nucleosomes upstream.\n4. Chromatin is made up of nucleosomes, where each nucleosome core particle consists of ∼147 bp of DNA wrapped around an octamer of histone proteins. A canonical histone octamer contains two H2A-H2B dimers and one H3-H4 tetramer. H2A.Z is a well-conserved histone variant in eukaryotes and is essential for viability in metazoans. It is found at +1 nucleosomes next to transcription start sites ...\n5. The histone variant H2A.Z is involved in several processes such as transcriptional control, DNA repair, regulation of centromeric heterochromatin and, not surprisingly, is implicated in diseases such as cancer. Here, we review the recent developments on H2A.Z focusing on its role in transcriptional activation and repression. H2A.Z, as a replication-independent histone, has been studied in ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the replacement of histone H2A with H2A.Z accelerate gene activation in yeasts?",
               "answer": "The provided evidence does not explicitly state whether the replacement of histone H2A with H2A.Z accelerates gene activation in yeasts. However, it does indicate that H2A.Z plays a role in transcriptional control and is involved in various biological functions, including gene regulation. The mention of \"promoter",
               "rationale": "1. Abstract. Chromatin structure and underlying DNA accessibility is modulated by the incorporation of histone variants. H2A.Z, a variant of the H2A core histone family, plays a distinct and essential role in a diverse set of biological functions including gene regulation and maintenance of heterochromatin-euchromatin boundaries.\n2. Abstract. The histone variant H2A.Z is involved in several processes such as transcriptional control, DNA repair, regulation of centromeric heterochromatin and, not surprisingly, is implicated in diseases such as cancer. Here, we review the recent developments on H2A.Z focusing on its role in transcriptional activation and repression.\n3. The histone variant H2A.Z is involved in several processes such as transcriptional control, DNA repair, regulation of centromeric heterochromatin and, not surprisingly, is implicated in diseases such as cancer. Here, we review the recent developments on H2A.Z focusing on its role in transcriptional activation and repression. H2A.Z, as a replication-independent histone, has been studied in ...\n4. H2A.Z, a variant of the H2A core histone family, plays a distinct and essential role in a diverse set of biological functions including gene regulation and maintenance of heterochromatin-euchromatin boundaries. Although it is currently unclear how the replacement of H2A with H2A.Z can regulate gene expression, the variance in their amino acid ...\n5. Here, we show that promoter-proximal nucleosomes are highly heterogeneous for H2A.Z in Saccharomyces cerevisiae, with substantial representation of nucleosomes containing one, two, or zero H2A.Z molecules. SWR1-catalyzed H2A.Z replacement in vitro occurs in a stepwise and unidirectional fashion, one H2A.Z-H2B dimer at a time, producing ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does the destabilization of +1 nucleosomes accelerate gene activation in yeasts?",
               "answer": "Yes, the destabilization of +1 nucleosomes can accelerate gene activation in yeasts. Evidence suggests that during gene activation, nucleosome ejection occurs, particularly at active genes or those poised for activation, where specific histone variants replace standard histones. This process is linked to the positioning and modifications of nucleosomes,",
               "rationale": "1. Nucleosome ejection during gene activation has been studied for some time at model target genes in Saccharomyces spp. 118,119,120,121,122,123,124,125 and other organisms 126. For example, during ...\n2. Eukaryotic nuclear DNA is packaged into nucleosomes. During the past decade, genome-wide nucleosome mapping across species revealed the high degree of order in nucleosome positioning. There is a conserved stereotypical nucleosome organization around transcription start sites (TSSs) with a nucleosome-depleted region (NDR) upstream of the TSS and a TSS-aligned regular array of evenly spaced ...\n3. Nucleosome, composed of a 147-bp segment of DNA helix wrapped around a histone protein octamer, serves as the basic unit of chromatin. Nucleosome positioning refers to the relative position of DNA double helix with respect to the histone octamer. The positioning has an important role in transcription, DNA replication and other DNA transactions since packing DNA into nucleosomes occludes the ...\n4. At active genes or at genes that are poised for activation, histones H2A and H3 are replaced by the histone variants H2A.Z and H3.3 (see REFS 3, 4 for reviews of histone variants). Beyond the nucleosome core is the linker histone, H1. Nucleosomes are arranged as a linear array along the DNA polymer as 'beads on a string'.\n5. Transcription initiation and the +1 nucleosome. Gene promoters, characterized by a nucleosome-depleted region, are bordered by the upstream −1 and downstream +1 nucleosomes [22]. Each nucleosome in the gene body is numbered consecutively (i.e., +1, +2, etc). The +1 nucleosome carries a distinct set of post-translational modifications and ...",
               "predicate": null
            }
         ],
         "row": 373,
         "id": 228910664254509060
      },
      {
         "claim": "Repressing IL-18 has negative effects on atherosclerotic lesion composition and progression.",
         "label": 0,
         "prediction": 1,
         "rationale": "IL-18, also known as interferon-gamma inducing factor, is a proinflammatory cytokine encoded by the IL18 gene in humans, synthesized as an inactive precursor that is activated by caspase-1. Repressing IL-18 may impact atherosclerotic lesion composition and progression, given its significant role in the pathogenesis of atherosclerosis, particularly in relation to plaque instability and rupture. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is IL-18?",
               "answer": "IL-18, also known as interferon-gamma inducing factor, is a proinflammatory cytokine encoded by the IL18 gene in humans. It is a member of the IL-1 family and is synthesized as an inactive precursor (pro-IL-18), which is activated by caspase-1.",
               "rationale": "1. Interleukin-18 (IL-18), also known as interferon-gamma inducing factor is a protein which in humans is encoded by the IL18 gene. The protein encoded by this gene is a proinflammatory cytokine. Many cell types, both hematopoietic cells and non-hematopoietic cells, have the potential to produce IL-18.\n2. Interleukin (IL)-18 is a potent inflammatory cytokine of the IL-1 family. It is synthesized as an inactive precursor (pro-IL-18), which is cleaved into its functionally active form by caspase-1. Resident cells of the CNS express IL-18 and caspase-1 constitutively, thus providing a local IL-18-dependent immune response.\n3. Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic and non-hematopoietic cells, including monocytes, macrophages, keratinocytes and mesenchymal cell. IL-18 could potentially induce inflammatory and ...\n4. Abstract. Initially described as an interferon (IFN)γ-inducing factor, interleukin (IL)-18 is indeed involved in Th1 and NK cell activation, but also in Th2, IL-17-producing γδ T cells and macrophage activation. IL-18, a member of the IL-1 family, is similar to IL-1β for being processed by caspase 1 to an 18 kDa-biologically active mature form.\n5. IL-18 is an IL-1 family cytokine with potent ability to induce IFNγ production. However, basic investigations and now clinical observations suggest a more complex picture. Unique aspects of IL-18 ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What are the effects of repressing IL-18 on atherosclerotic lesion composition and progression?",
               "answer": "The provided evidence suggests that Interleukin-18 (IL-18) plays a significant role in the pathogenesis of atherosclerosis, particularly in relation to plaque instability and rupture. While the snippets do not directly address the effects of repressing IL-18, they imply that IL-18 is involved in the inflammatory",
               "rationale": "1. Atherosclerosis is the leading cause of mortality in industrialized countries and carries an important socioeconomic burden. Unabated inflammatory mechanisms are responsible for changes in atherosclerotic plaque composition leading to plaque disruption and to the occurrence of acute ischemic syndromes, namely myocardial infarction and stroke. 1 Interleukin (IL)-18 is an inducer of interferon ...\n2. To examine the role of IL-18 in atherosclerosis, we determined the relation between IL-18 mRNA expression and signs of plaque instability using real-time quantitative PCR. ... plaques 17,18 and have been implicated in the immunoinflammatory response that determines both the size and the composition of the atherosclerotic lesion in animal models ...\n3. There is growing evidence on the role of innate and adaptive immunity in the pathogenesis of atherosclerosis. Interleukin-18 is one of the novel proinflammatory cytokines involved in atherogenesis, atherosclerotic plaque instability and plaque rupture. In this review, we overview the findings of preclinical and clinical studies about the role ...\n4. A possible effect of hypokalemia on atherosclerosis remains unknown. ... To characterize atherosclerotic lesion composition, ... Jawien, J. & Zhou, X. IL-18 accelerates atherosclerosis accompanied ...\n5. Atherosclerosis is a disease of the large and medium arteries, characterized by lipid-laden inflammatory lesions in the vessel wall. 1-3 It has been found that atherosclerotic lesions of all stages contain significant amounts of macrophages and activated T cells that express cytokines. 1,4,5 Interferon (IFN)-γ has been proposed to be a key cytokine in atherogenesis. 2,4,5 IFN-γ activates ...",
               "predicate": null
            }
         ],
         "row": 374,
         "id": 336416144832405563
      },
      {
         "claim": "Retinoic acid receptor-related orphan receptor gamma (RORγ) is a therapeutic target for castration-resistant prostate cancer (CRPC)",
         "label": 1,
         "prediction": 1,
         "rationale": "RORγ is a protein encoded by the RORC gene in humans, and it is a member of the nuclear receptor family of transcription factors that regulates cholesterol metabolism, particularly in triple negative breast cancer (TNBC). RORγ is a therapeutic target for castration-resistant prostate cancer (CRPC). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is RORγ?",
               "answer": "RORγ is a protein encoded by the RORC gene in humans, and it is a member of the nuclear receptor family of transcription factors. It has been identified as a novel master regulator of cholesterol metabolism, particularly in triple negative breast cancer (TNBC).",
               "rationale": "1. RAR-related orphan receptor gamma ( RORγ) is a protein that in humans is encoded by the RORC ( RAR -related orphan receptor C) gene. [5] RORγ is a member of the nuclear receptor family of transcription factors.\n2. Here the authors identify the nuclear receptor RORγ as a novel master regulator of cholesterol metabolism in triple negative breast cancer (TNBC) and find that RORγ small-molecule antagonists ...\n3. Currently, it is unclear to what extent the physical and functional interplays between RORγ and SREBP2 operate in other cancer types or normal tissues. Recent studies in this laboratory confirmed a crucial role of RORγ in control of several genes in cholesterol biosynthesis program in prostate cancer cells.\n4. The discovery that Th17-dependent inflammation is significantly attenuated in RORγ-deficient mice in several experimental autoimmune disease models, initiated a search for ROR modulators that led to the identification of a number of small molecular weight RORγ inverse agonists.\n5. RORγ antagonists cause tumor regression in patient-derived xenografts and immune-intact models. Their combination with cholesterol-lowering statins elicits superior anti-tumor synergy selectively in TNBC. Together, our study uncovers a master regulator of the cholesterol-biosynthesis program and an attractive target for TNBC.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is RORγ a therapeutic target for castration-resistant prostate cancer (CRPC)?",
               "answer": "Yes, RORγ is a therapeutic target for castration-resistant prostate cancer (CRPC). The evidence indicates that ROR-γ drives androgen receptor expression and has been established as a novel therapeutic target for CRPC, with studies showing that it can inhibit cell survival and induce apoptosis in CRPC cells.",
               "rationale": "1. The androgen receptor (AR) is overexpressed and hyperactivated in human castration-resistant prostate cancer (CRPC). However, the determinants of AR overexpression in CRPC are poorly defined. ... ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer Nat Med. 2016 May;22(5):488-96 ...\n2. Prostate cancer (PCa) patients who progress to metastatic castration-resistant PCa (mCRPC) mostly have poor outcomes due to the lack of effective therapies. Our recent study established the orphan nuclear receptor ROR γ as a novel therapeutic target for CRPC. Here, we reveal that elaiophylin (Elai), an antibiotic from Actinomycete streptomyces ...\n3. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Junjian Wang 1, June X Zou 1, Xiaoqian Xue 2, Demin Cai 1, Yan Zhang 2 ...\n4. Our recent study established the orphan nuclear receptor RORγ as a novel therapeutic target for CRPC. ... Elai inhibits castration-resistant prostate cancer (CRPC) cell survival and induces their apoptosis. To search for drug candidates for the treatment of human CRPC, we screened a chemical library, which contains 500 marine natural compounds ...\n5. However, the emergence of castration-resistant prostate cancer (CRPC) underscores a significant shortfall in these strategies, highlighting the urgent need for novel therapeutic targets that can ...",
               "predicate": null
            }
         ],
         "row": 375,
         "id": 315654082743681162
      },
      {
         "claim": "Rhythmic expression of Cry1 translates directly into a circadian regulation of cAMP signaling in gluconeogenesis.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cry1 encodes the CRY1 protein, a mammalian circadian photoreceptor and transcriptional coregulator associated with the circadian clock, regulating circadian rhythms and DNA repair. Cry1 is involved in the regulation of cAMP signaling in gluconeogenesis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Cry1?",
               "answer": "Cry1 encodes the CRY1 protein, which is a mammalian circadian photoreceptor and a transcriptional coregulator associated with the circadian clock. It plays a role in regulating circadian rhythms, is hormone-regulated, and has been identified as a tumor-specific regulator of DNA repair, particularly in",
               "rationale": "1. Cry1 encodes the CRY1 protein which is a mammalian circadian photoreceptor. In mice, Cry1 expression displays circadian rhythms in the suprachiasmatic nucleus, a brain region involved in the generation of circadian rhythms, with mRNA levels peaking during the light phase and reaching a minimum in the dark.\n2. Cryptochrome 1 (CRY1) is a transcriptional coregulator associated with the circadian clock. Here the authors reveal that CRY1 is hormone-regulated, stabilized by genomic insult, and promotes DNA ...\n3. Here, the circadian factor CRY1, an evolutionally conserved transcriptional coregulator, is identified as a tumor specific regulator of DNA repair. Key findings demonstrate that CRY1 expression is androgen-responsive and associates with poor outcome in prostate cancer. Functional studies and first-in-field mapping of the CRY1 cistrome and ...\n4. Cry1 knockdown reduces in vitro period but heterozygote Cry1 −/+ mice do not demonstrate a circadian impairment in behavior . Our metabolomics results highlighted the physiologic importance of this interaction. The reduction of CRY1 alters one carbon and amino acid metabolism, metabolic reactions that are central to life.\n5. The CRY1 PHR region does not have this DNA-binding groove (Figure 2a), indicating that it may not bind DNA directly. Second, the surface of CRY1 PHR is predominantly negatively charged, except for a small concentration of positive charges near the FAD-access cavity .",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Cry1 involved in the regulation of cAMP signaling in gluconeogenesis?",
               "answer": "Yes, Cry1 is involved in the regulation of cAMP signaling in gluconeogenesis. The evidence indicates that Cry1 overexpression lowers glucose levels, suggesting a functional effect on hepatic gluconeogenesis. Additionally, it is mentioned that CRY inhibits glucagon-stimulated cAMP production, which points to its role in",
               "rationale": "1. Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated by the circadian clock, which coordinates glucose metabolism with changes in the external environment. Circadian control of gene expression is achieved by two transcriptional activators, Clock and Bmal1, which stimulate cryptochrome (Cry1 and Cry2) and ...\n2. Pointing to a functional effect on hepatic gluconeogenesis, Cry1 overexpression also lowered glucose ... Schematic diagram indicating that the circadian regulation of cAMP signaling in liver is ...\n3. Fasting signal induces gluconeogenesis program through activation of cAMP/CREB signaling (red box). Zhang et al. 1 found that CRY inhibits glucagon-stimulated cAMP production possibly through ...\n4. During fasting, mammals maintain glucose homeostasis by stimulating hepatic gluconeogenesis 1. Elevations in circulating glucagon (GLU) and epinephrine trigger the cAMP mediated phosphorylation of Creb and dephosphorylation of the Creb coactivator Crtc2 2. Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated ...\n5. between Creb signaling and clock regulation, we plotted the distri- bution of the Creb-targeted CCGs according to the circadian time- points of their peak expression.",
               "predicate": null
            }
         ],
         "row": 376,
         "id": 293009840256628647
      },
      {
         "claim": "Rhythmic expression of Cry1 translates directly into a circadian regulation of cAMP signaling in hepatic glucose metabolism.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cry1, or Cryptochrome 1, is a gene that encodes a protein functioning as a mammalian circadian photoreceptor and transcriptional coregulator associated with the circadian clock, regulating circadian rhythms, involved in DNA repair, and identified as a tumor suppressor. CRY1 is involved in the regulation of hepatic glucose metabolism. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Cry1?",
               "answer": "Cry1, or Cryptochrome 1, is a gene that encodes a protein functioning as a mammalian circadian photoreceptor and transcriptional coregulator associated with the circadian clock. It plays a role in regulating circadian rhythms, is involved in DNA repair, and has been identified as a tumor",
               "rationale": "1. Cry1 encodes the CRY1 protein which is a mammalian circadian photoreceptor. In mice, Cry1 expression displays circadian rhythms in the suprachiasmatic nucleus, a brain region involved in the generation of circadian rhythms, with mRNA levels peaking during the light phase and reaching a minimum in the dark.\n2. Cryptochrome 1 (CRY1) is a transcriptional coregulator associated with the circadian clock. Here the authors reveal that CRY1 is hormone-regulated, stabilized by genomic insult, and promotes DNA ...\n3. Here, the circadian factor CRY1, an evolutionally conserved transcriptional coregulator, is identified as a tumor specific regulator of DNA repair. Key findings demonstrate that CRY1 expression is androgen-responsive and associates with poor outcome in prostate cancer. Functional studies and first-in-field mapping of the CRY1 cistrome and ...\n4. In summary, Cry1 was characterized as a tumor suppressor and exerted its tumor suppressive activity through activation of Akt/P53/p21signaling in human osteosarcoma cells. Cry1 may serve as a prognostic predictor for osteosarcoma patients, and the Cry1-Akt axis is a potential therapeutic target for treating osteosarcoma.\n5. Cry1 knockdown reduces in vitro period but heterozygote Cry1 −/+ mice do not demonstrate a circadian impairment in behavior . Our metabolomics results highlighted the physiologic importance of this interaction. The reduction of CRY1 alters one carbon and amino acid metabolism, metabolic reactions that are central to life.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Cry1 involved in the regulation of hepatic glucose metabolism?",
               "answer": "Yes, CRY1 is involved in the regulation of hepatic glucose metabolism. The evidence indicates that CRY1 is activated by insulin-induced SREBP1c and plays a role in decreasing hepatic gluconeogenesis through the degradation of FOXO1. Additionally, the data suggest that the stability of CRY1 is crucial",
               "rationale": "1. On the other hand, SREBP1c has been proposed to be involved in the regulation of hepatic glucose metabolism. SREBP1c is a basic-helix-loop-helix-leucine zipper (bHLH-LZ) transcription factor that regulates de novo lipogenesis 13,14,15,16,17. Activation of SREBP1c is mediated by AKT and mTORC1 on insulin signalling 18,19.\n2. Here we show that CRY1 is activated by insulin-induced SREBP1c and decreases hepatic gluconeogenesis through FOXO1 degradation, at least, at specific circadian time points. SREBP1c(-/-) and CRY1(-/-) mice show higher blood glucose than wild-type (WT) mice in pyruvate tolerance tests, accompanied with enhanced expression of PEPCK and G6Pase genes.\n3. Accordingly, in diabetic mice, GSK3β inhibitors effectively decreased HGP by facilitating the effect of CRY1-mediated FOXO1 degradation on glucose metabolism. Collectively, these data suggest that tight regulation of hepatic CRY1 protein stability is crucial for maintaining systemic glucose homeostasis.\n4. Although SREBP1c appears to be involved in suppression of hepatic gluconeogenesis, the ... in the regulation of hepatic glucose metabolism. SREBP1c is a ... CRY1 could repress hepatic glucose ...\n5. Since the liver clock is regulated by nutrients, insulin, and glucagon, and since glucagon activates autophagy (. Deter and De Duve, 1967. ), we considered the possibility that autophagy, regulation of liver clock, and glucose metabolism are interlinked. Autophagy degrades cytoplasmic contents in lysosomes (.",
               "predicate": null
            }
         ],
         "row": 377,
         "id": 236028825638884518
      },
      {
         "claim": "Ribosomopathies have a high degree of cell and tissue specific pathology.",
         "label": 1,
         "prediction": 1,
         "rationale": "Ribosomopathies are a group of diseases caused by abnormalities in the structure or function of ribosomal component proteins or rRNA genes, as well as other genes involved in ribosome biogenesis, resulting from defects in ribosome biogenesis, assembly, and function. Ribosomopathies have cell and tissue specific pathology. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are ribosomopathies?",
               "answer": "Ribosomopathies are a group of diseases caused by abnormalities in the structure or function of ribosomal component proteins or rRNA genes, as well as other genes involved in ribosome biogenesis. These disorders result from defects in ribosome biogenesis, assembly, and function, leading to specific clinical phenotypes.",
               "rationale": "1. Ribosomopathies are diseases caused by abnormalities in the structure or function of ribosomal component proteins or rRNA genes, or other genes whose products are involved in ribosome biogenesis.\n2. Defects in ribosome biogenesis, assembly, and function of individual ribosomes are termed ribosomopathies. This article explains more about these tissue-specific phenotypic abnormalities that ...\n3. Ribosomopathies are diseases caused by alterations in the structure or function of ribosomal components. Progress in our understanding of the role of the ribosome in translational and transcriptional regulation has clarified the mechanisms of the ribosomopathies ...\n4. Ribosomopathies compose a collection of disorders in which genetic abnormalities cause impaired ribosome biogenesis and function, resulting in specific clinical phenotypes. Congenital mutations in RPS19 and other genes encoding ribosomal proteins cause Diamond-Blackfan anemia, a disorder characterized by hypoplastic, macrocytic anemia.\n5. Ribosomopathies are a group of rare diseases in which genetic mutations cause defects in either ribosome biogenesis or function, given specific phenotypes. Ribosomal proteins, and multiple other factors that are necessary for ribosome biogenesis (rRNA ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do ribosomopathies have cell and tissue specific pathology?",
               "answer": "Yes, ribosomopathies have cell and tissue specific pathology. The evidence indicates that although ribosome biogenesis occurs in all cells, certain mutations in ribosomal proteins can lead to specific defects in particular tissues. This tissue specificity is highlighted in the descriptions of ribosomopathies and their associated clinical phenotypes.",
               "rationale": "1. Ribosomopathies are a diverse subset of diseases caused by reduced expression of or mutations in factors necessary for making ribosomes, the protein translation machinery in the cell. Despite a ubiquitous need for ribosomes in all cell types, ribosomopathies manifest with tissue specific defects and sometimes increased cancer susceptibility ...\n2. Ribosomopathy Phenotypes. Although ribosome biogenesis is a global process that occurs in all cells, a growing body of literature has revealed that certain mutations in ribosomal proteins (RPs) can result in tissue specific defects. A summary of identified human ribosomal gene mutations, and existing animal models, presented in Table 1, shows ...\n3. Ribosomopathies are a diverse subset of diseases caused by reduced expression of, or mutations in, factors necessary for making ribosomes, the protein translation machinery in the cell. Despite the ubiquitous need for ribosomes in all cell types, ribosomopathies manifest with tissue-specific defects and sometimes increased cancer susceptibility, but few treatments target the underlying cause.\n4. Explaining the tissue-specificity of ribosomopathies is also challenging and will expand the possibilities of proposing target therapy associated with specific drug delivery to the affected tissue. In the past few years, studies on ribosomopathies have refocused on the crucial role played by ribosome function in cell biology [ 144 ].\n5. Abstract. Ribosomopathies compose a collection of disorders in which genetic abnormalities cause impaired ribosome biogenesis and function, resulting in specific clinical phenotypes. Congenital mutations in RPS19 and other genes encoding ribosomal proteins cause Diamond-Blackfan anemia, a disorder characterized by hypoplastic, macrocytic anemia.",
               "predicate": null
            }
         ],
         "row": 378,
         "id": 311658525361926044
      },
      {
         "claim": "Risedronate increases risk of vertebral and non-vertebral fractures.",
         "label": 0,
         "prediction": 0,
         "rationale": "Risedronate is a prescription medication that belongs to the class of drugs known as bisphosphonates, used to treat and prevent osteoporosis and Paget's disease of bone by slowing down bone loss. Risedronate does not increase the risk of fractures, but rather helps to reduce the risk of fractures in people with osteoporosis and other bone conditions. Risedronate reduces the risk of non-vertebral fractures and has been shown to significantly reduce the risk of both vertebral and non-vertebral fractures. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Risedronate?",
               "answer": "Risedronate is a prescription medication that belongs to the class of drugs known as bisphosphonates. It is used to treat and prevent osteoporosis, particularly in postmenopausal women and men, as well as to treat Paget's disease of bone. Risedronate works by slowing down bone loss",
               "rationale": "1. Risedronate is a bisphosphonate medicine that treats osteoporosis and Paget's disease of bone. It can cause serious problems in the stomach or esophagus, and should be taken with plain water and in an upright position.\n2. What is risedronate used for? Risedronate is commonly used for the following conditions. Treatment or prevention of osteoporosis in women after menopause.Osteoporosis is a condition in which your ...\n3. Risedronate strengthens bones by slowing down bone loss and allowing osteoblasts (bone-building cells) to work more effectively, improving bone mass. Risedronate belongs to the class of medicines known as bisphosphonates. 2. Upsides. Risedronate is used in the treatment and prevention of osteoporosis in postmenopausal women and men.\n4. Risedronate is a prescription drug that belongs to a class of drugs called bisphosphonates. It's used to prevent or treat osteoporosis and Paget's disease of bone. Learn about its side effects, interactions, warnings, and how to take it safely.\n5. Food and beverages (eg, mineral water, coffee, tea, or juice) will decrease the amount of risedronate absorbed by the body. Waiting longer than 30 minutes will allow more of the drug to be absorbed. Medicines such as antacids that contain calcium or calcium supplements also will decrease the absorption of risedronate. Swallow the regular tablet ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Risedronate increase the risk of fractures?",
               "answer": "No, Risedronate does not increase the risk of fractures. In fact, it helps to reduce the risk of fractures in people with osteoporosis and other bone conditions. The evidence indicates that the incidence of hip fractures among women taking Risedronate was lower compared to those on placebo, and it does not appear to",
               "rationale": "1. Actonel Vertebral Efficacy with Risedronate Therapy—Multinational Trial (VERT-MN) extension; Up to five years of treatment, bisphosphonates did help reduce fracture risk. Beyond that period, their benefits seemed to taper off. People in these studies who continued taking bisphosphonates for six years or more had fracture rates of 9.3% to 10.6%.\n2. Risedronate helps to reduce the risk of fracture in people with osteoporosis and some other bone conditions. Dosage instructions, including remaining upright for at least 30 minutes and taking with a full glass of water, must be strictly followed. The optimal length of therapy remains unknown. 5. Tips. Take risedronate exactly as directed by ...\n3. Overall, the incidence of hip fracture among all the women assigned to risedronate was 2.8 percent, as compared with 3.9 percent among those assigned to placebo (relative risk, 0.7; 95 percent ...\n4. We are uncertain on whether risedronate 5mg/day reduces clinical vertebral and wrist fractures. Compared to placebo, risedronate probably does not increase the risk of serious adverse events. For primary prevention, the benefit and harms of risedronate were supported by limited evidence with high uncertainty.\n5. In VERT-NA the significant anti-fracture efficacy was demonstrated the first year in a population at high risk (i.e. patients with at least 2 or more vertebral fractures): the risk reduction was 74%. Risedronate has also been shown to significantly reduce the risk of nonvertebral fractures by 39% (p = 0.02) after 3 years in VERT-NA.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does Risedronate reduce the risk of vertebral and non-vertebral fractures?",
               "answer": "Yes, Risedronate reduces the risk of non-vertebral fractures and has been shown to significantly reduce the risk of both vertebral and non-vertebral fractures in some studies. However, there is uncertainty regarding its effectiveness in reducing clinical vertebral and wrist fractures specifically.",
               "rationale": "1. This update recaps the key findings from our previous review that, for secondary prevention, risedronate 5 mg/day probably prevents non‐vertebral fracture, and may reduce the risk of hip fractures. We are uncertain on whether risedronate 5mg/day reduces clinical vertebral and wrist fractures.\n2. This update recaps the key findings from our previous review that, for secondary prevention, risedronate 5 mg/day probably prevents non-vertebral fracture, and may reduce the risk of hip fractures. We are uncertain on whether risedronate 5mg/day reduces clinical vertebral and wrist fractures. Compar …\n3. Risedronate is the only bisphosphonate that has been shown to reduce significantly the risk of both vertebral and non vertebral fractures in 6 months of therapy ( 13, 14 ).\n4. This update recaps the key findings from our previous review that, for secondary prevention, risedronate 5 mg/day probably prevents non-vertebral fracture, and may reduce the risk of hip fractures. We are uncertain on whether risedronate 5mg/day reduces clinical vertebral and wrist fractures. Compared to placebo, risedronate probably does not increase the risk of serious adverse events.\n5. Risedronate (Actonel, Procter & Gamble, Cincinnati), a pyridinyl bisphosphonate, decreases the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. 14,15 We ...",
               "predicate": null
            }
         ],
         "row": 379,
         "id": 644943175339863495
      },
      {
         "claim": "Risk of cardiovascular events can be cut by a third by using antihypertensive drug therapy among hemodialysis patients.",
         "label": 1,
         "prediction": 0,
         "rationale": "Antihypertensive drug therapy reduces all-cause mortality and cardiovascular events, with evening dosing associated with a significant reduction in ambulatory blood pressure and a lower risk of major adverse cardiac events. The provided evidence does not specifically address whether antihypertensive drug therapy cuts the risk of cardiovascular events by a third among hemodialysis patients. The percentage reduction in cardiovascular events associated with antihypertensive drug therapy among hemodialysis patients is not specified. Antihypertensive drug therapy among hemodialysis patients is associated with a 29% reduction in cardiovascular events. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of antihypertensive drug therapy on cardiovascular events?",
               "answer": "Antihypertensive drug therapy, particularly when administered as a single-pill combination, has been shown to reduce all-cause mortality and cardiovascular events. Additionally, evening dosing of antihypertensive medications is associated with a significant reduction in ambulatory blood pressure and a numerically lower risk of major adverse cardiac events, cardiovascular",
               "rationale": "1. Conclusions: Antihypertensive combination therapy reduces all-cause mortality and cardiovascular events when provided as single pill compared to identical drugs as multipills. This strongly supports the European Society of Cardiology/European Society of Hypertension and International Society of Hypertension guidelines recommending the use of a single-pill combination and thus should be more ...\n2. This systematic review and meta-analysis of 72 randomized controlled trials evaluated the effect of antihypertensive drugs morning versus evening dosing and showed significant reduction of ambulatory blood pressure (BP) and numerically lower risk of major adverse cardiac event, cardiovascular mortality, all-cause mortality, and heart failure in patients randomized to evening dosing when ...\n3. Evidence-to-decision considerations The value of antihypertensive therapy is well accepted by most patients, health care providers, health systems, professional societies and government agencies. From a patient's perspective, preventing cardiovascular events is highly valued.\n4. Objectives: Describe the guidelines for using antihypertensive medications and guide the treatment choices for first-line treatment. Review the different anti-hypertensive medication classes, summarizing the guidelines for the indication to use combination treatment when mono-therapy fails. Outline the significant side effects of each class of antihypertensive medications. Identify the ...\n5. This study evaluated the effects of initial versus delayed treatment with a drug combination on blood pressure (BP) control and the risk of cardiovascular (CV) events in hypertensive patients. Clinical trials suggest that the time to BP control is an important determinant of long-term outcomes, but real-world evidence is scarce. Using electronic medical charts (2005-2009), we retrospectively ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does antihypertensive drug therapy cut the risk of cardiovascular events by a third among hemodialysis patients?",
               "answer": "The provided evidence does not specifically address whether antihypertensive drug therapy cuts the risk of cardiovascular events by a third among hemodialysis patients. While it mentions that patients on long-term dialysis receiving antihypertensive therapy were included in a meta-analysis assessing cardiovascular events and all-cause mortality, it does not provide",
               "rationale": "1. Conclusions: Antihypertensive combination therapy reduces all-cause mortality and cardiovascular events when provided as single pill compared to identical drugs as multipills. This strongly supports the European Society of Cardiology/European Society of Hypertension and International Society of Hypertension guidelines recommending the use of a single-pill combination and thus should be more ...\n2. SPRINT therefore contributed to answering the second of the questions by showing that antihypertensive treatment achieving low values of SBP was still associated with a consistent reduction of cardiovascular events, although at the expense of some increase in serious adverse events.\n3. Blood-pressure-lowering therapy with antihypertensive drugs can reduce the risk of cardiovascular morbidity and mortality in patients with hypertension.\n4. Importance: Antihypertension medications have been associated with prevention of cardiovascular events, although less is known about the comparative effectiveness of different medication classes. Objective: To compare contemporary aggregated first-in-trial cardiovascular events among patients with hypertension and no substantial comorbidities.\n5. Patients on long-term dialysis participating in randomized, controlled trials and receiving antihypertensive drug therapy were the subject of this meta-analysis. Outcomes assessed were the hazard ratio of cardiovascular events and all-cause mortality in treated group compared with controls.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What percentage reduction in cardiovascular events is associated with antihypertensive drug therapy among hemodialysis patients?",
               "answer": "The provided evidence snippets do not specifically mention the percentage reduction in cardiovascular events associated with antihypertensive drug therapy among hemodialysis patients. Therefore, I cannot provide a specific percentage based on the information given.",
               "rationale": "1. Arterial hypertension, the number one risk factor for the leading cause of mortality worldwide, can be effectively treated by lifestyle changes and antihypertensive medication. 1,2 Every 5 mm Hg reduction in systolic blood pressure (BP) substantially reduces the incidence of major cardiovascular disease events, stroke, heart failure, and all-cause mortality. 3,4 However, in most European ...\n2. Similarly, intensive management of LDL is associated with significant reduction of cardiovascular events in patients with PAD. 50 ... Combination antihypertensive drug therapy is typically needed to achieve and to sustain effective long-term BP control. ... MI, or coronary artery revascularization. Forty-six percent of patients were ...\n3. The anticipated harms were mostly not serious side-effects, and some were a surrogate outcome, such as rise in creatinine that may not be clinically relevant. On average, treatment was associated with a reduction in deaths and cardiovascular events that ranged from 5 to 10/1000 and harms that ranged from 20 to 30/1000.\n4. Multiple studies have shown, and all major guidelines consistently recommend, that overall, the magnitude of BP reduction and not the use of a specific group of antihypertensive medication class is the major determinant of reducing adverse cardiovascular events. The use of multiple drug therapy as the initial approach and strategies that can ...\n5. Importance: Antihypertension medications have been associated with prevention of cardiovascular events, although less is known about the comparative effectiveness of different medication classes. Objective: To compare contemporary aggregated first-in-trial cardiovascular events among patients with hypertension and no substantial comorbidities.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What percentage reduction in cardiovascular events is associated with antihypertensive drug therapy among hemodialysis patients?",
               "answer": "The percentage reduction in cardiovascular events associated with antihypertensive drug therapy among hemodialysis patients is 29%.",
               "rationale": "1. In a meta-analysis of randomized controlled trials of antihypertensive therapy in hemodialysis patients, blood pressure lowering treatment was associated with a 29% lower relative risk of cardiovascular events, a 29% lower relative risk of cardiovascular mortality and a 20% lower relative risk of all-cause mortality ( 8 ).\n2. Arterial hypertension, the number one risk factor for the leading cause of mortality worldwide, can be effectively treated by lifestyle changes and antihypertensive medication. 1,2 Every 5 mm Hg reduction in systolic blood pressure (BP) substantially reduces the incidence of major cardiovascular disease events, stroke, heart failure, and all-cause mortality. 3,4 However, in most European ...\n3. Epidemiological studies demonstrate that a lower blood pressure and decline in blood pressure over months or years are associated with higher mortality in dialysis patients. In contrast, randomized, controlled trials lack power to establish benefits of antihypertensive therapy. Patients on long-term dialysis participating in randomized, controlled trials and receiving antihypertensive drug ...\n4. Hypertension is the most common chronic disease among adults in the United States. 1 According to data from the 2015 to 2018 National Health and Nutrition Examination Survey (NHANES), 47% of the US adult population (116 million people) had hypertension, defined as a blood pressure (BP) >130/80 mm Hg. 2 Hypertension increases the risk of stroke and heart disease, which are the leading causes of ...\n5. Key Points. Question Which classes of antihypertension medications are reported to be associated with reductions in first-in-trial cardiovascular events?. Findings In this systematic review and network meta-analysis of 46 randomized clinical trials that performed direct comparisons of individual antihypertension medication classes among 248 887 patients with hypertension and no substantial ...",
               "predicate": null
            }
         ],
         "row": 380,
         "id": 218211273337752543
      },
      {
         "claim": "Risk-adjusted mortality rates are similar in teaching and non-teaching hospitals.",
         "label": 1,
         "prediction": 0,
         "rationale": "Risk-adjusted mortality rates are mortality rates adjusted to account for the predicted risk of death based on various patient and case characteristics, allowing for a more accurate comparison of healthcare institutions' performance. Risk-adjusted mortality rates in teaching hospitals are not similar to those in non-teaching hospitals, with teaching hospitals having significantly lower adjusted 30-day mortality rates. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are risk-adjusted mortality rates?",
               "answer": "Risk-adjusted mortality rates (RAMR) are mortality rates that have been adjusted to account for the predicted risk of death based on various patient and case characteristics. This adjustment allows for a more accurate comparison of the performance of healthcare institutions, such as hospitals or surgeons, by considering the differing risk profiles of patients. The RAM",
               "rationale": "1. Why risk-adjusted mortality rates don't always reflect care quality. Risk-adjusted mortality rates have become key indicators of the quality of hospital care; the data are now widely available on the Internet. The Centers for Medicare & Medicaid Services hold hospitals accountable for such data by disallowing some payments based on certain ...\n2. The Risk-Adjusted Mortality Rate. The RAMR attempts to account for the differing risk profiles of patients. It is standard practice to use a logistic regression model for a given procedure or illness to estimate each patient's probability of death based on their patient and case characteristics.\n3. The risk adjusted mortality rate (RAMR) is a mortality rate that is adjusted for predicted risk of death. It is usually utilized to observe and/or compare the performance of certain institution(s) or person(s), e.g., hospitals or surgeons. It can be found as:\n4. 9. Before CMS publicly reports the hospital acute myocardial infarction (AMI) and heart failure (HF) risk-adjusted 30-day mortality rates, will hospitals have an opportunity to preview their data? 10. What years of data were used to calculate the AMI and HF 30-day mortality measures to be published in June 2007?\n5. Risk-adjusted/ Standardized mortality rates; Risk-adjustment often does not take into account preventability and end of life preferences. Risk-adjustment methodology depends on accurate administrative data. Morbidity and Mortality Conferences • Traditional forums attended by physicians",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are risk-adjusted mortality rates in teaching hospitals similar to those in non-teaching hospitals?",
               "answer": "Based on the provided evidence snippet, risk-adjusted mortality rates in teaching hospitals are not similar to those in non-teaching hospitals. The findings indicate that adjusted 30-day mortality rates are significantly lower at major teaching hospitals compared to non-teaching hospitals (8.3% vs. 9.4%). Additionally, among",
               "rationale": "1. Key Points. Question Is there a difference in mortality rates at US teaching hospitals compared with other hospitals?. Findings In an observational study of approximately 21 million hospitalizations of Medicare beneficiaries, adjusted 30-day mortality rates were significantly lower at 250 major teaching hospitals compared with 894 minor teaching and 3339 nonteaching hospitals overall (8.3% vs ...\n2. Importance: Few studies have analyzed contemporary data on outcomes at US teaching hospitals vs nonteaching hospitals. Objective: To examine risk-adjusted outcomes for patients admitted to teaching vs nonteaching hospitals across a broad range of medical and surgical conditions. Design, setting, and participants: Use of national Medicare data to compare mortality rates in US teaching and ...\n3. Among large hospitals, the overall 30-day mortality rate was 8.1% for 187 major teaching hospitals, 8.9% for 185 minor teaching hospitals, and 9.4% for 76 nonteaching hospitals, with a 1.2% difference (95% CI, 0.9% to 1.5%) between major and nonteaching hospitals ( P < .001).\n4. Adjusted in-hospital mortality rates higher in teaching hospitals than in nonteaching hospitals. Horbar et al. 1997: 7,672 low birth weight infants in neonatal intensive care units of 62 hospitals in Vermont Oxford Network Database during 1991-92. Similar risk of mortality within 28 days of birth in teaching and nonteaching hospitals.\n5. Results were similar in studies using clinical and those using administrative databases. ... to address specifically whether healthcare structures that perform limited teaching have different mortality rates than nonteaching ones. ... had performed these adjustments and showed similar trends for increased death risk in teaching hospitals (RR 1. ...",
               "predicate": null
            }
         ],
         "row": 381,
         "id": 197078718361460189
      },
      {
         "claim": "Rotator cuff exercises are more effective than general exercise therapy in reducing pain and improving function of the shoulder.",
         "label": 1,
         "prediction": 1,
         "rationale": "Rotator cuff exercises can have a positive effect on shoulder pain and function. General exercise therapy reduces pain and improves functional disability in individuals with shoulder pain, particularly in cases of rotator cuff-related shoulder pain. Rotator cuff-specific exercises have a better effect on shoulder pain and function compared to general exercise therapy. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of rotator cuff exercises on shoulder pain and function?",
               "answer": "The provided evidence suggests that rotator cuff exercises can have a positive effect on shoulder pain and function. Clinical guidelines recommend exercise for rotator cuff-related pain, indicating that engaging in specific exercises may help alleviate symptoms. The review mentioned aims to estimate the effects of different types of exercises (resisted and progressive versus non-resisted",
               "rationale": "1. Introduction. Shoulder pain is one of the most frequent musculoskeletal (MSK) complaints in the general population with a lifetime prevalence of up to 70%. 1 The overall prognosis is highly variable, with up to 50% of patients still reporting persistent pain 6-12 months after seeking an initial primary care consultation. 1 Rotator cuff-related shoulder pain (RCRSP), a broad term that ...\n2. Rotator cuff issues are common, an unfortunate side effect from the wear and tear of daily life. More than 2 million Americans visit their doctor every year because of rotator cuff pain.\n3. Step-by-step directions. Hold a stick behind your back with one hand, and lightly grasp the other end of the stick with your other hand. Pull the stick horizontally as shown so that your shoulder is passively stretched to the point of feeling a pull without pain. Hold for 30 seconds and then relax for 30 seconds.\n4. Clinical guidelines recommend exercise for rotator cuff-related pain but make no distinction about the type of exercise prescribed. This review aimed to estimate the average effect of resisted and progressive exercise and non-resisted or non-progressive exercise, both compared to no treatment or placebo. ... The primary outcome was a composite ...\n5. The rotator cuff is a group of muscles and tendons that surround the shoulder joint, keeping the head of the upper arm bone firmly within the shallow socket of the shoulder. A rotator cuff injury can cause a dull ache in the shoulder that worsens at night. Rotator cuff injuries are common and increase with age.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of general exercise therapy on shoulder pain and function?",
               "answer": "General exercise therapy (ET) has been shown to reduce pain and improve functional disability in individuals with shoulder pain, particularly in cases of rotator cuff-related shoulder pain (RCRSP). While most people with subacromial shoulder pain improve with physical therapy, the specific efficacy of exercise therapy can vary, and the influence",
               "rationale": "1. Shoulder pain is common, especially as we age. Pain that limits your ability to raise your arm above your head or rotate your shoulder is called \"subacromial shoulder pain.\" The good news is that most people with subacromial shoulder pain improve with physical therapy. A review of the most up-to-date research published in the March 2020 issue of JOSPT concluded that shoulder exercises are ...\n2. Abstract. Shoulder pain is common, especially as we age. Pain that limits your ability to raise your arm above your head or rotate your shoulder is called \"subacromial shoulder pain.\" The good news is that most people with subacromial shoulder pain improve with physical therapy. A review of the most up-to-date research published in the March ...\n3. Shoulder pain is the third most common musculoskeletal disorder27 with the rotator cuff tendons and associated structures around the sub-acromial space most commonly involved, also known as rotator cuff-related shoulder pain (RCRSP).6 Exercise can reduce pain and improve functional disability in RCRSP,25 although the influence of exercise prescription parameters are not fully understood.26 In ...\n4. Background Exercise therapy (ET) is frequently an early treatment of choice when managing shoulder pain, yet evidence on its efficacy to expedite recovery is inconsistent. Moreover, the value of adding adjunct therapies (i.e. injections, manual therapy, electrotherapy) to ET is currently unclear. This study combined both direct and indirect evidence across studies on the effectiveness of ET ...\n5. Shoulder pain is the third leading musculoskeletal complaint seen by general practitioners. Physical therapy is often the first line of intervention in this population; however, there is limited description of what constitutes effective physical therapy treatment. No study has examined the effectiveness of therapeutic exercise across all painful shoulder conditions. Our purpose was to examine ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is the effect of rotator cuff exercises on shoulder pain and function better than the effect of general exercise therapy?",
               "answer": "Based on the provided evidence snippets, it appears that rotator cuff-specific exercises may have a better effect on shoulder pain and function compared to general exercise therapy. Evidence 1 suggests that strength training specifically targeting the rotator cuff and scapular stabilizers, which allowed for pain during exercise, was more effective than non-specific shoulder",
               "rationale": "1. When we consider the literature relating to painful exercise, strength training for rotator cuff and scapular stabilisers which allowed pain during exercise was better than non-specific shoulder or neck exercises, with considerably more patients in the specific exercise group withdrawing from the waiting list for surgery. 5 A pilot study using ...\n2. Background Exercise therapy is a popular non-surgical treatment to help manage individuals with rotator cuff-related shoulder pain (RCRSP) and is recommended in all clinical practice guidelines. Due to modest effect sizes, low quality evidence, uncertainty relating to efficacy, and mechanism (s) of benefit, exercise as a therapeutic intervention has been the subject of increasing scrutiny.\n3. Rotator cuff injuries can make it difficult to do simple daily activities. Learn what stretches and exercises can help you get back to a normal — and pain-free — routine.\n4. This protocol for a randomized clinical trial aims to compare the effects of two types of exercise (isometric and isotonic) on shoulder pain, functioning, muscle strength, and electromyographic activity in individuals with rotator cuff tendinopathy.\n5. Introduction Lifetime prevalence of shoulder pain is 70%, and approximately 50% of people with shoulder pain will experience pain for more than a year. Rotator cuff-related shoulder pain (RCRSP) is the most common shoulder condition and the main non-surgical intervention is exercise therapy.",
               "predicate": null
            }
         ],
         "row": 382,
         "id": 306379856811786256
      },
      {
         "claim": "Satellite cell dysfunction is a key factor in sarcopenia development.",
         "label": 0,
         "prediction": 1,
         "rationale": "Sarcopenia is the age-related loss of muscle mass, strength, and function that primarily affects older adults. Satellite cell dysfunction is a factor in the development of sarcopenia. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is sarcopenia?",
               "answer": "Sarcopenia is the age-related loss of muscle mass, strength, and function that primarily affects older adults. It can lead to decreased mobility, balance issues, and difficulties in performing daily activities. Factors contributing to sarcopenia include reduced physical activity, hormonal changes, and inadequate protein intake. Prevention and treatment strategies",
               "rationale": "1. Sarcopenia is the age-related loss of muscle mass and strength that affects mostly older adults. Learn about the risk factors, diagnosis and prevention of this condition and how to improve your muscle health with exercise and diet.\n2. Sarcopenia is the severe loss of muscle mass due to aging. It can affect your mobility, balance, and daily activities. Learn about the possible causes, such as reduced physical activity, hormone levels, and protein intake, and how to treat and prevent it with exercise and nutrition.\n3. Sarcopenia is a condition of age-related muscle loss that affects 10% of adults over 50. Learn about the factors that accelerate sarcopenia, the signs of muscle weakness and how exercise, diet and other strategies can prevent or reverse it.\n4. Sarcopenia is the age-related loss of muscle mass and function that affects people from their 30s onward. Learn how sarcopenia affects strength, mobility, and health, and what you can do to prevent or treat it with exercise and medication.\n5. Sarcopenia is a progressive, age-related loss of muscle mass, strength, and motor function. Learn about the signs, factors, and treatments of this condition that affects balance and mobility in older adults.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Satellite cell dysfunction a factor in sarcopenia development?",
               "answer": "Yes, satellite cell dysfunction is a factor in the development of sarcopenia. The evidence indicates that reduced satellite cell function, which is influenced by environmental factors and oxidative stress, contributes to the mechanisms underlying sarcopenia. Additionally, alterations in systemic factors that regulate satellite cell activity and differentiation further impact their function in",
               "rationale": "1. Abstract. The mechanisms contributing to sarcopenia include reduced satellite cell (myogenic stem cell) function that is impacted by the environment (niche) of these cells. Satellite cell function is affected by oxidative stress, which is elevated in aged muscles, and this along with changes in largely unknown systemic factors, likely ...\n2. Sarcopenia, a disorder characterized by age-related muscle loss and reduced muscle strength, is associated with decreased individual independence and quality of life, as well as a high risk of death. Skeletal muscle houses a normally mitotically quiescent population of adult stem cells called muscle satellite cells (MuSCs) that are responsible ...\n3. In sarcopenic skeletal muscle, satellite cells' function may be reduced by alterations of systemic factors that regulate their activity and differentiation such as muscle stem cell niche factors, transforming growth factor-beta (TGF-β), and myogenin. Myogenin is a transcription factor that induces myogenesis in a variety of cell types.\n4. The mechanisms contributing to sarcopenia include reduced satellite cell (myogenic stem cell) function that is impacted by the environment (niche) of these cells. Satellite cell function is affected by oxidative stress, which is elevated in aged muscles, and this along with changes in largely unknown systemic factors, likely contribute to the ...\n5. Understanding the molecular mechanisms involved in their dysregulations is essential for improving current treatments, such as exercise, and developing personalized approaches to reactivate SCs. Keywords: satellite cells, skeletal muscle regeneration, sarcopenia, muscular dystrophy, cancer cachexia",
               "predicate": null
            }
         ],
         "row": 383,
         "id": 303236009988829826
      },
      {
         "claim": "Scapular stabilizer exercises are more effective than general exercise therapy in reducing pain and improving function of the shoulder.",
         "label": 1,
         "prediction": 1,
         "rationale": "The purpose of scapular stabilizer exercises is to manage shoulder pain, restore functional mobility, and help individuals regain normal use of their arm and shoulder by strengthening the muscles around the scapula. General exercise therapy reduces pain and improves function of the shoulder. Scapular stabilizer exercises are more effective than general exercise therapy in reducing pain and improving function of the shoulder. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the purpose of scapular stabilizer exercises?",
               "answer": "The purpose of scapular stabilizer exercises is to manage shoulder pain, restore functional mobility, and help individuals regain normal use of their arm and shoulder. These exercises strengthen the muscles around the scapula, contributing to improved stability and function of the shoulder joint.",
               "rationale": "1. Now let's look at some of the best exercises for scapular stabilization using a resistance band. 1. Resistance Band Rows. Tie the resistance band to something stable e.g. door handle and hold it in both hands. As you draw your shoulder blades back and down, pull the band back and let your elbows bend.\n2. Scapular pushups. Complete 2 to 3 sets of 15 to 20 repetitions. Stand facing a wall with hands placed on the wall, chest height and shoulder-width apart. Keep arms locked out and palms flat on ...\n3. This is a good strengthening exercise for scapular stability from the retraction, anterior tilt, and protraction position. Strengthens: Serratus Anterior. 3 sets x 10 reps. Assume a position with your knees underneath your hips, hip-width apart, and your hands underneath your shoulders, shoulder-width apart.\n4. Also known as scapular stabilization exercises, they help to manage shoulder pain, restore functional mobility, and help you regain normal use of your arm and shoulder. The scapula, or shoulder blade, is the triangular-shaped bone on each side of your upper back. The socket of the shoulder joint is a part of the scapula.\n5. Scapular Stabilization. Description. o. shoulder impingement, is stabilization the base of shoulder can contribute instability, to shoulder of movements quadrant entrapments, of syndromes the upper and extremity. Hints. performing exercises, keep shoulder rolled back and down. s)and n ck. shouldersFre.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does general exercise therapy also reduce pain and improve function of the shoulder?",
               "answer": "Yes, general exercise therapy does reduce pain and improve function of the shoulder. The evidence indicates that exercise therapy is the first-line treatment for improving pain, function, and range of motion in individuals with shoulder pain, particularly subacromial shoulder pain. Additionally, physical activity and exercise interventions are associated with few adverse events and",
               "rationale": "1. Shoulder pain is common, especially as we age. Pain that limits your ability to raise your arm above your head or rotate your shoulder is called \"subacromial shoulder pain.\" The good news is that most people with subacromial shoulder pain improve with physical therapy. A review of the most up-to-date research published in the March 2020 issue of JOSPT concluded that shoulder exercises are ...\n2. High evidence that exercise therapy should be the first-line treatment to improve pain, function, and range of motion No effect sizes reported: Low (PEDro scale) High: Saito et al 29: 6: 250: High evidence that scapula-focused interventions can improve shoulder pain and function in the short term (4 weeks post commencement of treatment)\n3. Abstract. Shoulder pain is common, especially as we age. Pain that limits your ability to raise your arm above your head or rotate your shoulder is called \"subacromial shoulder pain.\" The good news is that most people with subacromial shoulder pain improve with physical therapy. A review of the most up-to-date research published in the March ...\n4. The available evidence suggests physical activity and exercise is an intervention with few adverse events that may improve pain severity and physical function, and consequent quality of life. ... or waiting list controls. This also included 'exercise therapy + another intervention (e.g. taping) versus the other intervention alone (e.g. taping ...\n5. The goal of exercise as part of the physiotherapy management is to correct modifiable physical impairments thought to contribute to pain and dysfunction, rather than to treat the pathology. Therapeutic exercise is commonly used in the treatment and management of a range of shoulder disorders, is commonly advocated to address dysfunctions in ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Are scapular stabilizer exercises more effective than general exercise therapy in reducing pain and improving function of the shoulder?",
               "answer": "Based on the provided evidence snippet, scapular stabilization exercises (SSE) appear to be more effective than general exercise therapy in improving shoulder function and reducing pain, particularly for patients with conditions like subacromial pain syndrome (SAPS). The studies referenced indicate moderate evidence supporting the efficacy of SSE in these areas, with",
               "rationale": "1. The significance of scapular stabilization exercise has drawn considerable attention from research scientists and clinicians, and some studies have not revealed that scapular stabilization exercise is effective in improving shoulder function [19-22] (Table (Table1). 1). The purpose of scapular stabilization exercise is to restore the position ...\n2. The study also concluded that scapular stabilization exercise protocol is effective in improving pain and disability among shoulder impingement subjects. Turgut et al. (2017) , investigated the effect of scapular stabilization exercise (n=15) with conventional exercises (n=15) in Turkey.\n3. In summary, the existing research provides moderate evidence supporting the efficacy of scapular stabilization exercises (SSE) in reducing pain and improving function for patients with subacromial pain syndrome (SAPS). However, it is important to note that these studies do not demonstrate a significant improvement in the range of motion (ROM).\n4. Results. From the 8318 records identified, 8 (high to low risk of bias- scoring from 4 to 8 on the PEDro scale) were included. The overall data, before sensitivity analysis, indicated that the scapular therapeutic exercises are: a) more effective than comparators in improving shoulder function (standardized mean difference [SMD] = 0.52 [95% Cl: 0.05, 0.99], P = .03, I 2 = 76%); and b) as ...\n5. Now let's look at some of the best exercises for scapular stabilization using a resistance band. 1. Resistance Band Rows. Tie the resistance band to something stable e.g. door handle and hold it in both hands. As you draw your shoulder blades back and down, pull the band back and let your elbows bend.",
               "predicate": null
            }
         ],
         "row": 384,
         "id": 703140543875026081
      },
      {
         "claim": "Sepsis related mortality has remained stable between 2009-2014.",
         "label": 1,
         "prediction": 1,
         "rationale": "The exact sepsis-related mortality rates for the years 2009 and 2014 are not specified, but the incidence of sepsis and related mortality or discharge to hospice remained stable between 2009-2014. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the sepsis related mortality rates for 2009 and 2014?",
               "answer": "The provided evidence does not specify the exact sepsis-related mortality rates for the years 2009 and 2014. It mentions that the incidence of sepsis and related mortality or discharge to hospice remained stable between 2009-2014, but it does not provide specific numerical rates for those years. Therefore, the",
               "rationale": "1. Sepsis Mortality Rates per Age Group, Sex, Race, and Hospital Type. eTable 5. Accuracy of EHR Definition vs Claims Relative to Medical Record Review ... the incidence of sepsis, and related mortality or discharge to hospice, has remained stable between 2009-2014. The findings also suggest that clinical data provide more objective estimates than ...\n2. Septicemia Mortality by State. Sepsis is the body's extreme response to an infection. If not identified and treated quickly, sepsis may lead to serious medical consequences and death. For more information on sepsis. 1 The number of deaths per 100,000 total population. Source: https://wonder.cdc.gov. States are categorized from highest rate to ...\n3. In clinical data from 409 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analyses, neither the incidence of sepsis nor the combined outcome of death or discharge to hospice changed significantly between 2009-2014. The findings also suggest that EHR-bas …\n4. Sepsis-related death rates for males were higher than rates for females among adults aged 65-74 (172.6 compared with 131.5), adults aged 75-84 (387.1 compared with 288.7), and adults aged 85 and over (892.4 compared with 669.9). Figure 2. Sepsis-related death rates for adults aged 65 and over, by age group and sex: United States, 2019\n5. Importantly, though, sepsis mortality rates decreased from 1991 to 2000 but then increased from 26.6% in 2001-2005 to 29.2% in 2006-2009, calling into question their conclusion that sepsis mortality rates are indeed steadily decreasing.",
               "predicate": null
            }
         ],
         "row": 385,
         "id": 177311130372665583
      },
      {
         "claim": "Sepsis related mortality has risen from 2009 to 2014.",
         "label": 0,
         "prediction": 1,
         "rationale": "The exact sepsis-related mortality rates for the year 2009 are not specified. In 2014, there were approximately 270,000 sepsis-related deaths in the United States. The provided evidence does not explicitly state whether sepsis-related mortality rates in 2014 were higher than in 2009. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What were the sepsis related mortality rates in 2009?",
               "answer": "The provided evidence does not specify the exact sepsis-related mortality rates for the year 2009. It mentions that overall sepsis-related mortality rates remained stable during the period from 2009 to 2014, but does not provide specific numerical values for 2009. Therefore, the answer cannot be determined from the",
               "rationale": "1. Meaning Based on clinical data, the incidence of sepsis, and related mortality or discharge to hospice, has remained stable between 2009-2014. The findings also suggest that clinical data provide more objective estimates than claims-based data for sepsis surveillance. ... Adjusted rates for 2009-2013 were generated by creating binary indicators ...\n2. Sepsis-related death rates for males were higher than rates for females among adults aged 65-74 (172.6 compared with 131.5), adults aged 75-84 (387.1 compared with 288.7), and adults aged 85 and over (892.4 compared with 669.9). Figure 2. Sepsis-related death rates for adults aged 65 and over, by age group and sex: United States, 2019\n3. When sepsis hospitalizations were identified using implicit codes, the absolute incidence was higher and mortality lower compared to explicit sepsis codes, but trends were similar. Among sepsis patients identified using EHR clinical criteria, there was an increase over time in the proportion assigned sepsis codes (from 24.9% in 2009 to 30.5% in ...\n4. The overall sepsis-related mortality rates remained stable in both males (57 deaths per 100,000) and females (45.1 deaths per 100,000) during this period. Compared with Whites, the sepsis-related mortality rates were higher in Blacks (rate ratio = 1.78), Native Americans (rate ratio = 1.43), and Hispanics (rate ratio = 1.04) and were lower in ...\n5. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007; 35: ... 2009-2014. JAMA. 2017; 318: 1241-1249. ... deaths per 100 000 population. Sepsis-related deaths were identified across the full spectrum of underlying causes of death, including non ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What were the sepsis related mortality rates in 2014?",
               "answer": "In 2014, there were approximately 270,000 sepsis-related deaths in the United States.",
               "rationale": "1. Sepsis Mortality Rates per Age Group, Sex, Race, and Hospital Type. ... Meaning Based on clinical data, the incidence of sepsis, and related mortality or discharge to hospice, has remained stable between 2009-2014. The findings also suggest that clinical data provide more objective estimates than claims-based data for sepsis surveillance ...\n2. Sepsis-related death rates for males were higher than rates for females among adults aged 65-74 (172.6 compared with 131.5), adults aged 75-84 (387.1 compared with 288.7), and adults aged 85 and over (892.4 compared with 669.9). Figure 2. Sepsis-related death rates for adults aged 65 and over, by age group and sex: United States, 2019\n3. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. ... most sepsis-related deaths were due to ... data to estimate that there were 1·7 million incident adult sepsis cases requiring admission to hospital in the USA in 2014, with 270 000 sepsis-related deaths. This is ...\n4. During this period, the annual number of all reported sepsis-related deaths increased 31%, from 139,086 in 1999 to 182,242 in 2014 . Approximately 15% of all sepsis-related deaths during this period occurred in nonacute care settings (e.g., at home, long-term care facilities, hospice, and unknown setting).\n5. Objectives: To examine the trends in hospitalization rates, mortality, and costs for sepsis during the years 2005 to 2014. Methods: This was a retrospective serial cross-sectional analysis of patients ≥18 years admitted for sepsis in National Inpatient Sample. Trends in sepsis hospitalizations were estimated, and age- and sex-adjusted rates were calculated for the years 2005 to 2014.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Were sepsis-related mortality rates in 2014 higher than in 2009?",
               "answer": "The provided evidence does not explicitly state whether sepsis-related mortality rates in 2014 were higher than in 2009. However, it mentions that sepsis incidence rates in 2014 were higher (7.1% vs 6.0%) but does not provide specific mortality rates for those years. Therefore,",
               "rationale": "1. From 2004 to 2018, using the MCOD, the age-adjusted mortality rate per 1,000,000 population from pulmonary sepsis was 111.8, from abdominal sepsis was 46.7, and from genitourinary sepsis was 52. Mortality rates from all three sites increased. Males had a higher mortality rate from pulmonary sepsis and abdominal sepsis and lower mortality rate ...\n2. Trends in sepsis-related death rates among adults aged 65 and over varied from 2000 through 2019, overall and by age group. Death rates were higher for males than females and for adults in rural compared with urban areas. Sepsis-related death rates for non-Hispanic black adults were higher than those for other race and Hispanic-origin groups.\n3. Sepsis Mortality Rates per Age Group, Sex, Race, and Hospital Type. ... Annual trends in sepsis incidence and in-hospital mortality from 2009-2014 were calculated in the subset of hospitals with historical data ... sepsis incidence rates in 2014 were higher (7.1% vs 6.0%; difference, 1.1% [95% CI, ...\n4. The good news is that they found that rates of death from sepsis are actually declining: In 1990 there were an estimated 60.2 million cases of sepsis and 15.7 million deaths related to the ...\n5. The overall sepsis-related mortality rates remained stable in both males (57 deaths per 100,000) and females (45.1 deaths per 100,000) during this period. Compared with Whites, the sepsis-related mortality rates were higher in Blacks (rate ratio = 1.78), Native Americans (rate ratio = 1.43), and Hispanics (rate ratio = 1.04) and were lower in ...",
               "predicate": null
            }
         ],
         "row": 386,
         "id": 306597946960579998
      },
      {
         "claim": "Side effects associated with antidepressants do not represent a mortality risk to postmenopausal women.",
         "label": 0,
         "prediction": 0,
         "rationale": "The side effects associated with antidepressants include nausea, weight gain, trouble sleeping, dry mouth, blurred vision, dizziness, diarrhea, sexual problems, and headaches, with some individuals also experiencing weight gain or loss. The side effects associated with antidepressants may pose a mortality risk to postmenopausal women, particularly due to an increased risk of falls that could lead to serious injuries or death. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the side effects associated with antidepressants?",
               "answer": "The side effects associated with antidepressants include nausea, weight gain, trouble sleeping, dry mouth, blurred vision, dizziness, diarrhea, sexual problems (such as delayed ejaculations in men and lack of orgasm in women), and headaches. Additionally, some individuals may experience weight gain or loss. While more serious side effects are rare",
               "rationale": "1. The chart below is a general comparison of the some of the more common side effects associated with different antidepressants. When using this chart, keep a few things in mind:\n2. Antidepressant Side Effects. Everyone reacts to medicines differently, but some side effects are typical. These include: Nausea. Weight gain. Trouble sleeping. Dry mouth. Blurred vision. Dizziness.\n3. Introduction. Antidepressants can cause unpleasant side effects. Signs and symptoms such as nausea, weight gain or sleep problems can be common initially. For many people, these improve within weeks of starting an antidepressant. In some cases, however, antidepressants cause side effects that don't go away.\n4. More-commonly prescribed antidepressants in this category include trazodone, mirtazapine (Remeron), vortioxetine (Trintellix), vilazodone (Viibryd) and bupropion (Forfivo XL, Wellbutrin SR, others). Bupropion is one of the few antidepressants not frequently associated with sexual side effects.\n5. Diarrhea. Sexual problems, such as delayed ejaculations in men and lack of orgasm in women. Headaches. Dizziness. Weight gain or loss. Other more serious side effects are rare but possible ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do the side effects associated with antidepressants represent a mortality risk to postmenopausal women?",
               "answer": "The provided evidence suggests that while antidepressants have potential health benefits, they are also associated with various side effects, some of which may pose risks to specific populations, including postmenopausal women. Evidence point 5 mentions that there is an increased risk of falls associated with antidepressants, which could lead to serious injuries or",
               "rationale": "1. 2. Antidepressants and Suicidal Risk. Only recently has the effect of antidepressant treatments on suicidal behavior and the increased overall mortality associated with major psychiatric disorders become a focus of research interest [32,33,34].A highly controversial question is whether antidepressant treatment modifies the risk of various aspects of \"suicidality\" among patients with major ...\n2. Taken together, these results suggest that anxious symptom severity and the presence of anxious depression do not impact the severity of side effects over the course of antidepressant treatment. A greater burden of side effects was associated with poorer QIDS-SR 16 remission and response at every timepoint, except for week 4 QIDS-SR 16 response\n3. Whether for children or adults, antidepressants have other risks in addition to the possible risk of suicide. Common side effects include nausea, anxiety, restlessness, decreased sex drive, dizziness, weight gain or loss, tremors, sweating, sleepiness, fatigue, dry mouth, diarrhea, constipation, and headaches.\n4. While antidepressants have potential health benefits, they are associated with various side effects. Postmenopausal individuals represent a high-risk group for depressive symptoms and ...\n5. A number of factors are likely to explain the increased risk of falls associated with antidepressants ... with selective serotonin reuptake inhibitors having fewer side effects and ... Cochrane BB, Curb JD, Perlis RH, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's ...",
               "predicate": null
            }
         ],
         "row": 387,
         "id": 306456630869430071
      },
      {
         "claim": "Side effects associated with antidepressants increases risk of stroke.",
         "label": 1,
         "prediction": 1,
         "rationale": "The side effects associated with antidepressants may include nausea, weight gain, drowsiness, insomnia, dry mouth, constipation, dizziness, anxiety, and sexual side effects. Certain antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), may be associated with an increased risk of ischemic stroke. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the side effects associated with antidepressants?",
               "answer": "The side effects associated with antidepressants may include nausea, weight gain, drowsiness, insomnia, dry mouth, constipation, dizziness, anxiety, and sexual side effects.",
               "rationale": "1. Antidepressant side effects can range from mild discomfort to severe impacts on your daily life. We'll go over and compare the common side effects associated with different types of antidepressants.\n2. What side effects should you expect when you take antidepressants to treat your depression? Learn what to watch for.\n3. Side effects may include nausea, weight gain, drowsiness, insomnia, dry mouth, constipation, dizziness, anxiety or sexual side effects. Learn how to cope.\n4. Like any medication, antidepressants can cause side effects. The specific problems vary from drug to drug -- and from person to person.\n5. Finding the right antidepressant There are many types of antidepressants available that work in slightly different ways and have different side effects. When choosing an antidepressant that's likely to work well for you, your health care provider may consider: Your particular symptoms. Symptoms of depression can vary, and one antidepressant may relieve certain symptoms better than another. For ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do the side effects associated with antidepressants increase the risk of stroke?",
               "answer": "Yes, the evidence suggests that certain antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), may be associated with an increased risk of ischemic stroke (IS). While some studies indicate a potential increased risk, there are also conflicting findings that show decreased or neutral effects. Additionally, the side effects of these medications",
               "rationale": "1. Certain drugs may increase the risk of ischemic stroke (IS). Our goal was to review associations between frequently used drugs and IS. We created an initial list of frequently used drugs to search Pubmed/MEDLINE from 1966 to 2020 and reviewed phase III and IV data, case series, and drug authorities' safety warnings to assess a potential association with IS. Drugs were grouped according to ...\n2. It is also possible that the side effects of certain antidepressants have contributed to the unexpected increased risk for stroke. 41 A major strength of our meta-analysis is that all included primary studies used a community-based or population-based and prospective design, which enhanced the generalizability of the findings and reduced the ...\n3. The relationship between the use of selective serotonin reuptake inhibitors (SSRIs), the most widely prescribed antidepressants, and ischemic stroke has been a matter of controversy for the last 2 decades, with many studies suggesting an increased risk, 1-5 while a few showing a decreased risk 6,7 or a neutral effect. 8 These findings seem to be a pharmacological paradox as SSRIs have a ...\n4. The results should reassure clinicians that it is safe to prescribe SSRI and SNRI antidepressants early after stroke, he said. \"However, caution is needed when considering the risk-benefit profile for stroke patients receiving dual antiplatelet therapy because we did find an increased risk of bleeding among this group.\"\n5. Overall, clinicians should adopt a personalized, tailored approach for discussing and managing individual risk of stroke with younger patients, she said. Gaffey also called for more in-depth studies that look at stroke risk and SSRI use among non-veterans, including older adults and women. Most of the veterans in the new study were men.",
               "predicate": null
            }
         ],
         "row": 388,
         "id": 232156318516896865
      },
      {
         "claim": "Sildenafil worsens erectile function in men who experience sexual dysfunction as a result of the use of SSRI antidepressants.",
         "label": 0,
         "prediction": 0,
         "rationale": "Sildenafil is a medication that relaxes blood vessels and improves blood flow to certain areas of the body, used to treat erectile dysfunction and pulmonary arterial hypertension. Sildenafil does not worsen erectile function in men who experience sexual dysfunction as a result of the use of SSRI antidepressants. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Sildenafil?",
               "answer": "Sildenafil is a medication that relaxes blood vessels and improves blood flow to certain areas of the body. It is used to treat erectile dysfunction (under the brand name Viagra) and pulmonary arterial hypertension (under the brand name Revatio). Sildenafil works by blocking an enzyme that breaks down cyclic GMP, a chemical that helps relax",
               "rationale": "1. Sildenafil is a medicine that relaxes blood vessels and improves blood flow to certain areas of the body. It can treat erectile dysfunction (Viagra) or pulmonary arterial hypertension (Revatio), but it can also cause serious interactions and side effects.\n2. Viagra is a prescription drug that treats erectile dysfunction in males by blocking an enzyme that breaks down cGMP, a protein that helps blood flow to the penis. Learn how Viagra works, how long it lasts, what side effects it may cause, and how it compares with other drugs.\n3. Viagra is a brand-name tablet for erectile dysfunction (ED) that contains the active ingredient sildenafil. Sildenafil works by blocking an enzyme that breaks down cyclic GMP, a chemical that relaxes blood vessels and muscles in the penis.\n4. Sildenafil is a medication that can treat erectile dysfunction (ED) or pulmonary arterial hypertension (PAH). Learn how it works, what side effects it may cause, and what precautions you should take before using it.\n5. Sildenafil can cause a serious drop in your blood pressure when used with nitrates. A serious drop in blood pressure can lead to dizziness, fainting, and rarely heart attack or stroke.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Sildenafil worsen erectile function in men who experience sexual dysfunction as a result of the use of SSRI antidepressants?",
               "answer": "No, Sildenafil does not worsen erectile function in men who experience sexual dysfunction as a result of the use of SSRI antidepressants. In fact, the evidence suggests that Sildenafil is efficacious in improving erectile function in these patients.",
               "rationale": "1. Tadalafil with the dose of 10 to 20 mg per day was found to be efficacious in patients who had SSRI-induced sexual dysfunction, with an improvement in erectile function, orgasm, and sexual satisfaction. 55 Sildenafil of 25 to 100 mg was reported to be efficacious in male patients who experienced SSRI-induce sexual dysfunction and to lead to ...\n2. However, 25% to 73% of people who take SSRIs experience sexual side effects. In fact, most people who take an SSRI experience genital sensory changes within 30 minutes of taking the drug. Sexual side effects of SSRIs may include: Erectile dysfunction (ED), and inability to achieve or maintain an erection sufficient for penetrative sex. Anorgasmia.\n3. A systematic review of randomized control trials found that phosphodiesterase 5 (PDE5) inhibitors, such as sildenafil and tadalafil, improved erectile dysfunction better than placebo in male subjects with sexual dysfunction as a result of antidepressant treatment.30 However, it was unclear whether PDE5 inhibitors would be beneficial to treat ...\n4. Sexual dysfunction is a common side effect of antidepressants and can have significant impact on the person's quality of life, relationships, mental health, and recovery. The reported incidence of sexual dysfunction associated with antidepressant medication varies considerably between studies, making it difficult to estimate the exact ...\n5. The evidence currently available is rather limited. For men with antidepressant-induced erectile dysfunction, the addition of sildenafil or tadalafil appears to be an effective strategy. For women with antidepressant-induced sexual dysfunction the addition of bupropion at higher doses appears to be the most promising approach studied so far.",
               "predicate": null
            }
         ],
         "row": 389,
         "id": 276220762903181453
      },
      {
         "claim": "Smc5/6 engagment halts the activation of SUMO E3 ligase Mms21 by ATP-dependent remolding.",
         "label": 0,
         "prediction": 0,
         "rationale": "Smc5/6 is a protein complex that plays essential roles in genome maintenance, including genome stability, resistance to genotoxins, and host defense, by recognizing unusual DNA configurations. The engagement of Smc5/6 affects the activation of the SUMO E3 ligase Mms21 (Nse2). The provided evidence does not directly address whether ATP-dependent remodeling halts the activation of the SUMO E3 ligase Mms21. The provided evidence does not explicitly state whether ATP-dependent remodeling halts the activation of SUMO E3 ligase Mms21 by Smc5/6 engagement. The engagement of the Smc5/6 complex does not halt the activation of SUMO E3 ligase Mms21 by ATP-dependent remodeling. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Smc5/6?",
               "answer": "Smc5/6 is a protein complex that is part of the eukaryotic structural maintenance of chromosomes (SMC) family. It plays essential roles in genome maintenance, including the maintenance of genome stability, resistance to genotoxins, and host defense. The complex is involved in recognizing unusual DNA configurations and",
               "rationale": "1. Smc5/6 extrudes loops in the form of dimers, whereas monomeric Smc5/6 unidirectionally translocates along DNA. We also find that the subunits Nse5 and Nse6 (Nse5/6) act as negative regulators of ...\n2. SMC5. Structural maintenance of chromosomes protein 5 is a protein encoded by the SMC5 gene in human. [5] [6] The structural maintenance of chromosomes' complex underlying mechanisms involved in the dynamics of chromatin dynamics is unknown, and discoveries are shedding light on the various functions. [7]\n3. Smc5/6 is a member of the eukaryotic structural maintenance of chromosomes (SMC) family of complexes with important roles in genome maintenance and viral restriction. However, limited structural ...\n4. The importance of Smc5/6 for growth, genotoxin resistance and host defense across species is highlighted by its involvement in disease prevention in plants and animals. Accelerated progress in ...\n5. The Smc5/6 proteins play essential roles in the maintenance of genome stability, yet their mode of action is not fully understood. Here we show that the human Smc5/6 complex recognizes unusual DNA configurations and uses the energy of ATP hydrolysis to promote their compaction. Structural analyses reveal subunit interfaces responsible for the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Smc5/6 engagement affect the activation of SUMO E3 ligase Mms21?",
               "answer": "Yes, the engagement of Smc5/6 affects the activation of the SUMO E3 ligase Mms21 (Nse2). Evidence 1 suggests that the ATPase activity in the Smc5/6 complex may promote the activation of Nse2 after DNA is entrapped inside the Smc5",
               "rationale": "1. As the Nse2 SUMO ligase docks to the coiled coil domain of Smc5, it is possible that the ATPase in the Smc5/6 complex might not only alter the juxtaposition of the coiled coils (Alt et al, 2017; Bürmann et al, 2017), but also promote the concomitant activation of Nse2 after entrapment of DNA inside the Smc5/6 ring.\n2. Here we show that the Nse2 SUMO E3 in the Smc5/6 complex, a critical player during recombinational DNA repair, is directly stimulated by binding to DNA Activation of sumoylation requires the electrostatic interaction between DNA and a positively charged patch in the ARM domain of Smc5, which acts as a DNA sensor that subsequently promotes a ...\n3. Here, we present the crystal structure of the Smc5/Nse2 E3 ligase in complex with an E2-SUMO D thioester mimetic at 3.3 Å resolution (SUMO D refers to donor SUMO), which sheds light on the SUMO ...\n4. The SUMO E3 ligase Nse2/Mms21 is part of the conserved SMC5‐SMC6 complex, which alongside cohesin and condensin are the representative members of the multi‐subunit structural maintenance of chromosomes (SMC) complexes (Uhlmann, 2016). These complexes form ring‐shaped structures able to hold one or more DNA strands, giving them diverse key ...\n5. MPH1 protein, S cerevisiae. DEAD-box RNA Helicases. The budding yeast E3 SUMO ligase Mms21, also known as Nse2, is a component of the Smc5/6 complex, which regulates sister chromatid cohesion, DNA replication, and repair. Our study shows that the mms21RINGΔ mutant exhibits (1) reduced ribosomal RNA production; (2) nuclear accumulation of ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the ATP-dependent remolding halt the activation of SUMO E3 ligase Mms21?",
               "answer": "The provided evidence snippet does not directly address whether ATP-dependent remodeling halts the activation of the SUMO E3 ligase Mms21. The information focuses on the interaction of Mms21 with other proteins, its role in SUMOylation, and its effects on drought tolerance in Arabidopsis. To determine the",
               "rationale": "1. The stability of Aux/IAA proteins is important for transcription initiation and downstream auxin-related gene expression. Here, we report that the Aux/IAA protein IAA17 interacts with the small ubiquitin-related modifier (SUMO) E3 ligase METHYL METHANESULFONATE-SENSITIVE 21 (AtMMS21) in Arabidopsis (Arabidopsis thaliana).\n2. The Arabidopsis genome contains a putative MMS21 homologue capable of interacting with the SUMO E2 conjugating enzyme AtSCE1a, as indicated by a yeast two-hybrid screen and bimolecular fluorescence complementation experiments. In vitro and in vivo data demonstrated that AtMMS21 was a SUMO E3 ligase.\n3. The MMS21 is a newly-identified Arabidopsis thaliana L. SUMO E3 ligase gene aside from the SIZ1, and its function requires further elucidation. Here, we show that MMS21 deficient plants display improved drought tolerance, and constitutive expression of MMS21 reduces drought tolerance.\n4. Similar with ubiquitination, SUMOylation is mediated by a cascade containing an activating enzyme (E1), a conjugating enzyme (E2), and usually a ligase (E3), which may enhance the reaction in physiological conditions ( Wilkinson and Henley, 2010 ). MMS21 is a conserved SUMO ligase and important for genome stability ( Stephan et al., 2011 ).\n5. SUMOylation, which involves the transfer of a polypeptide small ubiquitin-like modifier (SUMO) onto protein substrates, is a type of important posttranslational modification that is widely found in plants. One of the major functions of SUMOylation is regulating protein stability ( Verma et al., 2018 ). Previous research has revealed that the T-DNA insertion mutant mms21-1 of SUMO E3 ligase ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does ATP-dependent remolding halt the activation of SUMO E3 ligase Mms21 by Smc5/6 engagement?",
               "answer": "The provided evidence does not explicitly state whether ATP-dependent remodeling halts the activation of SUMO E3 ligase Mms21 by Smc5/6 engagement. However, it does suggest that the engagement of the Smc5 head region with the Smc6 head could facilitate the activity of the SUMO E3",
               "rationale": "1. The Nse2 subunit (also known as Mms21) has SUMO E3 ligase activity 5,6,7, ... As such, head-ATP engagement could occur once the Smc5 head region is brought into proximity to the Smc6 head. The ...\n2. Nse2 is a SUMO E3 ligase component of the Smc5/6 multisubunit complex involved in the DNA repair and chromosome integrity. Here, the structure of the Nse2 in complex with an E2-SUMO thioester ...\n3. Enhancement of the SUMO E3 ligase activity of Smc5‐Nse2 upon binding to DNA. Time‐course conjugation reaction of SUMO1 (left) or Smt3 (right) in the presence or absence of ssDNA (virion ϕx174) at 8 nM using full‐length Smc5‐Nse2 complex. The substrate utilized was the C‐terminal kleisin domain of Nse4 ( cNse4 ).\n4. The Mms21 SUMO ligase docks to the arm region of the Smc5 protein in the Smc5/6 complex; together, they cooperate during recombinational DNA repair. Yet how the activity of the SUMO ligase is controlled remains unknown. Here we show that the SUMO ligase and the chromosome disjunction functions of Mms21 depend on its docking to an intact and ...\n5. Similar with ubiquitination, SUMOylation is mediated by a cascade containing an activating enzyme (E1), a conjugating enzyme (E2), and usually a ligase (E3), which may enhance the reaction in physiological conditions (Wilkinson and Henley, 2010). MMS21 is a conserved SUMO ligase and important for genome stability (Stephan et al., 2011).",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does Smc5/6 engagement halt the activation of SUMO E3 ligase Mms21 by ATP-dependent remolding?",
               "answer": "No, the evidence suggests that the engagement of the Smc5/6 complex does not halt the activation of SUMO E3 ligase Mms21 (Nse2) by ATP-dependent remodeling. In fact, it indicates that the Smc5/6 complex can be activated by ATP-dependent remodeling, which facilitates",
               "rationale": "1. Here we show that the Nse2 SUMO E3 in the Smc5/6 complex, a critical player during recombinational DNA repair, is directly stimulated by binding to DNA Activation of sumoylation requires the electrostatic interaction between DNA and a positively charged patch in the ARM domain of Smc5, which acts as a DNA sensor that subsequently promotes a ...\n2. Nse2 is a SUMO E3 ligase component of the Smc5/6 multisubunit complex involved in the DNA repair and chromosome integrity. Here, the structure of the Nse2 in complex with an E2-SUMO thioester ...\n3. Therefore, we speculate that the Smc5/6 complex can be first activated by ATP‐dependent remodeling of the molecule and loading onto DNA; this would facilitate contacts between DNA and the DNA sensor patch in Smc5, which would subsequently activate the SUMO E3 ligase activity of Nse2 (Fig 7 ).\n4. Mms21 (Nse2), the relatively well-studied subunit in Smc5/6, contains a SP-like-RING finger motif on the C-terminus and was identified as a SUMO E3 ligase. Deletion of Mms21 is lethal; however, while deficient in DNA damage repair, SUMO ligase mutants remain viable. These functions of Mms21 in Smc5/6 are hard to address without understanding ...\n5. (2018) present exciting new insights into how the SUMO E3 ligase activity of yeast Nse2 is stimulated by the presence of DNA when in complex with SMC5. While enhancement was found also with double-stranded DNA, the experiments revealed a clear preference for single-stranded DNA, which perfectly fits with the role of Nse2-dependent sumoylation ...",
               "predicate": null
            }
         ],
         "row": 390,
         "id": 258424887196386739
      },
      {
         "claim": "Splenomegaly is observed in knockin mouse lacking the SHP-2 MAPK pathway.",
         "label": 1,
         "prediction": 1,
         "rationale": "SHP-2 is a protein tyrosine phosphatase that plays a critical role in the Ras/Mitogen-Activated Protein Kinase (MAPK) pathway, which is important for cell signaling related to growth, differentiation, and survival. Lacking the SHP-2 MAPK pathway in knockin mice does not significantly affect NK cell development and responsiveness. Splenomegaly is observed in knockin mice lacking the SHP-2 MAPK pathway. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is SHP-2 MAPK pathway?",
               "answer": "SHP-2 is a protein tyrosine phosphatase that plays a critical role in the Ras/Mitogen-Activated Protein Kinase (MAPK) pathway, which is important for cell signaling related to growth, differentiation, and survival. It has been proposed that SHP-2 dephosphorylates",
               "rationale": "1. Shp-2 has therefore been proposed to dephosphorylate negative regulators of the MAPK pathway 12. Along these lines, SHP-2 overactivation is involved in cancer development and novel inhibitors have ...\n2. The addition of SHP2is improves G12Ci efficacy in several ways. First, G12Cis target the GDP-bound state of KRAS (KRAS-GDP). Effectively, then, G12Ci action is opposed by RAS-GEF activity. By preventing SOS1/2 action, SHP2is increase the amount of KRAS-GDP and thus the \"target\" of G12Cis [13, 22].\n3. The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal. 2008;20:453-9. CAS PubMed Google Scholar\n4. Targeting SHP2 plays multiple roles in cancer. ① SHP2 is a critical regulator of RAS-MAPK pathway. SHP2i may inhibit cancers driven by RTK or KRAS alteration. ② SHP2 is a critical downstream effector for PD-1/PD-L1 and CD28 pathway. ... PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor ...\n5. Within a single signaling pathway, SHP-2 may act at multiple sites to participate in the signal relay. For instance, SHP-2 directly interacts with cytokine and growth factor receptors, such as ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of lacking the SHP-2 MAPK pathway in knockin mice?",
               "answer": "The evidence indicates that lacking SHP-2 in the NK lineage of knockin mice does not significantly affect NK cell development and responsiveness. This suggests that the SHP-2 MAPK pathway may not be critical for these specific immune functions in the context of NK cells.",
               "rationale": "1. Here we show, using mice conditionally deficient for Shp-2 in the NK lineage, that NK cell development and responsiveness are largely unaffected.\n2. Activation of the RAS-MAPK pathway and its downstream signaling elements is critical for tumor cell survival, proliferation, and differentiation [ 50 ]. SHP2 acts as a transducer of signals from upstream RTKs to SOS1 to activate the oncogenic RAS-MAPK pathway in different types of tumors [ 51 ].\n3. This lack of anti-tumor immune response correlated with (and was likely caused by) failure to alter the expression of genes encoding specific cytokines and chemokines. Despite the lack of significant regression, however, there was a marked \"treatment effect\", characterized by a reduction in tumor cell number and collagen scarring.\n4. The mitogen-activated protein kinase (MAPK) pathway is an important bridge in the switch from extracellular signals to intracellular responses. Alterations of signaling cascades are found in various diseases, including cancer, as a result of genetic and epigenetic changes. Numerous studies focused on both the homeostatic and the pathologic ...\n5. Here, we review recent efforts to validate individual components of the mitogen-activated protein kinase (MAPK) pathway as targets to treat KRAS -mutant cancers by comparing genetic information derived from experimental mouse models of KRAS-driven lung and pancreatic tumors with the outcome of selective MAPK inhibitors in clinical trials.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is Splenomegaly observed in knockin mice lacking the SHP-2 MAPK pathway?",
               "answer": "Yes, splenomegaly is observed in knockin mice lacking the SHP-2 MAPK pathway, as indicated in the second piece of evidence.",
               "rationale": "1. However, Shp-2 deficiency does not phenocopy the NK cell defects observed in IL-15- and PI3K-deficient mice or in mice conditionally deficient for mTORC1 and mTORC2 in the NK lineage 30,34,43,56 ...\n2. We observed that a knockin mouse lacking the SHP-2 MAPK pathway (named the gp130 F759/F759 mouse) has splenomegaly and lymphadenopathy from an early age . In this study, we analyzed the role of IL-6 on DC activation/maturation in vivo, using several mutant mice, including the IL-6 knockout (IL-6 KO) and gp130 knockin mice.\n3. No cells of SHP-2 −/− origin could be detected in bone marrow or thymus of the SHP-2 −/− RAG-2 −/− chimeras, indicating the requirement for SHP-2 in early lymphopoiesis. To bypass the early developmental steps, transgenic mice were generated that express the putative dominant negative mutant SHP-2 C/S in the T-cell lineage at a ...\n4. Some interesting phenotypes were observed in chimeric mice containing SHP-2 mutant cells, such as abnormal development of the skeleton and limbs 45, 46. Another striking observation was that 50 % ...\n5. This establishes that the fine-tuning of the ERK/MAPK pathway is critical to regulate B and T cell activation and function and that each MEK isoform plays distinct roles during lymphocyte activation and disease development. ... we performed a systematic characterization of leukocyte differentiation and maturation in 2- to 3-month-old mice ...",
               "predicate": null
            }
         ],
         "row": 391,
         "id": 206486274574760751
      },
      {
         "claim": "Stiff substrates encourage mesodermal differentiation by degrading beta-catenin in an integrin-dependent manner.",
         "label": 0,
         "prediction": 1,
         "rationale": "Beta-catenin plays a critical role in mesodermal differentiation by promoting the differentiation of cells towards mesodermal lineages through its involvement in Wnt signaling. The regulation of β-catenin is crucial for mesodermal differentiation. Beta-catenin degradation is not directly dependent on integrin. A stiff substrate does not degrade beta-catenin in an integrin-dependent manner, but rather integrin activation promotes Wnt signaling in response to a stiff extracellular matrix. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of beta-catenin in mesodermal differentiation?",
               "answer": "Beta-catenin plays a critical role in mesodermal differentiation by promoting the differentiation of cells towards mesodermal lineages. It is involved in Wnt signaling, which is essential for the formation of different body regions during early embryonic development. Additionally, beta-catenin is a key nuclear effector",
               "rationale": "1. The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signalling often leads ...\n2. β-Catenin (Armadillo in Drosophila) is a multitasking and evolutionary conserved molecule that in metazoans exerts a crucial role in a multitude of developmental and homeostatic processes.More specifically, β-catenin is an integral structural component of cadherin-based adherens junctions, and the key nuclear effector of canonical Wnt signalling in the nucleus.\n3. Supplementary Figure 1: Effects of short initial CHIR treatment on β-catenin regulation and proliferation during CBiPSC mesoderm differentiation.(A) Western blot analysis for active and total β-catenin during the first 7 days of mesoderm differentiation in CHIR-treated cells and the respective DMSO control in two independent experiments.(B) DNA quantification during mesodermal ...\n4. Catenin beta-1, also known as β-catenin ... Wnt signaling and β-catenin dependent gene expression plays a critical role during the formation of different body regions in the early embryo. ... β-catenin may promote differentiation, especially towards mesodermal cell lineages. Epithelial-to-mesenchymal transition\n5. The three germ layers — mesoderm, endoderm and ectoderm — constituting the cellular blueprint for the tissues and organs that will form during embryonic development, are specified at gastrulation. Cells of mesodermal origin are the most abundant in the human body, representing a great variety of cell types, including the musculoskeletal ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does beta-catenin degradation encourage mesodermal differentiation?",
               "answer": "The provided evidence does not directly indicate whether beta-catenin degradation encourages mesodermal differentiation. However, it does highlight the importance of the Wnt/β-catenin pathway in regulating cell fate during embryogenesis and suggests that the regulation of β-catenin is crucial for mesodermal differentiation. Specifically",
               "rationale": "1. Supplementary Figure 1: Effects of short initial CHIR treatment on β-catenin regulation and proliferation during CBiPSC mesoderm differentiation.(A) Western blot analysis for active and total β-catenin during the first 7 days of mesoderm differentiation in CHIR-treated cells and the respective DMSO control in two independent experiments.(B) DNA quantification during mesodermal ...\n2. The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signalling often leads ...\n3. Mesodermal differentiation of induced pluripotent stem cells (iPSCs) in vitro and subsequent specification into mesodermal derivatives like chondrocytes is currently afflicted with a substantial cell loss that severely limits tissue yield. More knowledge on the key players regulating mesodermal differentiation of iPSCs is currently needed to drive all cells into the desired lineage and to ...\n4. Introduction. WNT/β-catenin signaling is a tightly controlled and highly conserved pathway that regulates cell fate during embryogenesis, hepatobiliary development, liver homeostasis, repair in adulthood, cell proliferation, differentiation, and cell polarity (1, 2).The intracellular responses that WNT ligands trigger can be classified into canonical (β-catenin-dependent) and non-canonical ...\n5. To validate the role of mesodermal Wnt signaling, we genetically ablated Ctnnb1, also known as β-catenin, which is a core component of canonical Wnt signaling, from embryonic mesoderm.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is beta-catenin degradation dependent on integrin?",
               "answer": "Based on the provided evidence snippet, beta-catenin degradation is not directly dependent on integrin. The evidence indicates that in the absence of Wnt signaling, beta-catenin is recruited to a complex that leads to its phosphorylation and subsequent degradation. However, the snippet also mentions that integrin-dependent activation of Wnt",
               "rationale": "1. On the one hand, when the WNT pathway is activated, ICAT blocks the interaction of β-catenin-APC and inhibits the degradation of β-catenin by competing with APC for the binding site of β-catenin.\n2. In the absence of wnt signaling, cytoplasmic β-catenin is recruited to a complex containing axin, APC and GSK-3β, which is then able to phosphorylate β-catenin, triggering its ubiquitin-dependent degradation.\n3. In summary, the current data describe a mechanism for integrin-dependent activation of Wnt/β-catenin signaling that may play a role in metastatic progression even in tumor cells devoid of Wnt pathway mutations.\n4. WNT/β-catenin signaling is a highly complex pathway that plays diverse roles in various cellular processes. While WNT ligands usually signal through their dedicated Frizzled receptors, the decision to signal in a β-catenin-dependent or -independent manner rests upon the type of co-receptors used. Canonical WNT signaling is β-catenin ...\n5. Our finding of integrin-dependent tyrosine phosphorylation of Y654-β-catenin is important because phosphorylation of β-catenin at Y654 is known to promote both dissociation of β-catenin from E-cadherin and stabilization of β-catenin from ubiquitination and degradation ( Brembeck et al., 2006 ).",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does stiff substrate degrade beta-catenin in an integrin-dependent manner?",
               "answer": "The provided evidence does not directly indicate that a stiff substrate degrades beta-catenin in an integrin-dependent manner. Instead, it suggests that the integrin-activated β-catenin/Wnt pathway forms a positive feedback loop that promotes Wnt signaling in response to a stiff extracellular matrix (ECM). Additionally,",
               "rationale": "1. The integrin-activated β-catenin/Wnt pathway connects with canonical Wnt/β-catenin pathway to form a positive feedback loop, which is crucial to the promotion of Wnt signal by stiff ECM and the ...\n2. Our finding of integrin-dependent tyrosine phosphorylation of Y654-β-catenin is important because phosphorylation of β-catenin at Y654 is known to promote both dissociation of β-catenin from E-cadherin and stabilization of β-catenin from ubiquitination and degradation (Brembeck et al., 2006). Therefore, independently of Wnt signaling, our ...\n3. WNT/β-catenin signaling is a highly complex pathway that plays diverse roles in various cellular processes. While WNT ligands usually signal through their dedicated Frizzled receptors, the decision to signal in a β-catenin-dependent or -independent manner rests upon the type of co-receptors used. Canonical WNT signaling is β-catenin ...\n4. Integrin α5-dependent beta-catenin activation is implicated in glioma cell migration. In addition to its role in proliferation or survival, beta-catenin also impacts on cell migration . We already have shown that α5 integrin expression in glioma cells triggers single cell migration which is blocked by specific antagonists . To uncover a ...\n5. Reversible modulation of integrin-regulated cell-matrix adhesion and epithelial (E)-cadherin-mediated cell-cell adhesion plays a critical role in the establishment of ovarian cancer metastases. In contrast to most epithelial cell-derived tumors that down-regulate E-cadherin expression during progression, acquisition of E-cadherin expression accompanies malignant transformation of the ovarian ...",
               "predicate": null
            }
         ],
         "row": 392,
         "id": 307684965214711755
      },
      {
         "claim": "Stiff substrates inhibit mesodermal differentiation by degrading beta-catenin in an integrin-dependent manner.",
         "label": 1,
         "prediction": 1,
         "rationale": "Integrins, particularly integrin αV and integrin α5, play a crucial role in mesodermal differentiation by mediating interactions between cells and the extracellular matrix. Stiff substrates do not degrade β-catenin in an integrin-dependent manner. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of integrin in mesodermal differentiation?",
               "answer": "Integrins play a crucial role in mesodermal differentiation by mediating interactions between cells and the extracellular matrix (ECM). Specifically, integrin αV and integrin α5 have been implicated in the differentiation processes of mesodermal cells. The evidence suggests that integrin αVβ5 is involved in",
               "rationale": "1. ABSTRACT. We have examined the role of cell-cell and cell-extracellular matrix (ECM) interactions during mesoderm differentiation and migration at the primitive streak of the mouse embryo with the use of function-perturbing antibodies. Explants of epiblast or mesoderm tissue dissected from the primitive streak of 7.5- to 7.8-day mouse embryos were cultured on a fibronectin substratum in serum ...\n2. The three germ layers — mesoderm, endoderm and ectoderm — constituting the cellular blueprint for the tissues and organs that will form during embryonic development, are specified at gastrulation. Cells of mesodermal origin are the most abundant in the human body, representing a great variety of cell types, including the musculoskeletal ...\n3. Further data on the role of integrin αV in DE differentiation were also shown through a short hairpin RNA-mediated conditional knockdown of integrins αV and α5 in hESC.31 Integrin αVβ5 has been demonstrated ... respectively,51,52 and gene mutation of integrin α5 leads to mesodermal defects in mice embryogenesis.53 These data imply that ...\n4. Many cellular responses during development are regulated by interactions between integrin receptors and extracellular matrix proteins (ECMPs). Although the majority of recent studies in human ...\n5. Overview of the mesodermal ... these results show that Foxc1 and Foxc2 are essential for paraxial mesoderm differentiation and fate determination. ... and integrin during pericardial coelom ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does stiff substrate degrade beta-catenin in an integrin-dependent manner?",
               "answer": "No, the evidence suggests that stiff substrates do not degrade β-catenin in an integrin-dependent manner. Instead, the integrin-activated β-catenin/Wnt pathway forms a positive feedback loop that promotes Wnt signaling in response to stiff extracellular matrix (ECM). Additionally, the phosphorylation of β-caten",
               "rationale": "1. The integrin-activated β-catenin/Wnt pathway connects with canonical Wnt/β-catenin pathway to form a positive feedback loop, which is crucial to the promotion of Wnt signal by stiff ECM and the ...\n2. Our finding of integrin-dependent tyrosine phosphorylation of Y654-β-catenin is important because phosphorylation of β-catenin at Y654 is known to promote both dissociation of β-catenin from E-cadherin and stabilization of β-catenin from ubiquitination and degradation ( Brembeck et al., 2006 ).\n3. These results indicate that β1 integrin-dependent adhesion signaling plays a decisive role in matrix stiffness-modulated Cav1 protein turnover, and suggest that reciprocal regulation between β1 ...\n4. On substrates with reduced stiffness, Piezo1 is potentiated to mediate Ca 2+ influx and thereby activates calpain, leading to the degradation of integrin-β1 and the stabilization of E-cadherin, which finally promotes DRG neuron aggregation.\n5. Thus, while stiffness-induced activation of the Wnt and mechanotransduction pathways promotes osteogenesis on MC-GAG, activated β-catenin is a limiting agent and may serve as a useful target or readout for optimal modulation of stiffness in skeletal regenerative materials. Keywords: Wnt; beta-catenin; bone regeneration; nanoparticulate ...",
               "predicate": null
            }
         ],
         "row": 393,
         "id": 164652976531557848
      },
      {
         "claim": "Stroke patients with prior use of direct oral anticoagulants have a higher risk of in-hospital mortality than stroke patients with prior use of warfarin.",
         "label": 0,
         "prediction": 0,
         "rationale": "Direct oral anticoagulants (DOACs) significantly reduce the risk of ischemic stroke in patients with atrial fibrillation, and are at least as effective and safe as traditional vitamin K antagonists like warfarin. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of direct oral anticoagulants on stroke patients?",
               "answer": "Direct oral anticoagulants (DOACs) have a significant effect on reducing the risk of ischemic stroke in patients with atrial fibrillation (AF). Since their introduction, DOACs have been shown to be at least as effective and safe as traditional vitamin K antagonists (VKAs) like warfarin",
               "rationale": "1. Direct oral anticoagulants (DOACs) have been the drug of choice for preventing ischemic stroke in patients with atrial fibrillation since 2014. In previous studies, the stroke risk while taking warfarin was 2 per 100 patient‐years and 1.5% per year while taking DOACs. We hypothesized that even if ...\n2. Since the pivotal RE‐LY (Randomized Evaluation of Long‐Term Anticoagulation Therapy) trial 11 in 2009, the introduction of direct oral anticoagulants (DOACs) has revolutionized stroke prevention in AF, with all DOACs showing superior or noninferior efficacy and safety compared with vitamin K antagonists (VKAs). However, slight discrepancies remain between the results of each drug's ...\n3. Direct oral anticoagulant (DOAC) therapy is the first‐line oral anticoagulant therapy for patients with atrial fibrillation (AF). 1, 2, 3 Nevertheless, despite receiving DOAC therapy, ≈1% to 2% of patients with AF still experience stroke. 4 The causes are multifactorial, including off‐label drug dose, 5 poor drug adherence, 6 insufficient ...\n4. Abstract. Vitamin K antagonists, such as warfarin, have been the anticoagulants of choice for many years for patients with AF and other thrombotic conditions. The introduction of direct oral anticoagulants (DOACs) as alternatives represents a major advance in anticoagulation. DOACs have been found to be at least as safe and effective as vitamin ...\n5. Abstract. Direct oral anticoagulants (DOACs) are a more manageable alternative than vitamin K antagonists (VKAs) to prevent stroke in patients with nonvalvular atrial fibrillation and to prevent and treat venous thromboembolism. Despite their widespread use in clinical practice, there are still some unresolved issues on optimizing their use in ...",
               "predicate": null
            }
         ],
         "row": 394,
         "id": 180035688177713939
      },
      {
         "claim": "Students who perform poorly in the early years of medical school are at increased risk for professional misconduct later in their careers.",
         "label": 1,
         "prediction": 1,
         "rationale": "Professional misconduct in the context of medical careers refers to any practice or action by healthcare professionals that deviates from established ethical and professional standards and guidelines. There is a correlation between poor performance in the early years of medical school and an increased risk of professional misconduct later in their careers. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of professional misconduct in the context of medical careers?",
               "answer": "Professional misconduct in the context of medical careers refers to any practice or action by healthcare professionals, such as nurses and doctors, that deviates from established ethical and professional standards and guidelines. This misconduct can have serious consequences, including physical and mental harm to patients, loss of trust in the healthcare system, and potential disciplinary actions against",
               "rationale": "1. Professional misconduct refers to any practice or action by nurses that deviates from the established ethical and professional standards and guidelines [8, 9]. Professional misconduct in nursing is a multifaceted issue with wide-ranging outcomes in patient safety (physical and mental harm or even death), trust in the healthcare system, and ...\n2. In the light of its surprising absence in extant literature in the domain of the sociology of work, specifically within the journal Work, Employment and Society, this article represents a 'call to arms' for research focused upon professional misconduct in healthcare.Specifically, interrogation of four dimensions of professional misconduct in healthcare is called for: a broader definition ...\n3. related to the definition of professional misconduct. Indeed, the loose definition of the 'standard expected among doctors' is a double-edged sword. It can be applied so sub-jectively that the defendant doctor and Counsel cannot help but feel the outcome of disciplinary hearings is completely at the whim of the particular members involved ...\n4. The obligation to address misconduct falls on both individual physicians and on the profession as a whole. The goal of disciplinary review is both to protect patients and to help ensure that colleagues receive appropriate assistance from a physician health program or other service to enable them to practice safely and ethically.\n5. The paucity of research on professional misconduct in healthcare, coupled with an increase in public interest in such matters, makes it an important domain for research from a work sociology perspective. It is therefore surprising that Cooke (2006) apart, it has never been subject to specific analytical investigation in Work, Employment & Society.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is there a correlation between poor performance in early years of medical school and increased risk of professional misconduct later in their careers?",
               "answer": "Yes, there is a correlation between poor performance in the early years of medical school and an increased risk of professional misconduct later in their careers. Earlier studies mentioned in the evidence indicate a strong association between poor performance in preclinical years and serious professional misconduct in later practice. This suggests that students who struggle academically early on may be",
               "rationale": "1. Little recent published evidence explores the relationship between academic performance in medical school and performance as a junior doctor. Although many forms of assessment are used to demonstrate a medical student's knowledge or competence, these measures may not reliably predict performance in clinical practice following graduation. This descriptive cohort study explores the ...\n2. Earlier studies have shown a strong association between poor performance in preclinical years, burn out and serious professional misconduct in later practice.(7,8) Studies have also shown that males from lower socioeconomic backgrounds who routinely performed badly in their initial years of medical study tend to perform serious errors in their ...\n3. Objectives Differential attainment in school examinations is one of the barriers to increasing student diversity in medicine. However, studies on the predictive validity of prior academic achievement and educational performance at medical school are contradictory, possibly due to single-site studies or studies which focus only on early years' performance. To address these gaps, we examined ...\n4. Background Medical students are exposed to high amounts of stress. Stress and poor academic performance can become part of a vicious circle. In order to counteract this circularity, it seems important to better understand the relationship between stress and performance during medical education. The most widespread stress questionnaire designed for use in Medical School is the \"Perceived ...\n5. In a study on 491 first-, second-, and third-year medical students, there was a correlation between academic performance and the amount of nighttime sleep as well as daytime sleepiness. 25 In a similar study on medical students, lack of sleep at night, late going to bed, and daytime sleepiness had a negative effect on the academic performance ...",
               "predicate": null
            }
         ],
         "row": 395,
         "id": 203996964581018633
      },
      {
         "claim": "Students who perform poorly in the early years of medical school are less likely to commit professional misconduct later in their careers.",
         "label": 0,
         "prediction": 0,
         "rationale": "Professional misconduct in the context of medical careers refers to any practice or action by healthcare professionals that deviates from established ethical and professional standards and guidelines. There is no direct evidence to suggest a correlation between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers. There is no direct evidence to suggest a relationship between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers. The likelihood of committing professional misconduct later in their careers for students who perform poorly in the early years of medical school is not directly addressed by the provided evidence. There is no direct evidence on the likelihood of committing professional misconduct later in their careers for students who perform well in the early years of medical school. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of professional misconduct in the context of medical careers?",
               "answer": "Professional misconduct in the context of medical careers refers to any practice or action by healthcare professionals, such as nurses and doctors, that deviates from established ethical and professional standards and guidelines. It encompasses behaviors that are considered egregious and violate the norms of the profession, potentially leading to serious consequences such as disciplinary action, rev",
               "rationale": "1. Professional misconduct refers to any practice or action by nurses that deviates from the established ethical and professional standards and guidelines [8, 9]. Professional misconduct in nursing is a multifaceted issue with wide-ranging outcomes in patient safety (physical and mental harm or even death), trust in the healthcare system, and ...\n2. In the light of its surprising absence in extant literature in the domain of the sociology of work, specifically within the journal Work, Employment and Society, this article represents a 'call to arms' for research focused upon professional misconduct in healthcare.Specifically, interrogation of four dimensions of professional misconduct in healthcare is called for: a broader definition ...\n3. Serious professional misconduct is defined as behavior that is deemed particularly egregious and goes against the established norms of the profession. This can result in disciplinary action, including revocation of professional licenses or certifications.\n4. related to the definition of professional misconduct. Indeed, the loose definition of the 'standard expected among doctors' is a double-edged sword. It can be applied so sub-jectively that the defendant doctor and Counsel cannot help but feel the outcome of disciplinary hearings is completely at the whim of the particular members involved ...\n5. The paucity of research on professional misconduct in healthcare, coupled with an increase in public interest in such matters, makes it an important domain for research from a work sociology perspective. It is therefore surprising that Cooke (2006) apart, it has never been subject to specific analytical investigation in Work, Employment & Society.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is there a correlation between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers?",
               "answer": "The provided evidence snippets do not directly address the correlation between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers. The snippets focus on various aspects of academic performance, motivation, learning preferences, and the predictive validity of prior academic achievement, but they do not specifically explore the relationship between early",
               "rationale": "1. Background Little recent published evidence explores the relationship between academic performance in medical school and performance as a junior doctor. Although many forms of assessment are used to demonstrate a medical student's knowledge or competence, these measures may not reliably predict performance in clinical practice following graduation. Methods This descriptive cohort study ...\n2. Objectives Differential attainment in school examinations is one of the barriers to increasing student diversity in medicine. However, studies on the predictive validity of prior academic achievement and educational performance at medical school are contradictory, possibly due to single-site studies or studies which focus only on early years' performance. To address these gaps, we examined ...\n3. Introduction. Motivation matters in medical students' academic performance due to the highly intensive nature of medicine programs. For example, following a specifically defined path to become a doctor requires carrying out clinical work along with school courses [1,2].The types of motivation may vary, but they can be generally classified into two categories.\n4. Purpose: Students have diverse learning preferences that can impact the achievement of learning outcomes. However, there is a lack of unequivocal evidence for an association between the learning preferences and academic success. The purpose of the study was to examine the association between learning approaches and academic success of medical students during the basic science curriculum.\n5. The obtained data were included in the study. The inclusion criteria for the articles were as follows: being a correlation between study skill and stress with academic performance, observational study design, preclinical medical students, without any language, or time limitation from January 1987 to January 2018.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the relationship between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers?",
               "answer": "The provided evidence snippet does not directly address the relationship between students' early performance in medical school and their likelihood of committing professional misconduct later in their careers. While it discusses various aspects of academic performance, assessment methods, and the predictive validity of prior academic achievement, it does not specifically explore or provide findings related to professional misconduct.",
               "rationale": "1. Objectives. Differential attainment in school examinations is one of the barriers to increasing student diversity in medicine. However, studies on the predictive validity of prior academic achievement and educational performance at medical school are contradictory, possibly due to single-site studies or studies which focus only on early years' performance.\n2. Background. While we know the purpose of medical schools is to educate and train medical students in preparation for the role of junior doctor, the role of the medical student and the role of the junior doctor are different [].If assessment is matched to role, it may be difficult therefore, to assess medical students' readiness to begin practice as a junior doctor, and to ensure that ...\n3. Little recent published evidence explores the relationship between academic performance in medical school and performance as a junior doctor. Although many forms of assessment are used to demonstrate a medical student's knowledge or competence, these measures may not reliably predict performance in clinical practice following graduation. This descriptive cohort study explores the ...\n4. To address this gap, our aim was to identify the relationship between academic performance and rural practice intention. Methods: Data were collected via a cross-sectional (self-report) survey in 2021. Participants were students from 60 of the 96 rural order directed (RODs) medical programmes across China. We asked students their rural practice ...\n5. Consistent with these concerns, the purpose of this study was to examine the relationship between students' performance on a medical school's third-year Objective Structured Clinical Skills Examination (OSCE) and Step 2 CS. We expected positive relationships because of similarities in the structure and content of the two tests.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the likelihood of committing professional misconduct later in their careers for students who perform poorly in the early years of medical school?",
               "answer": "The provided evidence does not directly address the likelihood of committing professional misconduct later in their careers for students who perform poorly in the early years of medical school. However, it does highlight the importance of ethical standards and professional conduct in healthcare, suggesting that those who enter the field with a strong ethical foundation are less likely to engage in",
               "rationale": "1. Background. Nurses play a vital role in ensuring patients' well-being and recovery. They are patients' trustworthy caregivers, advocates, and instructors [].According to the code of ethics for nurses, they have the responsibility for protecting the patient, society, and the profession against possible harm [].Maintaining nurses' ethical standards and professional conduct is imperative in ...\n2. But for those who work in high-risk sectors and with vulnerable people - teachers and doctors, among others - the outcome of professional misconduct can be career-ending. Disciplinary bodies ...\n3. Such issue is especially true while students progress from high school to college, from first degree to a Master's degree and then to a Ph.D. degree. In terms of fields of study, students from the field of business are ranked first in dishonesty and succeeded by engineering, while students in health sciences are found to be more ethical ...\n4. In the light of its surprising absence in extant literature in the domain of the sociology of work, specifically within the journal Work, Employment and Society, this article represents a 'call to arms' for research focused upon professional misconduct in healthcare.Specifically, interrogation of four dimensions of professional misconduct in healthcare is called for: a broader definition ...\n5. The obligation to report incompetent or unethical conduct that may put patients at risk is recognized in both the ethical standards of the profession and in law, and physicians should be able to report such conduct without fear or loss of favor. Reporting a colleague who is incompetent or who engages in unethical behavior is intended not only ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the likelihood of committing professional misconduct later in their careers for students who perform well in the early years of medical school?",
               "answer": "The provided evidence snippets do not directly address the likelihood of committing professional misconduct later in their careers for students who perform well in the early years of medical school. The focus of the evidence is on the consequences of professional misconduct in high-risk sectors, the ethical responsibilities of healthcare professionals, and the need for research on professional misconduct in",
               "rationale": "1. But for those who work in high-risk sectors and with vulnerable people - teachers and doctors, among others - the outcome of professional misconduct can be career-ending. Disciplinary bodies ...\n2. Background. Nurses play a vital role in ensuring patients' well-being and recovery. They are patients' trustworthy caregivers, advocates, and instructors [].According to the code of ethics for nurses, they have the responsibility for protecting the patient, society, and the profession against possible harm [].Maintaining nurses' ethical standards and professional conduct is imperative in ...\n3. Social Work Today. Vol. 15 No. 5 P. 20. Although infrequent, social workers' misconduct and negligence can lead to lawsuits, licensing board complaints, and other disciplinary action. Belinda was a clinical social worker in a prominent mental health center that serves adults, adolescents, and children. She was the clinical director of the ...\n4. In the light of its surprising absence in extant literature in the domain of the sociology of work, specifically within the journal Work, Employment and Society, this article represents a 'call to arms' for research focused upon professional misconduct in healthcare.Specifically, interrogation of four dimensions of professional misconduct in healthcare is called for: a broader definition ...\n5. Usually we pick up the pieces and move on. But for those who work in high-risk sectors and with vulnerable people—teachers and doctors, among others—the outcome of professional misconduct can ...",
               "predicate": null
            }
         ],
         "row": 396,
         "id": 145850237656476972
      },
      {
         "claim": "Suboptimal nutrition is a leading cause of premature death",
         "label": 1,
         "prediction": 1,
         "rationale": "Suboptimal nutrition refers to a nutritional status that is inadequate in energy and nutrient intakes, contributing to the development and progression of chronic diseases and predicting mortality, characterized by deficiencies or imbalances in dietary intake that do not meet the body's needs for optimal health and functioning. Suboptimal nutrition is a leading cause of premature death. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of suboptimal nutrition?",
               "answer": "Suboptimal nutrition refers to a nutritional status that is inadequate in energy and nutrient intakes, which can contribute to the development and progression of chronic diseases and predict mortality. It is characterized by deficiencies or imbalances in dietary intake that do not meet the body's needs for optimal health and functioning.",
               "rationale": "1. Nutrition Diagnosis Etiology Matrix. Below are the etiology categories and their definitions. Etiologies are grouped by the type of cause or contributing risk factor. In two specific instances, Access and Behavior etiologies, these alone may be the cause or contributing risk factor of the nutrition diagnosis or the practitioner may determine a ...\n2. Abstract. Demonstrating in an unambiguous manner that a diet, let alone a single product, 'optimizes' health, presents an enormous challenge. The least complicated is when the starting situation is clearly suboptimal, like with nutritional deficiencies, malnutrition, unfavourable lifestyle, or due to disease or ageing.\n3. This study provides a comprehensive picture of the potential impact of suboptimal diet on NCD mortality and morbidity, highlighting the need for improving diet across nations. Our findings will inform implementation of evidence-based dietary interventions and provide a platform for evaluation of their impact on human health annually.\n4. Suboptimal nutritional status contributes to the development and progression of chronic diseases and predicts mortality [1,2,3].Inadequate energy and nutrient intakes are hallmarks of suboptimal ...\n5. Nutrition is one of the modifiable risk factors for cognitive decline and Alzheimer's disease (AD) dementia, and is therefore highly relevant in the context of prevention. ... and a higher trans-fat intake with poorer executive functioning. In conclusion, a suboptimal diet is associated with more severely impaired cognition-this association is ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is suboptimal nutrition a leading cause of premature death?",
               "answer": "Yes, suboptimal nutrition is a leading cause of premature death. The evidence indicates that a significant proportion of deaths from major non-communicable diseases, such as coronary artery disease, cancer, and stroke, could be prevented through improvements in dietary quality. Additionally, suboptimal diet quality is identified as a leading risk factor",
               "rationale": "1. Suboptimal diet is an important preventable risk factor for non-communicable diseases (NCDs); however, its impact on the burden of NCDs has not been systematically evaluated. ... Cardiovascular disease was the leading cause of diet-related deaths (10 million [9-10] deaths) and DALYs (207 million [192-222] DALYs), followed by cancers (913 ...\n2. About 1 in 3 deaths due to coronary artery disease (PAF = 35.8%) could be prevented by a global improvement in dietary quality from current national diets to the reference healthy diet. The improvement in dietary quality could prevent about 1 in 6 premature deaths due to cancer (PAF = 16.4%) and stroke (PAF = 17.1%).\n3. Suboptimal diet quality is the leading risk factor for death from major noncommunicable diseases in the United States. 18 A comprehensive systematic review recently concluded that the highest-quality diet scores were associated with lower risk of all-cause mortality, CVD incidence or mortality, cancer incidence or mortality, type 2 diabetes ...\n4. Suboptimal diet is the leading risk factor for death and disability in the United States and worldwide. 1,2 Among disadvantaged populations in all nations, hunger and malnutrition cause enormous suffering. Simultaneously, diet-related cardiometabolic diseases such as coronary heart disease (CHD), stroke, type 2 diabetes mellitus, and obesity produce even larger global health burdens.\n5. Poor diet is a leading cause of disease worldwide, ... (optimal or suboptimal ... D. D. et al. Global improvement in dietary quality could lead to substantial reduction in premature death. J.",
               "predicate": null
            }
         ],
         "row": 397,
         "id": 325562177296035802
      },
      {
         "claim": "Surfactin producing cells and exopolymer producing cells cooperate to generate \"Van Gogh\" bundles that have sliding abilities on specialized media.",
         "label": 1,
         "prediction": 1,
         "rationale": "Surfactin is a cyclic lipopeptide produced by the bacterium Bacillus subtilis, known for its antimicrobial, antibacterial, and antiviral properties. Surfactin functions in cells primarily as an antibiotic, exhibiting antibacterial, antiviral, antifungal, and hemolytic effects, and also plays a role in cell differentiation and motility. Surfactin-producing cells and exopolymer-producing cells cooperate to generate \"van Gogh\" bundles. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Surfactin?",
               "answer": "Surfactin is a cyclic lipopeptide produced by the bacterium Bacillus subtilis. It is an effective biosurfactant known for its antimicrobial, antibacterial, and antiviral properties. Surfactin is an amphiphile, meaning it can function in both hydrophilic and hydrophobic environments, and it",
               "rationale": "1. Surfactin is a cyclic lipopeptide, commonly used as an antibiotic for its capacity as a surfactant. [2] It is an amphiphile capable of withstanding hydrophilic and hydrophobic environments.\n2. Surfactin, a cyclic lipopeptide produced by microbes belonging to the genus Bacillus, is one of the most effective biosurfactants available in many industrial fields. However, its low production and high cost have intensively constrained its commercial ...\n3. Surfactin. Surfactin is a cyclic lipopeptide produced by Bacillus subtilis that exhibits antimicrobial, antibacterial, and antiviral properties. It is widely used in various industries due to its ability to lower surface tension and act on both hydrophobic and hydrophilic environments.\n4. Surfactant, substance such as a detergent that, when added to a liquid, reduces its surface tension, thereby increasing its spreading and wetting properties. In the dyeing of textiles, surfactants help the dye penetrate the fabric evenly. Learn more about surfactants in this article.\n5. Surfactin, a lipopeptide-type biosurfactant produced by the gram-positive, endospore-producing bacteria Bacillus subtilis, is one of the most efficient biosurfactants. Surfactin is comprised of seven amino acids linked to carboxyl and hydroxy groups on long-chain fatty acids (C13-C15).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of Surfactin in cells?",
               "answer": "Surfactin functions in cells primarily as an antibiotic, exhibiting antibacterial, antiviral, antifungal, and hemolytic effects. It also plays a role in the differentiation of specialized cell types by inhibiting the motility of certain cell subpopulations while promoting swarming in non-motile cells. Additionally, surfact",
               "rationale": "1. 2. Structure and physicochemical properties of surfactin. The discovery history of surfactin could date back to 1968, when this biologically active secondary metabolite was first identified in cultures of Bacillus subtilis strains .The structure of surfactin has a cyclic peptide chain with 7 amino acids and a 13-16 carbon atom hydroxy fatty acid chain, which together create a cyclic lactone ...\n2. Surfactin is a cyclic lipopeptide, commonly used as an antibiotic for its capacity as a surfactant. It is an amphiphile capable of withstanding hydrophilic and hydrophobic environments. The Gram-positive bacterial species Bacillus subtilis produces surfactin for its antibiotic effects against competitors. Surfactin showcases antibacterial, antiviral, antifungal, and hemolytic effects.\n3. Surfactin inhibits the motility of certain cell subpopulations, although it helps the non-motile cells to swarm. Thus, surfactin plays significant roles in the differentiation of different subpopulations of specialized cell types of B ... In addition to its function as a biosurfactant, surfactin exhibits antibacterial and antitumor properties.\n4. Surfactin, a cyclic lipopeptide produced by microbes belonging to the genus Bacillus, is one of the most effective biosurfactants available in many industrial fields. However, its low production and high cost have intensively constrained its commercial applications. In this review, we first summarize the molecular structure, biological properties, beneficial roles and potential applications of ...\n5. E ven after forty years of its discovery by Arima et al7, surfactin, a potent lipopeptide biosurfactant, still attracts attention and fancy of the applied microbiologists and biotechnologists worldwide, mainly due to its versatile bioactive properties and potential industrial implications. Starting from its first invented characteristic as an ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do Surfactin producing cells and exopolymer producing cells cooperate to generate \"Van Gogh\" bundles?",
               "answer": "Yes, surfactin-producing cells and exopolymer-producing (EPS-producing) cells cooperate to generate \"van Gogh\" bundles. Evidence 2 specifically states that at the vanguard of a sliding population, these two types of cells work together to create the characteristic bundles, indicating a coordinated effort and division of labor between the",
               "rationale": "1. At this early growth phase, matrix-producing cells do form multicellular clumps, but these clumps lack the tight alignment of cells that characterizes the van Gogh bundles. Thus, the mere presence of surfactin-producing and matrix-producing cells does not guarantee the formation of van Gogh bundles.\n2. At the vanguard of a sliding population, combinations of surfactin-producing cells and EPS-producing cells cooperate to generate \"van Gogh\" bundles characteristic of sliding on specialized media . The coordinated activities of cell subpopulations within a colony indicates orchestration of multiple events to promote cooperative sliding.\n3. The two cell types perform two complementary and essential tasks, resulting in a division of labor. (C) Spatial organization: the matrix-producing cells form van Gogh bundles, consisting of highly aligned and interconnected cells. Surfactin-producing cells are excluded from the bundles and have no particular spatial arrangement. (D) Collective ...\n4. The TasA protein, which is the major structural protein component of B. subtilis biofilms, only accumulated at the cell poles of TasA-producing cells inside the van Gogh bundle. Using a mathematical model, it was proposed that TasA might affect bundle rigidity through pole-pole interactions and therefore affect folding of the van Gogh bundles ...\n5. Surfactin-producing cells facilitate migration by reducing the friction between cells and their substrate, thereby allowing matrix-producing cells to organize themselves into bundles that form ...",
               "predicate": null
            }
         ],
         "row": 398,
         "id": 146029727266715477
      },
      {
         "claim": "Surgical treatment is not superior to non-surgical in treating adults with displaced fractures of the proximal humerus.",
         "label": 1,
         "prediction": 1,
         "rationale": "Displaced fractures of the proximal humerus are defined as fractures where the major parts of the proximal humerus are separated or misaligned. Surgical treatment for adults with displaced fractures of the proximal humerus does not result in better shoulder functional outcomes compared to non-surgical treatment, although it may have an impact on health-related quality of life. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of displaced fractures of the proximal humerus?",
               "answer": "Displaced fractures of the proximal humerus are defined as fractures where the major parts of the proximal humerus are separated or misaligned. The severity of these fractures is categorized based on the number of parts that are displaced, which can be classified as 2-part, 3-part, or 4-part fractures. A",
               "rationale": "1. The proximal end of your humerus is the top. The distal end is the bottom. So, if you have a proximal humerus fracture, your upper arm bone is broken near its top — the end that connects to your shoulder. Similarly, if you have a distal humerus fracture that means your bone is broken at the bottom, closer to your elbow.\n2. In proximal humerus fractures, the severity is often described by how many of the major parts of the proximal humerus fracture are displaced. There are four \"parts\" of the proximal humerus, so a displaced fracture can either be 2-part, 3-part, or 4-part (a non-displaced fracture is, by definition, 1-part).\n3. A proximal humerus fracture is when the top part of the upper arm bone, which is shaped like a ball, is broken. It may also be referred to as a shoulder fracture. The most common cause of proximal humerus fractures is a fall particularly when falling onto an outstretched hand. High speed motor vehicle accidents are another common cause.\n4. Proximal humerus fractures (PHF) account for 5-6% of all adult fractures[1]. There is increasing recognition given in regard to managing these fractures in the setting of elderly, low-energy falls as these events are contributing to the global impact of direct and indirect costs of osteoporosis and fragility fractures. Moreover, as the general population continues to age and an increasing ...\n5. A proximal humerus fracture usually occurs close to the shoulder joint and can be located at different levels with different fracture patterns: simple or comminuted. A humerus shaft fracture, on the other hand, is one that is localized at the mid portion of the upper arm.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the outcome of surgical treatment compared to non-surgical treatment for adults with displaced fractures of the proximal humerus?",
               "answer": "The outcome of surgical treatment compared to non-surgical treatment for adults with displaced fractures of the proximal humerus indicates that surgery does not result in better shoulder functional outcomes, as measured by the Constant-Murley Score, when compared with conservative and non-surgical treatments. However, health-related quality of life (QoL)",
               "rationale": "1. Importance: The need for surgery for the majority of patients with displaced proximal humeral fractures is unclear, but its use is increasing. Objective: To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck. Design, setting, and participants: A pragmatic, multicenter, parallel-group ...\n2. A Cochrane review by Handoll and Brorson 18 suggested that \"there is high or moderate quality evidence that, compared with non-surgical treatment, surgery does not result in a better outcomes at one and two years after injury for people with displaced proximal humeral fractures involving the humeral neck\". It is important to note however ...\n3. Conclusions: Surgical treatment of displaced, multi-fragment fractures of the proximal humerus did not improve shoulder functional outcome, based on the Constant-Murley Score, when compared with conservative and non-surgical treatments. However, health-related QoL was significantly improved with surgical treatment compared with conservative ...\n4. The ProFHER RCT 6 evaluated the clinical and cost-effectiveness of surgery compared with conservative treatment of displaced proximal humerus fractures involving the surgical neck. The study included adults aged 16 or over presenting within 3 weeks of the injury. Radiographs were assessed to confirm displacement and involvement of the surgical ...\n5. Authors' conclusions: There is high- or moderate-certainty evidence that, compared with non-surgical treatment, surgery does not result in a better outcome at one and two years after injury for people with displaced proximal humeral fractures. It may increase the need for subsequent surgery. The evidence is absent or insufficient for people ...",
               "predicate": null
            }
         ],
         "row": 399,
         "id": 295627394426845103
      },
      {
         "claim": "Sympathetic nerve activity is elevated throughout normal pregnancy.",
         "label": 1,
         "prediction": 1,
         "rationale": "Sympathetic nerve activity refers to the activation of the sympathetic nervous system, which triggers the body's stress response and results in physiological changes such as increased heart rate. Sympathetic nerve activity increases during normal pregnancy. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is sympathetic nerve activity?",
               "answer": "Sympathetic nerve activity refers to the activation of the sympathetic nervous system (SNS), which is responsible for the body's stress response. It is triggered when the brain perceives danger or stress, leading to the initiation of the \"fight-or-flight\" response. This activity results in various physiological changes, such as increased heart rate",
               "rationale": "1. Sympathetic Nervous System (SNS) Your sympathetic nervous system is a network of nerves that helps your body activate its \"fight-or-flight\" response. This system's activity increases when you're stressed, in danger or physically active. Its effects include increasing your heart rate and breathing ability, improving your eyesight and ...\n2. The sympathetic nervous system (SNS) is responsible for the body's stress response and is activated when you perceive danger. The brain sends messages to the rest of the body to prepare for and respond to danger, initiating a fight, flight, freeze, or fawn stress response. If the SNS is chronically activated, it can impact your health.\n3. The sympathetic nervous system (SNS) is one of the three divisions of the autonomic nervous system, ... whereby the central nervous system stimulates sympathetic nerve activity in specific target organs or tissues via neurohumoral signals. In terms of hypertension, the overactivation of the sympathetic system results in vasoconstriction and ...\n4. Nervous system breakdown (diagram) The autonomic nervous system (ANS) is a functional division of the nervous system that controls involuntary actions of muscles, glands and internal organs (e.g. bowel movements). Together with endocrine glands, the ANS affects important body functions without the direct involvement of the cerebral cortex.\n5. The sympathetic nervous system is a sub-system of your peripheral nervous system. Whenever you touch, taste, or see something, it's because nerves are sending impulses to your brain to help you ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does sympathetic nerve activity increase during normal pregnancy?",
               "answer": "Yes, sympathetic nerve activity increases during normal pregnancy. The evidence indicates that muscle sympathetic nerve activity (MSNA) is higher during early pregnancy compared to pre-pregnancy, and there is an increase in neural activity that is likely associated with increased neurotransmitter release. Additionally, the findings suggest that central sympathetic output is increased in",
               "rationale": "1. Associated Data. We conducted a systematic review and meta‐analysis to quantify the impact of healthy and complex pregnancy on muscle sympathetic nerve activity (MSNA) at rest, and in response to stress. Structured searches of electronic databases were performed until February 23, 2022. All study designs (except reviews) were included ...\n2. Muscle sympathetic nerve activity (MSNA) responses to upright tilt. MSNA burst frequency and burst incidence were higher during early pregnancy compared to pre-pregnancy. Upright tilt induced an increase in MSNA during both phases, and the magnitude of the responses was not different from pre- to early pregnancy.\n3. The increase in neural activity during pregnancy is likely manifest as an increase in neurotransmitter release. 38 Sympathetic nerve firing results in the release of neurotransmitters, including norepinephrine and neuropeptide Y, which are stored in vesicles in nerve terminals. 39 Concentrations of circulating plasma norepinephrine have long ...\n4. Conclusions Central sympathetic output was increased in women with normal pregnancy and was even greater in the hypertensive pregnant group. The findings suggest that the moderate sympathetic hyperactivity during the latter months of normal pregnancy may help to return the arterial pressure to nonpregnant levels, although when the increase in activity is excessive, hypertension may ensue.\n5. We tested the hypothesis that sympathetic activation occurs early during pregnancy in humans. Eleven healthy women (29 ± 3 (SD) years) without prior hypertensive pregnancies were tested during the mid-luteal phase (PRE) and early pregnancy (EARLY; 6.2 ± 1.2 weeks of gestation). Muscle sympathetic nerve activity (MSNA) and haemodynamics were ...",
               "predicate": null
            }
         ],
         "row": 400,
         "id": 204146531398929966
      },
      {
         "claim": "Sympathetic nerve activity is reduced throughout normal pregnancy.",
         "label": 0,
         "prediction": 0,
         "rationale": "Sympathetic nerve activity refers to the activation of the sympathetic nervous system, which prepares the body to respond to perceived danger or stress by initiating the \"fight-or-flight\" response. Sympathetic nerve activity does not decrease during normal pregnancy, but rather increases to counteract primary vasodilation. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is sympathetic nerve activity?",
               "answer": "Sympathetic nerve activity refers to the activation of the sympathetic nervous system (SNS), which is a part of the autonomic nervous system responsible for the body's stress response. When the SNS is activated, it prepares the body to respond to perceived danger or stress by initiating the \"fight-or-flight\" response. This includes physiological",
               "rationale": "1. Sympathetic Nervous System (SNS) Your sympathetic nervous system is a network of nerves that helps your body activate its \"fight-or-flight\" response. This system's activity increases when you're stressed, in danger or physically active. Its effects include increasing your heart rate and breathing ability, improving your eyesight and ...\n2. The sympathetic nervous system (SNS) is responsible for the body's stress response and is activated when you perceive danger. The brain sends messages to the rest of the body to prepare for and respond to danger, initiating a fight, flight, freeze, or fawn stress response. If the SNS is chronically activated, it can impact your health.\n3. The sympathetic nervous system (SNS) is one of the three divisions of the autonomic nervous system, ... whereby the central nervous system stimulates sympathetic nerve activity in specific target organs or tissues via neurohumoral signals. In terms of hypertension, the overactivation of the sympathetic system results in vasoconstriction and ...\n4. Nervous system breakdown (diagram) The autonomic nervous system (ANS) is a functional division of the nervous system that controls involuntary actions of muscles, glands and internal organs (e.g. bowel movements). Together with endocrine glands, the ANS affects important body functions without the direct involvement of the cerebral cortex.\n5. The sympathetic nervous system is a sub-system of your peripheral nervous system. Whenever you touch, taste, or see something, it's because nerves are sending impulses to your brain to help you ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does sympathetic nerve activity decrease during normal pregnancy?",
               "answer": "No, sympathetic nerve activity does not decrease during normal pregnancy. In fact, the evidence indicates that there is an increase in basal sympathetic nerve activity during normal pregnancy, which helps counteract the profound primary vasodilation that occurs.",
               "rationale": "1. Eleven healthy women (29 ± 3 (SD) years) without prior hypertensive pregnancies were tested during the mid-luteal phase (PRE) and early pregnancy (EARLY; 6.2 ± 1.2 weeks of gestation). Muscle sympathetic nerve activity (MSNA) and haemodynamics were measured supine, at 30 deg and 60 deg upright tilt for 5 min each.\n2. Although hyperoxia did not reduce burst frequency in uncomplicated pregnancies (N = 42; MD: −2.45 bursts/min, ... Sympathetic nerve discharge in normal pregnancy and pregnancy‐induced hypertension. Journal of ... Regulation of sympathetic nerve activity during the cold pressor test in normotensive pregnant and nonpregnant women ...\n3. The increase in neural activity during pregnancy is likely manifest as an increase in neurotransmitter release. 38 Sympathetic nerve firing results in the release of neurotransmitters, including norepinephrine and neuropeptide Y, which are stored in vesicles in nerve terminals. 39 Concentrations of circulating plasma norepinephrine have long ...\n4. There is an increase in basal sympathetic nerve activity (SNA) during normal pregnancy; this counteracts profound primary vasodilation. However, pregnancy also impairs baroreflex control of heart rate and SNA, contributing to increased mortality secondary to peripartum hemorrhage. Pregnancy-induced hypertensive disorders evoke even greater ...\n5. Abstract: The adaptations of sympathetic nerve activity (SNA) during pregnancy remain poorly understood. An increase in blood volume, cardiac output and SNA, with a concomitant drop in total peripheral resistance (TPR), suggest that during pregnancy there is a reduced transduction of SNA into TPR. Most of these findings have originated from ...",
               "predicate": null
            }
         ],
         "row": 401,
         "id": 127299371508318409
      },
      {
         "claim": "Systemic immunosuppressive (IS) therapy does not enhance the chance of cancer mortality in patients with inflammatory eye disease (IED)",
         "label": 1,
         "prediction": 0,
         "rationale": "The effect of systemic immunosuppressive therapy on cancer mortality in patients with immune-mediated eye diseases appears to be complex. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of systemic immunosuppressive therapy on cancer mortality in patients with IED?",
               "answer": "The effect of systemic immunosuppressive therapy on cancer mortality in patients with immune-mediated eye diseases (IED) appears to be complex. According to the evidence provided, during a follow-up period of over 187,151 person-years, there were 1970 deaths observed, with 435 of those due to cancer.",
               "rationale": "1. Therefore, the OID group is an ideal cohort in which to study the relationship between immunosuppressive therapy use and cancer. In the companion paper (Kempen et al5), the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study evaluated all eligible patients at academic ocular inflammation practices in the USA. Among the 15 ...\n2. With the increasing use of immuno-therapeutic agents, it is vital for physicians to acquaint themselves with these adverse effects. The aim of this review is to investigate the common systemic adverse effects and toxicities associated with the use of different classes of immunotherapeutic agents. We provide an overview of potential adverse ...\n3. Thus, therapeutic strategies targeting these immunosuppressive cells include remodeling the TME and increasing the anti-tumor efficacy of immunotherapies. However, even achieved certain success in preclinical studies, some therapies or targets presented limited effectiveness in clinical patients.\n4. Over 187 151 person-years (median follow-up 10.0 years), during which 15 938 patients were at risk for mortality, we observed 1970 deaths, 435 due to cancer. Both patients unexposed to immunosuppressants (standardized mortality ratio [SMR] = 0.95, 95% confidence interval [CI], 0.90-1.01) and those exposed to immunosuppressants but free of ...\n5. Immunosuppression is widely used for immune-mediated disease management. 1, 2 Some of the major benefits of immunosuppression include direct anti-inflammatory effects and avoiding risks of long-term higher-dose corticosteroid therapy by allowing corticosteroid dosage reduction. 3, 4 However, a reasonable rationale exists that immunosuppressive drugs might cause cancer; 2 in fact, the ...",
               "predicate": null
            }
         ],
         "row": 402,
         "id": 172047979227074734
      },
      {
         "claim": "Systemic immunosuppressive (IS) therapy increases the chance of cancer mortality in patients with inflammatory eye disease (IED)",
         "label": 0,
         "prediction": 0,
         "rationale": "Systemic immunosuppressive therapy can help suppress the immune inflammatory response in patients with inflammatory eye disease, preserving the integrity of the eye and maintaining visual function. Systemic immunosuppressive therapy may increase the risk of cancer in patients with inflammatory eye disease. Systemic immunosuppressive therapy does not definitively increase the chance of cancer mortality in patients with inflammatory eye disease. Systemic immunosuppressive therapy is not significantly associated with an increased cancer mortality rate in patients with inflammatory eye disease. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of systemic immunosuppressive therapy on patients with inflammatory eye disease?",
               "answer": "Systemic immunosuppressive therapy can be beneficial for patients with inflammatory eye disease by helping to suppress the immune inflammatory response, which is crucial for preserving the integrity of the eye and maintaining visual function. This therapy is particularly indicated for patients who require chronic oral corticosteroid therapy, especially at higher doses, as it may help",
               "rationale": "1. Anterior uveitis is typically treated with topical steroids; however, systemic steroids and other immunosuppressive agents may be required for all forms of uveitis. Scleritis causes severe pain worsened by eye movements and palpation and is treated with either oral non-steroidal antiinflammatory drugs or systemic steroids.\n2. This recommendation falls into line with the most recent expert panel guidelines for the use of immunosuppressive agents in ocular inflammatory disorders, which concluded that \"patients who require chronic oral corticosteroid therapy, especially at doses greater than 10 mg per day, may require immunosuppressive drug therapy.\"¹.\n3. Immunosuppressants are drugs that prevent your immune system from attacking healthy cells and tissues by mistake. Healthcare providers prescribe immunosuppressants to treat certain autoimmune diseases and prevent organ or stem cell transplant rejection. These medications also increase your risk of infection because your immune system isn't ...\n4. With the increasing use of immuno-therapeutic agents, it is vital for physicians to acquaint themselves with these adverse effects. The aim of this review is to investigate the common systemic adverse effects and toxicities associated with the use of different classes of immunotherapeutic agents. We provide an overview of potential adverse ...\n5. New modalities and effective therapies to control ocular inflammatory disease have been developed. The goal of therapy is to suppress the immune inflammatory response in order to preserve the integrity of the eye and therefore preserve visual function.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does systemic immunosuppressive therapy increase the risk of cancer in patients with inflammatory eye disease?",
               "answer": "The provided evidence suggests that there is a concern regarding the potential association between systemic immunosuppressive therapy and an increased risk of cancer in patients with ocular inflammatory disease (OID). While immunosuppressive therapy is effective for managing severe ocular inflammatory conditions and can reduce the need for higher doses of corticosteroids, there is a",
               "rationale": "1. Objective Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID).Methods and analysis We performed a retrospective cohort study of patients from 10 US OID subspecialty practices. Patients with non-infectious OID were included; HIV-infected patients were excluded. Time-dependent exposure to drug classes (ie ...\n2. Figure 2 Forest plot indicating the relative hazard of cancer mortality (CM) in association with classes of drugs and specific drugs in patients with ocular inflammatory diseases (OIDs) participating in the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.\n3. However, these agents also have side effects, which must be considered in each patient's management. In this report, we summarize the effectiveness and safety of immunosuppressive drug therapy utilized in the treatment of ocular inflammatory diseases. Keywords: drug safety, inflammation, immunosuppressive agents, treatment outcome, uveitis\n4. Immunosuppression is widely used for immune-mediated disease management. 1,2 Some of the major benefits of immunosuppression include direct anti-inflammatory effects and avoiding risks of long-term higher-dose corticosteroid therapy by allowing corticosteroid dosage reduction. 3,4 However, a reasonable rationale exists that immunosuppressive drugs might cause cancer; 2 in fact, the ...\n5. Although there is strong scientific evidence indicating the effectiveness of immunosuppression for severe ocular in-ammatory disease,1 patients and health care providers often fl ask whether the benets of systemic immunosuppressive fi therapy warrant potentially associated risks. The risk of developing a signi cant illness, such as cancer, is of fi particular interest. Accurate information ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does systemic immunosuppressive therapy increase the chance of cancer mortality in patients with inflammatory eye disease?",
               "answer": "The evidence provided does not definitively conclude that systemic immunosuppressive therapy increases the chance of cancer mortality in patients with inflammatory eye disease. While it is noted that there is a concern that immunosuppressive treatments may lead to an increased risk of cancer, the data presented shows that both patients unexposed to immun",
               "rationale": "1. Objective Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID).Methods and analysis We performed a retrospective cohort study of patients from 10 US OID subspecialty practices. Patients with non-infectious OID were included; HIV-infected patients were excluded. Time-dependent exposure to drug classes (ie ...\n2. Over 187 151 person-years (median follow-up 10.0 years), during which 15 938 patients were at risk for mortality, we observed 1970 deaths, 435 due to cancer. Both patients unexposed to immunosuppressants (standardized mortality ratio [SMR] = 0.95, 95% confidence interval [CI], 0.90-1.01) and those exposed to immunosuppressants but free of ...\n3. treatments may lead to increased risk of cancer.9 If even a modest increase in cancer risk were demonstrated, the indications for use of systemic immunosuppression for inflammatory diseases might change. Patients with non-infectious ocular inflammatory diseases (OID), eye- limited, immune-mediated diseases, often receive immu -\n4. Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group. ... 17 Ocular Inflammatory Disease Center, Jules Stein Eye Institute, ... during which 15,938 patients were at risk for mortality-we observed 1,970 deaths, 435 attributed to cancer. Both patients unexposed to immunosuppressants (Standardized Mortality Ratio ...\n5. Immunosuppression is widely used for immune-mediated disease management. 1, 2 Some of the major benefits of immunosuppression include direct anti-inflammatory effects and avoiding risks of long-term higher-dose corticosteroid therapy by allowing corticosteroid dosage reduction. 3, 4 However, a reasonable rationale exists that immunosuppressive drugs might cause cancer; 2 in fact, the ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the relationship between systemic immunosuppressive therapy and cancer mortality in patients with inflammatory eye disease according to the evidence?",
               "answer": "The evidence suggests that there is no significant association between systemic immunosuppressive therapy and cancer mortality in patients with inflammatory eye disease. In the retrospective cohort study involving 15,938 patients, the overall cancer mortality rate was not found to be increased among those exposed to immunosuppressants compared to those who were not.",
               "rationale": "1. Objective Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID).Methods and analysis We performed a retrospective cohort study of patients from 10 US OID subspecialty practices. Patients with non-infectious OID were included; HIV-infected patients were excluded. Time-dependent exposure to drug classes (ie ...\n2. between immunosuppressive therapy use and cancer. In the companion paper (Kempen 5), the Systemic et al Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study evaluated all eligible patients at academic ocular inflammation practices in the USA. Among the 15 938 subjects, the study found no evidence of increased overall or cancer ...\n3. Over 187 151 person-years (median follow-up 10.0 years), during which 15 938 patients were at risk for mortality, we observed 1970 deaths, 435 due to cancer. Both patients unexposed to immunosuppressants (standardized mortality ratio [SMR] = 0.95, 95% confidence interval [CI], 0.90-1.01) and those exposed to immunosuppressants but free of ...\n4. Immunosuppression is widely used for immune-mediated disease management. 1, 2 Some of the major benefits of immunosuppression include direct anti-inflammatory effects and avoiding risks of long-term higher-dose corticosteroid therapy by allowing corticosteroid dosage reduction. 3, 4 However, a reasonable rationale exists that immunosuppressive drugs might cause cancer; 2 in fact, the ...\n5. Objective: To determine the incidence of all-cause and cancer mortality in association with immunosuppression. Design: Retrospective cohort study at ocular inflammatory disease (OID) subspecialty centers. We harvested exposure and covariate data retrospectively from clinic inception (earliest in 1979) through 2010 inclusive.",
               "predicate": null
            }
         ],
         "row": 403,
         "id": 105183777973201288
      },
      {
         "claim": "Systemic lupus erythematosus is a risk factor for cardiovascular disease.",
         "label": 1,
         "prediction": 1,
         "rationale": "Systemic lupus erythematosus (SLE) is a disease, specifically an autoimmune disease where the body's immune system mistakenly attacks its own tissues and organs. Systemic lupus erythematosus is associated with cardiovascular disease. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is systemic lupus erythematosus a disease?",
               "answer": "Yes, systemic lupus erythematosus (SLE) is a disease. It is classified as an autoimmune disease where the body's immune system mistakenly attacks its own tissues and organs, leading to inflammation and damage.",
               "rationale": "1. Overview Lupus is a disease that occurs when your body's immune system attacks your own tissues and organs (autoimmune disease). Inflammation caused by lupus can affect many different body systems — including your joints, skin, kidneys, blood cells, brain, heart and lungs. Lupus can be difficult to diagnose because its signs and symptoms often mimic those of other ailments. The most ...\n2. Symptoms of systemic lupus erythematosus (SLE) vary from person to person and they may come and go and change over time. Lupus shares symptoms with other diseases, which can make it difficult to diagnose. The most common symptoms include: Skin rashes. Pain or swelling in the joints (arthritis)\n3. Systemic lupus erythematosus (SLE), often just called lupus, is: An autoimmune disease. This means the body's immune system mistakenly attacks its own healthy cells and tissues, leading to inflammation and damage in organs or systems. A long-term (chronic) disease that affects many different parts of the body.\n4. Lupus (Systemic Lupus Erythematosus) Lupus is an autoimmune disease that makes your immune system damage organs and tissue throughout your body. It causes inflammation that can affect your skin, joints, blood and organs like your kidneys, lungs and heart. A healthcare provider will help you find medications to manage your symptoms and reduce how often you experience flare-ups. Contents ...\n5. Systemic lupus erythematosus (lupus) is a chronic (long-lasting) autoimmune disease that can affect many parts of the body. Lupus occurs when the immune system, which normally helps protect the body from infection and disease, attacks its own tissues. This attack causes inflammation, and in some cases permanent tissue damage, which can be ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is systemic lupus erythematosus associated with cardiovascular disease?",
               "answer": "Yes, systemic lupus erythematosus (SLE) is associated with cardiovascular disease. The evidence indicates that cardiovascular disease is the leading cause of death in people with SLE, and the condition is linked to increased risks for accelerated atherosclerosis and various cardiovascular events. Additionally, the shared pathophysiology between",
               "rationale": "1. Lupus can affect the cardiovascular system, which includes your heart and blood vessels. In fact, cardiovascular disease, not lupus itself, is the number one cause of death in people with SLE. Therefore, it is very important that you take steps to maintain optimal cardiovascular health. Do not smoke, since smoking increases the risk of ...\n2. Systemic lupus erythematosus (SLE) is a disease with a relapsing-remitting autoimmune course that may affect practically any organ in the body. It is characterized by the generation of autoantibodies, the formation of immune complexes, and the deposition of autoantibodies, resulting in systemic inflammation and tissue damage [ 1 ].\n3. The article reviews the shared pathophysiology of SLE and cardiovascular disease along with the most common SLE- associated cardiac risks, events, and management. Keywords: metabolic syndrome, carditis, disrupted immune system, endothelial dysfunction, systemic lupus erythematosus\n4. Steroids and other immuno-suppressants are mainstay in the management of lupus myocarditis and pericarditis and treatment tailored according to the severity of the disease. The cardiovascular benefit of hydroxychloroquine is overwhelming compared to the small risk of cardiomyopathy.\n5. Systemic Lupus Erythematosus (SLE) is associated with increased risk for accelerated atherosclerosis and cardiovascular (CV) events including coronary heart disease, cerebrovascular and peripheral artery disease. CV events occur both early and late during the disease course, with younger patients be …",
               "predicate": null
            }
         ],
         "row": 404,
         "id": 299195595537599260
      },
      {
         "claim": "T cell receptor /CD3 microdomains are required to induce the immunologic synapse.",
         "label": 1,
         "prediction": 1,
         "rationale": "The immunological synapse is the interface between an antigen-presenting cell and a lymphocyte, such as a T cell, responsible for antigen recognition and T-cell activation. The presence of an antigen-presenting cell and a T cell, along with the recognition of antigens presented by the APC, is required to induce the immunological synapse. T cell receptor/CD3 microdomains are part of the factors that influence the formation of the immunological synapse. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the immunologic synapse?",
               "answer": "The immunological synapse (IS) is the interface between an antigen-presenting cell (APC) and a lymphocyte, such as a T cell. It is a critical structure responsible for antigen recognition and T-cell activation. The IS is characterized by specific arrangements of membrane proteins and can exhibit a mature synapse structure",
               "rationale": "1. Synapse formation was induced by Staphylococcal enterotoxin E superantigen. In immunology, an immunological synapse (or immune synapse) is the interface between an antigen-presenting cell or target cell and a lymphocyte such as a T cell, B cell, or natural killer cell. The interface was originally named after the neuronal synapse, with which it ...\n2. The molecular interactions underlying regulation of the immune response take place in a nano-scale gap between T cells and antigen presenting cells, termed the immunological synapse. If these interactions are regulated appropriately, the host is defended ...\n3. An immunological synapse (IS) is formed at the interface between antigen-presenting cells and T cells, and is believed to be the structure responsible for antigen recognition and T-cell activation. However, recent imaging analyses reveal that T-cell receptor microclusters (MCs) formed prior to IS are the site for antigen recognition and T-cell ...\n4. The immunological synapse has been an area of very active scientific interest over the last decade. Surprisingly, much about the synapse remains unknown or is controversial. Here we review some of these current issues in the field: how ...\n5. The term immunological synapse (IS) refers to the contact site between a T cell and an antigen-presenting cell (APC). In some cases, the IS exhibits a specific arrangement of membrane proteins, with separation of receptors into a pattern referred to as a mature synapse. In the mature synapse, a central structure called the central ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is required to induce the immunologic synapse?",
               "answer": "To induce the immunological synapse, the presence of an antigen-presenting cell (APC) and a T cell is required, along with the recognition of antigens presented by the APC. Additionally, the formation of the immunological synapse can be influenced by factors such as superantigens (e.g., St",
               "rationale": "1. Abstract. The molecular interactions underlying regulation of the immune response take place in a nano-scale gap between T cells and antigen presenting cells, termed the immunological synapse. If these interactions are regulated appropriately, the host is defended against a wide range of pathogens and deranged host cells.\n2. Synapse formation was induced by Staphylococcal enterotoxin E superantigen. In immunology, an immunological synapse (or immune synapse) is the interface between an antigen-presenting cell or target cell and a lymphocyte such as a T cell, B cell, or natural killer cell. The interface was originally named after the neuronal synapse, with which it ...\n3. The immunological synapse has been an area of very active scientific interest over the last decade. Surprisingly, much about the synapse remains unknown or is controversial. ... This suggests that stable T-DC interactions may be important to induce the formation of immunological memory, but not required for other early aspects of T-cell ...\n4. T cells continuously scan for antigens presented by potentially infected or cancerous cells in our body. The immunological synapse is a tight, yet highly dynamic contact formed between the T cell and the antigen-presenting cell. Mechanical, chemical, and electrical signals are integrated during this contact to initiate an immune response. In this work, we focus on Kv1.3, the main voltage-gated ...\n5. An immunological synapse (IS) is formed at the interface between antigen-presenting cells and T cells, and is believed to be the structure responsible for antigen recognition and T-cell activation. However, recent imaging analyses reveal that T-cell receptor microclusters (MCs) formed prior to IS are the site for antigen recognition and T-cell ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Are T cell receptor /CD3 microdomains part of the factors that influence the formation of the immunological synapse?",
               "answer": "Yes, T cell receptor/CD3 microdomains are part of the factors that influence the formation of the immunological synapse. Evidence from the snippets indicates that TCR microclusters, along with kinases and adaptors, are generated upon antigen recognition, which plays a crucial role in T cell activation and the formation of the",
               "rationale": "1. Abstract. The adaptive immune response is initiated by the interaction of T cell antigen receptors with major histocompatibility complex molecule-peptide complexes in the nanometer scale gap between a T cell and an antigen-presenting cell, referred to as an immunological synapse. In this review we focus on the concept of immunological synapse ...\n2. T cells are activated when a cluster of proteins on the cell surface, the T cell receptor complex, binds to molecules called antigens derived from pathogenic organisms or present on diseased cells.\n3. How membrane receptors initiate signal transduction upon ligand binding is a matter of intense scrutiny. The T cell receptor complex (TCR-CD3) is composed of TCRα/β ligand binding subunits bound to the CD3 subunits responsible for signal transduction. Although it has long been speculated that TCR-CD3 may undergo a conformational change, confirmation is still lacking. We present strong ...\n4. This interaction results in the formation of the immunological synapse, which had been considered to be responsible for antigen recognition and T cell activation. Recent advances in imaging analysis have provided new insights into T cell activation. The T cell receptor (TCR) microclusters, TCRs, kinases, and adaptors are generated upon antigen ...\n5. Abstract. The T cell receptor (TCR) is one of the most complicated receptors in mammalian cells, and its triggering mechanism remains mysterious. As an octamer complex, TCR comprises an antigen ...",
               "predicate": null
            }
         ],
         "row": 405,
         "id": 318926017680748481
      },
      {
         "claim": "TMEM27 is a marker for beta cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "TMEM27, also known as collectrin, is a transmembrane protein that plays a significant role in pancreatic β cells, regulating amino acid transporters and maintaining metabolic characteristics. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TMEM27?",
               "answer": "TMEM27, also known as collectrin, is a transmembrane protein that plays a significant role in pancreatic β cells. It is involved in the regulation of amino acid transporters and is essential for maintaining metabolic characteristics in these cells. TMEM27 expression is influenced by various factors, including genetic background and metabolic conditions",
               "rationale": "1. Expression of Tmem27 is reduced in Tcf1(-/-) mice and is increased in islets of mouse models with hypertrophy of the endocrine pancreas. Tmem27 forms dimers and its extracellular domain is glycosylated, cleaved and shed from the plasma membrane of beta cells. This cleavage process is beta cell specific and does not occur in other cell types.\n2. The signals and molecular mechanisms that regulate the replication of terminally differentiated β cells are unknown. Here, we report the identification and characterization of transmembrane protein 27 (Tmem27, collectrin) in pancreatic β cells. Expression of Tmem27 is reduced in Tcf1−/− mice and is increased in islets of mouse models with hypertrophy of the endocrine pancreas. Tmem27 ...\n3. As TMEM27 is an essential chaperone of amino acid transporters, it is tempting to speculate that loss of TMEM27 alters metabolic characteristics in tumor cells. In this regard, mice lacking TMEM27 display increased insulin sensitivity, and up-regulation of energy-generating processes, including carbohydrate and lipid oxidation [Citation 15].\n4. The TMEM127 gene provides instructions for making a protein that acts as a tumor suppressor protein, which means it prevents cells from growing and dividing too quickly or in an uncontrolled way. The TMEM127 protein controls a signaling pathway that leads to cell growth and survival. Research shows that this pathway, regulated by a protein complex called mTORC1, is blocked (inhibited) by the ...\n5. TMEM27 mRNA levels in islets are lower in diabetic donors than in controls. Its gene expression correlates with that of insulin and SNAPIN in human islets. TMEM27 expression is downregulated in islets of tungstate-treated rats, which exhibit decreased insulin secretion and increased proliferation. TMEM27 overproduction in a beta cell line and ...",
               "predicate": null
            }
         ],
         "row": 406,
         "id": 256140414433603247
      },
      {
         "claim": "TNFAIP3 is a glioblastoma tumor enhancer.",
         "label": 1,
         "prediction": 0,
         "rationale": "TNFAIP3, also known as A20, is a protein that plays a critical role in regulating immune responses. TNFAIP3 is associated with glioblastoma tumors. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TNFAIP3?",
               "answer": "TNFAIP3, also known as tumor necrosis factor, alpha-induced protein 3 or A20, is a protein encoded by the TNFAIP3 gene in humans. It is a zinc finger protein and a deubiquitinating enzyme that plays a critical role in regulating immune responses, particularly by terminating NF",
               "rationale": "1. TNFAIP3. Tumor necrosis factor, alpha-induced protein 3 or A20 is a protein that in humans is encoded by the TNFAIP3 gene. [5] [6] This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and a deubiquitinating enzyme, and has been shown ...\n2. TNFAIP3 (TNF Alpha Induced Protein 3) is a Protein Coding gene. Diseases associated with TNFAIP3 include Autoinflammatory Syndrome, Familial, Behcet-Like 1 and Familial Behcet-Like Autoinflammatory Syndrome .\n3. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Together, the findings indicate a new role of miR-29c in IAV infection and suggest its induction may contribute to counteract the innate immune response.\n4. TNFAIP3 and TNIP1 The zinc finger A20 protein (encoded by TNFAIP3) is an ubiquitin-modifying enzyme critical for termination of NF-κB responses downstream of signal transduction through tumor necrosis factor- receptor (TNF-R), TLR, IL-1 receptor (IL-1R), and nucleotide-binding oligomerization domain containing 2 (NOD2).\n5. Furthermore, TNFAIP3 mutations significantly correlated with T-cell large granular lymphocytic leukemia (T-LGLL) with a favorable prognosis in the JNU dataset ( P = 0.002). Notably, the different mutation patterns of TNFAIP3 when comparing our center and the COSMIC datasets might be due to different ethnic and genetic backgrounds.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is TNFAIP3 associated with glioblastoma tumors?",
               "answer": "Yes, TNFAIP3 is associated with glioblastoma tumors. The evidence indicates that TNFAIP3 is involved in the inflammatory response related to glioblastoma and has been identified as a factor significantly associated with glioblastoma cell resistance. Additionally, its expression is linked to NF-κB activation, which is",
               "rationale": "1. Most genes classically associated with the inflammatory compartment are part of the NF-kappaB signaling pathway including TNFAIP3 and BIRC3 that have been shown to be involved in resistance to chemotherapy.Our results associate hypoxia-driven tumor response with inflammation in glioblastoma, hence underlining the importance of tumor-host ...\n2. While, TNFAIP3 was also thought to be an oncogene in numbers of solid tumors such as ductal carcinoma in situ, gastric carcinoma, basal-like breast cancer [33-35]. Moreover, TNFAIP3 promotes CD4+ T cell survival by restricting ubiquitination of the mTOR (mechanistic target of rapamycin kinase) complex and increased autophagy [ 36 ].\n3. Within this pathway, we have identified the tumor necrosis factor α-induced protein 3 (TNFAIP3) gene as a new factor significantly associated with glioblastoma cell resistance. expression of the corresponding zinc finger protein A20 closely mirrored the expression of the TNFAIP3 transcript, and was immediately related to NF-κB activation ...\n4. Abstract. Glioblastoma are rapidly proliferating brain tumors in which hypoxia is readily recognizable, as indicated by focal or extensive necrosis and vascular proliferation, two independent diagnostic criteria for glioblastoma. Gene expression profiling of glioblastoma revealed a gene expression signature associated with hypoxia-regulated genes.\n5. Purpose Pre-existing and acquired drug resistance are major obstacles to the successful treatment of glioblastomas. Methods We used an integrated resistance model and genomics tools to globally explore molecular factors and cellular pathways mediating resistance to O6-alkylating agents in glioblastoma cells. Results We identified a transcriptomic signature that predicts a common in vitro and ...",
               "predicate": null
            }
         ],
         "row": 407,
         "id": 312209039520734160
      },
      {
         "claim": "TNFAIP3 is a glioblastoma tumor suppressor.",
         "label": 0,
         "prediction": 1,
         "rationale": "TNFAIP3, also known as Tumor Necrosis Factor Alpha-Induced Protein 3 or A20, is a protein-coding gene in humans that encodes a zinc finger protein and a deubiquitinating enzyme. The provided evidence does not explicitly state whether TNFAIP3 is a tumor suppressor for glioblastoma. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TNFAIP3?",
               "answer": "TNFAIP3, also known as Tumor Necrosis Factor Alpha-Induced Protein 3 or A20, is a protein-coding gene in humans that encodes a zinc finger protein and a deubiquitinating enzyme. It is rapidly induced by tumor necrosis factor (TNF) and serves as a",
               "rationale": "1. TNFAIP3. Tumor necrosis factor, alpha-induced protein 3 or A20 is a protein that in humans is encoded by the TNFAIP3 gene. [5] [6] This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and a deubiquitinating enzyme, and has been shown ...\n2. TNFAIP3 (TNF Alpha Induced Protein 3) is a Protein Coding gene. Diseases associated with TNFAIP3 include Autoinflammatory Syndrome, Familial, Behcet-Like 1 and Familial Behcet-Like Autoinflammatory Syndrome.Among its related pathways are TNF signaling and Metabolism of proteins.Gene Ontology (GO) annotations related to this gene include ligase activity and cysteine-type deubiquitinase activity.\n3. TNFAIP3 is a well-known negative regulator of the NF-κB signaling pathway, and mutations in this gene are usually observed in cancer, including hematological malignancies, which affect the clinical outcome of patients ...\n4. A20 in Inflammation. A20, encoded by the tumor necrosis factor-α (TNF-α)-induced protein 3 gene (TNFAIP3), has emerged as a central negative regulator of NF-κB (122, 133).Compared with other organs, A20 mRNA expression in the lung is relatively high and protein levels are detectable in whole lung homogenate of rodents (132, 145).A20 is rapidly induced after host TLR-pathogen interaction and ...\n5. A20 (also known as TNFAIP3) is a potent anti-inflammatory signalling molecule that restricts multiple intracellular signalling cascades. Recent studies in three general areas have converged to ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is TNFAIP3 a tumor suppressor for glioblastoma?",
               "answer": "The provided evidence does not explicitly state whether TNFAIP3 is a tumor suppressor for glioblastoma (GBM). However, it mentions that the TNFAIP3-mediated NF-κB signaling pathway is stimulated, which suggests a role in the signaling mechanisms associated with GBM. To determine if TNFAIP",
               "rationale": "1. Introduction. Glioblastoma (GBM) is the most common primary tumor of the central nervous system (CNS) in adults, and carries with a dire prognosis, with median survival of just over 14 months in spite of maximal therapy including surgical resection, radiation, and chemotherapy with temozolomide (1, 2).This paradigm has remained essentially unchanged since 2005 and, while recent advances ...\n2. Here, we report a new mechanism of NF-κB activation in glioblastoma through depletion of the KLF6 tumor suppressor. We show that KLF6 transactivates multiple genes negatively controlling the NF ...\n3. Resistance to genotoxic therapies and tumor recurrence are hallmarks of glioblastoma (GBM), an aggressive brain tumor. In this study, we investigated functional drivers of post-treatment recurrent ...\n4. In the late 1990s, the isolation of tumor suppressor genes accelerated studies on genetic alterations in human cancer cells. ... TNFAIP3-mediated NF-κB signaling pathway is stimulated by primary ...\n5. A robust link exists between the Ras oncogene and NF-κB; while RAS mutation is rare in GBM, high levels of active Ras are found in GBM due to hyperactive RTKs and loss of tumor suppressors such as NF1. 26 Ras signaling activates NF-κB via p65 by a pathway that is independent of classical IκK signaling. 41 Importantly, NF-κB is required for ...",
               "predicate": null
            }
         ],
         "row": 408,
         "id": 122752259773274114
      },
      {
         "claim": "TNFAIP3 is a tumor enhancer in glioblastoma.",
         "label": 1,
         "prediction": 0,
         "rationale": "TNFAIP3, also known as tumor necrosis factor alpha-induced protein 3 or A20, is a protein-coding gene in humans that encodes a zinc finger protein and a deubiquitinating enzyme, playing a crucial role as a negative regulator of the NF-κB signaling pathway. The provided evidence does not explicitly state whether TNFAIP3 (A20) acts as a tumor enhancer in glioblastoma. The provided evidence does not explicitly state whether TNFAIP3 promotes tumor growth in glioblastoma. TNFAIP3 (A20) is overexpressed in glioblastoma stem cells (GSCs) relative to non-stem glioblastoma cells. There is no indication that TNFAIP3 overexpression correlates with poor prognosis in glioblastoma. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TNFAIP3?",
               "answer": "TNFAIP3, also known as tumor necrosis factor alpha-induced protein 3 or A20, is a protein-coding gene in humans that encodes a zinc finger protein and a deubiquitinating enzyme. It plays a crucial role as a negative regulator of the NF-κB signaling pathway and is",
               "rationale": "1. TNFAIP3. Tumor necrosis factor, alpha-induced protein 3 or A20 is a protein that in humans is encoded by the TNFAIP3 gene. [5] [6] This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and a deubiquitinating enzyme, and has been shown ...\n2. TNFAIP3 (TNF Alpha Induced Protein 3) is a Protein Coding gene. Diseases associated with TNFAIP3 include Autoinflammatory Syndrome, Familial, Behcet-Like 1 and Familial Behcet-Like Autoinflammatory Syndrome.Among its related pathways are TNF signaling and Metabolism of proteins.Gene Ontology (GO) annotations related to this gene include ligase activity and cysteine-type deubiquitinase activity.\n3. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Together, the findings indicate a new role of miR-29c in IAV infection and suggest its induction may contribute to counteract the innate immune response.\n4. TNFAIP3 is the human gene coding for the A20 protein. It is located in the 6q23.3 chromosome and comprises 13 exons (NM_001270508.2). The transcript length is about 4665 bp, translated into the protein composed of 790 residues (NP_001257437.1).\n5. TNFAIP3 is a well-known negative regulator of the NF-κB signaling pathway, and mutations in this gene are usually observed in cancer, including hematological malignancies, which affect the clinical outcome of patients ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is TNFAIP3 a tumor enhancer in glioblastoma?",
               "answer": "The provided evidence does not explicitly state whether TNFAIP3 (A20) acts as a tumor enhancer in glioblastoma. It mentions that TNFAIP3 is a regulator of cellular pathways distinct from the bulk tumor and may be a useful therapeutic target, but it does not clarify its role as an enhancer or suppress",
               "rationale": "1. Glioblastomas are deadly cancers that display a functional cellular hierarchy maintained by self-renewing glioblastoma stem cells (GSCs). GSCs are regulated by molecular pathways distinct from the bulk tumor that may be useful therapeutic targets. We determined that A20 (TNFAIP3), a regulator of cel …\n2. Enhancers regulate gene expression and have been linked with disease pathogenesis. Little is known about enhancers that regulate human disease-associated genes in primary cells relevant for ...\n3. Purpose Pre-existing and acquired drug resistance are major obstacles to the successful treatment of glioblastomas. Methods We used an integrated resistance model and genomics tools to globally explore molecular factors and cellular pathways mediating resistance to O6-alkylating agents in glioblastoma cells. Results We identified a transcriptomic signature that predicts a common in vitro and ...\n4. Glioblastoma (GBM), classified as World Health Organization grade IV glioma, is incurable and the most aggressive primary intracranial tumor, with a median survival of 14.6 months and a 5-year ...\n5. Glioblastoma is the most aggressive primary brain cancer and is particularly difficult to treat. A report in Science Translational Medicine shows that the targeted delivery of TNF via an antibody ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does TNFAIP3 promote tumor growth in glioblastoma?",
               "answer": "The provided evidence does not explicitly state whether TNFAIP3 (A20) promotes tumor growth in glioblastoma. It mentions that TNFAIP3 is a regulator of cellular pathways distinct from the bulk tumor and suggests that it may be a useful therapeutic target. However, it does not provide a clear conclusion about its",
               "rationale": "1. 1. Introduction. Glioblastoma is the most common and malignant primary brain tumor [].Despite the advances in diagnosis and treatment, life expectancy still remains at approximately 12-18 months [].Invasion ability towards the surrounding tissue is a determinant for malignant tumor progression [].The high mortality of glioblastoma patients is partly attributed to the tumors' therapy ...\n2. Glioblastomas are deadly cancers that display a functional cellular hierarchy maintained by self-renewing glioblastoma stem cells (GSCs). GSCs are regulated by molecular pathways distinct from the bulk tumor that may be useful therapeutic targets. We determined that A20 (TNFAIP3), a regulator of cel …\n3. There are basically two ways cancer cells can grow. The first way \"is that they take up shop in one part of the brain and continue to grow as a mass — what we think of conventionally as a tumor,\" said Dr. Bagley. Defined broadly, a tumor is a lump of abnormal cells that takes on \"a roundish shape, like a ball. It's what the surgeon ...\n4. Tumor metabolism is emerging as a potential target for cancer therapies. This new approach holds particular promise for the treatment of glioblastoma, a highly lethal brain tumor that is resistant to conventional treatments, for which improving therapeutic strategies is a major challenge. The presence of glioma stem cells is a critical factor ...\n5. By the same token, GSC may also interact with differentiated GBM cells, as Wang et al. demonstrated that differentiated tumor cells promote the glioblastoma hierarchy and tumor growth through a paracrine feedback loop, describing neurotrophin signaling in cooperation with stem cell-like tumor cells.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is TNFAIP3 overexpressed in glioblastoma?",
               "answer": "Yes, TNFAIP3 (A20) is overexpressed in glioblastoma stem cells (GSCs) relative to non-stem glioblastoma cells, as indicated in the first piece of evidence.",
               "rationale": "1. GSCs are regulated by molecular pathways distinct from the bulk tumor that may be useful therapeutic targets. We determined that A20 (TNFAIP3), a regulator of cell survival and the NF-kappaB pathway, is overexpressed in GSCs relative to non-stem glioblastoma cells at both the mRNA and protein levels.\n2. Tumor necrosis factor alpha-induced protein 3 (TNFAIP3, also known as A20), which acts in a negative feedback loop to block NF-κB activity and is significantly associated with resistance to TMZ ...\n3. BIRC3 is highly expressed in cisplatin-resistant prostate cancer cell lines , and in doxorubicine- and busulfan-resistant leukaemia cell lines , while TNFAIP3 is overexpressed in tamoxifen-resistant breast carcinoma cell lines and part of a signature for resistance to alkylating agents in glioblastoma cells . Hence, resistance to hypoxia may ...\n4. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas. However, at least 50% of TMZ treated patients do not respond to TMZ. This is due primarily to the over-expression of O 6 -methylguanine methyltransferase (MGMT) and/or lack of a DNA repair pathway in GBM cells.\n5. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas. However, at least 50% of TMZ treated patients do not respond to TMZ. This is due primarily to the over-expression of O 6-methylguanine methyltransferase (MGMT) and/or lack of a DNA repair pathway in GBM cells. Multiple GBM cell lines are ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does TNFAIP3 overexpression correlate with poor prognosis in glioblastoma?",
               "answer": "The provided evidence does not indicate any correlation between TNFAIP3 overexpression and poor prognosis in glioblastoma. The information primarily focuses on glioblastoma characteristics, the role of TRIM27, and the importance of exosomes in tumor progression, but it does not mention TNFAIP3 or its expression levels in",
               "rationale": "1. Glioblastoma is the most common tumour that originates in the brain in adults. Most of the published data on glioblastoma are from patients in clinical trials who tend to be younger and fitter than the average patient. We therefore looked at patient demographic, ...\n2. Abstract Glioblastoma is the prevailing and highly malignant form of primary brain neoplasm with poor prognosis. Exosomes derived from glioblastoma cells act a vital role in malignant progression via regulating tumor microenvironment (TME), exosomal tetraspanin protein family members (TSPANs) are important actors of cell communication in TME.\n3. In the present study, we provide evidence that TRIM27 was upregulated in GBM tissues and that high TRIM27 levels significantly correlated with poor prognosis of GBM patients. Loss- and gain-of-function studies also indicated that TRIM27 could promote the Warburg effect and the progression of glioblastoma by inhibiting the LKB1/AMPK/mTOR axis.\n4. Glioblastoma (GBM), the most severe and common brain tumor in adults, is characterized by multiple somatic mutations and aberrant activation of inflammatory responses.\n5. Abstract Background: It is imperative to explore potential biomarkers for predicting clinical outcome and developing targeted therapies for T-cell acute lymphoblastic leukemia (T-ALL). This study aimed to investigate the mutation patterns of tumor necrosis factor-alpha-inducing protein 3 (TNFAIP3, also known as A20) and its role in the prognosis of T-ALL patients.",
               "predicate": null
            }
         ],
         "row": 409,
         "id": 116497637381418569
      },
      {
         "claim": "TRAP+ osteoclasts regulate mature osteoblast maintenance.",
         "label": 1,
         "prediction": 1,
         "rationale": "TRAP+ osteoclasts are osteoclasts that express tartrate-resistant acid phosphatase (TRAP), an enzyme that serves as a marker for these cells. TRAP+ osteoclasts regulate mature osteoblast maintenance. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TRAP+ osteoclasts?",
               "answer": "TRAP+ osteoclasts are osteoclasts that express tartrate-resistant acid phosphatase (TRAP), an enzyme that serves as a marker for these cells. TRAP is involved in various biological processes, including skeletal development and bone mineralization. The presence of TRAP indicates the differentiation and activity of",
               "rationale": "1. Abstract. Tartrate-resistant acid phosphatase (TRAP), once considered to be just a histochemical marker of osteoclasts is now recognised to be a molecule of widespread occurrence with functions in both the skeleton and the immune system. TRAP is expressed by osteoclasts, macrophages, dendritic cells and a number of other cell types.\n2. TRAP is expressed by osteoclasts, macrophages, dendritic cells and a number of other cell types. It has a critical role in many biological processes including skeletal development, collagen synthesis and degradation, the mineralisation of bone, cytokine production by macrophages and dendritic cells, macrophage recruitment, dendritic cell ...\n3. Tartrate-resistant acid phosphatase (TRAP or TRAPase), also called acid phosphatase 5, tartrate resistant (ACP5), is a glycosylated monomeric metalloprotein enzyme expressed in mammals. It has a molecular weight of approximately 35kDa, a basic isoelectric point (7.6-9.5), and optimal activity in acidic conditions. TRAP is synthesized as latent proenzyme and activated by proteolytic cleavage ...\n4. TGF-β was sufficient to induce formation of TRAP+ osteoclasts in cultures of human monocytes or RAW264.7 pre-osteoclast cells independent of RANKL, TNFα, IL-6, or IL-11 . Alternatively, TNFα can bind to the tumor necrosis factor receptor 1 (TNFR1) and can stimulate downstream osteoclast differentiation signaling pathways .\n5. In vitro osteoclastogenesis is a central assay in bone biology to study the effect of genetic and pharmacologic cues on the differentiation of bone resorbing osteoclasts. To date, identification of TRAP+ multinucleated cells and measurements of osteoclast number and surface rely on a manual tracing requiring specially trained lab personnel.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do TRAP+ osteoclasts regulate mature osteoblast maintenance?",
               "answer": "Yes, TRAP+ osteoclasts do regulate mature osteoblast maintenance. The evidence indicates that osteoclasts play an active role in promoting bone formation and facilitating osteoblast migration to remodeling sites. This suggests that osteoclasts influence osteoblast function and maintenance through various mechanisms, including direct interactions and the release",
               "rationale": "1. Osteoblast-osteoclast communications are essential for fine-tuning of bone remodeling during bone homeostasis. (1) Osteoblasts and osteoclasts have direct contacts through the interactions between EFNB2-EPHB4, FAS-FASL and NRP1-SEMA3A to regulate cell proliferation, differentiation, and survival. (2) Osteoclast-mediated bone resorption releases ...\n2. Osteocytes account for most of the cells found in mature mineralized bone and coordinate bone maintenance through interactions between osteoblasts and osteoclasts 7, 8, 9 (Fig. 1 ).\n3. In the past few years, a fascinating new role for osteoclasts has been unveiled in promoting bone formation and facilitating osteoblast migration to the remodeling sites through a number of different mechanisms, including the release of factors from the bone matrix following bone resorption and direct cell-cell interactions.\n4. A comprehensive review focusing on the role of osteoclasts as active regulators of bone homeostasis by influencing osteoblast function explores the currently known mechanisms and coupling factors involved in osteoclast-osteoblast communication and their potential as treatments for bone diseases.\n5. Indeed, newly discovered notions of osteoclast origin and cell recycling have changed our interpretations of osteoclast cell fate, determination and longevity, and provide new insights into osteoclast formation and maintenance. Here, we review these recent developments in understanding the origin and roles of osteoclasts.",
               "predicate": null
            }
         ],
         "row": 410,
         "id": 218988943763054920
      },
      {
         "claim": "Taking 400mg of α-tocopheryl acetate does not prevent prostate cancer.",
         "label": 1,
         "prediction": 1,
         "rationale": "α-Tocopheryl acetate, also known as vitamin E acetate, is a form of vitamin E that exists in both natural and synthetic forms, and is an ester of acetic acid and α-tocopherol. Taking 400mg of α-tocopheryl acetate does not prevent prostate cancer. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is α-tocopheryl acetate?",
               "answer": "α-Tocopheryl acetate, also known as vitamin E acetate, is a form of vitamin E that exists in both natural (D-Alpha Tocopheryl Acetate) and synthetic (DL-Alpha Tocopheryl Acetate) forms. It is an ester of acetic acid and α-tocopher",
               "rationale": "1. α-Tocopheryl acetate (alpha-tocopherol acetate), also known as vitamin E acetate, is a form of vitamin E with D-Alpha Tocpheryl Acetate as the natural form and DL-Alpha Tocopheryl Acetate as the synthetic form. DL-indicates the synthetic form where as D- indicates the natural form. It is the ester of acetic acid and α-tocopherol.. The U.S. Centers for Disease Control and Prevention says that ...\n2. Tocopheryl acetate is a form of vitamin E that's often found in skin care products and dietary supplements. Learn about its potential benefits and risks.\n3. Alpha-tocopheryl acetate (ATA), also known simply as tocopheryl acetate, is a synthetic form of vitamin E found in dietary supplements and skin care products. It is considered the most stable and active form of vitamin E and the best option overall for treating vitamin E deficiency. Tocopheryl acetate is marketed to prevent several health ...\n4. Dl-alpha-tocopherol is a synthetic form of alpha-tocopherol. This synthetic form of alpha-tocopherol is less bioavailable than the d-alpha-tocopherol and is only half as potent, notes the Oregon State University Linus Pauling Institute. This form of alpha-tocopherol is frequently found in nutritional supplements and fortified foods.\n5. Tocopheryl acetate is often used as an alternative to pure tocopherol because the phenolic hydroxyl group is blocked, providing a less acidic product with a longer shelf life. The lipophilic or oil-based nature of tocopherol makes it a great ingredient for providing the skin with moisture protecting oil that allows for its benefits to be ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does taking 400mg of α-tocopheryl acetate prevent prostate cancer?",
               "answer": "No, taking 400 IU/day (180 mg) of α-tocopheryl acetate does not prevent prostate cancer. In fact, the SELECT trial indicated that vitamin E supplements may increase the risk of prostate cancer in adult men.",
               "rationale": "1. Abstract. The cancer preventive activity of vitamin E has been suggested by many epidemiologic studies. However, several recent large-scale human trials with α-tocopherol, the most commonly recognized and used form of vitamin E, failed to show a cancer preventive effect. The recently finished follow-up of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) even showed higher prostate ...\n2. However, results from the recently published, large SELECT trial show that vitamin E supplements (400 IU/day [180 mg] as dl-alpha-tocopheryl acetate) may harm adult men in the general population by increasing their risk of prostate cancer . Follow-up studies are assessing whether the cancer risk was associated with baseline blood levels of ...\n3. Heinonen OP, et al. Prostate cancer and supplementation with alpha-tocopherol and B-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6. Alpha-Tocopherol, Beta carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.\n4. The result showed that daily supplementation with a combination of all-rac-α-tocopheryl acetate (50 mg), β-carotene (15 mg) and selenium (50 μg) (Factor D) to ... to MNU-treated rats did not prevent prostate formation 92. The cancer preventive activity of γ-TmT was also demonstrated in a novel prostate carcinogenesis model in the CYP1A ...\n5. Prostate cancer is the most common human malignancy and the second leading cause of cancer death among men in western nations. The high global incidence of prostate cancer, the unsatisfactory ...",
               "predicate": null
            }
         ],
         "row": 411,
         "id": 262613064081220218
      },
      {
         "claim": "Taking 400mg of α-tocopheryl acetate in combination with vitamin C reduces the risk of prostate cancer.",
         "label": 0,
         "prediction": 0,
         "rationale": "α-Tocopheryl acetate, also known as vitamin E acetate, is a form of vitamin E that exists in both natural and synthetic forms, and is an ester of acetic acid and α-tocopherol. Taking 400 IU of α-tocopheryl acetate in combination with vitamin C does not reduce the risk of prostate cancer. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is α-tocopheryl acetate?",
               "answer": "α-Tocopheryl acetate, also known as vitamin E acetate, is a form of vitamin E that exists in both natural (D-Alpha Tocopheryl Acetate) and synthetic (DL-Alpha Tocopheryl Acetate) forms. It is an ester of acetic acid and α-tocopher",
               "rationale": "1. α-Tocopheryl acetate ( alpha-tocopherol acetate ), also known as vitamin E acetate, is a form of vitamin E with D-Alpha Tocpheryl Acetate as the natural form and DL-Alpha Tocopheryl Acetate as the synthetic form. DL-indicates the synthetic form where as D- indicates the natural form. It is the ester of acetic acid and α-tocopherol.\n2. Tocopheryl acetate is a form of vitamin E that's often found in skin care products and dietary supplements. Learn about its potential benefits and risks.\n3. Alpha-tocopheryl acetate (ATA), also known simply as tocopheryl acetate, is a synthetic form of vitamin E found in dietary supplements and skin care products. It is considered the most stable and active form of vitamin E and the best option overall for treating vitamin E deficiency. Tocopheryl acetate is marketed to prevent several health ...\n4. Alpha- (or α-) tocopherol is the only form that is recognized to meet human requirements. Serum concentrations of vitamin E (alpha-tocopherol) depend on the liver, which takes up the nutrient after the various forms are absorbed from the small intestine. ... The body hydrolyzes and absorbs these esters (alpha-tocopheryl acetate and succinate ...\n5. Tocopheryl acetate is often used as an alternative to pure tocopherol because the phenolic hydroxyl group is blocked, providing a less acidic product with a longer shelf life. The lipophilic or oil-based nature of tocopherol makes it a great ingredient for providing the skin with moisture protecting oil that allows for its benefits to be ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does taking 400mg of α-tocopheryl acetate in combination with vitamin C reduce the risk of prostate cancer?",
               "answer": "Based on the provided evidence snippets, taking 400 IU of α-tocopheryl acetate (a form of vitamin E) in combination with vitamin C does not reduce the risk of prostate cancer. The evidence indicates that large-scale human trials, including the SELECT trial, showed no significant effects on prostate cancer incidence or death from",
               "rationale": "1. The cancer preventive activity of vitamin E has been suggested by many epidemiological studies. However, several recent large-scale human trials with α-tocopherol, the most commonly recognized and used form of vitamin E, failed to demonstrate a cancer preventive effect. The recently finished follow-up of the Selenium and Vitamin E Cancer ...\n2. Abstract. The cancer preventive activity of vitamin E has been suggested by many epidemiologic studies. However, several recent large-scale human trials with α-tocopherol, the most commonly recognized and used form of vitamin E, failed to show a cancer preventive effect. The recently finished follow-up of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) even showed higher prostate ...\n3. Twenty-nine thousand Finnish male smokers between the ages of 50-69 years old were randomly assigned to take dl-α-tocopheryl acetate (50 mg/day), β-carotene (20mg/day), both or placebo. A statistically significant negative correlation was found between α-tocopherol levels and prostate cancer incidence [10,56].\n4. Data on whether Vitamin E supplementation can reduce cancer risk are mixed , and some studies even suggest it may increase cancer risk . In prostate cancer, data from the SELECT trial showed that vitamin E alone or with selenium for 5 years did not reduce prostate cancer risk (35) , and significantly increased risk at 7 years' follow-up (41) .\n5. 400 IU synthetic α-tocopherol every other day and vitamin C 500 mg daily: 1': PCa for vitamin E and total cancer for vitamin C 2': Total cancer for vitamin E Outcomes: no effects on prostate or total cancer incidence or death: Progression from HGPIN to PCa, Canada ; 3 y of supplements plus 3-y follow-up (2003-2010)",
               "predicate": null
            }
         ],
         "row": 412,
         "id": 241598186875076081
      },
      {
         "claim": "Taking anti-depresents is associated with a decrease in the Aβ level in the brain of experimental animals.",
         "label": 1,
         "prediction": 1,
         "rationale": "Aβ, or amyloid beta peptide, is a 4 kDa fragment derived from the amyloid precursor protein (APP) and is the main component of amyloid plaques found in the brains of individuals with Alzheimer's disease. The provided evidence does not directly address the effect of antidepressants on Aβ levels in the brain of experimental animals. Anti-depressants, specifically the selective serotonin reuptake inhibitor escitalopram, may suppress brain Aβ levels and reduce plaque load in experimental animals. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Aβ?",
               "answer": "Aβ, or amyloid beta peptide, is a 4 kDa fragment derived from the amyloid precursor protein (APP). It is the main component of amyloid plaques found in the brains of individuals with Alzheimer's disease and can also form deposits in cerebral blood vessels in conditions like cerebral amyloid angiopathy. Aβ",
               "rationale": "1. Aβ is the main component of amyloid plaques, extracellular deposits found in the brains of people with Alzheimer's disease. Aβ can also form the deposits that line cerebral blood vessels in cerebral amyloid angiopathy.The plaques are composed of a tangle of Aβ oligomers and regularly ordered aggregates called amyloid fibrils, a protein fold shared by other peptides such as the prions ...\n2. The Aβ is a 4 kDa fragment of the amyloid precursor protein (APP), a larger precursor molecule widely produced by brain neurons, vascular and blood cells (including platelets), and, to a lesser ...\n3. Amyloid beta peptide (Aβ) is produced through the proteolytic processing of a transmembrane protein, amyloid precursor protein (APP), by β- and γ-secretases. Aβ accumulation in the brain is ...\n4. Amyloid beta peptide (Aβ) is produced through the proteolytic processing of a transmembrane protein, amyloid precursor protein (APP), by β- and γ-secretases. Aβ accumulation in the brain is proposed to be an early toxic event in the pathogenesis of Alzheimer's disease, which is the most common form …\n5. Aβ Metabolism, Catabolism and Clearance. The ~4 kDa Aβ peptide, derived from the larger APP, was first isolated as the principal component of amyloid deposits in the brain and cerebrovasculature of AD and Down's Syndrome patients [6-8].Although the function of APP itself has not been resolved, extensive research has advanced our knowledge of how the Aβ peptide is produced, and how it is ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What effect do anti-depressants have on Aβ levels in the brain of experimental animals?",
               "answer": "The provided evidence snippets do not directly address the effect of antidepressants on Aβ levels in the brain of experimental animals. However, they do suggest that antidepressants may induce changes in neurochemical processes that could potentially influence various biological mechanisms, including those related to cognitive and emotional processes. Specifically, while the second snippet discusses the",
               "rationale": "1. These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation ...\n2. Most antidepressant drugs prescribed today have been available for decades. Nonetheless, their mechanism of action in treating depression has remained elusive. On the basis of neurochemical studies in laboratory animals, hypotheses explaining their therapeutic effects have been formulated. The most attractive of these theories involves antidepressant-induced changes in the sensitivity of ...\n3. The presence of multiple Aβ clearance mechanisms in the brain reduces harmful effects of Aβ and the most momentous is Aβ transfer across the BBB (Tanzi et al., 2004). This essential structure controls the exchange of substances between the brain and the blood, maintaining homeostasis of the central nervous system (CNS).\n4. The potential effects of a number of variables at screening (MMSE score, age, education, diagnosis, HAM-D, antidepressant use, APOE genotype) on Aβ plasma levels at Year 3 were evaluated with ...\n5. Abstract. Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the appearance of senile plaques which contain Aβ depositions. Aβ is a complex biological molecule which interacts with many types of receptors and/or ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of anti-depressants on Aβ levels in the brain of experimental animals?",
               "answer": "The evidence suggests that the selective serotonin reuptake inhibitor (SSRI) escitalopram may suppress brain Aβ levels and reduce plaque load in experimental animals, specifically in mice. This indicates that anti-depressants, particularly those that target serotonin signaling, could have a beneficial effect on Aβ levels in the brain",
               "rationale": "1. Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the appearance of senile plaques which contain Aβ depositions. Aβ is a complex biological molecule which interacts with many types of receptors and/or forms ...\n2. High BACE1 enzymatic activity is found in human AD brain extracts, consistent with experimental evidence of neurons producing higher levels of Aβ in AD than 'normal' aging [ 108 ].\n3. Given that serotonin signaling is one synaptic mechanism that regulates Aβ, we proposed that the SSRI escitalopram, the most selective drug in this class for blocking serotonin reuptake as opposed to norepinephrine, 22 would suppress brain Aβ levels and reduce plaque load in mice.\n4. Recent studies have shown that high levels of Aβ could flow from the brain to the periphery, and physiological catabolism of brain-derived Aβ in the peripheral system has been revealed in both humans and mice [ 8 ], providing a novel perspective for understanding the pathogenesis of and developing therapeutics for AD.\n5. The accumulation of amyloid-β (Aβ) peptide in the brain and its aggregation into amyloid plaques are currently considered the pathological trigger for AD ( 2 ). In humans, cerebrospinal fluid (CSF) Aβ concentrations begin changing before tau levels; amyloid deposition occurs in the brain decades before the onset of clinical symptoms ( 3 - 5 ).",
               "predicate": null
            }
         ],
         "row": 413,
         "id": 161987748412372830
      },
      {
         "claim": "Taxation of sugar-sweetened beverages reduced the incidence rate of type II diabetes in India.",
         "label": 1,
         "prediction": 0,
         "rationale": "It is unclear if sugar-sweetened beverage taxation has been implemented in India. The incidence rate of type II diabetes in India has not decreased, but rather has shown a significant increasing pattern between 1990 and 2019. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Has taxation of sugar-sweetened beverages been implemented in India?",
               "answer": "The provided evidence snippet does not mention whether sugar-sweetened beverage (SSB) taxation has been implemented in India. Therefore, based on the information given, it is unclear if such a tax exists in India.",
               "rationale": "1. Today, WHO released its first-ever global tax manual for sugar-sweetened beverages (SSBs). Currently, at least 85 countries implement some type of SBB taxation. The WHO manual highlights the experiences of countries who have successfully implemented the tax, including Mexico, South Africa, and the United Kingdom.\n2. Introduction. Sugar-sweetened beverage (SSB) taxes are proposed as a policy tool to address the increasing prevalence of poor diet, obesity, and related economic and social costs. 1,2 Noncommunicable diseases (NCDs) account for 71% of deaths globally, of which an estimated 40% could be attributed to dietary factors. 3,4 Recently, concerns about diet-related NCDs grew further because of their ...\n3. Welcome to the Global SSB Tax Database. The Global SSB Tax Database is an open source of data on sugar-sweetened beverage (SSB) tax designs worldwide. It is intended to support research, inform policy decisions, and guide the development of SSB taxation best practice. Scroll down to explore our interactive data visualizations, maps and stories.\n4. Sugar-sweetened beverage tax coverage is higher than previously reported, with clear differences in designs between regions and income groups. ... [56%]). No low-income economy and only 1 lower-middle-income economy (Morocco) have implemented excise taxes with sugar content thresholds. Most tiered excise taxes (41 of 54 [75%]) include tiers ...\n5. Per January 2021, sugar-sweetened beverage (SSB) taxes cover less than 10% of the global population (), despite ample evidence that they can effectively address the increasing burden of (dental) diseases related to sugar consumption.Caries is the most common noncommunicable disease (NCD) worldwide and substantiates a high disease and economic burden to individuals and society.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Has the incidence rate of type II diabetes in India decreased?",
               "answer": "No, the incidence rate of type II diabetes in India has not decreased. The evidence indicates a significant increasing pattern of incidence rate in India between 1990 and 2019, with a reported average annual percentage change (AAPC) of 1.59, which is statistically significant (p < 0.001",
               "rationale": "1. This study also reported a diabetes prevalence of 16.3% in Karachi, Pakistan, which is lower than the two cities in India. In the CARRS cohort, the lifetime diabetes risk for 20-year-old men was 55.5% compared to 64.6% for women and was high among obese women (86.0%) and men (86.9%).\n2. The age standardized diabetes incidence rate in India between 1990 and 2019 ranged from 199.14 to 317.02 per 100,000 population. The regression model showed a significant increasing pattern of incidence rate in India between 1990 and 2019 (AAPC: 1.59; 95 % CI: 1.51 to 1.67; p < 0.001). ... a clinically diagnosed incidence of type-2 diabetes has ...\n3. For age-specific rates, incidence increased in most age groups, with exception of age groups 5-9, 70-74, 75-79 and 80-84 in male, and age groups 5-9, 75-79 and 80-84 in female. Mortality in male saw a decreasing trend till age group 20-24, whereas in female, the rate decreased till age group 35-39.\n4. A new study published in Lancet estimates that 101 million people in India - 11.4% of the country's population - are living with diabetes. A survey commissioned by the health ministry also found ...\n5. The increase in health loss from diabetes since 1990 in India is the highest among major non-communicable diseases. With this increase observed in every state of the country, and the relative rate of increase highest in several less developed low ETL states, policy action that takes these state-level differences into account is needed urgently to control this potentially explosive public ...",
               "predicate": null
            }
         ],
         "row": 414,
         "id": 337276714954896606
      },
      {
         "claim": "Ten percent (10%) of kidney cancers in the UK are attributable to excess weight.",
         "label": 1,
         "prediction": 1,
         "rationale": "At least 10% of kidney cancers in the UK are attributable to excess weight. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What percentage of kidney cancers in the UK are attributable to excess weight?",
               "answer": "The provided evidence indicates that 10% or more of kidney cancers could be attributable to excess weight. Therefore, the percentage of kidney cancers in the UK that are attributable to excess weight is at least 10%.",
               "rationale": "1. Kidney cancer incidence projections. The number of new kidney cancer cases on average each year in the UK is projected to rise from around 16,300 cases in 2023-2025 to around 21,900 cases in 2038-2040. [ 1] Kidney cancer incidence rates are projected to rise by 15% in the UK between 2023-2025 and 2038-2040, to 27 cases per 100,000 people on ...\n2. There are around 13,800 new kidney cancer cases in the UK every year, that's 38 every day (2017-2019). Kidney cancer is the 6th most common cancer in the UK, accounting for 4% of all new cancer cases (2017-2019). In females in the UK, kidney cancer is the 10th most common cancer, with around 5,100 new cases every year (2017-2019).\n3. Kidney Cancer UK 2019 Patient Survey Report The UK has one of the worst kidney cancer survival rates in Europe3 The incidence of kidney cancer is growing. Around 50% of all sufferers will die from kidney cancer. In 2014-2016 in the UK, there were around 12 kidney cancer deaths every day. Continued late diagnosis hampering eﬀective\n4. Assuming causality, 41% of uterine and 10% or more of gallbladder, kidney, liver, and colon cancers could be attributable to excess weight. We estimated that a 1 kg/m 2 population-wide increase in BMI would result in 3790 additional annual UK patients developing one of the ten cancers positively associated with BMI.\n5. International Agency for Research on Cancer (IARC) classifies the role of this risk factor in cancer development.[] 13% of kidney cancer cases in the UK are caused by smoking.[]Kidney cancer risk is 33% higher in current smokers compared with non-smokers, a meta-analysis showed.[]Kidney cancer risk increases with the number of cigarettes smoked per day and smoking duration, a meta-analysis ...",
               "predicate": null
            }
         ],
         "row": 415,
         "id": 757018651527111085
      },
      {
         "claim": "The C-type lectin receptor (CLEC-2) rearranges the actin cytoskeleton in dendritic cells to promote efficient motility along stromal surfaces.",
         "label": 1,
         "prediction": 1,
         "rationale": "The function of the C-type lectin receptor (CLEC-2) in dendritic cells is not specified in the provided evidence snippets. The function of the C-type lectin receptor (CLEC-2) in dendritic cells regarding actin cytoskeleton rearrangement is not specified in the provided evidence snippets. CLEC-2 promotes efficient motility along stromal surfaces in dendritic cells. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the C-type lectin receptor (CLEC-2) in dendritic cells?",
               "answer": "The provided evidence snippets do not specifically mention the function of the C-type lectin receptor (CLEC-2) in dendritic cells. Instead, they focus on CLEC-2's role in platelets, particularly in platelet activation, aggregation, and its involvement in processes such as thrombosis, tumor metastasis,",
               "rationale": "1. The C-type lectins are a superfamily of proteins that recognize a broad repertoire of ligands and that regulate a diverse range of physiological functions. Most research attention has focused on ...\n2. PDPN was found to be the endogenous ligand of C-type lectin-like receptor 2 (CLEC-2) on platelets and is involved in platelet aggregation induced by tumor cells 4, which facilitates invasion and ...\n3. C-type lectin-like receptor-2 (CLEC-2) is a member of the C-type lectin superfamily of cell surface receptors. The first confirmed endogenous and exogenous ligands of CLEC-2 are podoplanin and rhodocytin, respectively. CLEC-2 is expressed on the surface of platelets, which participates in platelet activation and aggregation by binding with its ligands. CLEC-2 and its ligands are involved in ...\n4. Abstract. C-type lectin-like receptor 2 (CLEC-2) has been identified on the surface of platelets as a receptor for a platelet activating snake venom, rhodocytin/aggretin. CLEC-2 belongs to a C-type lectin superfamily and binds to a sialoglycoprotein, podoplanin, in vivo. Platelets play a crucial role in hemostasis and thrombosis, but recent ...\n5. CLEC-2 (C-type lec tin-like receptor-2) has been described recently as playing crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis based on the following findings, reported mainly by us. (i) The snake venom rhodocytin is known as a strong platelet activator, and this effect has been shown to be mediated by CLEC-2",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of the C-type lectin receptor (CLEC-2) in dendritic cells regarding actin cytoskeleton rearrangement?",
               "answer": "The provided evidence snippets do not specifically mention the function of the C-type lectin receptor (CLEC-2) in dendritic cells regarding actin cytoskeleton rearrangement. However, it is known from broader scientific literature that CLEC-2 can influence actin cytoskeleton rearrangement in various cell types,",
               "rationale": "1. Recently discovered roles for C-type lectins in development, homeostasis, cell death, cancer and autoimmune and inflammatory diseases extend the functions of this superfamily beyond their well ...\n2. Here, Teunis Geijtenbeek and Sonja Gringhuis discuss the role of the signalling pathways induced by C-type lectin receptors in determining T helper cell lineage commitment and describe how these ...\n3. C-type lectins, originally defined as proteins binding carbohydrates in a Ca 2+ -dependent manner, form a large family containing soluble and membrane-bound proteins. Among them, those expressed on phagocytes and working as pathogen pattern-recognition receptors were designated as C-type lectin receptors (CLRs), in accordance with Toll-like ...\n4. PDPN was found to be the endogenous ligand of C-type lectin-like receptor 2 (CLEC-2) on platelets and is involved in platelet aggregation induced by tumor cells 4, which facilitates invasion and ...\n5. Abstract. C-type lectin-like receptor 2 (CLEC-2) has been identified on the surface of platelets as a receptor for a platelet activating snake venom, rhodocytin/aggretin. CLEC-2 belongs to a C-type lectin superfamily and binds to a sialoglycoprotein, podoplanin, in vivo. Platelets play a crucial role in hemostasis and thrombosis, but recent ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does CLEC-2 promote efficient motility along stromal surfaces in dendritic cells?",
               "answer": "Yes, CLEC-2 promotes efficient motility along stromal surfaces in dendritic cells. The evidence indicates that activation of CLEC-2 by podoplanin (PDPN) rearranges the actin cytoskeleton in dendritic cells, facilitating their movement along stromal surfaces.",
               "rationale": "1. CLEC-2 activation triggered cell spreading via downregulation of RhoA activity and myosin light-chain phosphorylation and triggered F-actin-rich protrusions via Vav signaling and Rac1 activation. Thus, activation of CLEC-2 by PDPN rearranges the actin cytoskeleton in DCs to promote efficient motility along stromal surfaces.\n2. PDPN is expressed on the surface of various types of cells, ... CLEC-2 on dendritic cells acts on the PDPN ... S. et al. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte ...\n3. Cell migration is central to evoking a potent immune response. Dendritic cell (DC) migration to lymph nodes is dependent on the interaction of C-type lectin-like receptor 2 (CLEC-2; encoded by the gene Clec1b), expressed by DCs, with podoplanin, expressed by lymph node stromal cells, although the underlying molecular mechanisms remain elusive.Here, we show that CLEC-2-dependent DC migration is ...\n4. Thus, activation of CLEC-2 by PDPN rearranges the actin cytoskeleton in DCs to promote efficient motility along stromal surfaces. AB - To initiate adaptive immunity, dendritic cells (DCs) move from parenchymal tissues to lymphoid organs by migrating along stromal scaffolds that display the glycoprotein podoplanin (PDPN).\n5. The podoplanin-CLEC-2 interaction endows DCs with the capacity to crawl along stromal cell scaffolds of secondary lymphoid organs and to find and properly activate T cells.",
               "predicate": null
            }
         ],
         "row": 416,
         "id": 330829161375949734
      },
      {
         "claim": "The DESMOND program caused substantial weight loss in most participants.",
         "label": 0,
         "prediction": 1,
         "rationale": "The DESMOND program is a patient education initiative that provides education and support for self-management to individuals with diabetes, particularly those newly diagnosed with type 2 diabetes. The DESMOND program led to a significant reduction in weight among participants, with an average weight loss of 2.98 kg. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the DESMOND program?",
               "answer": "The DESMOND program, which stands for Diabetes Education and Self Management for Ongoing and Newly Diagnosed, is a patient education initiative developed by various NHS organizations aimed at individuals with diabetes, particularly those newly diagnosed with type 2 diabetes. It focuses on providing education and support for self-management, integrating lifelong learning, care",
               "rationale": "1. DESMOND is the acronym for Diabetes Education and Self Management for Ongoing and Newly Diagnosed. It is part of a school of patient education for people with diabetes, developed by a number of NHS Organisations. Educators on the NHS may now be specifically trained in DESMOND.\n2. The DESMOND intervention for people with newly diagnosed type 2 diabetes was always intended to be included within an ongoing model of education and clinical care, integrating life long learning, care planning, and treatment optimisation. However, a key aspect of the study design was to show at what point any benefits of intervention begin to ...\n3. 1 2. A type 2 diabetes prevention programme suitable for individuals who find themselves at risk of developing type 2 diabetes. 1 2. Designed specifically for women who have previously been diagnosed with gestational diabetes. 1 2. An online Low-ENergy Approach programme to support weight loss, in conjunction with. 1 2.\n4. Here at DESMOND we are known for our unique non-didactic, interactive delivery style and the strong philosophical underpinning that is paramount to the success of our programmes. Our vision is to take healthcare self-management education to the next level. As part of the Leicester Diabetes Centre, we strive to set the bar nationally and ...\n5. The programme was qualitatively evaluated between April and June 2014 with participants being asked a number of questions regarding their experience of attending DESMOND; these are shown in Table 3.Of the overall number of DESMOND participants during this period, 302/1678 (18%) completed the survey immediately after completing the course.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Did the DESMOND program cause substantial weight loss in most participants?",
               "answer": "The evidence suggests that the DESMOND program did lead to a significant reduction in weight among participants, with a reported average weight loss of 2.98 kg (p = 0.027) in one of the studies. Additionally, another study indicated that the intervention group lost an additional 1.1 kg after",
               "rationale": "1. In the DESMOND RCT, at 12 months, HbA 1c was reduced by 1.49% which was not statistically significant (p = 0.052), whereas there was a significant reduction in weight of 2.98 kg (p = 0.027), smoking cessation (p = 0.033), positive change in illness beliefs (p < 0.001), and reduced depression score (p = 0.032). 6 This real-world study ...\n2. A large-scale (n = 824) cluster randomized controlled trial of DESMOND demonstrated that at one year follow up DESMOND participants had (i) greater understanding of their diabetes, (ii) greater weight loss, (iii) higher smoking cessation rates, (iv) less depression, and (v) better cardiovascular risk profiles, with some of these changes ...\n3. One conclusion was that weight loss strategies including dietary, physical activity, or behavioural interventions produced small improvements in weight between the groups, similar to our results. Within our study (which did not specifically target weight loss), after adjustment for clustering the intervention group lost an additional 1.1 kg.\n4. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...\n5. The secondary outcomes were blood pressure, weight, blood lipid levels, smoking status, physical activity, quality of life, beliefs about illness, depression, emotional impact of diabetes, and drug use at three years. ... such as DESMOND, may incur benefits to participants in the longer term, as participants who successfully acquire, embrace ...",
               "predicate": null
            }
         ],
         "row": 417,
         "id": 241724734598144603
      },
      {
         "claim": "The DESMOND program demonstrates no significant impact on biochemical outcomes.",
         "label": 1,
         "prediction": 1,
         "rationale": "The DESMOND program is not clearly defined in the provided evidence snippets, but it may relate to housing or community support initiatives. The DESMOND program is a patient education initiative for individuals with type 2 diabetes, consisting of group self-management education modules, toolkits, and care pathways to support people with the condition. The provided evidence does not explicitly state whether the DESMOND program demonstrates a significant impact on biochemical outcomes. The DESMOND program may have a positive impact on biochemical outcomes, such as glycaemic control, although further long-term evaluations are needed to assess its effects. The DESMOND program has a mixed impact on biochemical outcomes, with a non-statistically significant reduction in HbA1c of 1.49% at 12 months. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the DESMOND program?",
               "answer": "The provided evidence snippets do not contain specific information about the DESMOND program. However, the mention of \"Desmond\" in the context of a community meeting about transforming a La Quinta Inn into interim housing suggests that it may relate to housing or community support initiatives. To accurately define the DESMOND program, additional context",
               "rationale": "1. A suspect has finally been charged for the brutal murder of Dr. Devon Hoover, the beloved Detroit neurosurgeon who was found slain in his own home last year. Desmond Burks, 34, is accused of ...\n2. Jillian Desmond, crime analyst with CPD, said while officers are seeing a reduction in all crime categories, nipping at deeper trends exacerbating violence is a top priority.\n3. CPD Chief Teresa Theetge told Cincinnati City Council that both violent crime and property crime are down from last year. But there are still serious issues.\n4. Heath Aldrich had the most challenging offseason of his coaching career, and that's without having to worry about the City View football program.\n5. Desmond: Hundreds of residents had shown up to protest a plan that would transform a La Quinta Inn into interim housing. Clip of community meeting: So 99 units of permanent supportive housing is ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the DESMOND program?",
               "answer": "The DESMOND program, which stands for Diabetes Education and Self Management for Ongoing and Newly Diagnosed, is a patient education initiative developed by various NHS organizations for individuals with type 2 diabetes. It includes a family of group self-management education modules, toolkits, and care pathways aimed at supporting people with, or",
               "rationale": "1. DESMOND is the acronym for Diabetes Education and Self Management for Ongoing and Newly Diagnosed. It is part of a school of patient education for people with diabetes, developed by a number of NHS Organisations.\n2. The DESMOND intervention for people with newly diagnosed type 2 diabetes was always intended to be included within an ongoing model of education and clinical care, integrating life long learning, care planning, and treatment optimisation.\n3. myDesmond brings together the content and research evidence from our NICE approved face-to-face DESMOND self-management programmes to a portable interactive web-based platform to support you in managing your health. This means you are getting the same quality but delivered at a pace adjusted to suit your needs.\n4. DESMOND is the collaborative name for a family of group self management education modules, toolkits and care pathways for people with, or at risk of, Type 2 diabetes.\n5. The Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) programme has been recommended by the National Institute for Health and Care Excellence (NICE) as a validated education programme for people with type 2 diabetes in the UK since 2008. The programme consists of a 6-hour face-to-face education session delivered by two trained educators over one day or two half ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the DESMOND program demonstrate a significant impact on biochemical outcomes?",
               "answer": "The provided evidence snippet does not explicitly state whether the DESMOND program demonstrates a significant impact on biochemical outcomes, such as HbA1c levels. However, it mentions that diabetes self-management education (DSME) improves quality of care and clinical outcomes, and that the study aims to determine the impact of the DSME",
               "rationale": "1. Introduction. Biomedical, psychosocial and behavioural outcomes are improved when people with diabetes are empowered and skilled to self-manage their condition. 1 Robust diabetes self-management education (DSME) programmes should be developed using the Medical Research Council framework for complex interventions 2 and comprise an evidence-based structured curriculum which is delivered by ...\n2. Objective To measure whether the benefits of a single education and self management structured programme for people with newly diagnosed type 2 diabetes mellitus are sustained at three years. Design Three year follow-up of a multicentre cluster randomised controlled trial in primary care, with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United ...\n3. Diabetes self-management education improves quality of care and clinical outcomes determined by a diabetes bundle measure: Brunisholz KD, Briot P, Hamilton S, et al. (2014) This study aims to determine the impact of the DSME intervention by measuring HbA1c and diabetes bundle components so that diabetes care can be improved.\n4. Methods. The study methods, intervention, and outcomes at 12 months have been reported in detail previously. 18 19 Briefly, a robust cluster randomised controlled trial was undertaken to assess the effectiveness of a structured self management education programme that took place in 13 primary care sites (207 practices) across England and Scotland. . Randomisation took place at the level of the ...\n5. The DESMOND program is a group education program whose curriculum has previously been detailed [10]. DESMOND is underpinned by the following learning theories: Leventhal's common sense theory [ 23 ], dual process theory, and social learning theory [ 24 ], which align with a person-centered philosophy of care [ 9 ].",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the impact of the DESMOND program on biochemical outcomes?",
               "answer": "The provided evidence does not directly address the impact of the DESMOND program on biochemical outcomes. However, it does mention improvements in glycaemic control associated with self-management interventions, including educational approaches, which may imply potential positive effects on biochemical markers related to diabetes management. Further long-term evaluations are suggested to assess the impact",
               "rationale": "1. We evaluated whether the impact of a single structured self management education programme (DESMOND) with six hours contact time within six weeks of diagnosis was sustained at three years.\n2. Further long-term evaluation is also necessary to determine the impact of DESMOND on cardiovascular outcomes and mortality in the real world, especially in conjunction with newer glucose-lowering agents such as GLP-1 receptor agonists and SGLT2 inhibitors associated with improved cardiovascular outcomes, although this would require very large ...\n3. A recent meta-analysis assessing the impact of self management interventions in people with type 2 diabetes published before 2007 reported improvements to glycaemic control in people who received self management treatment, with a small advantage of an intervention with an educational approach. 21 The results of the DESMOND intervention ...\n4. The costs of delivering the DESMOND programme and its effects on health related quality of life, particularly in relation to reductions in weight and smoking, will accrue over the long term, and, therefore, an analysis using only the 12 month outcomes from our previous trial would be inappropriate.\n5. Objective To evaluate the effects of the Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) program on patient activation in adults living with type 2 diabetes (T2D).",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does the DESMOND program have a significant impact on biochemical outcomes?",
               "answer": "The evidence suggests that the DESMOND program has a mixed impact on biochemical outcomes. Specifically, at 12 months, the reduction in HbA1c (a key biochemical marker for diabetes management) was 1.49%, which was not statistically significant (p = 0.052). However, there was a",
               "rationale": "1. Objective To measure whether the benefits of a single education and self management structured programme for people with newly diagnosed type 2 diabetes mellitus are sustained at three years. Design Three year follow-up of a multicentre cluster randomised controlled trial in primary care, with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United ...\n2. Long term outcomes at four years have reported favourable clinical, cognitive, and psychological outcomes in a cohort with established type 2 diabetes. 35 The intervention comprised one hour education sessions delivered on a three monthly basis, whereas the DESMOND module was delivered as a single intervention involving six hours of contact ...\n3. In the DESMOND RCT, at 12 months, HbA 1c was reduced by 1.49% which was not statistically significant (p = 0.052), whereas there was a significant reduction in weight of 2.98 kg (p = 0.027), smoking cessation (p = 0.033), positive change in illness beliefs (p < 0.001), and reduced depression score (p = 0.032). 6 This real-world study ...\n4. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes.. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...\n5. Intervention - DESMOND program. The DESMOND program is a group education program whose curriculum has previously been detailed [10]. DESMOND is underpinned by the following learning theories: Leventhal's common sense theory [23], dual process theory, and social learning theory [24], which align with a person-centered philosophy of care [9 ...",
               "predicate": null
            }
         ],
         "row": 418,
         "id": 279995908235588309
      },
      {
         "claim": "The DESMOND program demonstrates no significant impact on lifestyles outcomes.",
         "label": 1,
         "prediction": 0,
         "rationale": "The DESMOND program is a structured education initiative for individuals with type 2 diabetes, aiming to provide education and support for self-management. The DESMOND program leads to initial improvements in lifestyle factors, which are maintained at three years, including continuing improvements in positive health beliefs and smoking cessation. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the DESMOND program?",
               "answer": "The DESMOND program, which stands for Diabetes Education and Self Management for Ongoing and Newly Diagnosed, is a structured education initiative developed by various NHS organizations for individuals with type 2 diabetes. It aims to provide education and support for self-management, integrating lifelong learning, care planning, and treatment optimization. DESMON",
               "rationale": "1. DESMOND is the acronym for Diabetes Education and Self Management for Ongoing and Newly Diagnosed. It is part of a school of patient education for people with diabetes, developed by a number of NHS Organisations. Educators on the NHS may now be specifically trained in DESMOND.\n2. The DESMOND intervention for people with newly diagnosed type 2 diabetes was always intended to be included within an ongoing model of education and clinical care, integrating life long learning, care planning, and treatment optimisation. However, a key aspect of the study design was to show at what point any benefits of intervention begin to ...\n3. 1 2. A type 2 diabetes prevention programme suitable for individuals who find themselves at risk of developing type 2 diabetes. 1 2. Designed specifically for women who have previously been diagnosed with gestational diabetes. 1 2. An online Low-ENergy Approach programme to support weight loss, in conjunction with. 1 2.\n4. DESMOND is the first national education programme created for people with Type 2 diabetes. DESMOND meets the criteria NICE identified as being the characteristics of a quality, evidence-based structured education programme.. A NHS training course is available for type 1 diabetics called DAFNE (Dose Adjustment for Normal Eating).\n5. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the outcome of the DESMOND program on lifestyles?",
               "answer": "The outcome of the DESMOND program on lifestyles includes initial improvements in lifestyle factors, which were maintained at three years. Specifically, there were continuing improvements in positive health beliefs and smoking cessation among participants. The program has been shown to improve biomedical, psychosocial, and lifestyle outcomes.",
               "rationale": "1. The initial improvements in biomedical, lifestyle and psychosocial outcomes observed at 12 months in the DESMOND cluster randomised controlled trial (RCT) 6 were maintained at three years with continuing improvement in positive health beliefs and smoking cessation. 7 Health economic analysis of DESMOND has also confirmed that the programme was ...\n2. Methods. The study methods, intervention, and outcomes at 12 months have been reported in detail previously.18 19 Briefly, a robust cluster randomised controlled trial was undertaken to assess the effectiveness of a structured self management education programme that took place in 13 primary care sites (207 practices) across England and Scotland. . Randomisation took place at the level of the ...\n3. Whether participation in structured diabetes self-management education (DSME) programs for participants with diabetes mellitus is associated with healthy lifestyles in routine care apart from randomized controlled studies remains unclear and is a question of this study. Cross-sectional population-based analysis: 15 participants: 2\n4. The structured \"Diabetes Education and Self-Management for Ongoing and Newly Diagnosed\" (DESMOND) program is a group education program with a structured curriculum and underpinned by multiple learning theories. It has previously been shown to improve biomedical, psychosocial and lifestyle outcomes [7, 9, 10].\n5. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes.. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...",
               "predicate": null
            }
         ],
         "row": 419,
         "id": 340081393316963870
      },
      {
         "claim": "The DESMOND program demonstrates no significant impact on weight loss.",
         "label": 1,
         "prediction": 0,
         "rationale": "The DESMOND program is a patient education initiative for individuals with diabetes, particularly those newly diagnosed with type 2 diabetes, aimed at providing group self-management education modules, toolkits, and care. The DESMOND program has an impact on weight loss, with participants experiencing a significant reduction in weight of 2.98 kg at 12 months. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the DESMOND program?",
               "answer": "The DESMOND program, which stands for Diabetes Education and Self Management for Ongoing and Newly Diagnosed, is a patient education initiative developed by various NHS organizations aimed at individuals with diabetes, particularly those newly diagnosed with type 2 diabetes. It encompasses a family of group self-management education modules, toolkits, and care",
               "rationale": "1. DESMOND is the acronym for Diabetes Education and Self Management for Ongoing and Newly Diagnosed. It is part of a school of patient education for people with diabetes, developed by a number of NHS Organisations. Educators on the NHS may now be specifically trained in DESMOND.\n2. The DESMOND intervention for people with newly diagnosed type 2 diabetes was always intended to be included within an ongoing model of education and clinical care, integrating life long learning, care planning, and treatment optimisation. However, a key aspect of the study design was to show at what point any benefits of intervention begin to ...\n3. DESMOND is the collaborative name for a family of group self management education modules, toolkits and care pathways for people with, or at risk of, Type 2 diabetes.\n4. Here at DESMOND we are known for our unique non-didactic, interactive delivery style and the strong philosophical underpinning that is paramount to the success of our programmes. Our vision is to take healthcare self-management education to the next level. As part of the Leicester Diabetes Centre, we strive to set the bar nationally and ...\n5. 1 2. A type 2 diabetes prevention programme suitable for individuals who find themselves at risk of developing type 2 diabetes. 1 2. Designed specifically for women who have previously been diagnosed with gestational diabetes. 1 2. An online Low-ENergy Approach programme to support weight loss, in conjunction with. 1 2.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the DESMOND program have an impact on weight loss?",
               "answer": "Yes, the DESMOND program has an impact on weight loss. In the DESMOND RCT, there was a significant reduction in weight of 2.98 kg (p = 0.027) at 12 months, indicating that participants in the program experienced weight loss.",
               "rationale": "1. In the DESMOND RCT, at 12 months, HbA 1c was reduced by 1.49% which was not statistically significant (p = 0.052), whereas there was a significant reduction in weight of 2.98 kg (p = 0.027), smoking cessation (p = 0.033), positive change in illness beliefs (p < 0.001), and reduced depression score (p = 0.032). 6 This real-world study ...\n2. Educators on the NHS may now be specifically trained in DESMOND. So what is DESMOND? DESMOND is a way to learn more about Type 2 diabetes. DESMOND is a resource to help manage diabetes-related changes. DESMOND is a way to meet and share life experiences with others. DESMOND is a group of education programmes designed for people with diabetes.\n3. Objective To measure whether the benefits of a single education and self management structured programme for people with newly diagnosed type 2 diabetes mellitus are sustained at three years. Design Three year follow-up of a multicentre cluster randomised controlled trial in primary care, with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United ...\n4. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes.. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...\n5. Objectives To assess the long term clinical and cost effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) intervention compared with usual care in people with newly diagnosed type 2 diabetes. Design We undertook a cost-utility analysis that used data from a 12 month, multicentre, cluster randomised controlled trial and, using the Sheffield type ...",
               "predicate": null
            }
         ],
         "row": 420,
         "id": 317622829088333238
      },
      {
         "claim": "The DdrB protein from Deinococcus radiodurans functions as a pentamer.",
         "label": 1,
         "prediction": 1,
         "rationale": "The DdrB protein from Deinococcus radiodurans is a bacterial single-stranded DNA-binding protein that plays a significant role in genome reconstitution and exhibits single-strand annealing activity. The structure of the DdrB protein from Deinococcus radiodurans was solved using SAD phasing with a 2.8 Å dataset collected from Selenomethionine. The DdrB protein from Deinococcus radiodurans functions as a pentamer. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the DdrB protein from Deinococcus radiodurans?",
               "answer": "The DdrB protein from Deinococcus radiodurans is a bacterial single-stranded DNA-binding protein that is induced to high levels following exposure to ionizing radiation. It plays a significant role in genome reconstitution and exhibits single-strand annealing activity. DdrB is part of the cellular response to extreme radiation",
               "rationale": "1. Deinococcus radiodurans exhibits an extraordinary resistance to the effects of exposure to ionizing radiation (IR). DdrB is one of five proteins induced to high levels in Deinococcus following extreme IR exposure and that play a demonstrable role in genome reconstitution. Although homology is limited, DdrB is a bacterial single-stranded DNA-binding protein. DdrB features a stable core with a ...\n2. Almost all the Deinococcus proteins solved by X-ray crystallography come from D. radiodurans, the most extensively studied Deinococcus species, and most structural information of protein-protein or protein-substrate complex listed in Table 1 are currently not available from other bacteria. DdrB and DdrO (both species-specific) are the only ...\n3. In D. radiodurans, the RecO protein seems to play only a minor role in plasmid transformation when DdrB is present in the cells, consistent with the low in vitro DNA single strand pairing activity of the Deinococcal RecO protein (Makharashvili et al., 2004) and the single strand annealing activity of the DdrB protein (Xu et al., 2010).\n4. In D. radiodurans, the RecO protein seems to play only a minor role in plasmid transformation when DdrB is present in the cells, consistent with the low in vitro DNA single strand pairing activity of the Deinococcal RecO protein (Makharashvili et al., 2004) and the single strand annealing activity of the DdrB protein (Xu et al., 2010).\n5. In D. radiodurans, ddrB (DR0070) experiences a >40-fold induction immediately following exposure to 3 kGy of γ ... The discovery of a new SSB-like protein in Deinococcus spp. opens the question of whether additional specialized SSB-like proteins may also exist in other organisms that have missed being identified due to sequence and structural ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the structure of the DdrB protein from Deinococcus radiodurans?",
               "answer": "The structure of the DdrB protein from Deinococcus radiodurans was solved using SAD phasing with a 2.8 Å dataset collected from Selenomethionine. The determination of its crystal structure aimed to clarify whether DdrB is a distantly related homolog of the standard single-stranded DNA",
               "rationale": "1. Almost all the Deinococcus proteins solved by X-ray crystallography come from D. radiodurans, the most extensively studied Deinococcus species, and most structural information of protein-protein or protein-substrate complex listed in Table 1 are currently not available from other bacteria. DdrB and DdrO (both species-specific) are the only ...\n2. The single-stranded DNA (ssDNA)-binding protein from the radiation-resistant bacterium Deinococcus radiodurans (DrSSB) functions as a homodimer in which each monomer contains two oligonucleotide-binding (OB) domains. This arrangement is exceedingly rare among bacterial SSBs, which typically form homotetramers of single-OB domain subunits.\n3. By determining its crystal structure, we hoped to answer the question of whether DdrB is a distantly related homolog of the standard SSB, or a structurally distinct protein that has arisen to perform a specialized function in Deinococcus spp. The structure of DdrB was solved by SAD phasing using a 2.8 Å dataset collected from Selenomethionine ...\n4. Deinococcus radiodurans exhibits an extraordinary resist-ance to the effects of exposure to ionizing radiation (IR). ... The proteins induced in Deinococcus upon exposure to IR havebeenstudiedusingmicroarray-basedtranscriptomeanal-yses (10, 11). Five novel proteins, called DdrA, DdrB, DdrC, ... The DdrB protein remained in the pellet and was ...\n5. Deinococcus radiodurans exhibits an extraordinary resistance to the effects of exposure to ionizing radiation (IR). DdrB is one of five proteins induced to high levels in Deinococcus following extreme IR exposure and that play a demonstrable role in genome reconstitution. Although homology is limited, DdrB is a bacterial single-stranded DNA-binding protein. DdrB features a stable core with a ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the DdrB protein from Deinococcus radiodurans function as a pentamer?",
               "answer": "Yes, the DdrB protein from Deinococcus radiodurans functions as a pentamer. Evidence 4 states, \"In solution, the protein functions as a pentamer.\"",
               "rationale": "1. Almost all the Deinococcus proteins solved by X-ray crystallography come from D. radiodurans, the most extensively studied Deinococcus species, and most structural information of protein-protein or protein-substrate complex listed in Table 1 are currently not available from other bacteria. DdrB and DdrO (both species-specific) are the only ...\n2. Deinococcus radiodurans exhibits an extraordinary resistance to the effects of exposure to ionizing radiation (IR). DdrB is one of five proteins induced to high levels in Deinococcus following extreme IR exposure and that play a demonstrable role in genome reconstitution. Although homology is limited, DdrB is a bacterial single-stranded DNA-binding protein.\n3. DdrB was first identified from two independent analyses of the IR-induced transcriptional response of Deinococcus radiodurans ( 7, 8 ). DdrB binds ssDNA ( 9 ); however, unlike SSB, DdrB promotes accurate DNA-strand annealing ( 5, 10 ), providing evidence for a role in repair by single-strand annealing. This biological role is further supported ...\n4. Deinococcus radiodurans exhibits an extraordinary resist-ance to the effects of exposure to ionizing radiation (IR). ... In solution, the protein functions as a pentamer. The protein binds single-stranded DNA but not duplex DNA. Electron microscopy and assays with two RecA ... The DdrB protein remained in the pellet and was eluted from ...\n5. By determining its crystal structure, we hoped to answer the question of whether DdrB is a distantly related homolog of the standard SSB, or a structurally distinct protein that has arisen to perform a specialized function in Deinococcus spp. The structure of DdrB was solved by SAD phasing using a 2.8 Å dataset collected from Selenomethionine ...",
               "predicate": null
            }
         ],
         "row": 421,
         "id": 610106258247935404
      },
      {
         "claim": "The M2-phenotype in brown adipose tissue macrophages increases brown adipose tissue thermogenic activity.",
         "label": 1,
         "prediction": 1,
         "rationale": "The M2-phenotype in brown adipose tissue macrophages is associated with a regulatory role that promotes tissue homeostasis and supports the health of adipocytes, involving anti-inflammatory responses and tissue repair. The M2-phenotype in brown adipose tissue macrophages increases brown adipose tissue thermogenic activity. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the M2-phenotype in brown adipose tissue macrophages?",
               "answer": "The M2-phenotype in brown adipose tissue macrophages (ATMs) is associated with a regulatory role that promotes tissue homeostasis and supports the health of adipocytes. Unlike the pro-inflammatory M1 phenotype, M2 macrophages are involved in anti-inflammatory responses and tissue repair. They help in remodeling adipose",
               "rationale": "1. Obesity exhibits a correlation with metabolic inflammation and endoplasmic reticulum stress, promoting the progression of metabolic disease such as diabetes, hyperlipidemia, hyperuricemia and so on. Adipose tissue macrophages (ATMs) are central players in obesity-associated inflammation and metabolic diseases. Macrophages are involved in lipid and energy metabolism and mitochondrial function ...\n2. Abstract Adipose tissue not only functions as the major energy-storing tissue, but also functions as an endocrine organ that regulates systemic metabolism by releasing various hormones called adipokines. Macrophages play a critical role in maintaining adipocyte health in a lean state and in remodeling during the progression of obesity.\n3. Macrophages serve important functions in defense and tissue homeostasis. Jung and colleagues demonstrate that a resident population of macrophages controls the innervation of brown adipose tissue ...\n4. Mutant macrophages overexpressed the signaling receptor and ligand PlexinA4, which might contribute to the phenotype by repulsion of sympathetic axons expressing the transmembrane semaphorin Sema6A. Collectively, we report a previously unappreciated homeostatic role for macrophages in the control of tissue innervation.\n5. Background Adipose tissue macrophages (ATMs) are a well characterized regulator of adipose tissue inflammatory tone. Previously defined by the M1 vs M2 classification, we now have a better understanding of ATM diversity that departs from the old paradigm and reports a spectrum of ATM function and phenotypes in both brown and white adipose tissue.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the M2-phenotype in brown adipose tissue macrophages increase brown adipose tissue thermogenic activity?",
               "answer": "Yes, the M2-phenotype in brown adipose tissue macrophages does increase brown adipose tissue thermogenic activity. Evidence from point 5 indicates that M2 macrophages activated by cold exposure upregulate thermogenic gene expression in brown adipose tissue, which suggests that these macrophages play a role in enhancing",
               "rationale": "1. Macrophages serve important functions in defense and tissue homeostasis. Jung and colleagues demonstrate that a resident population of macrophages controls the innervation of brown adipose tissue ...\n2. Brown adipose tissue (BAT) has been encouraged as a potential treatment for obesity and comorbidities due to its thermogenic activity capacity and contribution to energy expenditure. Some interventions such as cold and β-adrenergic drugs are able to activate BAT thermogenesis as well as promote differentiation of white adipocytes into brown ...\n3. Tissue macrophages provide immunological defense and contribute to the establishment and maintenance of tissue homeostasis. Here we used constitutive and inducible mutagenesis to delete the nuclear transcription regulator Mecp2 in macrophages. Mice that lacked the gene encoding Mecp2, which is associated with Rett syndrome, in macrophages did ...\n4. Brown adipose tissue (BAT) has been encouraged as a potential treatment for obesity and comorbidities due to its thermogenic activity capacity and contribution to energy expenditure. Some interventions such as cold and β-adrenergic drugs are able to activate BAT thermogenesis as well as promote differentiation of white adipocytes into brown-like cells (browning), enhancing the thermogenic ...\n5. M2 macrophages activated by cold exposure upregulate thermogenic gene expression in brown adipose tissue and promote fatty acid mobilization in white adipose tissue 48. Meteorin-like is a novel hormone secreted in response to exercise and cold exposure that stimulates eosinophil IL-4 release and alternative activation of macrophages in adipose ...",
               "predicate": null
            }
         ],
         "row": 422,
         "id": 278418211745764821
      },
      {
         "claim": "The NF-κB essential modulator gene induces intestinal inflammation by promoting receptor-interacting protein (RIP) kinase 1 kinase activity-mediated epithelial cell death.",
         "label": 0,
         "prediction": 1,
         "rationale": "The NF-κB essential modulator (NEMO) gene functions as a key regulator in NF-κB-mediated signaling, acting as an adapter molecule critical for the canonical activation of NF-κB, which controls immune responses, inflammation, and cell growth. The NF-κB essential modulator (NEMO) gene prevents receptor-interacting protein (RIP) kinase 1-mediated epithelial cell death. The NF-κB essential modulator gene's direct role in inducing intestinal inflammation is not specifically mentioned in the provided evidence snippets. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the NF-κB essential modulator gene?",
               "answer": "The NF-κB essential modulator (NEMO) gene functions as a key regulator in NF-κB-mediated signaling. It acts as an adapter molecule that is critical for the canonical activation of NF-κB, which is involved in controlling various physiological processes such as immune responses, inflammation, and cell growth",
               "rationale": "1. NEMO protein, mouse. NF-kappa B. The I-κB kinase (IKK) subunit NEMO/IKKγ (NEMO) is an adapter molecule that is critical for canonical activation of NF-κB, a pleiotropic transcription factor controlling immunity, differentiation, cell growth, tumorigenesis, and apoptosis. To explore the functional role of canonical NF-κB signaling i ….\n2. Abstract. The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune development, immune responses, inflammation, and cancer. The NFκB signaling system (defined by the interactions between NFκB dimers, IκB regulators, and IKK complexes) is responsive to a number of stimuli, and upon ligand-receptor ...\n3. NF-κB forms a family of transcription factors that play essential roles in multiple physiological and pathological processes. There are two different NF-κB pathways, the canonical and non ...\n4. The nuclear factor (NF)-κB essential modulator (NEMO) is a key regulator in NF-κB-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-κB-regulated genes. NEMO dysfunction is associated with inherited diseases such as incontinentia pigmenti (IP), ectodermal dysplasia, anhidrotic, with immunodeficiency (EDA-ID), and some cancers. We focus on ...\n5. The transcription factor NF-κB regulates multiple aspects of innate and adaptive immune functions and serves as a pivotal mediator of inflammatory responses. NF-κB induces the expression of ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene promote receptor-interacting protein (RIP) kinase 1 kinase activity-mediated epithelial cell death?",
               "answer": "No, the NF-κB essential modulator (NEMO) gene does not promote receptor-interacting protein (RIP) kinase 1-mediated epithelial cell death. In fact, the evidence suggests that NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation through both NF-κB",
               "rationale": "1. NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions ... IEC-specific ablation of nuclear factor κB (NF-κB) essential modulator (NEMO) caused Paneth cell apoptosis and impaired antimicrobial factor expression in the ileum, as well as colonocyte apoptosis ...\n2. The nuclear factor (NF)-κB essential modulator (NEMO) is a key regulator in NF-κB-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-κB-regulated genes. NEMO dysfunction is associated with inherited diseases such as incontinentia pigmenti (IP), ectodermal dysplasia, anhidrotic, with immunodeficiency (EDA-ID), and some cancers. We focus on ...\n3. NF-κB is a central mediator of the priming signal of NLRP3 inflammasome activation and acts by inducing the transcriptional expression of NLRP3 and pro-IL-1β in response to various PRR ligands ...\n4. NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin ...\n5. Receptor-interacting protein (RIP1) is a key upstream regulator of signalling pathways that lead to either inflammation or cell death by apoptosis or necroptosis. Recent evidence indicates that ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene induce intestinal inflammation?",
               "answer": "The provided evidence snippets do not specifically mention the NF-κB essential modulator gene or its direct role in inducing intestinal inflammation. However, they do highlight the role of NF-κB as a key regulator of inflammation and its involvement in immune responses and cancer development. Since NF-κB signaling is implicated in medi",
               "rationale": "1. Nuclear factor-κB (NF-κB) represents a family of inducible transcription factors, which regulates a large array of genes involved in different processes of the immune and inflammatory responses ...\n2. NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth ...\n3. Nuclear factor kappa-B (NF-κB) is a nuclear transcription factor that plays a key factor in promoting inflammation, which can lead to the development of cancer in a long-lasting inflammatory ...\n4. Abstract. The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune development, immune responses, inflammation, and cancer. The NFκB signaling system (defined by the interactions between NFκB dimers, IκB regulators, and IKK complexes) is responsive to a number of stimuli, and upon ligand-receptor ...\n5. The NF-κB family of transcription factors has an essential role in inflammation and innate immunity. Furthermore, NF-κB is increasingly recognized as a crucial player in many steps of cancer initiation and progression. During these latter processes NF-κB cooperates with multiple other signaling molecules and pathways. Prominent nodes of crosstalk are mediated by other transcription factors ...",
               "predicate": null
            }
         ],
         "row": 423,
         "id": 295885652219322511
      },
      {
         "claim": "The NF-κB essential modulator gene prevents intestinal inflammation by inhibiting receptor-interacting protein (RIP) kinase 1 kinase activity-mediated epithelial cell death.",
         "label": 1,
         "prediction": 0,
         "rationale": "The NF-κB essential modulator gene encodes the NEMO protein, which is a critical adapter molecule for the canonical activation of the NF-κB signaling pathway, regulating processes such as immunity, differentiation, cell growth, and tumorigenesis. The NF-κB essential modulator gene's role in inhibiting receptor-interacting protein kinase 1 kinase activity-mediated epithelial cell death is not directly addressed by the provided evidence. The NF-κB essential modulator gene is involved in regulating inflammatory responses, including those in the intestinal immune system, but it is not directly stated to prevent intestinal inflammation. The provided evidence does not directly address whether the NF-κB essential modulator (NEMO) gene inhibits receptor-interacting protein (RIP) kinase 1 kinase activity. The provided evidence does not directly address whether the NF-κB essential modulator (NEMO) gene inhibits receptor-interacting protein (RIP) kinase 1 (RIP1) kinase activity in epithelial cells. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the NF-κB essential modulator gene?",
               "answer": "The NF-κB essential modulator gene (IKBKG) encodes the NEMO protein, which is a critical adapter molecule for the canonical activation of the NF-κB signaling pathway. This pathway plays a vital role in regulating various cellular processes, including immunity, differentiation, cell growth, tumorigenesis",
               "rationale": "1. NF-kappa-B essential modulator (NEMO) also known as inhibitor of nuclear factor kappa-B kinase subunit gamma (IKK-γ) is a protein that in humans is encoded by the IKBKG gene.NEMO is a subunit of the IκB kinase complex that activates NF-κB. The human gene for IKBKG is located on the chromosome band Xq28. Multiple transcript variants encoding different isoforms have been found for this gene.\n2. NEMO protein, mouse. NF-kappa B. The I-κB kinase (IKK) subunit NEMO/IKKγ (NEMO) is an adapter molecule that is critical for canonical activation of NF-κB, a pleiotropic transcription factor controlling immunity, differentiation, cell growth, tumorigenesis, and apoptosis. To explore the functional role of canonical NF-κB signaling i ….\n3. Mechanism of NF-κB action.The classic \"canonical\" NF-κB complex is a heterodimer of p50 and RelA, as shown. NF-κB waits for activation in the cytosol, complexed with the inhibitory protein IκBα.Various extracellular signals can enter the cell via membrane receptors and activate the enzyme IκB kinase (IKK). IKK, in turn, phosphorylates the IκBα protein, which results in ubiquitination ...\n4. The I-κB kinase (IKK) subunit NEMO/IKKγ (NEMO) is an adapter molecule that is critical for canonical activation of NF-κB, a pleiotropic transcription factor controlling immunity, differentiation, cell growth, tumorigenesis, and apoptosis. To explore the functional role of canonical NF-κB signaling in thyroid gland differentiation and ...\n5. NEMO. The IKBKG gene encoding NF-κB essential modulator (NEMO) is located on the X chromosome in humans. Its mutation or truncation causes the disease incontinentia pigmenti, which is lethal in ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene inhibit receptor-interacting protein (RIP) kinase 1 kinase activity-mediated epithelial cell death?",
               "answer": "The provided evidence snippets do not directly address whether the NF-κB essential modulator (NEMO) gene inhibits receptor-interacting protein (RIP) kinase 1 (RIPK1) kinase activity-mediated epithelial cell death. However, they do indicate that NEMO is a key regulator in NF-",
               "rationale": "1. The nuclear factor (NF)-κB essential modulator (NEMO) is a key regulator in NF-κB-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-κB-regulated genes. NEMO dysfunction is associated with inherited diseases such as incontinentia pigmenti (IP), ectodermal dysplasia, anhidrotic, with immunodeficiency (EDA-ID), and some cancers. We focus on ...\n2. IKK performs a dual function of activating NF-κB and inhibiting the cell death pathway. 7 In unstimulated cells, IκB inhibits the DNA-binding activity of NF-κB dimers and keeps them homeostatic ...\n3. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) functions in a variety of cellular pathways related to both cell survival and death. In terms of cell death, RIPK1 plays a role in apoptosis and necroptosis.Some of the cell survival pathways RIPK1 participates in include NF-κB, Akt, and JNK.. RIPK1 is an enzyme that in humans is encoded by the RIPK1 gene, which is located on ...\n4. Introduction. The transcription factor NF-κB was discovered in 1986 as a nuclear factor that binds to the enhancer element of the immunoglobulin kappa light-chain of activated B cells (thereby coining the abbreviation NF-κB) [].Soon afterwards it became clear that proteins, which harbor this specific DNA binding activity are expressed in nearly all cell types and regulate many target genes ...\n5. Receptor-interacting protein (RIP1) is a key upstream regulator of signalling pathways that lead to either inflammation or cell death by apoptosis or necroptosis. Recent evidence indicates that ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene prevent intestinal inflammation?",
               "answer": "The provided evidence does not directly state that the NF-κB essential modulator (NEMO) gene prevents intestinal inflammation. However, it does indicate that NF-κB plays a crucial role in regulating inflammatory responses, including those in the intestinal immune system. The evidence suggests that NF-κB is involved in",
               "rationale": "1. NF-κB is a central mediator of the priming signal of NLRP3 inflammasome activation and acts by inducing the transcriptional expression of NLRP3 and pro-IL-1β in response to various PRR ligands ...\n2. Phosphorylation of RelA by IKKα at Ser536 (Ser534 in mice) is an important mechanism for the negative regulation of pro-inflammatory gene expression . The Inhibitors of NF-κB Kinase (IKK) complex consist of the catalytic subunits IKKα, IKKβ, and regulatory subunit NEMO, for NF-κB essential modulator, which is also called IKKγ in human.\n3. NF-κB forms a family of transcription factors that play essential roles in multiple physiological and pathological processes. There are two different NF-κB pathways, the canonical and non ...\n4. NF-κB is a pleiotropic transcription factor with key functions in the intestinal immune system. NF-κB family members control transcriptional activity of various promoters of proinflammatory cytokines, cell surface receptors, transcription factors, and adhesion molecules that are involved in intestinal inflammation. The perpetuated activation of NF-κB in patients with active inflammatory ...\n5. Abstract. The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune development, immune responses, inflammation, and cancer. The NFκB signaling system (defined by the interactions between NFκB dimers, IκB regulators, and IKK complexes) is responsive to a number of stimuli, and upon ligand-receptor ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene inhibit receptor-interacting protein (RIP) kinase 1 kinase activity?",
               "answer": "The provided evidence snippets do not directly address whether the NF-κB essential modulator (NEMO) gene inhibits receptor-interacting protein (RIP) kinase 1 kinase activity. The snippets discuss the role of NEMO in NF-κB signaling, its association with various diseases, and the activation of",
               "rationale": "1. Integral to this post-translational regulation is the polyubiquitin-binding protein NF-κB essential modulator (NEMO), which controls the modification of numerous NF-κB signalling proteins, such ...\n2. The nuclear factor (NF)-κB essential modulator (NEMO) is a key regulator in NF-κB-mediated signaling. By transmitting extracellular or intracellular signals, NEMO can control NF-κB-regulated genes. NEMO dysfunction is associated with inherited diseases such as incontinentia pigmenti (IP), ectodermal dysplasia, anhidrotic, with immunodeficiency (EDA-ID), and some cancers. We focus on ...\n3. The investigation into interleukin 1 receptor-associated kinase (IRAK) as an essential component for IL-1 activation of NF-κB signaling originated from the discovery by Zhaodan Cao et al. that ...\n4. Activation and regulation of canonical NF-κB pathway. a Ligation of TNFR leads to the recruitment of TRADD and interaction of the E3 ubiquitin ligases cIAP1/2, TRAF2 with the protein kinase RIP1 ...\n5. Site-specific NF-κB phosphorylation may promote or inhibit NF-κB activity through control of interactions with other factors, modulation of transcriptional activity and/or protein stability.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does the NF-κB essential modulator gene inhibit receptor-interacting protein (RIP) kinase 1 kinase activity in epithelial cells?",
               "answer": "The provided evidence snippets do not directly address whether the NF-κB essential modulator (NEMO) gene inhibits receptor-interacting protein (RIP) kinase 1 (RIP1) kinase activity in epithelial cells. The snippets discuss the role of NEMO in the NF-κB signaling pathway and",
               "rationale": "1. NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin ...\n2. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO-NEMO ...\n3. Activation and regulation of canonical NF-κB pathway. a Ligation of TNFR leads to the recruitment of TRADD and interaction of the E3 ubiquitin ligases cIAP1/2, TRAF2 with the protein kinase RIP1 ...\n4. The nuclear factor kappa B (NFκB) family of transcription factors is a key regulator of immune development, immune responses, inflammation, and cancer. The NFκB signaling system (defined by the interactions between NFκB dimers, IκB regulators, and IKK complexes) is responsive to a number of stimuli, and upon ligand-receptor engagement ...\n5. TCR/BCR-Mediated NF-κB Signaling . In T and B cells, recognition of an antigen by the T Cell Receptor (TCR) or activation of the B cell receptor (BCR) induces the interaction of CARMA1 with a preassembled dimer of MALT1 and BCL10 following its phosphorylation by Protein Kinase C-θ (PKC-θ) or β (PKC−β)s.",
               "predicate": null
            }
         ],
         "row": 424,
         "id": 329576620360885942
      },
      {
         "claim": "The PDPN gene deactivates the C-type lectin receptor (CLEC-2).",
         "label": 0,
         "prediction": 0,
         "rationale": "The PDPN gene encodes podoplanin, a protein that plays a critical role in lymphangiogenesis and is associated with cancer progression. The PDPN gene-encoded podoplanin interacts with the C-type lectin receptor (CLEC-2). The interaction between PDPN-encoded podoplanin and CLEC-2 does not result in the deactivation of CLEC-2. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the PDPN gene?",
               "answer": "The PDPN gene encodes a type-I integral membrane glycoprotein known as podoplanin, which plays a critical role in various physiological processes. It is involved in lymphangiogenesis, which is the formation of lymphatic vessels, and is associated with cancer progression by enhancing tumor cell clonal capacity, epithelial-m",
               "rationale": "1. PDPN has been studied extensively in the cancer field. It is a specific lymphatic vessel marker, and since lymphangiogenesis levels are correlated with poor prognosis in cancer patients, it can be used as a diagnostic marker. It is often upregulated in certain types of cancer, including several types of squamous cell carcinomas, malignant mesothelioma and brain tumors.\n2. NCBI Gene Summary for PDPN Gene. This gene encodes a type-I integral membrane glycoprotein with diverse distribution in human tissues. The physiological function of this protein may be related to its mucin-type character. The homologous protein in other species has been described as a differentiation antigen and influenza-virus receptor.\n3. Podoplanin (PDPN) is a well-conserved, mucin-type transmembrane protein expressed in multiple tissues during ontogeny and in adult animals, including the brain, heart, kidney, lungs, osteoblasts, and lymphoid organs. Studies of PDPN-deficient mice have demonstrated that this molecule plays a critical role in development of the heart, lungs, and ...\n4. Podoplanin (PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression.In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migration, invasion, metastasis and inflammation. Antibodies, CAR ‐T cells, biologics and synthetic ...\n5. 2 Podoplanin structure, protein partners and cellular expression. Pdpn is composed of an extracellular domain with about 130 amino acids, a transmembrane domain with approximately 25 amino acids, and a short intracellular domain of approximately 10 amino acids (Martín-Villar et al., 2005).Due to the lack of enzymatic motifs, it exerts its function mainly through protein-protein interactions.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the PDPN gene-encoded podoplanin interact with the C-type lectin receptor (CLEC-2)?",
               "answer": "Yes, the PDPN gene-encoded podoplanin interacts with the C-type lectin receptor (CLEC-2). The evidence indicates that PDPN is the endogenous ligand for CLEC-2, which is expressed on platelets, and this interaction is involved in processes such as platelet aggregation and tumor cell invasion.",
               "rationale": "1. PDPN was found to be the endogenous ligand of C-type lectin-like receptor 2 (CLEC-2) on platelets and is involved in platelet aggregation induced by tumor cells 4, which facilitates invasion and ...\n2. PDPN is the endogenous ligand for the C-type lectin receptor CLEC-2 ... deleted by Cre expressed from the gene encoding the ... of the PDPN-CLEC-2 interaction have focused on signaling ...\n3. Podoplanin (PDPN) is intensely expressed on the podocyte membrane in an evolutionally conserved manner. CLEC-2, the endogenous ligand of PDPN, is highly expressed in platelets and also exists in a soluble form in plasma. ... but when the glomerular barrie … C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological ...\n4. Podoplanin (PDPN) is a well-conserved, mucin-type transmembrane protein expressed in multiple tissues during ontogeny and in adult animals, including the brain, heart, kidney, lungs, osteoblasts, and lymphoid organs. Studies of PDPN-deficient mice have demonstrated that this molecule plays a critical role in development of the heart, lungs, and ...\n5. Podoplanin (PDPN) expressed on tumour cells interacts with platelet C-type lectin-like receptor 2 (CLEC-2). This study aimed to investigate the role of the PDPN-platelet CLEC-2 interaction in melanoma pulmonary metastasis. Murine melanoma B16-F0 cells, which have two populations that express podoplanin, were sorted by FACS with anti-podoplanin staining to obtain purified PDPN + and PDPN- B16 ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the interaction between PDPN-encoded podoplanin and CLEC-2 result in the deactivation of CLEC-2?",
               "answer": "No, the interaction between PDPN-encoded podoplanin and CLEC-2 does not result in the deactivation of CLEC-2. Instead, the evidence suggests that this interaction is crucial for platelet activation and has multiple roles beyond hemostasis. Specifically, while CLEC-2 can inhibit the basal function",
               "rationale": "1. 2 Podoplanin structure, protein partners and cellular expression. Pdpn is composed of an extracellular domain with about 130 amino acids, a transmembrane domain with approximately 25 amino acids, and a short intracellular domain of approximately 10 amino acids (Martín-Villar et al., 2005).Due to the lack of enzymatic motifs, it exerts its function mainly through protein-protein interactions.\n2. Podoplanin (PDPN) is a 36- to 43-kDa mucin-type transmembrane protein. It has homologues in humans, mice, rats, dogs, and hamsters and is relatively well conserved between species. PDPN has a wide variety of functions including regulation of organ development, cell motility, and tumorigenesis and metastasis ( Wicki and Christofori, 2007; Suzuki ...\n3. Similarly, CLEC-2 inhibits the basal function of PDPN in keratinocytes and lymphatic endothelial cells 11,27, but in these cases the net effect of CLEC-2 is the inhibition of cell migration, which ...\n4. A transmembrane O-glycoprotein podoplanin (PDPN) expressed on fibroblastic reticular cells is the activating ligand for platelet receptor CLEC-2; this interaction leads to perivenular release of ...\n5. CLEC-2 belongs to the family of the non-classical C-type lectins, expressed on dendritic cells, neutrophils, and platelets and to date, podoplanin is the only known endogenous ligand for CLEC-2. 2, 4-8 The interaction between platelet CLEC-2 and podoplanin is the key for platelet activation and its multiple roles besides hemostasis. 5 The ...",
               "predicate": null
            }
         ],
         "row": 425,
         "id": 148707732248361452
      },
      {
         "claim": "The PRDM1 gene is a key determinant of primordial germ cells.",
         "label": 1,
         "prediction": 0,
         "rationale": "The PRDM1 gene encodes the protein BLIMP-1, which is a 'master regulator' of hematopoietic stem cells and plays a critical role in the development of plasma B cells, T cells, and dendritic cells, functioning as a transcription factor that regulates gene expression. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the PRDM1 gene?",
               "answer": "The PRDM1 gene encodes the protein BLIMP-1, which is a 'master regulator' of hematopoietic stem cells and plays a critical role in the development of plasma B cells, T cells, and dendritic cells. It functions as a transcription factor that regulates gene expression, particularly in the terminal",
               "rationale": "1. PRDM1. PR domain zinc finger protein 1, or B lymphocyte-induced maturation protein-1 ( BLIMP-1 ), is a protein in humans encoded by the gene PRDM1 located on chromosome 6q21. [5] BLIMP-1 is considered a 'master regulator' of hematopoietic stem cells, and plays a critical role in the development of plasma B cells, T cells, dendritic cells (DCs ...\n2. PRDM1 (PR/SET Domain 1) is a Protein Coding gene. Diseases associated with PRDM1 include Plasmablastic Lymphoma and B-Cell Lymphoma.Among its related pathways are Gene expression (Transcription) and Regulation of TP53 Activity.Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA ...\n3. Data regarding the gene expression profiles of PRDM1 were extracted from the 33 cancer types in TCGA to form an expression matrix, which is further merged with corresponding clinical information based on patient ID. ... To understand the involved biological functions and pathways of PRDM1, gene set enrichment analysis (GSEA) was performed on PRDM1.\n4. The PRDM1 gene has two alternative promoters, transcribing two isoforms (i.e., PRDM1α and PRDM1β) with opposite functions, but both still able to bind to DNA (a phenomenon described as 'Yin and Yang') .\n5. 2.1. PRDM1. PRDM1/BLIMP1 (B lymphocyte-induced maturation protein-1) was firstly identified as a repressor of human β-interferon gene expression [].Then, it appeared as a pleiotropic regulatory factor participating at the B lymphocyte terminal differentiation [].PRDM1/BLIMP1 is also expressed in T and NK (natural killer) cells where it regulates their homeostasis [15,16,17].",
               "predicate": null
            }
         ],
         "row": 426,
         "id": 142048950409355320
      },
      {
         "claim": "The PRDM1 gene, when combined with the PRDM14 gene, plays an important role during primordial germ cell specification.",
         "label": 1,
         "prediction": 1,
         "rationale": "The PRDM1 gene encodes the protein BLIMP-1, which is a 'master regulator' of hematopoietic stem cells and plays a critical role in the development of plasma B cells, T cells, and dendritic cells, functioning as a transcription factor that regulates gene expression. The PRDM14 gene plays a critical role in germ cell specification and fate determination, influencing the transcriptome of human primordial germ cell-like cells and early-specific expression in the developing germ cell lineage. The combination of PRDM1 and PRDM14 genes plays a significant role in the specification of primordial germ cells, with PRDM1 establishing the germ cell program and repressing the somatic mesodermal program. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the PRDM1 gene?",
               "answer": "The PRDM1 gene encodes the protein BLIMP-1, which is a 'master regulator' of hematopoietic stem cells and plays a critical role in the development of plasma B cells, T cells, and dendritic cells. It functions as a transcription factor that regulates gene expression, particularly in the terminal",
               "rationale": "1. PRDM1. PR domain zinc finger protein 1, or B lymphocyte-induced maturation protein-1 ( BLIMP-1 ), is a protein in humans encoded by the gene PRDM1 located on chromosome 6q21. [5] BLIMP-1 is considered a 'master regulator' of hematopoietic stem cells, and plays a critical role in the development of plasma B cells, T cells, dendritic cells (DCs ...\n2. PRDM1 (PR/SET Domain 1) is a Protein Coding gene. Diseases associated with PRDM1 include Plasmablastic Lymphoma and B-Cell Lymphoma.Among its related pathways are Gene expression (Transcription) and Regulation of TP53 Activity.Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA ...\n3. Data regarding the gene expression profiles of PRDM1 were extracted from the 33 cancer types in TCGA to form an expression matrix, which is further merged with corresponding clinical information based on patient ID. ... To understand the involved biological functions and pathways of PRDM1, gene set enrichment analysis (GSEA) was performed on PRDM1.\n4. The PRDM1 gene has two alternative promoters, transcribing two isoforms (i.e., PRDM1α and PRDM1β) with opposite functions, but both still able to bind to DNA (a phenomenon described as 'Yin and Yang') .\n5. 2.1. PRDM1. PRDM1/BLIMP1 (B lymphocyte-induced maturation protein-1) was firstly identified as a repressor of human β-interferon gene expression [].Then, it appeared as a pleiotropic regulatory factor participating at the B lymphocyte terminal differentiation [].PRDM1/BLIMP1 is also expressed in T and NK (natural killer) cells where it regulates their homeostasis [15,16,17].",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of the PRDM14 gene?",
               "answer": "The PRDM14 gene plays a critical role in germ cell specification and fate determination. It is essential for the efficiency of germ cell specification and influences the transcriptome of human primordial germ cell-like cells (hPGCLCs). Additionally, PRDM14 is involved in the early-specific expression in the developing germ cell lineage.",
               "rationale": "1. We reveal an indispensable role for PRDM14 in germ cell fate, since loss of function affects the efficiency of specification and results in an aberrant hPGCLC transcriptome. Notably, PRDM14 targets are not conserved between mouse and human, reflecting the evolutionary divergence in the molecular network for PGC specification.\n2. Here, PRDM14 protein depletion using auxin-inducible degron uncovers a critical role for human germ cell specification, but regulation of a different set of target genes than in mouse.\n3. Complete information for PRDM14 gene (Protein Coding), PR/SET Domain 14, including: function, proteins, disorders, pathways, orthologs, and expression. GeneCards - The Human Gene Compendium\n4. These findings establish that Prdm14 is the gene with the earliest-specific expression so far identified in the developing germ cell lineage. Figure 1: Expression of Prdm14 in germ cell development.\n5. PRDM14 function has been particularly well characterized in lymphoid leukemias and T-ALL mouse models, demonstrating full penetrance and accelerated disease onset due to expansion of hematopoietic stem cells, lymphoid progenitors, and blockade of pro-differentiating cellular programs [ 125 ].",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the role of the combination of PRDM1 and PRDM14 genes in primordial germ cell specification?",
               "answer": "The combination of PRDM1 and PRDM14 genes plays a significant role in the specification of primordial germ cells (PGCs). PRDM1 is critical for establishing the germ cell program and repressing the somatic mesodermal program, while PRDM14, although its role in humans is less clear, has",
               "rationale": "1. PRDM14 is a critical transcription factor for mouse primordial germ cell specification, but its role in human remains unclear. Here, PRDM14 protein depletion using auxin-inducible degron uncovers ...\n2. Together, SOX17 and PRDM1 establish the human germ cell programme, whereas the role of AP2γ and PRDM14 in human PGC (hPGC) specification remains to be clarified. Notably, SOX2 is absent in hPGCs.\n3. PRDM14 is a critical transcription factor for mouse primordial germ cell specification, but its role in human remains unclear. Here, PRDM14 protein depletion using auxin-inducible degron uncovers a critical role for human germ cell specification, but regulation of a different set of target genes than in mouse.\n4. Prdm1 seems to be critical for the repression of the somatic mesodermal program. Considering the severe phenotype of the Prdm1 mutants 6, it may also be critical in the two other processes. Prdm14 ...\n5. Abstract. PRDM14 is a crucial regulator of mouse primordial germ cells (mPGCs), epigenetic reprogramming and pluripotency, but its role in the evolutionarily divergent regulatory network of human PGCs (hPGCs) remains unclear. Besides, a previous knockdown study indicated that PRDM14 might be dispensable for human germ cell fate.",
               "predicate": null
            }
         ],
         "row": 427,
         "id": 171332962025390638
      },
      {
         "claim": "The RANK-RANK-Ligand (RANKL) pathway is involved in the development of Aire-expressing medullary thymic epithelial cells (mTECs).",
         "label": 1,
         "prediction": 1,
         "rationale": "The RANK-RANKL pathway, also known as the RANK/RANKL/OPG system, is a critical signaling mechanism involved in bone metabolism, specifically in the processes of bone formation and resorption. The RANK-RANKL pathway is involved in the development of Aire-expressing medullary thymic epithelial cells (mTECs). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the RANK-RANK-Ligand (RANKL) pathway?",
               "answer": "The RANK-RANKL pathway, also known as the RANK/RANKL/OPG system, is a critical signaling mechanism involved in bone metabolism, specifically in the processes of bone formation and resorption. It consists of three main components: receptor activator of NF-kB (RANK), receptor activator",
               "rationale": "1. The RANK/RANKL/OPG Pathway. The RANKL/RANK/OPG system is known for its roles in osteoclasts maturation, bone modeling, and bone remodeling. Receptor activator of NF-kB (RANK), receptor activator of NF-kB ligand (RANKL), and osteoprotegerin (OPG) are the main components of this signaling system.\n2. Bone metabolism is a dynamic process that balances bone formation and bone resorption. central to this process is the RANK/RANKL/OPG pathway. bone formation. performed by stimulating osteoblasts and inhibiting osteoclasts. bone resorption. performed by active osteoclast. stimulated by RANKL in normal process.\n3. Background. The original identification of the RANKL/RANK/OPG triad took place in the late 1990s [].Receptor activator of NF-κB (RANK) ligand (RANKL) and its receptor RANK were discovered in the field of immunology [].In the first report, a novel cytokine of the tumor necrosis factor (TNF) family was shown to be highly expressed in T cells in response to T cell receptor (TCR) signaling, and ...\n4. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. RANKL is an apoptosis regulator gene, a binding partner of osteoprotegerin (OPG), a ligand for the receptor RANK and controls cell proliferation by modifying protein levels of Id4, Id2 and cyclin D1.\n5. The RANK/RANKL/OPG system. The binding of RANKL to RANK leads to TRAF6 recruitment, which activates NF-kB, MAPK and Fos/AP-1 pathways. These activating signals together lead to the activation of NFATc1, a key transcription factor for downstream osteoclast-associated gene activation, which is the hallmark event of osteoclast formation.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the RANK-RANK-Ligand (RANKL) pathway involved in the development of Aire-expressing medullary thymic epithelial cells (mTECs)?",
               "answer": "Yes, the RANK-RANKL pathway is involved in the development of Aire-expressing medullary thymic epithelial cells (mTECs). The evidence indicates that the development of mTECs, which are crucial for expressing a variety of tissue-specific self-antigens and eliminating self-antigen reactive T cells in",
               "rationale": "1. Background. The original identification of the RANKL/RANK/OPG triad took place in the late 1990s [].Receptor activator of NF-κB (RANK) ligand (RANKL) and its receptor RANK were discovered in the field of immunology [].In the first report, a novel cytokine of the tumor necrosis factor (TNF) family was shown to be highly expressed in T cells in response to T cell receptor (TCR) signaling, and ...\n2. The development of epithelial cells localized in the thymic medulla (mTECs) is also regulated by the RANKL-RANK signal. Given that the unique property of mTECs to express a wide variety of tissue-specific self-antigens is critical for the elimination of self-antigen reactive T cells in the thymus, the RANKL-RANK interaction contributes to the ...\n3. Receptor activator of NF-κB (RANK) ligand (RANKL) induces the differentiation of monocyte/macrophage-lineage cells into the bone-resorbing cells called osteoclasts. Because abnormalities in RANKL, its signaling receptor RANK, or decoy receptor osteoprotegerin (OPG) lead to bone diseases such as osteopetrosis, the RANKL/RANK/OPG system is essential for bone resorption. RANKL was first ...\n4. 1. Introduction. Identified over two decades ago [1,2,3], the receptor activator of the nuclear factor-κB ligand (RANKL)/RANK pathway remains a hot topic in cancer research.Long studied for its role as a master regulator of osteoclastogenesis [1,4], this pathway gained renewed interest over the past decade as an important player in breast carcinogenesis [5,6,7].\n5. Additionally, RANKL-RANK interactions (in cooperation with CD40-CD40 ligand signalling) are required for the development of the physiologically normal thymic medullary microenvironment in ...",
               "predicate": null
            }
         ],
         "row": 428,
         "id": 307309450299818716
      },
      {
         "claim": "The Snf1 complex regulates carbon and energy metabolism in baker's yeast (Saccharomyces cerevisiae).",
         "label": 1,
         "prediction": 1,
         "rationale": "The Snf1 complex in baker's yeast regulates cellular metabolism in response to nutrient availability and stress conditions, playing a crucial role in transcriptional activation and repression of gene expression, particularly in glucose derepression. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the Snf1 complex in baker's yeast?",
               "answer": "The Snf1 complex in baker's yeast functions primarily as a regulator of cellular metabolism in response to nutrient availability and various stress conditions. It plays a crucial role in the transcriptional activation and repression of gene expression, particularly in the context of glucose derepression, allowing yeast cells to adjust their metabolic pathways to ensure survival under",
               "rationale": "1. The Sucrose Non-Fermenting kinase Snf1 is the AMPK orthologue in baker's yeast, Saccharomyces cerevisiae. 2 Yeast cells adjust their metabolism in response to nutrient availability to ensure cell survival. 3 Glucose and fructose cause the repression of numerous genes encoding nutrient uptake systems and metabolic enzymes, and cells shifted to ...\n2. In yeast, SNF1 protein kinase is the orthologue of mammalian AMPK complex. It is a trimeric complex composed of Snf1 protein kinase (orthologue of AMPKα catalytic subunit), Snf4 (orthologue of AMPKγ regulatory subunit), and a member of the Gal83/Sip1/Sip2 family of proteins (orthologues of AMPKβ subunit) that act as scaffolds and also regulate the subcellular localization of the complex.\n3. Background Freezing stress is the key factor that affecting the cell activity and fermentation performance of baker's yeast in frozen dough production. Generally, cells protect themselves from injury and maintain metabolism by regulating gene expression and modulating metabolic patterns in stresses. The Snf1 protein kinase is an important regulator of yeast in response to stresses. In this ...\n4. Abstract. Sucrose non-fermenting 1 (Snf1) protein kinase, a yeast homologue of mammalian AMP-activated protein kinase, plays a main role in transcriptional activation and repression of gene expression. In addition, Snf1 kinase has a broad role in the cellular response to several forms of stress, such as nutrient limitation, salt stress and heat ...\n5. The yeast SNF1 complex is best known for its role in glucose derepression. Methods: We performed a network reconstruction of the Snf1 pathway based on a comprehensive literature review. The network was formalised in the rxncon language, and we used the rxncon toolbox for model validation and gap filling.",
               "predicate": null
            }
         ],
         "row": 429,
         "id": 682777275471531138
      },
      {
         "claim": "The US health care system can save up to $5 billion if 7% of patients waiting for kidney transplants participate in the optimized national kidney paired donation program.",
         "label": 0,
         "prediction": 1,
         "rationale": "The National Kidney Registry (NKR) is the optimized national kidney paired donation program, facilitating kidney paired donation by allowing incompatible donor-recipient pairs to exchange kidneys, thereby increasing the chances of finding a compatible match. The potential savings for the U.S. healthcare system if 7% of patients waiting for kidney transplants participate in the National Kidney Registry cannot be determined with the provided information. The costs associated with kidney transplants versus ongoing dialysis treatment can vary significantly, with dialysis treatment incurring substantial expenses. The average annual cost of dialysis treatment in the US varies, with hemodialysis costing approximately $99,325 and in-center hemodialysis costing between $72,000 and $91,000. The average annual cost of a kidney transplant in the US ranges from $300,000 to $500,000, with an average of approximately $442,500 in 2020 and $414,800 in 2017. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the optimized national kidney paired donation program?",
               "answer": "The optimized national kidney paired donation program is the National Kidney Registry (NKR). It facilitates kidney paired donation (KPD) by allowing incompatible donor-recipient pairs to exchange kidneys, thereby increasing the chances of finding a compatible match. The NKR has significantly reduced the wait time for kidney patients from years to approximately 90",
               "rationale": "1. Kidney Paired Donation (KPD) In KPD, a donor will donate their kidney to another recipient in exchange for a compatible kidney for their friend or family member. KPD was originally created to overcome donor-recipient incompatibility; however, compatible pairs often participate in KPD to find a donor who is a better match to their paired ...\n2. In kidney paired exchange, you have a donor willing to donate a kidney on your behalf, but you are incompatible with the donor or want to try to find a better match. With kidney paired exchange, your donor will donate their kidney to another recipient in exchange for a compatible kidney for you. In the example at right, the first pair, a mother ...\n3. Kidney patients on the waitlist for a kidney from a deceased donor can wait up to 10 years due to the scarcity of organs. With the NKR's paired kidney exchange program, the typical wait time for a kidney patient to find a matching kidney from a living donor is 90 days. Paired kidney exchange increases overall transplantation rates.\n4. Kidney paired donation — KPD. Sometimes a transplant candidate has someone who wants to donate a kidney to them, but tests reveal that the kidney would not be a good medical match. Kidney paired donation, or KPD, also called kidney exchange, gives that transplant candidate another option. In KPD, living donor kidneys are swapped so each ...\n5. The largest KPD program is the National Kidney Registry (NKR), which was founded by the father of one of our young transplant candidates at NewYork-Presbyterian/Weill Cornell. Since 2008, we have performed over 200 kidney paired donation transplants by working with the National Kidney Registry.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "How much can the US health care system save if 7% of patients waiting for kidney transplants participate in the National Kidney Registry?",
               "answer": "The provided evidence snippets do not contain specific information regarding the potential savings for the U.S. healthcare system if 7% of patients waiting for kidney transplants participate in the National Kidney Registry. To determine the savings, additional data would be needed, such as the costs associated with kidney transplants versus ongoing dialysis treatment, as",
               "rationale": "1. The year 2022 had continued successes and challenges for the field of kidney transplantation, as the community adapted to ongoing surges of the COVID-19 pandemic and broader geographic organ distribution. The total number of kidney transplants in the United States reached a record count of 26,309, driven by continued growth in deceased donor kidney transplants (DDKTs). The total number of ...\n2. Delayed graft function continues an upward trend and occurred in 24% of adult kidney transplants in 2021. Five-year graft survival after living compared with deceased donor transplant was 88.6% versus 80.7% for recipients aged 18-34 years, and 82.1% versus 68.0% for recipients aged 65 years or older.\n3. The almost 750,000 people who live with kidney failure are 1% of the U.S. Medicare population but account for roughly 7% of the Medicare budget. Medicare spending for kidney failure patients is at $35 billion in 2016. Hemodialysis care costs the Medicare system an average of $90,000 per patient annually in the United States, for a total of $28 ...\n4. Continuous growth of the end stage renal disease population treated by dialysis, outpaces deceased donor kidneys available, lengthens the waiting time for a deceased donor transplant. As estimated by the United States Department of Health & Human Services: '17 people die each day waiting for transplants that can't take place because of the shortage of donated organs.' Strategies to ...\n5. The United States Renal Data System 2023 Annual Data Report (ADR) contains updated information about the CKD and ESRD populations in the U.S. through the end of 2021. As such, it offers information about ESRD incidence, prevalence, and outcomes during the second year of the COVID-19 pandemic, in which the more transmissible delta variant became ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What are the costs associated with kidney transplants versus ongoing dialysis treatment?",
               "answer": "The costs associated with kidney transplants versus ongoing dialysis treatment can vary significantly. While the specific costs of kidney transplantation are not detailed in the provided evidence, it is noted that dialysis treatment incurs substantial expenses. For instance, in the United States, the average cost of an emergency department (ED) visit related to hemodial",
               "rationale": "1. Kidney transplantation offers improved survival and quality of life compared to dialysis for most recipients; however, benefits for elderly patients (>70 years) remain uncertain. Using the Australia and New Zealand Dialysis and Transplant Registry (2009-2019), elderly transplant recipients were matched to a waitlisted dialysis patient by age, cause of end-stage kidney disease, and dialysis ...\n2. This study aimed to estimate the healthcare costs of kidney transplantation compared with dialysis using a propensity score approach to handle potential treatment selection bias. We included 693 ...\n3. In the United States, dialysis provision is an example of a robust, single-payer dominant system with cost containment. When compared with the cost of dialysis in other countries, Medicare dialysis costs in the United States as a function of overall health care expenditures are approximately $60,000 per patient less than expected, likely due to substantial cost containment imposed by Medicare ...\n4. Individual studies indicate that kidney transplantation is associated with lower mortality and improved quality of life compared with chronic dialysis treatment. We did a systematic review to summarize the benefits of transplantation, aiming to identify characteristics associated with especially large or small relative benefit. Results were not pooled because of expected diversity inherent to ...\n5. The mean cost of an ED visit for an acute hemodialysis indication in Texas in 2017 was $3,239/insured patient compared to $2,102/uninsured patient 4. while the national US average for an ED visit related to hemodialysis was $10,986/insured patient and $5,992/uninsured patient 5. ii.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the average annual cost of dialysis treatment in the US?",
               "answer": "The average annual cost of dialysis treatment in the US varies depending on the type of dialysis. According to the evidence provided:\n\n1. The annual cost of hemodialysis is approximately $99,325, with variations based on age.\n2. The average cost for in-center hemodialysis is reported to be between",
               "rationale": "1. This study demonstrates the annual cost of dialysis per patient in the United States is approximately US$60,000 below its predicted cost. Considering that approximately 550,000 patients currently receive maintenance dialysis in the United States, this equates to a more than US$33 billion difference in expenditures if all patients on maintenance dialysis in the United States had Medicare fee ...\n2. Hemodialysis typically costs more than peritoneal dialysis, according to a report from the U.S. Renal Data System. Medicare's inflation-adjusted per-person, per-year (PPPY) spending in 2021 for hemodialysis was $99,325. The PPPY cost varied by age. Adults ranged from $97,373 to $102,206, while children were $119,392.\n3. Peritoneal Dialysis (PD) At Home. $53,000 - $65,000. $145 - $180 (per day) The average cost for in-center hemodialysis (three times a week) was reported to be approximately $72,000 to $88,000 per year . The cost per session could range from approximately $250 to $350 or more, given that a typical schedule is three sessions a week.\n4. Davita Dialysis is charging $20,000.00 per week ( 3 treatments) for a cost of 1,040.000.00 /year. after repricing is is 14,000.00 per treatment for a yearly cost of 728,000.00. How can they get away with that kind of increase. And in NY it is even higher.\n5. Dialysis in a center or your home; Home dialysis training, equipment and supplies; Medicines you take during dialysis; Outpatient hospital care It covers 80% of the cost of dialysis. Helps pay the cost of prescription medicines. Costs you may pay. Premium: There is no monthly bill if you have paid the required amount in taxes through your job.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the average annual cost of a kidney transplant in the US?",
               "answer": "The average cost of a kidney transplant in the United States ranges from $300,000 to $500,000, with specific estimates indicating an average of approximately $442,500 in 2020 and $414,800 according to a 2017 report. Additionally, after the transplant, the ongoing annual cost for anti",
               "rationale": "1. The cost of a kidney transplant can vary widely depending on several factors, including the location of the transplant center, the specific medical circumstances of the recipient, and the type of insurance coverage held by the individual. The average cost of a kidney transplant in the United States ranges from $300,000 to $500,000.\n2. Health insurance will typically cover a kidney transplant. For patients not covered by health insurance, a kidney transplant typically costs up to $260,000 or more total for the pre-transplant screening, donor matching, surgery, post-surgical care and the first six months of drugs. Afterward, it costs about $17,000 a year for anti-rejection drugs.\n3. Kidney Transplantation Costs. In 2020, the average kidney transplant cost was US$442,500 . Charges for the transplant admission, which include the surgery itself, are the most expensive line item, accounting for 34% of the total cost. ... Approximately 29% of US centers transplant kidneys from hepatitis C nucleic acid-positive donors into ...\n4. 65 and 65-and-over populations by age, respectively. These PMPM costs reflect average annual increases of 11.0% and 10.5%, respectively, from our 2017 report. · There is a wide range of annual changes in utilization and billed charges by type of transplant, relative to our 2017 report.\n5. The cost of a kidney transplant depends on a number of factors, including the transplant center, location, and your level and type of insurance coverage. According to a 2017 report, the average estimated billed charges for a kidney transplant, including all pre- and post-transplant care, is $414,800. Depending on your insurance, most, or all ...",
               "predicate": null
            }
         ],
         "row": 430,
         "id": 174961329181358788
      },
      {
         "claim": "The combination of physical examinations with C-reactive protein values do not improve the accuracy of radiographic verified pneumonia predictions.",
         "label": 0,
         "prediction": 0,
         "rationale": "C-reactive protein (CRP) is a liver protein that increases in response to inflammation in the body. The combination of physical examinations with CRP values improves the accuracy of radiographic verified pneumonia predictions. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is C-reactive protein?",
               "answer": "C-reactive protein (CRP) is a liver protein that increases in response to inflammation in the body. It is an acute-phase protein whose levels can be measured through a blood test to help diagnose various conditions, including infections, inflammatory diseases, and heart problems. CRP levels rise following the secretion of interleukin",
               "rationale": "1. C-reactive protein (CRP) is a marker of inflammation in the body. Learn why a CRP test is done, how to prepare for it, and what the results mean for your health.\n2. C-reactive protein (CRP) is a liver protein that increases with inflammation in the body. A blood test can measure CRP level and help diagnose infection, inflammatory disease or heart risk.\n3. A CRP test measures the level of a protein in your blood that indicates inflammation. Learn why healthcare providers order this test, how to prepare for it and what the results mean.\n4. A CRP test is a blood test that checks for inflammation in the body. It can help diagnose various conditions, such as infections, autoimmune diseases, and heart problems, and predict the risk of severe COVID-19.\n5. C-reactive protein. C-reactive protein ( CRP) is an annular (ring-shaped) pentameric protein found in blood plasma, whose circulating concentrations rise in response to inflammation. It is an acute-phase protein of hepatic origin that increases following interleukin-6 secretion by macrophages and T cells.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the combination of physical examinations with CRP values improve the accuracy of radiographic verified pneumonia predictions?",
               "answer": "Yes, the combination of physical examinations with CRP values improves the accuracy of radiographic verified pneumonia predictions. Evidence suggests that physical examinations have reliable diagnostic accuracy for pneumonia, and CRP is identified as a useful and accurate biomarker for diagnosing community-acquired pneumonia (CAP). Therefore, integrating both physical examination findings and CRP",
               "rationale": "1. Pneumonia is usually diagnosed by a combination of clinical history, physical examination and/or laboratory tests. According to most clinical guidelines globally, the supposed gold standard tool for diagnosing pneumonia is a chest X-ray (CXR) which can distinguish pneumonia from other respiratory tract infections 3 , 4 .\n2. Community-acquired pneumonia (CAP) is one of the most commonly diagnosed illnesses worldwide. The clinical presentation of CAP varies, ranging from mild disease characterized by limited shortness of breath and productive cough to severe disease characterized by fever, respiratory distress, and sepsis. Because of the wide spectrum of associated ...\n3. We reviewed the evidence for the diagnostic accuracy of the physical examination in diagnosing pneumonia, pleural effusion, chronic obstructive pulmonary disease, and congestive heart failure in patients with dyspnea and found that the physical examination has reliable diagnostic accuracy for these common conditions.\n4. Bottom Line. This review found that the best evidence supports CRP as the most useful and accurate biomarker for diagnosing CAP in adults presenting with lower respiratory tract symptoms ...\n5. The robustness and accuracy of CRP-POCT compared with ... patients should be carefully assessed based on the combination of medical history, physical examination, and CRP value:-CRP 20 to 50 mg/L = pneumonia very unlikely ... Aaraas I., Fleten N., Kolstrup N., Mikalsen J.I. [The value of C-reactive protein testing in suspected lower respiratory ...",
               "predicate": null
            }
         ],
         "row": 431,
         "id": 209973199962613852
      },
      {
         "claim": "The deamination of cytidine to uridine on the minus strand of viral DNA can inactivate the viral genome by inducing G-to-A mutations.",
         "label": 1,
         "prediction": 1,
         "rationale": "The deamination of cytidine to uridine on viral DNA results in the modification of the viral genetic material, introducing mutations that may affect the virus's ability to replicate and evade. The deamination of cytidine to uridine on the minus strand of viral DNA induces G-to-A mutations. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of deamination of cytidine to uridine on viral DNA?",
               "answer": "The deamination of cytidine to uridine on viral DNA, facilitated by the cellular deaminase incorporated into the virion during reverse transcription, results in the modification of the viral genetic material. This process can lead to the introduction of mutations in the viral genome, which may affect the virus's ability to replicate and evade",
               "rationale": "1. The deamination of cytidine to uridine contributes, on the one hand, to maintaining nucleotide pool balance for DNA and RNA synthesis. On the other hand, such conversion is also necessary for the catabolism of the pyrimidine cycle, a source of carbon and nitrogen, which results in the formation of β-alanine ( Figure 2 ).\n2. Cytidine deamination was discovered as a mechanism of editing mRNA transcripts in eukaryotes (RNA editing) ( 1, 2 ). RNA editing modifies transcripts in many organisms and thus contributes to expanding the number of gene products without the generation of new genes. Deamination of cytidine (C) to uridine (U) in RNA may create start codons, thus originating new open reading frames; it may ...\n3. The APOBEC family of proteins comprises deaminase enzymes that edit DNA and/or RNA sequences. The APOBEC3 subgroup plays an important role on the innate immune system, acting on host defense against exogenous viruses and endogenous retroelements. The role of APOBEC3 proteins in the inhibition of viral infection was firstly described for HIV-1.\n4. Cytidine deaminase catalyzes the hydrolytic deamination of cytidine into uridine and ammonia with a 4×1011 -fold rate enhancement. 28 Uridine is converted to the base uracil, and the ultimate catabolism of cytidine yields the amino acid β-alanine and malonyl-CoA which can enter into fatty acid biosynthesis.\n5. The cellular deaminase is incorporated into the virion during the reverse transcription to direct the deamination of cytidine to uridine on the minus strand of viral DNA.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the deamination of cytidine to uridine on the minus strand of viral DNA induce G-to-A mutations?",
               "answer": "Yes, the deamination of cytidine to uridine on the minus strand of viral DNA induces G-to-A mutations. Evidence from point 3 indicates that the incorporation of A3F or A3G proteins into HIV-1Δvif virions leads to extensive cytidine deamination during reverse transcription, resulting in",
               "rationale": "1. Cytidine deamination was discovered as a mechanism of editing mRNA transcripts in eukaryotes (RNA editing) ( 1, 2 ). RNA editing modifies transcripts in many organisms and thus contributes to expanding the number of gene products without the generation of new genes. Deamination of cytidine (C) to uridine (U) in RNA may create start codons, thus originating new open reading frames; it may ...\n2. INTRODUCTION Deamination of the nucleobases in DNA and RNA is a result of spontaneous hydrolysis, endogenous or environmental factors as well as deaminase enzymes ( 1, 2 ). As a result (deoxy)cytidine, (deoxy)adenosine and (deoxy)guanosine are transformed into (deoxy)uridine, (deoxy)inosine, and (deoxy)xanthosine (dX, X) and (deoxy)oxanosines (dO, O). This can alter the genetically encoded ...\n3. The incorporation of A3F or A3G protein into HIV-1Δvif virions causes extensive cytidine deamination on the viral minus-strand DNA during reverse transcription (RT), subsequently resulting in the massive G-to-A hypermutation of the viral genome (4, 10, 11, 18, 21, 23, 42, 48, 53, 56).\n4. In this Perspective, Pecori et al. provide an overview of the AID/APOBEC cytidine deaminase family, discussing key structural features, how they contribute to viral and tumour evolution and how ...\n5. The deamination of cytidine to uridine contributes, on the one hand, to maintaining nucleotide pool balance for DNA and RNA synthesis. On the other hand, such conversion is also necessary for the catabolism of the pyrimidine cycle, a source of carbon and nitrogen, which results in the formation of β-alanine ( Figure 2 ).",
               "predicate": null
            }
         ],
         "row": 432,
         "id": 781190562779332596
      },
      {
         "claim": "The density of cytokine receptor bearing cells affects the distance over which cytokines act.",
         "label": 1,
         "prediction": 1,
         "rationale": "A cytokine receptor bearing cell is a cell that expresses cytokine receptors on its surface, allowing it to bind to specific cytokines and initiate signal transduction pathways that lead to various biological responses. Cytokine receptors affect the distance over which cytokines act, influencing both paracrine and endocrine signaling. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is a cytokine receptor bearing cell?",
               "answer": "A cytokine receptor bearing cell is a cell that expresses cytokine receptors on its surface, allowing it to bind to specific cytokines. This binding initiates signal transduction pathways that lead to various biological responses, such as immune responses, cell growth, and differentiation. These cells can respond to cytokines in different ways,",
               "rationale": "1. Signal transduction. (Cytokine receptor at center left.) Cytokine receptors are receptors that bind to cytokines. [1] In recent years, the cytokine receptors have come to demand the attention of more investigators than cytokines themselves, partly because of their remarkable characteristics, and partly because a deficiency of cytokine receptors ...\n2. Cytokines, their Receptors and their Genes. Table 1 introduces the human cytokines and lists some of their properties, such as receptor usage and physical characteristics.Each human cytokine described in Table 1 has a murine counterpart so the basic list can be used interchangeably in regards to terminology. Hundreds of cytokines have been identified. In the interest of conciseness the table ...\n3. Cytokines are proteins that function as chemical messengers in your immune system. Your immune system is a network with several parts that work together to protect your body from threats, like germs that can make you sick. It contains immune cells that fight invading pathogens (like viruses and bacteria), allergens and other harmful substances ...\n4. The downstream effects of a particular cytokine occurs through its high-affinity binding of its receptor expressed on the surface of a target cell. This action may occur in an autocrine (acts on same cell), paracrine (acts on nearby cell) or endocrine (acts on distant cell; not the normal manner for cytokine responses) manner.\n5. Class I Cytokine Receptors. Members of the class I cytokine receptor family (also known as the hematopoietin superfamily) are fundamentally important in a diverse range of biological processes, and their dysregulation is implicated in roles in cancers, inflammatory bowel disease, osteoporosis, multiple sclerosis, as well as disorders related to blood cell formation, postnatal growth, obesity ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do cytokine receptors affect the distance over which cytokines act?",
               "answer": "Yes, cytokine receptors affect the distance over which cytokines act. The evidence indicates that cytokines can engage in paracrine signaling, where they bind to receptors on nearby cells, and endocrine signaling, where they bind to receptors on cells located far away from the cell that released the cytokines. This suggests that the",
               "rationale": "1. These cytokines bind to class I cytokine receptors, membrane proteins with a characteristic modular architecture that do not have intrinsic enzymatic activity, and for signaling often need to recruit additional receptor proteins shared by different cytokines: gp130, βc, or γc. ... IL-31 is the only IL-6 type cytokine that does not require the ...\n2. bearing specific receptors . - Expression of cytokines and their receptors is highly regulated . - E.g. IL-2 receptor Cytokines can act in an:-Autocrine (same cell), -Paracrine (close proximity)-Endocrine (long distance) 1. Cytokines are pleiotropic … one cytokine can have different effects on different cells. Kuby Fig 12-2a 2. Cytokines can ...\n3. Cytokine receptor abundance can be used to estimate the rate of cytokine consumption, as cytokines bind to receptors according to well-characterized biophysical models and are endocytosed at a ...\n4. Paracrine signaling: Cytokines can bind to receptors on nearby cells. Endocrine signaling: Cytokines can bind to receptors on cells located far away from the cell that released the cytokines. Cells with cytokine receptors are located throughout your body. In fact, most of your body's organs contain cells with cytokine receptors.\n5. Cytokines, their Receptors and their Genes. Table 1 introduces the human cytokines and lists some of their properties, such as receptor usage and physical characteristics.Each human cytokine described in Table 1 has a murine counterpart so the basic list can be used interchangeably in regards to terminology. Hundreds of cytokines have been identified. In the interest of conciseness the table ...",
               "predicate": null
            }
         ],
         "row": 433,
         "id": 453771226648806683
      },
      {
         "claim": "The density of cytokine receptor bearing cells has no effect on the distance over which cytokines act.",
         "label": 0,
         "prediction": 0,
         "rationale": "Cytokine receptor-bearing cells receive signals from cytokines, activating signal transduction pathways that allow the cells to respond to the message conveyed by the cytokine. The density of cytokine receptor-bearing cells may influence the distance over which cytokines act, as cytokines exert their effects by binding to specific receptors on target cells. The distance over which cytokines act may be influenced by various factors, but the provided evidence does not directly address its dependence on the density of cytokine receptor-bearing cells. The effectiveness of cytokine signaling can be influenced by several factors, including cytokine levels and regulatory proteins. The density of cytokine receptor-bearing cells may affect the effectiveness of cytokine signaling, although the provided evidence does not directly address this question. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of cytokine receptor bearing cells?",
               "answer": "The function of cytokine receptor-bearing cells is to receive signals from cytokines, which act as messengers. When a cytokine binds to its corresponding receptor on these cells, it activates various signal transduction pathways, allowing the cells to respond appropriately to the message conveyed by the cytokine. This communication is essential for coordinating",
               "rationale": "1. Cytokines, their Receptors and their Genes. Table 1 introduces the human cytokines and lists some of their properties, such as receptor usage and physical characteristics.Each human cytokine described in Table 1 has a murine counterpart so the basic list can be used interchangeably in regards to terminology. Hundreds of cytokines have been identified. In the interest of conciseness the table ...\n2. Signal transduction. (Cytokine receptor at center left.) Cytokine receptors are receptors that bind to cytokines. [1] In recent years, the cytokine receptors have come to demand the attention of more investigators than cytokines themselves, partly because of their remarkable characteristics, and partly because a deficiency of cytokine receptors ...\n3. Cytokines: Introduction. In order to mount and coordinate an effective immune response, a mechanism by which lymphocytes, inflammatory cells and haematopoietic cells can communicate with each other is required. Cytokines perform this function. Cytokines are a large, diverse family of small proteins or glycoproteins (usually smaller than 30 kDa).\n4. Certain cells release cytokines while other cells contain cytokine receptors. Think of a cytokine as a key and the receptor on the receiving cell like a lock. When the cytokine (key) enters the cytokine receptor (lock), the receiving cell receives a message that tells it what to do. The cell acts based on the message it receives.\n5. Cytokines function by binding to their cognate receptors to activate various signal transduction pathways [ 4]. Like many neurotransmitters, cytokines are small soluble molecules whose signaling is subject to ligand-receptor specificity. In the CNS, cytokine receptors are widely expressed in various cell types, including neurons [20 ].",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the density of cytokine receptor bearing cells affect the distance over which cytokines act?",
               "answer": "The provided evidence does not directly address whether the density of cytokine receptor-bearing cells affects the distance over which cytokines act. However, it does imply that cytokines exert their effects by binding to specific receptors on target cells, and that the presence and concentration of these receptors can influence the immune response. \n\nIn general,",
               "rationale": "1. Chapter 13: Cytokines. Definition: secreted, low-molecular-weight proteins that regulate the nature, intensity and duration of the immune response by exerting a variety of effects on lymphocytes and/or other cells. Cytokines bind to specific receptors on target cells. Originally were called lymphokines because they were initially thought to be ...\n2. When the molar concentrations of a cytokine present at the start ([cytokine] in) and end ([cytokine] out) of a reaction are known, the number of receptors for that cytokine per cell in a reaction ...\n3. Cytokines are the chemical mediators that regulate immune cell homeostasis and coordinate signal-dependent immune responses. Cytokine signaling circuits include multiple regulatory checkpoints ...\n4. Most other receptor subunits of the cytokine receptor superfamily including the α chains for GM-CSF, IL-3, and IL-5 contain only a single copy of the cytokine receptor module. The role of the individual cytokine receptor domains of β c is poorly understood. Studies to identify ligand binding determinants have focussed on the membrane proximal ...\n5. Abstract. Cytokines are pleiotropic polypeptides that control the development of and responses mediated by immune cells. Cytokine classification predominantly relies on [1] the target receptor (s), [2] the primary structural features of the extracellular domains of their receptors, and [3] their receptor composition.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the distance over which cytokines act depend on the density of cytokine receptor bearing cells?",
               "answer": "The provided evidence does not directly address whether the distance over which cytokines act depends on the density of cytokine receptor-bearing cells. However, it does highlight the importance of cytokine signaling and the interaction between cytokines and their receptors in the immune system. The effectiveness of cytokine signaling can be influenced by factors such as",
               "rationale": "1. Intercellular communication mediated by cytokines is the main mechanism by which cells of the immune system talk to each other. Many aspects of cytokine signalling in the immune system have been ...\n2. Cells communicate through direct contact or at a distance using ligand-receptor interactions. So cellular communication encompasses two essential processes: cell signal conduction for generation ...\n3. These cytokine/receptor complexes are not built around two gp130 chains but instead are built around a heterodimer between gp130 and another JAK‐binding tall receptor called LIFRβ. 57, 58 As is the case for IL‐6, these cytokines first bind to cytokine‐specific non‐signaling alpha receptor chains and the resulting complexes then recruit ...\n4. Introduction. Cell-to-cell communication is a defining property of multicellular organisms. In particular, the release, sensing and uptake of cytokines, small signaling proteins, by cells is essential for the regulation of the mammalian immune system [].Prominent quantitative characteristics of cytokine signaling are high receptor specificity (with K d ≈ 10 −10 nM) and low free cytokine ...\n5. Keywords: biosensors, clinical significance, cytokines, in vitro and in vivo assays, quantification. Cytokines are important cellular signaling molecules and immune system mediators. Abnormal cytokine levels may cause cytokine storm and diseases. Consequently, quantification of cytokines is valuable for diseases diagnosisand therapy.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What factors can influence the effectiveness of cytokine signaling?",
               "answer": "The effectiveness of cytokine signaling can be influenced by several factors, including:\n\n1. **Cytokine Levels**: Abnormal levels of cytokines can lead to conditions such as cytokine storms, which can negatively impact signaling effectiveness and contribute to diseases.\n\n2. **Regulatory Proteins**: The presence and",
               "rationale": "1. Here we review molecular details of the cytokine‐induced signaling cascade and describe the architectures of the proteins involved, including the receptors, kinases, and transcription factors that initiate and propagate signaling and the regulatory proteins that control it.\n2. Cytokines are important cellular signaling molecules and immune system mediators. Abnormal cytokine levels may cause cytokine storm and diseases. Consequently, quantification of cytokines is valuable for diseases diagnosisand therapy. The clinical significance of cytokines, factors affecting cytokine quantification, and advances of cytokine detection are summarized, providing a prospective for ...\n3. In this review, we summarized the current understanding and therapeutic implications of targeting cytokine and chemokine signaling pathways in cancer.\n4. Abstract. Cytokine-based therapies have the potential to provide novel treatments for cancer, autoimmune diseases, and many types of infectious disease. However, to date, the full clinical potential of cytokines as drugs has been limited by a number of factors. To discuss these limitations and explore ways to overcome them, the FDA partnered ...\n5. CytoSig, an interactive database and model to predict cytokine signaling activity at bulk and single-cell levels.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does the density of cytokine receptor bearing cells affect the effectiveness of cytokine signaling?",
               "answer": "The provided evidence snippets do not directly address the question of whether the density of cytokine receptor-bearing cells affects the effectiveness of cytokine signaling. However, they do highlight the importance of receptor complexes and the mechanisms of cytokine signaling. \n\nFrom the information given, we can infer that the assembly and orientation of receptor complexes are",
               "rationale": "1. Cytokines are critical for intercellular communication in human health and disease, but the investigation of cytokine signaling activity has remained challenging due to the short half-lives of ...\n2. Cytokines . Structures of members of the TNFα‐family, TGFβ‐family, IL‐1‐like cytokines, chemokines (CXCL8), cytokines that signal through receptor tyrosine‐kinases (M‐CSF) or the JAK/STAT pathway (IL‐6) are shown on the left. JAK/STAT cytokines are helical bundle cytokines and can be divided into two classes.\n3. Intercellular communication mediated by cytokines is the main mechanism by which cells of the immune system talk to each other. Many aspects of cytokine signalling in the immune system have been ...\n4. The general question of how the particular pathway by which receptor complexes assemble on the cell affects the function and regulation of receptor signaling, and therefore why nature has evolved the different receptor structures and stoichiometries illustrated in Figures 1b and and3, 3, represents an aspect of receptor signaling about which we ...\n5. Cytokines exert their effects through receptor dimers on the cell surface that activate the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway (1-5).Although there are many variations on this theme, cytokine engagement generally occurs through a two-site binding paradigm that orients the receptors into homo- or heterodimeric signaling complexes ().",
               "predicate": null
            }
         ],
         "row": 434,
         "id": 257205047746880420
      },
      {
         "claim": "The generation of reactive oxygen species by activated oncogenes contributes to the increased genomic instability of leukaemia cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "Activated oncogenes confer a growth advantage to leukaemia cells by altering the structure of protooncogenes through genetic changes such as mutation, gene amplification, and chromosome rearrangements. The generation of reactive oxygen species contributes to genomic instability. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of activated oncogenes on leukaemia cells?",
               "answer": "Activated oncogenes confer a growth advantage to leukaemia cells by altering the structure of protooncogenes through genetic changes such as mutation, gene amplification, and chromosome rearrangements. These alterations program the fate of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (H",
               "rationale": "1. As outlined above, some oncogenes can set the cell lineage of HSCs/HPCs and their offspring. Transformation of lineage-affiliated HSCs might well offer an immediate explanation of why the leukemia cells belong to just one cell lineage. However, two findings favor the view that the oncogene per se programs the fate of HSCs/HPCs.\n2. The activation of oncogenes involves genetic changes to cellular protooncogenes. The consequence of these genetic alterations is to confer a growth advantage to the cell. Three genetic mechanisms activate oncogenes in human neoplasms: (1) mutation, (2) gene amplification, and (3) chromosome rearrangements. These mechanisms result in either an alteration of protooncogene structure or an ...\n3. Since the discovery that human tumours contain activated oncogenes (Der et ... in which the fate-changing effect of the oncogene takes place at the stem cell level (in ... these combined studies of the effect of BCR-ABL in cancer development show that leukaemia stem cells are not oncogene addicted, and are most likely extensible to many other ...\n4. Since the discovery that human tumours contain activated oncogenes (Der et al ... these combined studies of the effect of BCR‐ABL in cancer development show that leukaemia stem cells are not oncogene addicted, and are most likely extensible to many other pathologies (multiple myeloma, MALT lymphoma, CLL, etc.). ... The mechanism responsible ...\n5. Oncogenes. Oncogenes are important classes, or groups, of genetic mutations that cause cancer. They're mutated forms of genes that control how cells grow and divide. Research shows specific oncogenes drive and support certain cancers. By targeting oncogenes, medical researchers have developed new ways to treat these cancers.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the generation of reactive oxygen species contribute to genomic instability?",
               "answer": "Yes, the generation of reactive oxygen species (ROS) contributes to genomic instability. Evidence from the snippets indicates that oxidative DNA damage, caused by ROS, poses a constant challenge to the genome, leading to potential disruptions in genome function, instability, and mutations. Specifically, the second snippet mentions that plastid genome instability is associated",
               "rationale": "1. Living species are continuously subjected to all extrinsic forms of reactive oxidants and others that are produced endogenously. There is extensive literature on the generation and effects of reactive oxygen species (ROS) in biological processes, both in terms of alteration and their role in cellular signaling and regulatory pathways.\n2. First, we show that in why1why3polIb-1 and ciprofloxacin-treated plants, plastid genome instability is associated with increased reactive oxygen species production. Then, using different light regimens, we show that the elevated reactive oxygen species production correlates with the appearance of a yellow-variegated phenotype in the ...\n3. 1. Introduction. Oxidative DNA damage is a constant challenge of the genome, arising from exposure to reactive oxygen species (ROS). These can come from multiple external and internal sources, including but not limited to endogenous chemical processes through the cells' own metabolism and enzymatic activity , inflammatory processes , , toxins , or ionizing radiation , , .\n4. Abstract. Reactive oxygen species are a constant threat to DNA as they modify bases with the risk of disrupting genome function, inducing genome instability and mutation. Such risks are due to primary oxidative DNA damage and also mediated by the repair process. This leads to a delicate decision process for the cell as to whether to repair a ...\n5. Cancer Nanotechnology (2024) Reactive oxygen species (ROS) constitute a group of highly reactive molecules that have evolved as regulators of important signaling pathways. It is now well accepted ...",
               "predicate": null
            }
         ],
         "row": 435,
         "id": 126851282226061157
      },
      {
         "claim": "The innate immune response struggles to remove small numbers of parasites.",
         "label": 0,
         "prediction": 1,
         "rationale": "The innate immune response is the body's initial defense mechanism against invading pathogens, a non-specific and immediate reaction that includes physical and chemical barriers, such as skin. The innate immune response can struggle to remove small numbers of parasites. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the innate immune response?",
               "answer": "The innate immune response is the body's initial defense mechanism against invading pathogens, which is non-specific and reacts the same way to all types of pathogens. It is an antigen-nonspecific defense that occurs immediately or within several hours after exposure to microbes. The innate immune system includes physical and chemical barriers, such as skin, and",
               "rationale": "1. The adaptive immune system: Fighting the germs directly. If the innate (general) immune system fails to destroy the germs, the adaptive (specialized) immune system takes over. The adaptive immune system specifically targets the type of germ that is causing the infection. But to do that, it first needs to recognize the germ as such.\n2. innate immune system is non specific, that means it reacts all the same with all type of pathogens. whereas the primary immune response you mentioned is a part of active immunity (that is a part of adaptive immunity) primary immune response means the first exposure of pathogens to the adaptive immune cells, first exposure means, memory is yet ...\n3. Innate immunity. Innate immunity is an antigen-nonspecific defense mechanisms that a host uses immediately or within several hours after exposure to almost any microbe. This is the immunity one is born with and is the initial response by the body to eliminate microbes and prevent infection. Innate immunity can be divided into immediate innate ...\n4. The innate immune system is an alternate defense strategy and is the dominant immune system response found in plants, fungi, prokaryotes, and invertebrates (see Beyond vertebrates ). [2] The major functions of the innate immune system are to: act as a physical and chemical barrier to infectious agents; via physical measures such as skin and ...\n5. Summary. The innate immune responses are the first line of defense against invading pathogens. They are also required to initiate specific adaptive immune responses. Innate immune responses rely on the body's ability to recognize conserved features of pathogens that are not present in the uninfected host.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the innate immune response struggle to remove small numbers of parasites?",
               "answer": "Yes, the innate immune response can struggle to remove small numbers of parasites. While the innate immune response is the first line of defense and is designed to control or eliminate parasitic infestations, it may not always be effective against low levels of parasites. The evidence suggests that the immune response to parasites often evolves into an adaptive",
               "rationale": "1. Animal models have provided insight into innate immunity against parasitic infections; however, species-specific differences and complexity of innate immune responses make translation to humans challenging. Thus, there is a need for in vitro systems that can elucidate mechanisms of immune control and parasite dissemination.\n2. The innate immune response is the first mechanism for host defense found in all multicellular organisms. The innate immune system is more ancient than the acquired or adaptive immune response, and it has developed and evolved to protect the host from the surrounding environment in which a variety of toxins and infectious agents including bacteria, fungi, viruses and parasites are found (1).\n3. Immunoglobulin-E. An immune response to parasites, specifically worms, triggers an IgE response.12 IgE elicits an immune response by binding to Fc receptors on mast cells, eosinophils, and basophils, causing degranulation and cytokine release. In atopic individuals, IgE is also made to allergens. IgE is at low levels in the blood.\n4. Fortunately, the immune system has naturally evolved to arm the host against pathogens including parasites. Both innate and adaptive immune responses selectively recognize pathogens and help the host to get rid of many of them at first sight.\n5. Host immune responses to parasites include an early innate component designed to control or eliminate parasitic infestation and, over time, an adaptive response that controls the parasite in an antigen-specific fashion. The immune response to parasites is frequently TH 2 dominated and is known to share key features with tissue allergy, including the increased production of IL-4, IL-5, IL-13 ...",
               "predicate": null
            }
         ],
         "row": 436,
         "id": 109861530469436114
      },
      {
         "claim": "The latent infection of myeloid cells with human cytomegalovirus induces a number of changes in gene expression.",
         "label": 1,
         "prediction": 1,
         "rationale": "Human cytomegalovirus (HCMV) is a common virus that belongs to the herpesvirus family, infecting people of all ages and remaining in the body for life. Human cytomegalovirus (HCMV) can infect myeloid cells, establishing latency in non-permissive myeloid cells, which can be reactivated by glucocorticosteroids. Latent infection of myeloid cells with human cytomegalovirus induces changes in gene expression. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is human cytomegalovirus?",
               "answer": "Human cytomegalovirus (HCMV) is a common virus that belongs to the herpesvirus family. It is a member of the Betaherpesvirinae subfamily and is known to infect people of all ages. Once infected, the virus remains in the body for life and can reactivate or cause rein",
               "rationale": "1. Cytomegalovirus (CMV) is a common virus. Once infected, your body retains the virus for life. Most people don't know they have cytomegalovirus (CMV) because it rarely causes problems in healthy people. If you're pregnant or if your immune system is weakened, CMV is cause for concern.\n2. Cytomegalovirus (CMV) Cytomegalovirus (CMV) is a common infection from a herpes virus. Pregnant people infected with CMV can give birth to a baby with congenital CMV. Congenital CMV can cause hearing loss and developmental issues. CMV can cause serious complications in people who have a compromised immune system, such as transplant recipients.\n3. CMV is a common virus that infects people of all ages. In the United States, nearly 1 in 3 children is already infected with CMV by age 5. Over half of adults have been infected with CMV by age 40. Once CMV is in a person's body, it stays there for life and can reactivate. A person can also be re-infected with a different strain of the virus.\n4. Cytomegalovirus is a common virus.Over half of adults in the U.S. have it by age 40, but people of any age can get it. CMV spreads easily through an infected person's saliva or other body fluids.\n5. Cytomegalovirus (CMV) (from cyto-'cell' via Greek κύτος kútos - 'container' + μέγας mégas 'big, megalo-' + -virus via Latin vīrus 'poison') is a genus of viruses in the order Herpesvirales, in the family Herpesviridae, in the subfamily Betaherpesvirinae. Humans and other primates serve as natural hosts.The 11 species in this genus include human betaherpesvirus 5 (HCMV, human ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does human cytomegalovirus infect myeloid cells?",
               "answer": "Yes, human cytomegalovirus (HCMV) can infect myeloid cells. The evidence indicates that HCMV establishes latency in non-permissive myeloid cells and that glucocorticosteroids can trigger reactivation of the virus from these latently infected cells.",
               "rationale": "1. Overview of human cytomegalovirus entry into target cells and the establishment of latency in non-permissive myeloid cells. a | Human cytomegalovirus (HCMV) glycoproteins on the surface of the virion engage with receptors on the surface of cells and can drive entry by multiple processes in a cell type-dependent manner. In fibroblasts, glycoprotein H (gH), gL and gO form a trimer that binds to ...\n2. Human cytomegalovirus (HCMV), a widely-spread β-herpesvirus, is a major cause of birth defects and opportunistic infections in HIV-1/AIDS patients. HCMV displays an intricate system-wide modulation of the human cell proteome. An impressive array of virus-host protein interactions occurs throughout the infection.\n3. Van Damme, E. et al. Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.\n4. Human cytomegalovirus infections commonly are associated with the salivary glands. CMV infection may be asymptomatic in healthy people, but it can be life-threatening in an immunocompromised patient. ... Once CMV is transmitted, and the primary infection clears, the virus remains dormant in myeloid cells. Vital replication and reactivation are ...\n5. After initial infection, human cytomegalovirus remains in a persistent state with the host. Immunity against the virus controls replication, although intermitent viral shedding can still take place in the seropositive immunocompetent person. Replication of cytomegalovirus in the absence of an effective immune response is central to the pathogenesis of disease. Therefore, complications are ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does latent infection of myeloid cells with human cytomegalovirus induce changes in gene expression?",
               "answer": "Yes, latent infection of myeloid cells with human cytomegalovirus (HCMV) induces changes in gene expression. The evidence indicates that while there is a suppression of viral lytic gene expression in these cells, there is concomitant expression of known latency-associated viral genes. Additionally, latent infection is suggested to",
               "rationale": "1. Analyses of changes in the viral epigenome induced by allogeneic transplantation further strengthened this hypothesis by showing that ... Human cytomegalovirus gene expression during infection of primary ... The expression of human cytomegalovirus microRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A ...\n2. Consistent with cells of the myeloid lineage being sites of latent infection, analyses of the viral transcription programme in these cells generally shows a suppression of viral lytic gene expression 2,29,30,31,32 but concomitant expression of known latency-associated viral genes. 31,33,34,35,36,37 Importantly, these cells do not produce ...\n3. Background Human cytomegalovirus (HCMV) resides latently in cells of the myeloid compartment, including CD34+ hematopoietic progenitor cells and circulating monocytes. Healthy hosts maintain the virus latently, and this infection is, for the most part, asymptomatic. However, given the proper external cues, HCMV reactivates from latency, at which point the virus disseminates, causing disease ...\n4. Overview of human cytomegalovirus entry into target cells and the establishment of latency in non-permissive myeloid cells. a | Human cytomegalovirus (HCMV) glycoproteins on the surface of the virion engage with receptors on the surface of cells and can drive entry by multiple processes in a cell type-dependent manner. In fibroblasts, glycoprotein H (gH), gL and gO form a trimer that binds to ...\n5. The effect of latent infection on myeloid cells has now become a topic of considerable interest, and, far from the view that latency is a passive carriage of quiescent viral genomes, more recent studies suggest that latent infection imparts important changes on the cell, which support maintenance of latency and enable efficient virus reactivation",
               "predicate": null
            }
         ],
         "row": 437,
         "id": 275042357123387552
      },
      {
         "claim": "The mean suicide rate in women is higher after miscarriage than live birth.",
         "label": 1,
         "prediction": 0,
         "rationale": "The mean suicide rate in women after miscarriage is 2.9 per 100,000. The mean suicide rate in women after live birth is not specified. The mean suicide rate in women after live birth is 1.18 per 100,000 live births. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the mean suicide rate in women after miscarriage?",
               "answer": "The mean suicide rate in women after miscarriage is 2.9 per 100,000.",
               "rationale": "1. They were assessed for symptoms of depression and anxiety twice during their pregnancy and four times after giving birth, at 8 weeks, 8 months, 21 months and 33 months. The majority of women reported no miscarriages. But 2,823 women, or 21 percent, reported having one or more previous miscarriages, while 108 reported having one previous ...\n2. The mean age of women who died from suicide was 27 years old ± 8.3. 29.% of deaths by suicide occurred in pregnancy and 70.6% occurred in the first postpartum year. ... The suicide rate was 1.18 per 100,000 after giving birth, and 2.77 after and induced abortion, and 2.9 after a miscarriage. The majority of women who died by maternal suicide ...\n3. Pregnancy loss, in all its forms (miscarriage, abortion, and fetal death), is one of the most common adverse pregnancy outcomes, but the psychological impact of such loss is often underestimated. The individual response to this outcome may vary between women—and could be influenced by age, race, culture, or religious beliefs—but most ...\n4. Of the women, 59.1% were found to be at increased risk of postnatal depression and 48.9% of them at high risk of postnatal depression; 44.7% of women were considered to be at risk of post-traumatic stress. In general, psychological difficulties after miscarriage were found to be particularly common.\n5. The prevalence of suicidal ideation and self-harm may be on the rise among perinatal women.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the mean suicide rate in women after live birth?",
               "answer": "The provided evidence does not specify a mean suicide rate in women after live birth. It mentions that suicide is a leading cause of maternal mortality and provides statistics on perinatal maternal deaths and the prevalence of suicidal thoughts among childbearing women, but it does not give a specific rate or percentage for suicides occurring specifically after live",
               "rationale": "1. Suicide. Of 206 perinatal maternal deaths, 16 deaths were a result of suicide (including 6 from overdose). The mean age of women who died from suicide was 27 years old ± 8.3. 29.% of deaths by suicide occurred in pregnancy and 70.6% occurred in the first postpartum year.\n2. Suicide Risk During Pregnancy, After Childbirth on the Rise Study finds prevalence of suicidal thoughts and self-harm among childbearing women nearly tripled over a decade, with an estimated 24,000 individuals at potential suicide risk.\n3. The news Women who experience depression during pregnancy or in the year after giving birth have a greater risk of suicide and attempted suicide — risks that persist for years, two new studies ...\n4. The prevalence of suicidal ideation and self-harm may be on the rise among perinatal women.\n5. Suicide during the perinatal period (eg, during pregnancy and ≤1 year post partum) is a leading cause of maternal mortality in the US, contributing to 8.4% of pregnancy-related deaths. 1, 2 A Centers for Disease Control and Prevention (CDC) report from 36 state maternal mortality review committees considered more than 80% of maternal deaths ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the mean suicide rate in women after live birth?",
               "answer": "The mean suicide rate in women after live birth, based on the provided evidence, is 1.18 per 100,000 live births.",
               "rationale": "1. 67 cases of maternal suicide were identified, corresponding to a maternal suicide ratio of 2.3 per 100,000 live births. The suicide rate was 1.18 per 100,000 after giving birth, and 2.77 after and induced abortion, and 2.9 after a miscarriage. The majority of women who died by maternal suicide had a previous psychiatric history: Lewkowitz et al.\n2. Pregnancy and the period after delivering a baby can be one of the riskiest times for depressive symptoms, with suicide among the leading causes of death among new moms. And now a new study suggests that suicide \"near misses\" during pregnancy and after childbirth are increasing. The prevalence of suicidal thoughts and self-harm in the year before and after giving birth nearly\n3. Pregnancy and the period after delivering a baby can be one of the riskiest times for depressive symptoms, with suicide among the leading causes of death among new moms. And now a new study suggests that suicide \"near misses\" during pregnancy and after childbirth are increasing. The prevalence of suicidal thoughts and self-harm in the year ...\n4. Suicide deaths, plans, and attempts in the United States. More than 48,000 people died by suicide in 2021. That is 1 death every 11 minutes. 12.3 million adults seriously thought about suicide. 3.5 ... Data for race and Hispanic or Latino (Hispanic) origin should be interpreted with caution; studies comparing race and Hispanic origin on death ...\n5. The prevalence of suicidal ideation and self-harm may be on the rise among perinatal women.",
               "predicate": null
            }
         ],
         "row": 438,
         "id": 218146167574298017
      },
      {
         "claim": "The mean suicide rate in women is lower after miscarriage than live birth.",
         "label": 0,
         "prediction": 1,
         "rationale": "The mean suicide rate in women after a miscarriage is 2.9 per 100,000. The mean suicide rate in women after live birth is not specified. The mean suicide rate in women after live birth is not higher than 2.9 per 100,000. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the mean suicide rate in women after miscarriage?",
               "answer": "The mean suicide rate in women after a miscarriage is 2.9 per 100,000.",
               "rationale": "1. They were assessed for symptoms of depression and anxiety twice during their pregnancy and four times after giving birth, at 8 weeks, 8 months, 21 months and 33 months. The majority of women reported no miscarriages. But 2,823 women, or 21 percent, reported having one or more previous miscarriages, while 108 reported having one previous ...\n2. The mean age of women who died from suicide was 27 years old ± 8.3. 29.% of deaths by suicide occurred in pregnancy and 70.6% occurred in the first postpartum year. ... The suicide rate was 1.18 per 100,000 after giving birth, and 2.77 after and induced abortion, and 2.9 after a miscarriage. The majority of women who died by maternal suicide ...\n3. Mean annual rate for all women 11.3 ... they report that \"The suicide rate after an abortion was three times the general suicide rate and six times that associated with birth.\" ... The age adjusted relative risk of suicide admission for women admitted for miscarriage compared with women admitted for normal delivery was 2.84 (1.67 to 4.81, P<0. ...\n4. Of the women, 59.1% were found to be at increased risk of postnatal depression and 48.9% of them at high risk of postnatal depression; 44.7% of women were considered to be at risk of post-traumatic stress. In general, psychological difficulties after miscarriage were found to be particularly common.\n5. Spontaneous miscarriage is the loss of a pregnancy prior to 20 weeks of gestation, which is the most common complication of pregnancy [ 1 ]. Spontaneous miscarriages occur in about 20% of pregnancies in the United States [ 2 ]. Women experiencing miscarriage may be treated in a multitude of places: prenatal clinics, the emergency department (ED ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the mean suicide rate in women after live birth?",
               "answer": "The provided evidence snippets do not specify a numerical mean suicide rate in women after live birth. They indicate that suicide is one of the leading causes of death among new mothers and that the prevalence of suicidal thoughts and self-harm among childbearing women has increased, but they do not provide specific rates or statistics. Therefore, the",
               "rationale": "1. Suicide Risk During Pregnancy, After Childbirth on the Rise Study finds prevalence of suicidal thoughts and self-harm among childbearing women nearly tripled over a decade, with an estimated 24,000 individuals at potential suicide risk.\n2. Suicide Risk During Pregnancy, After Childbirth on the Rise Study finds prevalence of suicidal thoughts and self-harm among childbearing women nearly tripled over a decade, with an estimated 24,000 individuals at potential suicide risk.\n3. At a glance Suicide is one of the leading causes of death in the United States. This page shows the most recent suicide data overall and by selected demographic characteristics.\n4. The news Women who experience depression during pregnancy or in the year after giving birth have a greater risk of suicide and attempted suicide — risks that persist for years, two new studies ...\n5. A new study 1 finds that suicide attempts during pregnancy and after childbirth are increasing, nearly tripling over the past decade Nearly 24,000 individuals are at risk for suicide. Suicide is already among the leading causes of deaths among new mothers, and pregnancy/post-delivery are considered risky times for depressive symptoms.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is the mean suicide rate in women after live birth higher than 2.9 per 100,000?",
               "answer": "No, the mean suicide rate in women after live birth is not higher than 2.9 per 100,000. The evidence states that the suicide rate after giving birth is 1.18 per 100,000, which is significantly lower than 2.9.",
               "rationale": "1. Suicide deaths, plans, and attempts in the United States. More than 48,000 people died by suicide in 2021. That is 1 death every 11 minutes. 12.3 million adults seriously thought about suicide. 3.5 ... Data for race and Hispanic or Latino (Hispanic) origin should be interpreted with caution; studies comparing race and Hispanic origin on death ...\n2. Results: There were 73 suicides associated with pregnancy, representing 5.4% of all suicides in women in this age group. The mean annual suicide rate was 11.3 per 100,000. The suicide rate associated with birth was significantly lower (5.9) and the rates associated with miscarriage (18.1) and induced abortion (34.7) were significantly higher ...\n3. 67 cases of maternal suicide were identified, corresponding to a maternal suicide ratio of 2.3 per 100,000 live births. The suicide rate was 1.18 per 100,000 after giving birth, and 2.77 after and induced abortion, and 2.9 after a miscarriage. The majority of women who died by maternal suicide had a previous psychiatric history: Lewkowitz et al.\n4. Estimated ratio of male to female suicide rates; a ratio greater than one indicates higher suicide rates in men. Suicide deaths are underreported in many countries due to social stigma and cultural or legal concerns. This data includes modeling based on global suicide patterns, and includes adjustments and extrapolations that aim to account for missing data and underreporting.\n5. Suicide rate, by age Country by country. Suicide rate, by age Multiple countries. Suicide rate, by sex WHO GHE. Estimated annual number of suicides per 100,000 individuals in a given demographic. Suicide deaths are underreported in many countries due to social stigma and cultural or legal concerns. This data is based on modeling of global ...",
               "predicate": null
            }
         ],
         "row": 439,
         "id": 140921971388555158
      },
      {
         "claim": "The microtubule-dependent delivery and secretion of matrix metalloproteases (MMPs) is partially responsible for the disassembly of adhesion sites.",
         "label": 1,
         "prediction": 1,
         "rationale": "Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play a crucial role in the degradation and remodeling of the extracellular matrix (ECM). Matrix metalloproteinases (MMPs) play a crucial role in the disassembly of adhesion sites by degrading components of the extracellular matrix (ECM). The microtubule-dependent delivery and secretion of matrix metalloproteases (MMPs) are involved in the disassembly of adhesion sites. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are matrix metalloproteases (MMPs)?",
               "answer": "Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play a crucial role in the degradation and remodeling of the extracellular matrix (ECM). They are capable of degrading almost every component of the ECM, which is important for processes such as embryonic development, angiogenesis",
               "rationale": "1. Matrix metalloproteinases ( MMPs ), also known as matrix metallopeptidases or matrixins, are metalloproteinases that are calcium -dependent zinc -containing endopeptidases; [1] other family members are adamalysins, serralysins, and astacins. The MMPs belong to a larger family of proteases known as the metzincin superfamily.\n2. Abstract. Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component of the ECM. The degradation of the ECM is of great importance, since it is related to embryonic development and angiogenesis. It is also involved in cell repair ...\n3. The extracellular matrix (ECM) is a macromolecules network, in which the most abundant molecule is collagen. This protein in triple helical conformation is highly resistant to proteinases degradation, the only enzymes capable of degrading the collagen are matrix metalloproteinases (MMPs). This resistance and maintenance of collagen, and ...\n4. Abstract. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that are involved in the degradation of various proteins in the extracellular matrix (ECM). Typically, MMPs have a propeptide sequence, a catalytic metalloproteinase domain with catalytic zinc, a hinge region or linker peptide, and a hemopexin domain.\n5. Matrix metalloproteinases (MMPs) are members of an enzyme family that require a zinc ion in their active site for catalytic activity. MMPs are critical for maintaining tissue allostasis. MMPs are active at neutral pH and can therefore catalyze the normal turnover of extracellular matrix (ECM) macromolecules such as the interstitial and basement ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What role do matrix metalloproteases (MMPs) play in the disassembly of adhesion sites?",
               "answer": "Matrix metalloproteinases (MMPs) play a crucial role in the disassembly of adhesion sites by degrading components of the extracellular matrix (ECM). They are involved in the remodeling of the ECM, which is essential for processes such as morphogenesis, repair, and angiogenesis. By breaking down ECM components like",
               "rationale": "1. Abstract. Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component of the ECM. The degradation of the ECM is of great importance, since it is related to embryonic development and angiogenesis. It is also involved in cell repair ...\n2. Abstract. The extracellular matrix (ECM) is a macromolecules network, in which the most abundant molecule is collagen. This protein in triple helical conformation is highly resistant to proteinases degradation, the only enzymes capable of degrading the collagen are matrix metalloproteinases (MMPs). This resistance and maintenance of collagen ...\n3. Introduction. Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that belong to the metzicin superfamily and are involved in the degradation and remodeling of extracellular matrix (ECM) components, such as fibronectin, laminin, collagens, elastin, and basement membrane glycoproteins. MMPs play important roles in physiological ...\n4. 1 Introduction 1.1 Classification and structural characteristics of matrix metalloproteinases. MMPs are a kind of calcium-and zinc-dependent proteolytic enzyme (), that exist in invertebrates, vertebrates and plants ().They are produced by multiple cells and tissues, with neutrophils and dermal fibroblasts being the main sources ().Connective tissue, pro-inflammatory and uteroplacental cells ...\n5. Matrix metalloproteinases (MMPs) play roles in remodelling of the extracellular matrix that occurs during morphogenesis, repair, and angiogenesis. Dysregulation of extracellular matrix remodelling can lead to cell proliferation, invasion, and tissue fibrosis. Identi cation of a specic MMP(s) in a disease has been fi fi challenging due to the ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is the microtubule-dependent delivery and secretion of matrix metalloproteases (MMPs) involved in the disassembly of adhesion sites?",
               "answer": "Yes, the microtubule-dependent delivery and secretion of matrix metalloproteases (MMPs) are involved in the disassembly of adhesion sites. The evidence indicates that the localization of microtubule-associated proteins, such as CLASPs, adjacent to focal adhesions is temporally correlated with focal adhesion dis",
               "rationale": "1. In addition, FA-associated microtubules may provide a polarized microtubule track for localized secretion of matrix metalloproteases (MMPs). Thus, different aspects of the molecular mechanisms by which microtubules control FA turnover in migrating cells are beginning to emerge.\n2. Abstract. Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component of the ECM. The degradation of the ECM is of great importance, since it is related to embryonic development and angiogenesis. It is also involved in cell repair ...\n3. The extracellular matrix (ECM) is a macromolecules network, in which the most abundant molecule is collagen. This protein in triple helical conformation is highly resistant to proteinases degradation, the only enzymes capable of degrading the collagen are matrix metalloproteinases (MMPs). This resistance and maintenance of collagen, and ...\n4. The metalloproteinase (MP) family of zinc-dependent proteases, including matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) plays a crucial role in ...\n5. Current data suggest that the microtubule-dependent delivery and the subsequent secretion of matrix metalloproteases (MMPs) contribute to this process [ 74 ]. The localization of microtubule-associated CLASPs adjacent to focal adhesions has been temporally correlated with focal adhesion disassembly [ 74 ].",
               "predicate": null
            }
         ],
         "row": 440,
         "id": 441908471337507037
      },
      {
         "claim": "The minor G allele of FOXO3 downregulates pro-inflammatory cytokines.",
         "label": 1,
         "prediction": 1,
         "rationale": "The FOXO3 gene encodes the transcription factor forkhead box O-3 (FoxO3), which plays a crucial role in various cellular processes, including oxidative resistance, apoptosis, autophagy, energy metabolism, and extracellular matrix (ECM) remodeling. The minor G allele of FOXO3 is associated with a downregulation of pro-inflammatory cytokines. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the FOXO3 gene?",
               "answer": "The FOXO3 gene encodes the transcription factor forkhead box O-3 (FoxO3), which plays a crucial role in various cellular processes relevant to health and disease. It is involved in oxidative resistance, apoptosis, autophagy, energy metabolism, and extracellular matrix (ECM) remodeling. FOXO3",
               "rationale": "1. Function. FOXO3 belongs to the O subclass of the forkhead family of transcription factors which are characterized by a distinct fork head DNA-binding domain. There are three other FoxO family members in humans, FOXO1, FOXO4 and FOXO6. These transcription factors share the ability to be inhibited and translocated out of the nucleus on ...\n2. Abstract. Background: The gene FOXO3, encoding the transcription factor forkhead box O-3 (FoxO3), is one of only two for which genetic polymorphisms have exhibited consistent associations with longevity in diverse human populations. Objective: Here, we review the multitude of actions of FoxO3 that are relevant to health, and thus healthy ageing ...\n3. The gene FOXO3, encoding the transcription factor forkhead box O-3 (FoxO3), is one of only two for which genetic polymorphisms have exhibited consistent associations with longevity in diverse human populations.Here we review the multitude of actions of ...\n4. FOXO3 has versatile functions in human health and disease, and recent research offers new insights into the molecular mechanisms underlying the role and regulation of this essential transcription factor.\n5. FOXO3 participates in various cellular processes implicated in the progression of vascular aging, including oxidative resistance, apoptosis, autophagy, energy metabolism, and ECM remodeling processes by targeting the expression of effector genes. FOXO3 is a key protective factor in maintaining vascular homeostasis.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the minor G allele of FOXO3 downregulate pro-inflammatory cytokines?",
               "answer": "Yes, the minor G allele of FOXO3 is associated with a downregulation of pro-inflammatory cytokines. Evidence 1 indicates that the minor allele is linked to a milder course of inflammatory conditions due to a reduction in pro-inflammatory cytokines, including TNFα. Additionally, evidence 2 shows that FOX",
               "rationale": "1. The minor allele of FOXO3 SNP rs12212067 is associated with a milder course of the inflammatory conditions Crohn's disease and rheumatoid arthritis, ... and appeared to be a result of a reduction in pro-inflammatory cytokines, including TNFα, mediated by an effect of TGF-β1. As well there was an increase in production of anti-inflammatory ...\n2. Furthermore, FOXO3 knockout mice with ethanol-induced liver injury exhibited increased liver inflammation and mRNA transcription of pro-inflammatory cytokines such as TNF-α, IL-6, and MCP-1 in liver macrophages, but not the anti-inflammatory cytokine IL-4 [58]. Overall, these studies demonstrate that FOXO3 plays a critical role in regulating ...\n3. pro-inflammatory cytokines tumour necrosis factor (TNF), interleukin-1β ... ciation between the minor (G) allele of FOXO3 and a milder course of rheumatoid arthritis. This allele was\n4. Moreover, in a cross-sectional study including more than 30,000 individuals, the G allele of another longevity variant of FOXO3 was associated with a decrease in concentration of circulating insulin-like growth factor-1 (IGF-1), a marker of insulin resistance and chronic disease 56. Smaller-scale studies have yielded mixed results, albeit ...\n5. In a previous study, we demonstrated a protective effect on telomeres during aging linked to the FOXO3 genotype, specifically in carriers of the FOXO3 G-allele 20. Pro- and anti-inflammatory ...",
               "predicate": null
            }
         ],
         "row": 441,
         "id": 646573228126857585
      },
      {
         "claim": "The minor G allele of FOXO3 is related to less severe symptoms of Crohn's Disease.",
         "label": 1,
         "prediction": 1,
         "rationale": "The FOXO3 gene encodes a transcription factor that regulates energy metabolism, oxidative stress, proteostasis, apoptosis, and cell cycle regulation, playing a crucial role in aging and longevity. The minor G allele of FOXO3 SNP rs12212067 is not directly associated with disease susceptibility to Crohn's disease, but is associated with a milder course of the disease. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the FOXO3 gene?",
               "answer": "The FOXO3 gene encodes the transcription factor forkhead box O-3, which plays a crucial role in various biological processes related to aging and longevity. Its functions include regulating energy metabolism, managing oxidative stress, maintaining proteostasis, controlling apoptosis (programmed cell death), and influencing cell cycle regulation. Additionally, FOX",
               "rationale": "1. The gene FOXO3, encoding the transcription factor forkhead box O-3 ... We review the molecular genetics of FOXO3 in longevity, then current knowledge of FoxO3 function relevant to ageing and lifespan. We describe how FoxOs are involved in energy metabolism, oxidative stress, proteostasis, apoptosis, cell cycle regulation, metabolic processes ...\n2. FOXO3 belongs to the O subclass of the forkhead family of transcription factors which are characterized by a distinct fork head DNA-binding domain.There are three other FoxO family members in humans, FOXO1, FOXO4 and FOXO6.These transcription factors share the ability to be inhibited and translocated out of the nucleus on phosphorylation by proteins such as Akt/PKB in the PI3K signaling ...\n3. Background: The gene FOXO3, encoding ... Other functions concern metabolism, cell cycle arrest, apoptosis, destruction of potentially damaging reactive oxygen species and proteostasis. Conclusions: The mechanism by which longevity-associated alleles of FOXO3 reduce age-related mortality is currently of great clinical interest. The prospect of ...\n4. FOXO3 gene and protein expression is associated with age-related phenotypes in multiple tissues 47. ... FOXO3 has versatile functions in human health and disease, and recent research offers new insights into the molecular mechanisms underlying the role and regulation of this essential transcription factor. Over the last 3 years, an important ...\n5. Recently, it was shown that the 90 bp sequence around the FOXO3 intronic SNP rs2802292 has enhancer functions and that different types of cellular stresses induce the recruitment of HSF1, which promotes FOXO3 expression . HSF1 is an evolutionarily highly conserved transcription factor that plays a role in stress-induced transcription.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the minor G allele of FOXO3 associated with Crohn's Disease?",
               "answer": "The minor G allele of FOXO3 SNP rs12212067 is not directly associated with disease susceptibility to Crohn's disease; however, it is associated with a milder course of the disease. Therefore, while the G allele does not increase the risk of developing Crohn's disease, it is linked to a less",
               "rationale": "1. The minor allele of FOXO3 SNP rs12212067 is associated with a milder course of the inflammatory conditions Crohn's disease and rheumatoid arthritis, consistent with this variant having an anti-inflammatory role [ 38 ].\n2. We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn's disease and rheumatoid arthritis and with increased risk of severe malaria.\n3. In support of this premise, the minor allele of FOXO3 SNP rs12212067 (which is in linkage disequilibrium with rs2802292 and could act as a proxy) was associated with a milder clinical course of seemingly unrelated inflammatory conditions (Crohn's disease and rheumatoid arthritis) (Lee et al ., 2013 ).\n4. The first study on FOXO3 genetic variants implicated in longevity revealed that homozygosity for the rs2802292 G-allele is associated with a lower prevalence of coronary artery disease and cancer [ 35 ]. Subsequent studies confirmed the importance of this variant in longevity and age-related diseases.\n5. The minor allele of FOXO3 SNP rs12212067 is associated with a milder course of the inflammatory conditions Crohn's disease and rheumatoid arthritis, consistent with this variant having an anti-inflammatory role [ 38 ].",
               "predicate": null
            }
         ],
         "row": 442,
         "id": 244255518980590923
      },
      {
         "claim": "The minor G allele of FOXO3 up-regulates IL-10.",
         "label": 1,
         "prediction": 1,
         "rationale": "The FOXO3 gene encodes a transcription factor involved in various critical biological functions including metabolism, cell cycle arrest, apoptosis, stress response, and longevity. The provided evidence does not specifically mention the effect of the minor G allele of FOXO3 on IL-10. The minor G allele of FOXO3 is associated with an increase in IL-10 production. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the FOXO3 gene?",
               "answer": "The FOXO3 gene encodes the transcription factor forkhead box O-3, which is involved in various critical biological functions including metabolism, cell cycle arrest, apoptosis, the destruction of potentially damaging reactive oxygen species, and proteostasis. Additionally, FOXO3 plays a significant role in stress response and longevity, influencing age",
               "rationale": "1. FOXO3 belongs to the O subclass of the forkhead family of transcription factors which are characterized by a distinct fork head DNA-binding domain.There are three other FoxO family members in humans, FOXO1, FOXO4 and FOXO6.These transcription factors share the ability to be inhibited and translocated out of the nucleus on phosphorylation by proteins such as Akt/PKB in the PI3K signaling ...\n2. Recently, it was shown that the 90 bp sequence around the FOXO3 intronic SNP rs2802292 has enhancer functions and that different types of cellular stresses induce the recruitment of HSF1, which promotes FOXO3 expression . HSF1 is an evolutionarily highly conserved transcription factor that plays a role in stress-induced transcription.\n3. Background: The gene FOXO3, encoding ... Other functions concern metabolism, cell cycle arrest, apoptosis, destruction of potentially damaging reactive oxygen species and proteostasis. Conclusions: The mechanism by which longevity-associated alleles of FOXO3 reduce age-related mortality is currently of great clinical interest. The prospect of ...\n4. The gene FOXO3, encoding the transcription factor forkhead box O-3 ... We review the molecular genetics of FOXO3 in longevity, then current knowledge of FoxO3 function relevant to ageing and lifespan. We describe how FoxOs are involved in energy metabolism, oxidative stress, proteostasis, apoptosis, cell cycle regulation, metabolic processes ...\n5. FOXO3 gene and protein expression is associated with age-related phenotypes in multiple tissues 47. ... FOXO3 has versatile functions in human health and disease, and recent research offers new insights into the molecular mechanisms underlying the role and regulation of this essential transcription factor. Over the last 3 years, an important ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of the minor G allele of FOXO3 on IL-10?",
               "answer": "The provided evidence does not specifically mention the effect of the minor G allele of FOXO3 on IL-10. It discusses associations with other cytokines (IL-2, TNFα, IL-1β, and IL-6) and mentions the general role of FOXO3 in longevity and glucose metabolism,",
               "rationale": "1. FOXO3 effect on lifespan extension may be dependent on the accessibility of this region to transcription factors that positively regulate FOXO3 transcription. The presence of the G-allele creates a HSF1 binding site, which induces promoter-enhancer interaction by chromatin looping, thereby fostering FOXO3 expression and the activity of the ...\n2. There was no significant association of FOXO3 G-allele carrier frequency with cytokine levels as a function of age for IL-2, TNFα, and IL-1β (Supplementary Fig. 3), nor was there an association ...\n3. A study of 196 monozygotic Danish twins found that the longevity-associated FOXO3 rs2800292 G allele was associated with more favorable peripheral and hepatic insulin sensitivity and increased FOXO3 mRNA expression in skeletal muscle, suggesting that the beneficial effects of FoxO3 on glucose metabolism may be mediated through enhanced FOXO3 ...\n4. FOXO3 is one of the rare genes that have been consistently linked to longevity in in vivo models. This review provides an update of the most recent research pertaining to the role of FOXO3 in (i) the regulation of protein turnover in skeletal muscle, the largest protein pool of the body, and (ii) the genetic basis of longevity.\n5. FOXO3 mRNA expression increased slightly with age in both young (P = 0.02) and old (P = 0.08) G-allele carriers. Older female G-allele carriers displayed a modest decline in levels of pro-inflammatory cytokine IL-6 with age (P = 0.07). In contrast, older male G-allele carriers displayed an age-dependent increase in levels of anti-inflammatory ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the minor G allele of FOXO3 increase IL-10 production?",
               "answer": "Yes, the minor G allele of FOXO3 is associated with an increase in IL-10 production. Evidence from the snippets indicates that in subjects with the G allele, there is an increase in the production of anti-inflammatory cytokines, including IL-10. Additionally, it is mentioned that for older adult males, carriage",
               "rationale": "1. In monocytes of subjects with the minor allele the inflammatory responses was less severe, and appeared to be a result of a reduction in pro-inflammatory cytokines, including TNFα, mediated by an effect of TGF-β1. As well there was an increase in production of anti-inflammatory cytokines, including interleukin-10.\n2. The first study on FOXO3 genetic variants implicated in longevity revealed that homozygosity for the rs2802292 G-allele is associated with a lower prevalence of coronary artery disease and cancer [ 35 ]. Subsequent studies confirmed the importance of this variant in longevity and age-related diseases.\n3. production and an earlier increase in IL-10 production. Further investigations showed ... ciation between the minor (G) allele of FOXO3 and a milder course of rheumatoid arthritis. This allele was\n4. Moreover, in a cross-sectional study including more than 30,000 individuals, the G allele of another longevity variant of FOXO3 was associated with a decrease in concentration of circulating insulin-like growth factor-1 (IGF-1), a marker of insulin resistance and chronic disease 56. Smaller-scale studies have yielded mixed results, albeit ...\n5. In contrast, for older adult males, carriage of the FOXO3 G-allele was associated with an increase in IL-10 levels with age (Fig. 5, P = 0.04), whereas IL-10 levels remained relatively static ...",
               "predicate": null
            }
         ],
         "row": 443,
         "id": 319093492404075758
      },
      {
         "claim": "The most prevalent adverse events to Semaglutide are cardiovascular.",
         "label": 0,
         "prediction": 0,
         "rationale": "Semaglutide is associated with adverse events including gastrointestinal side effects, hypoglycemia, pancreatitis, pancreatic cancer, thyroid cancer, gallbladder events, cardiovascular issues, acute kidney injury, and complications related to diabetic retinopathy. Cardiovascular issues are not the most prevalent adverse events associated with semaglutide. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the adverse events associated with Semaglutide?",
               "answer": "The adverse events associated with semaglutide include gastrointestinal side effects, hypoglycemia, pancreatitis, pancreatic cancer, thyroid cancer, gallbladder events, cardiovascular issues, acute kidney injury, and complications related to diabetic retinopathy (DRP).",
               "rationale": "1. Results. We identified 5,442 cases of semaglutide-associated gastrointestinal AEs, with 45 signals detected, ranging from a ROR 025 of 1.01 (hypoaesthesia oral) to 42.03 (eructation), among which 17 AEs were identified as new and unexpected signals. Patient age (p < 0.001) and body weight (p = 0.006) rather than sex (p = 0.251) might be associated with an increased risk of gastrointestinal AEs ...\n2. In the current review we discuss the occurrence of adverse events associated with semaglutide focusing on hypoglycemia, gastrointestinal side effects, pancreatic safety (pancreatitis and pancreatic cancer), thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, diabetic retinopathy (DRP) complications and injection ...\n3. Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system Front Public Health. 2022 Oct 20 ... Results: We identified 5,442 cases of semaglutide-associated gastrointestinal AEs, with 45 signals detected, ranging from a ROR 025 of 1.01 (hypoaesthesia oral) to 42.03 ...\n4. In June of 2021, the US Food and Drug Administration (FDA) approved the drug semaglutide for chronic weight management under the brand name Wegovy, ushering in a new era of obesity treatment. Since then, demand for Wegovy and the type 2 diabetes therapy Ozempic—which contains the same drug and has commonly been prescribed off-label for weight loss—have outpaced production, causing ongoing ...\n5. In the current review we discuss the occurrence of adverse events associated with semaglutide focusing on hypoglycemia, gastrointestinal side effects, pancreatic safety (pancreatitis and pancreatic cancer), thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, diabetic retinopathy (DRP) complications and injection ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are cardiovascular issues the most prevalent adverse events to Semaglutide?",
               "answer": "No, cardiovascular issues are not the most prevalent adverse events associated with semaglutide. The evidence provided discusses the reduction of major adverse cardiovascular events (MACE) with semaglutide compared to placebo, indicating that cardiovascular events were monitored but not highlighted as the most common adverse events. Additionally, the mention of medication",
               "rationale": "1. Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...\n2. Two cardiovascular (CV) outcomes trials showed that in subjects with T2D at high risk of CV events there were fewer major adverse CV events (MACE; defined as CV death, non-fatal stroke, non-fatal myocardial infarction) with semaglutide than with placebo (hazard ratio [95% CI]: 0.74 [0.58;0.95] for once-weekly s.c. semaglutide and 0.79 [0.57;1. ...\n3. At baseline, 2735 of the patients (83.0%) had established cardiovascular disease, chronic kidney disease, or both. The primary outcome occurred in 108 of 1648 patients (6.6%) in the semaglutide ...\n4. Major adverse cardiovascular events occurred in 61 of 1591 patients (3.8%) in the oral semaglutide group and 76 of 1592 (4.8%) in the placebo group (hazard ratio, 0.79; 95% confidence interval [CI ...\n5. Being the most prevalent ... (21 [11.0%]), medication discontinuation due to adverse events (16 [8.4 ... a RCT studying the cardiovascular outcome of semaglutide showed that in patients ...",
               "predicate": null
            }
         ],
         "row": 444,
         "id": 328141032988285135
      },
      {
         "claim": "The most prevalent adverse events to Semaglutide are gastrointestinal.",
         "label": 1,
         "prediction": 1,
         "rationale": "Semaglutide is associated with adverse events including gastrointestinal side effects, hypoglycemia, pancreatic safety concerns, thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, and complications related to diabetic retinopathy. Gastrointestinal adverse events are the most prevalent adverse events associated with semaglutide. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the adverse events associated with Semaglutide?",
               "answer": "The adverse events associated with semaglutide include gastrointestinal side effects, hypoglycemia, pancreatic safety concerns (such as pancreatitis and pancreatic cancer), thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, and complications related to diabetic retinopathy (DRP). Additionally, gastrointestinal adverse events (A",
               "rationale": "1. Results. We identified 5,442 cases of semaglutide-associated gastrointestinal AEs, with 45 signals detected, ranging from a ROR 025 of 1.01 (hypoaesthesia oral) to 42.03 (eructation), among which 17 AEs were identified as new and unexpected signals. Patient age (p < 0.001) and body weight (p = 0.006) rather than sex (p = 0.251) might be associated with an increased risk of gastrointestinal AEs ...\n2. In the current review we discuss the occurrence of adverse events associated with semaglutide focusing on hypoglycemia, gastrointestinal side effects, pancreatic safety (pancreatitis and pancreatic cancer), thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, diabetic retinopathy (DRP) complications and injection ...\n3. In June of 2021, the US Food and Drug Administration (FDA) approved the drug semaglutide for chronic weight management under the brand name Wegovy, ushering in a new era of obesity treatment. Since then, demand for Wegovy and the type 2 diabetes therapy Ozempic—which contains the same drug and has commonly been prescribed off-label for weight loss—have outpaced production, causing ongoing ...\n4. Another previous real-world disproportionality analysis of GLP-1RAs-associated gastrointestinal AEs based on the FDA Adverse Event Reporting System (FAERS) from 2018 to 2020 included 2,047 cases of semaglutide and 4,075 cases of liraglutide for the treatment of obesity . This study demonstrated that semaglutide had a higher pooled ROR and later ...\n5. In the current review we discuss the occurrence of adverse events associated with semaglutide focusing on hypoglycemia, gastrointestinal side effects, pancreatic safety (pancreatitis and pancreatic cancer), thyroid cancer, gallbladder events, cardiovascular aspects, acute kidney injury, diabetic retinopathy (DRP) complications and injection ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are gastrointestinal adverse events the most prevalent adverse events to Semaglutide?",
               "answer": "Yes, gastrointestinal adverse events (AEs) are indicated as the most prevalent adverse events associated with semaglutide. The evidence highlights that gastrointestinal disorders, particularly mild-to-moderate nausea, are common and represent a dose-dependent class effect of GLP-1 receptor agonists (GLP-1RAs),",
               "rationale": "1. After the approval of semaglutide, the post-marketing concerns have been raised about its long-term safety and tolerability for clinical use. The most common adverse events (AEs) reported with GLP-1RAs were gastrointestinal disorders, such as nausea, diarrhea, vomiting, and abdominal pain, etc (7-9).\n2. Gastrointestinal (GI) adverse events (AEs), most commonly mild‐to‐moderate nausea, are a dose‐dependent class effect of GLP‐1RAs. 12 , 13 , 14 We conducted a pooled analysis of the STEP 1‐3 trials to evaluate the GI AE profile of semaglutide 2.4 mg. In addition, we explored whether GI AEs contributed to the weight‐loss effects of ...\n3. Aim: We evaluated gastrointestinal (GI) adverse events (AEs) with once-weekly semaglutide 2.4 mg in adults with overweight or obesity and their contribution to weight loss (WL). Materials and methods: AE analyses pooled data from the Semaglutide Treatment Effect in People With Obesity (STEP) 1-3 trials for participants randomized to 68 weeks of semaglutide 2.4 mg (n = 2117) or placebo (n = 1262).\n4. Most gastrointestinal adverse events were mild-to-moderate and transient, and such events led to permanent treatment discontinuation in six (3.9%) participants in the semaglutide group and one (0. ...\n5. Methods: Reporting odds ratio (ROR) was employed to quantify the signals of semaglutide-related gastrointestinal adverse events (AEs) from 2018 to 2022. Serious and non-serious cases were compared by Mann-Whitney U test or Chi-squared (χ 2 ) test, and signals were prioritized using a rating scale.",
               "predicate": null
            }
         ],
         "row": 445,
         "id": 259007420668179297
      },
      {
         "claim": "The myocardial cell lineage originally develops from cardiac progenitors of exclusively endodermal origin.",
         "label": 0,
         "prediction": 0,
         "rationale": "The origin of cardiac progenitors includes embryonic cardiac progenitors derived from cardiac mesoderm progenitors, epicardial progenitors, and cranial neural crest cells, as well as those sourced from the neonatal and adult heart. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the origin of cardiac progenitors?",
               "answer": "The origin of cardiac progenitors includes embryonic cardiac progenitors, which are derived from various populations such as cardiac mesoderm progenitors, epicardial progenitors, and cranial neural crest cells (CNCCs). Additionally, cardiac progenitors can also be sourced from the neonatal and adult heart, as well as",
               "rationale": "1. Neonatal and Adult Cardiac Progenitors. Though it has long been thought that a resident cardiac progenitor population does not exist in the postnatal heart (Rosenthal, 2003), the discovery of embryonic cardiac progenitors prompted a search for such progenitors in the neonatal and adult heart. The persistence of cardiac progenitors into the ...\n2. Heart cells are the unitary elements that define cardiac function and disease. The recent identification of distinct families of cardiovascular progenitor cells begins to build a foundation for our understanding of the developmental logic of human cardiovascular disease, and also points to new approaches to arrest and/or reverse its progression, a major goal of regenerative medicine. In this ...\n3. Here, we discuss cardiac progenitor cells from fetal and adult heart and from in vitro differentiated pluripotent stem cells because (1) alterations in the pool of cardiac progenitors during development may be causally related to congenital heart defects; (2) expansion of cardiac progenitors in culture is potentially the most efficient way of ...\n4. Abstract. The mammalian heart lacks the capacity to replace the large numbers of cardiomyocytes lost due to cardiac injury. Several different cell-based routes to myocardial regeneration have been explored, including transplantation of cardiac progenitors and cardiomyocytes into injured myocardium. As seen with cell-based therapies in other ...\n5. In the last few decades, with our growing knowledge of normal cardiac development and of cardiac precursor origin and regulation, the role of the different embryonic cardiac progenitor populations (cardiac mesoderm progenitors, epicardial progenitors, and CNCCs) in the etiology of CHD has begun to gain increasing interest.",
               "predicate": null
            }
         ],
         "row": 446,
         "id": 339667682567900454
      },
      {
         "claim": "The one-child policy has created a hospitable environment for female infants.",
         "label": 0,
         "prediction": 0,
         "rationale": "The one-child policy was a population planning initiative implemented by the Chinese government from 1979 to 2015, aimed at controlling the country's rapid population growth by limiting most families to one child each. The one-child policy does not create a hospitable environment for female infants, leading to a skewed sex ratio favoring males. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the one-child policy?",
               "answer": "The one-child policy was a population planning initiative implemented by the Chinese government from 1979 to 2015, aimed at controlling the country's rapid population growth by limiting most families to one child each. The policy was enforced through various methods, including financial incentives and penalties, and allowed rural couples to have a second child if",
               "rationale": "1. one-child policy, official program initiated in the late 1970s and early '80s by the central government of China, the purpose of which was to limit the great majority of family units in the country to one child each.The rationale for implementing the policy was to reduce the growth rate of China's enormous population.It was announced in late 2015 that the program was to end in early 2016.\n2. The one-child policy was a program in China that limited most Chinese families to one child each. It was implemented nationwide by the Chinese government in 1980, and it ended in 2016. The policy was enacted to address the growth rate of the country's population, which the government viewed as being too rapid.It was enforced by a variety of methods, including financial incentives for ...\n3. The text reads \"Planned child birth is everyone's responsibility.\" Birth rate in China, 1950-2015. The one-child policy ( Chinese: 一孩政策; pinyin: yī hái zhèngcè) was a population planning initiative in China implemented between 1979 and 2015 to curb the country's population growth by restricting many families to a single child.\n4. One-Child Policy: The one-child policy was a policy implemented by the Chinese government as a method of controlling the population, mandating that the vast majority of couples in the country ...\n5. For decades, China's family planning policy limited most urban couples to one child and rural couples to two if their first was a girl. \"The doctors would inject poison directly into the baby's ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the one-child policy create a hospitable environment for female infants?",
               "answer": "No, the one-child policy does not create a hospitable environment for female infants. The evidence indicates that the policy led to a skewed sex ratio favoring males, with approximately 3 to 4 percent more males than females. This gender imbalance suggests a societal preference for male children, which can result in negative consequences",
               "rationale": "1. The one child policy significantly curbed population growth, though there is no consensus on the magnitude. Under the policy, households tried to have additional children without breaking the law; some unintended consequences include higher reported rates of twin births and more Han-minority marriages.\n2. The 20th century witnessed the birth of modern family planning and its effects on the fertility of hundreds of millions of couples around the world. In 1979, China formally initiated one of the world's strictest family planning programs—the \"one child policy.\". Despite its obvious significance, the policy has been significantly ...\n3. In late 2015 the government announced that the one-child limit per family would end in 2016. Here are some of the major consequences of the policy. The fertility rate decreased after 1980. The birth rate decreased after 1980. The overall rate of natural increase (the difference between the birth rate and the death rate) declined.\n4. One-child policy - Population Control, Gender Imbalance, Social Impact: The one-child policy produced consequences beyond the goal of reducing population growth. Most notably, the country's overall sex ratio became skewed toward males—roughly between 3 and 4 percent more males than females. Traditionally, male children (especially firstborn ...\n5. one-child policy, official program initiated in the late 1970s and early '80s by the central government of China, the purpose of which was to limit the great majority of family units in the country to one child each.The rationale for implementing the policy was to reduce the growth rate of China's enormous population.It was announced in late 2015 that the program was to end in early 2016.",
               "predicate": null
            }
         ],
         "row": 447,
         "id": 257552817307968327
      },
      {
         "claim": "The peak incidence of fractures occurs during pubertal growth spurt in early adolescents.",
         "label": 1,
         "prediction": 0,
         "rationale": "The pubertal growth spurt typically occurs once puberty starts, with a sharp increase in growth of about 8 centimeters per year, peaking 6-12 months before menarche in girls and later in boys. The peak incidence of fractures in adolescents occurs at 11-12 years for girls and at 13-14 years for boys. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "When does the pubertal growth spurt occur?",
               "answer": "The pubertal growth spurt typically occurs once puberty starts, with a sharp increase in growth of about 8 centimeters (approximately 3 inches) per year. For girls, peak growth usually happens 6-12 months before the onset of their menstrual cycle (menarche), while boys tend to have their growth sp",
               "rationale": "1. Once puberty starts, there is a sharp increase in growth of about 8 centimeters/year. Peak growth for girls is typically 6-12 months before the onset of their menstrual cycle (menarche) and then significantly slows down after that. Girls can expect to grow an average of about 2-3 inches after menarche. Boys tend to have their growth spurt about ...\n2. The teenage years are also called adolescence. This is a time for growth spurts and puberty changes (sexual maturation). A teen may grow several inches in several months, followed by a time of very slow growth. Then they may have another growth spurt. Puberty changes may happen slowly. Or several changes may occur at the same time.\n3. A growth spurt of more than 3 inches per year occurs. Their skin becomes oilier, and acne develops. In Stage 4, puberty hits full stride. Between the ages of 10 and 15: Their breasts continue growing, and their nipples start to protrude. Pubic hair is still in a triangle, and there are now too many hairs to count.\n4. Growth spurts are physical changes that occur quickly as your child ages, including length, height and weight increases. Developmental milestones are actions and skills that mark your child's growing maturity at specific stages. Developmental milestones focus on how your child thinks (cognitive and language skills), plays (social and ...\n5. The teen years are also called adolescence. This is a time for growth spurts and puberty changes (sexual maturation). A teen may grow several inches in several months, followed by a time of very slow growth. Then they may have another growth spurt. Puberty changes may happen slowly. Or several changes may occur at the same time.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "When does the peak incidence of fractures occur in adolescents?",
               "answer": "The peak incidence of fractures in adolescents occurs at 11-12 years for girls and at 13-14 years for boys.",
               "rationale": "1. The incidence increased by 13% during the period 1998-2007, when we were able to control for registration errors. The most common fracture site was the distal forearm. The most common type of injury mechanism was falling. The peak incidence occurred at 11-12 years in girls and at 13-14 years in boys, with a male-to-female incidence ratio ...\n2. Introduction. The annual incidence rates of fractures in children under 16 years varies from 3.6 per 1000 to 50 per 1000 according to age, gender, social and environmental factors, and typically peaks at 11-12 years for girls and 13-14 years for boys [1-5].The male-to-female incidence ratio is 1.5 [].The distal forearm is the most affected site, and often caused by a fall [2, 5].\n3. An alternative explanation is that the fastest rate of bone mineralization occurs several months after the most rapid gains in bone size during adolescence.2 The incidence of childhood fractures appears to be on the rise in both the United States and Scandinavia, raising concerns about unhealthy lifestyle trends.1 Addressing this public health ...\n4. Introduction. It has long been known that fracture incidence in the population is bimodal, with elevated rates among children and adolescents, (1-3) which then decline only to rise again with advancing age. It is also evident from previous work that some types of fractures (e.g., hands and feet) typically occur early in life, more often in men and linked with recreational and occupational ...\n5. The incidence increased by 13% during the period 1998-2007, when we were able to control for registration errors. The most common fracture site was the distal forearm. The most common type of injury mechanism was falling. The peak incidence occurred at 11-12 years in girls and at 13-14 years in boys, with a male-to-female incidence ratio of 1.5.",
               "predicate": null
            }
         ],
         "row": 448,
         "id": 258544496245035314
      },
      {
         "claim": "The peak incidence of fractures occurs in toddlers.",
         "label": 0,
         "prediction": 0,
         "rationale": "The age range of toddlers is from 1 to 3 years old. The peak incidence of fractures occurs at 50-59 years of age for most fracture types, while the peak number of hip fractures occurs at 75-79 years of age. The peak incidence of fractures in toddlers is not the same as the peak incidence of fractures in the general population. The most common type of fracture in toddlers is a toddler's fracture, which is a spiral fracture of the tibia bone. A toddler's fracture, the most common type of fracture in toddlers, typically occurs in children from 9 months to 3 years of age. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the age range of toddlers?",
               "answer": "The age range of toddlers is from 1 to 3 years old.",
               "rationale": "1. The toddler age range is clearly defined and demystified, once and for all. Now you know all about the key ages that fall into the toddler category, which should make it easier for you to support your child's growth and adapt as they enter the toddler years and eventually grow out of them and into the preschool stage.\n2. Toddler: 1-3 yrs. Your child is advancing from infancy toward and into the preschool years. During this time, his physical growth and motor development will slow, but you can expect to see some tremendous intellectual, social, and emotional changes.\n3. The toddler age group starts at one year old, and while the end of the toddler age range is a little less definitive, it's generally thought to come to close when a child turns 3. \"There are no strict upper limits, but we consider toddlers one to 3 and preschool 3 to 5,\" says Dina DiMaggio, MD, a pediatrician with NYU Langone in New York ...\n4. The toddler age range is from 1 to 3 years old. As I mentioned already, you will probably see speech therapists talk about months more than they talk about years; so toddlers will be used to classify children between 12-36 months old. That's because children who are 12 months old and children who are 23 months old are both technically 1 year ...\n5. Newborn usually refers to a baby from birth to about 2 months of age. Children can be considered an infant anywhere from birth to 1 year old. Baby can refer to any child from birth to age 4 years ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "At what age does the peak incidence of fractures occur?",
               "answer": "The peak incidence of fractures occurs at 50-59 years of age for most fracture types, while the peak number of hip fractures occurs at 75-79 years of age.",
               "rationale": "1. With a substantial impact on disability, morbidity, and mortality, fractures place an enormous burden on healthcare systems 1-6.Although some previous studies reported estimates of hip, wrist, and vertebral fractures (e.g. 3.0% of the US older population had a hip fracture in 2005-2010 7, 12.0% of the US adults ≥50 years had a wrist fracture in 2017-2018 8, and 5.4% of the US adults ...\n2. Group F included fractures with a peak in incidence around 50 years of age. For two of the fracture types, a bimodal appearance with a smaller peak in the youngest individuals (around 20 years of age) was seen. Metatarsal, midfoot, and toe phalanx fractures belonged to this group (Fig 7).\n3. The age- and sex-adjusted (to the 2010 United States white population) incidence of any fracture was 2704 per 100,000 person-years (95% CI 2614-2793) and that for all fractures was 4017 per 100,000 (95% CI 3908-4127). Fracture incidence increased with age in both sexes, but age-adjusted rates were 49% greater among the women.\n4. The global age-standardised rates of incidence, prevalence, and YLDs for fractures decreased slightly from 1990 to 2019, but the absolute counts increased substantially. Older people have a particularly high risk of fractures, and more widespread injury-prevention efforts and access to screening and treatment of osteoporosis for older individuals should help to reduce the overall burden.\n5. The peak number of hip fractures occur at 75-79 years of age for both sexes; for all other fractures, the peak number occur at 50-59 years and decrease with age. Johnell, O. and J.A. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int, 2006. 17(12): p. 1726-33.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is the peak incidence of fractures in toddlers the same as the peak incidence of fractures in the general population?",
               "answer": "No, the peak incidence of fractures in toddlers is not the same as the peak incidence of fractures in the general population. The evidence indicates that in children between 9 and 24 months of age, forearm and lower leg fractures predominate, while fractures in children under the age of two are rare, particularly in",
               "rationale": "1. In children between 9 and 24 months of age, forearm, tibia and fibula fractures predominate [ 1 ]. We have previously shown, in a population-based cohort of 408 children under 2 years of age, that 149 (77 boys) children had a total of 162 fractures, yielding a fracture incidence of 5.9 per 1000 and an incidence of children with fractures of 5.4 ...\n2. In children under the age of two, fractures are rare, particularly in non-ambulatory infants, with a predilection for the clavicle and skull in those under 8 months of age [].In toddlers between 9 and 24 months of age, forearm and lower leg fractures predominate [1, 2].The incidence and pattern of fractures in children under the age of two is, however, poorly described in the literature.\n3. The pre-pandemic cohort (pre-PC; April 1-June 22 in 2018 and 2019) and post-peak pandemic cohort (post-peak PC; April 1-June 22, 2021) were used as comparison groups. In addition, trauma cases beyond June 22, 2020 were broken into 3-month intervals (i.e. July 1-September 30, 2020) ending in November 2021. These cohorts were each compared ...\n4. An alternative explanation is that the fastest rate of bone mineralization occurs several months after the most rapid gains in bone size during adolescence.2 The incidence of childhood fractures appears to be on the rise in both the United States and Scandinavia, raising concerns about unhealthy lifestyle trends.1 Addressing this public health ...\n5. Background Musculoskeletal injury, including fracture, is one of the most common causes of morbidity in pediatric patients. The purpose of this epidemiologic study is to determine the prevalence and risk factors for fracture in a large cohort of pediatric patients under the age of 5. Results Of the 233,869 patients included in the study, 13,698 fractures were identified in 10,889 patients. The ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the most common type of fracture in toddlers?",
               "answer": "The most common type of fracture in toddlers is a toddler's fracture, which is a spiral fracture of the tibia bone.",
               "rationale": "1. A toddler's fracture is a common fracture in the tibia bone (large bone in the lower leg) of children usually younger than 6 years old. It is most common in children in the early years of walking - 9 months to 3 years. A toddler's fracture is a spiral fracture of the tibia without any injury to the fibula (smaller bone in the lower leg ...\n2. Comminuted - Comminuted fractures cause the bone to break into more than just two pieces. Oblique - Oblique fractures cause the bone to crack at an angle. Front-view (anteroposterior) x-ray of the right forearm. The red arrow shows an oblique fracture of the forearm (radial shaft). An oblique fracture is when the bone is broken at an angle.\n3. Pediatric fractures heal more quickly than adult fractures due to children's growth potential and a thicker, more active periosteum (the periosteum contributes the largest part of new bone formation around a fracture) As children reach their growth potential, in adolescence and early adulthood, the rate of healing slows to that of an adult ...\n4. Here are the most common causes of fractured bones in toddlers and babies: [2] Falls. Slips and falls are the most common reason a baby or toddler fractures a bone. As your child walks, runs, jumps and plays, she may topple and land the wrong way, causing a crack or break in a bone. Car accidents.\n5. A fracture is a partial or complete break in the bone. A fracture happens when more force is applied to the bone than the bone can absorb. It can happen from overuse injuries, falls, trauma, or a direct hit to the body. A child with a broken bone may have pain, swelling, and trouble moving the injured area.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the age range when the most common type of fracture in toddlers, a toddler's fracture, typically occurs?",
               "answer": "The most common type of fracture in toddlers, a toddler's fracture, typically occurs in children in the early years of walking, specifically from 9 months to 3 years of age.",
               "rationale": "1. A toddler's fracture is a common fracture in the tibia bone (large bone in the lower leg) of children usually younger than 6 years old. It is most common in children in the early years of walking - 9 months to 3 years. A toddler's fracture is a spiral fracture of the tibia without any injury to the fibula (smaller bone in the lower leg ...\n2. This mechanism usually occurs when a toddler trips while walking or running, or when falling from a height. 1, 2 Toddler's fracture was first coined by Dunbar et al in 1964 as a nondisplaced spiral or oblique fracture of the distal third of the tibia extending downward medially. 3 ... The most common strategies were an AK circumferential cast ...\n3. Tags: A fracture is a break in a bone. A toddler's fracture is the name for a broken bone in the leg that typically occurs in children less than 3 years of age. A toddler's fracture is a spiral fracture (break) in the tibia (the shin bone). It is considered a low energy break, and usually presents as a hairline (small) crack without ...\n4. Broken bones or fractures are common in childhood, with up to 40 percent of girls and as many as 50 percent of boys experiencing a fracture. Fracture rate peaks from 11-15 years of age, the time when children have a pubertal growth spurt and the amount of minerals needed to keep bones strong often can't keep up with how fast the bones are ...\n5. Toddler's Fracture. A toddler's fracture is a common fracture in the tibia bone (large bone in the lower leg) of children usually younger than 6 years old. It is most common in children in the early years of walking - 9 months to 3 years. A toddler's fracture is a spiral fracture of the tibia without any injury to the fibula (smaller ...",
               "predicate": null
            }
         ],
         "row": 449,
         "id": 333132358622562649
      },
      {
         "claim": "The proliferative capacity of neural progenitors differs across species.",
         "label": 1,
         "prediction": 1,
         "rationale": "Neural progenitors are cells that are capable of dividing a limited number of times and have the capacity to differentiate into a restricted repertoire of neuronal and glial cell types. Neural progenitors do not have the same proliferative capacity in different species, with humans having a slightly increased capacity compared to chimpanzees. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of neural progenitors?",
               "answer": "Neural progenitors are cells that are capable of dividing a limited number of times and have the capacity to differentiate into a restricted repertoire of neuronal and glial cell types.",
               "rationale": "1. Many types of multipotent stem cells exist and can also be referred to as \"progenitor cells.\". The embryonic layers and each specific tissue, such as the central nervous system (CNS) tissue, develop from cellular divisions of progenitor cells. \"Neural progenitor cells (NPCs)\" are the progenitor cells of the CNS that give rise to many ...\n2. Neural progenitors (green) in olfactory bulb with astrocytes (blue). Example of the pattern of division of a progenitor cell (PC) which results in the production of an intermediate progenitor cell (IPC). Both cells later produce one or two neural cells (N). A progenitor cell is a biological cell that can differentiate into a specific cell type.\n3. Neural progenitor cells (NPCs) are being explored alongside neural stem cells for their potential to treat diseases of or injury to the central nervous system. A deeper understanding of how these cells function on a cellular and molecular basis is needed to progress from early experimental research to therapeutic use.\n4. Definition. Neural progenitors are cells that are capable of dividing a limited number of times and have the capacity to differentiate into a restricted repertoire of neuronal and glial cell types.\n5. Summary. The human brain undergoes rapid development at mid-gestation from a pool of neural stem and progenitor cells (NSPCs) that give rise to the neurons, oligodendrocytes, and astrocytes of the mature brain. Functional study of these cell types has been hampered by a lack of precise purification methods.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do neural progenitors have the same proliferative capacity in different species?",
               "answer": "No, neural progenitors do not have the same proliferative capacity in different species. The evidence indicates that there are subtle differences in cortical progenitors between humans and chimpanzees, with a small set of genes more highly expressed in human apical progenitors pointing to increased proliferative capacity in humans. This suggests that variations",
               "rationale": "1. Variations in neural progenitor cell types and consequently neurogenesis, as well as cell migration, may lead to a distinct functional spatial organization of the cortex in different species. For example, the neural map of orientation selectivity in the visual cortex shows a 'salt-and-pepper' organization in the mouse, whereas it is ...\n2. Consistent with this, the small set of genes more highly expressed in human apical progenitors points to increased proliferative capacity, and the proportion of neurogenic basal progenitors is lower in humans. These subtle differences in cortical progenitors between humans and chimpanzees may have consequences for human neocortex evolution.\n3. Progenitors in the developing mammalian hypothalamus. In the developing mammalian neocortex, neural progenitor types are well established 25,26,27,28,29,30.However, the molecular and cellular ...\n4. Drosophila melanogaster neural stem cells and mammalian cortical progenitors have emerged as the key model systems to study proliferation control in the brain. In D. melanogaster, the segregating ...\n5. Variations in neural progenitor cell types and consequently neurogenesis, as well as cell migration, may lead to a distinct functional spatial organization of the cortex in different species. For example, the neural map of orientation selectivity in the visual cortex shows a 'salt-and-pepper' organization in the mouse, whereas it is ...",
               "predicate": null
            }
         ],
         "row": 450,
         "id": 281094873047113962
      },
      {
         "claim": "The proliferative capacity of progenitors is regulated cell-autonomously.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cell-autonomously refers to a property of cells where they act independently of surrounding cells or tissues, driven by intrinsic mechanisms within individual cells. The proliferative capacity of progenitors is regulated by intrinsic mechanisms within individual cells. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of cell-autonomously?",
               "answer": "Cell-autonomously refers to a property of cells where they act independently of surrounding cells or tissues, driven by intrinsic mechanisms within individual cells rather than being regulated by external signals or influences. In the context of genetics, it describes a trait in multicellular organisms where only genotypically mutant cells exhibit the mutant phenotype, as",
               "rationale": "1. cell autonomous. Cell autonomous refers to a property of cells whereby they act independently of surrounding cells or tissues. Specifically, cell-autonomous processes are driven by intrinsic mechanisms within individual cells rather than being regulated by external signals or influences. Cell-autonomous mechanisms regulate many cellular processes.\n2. The ubiquity of cell-autonomous immunity highlights a biological reality not commonly addressed in human evolutionary studies—that pathogens can mediate the evolution of all body cells and, therefore, all body systems, affecting human evolution in a cell-type-specific fashion. Here we explore these very ancient tactics in light of ...\n3. For example, cell-autonomous genetic effects can be mimicked or masked by cell-nonautonomous effects, and these latter effects are unlikely to be uncovered by standard genetic approaches. Indeed, separating gene effects into autonomous and nonautonomous components can help explain genetic effects that are otherwise confounding. Thus, the CCA ...\n4. cell autonomous. Definition: Search for: Biology Glossary search by EverythingBio.com. A genetic trait in multicellular organisms in which only genotypically mutant cells exhibit the mutant phenotype. Conversely, a nonautonomous trait is one in which genotypically mutant cells cause other cells (regardless of their genotype) to exhibit a mutant ...\n5. The cell is an outstandingly attractive nutrient source for potential parasites and pathogens. All organisms must therefore have developed the ability to defend against such threats early during evolution ().In metazoans, specialized immune cells stimulate innate immunity and, in vertebrates, adaptive immunity; however, most other species rely entirely on intrinsic self-defense for protection ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the proliferative capacity of progenitors regulated by intrinsic mechanisms within individual cells?",
               "answer": "Yes, the proliferative capacity of progenitors is regulated by intrinsic mechanisms within individual cells. Evidence from the snippets indicates that there are intrinsic mechanisms involved in corticogenesis and the regulation of neuronal differentiation from progenitors, suggesting that these processes are controlled at the cellular level.",
               "rationale": "1. Introduction. Cell proliferation can be defined as an increase in total cell number that is achieved through cell growth and division. At the tissue level, proliferation rates are influenced by the size of the initial progenitor pool, the total number of progenitor divisions, the frequency with which progenitors divide and the fraction of proliferative and non-proliferative daughter cells that ...\n2. Drosophila melanogaster neural stem cells and mammalian cortical progenitors have emerged as the key model systems to study proliferation control in the brain. In D. melanogaster, the segregating ...\n3. The loss of the proliferative capacity of RGCs results in a dramatic loss of IPCs, ... Beyond coordinating temporal events within an individual, the differences in the relative timing of developmental events contribute to species-specific features of brain development. ... An intrinsic mechanism of corticogenesis from embryonic stem cells ...\n4. The survival, proliferation, and differentiation of NSCs/NPCs are important for neuronal regeneration and functional recovery because NSCs/NPCs can proliferate and differentiate into functional neural cells. Therefore, a better understanding of the fine regulatory mechanism of neuronal differentiation from progenitors is required.\n5. The cerebral cortex develops from a heterogeneous population of progenitor cells located in proliferative regions some distance from their final sites of residence ( Figure 1 ). The progenitor cells migrate to specific positions in the cerebral wall by radial or tangential dispersion. The generation of cell-type diversity and choice of ...",
               "predicate": null
            }
         ],
         "row": 451,
         "id": 294194457047632823
      },
      {
         "claim": "The recruitment of Wdr5 to its target loci depends on Kat8.",
         "label": 1,
         "prediction": 1,
         "rationale": "KAT8, also known as MOF or hMOF in humans, is a lysine acetyltransferase that plays a crucial role in various cellular functions, including DNA damage repair, apoptosis, and adipocyte development, specifically acetylating histone H4 at lysine 16. The recruitment of Wdr5 to its target loci depends on Kat8. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Kat8?",
               "answer": "KAT8, also known as MOF or hMOF in humans, is a lysine acetyltransferase (KAT) that plays a crucial role in various cellular functions, including DNA damage repair, apoptosis, and adipocyte development. It specifically acetylates histone H4 at lysine 16",
               "rationale": "1. KAT8 is also known as MOF, and in humans hMOF. Given its fundamental role in modulating higher-order chromatin structure, hMOF is involved in many of the steps of the DNA damage response. [7] The human hMOF gene encodes an enzyme that specifically acetylates histone H4 at lysine 16. [7] [8] The depletion of hMOF greatly decreases DNA double ...\n2. KAT8 is a lysine acetyltransferase (KAT) that plays a role in a variety of cellular functions ranging from DNA damage repair to apoptosis. The role of KAT8 in adipocyte development and function has not been studied. Notably, a large genome-wide association study identified KAT8 as part of a novel locus that significantly contributed to body ...\n3. KAT8 (Lysine Acetyltransferase 8) is a Protein Coding gene. Diseases associated with KAT8 include Li-Ghorbani-Weisz-Hubshman Syndrome and Non-Specific Syndromic Intellectual Disability.Among its related pathways are Chromatin organization and Gene expression (Transcription).Gene Ontology (GO) annotations related to this gene include enzyme binding and histone acetyltransferase activity.\n4. KAT8 regulates lipolysis accompanied by enhanced KAT8 acetylation after PA treatment in human CRC cells. KAT8 is essential for cell proliferation and plays a critical role in multiple ...\n5. KAT8-low cancers retain NSL complex function but lose H4K16ac globally (A) Western blot analysis and quantitation of KAT8, H4K16ac, and beta-actin in THP-1, Caki1, SKHEP1, SKMEL28, and SKMEL5 cells. (B) qRT-PCR quantitation of KANSL3 ChIP signal at a subset of NSL complex target TSSs in SKMEL5, SKHEP1, and Caki1 cells. Values are shown as mean ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the recruitment of Wdr5 to its target loci depend on Kat8?",
               "answer": "Yes, the recruitment of Wdr5 to its target loci depends on Kat8. Evidence 1 states that the recruitment of Wdr5 to its target loci, including key pluripotency genes, is dependent on Kat8.",
               "rationale": "1. In support of this notion, the recruitment of Wdr5 to its target loci, including key pluripotency genes, depends on Kat8 25. The fact that the binding of Wdr5 to these loci results in an enrichment of H3K4me3 indicates a hierarchical relationship between these histone modifications 25. Wdr5 has been shown to be required for efficient generation ...\n2. The NSL but not the MSL complex is essential for proliferation of human cells. To determine the functions of KAT8 and its associated complexes in human cells, we used the human acute myeloid leukemia cell line THP-1 as a main model because of the ability to study chromatin changes in both steady state and during cell differentiation into macrophages.\n3. Radzisheuskaya et al. report that histone acetyltransferase KAT8 switches functions depending on associated proteins. It catalyzes promoter-associated H4K5 and H4K8 acetylation as part of the NSL complex, which is required for the activation of essential genes. As part of the MSL complex, it places H4K16 acetylation marking all open chromatin.\n4. WDR5 has a very discrete pattern of localization on chromatin, with narrow ChIP-Seq peaks that suggest focal recruitment to specific locations at target loci. 3,13 Within PSGs, the majority of these peaks occur just downstream of the transcription start site, and they are highly conserved in disparate cell types, 3 suggesting that both the ...\n5. Taken together, we show that the catalytic activity of KAT8 is required for its function and that the NSL complex facilitates transcriptional initiation of its target genes potentially through acetylation of H4K5 and H4K8 at their TSSs. H4K16ac broadly correlates with open chromatin and does not regulate chromatin accessibility in vivo",
               "predicate": null
            }
         ],
         "row": 452,
         "id": 248799529129995180
      },
      {
         "claim": "The relationship between a breast cancer patient's capacity to metabolize tamoxifen and treatment outcome is independent of the patient's genetic make-up.",
         "label": 0,
         "prediction": 0,
         "rationale": "Tamoxifen is a selective estrogen receptor modulator used to treat or prevent hormone receptor-positive breast cancer in both women and men by blocking the effects of estrogen on breast cancer cells. The effectiveness of tamoxifen depends on the patient's genetic make-up, specifically regarding the enzyme cytochrome P450 2D6 (CYP2D6). Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is tamoxifen?",
               "answer": "Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator (SERM) used to treat or prevent hormone receptor-positive breast cancer in both women and men. It works by blocking the effects of estrogen on breast cancer cells, thereby slowing or stopping their growth. Tamox",
               "rationale": "1. Buying Tamoxifen Nolvadex online has become a convenient and accessible option for individuals seeking treatment for hormone receptor-positive breast cancer. Tamoхifen Nolvadex is а рresсription medication used to slow or stop the growth of hоrmone receptor-positive breast cancer cells. It is also used to reduce the risk of breast cancer ...\n2. Tamoxifen is a hormone therapy that treats or prevents hormone receptor-positive breast cancer. It blocks estrogen activity in your breast and may lower the risk of cancer recurrence, but it can also cause menopause-like symptoms, blood clots and other issues.\n3. Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. It is also being studied for other types of cancer. It has been used for Albright syndrome. Tamoxifen is typically taken daily by mouth for five years for breast cancer.. Serious side effects include a small increased risk of uterine cancer ...\n4. Tamoxifen is a medication that blocks the actions of estrogen, a female hormone, and is used to treat or prevent some types of breast cancer. Learn about the warnings, interactions, and how to take tamoxifen safely and effectively.\n5. Tamoxifen is a tablet that blocks the effects of oestrogen on breast cancer cells. It can treat or prevent breast cancer in women and men, and has various side effects.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the effectiveness of tamoxifen depend on the patient's genetic make-up?",
               "answer": "Yes, the effectiveness of tamoxifen does depend on the patient's genetic make-up, specifically regarding the enzyme cytochrome P450 2D6 (CYP2D6). The pharmacological activity of tamoxifen relies on its conversion by CYP2D6 to its active metabolite, endoxifen.",
               "rationale": "1. In this review, the PG of breast cancer therapeutics, including tamoxifen, which is the most widely used therapeutic for the treatment of hormone-dependent breast cancer, is reviewed. The pharmacological activity of tamoxifen depends on its conversion by cytochrome P450 2D6 (CYP2D6) to its abundant active metabolite, endoxifen.\n2. To some extent, this is due to several of its side effects, including an increased risk of endometrial cancer and pulmonary embolism, but these serious side effects are rare. The risks and benefits of tamoxifen chemoprevention should be considered for each patient. Keywords: tamoxifen, breast cancer, women, chemoprevention Go to:\n3. Tamoxifen (brand name Nolvadex) is a selective estrogen receptor modulator (SERM) that is commonly used in both the treatment and prevention of breast cancer. When taken for 5 years, tamoxifen almost halves the rate of breast cancer recurrence in individuals who have had surgery for estrogen-receptor-positive (ER+) breast cancer.\n4. Tamoxifen is also associated with other side effects, including hot flashes (an estrogen antagonist effect), vaginal discharge, menstrual irregularities, sexual dysfunction, and blood clots. Although longer treatment with tamoxifen increases the risk of adverse effects, the reduction in breast cancer mortality associated with longer treatment ...\n5. In this review, the PG of breast cancer therapeutics, including tamoxifen, which is the most widely used therapeutic for the treatment of hormone-dependent breast cancer, is reviewed. The pharmacological activity of tamoxifen depends on its conversion by cytochrome P450 2D6 (CYP2D6) to its abundant active metabolite, endoxifen.",
               "predicate": null
            }
         ],
         "row": 453,
         "id": 133796194480739722
      },
      {
         "claim": "The removal of reactive oxygen species by activated oncogenes contributes to the increased genomic instability of leukaemia cells.",
         "label": 0,
         "prediction": 0,
         "rationale": "Reactive oxygen species (ROS) are highly reactive chemicals formed from diatomic oxygen, water, and hydrogen peroxide, including molecules with at least one oxygen atom and one or more unpaired electrons, such as hydroperoxide and superoxide. Activated oncogenes do not remove reactive oxygen species, but are instead associated with their production. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are reactive oxygen species?",
               "answer": "Reactive oxygen species (ROS) are highly reactive chemicals formed from diatomic oxygen (O2), water, and hydrogen peroxide. They include molecules capable of independent existence that contain at least one oxygen atom and one or more unpaired electrons. Prominent examples of ROS are hydroperoxide (O2H), superoxide (",
               "rationale": "1. In chemistry and biology, reactive oxygen species ( ROS) are highly reactive chemicals formed from diatomic oxygen ( O2 ), water, and hydrogen peroxide. Some prominent ROS are hydroperoxide (O 2 H), superoxide (O 2- ), [1] hydroxyl radical (OH. ), and singlet oxygen. [2] ROS are pervasive because they are readily produced from O 2, which is ...\n2. Thus, in ROS biology and medicine, the term singlet oxygen, if not specified, usually refers to the 1 Δ g state. FIGURE 1. Excitation and univalent reduction of molecular oxygen to yield reactive oxygen species (ROS) in biological systems. As indicated, ground state molecular oxygen (O 2) is a free radical (actually a di-radical) because it ...\n3. Reactive oxygen species (ROS) are molecules capable of independent existence, containing at least one oxygen atom and one or more unpaired electrons. This group includes oxygen free radicals, e.g. superoxide anion radical, hydroxyl radical, hydroperoxyl radical, singlet oxygen, as well as free nitro …\n4. Oxygen in the atmosphere is a crucial component for life-sustaining aerobic respiration in humans. Approximately 95% of oxygen is consumed as energy and ultimately becomes water; however, the remaining 5% produces metabolites called activated oxygen or reactive oxygen species (ROS), which are extremely reactive.\n5. Reactive oxygen species, in particular hydroxyl and peroxyl radicals, hydrogen peroxide and superoxide radical anion, have long been implicated in oxidative damage inflicted on fatty acids, DNA and proteins as well as other cellular components. 9 ROS overproduction is associated with numerous disorders. 10 Oxidative stress caused by the imbalance between excessive formation of ROS and limited ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do activated oncogenes remove reactive oxygen species?",
               "answer": "No, activated oncogenes do not remove reactive oxygen species (ROS). Instead, the evidence suggests that oncogene-induced ROS can act as signaling molecules that mediate proliferative cues, but they can also cause DNA damage and lead to proliferative arrest. This indicates that activated oncogenes are associated with the production of",
               "rationale": "1. However, the expression of an activated oncogene in normal human cells does not lead to their transformation, but to a permanent cell cycle arrest known as cellular senescence. 1,2 Hence, oncogene-induced senescence ... The role of oncogene-induced reactive oxygen species (ROS) production in cancer development has been a controversial subject. ...\n2. In a biological context, reactive oxygen species (ROS) are formed as a natural by-product of cellular aerobic metabolism. ... Neutrophils are highly mobile and rapidly congregate at the focus of infection, attracted by cytokines expressed by activated endothelium, mast cells and macrophages. They recruit and activate other cells of the immune ...\n3. Oncogene-induced reactive oxygen species (ROS) have been proposed to be signaling molecules that mediate proliferative cues. However, ROS may also cause DNA damage and proliferative arrest. How ...\n4. Ogrunc, M. et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 21 , 998-1012 (2014).\n5. Oncogene-Induced Reactive Oxygen Species and Genome Instability: Hijacking the Good for Hyperproliferation Oncogenes are mutated forms of cellu-lar genes that are responsible for driving rampant cellular proliferation. However, the expression of an activated oncogene in normal human cells does not lead to their transformation, but to a ...",
               "predicate": null
            }
         ],
         "row": 454,
         "id": 744217341081889122
      },
      {
         "claim": "The repeat-variable diresidue (RVD) in the loop of Transcription-Activator Like (TAL) effectors specifies the nucleotides-amino acid contact at the target promoter element.",
         "label": 1,
         "prediction": 1,
         "rationale": "A Transcription-Activator Like (TAL) effector is a protein secreted by certain bacteria that aids in the infection of plant species by binding to specific DNA sequences in the host's genome and activating the expression of host genes. The repeat-variable diresidue (RVD) in the loop of Transcription-Activator Like (TAL) effectors mediates the recognition of specific nucleotides in DNA. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is a Transcription-Activator Like (TAL) effector?",
               "answer": "A Transcription-Activator Like (TAL) effector is a protein secreted by certain bacteria, particularly plant pathogenic Xanthomonas species, that aids in the infection of plant species. TAL effectors bind to specific DNA sequences in the host's genome and activate the expression of host genes, facilitating the bacterial infection",
               "rationale": "1. TAL ( transcription activator-like) effectors (often referred to as TALEs, but not to be confused with the t hree a mino acid l oop e xtension homeobox class of proteins) are proteins secreted by some β- and γ-proteobacteria. [1] Most of these are Xanthomonads. Plant pathogenic Xanthomonas bacteria are especially known for TALEs, produced via ...\n2. Transcription activator-like effector nucleases (TALEN) are restriction enzymes that can be engineered to cut specific sequences of DNA. They are made by fusing a TAL effector DNA-binding domain to a DNA cleavage domain (a nuclease which cuts DNA strands). Transcription activator-like effectors (TALEs) can be engineered to bind to practically any desired DNA sequence, so when combined with a ...\n3. Transcription activator-like effectors (TALEs) are proteins secreted by Xanthomonas bacteria to aid the infection of plant species. TALEs assist infections by binding to specific DNA sequences and activating the expression of host genes. Recent results show that TALE proteins consist of a central repeat domain, which determines the DNA ...\n4. Preface. Engineered nucleases enable the targeted alteration of any DNA sequence in a wide range of cell types and organisms. The newly-developed transcription activator-like effector nucleases ( TALEN s) comprise a non-specific DNA-cleaving nuclease fused to a DNA-binding domain that can be easily engineered so that TALENs can target ...\n5. Transcription Activator-Like Effector Nucleases (TALENs) are artificial restriction enzymes that have the ability to cut DNA at the point of contact with a series of nucleotides.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of the repeat-variable diresidue (RVD) in the loop of Transcription-Activator Like (TAL) effectors?",
               "answer": "The repeat-variable diresidue (RVD) in the loop of Transcription-Activator Like (TAL) effectors functions to mediate the recognition of specific nucleotides in DNA. The RVD consists of two highly variable amino acids at specific positions within the repeated sequence of the TAL effector, and these",
               "rationale": "1. TAL effectors are proteins that are secreted by Xanthomonas bacteria via their type III secretion system when they infect plants. The DNA binding domain contains a repeated highly conserved 33-34 amino acid sequence with divergent 12th and 13th amino acids. These two positions, referred to as the Repeat Variable Diresidue (RVD), are highly variable and show a strong correlation with specific ...\n2. Abstract. TAL effectors are proteins secreted by bacterial pathogens into plant cells, where they enter the nucleus and activate expression of individual genes. TAL effectors display a modular architecture that includes a central DNA-binding region comprising a tandem array of nearly identical repeats that are almost all 34 residues long.\n3. Abstract. Xanthomonas phytopathogenic bacteria produce unique transcription activator-like effector (TALE) proteins that recognize and activate specific plant promoters through a set of tandem repeats. A unique TALE-DNA-binding code uses two polymorphic amino acids in each repeat to mediate recognition of specific nucleotides.\n4. TAL ( transcription activator-like) effectors (often referred to as TALEs, but not to be confused with the t hree a mino acid l oop e xtension homeobox class of proteins) are proteins secreted by some β- and γ-proteobacteria. [1] Most of these are Xanthomonads. Plant pathogenic Xanthomonas bacteria are especially known for TALEs, produced via ...\n5. TAL (transcription activator-like) effectors are transcriptional activators injected into plant cells by plant pathogenic members of the ... These two positions are known as the repeat variable diresidue (RVD). ... Probing the diversity and functions of TAL effector activated S and R genes is essential to expand our knowledge of disease and ...",
               "predicate": null
            }
         ],
         "row": 455,
         "id": 857924257512598461
      },
      {
         "claim": "The risk of breast cancer among parous women decreases with placental weight of pregnancies.",
         "label": 0,
         "prediction": 0,
         "rationale": "Increasing placental weight may be associated with an increased risk of breast cancer. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between placental weight and breast cancer risk?",
               "answer": "The relationship between placental weight and breast cancer risk is suggested to be positive, as indicated by the hypothesis that increasing placental weight, which serves as an indirect marker of exposure to elevated hormone levels during pregnancy, may be associated with an increased risk of breast cancer. However, the specific effects of placental size on breast",
               "rationale": "1. The link between excess weight and increased cancer risk is well established. Being overweight or obese increases your risk for 12 cancers, including uterine, kidney, liver and colorectal cancer. When it comes to breast cancer, the story isn't so clear. Being overweight does affect your breast cancer risk. But that effect is different before ...\n2. Background. The hypothesis that the risk of developing breast cancer in adulthood may be increased by factors that first act in utero—in particular by fetal exposure to higher levels of maternal estrogen—was first proposed in 1990 [].Since then, several observational studies have examined this hypothesis by using birth weight as an index of the effects of intrauterine hormones on fetal ...\n3. Abstract. A growing body of evidence indicates that reproductive history influences survival in breast cancer, especially among women diagnosed during or shortly after a pregnancy. However, little is known about the underlying mechanisms. We hypothesized that increasing placental weight, as an indirect marker of exposure to elevated hormone levels during pregnancy, would be associated with ...\n4. To the Editor: Dr Cnattingius and colleagues1 describe a positive association between placental weight and maternal risk of breast cancer. However, they did not specifically address how placental size affects the risk of breast cancer compared with nulliparous women. In the absence of this...\n5. Women who gain weight in adulthood have an increased risk of breast cancer after menopause [ 88-92 ]. A meta-analysis that combined the results from 16 studies found that for every 11 pounds a woman gained after age 18, the risk of breast cancer after menopause increased 7% [ 76 ]. Weight gain in adulthood and a possible link to the risk of ...",
               "predicate": null
            }
         ],
         "row": 456,
         "id": 320677805059959016
      },
      {
         "claim": "The risk of cancer rises with level of alcohol consumption.",
         "label": 1,
         "prediction": 1,
         "rationale": "There is a link between alcohol consumption and cancer risk, with evidence indicating that alcohol drinking can cause several types of cancer. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is there a link between alcohol consumption and cancer risk?",
               "answer": "Yes, there is a link between alcohol consumption and cancer risk. The evidence indicates that alcohol drinking can cause several types of cancer, with a strong scientific consensus supporting this connection. Studies have shown that higher alcohol intake is associated with an increased risk of developing various cancers, including stomach, pancreatic, and prostate cancers. Additionally,",
               "rationale": "1. There is a strong scientific consensus that alcohol drinking can cause several types of cancer (1, 2).In its Report on Carcinogens, the National Toxicology Program of the US Department of Health and Human Services lists consumption of alcoholic beverages as a known human carcinogen.. The evidence indicates that the more alcohol a person drinks—particularly the more alcohol a person drinks ...\n2. Many studies have found a link between alcohol use and the risk of developing certain cancers. ... alcohol intake could also affect the risk of developing a new cancer. There are some cases during cancer treatment in which alcohol clearly should be avoided. For example, alcohol - even in very small amounts - can irritate mouth sores caused ...\n3. Some studies show that drinking three or more alcoholic drinks per day increases the risk of stomach and pancreatic cancers. Drinking alcohol may also increase prostate cancer risk. All alcoholic drinks—including red and white wine, beer, and liquor—are linked with cancer. Drinking less alcohol is better for your health than drinking more.\n4. There are many reasons why alcohol can increase your cancer risk. These include: Acetaldehyde: Alcoholic beverages contain ethanol. When the body breaks down ethanol, it becomes acetaldehyde, which Bevers says is a known carcinogen. \"This compound damages DNA and stops our cells from repairing the damage.\n5. The public is largely unaware of the link between alcohol consumption and increased cancer risk. Mixed messages from experts may have added to the confusion. There is strong and consistent evidence that drinking alcohol increases your risk of developing a cancer, based on a growing body of research.",
               "predicate": null
            }
         ],
         "row": 457,
         "id": 333934012998239253
      },
      {
         "claim": "The risk of female prisoners harming themselves is ten times that of male prisoners.",
         "label": 1,
         "prediction": 1,
         "rationale": "Male prisoners face a significant risk of harming themselves, with an estimated annual prevalence of self-harm at 5-6%. The risk of female prisoners harming themselves is significantly high, with an estimated annual prevalence of self-harm ranging from 20% to 24%. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the risk of male prisoners harming themselves?",
               "answer": "The risk of male prisoners harming themselves is significant, with an estimated annual prevalence of self-harm at 5-6%. Additionally, the overall rates of self-harm in prisons have been rising, particularly among older adult males. This indicates that male prisoners face a considerable risk of self-harm behavior while incarcerated.",
               "rationale": "1. More than 11 million individuals are imprisoned worldwide. 1 People who pass through prisons often have poor health profiles, including high frequencies of self-harm. 2, 3, 4 Self-harm is a leading cause of morbidity in prisoners; the annual prevalence of self-harm in prison has been estimated to be 5-6% in men and 20-24% in women, 5 which ...\n2. Research has consistently shown that the prevalence of poor mental health among prisoners is considerably higher than that in the community. Mental health services in prisons cite several other vulnerabilities, such as substance misuse problems and poor physical health, and report high rates of self-harm behaviour.1 In prisons, little is known about the underlying mechanisms for self-harm ...\n3. Levels of self-harm in prison. The incidence of self-harm in prisons is rising, particularly among older (over the age of 30) adult males. (MoJ Safety in Custody statistics, 2015). Since 2011, we have seen a decline in the rates of self-harm among women, while self-harm among men has risen.\n4. Self-harm is a prevalent and dangerous occurrence within correctional settings. 1 Inmates in jails and prisons attempt to harm themselves in many ways, resulting in outcomes ranging from trivial to fatal. Suicide is a leading cause of death among the incarcerated; however, suicide and suicide attempt represent a small share of all acts of self-harm. 2 The motivations of inmates who harm ...\n5. Introduction. Self-harm represents a substantial burden of morbidity in prisons. In England and Wales, rates of self-harm have increased sharply in recent years from 264 per 1,000 prisoners in 2004 to 629 per 1,000 prisoners in 2018, equivalent to 52,814 incidents [].An estimated 5-6% of male prisoners self-harm every year, with annual rates of 20-24% observed in female prisoners [].",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the risk of female prisoners harming themselves?",
               "answer": "The risk of female prisoners harming themselves is significantly high, with an estimated annual prevalence of self-harm ranging from 20% to 24%. This indicates that a substantial portion of female prisoners engage in self-harming behavior. Additionally, among those who self-harm, approximately 6-7% of incidents are severe",
               "rationale": "1. More than 11 million individuals are imprisoned worldwide. 1 People who pass through prisons often have poor health profiles, including high frequencies of self-harm. 2, 3, 4 Self-harm is a leading cause of morbidity in prisoners; the annual prevalence of self-harm in prison has been estimated to be 5-6% in men and 20-24% in women, 5 which ...\n2. Research has consistently shown that the prevalence of poor mental health among prisoners is considerably higher than that in the community. Mental health services in prisons cite several other vulnerabilities, such as substance misuse problems and poor physical health, and report high rates of self-harm behaviour.1 In prisons, little is known about the underlying mechanisms for self-harm ...\n3. The Oxford research team looked at self-harm incidents in all prisons in England and Wales between 2004 and 2009. It found that 5% to 6% of male prisoners and 20% to 24% of female prisoners ...\n4. An estimated 5-6% of male prisoners self-harm every year, with annual rates of 20-24% observed in female prisoners . Of those who self-harm, around 6-7% of incidents are severe enough to require transfer to external hospitals . Among the adverse outcomes following self-harm, the most serious is completed suicide inside custody and on release.\n5. Foston Hall in Derbyshire is the first women's prison to be given a \"poor\" rating for safety by inspectors. There were 1,750 incidents of self-harm over one year, and prisoners made about 1,000 ...",
               "predicate": null
            }
         ],
         "row": 458,
         "id": 122885525290230323
      },
      {
         "claim": "The tissue surrounding the granuloma in an immune cell induces an anti-inflammatory immune response.",
         "label": 1,
         "prediction": 0,
         "rationale": "A granuloma is a cluster of immune cells, primarily macrophages, that forms in response to a persistent inflammatory stimulus or infection, attempting to isolate and contain foreign substances. The tissue surrounding the granuloma facilitates the immune response by aiding in the trafficking of dendritic cells to the lymph nodes and promoting the expansion of T cells specific for granuloma antigens. The tissue surrounding the granuloma does not induce an anti-inflammatory immune response. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is a granuloma in an immune cell?",
               "answer": "A granuloma is a cluster or aggregation of immune cells, primarily macrophages, that forms in response to a persistent inflammatory stimulus or infection. It occurs when the immune system attempts to isolate and contain foreign substances that it is unable to eliminate, such as infectious organisms or foreign materials. Granulomas are characterized by the compact",
               "rationale": "1. A granuloma is a cluster of immune cells in your body. They form around an infection or foreign object. They can be a symptom of a chronic condition or infection. Locations: ... Macrophages are special immune cells that \"swallow\" things that don't belong in your body and destroy them. If they aren't able to destroy something, it might ...\n2. Granulomas form when the immune system responds to a causative agent, eventually leading macrophage transformation to epithelioid cells, which may bind tightly together, forming the granuloma. Granulomas are typically diagnosed by a medical evaluation, imaging, biopsy, and blood tests.\n3. A granuloma is a focal aggregate of immune cells that forms in response to a persistent inflammatory stimulus. It characteristically demonstrates the compact organization of mature macrophages, which may or may not be associated with other inflammatory cell types. Granulomas are evolutionarily ancient structures found throughout both vertebrate and invertebrate species and are likely to have ...\n4. A granuloma is an aggregation of macrophages (along with other cells) that forms in response to chronic inflammation.This occurs when the immune system attempts to isolate foreign substances that it is otherwise unable to eliminate. Such substances include infectious organisms including bacteria and fungi, as well as other materials such as foreign objects, keratin, and suture fragments.\n5. Granulomas form when immune cells clump together and create tiny nodules at the site of the infection or inflammation. A granuloma is the body's way of: containing a bacterial, viral or fungal infection, to keep it from spreading (also called a caseating granuloma);",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of the tissue surrounding the granuloma in an immune cell?",
               "answer": "The tissue surrounding the granuloma plays a role in facilitating the immune response, particularly by aiding in the trafficking of dendritic cells (DCs) to the lymph nodes and promoting the expansion of T cells that are specific for granuloma antigens. The increased lymphatic vessels around the granuloma enhance this process, indicating that",
               "rationale": "1. Granulomas on your skin are hard lumps that can be lighter or darker than the surrounding skin, often in shades of pink or purple. Sometimes, they're painful to touch. Under a microscope, granulomas contain cells that are tightly packed together, so it can be hard to tell where the edges of one cell ends and another begins.\n2. A granuloma is a focal aggregate of immune cells that forms in response to a persistent inflammatory stimulus. It characteristically demonstrates the compact organization of mature macrophages, which may or may not be associated with other inflammatory cell types. Granulomas are evolutionarily ancient structures found throughout both vertebrate and invertebrate species and are likely to have ...\n3. Granulomas in patients with Crohn's disease there is an absence of this halo of lymphocytes and an increase in neutrophils and sclerosis in the surrounding tissue (Janssen et al., 2012). Summary Our understanding of the complex mechanisms that underlie granuloma formation and maintenance is growing, particularly the role of the innate immune ...\n4. Chronic granulomatous (gran-u-LOM-uh-tus) disease (CGD) is an inherited disorder that occurs when a type of white blood cell, called a phagocyte, doesn't work properly. Phagocytes usually help your body fight infections. When they don't work as they should, phagocytes can't protect your body from bacterial and fungal infections.\n5. Around granulomas there is a finger like outgrowth from the neighboring lymphoid vessels(Fig. 2b). The increased lymphatics help DCs to traffic in to the lymph node and facilitate the expansion of T cells specific for granuloma antigens. Inhibitors of lymphangiogenesis restrict T cell response to granuloma antigens (Harding et al. 2015b).",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the tissue surrounding the granuloma induce an anti-inflammatory immune response?",
               "answer": "The provided evidence does not explicitly state that the tissue surrounding the granuloma induces an anti-inflammatory immune response. Instead, it focuses on the characteristics and functions of granulomas, which are primarily associated with a pro-inflammatory response to persistent irritants, infectious agents, and foreign materials. Granulomas are described as organized immune structures",
               "rationale": "1. Granuloma lesions are highly dynamic and depend on continuous cell replacement. This feature provides new therapeutic approaches to treat granulomatous diseases. Keywords: granuloma, cell traffic, VEGF, dendritic cells. Irritants, infectious agents and foreign materials can induce an innate and cognate immune response.\n2. The granuloma then secretes pro-inflammatory cytokines and presents antigens to the adaptive immune system resulting in T cell activation. This response drives a chronic inflammatory condition which is the hallmark of Crohn's disease and the focus of the majority of current therapeutic agents.\n3. Granuloma in TB and sarcoidosis: composition and structure. A granuloma is an organized immune entity, comprising macrophages, lymphocytes, and, to a lesser extent, monocytes, neutrophils, and fibroblasts. It is a reaction to an intracellular pathogen or substance that macrophages have failed to destroy.\n4. Granulomas are organized aggregates of macrophages, often with characteristic morphological changes, and other immune cells. These evolutionarily ancient structures form in response to persistent particulate stimuli-infectious or noninfectious-that individual macrophages cannot eradicate. Granulomas evolved as protective responses to destroy or ...\n5. Persistent irritants that are resistant to innate and cognate immunity induce granulomas. These macrophage-dominated lesions that partially isolate the healthy tissue from the irritant and the irritant induced inflammation. Particles, toxins, autoantigens and infectious agents can induce granulomas. The corresponding lesions can be protective ...",
               "predicate": null
            }
         ],
         "row": 459,
         "id": 130186691290882750
      },
      {
         "claim": "Therapeutics receiving accelerated approval encounter a lower frequency of post-marketing safety events",
         "label": 0,
         "prediction": 0,
         "rationale": "Accelerated approval is a program that allows for the earlier approval of drugs that treat serious conditions and fulfill an unmet medical need, based on the use of surrogate endpoints. Drugs with accelerated approval do not have fewer post-marketing safety events, and may actually have greater safety risks and higher rates of post-market safety events. The frequency of post-marketing safety events for therapeutics that receive standard approval is not specified in the provided evidence. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is accelerated approval?",
               "answer": "Accelerated approval is a program instituted by the FDA that allows for the earlier approval of drugs that treat serious conditions and fulfill an unmet medical need, based on the use of surrogate endpoints. This pathway enables faster access to new therapies, particularly in oncology, by relying on markers that are believed to predict clinical benefit rather than waiting",
               "rationale": "1. The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint. A surrogate ...\n2. The United States Food and Drug Administration (FDA) initiated the FDA Accelerated Approval Program in 1992 to allow faster approval of drugs for serious conditions that fill an unmet medical need. The faster approval relies on use of surrogate endpoints. [1] Drug approval typically requires clinical trials with endpoints that demonstrate a ...\n3. Accelerated Approval; Fast Track; Because each of these approaches implies speed, there can be confusion about the specific meaning of each and the distinctions among them. ...\n4. A surrogate endpoint used for accelerated approval is a marker - a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit, but is ...\n5. The FDA Accelerated Approval pathway, which has been pivotal in enabling early access to new oncology drugs over the past three decades, has recently come under increased scrutiny. New draft ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do drugs with accelerated approval have fewer post-marketing safety events?",
               "answer": "No, drugs with accelerated approval do not have fewer post-marketing safety events. In fact, the evidence suggests that drugs approved via expedited pathways, such as accelerated approval, may have greater safety risks and higher rates of post-market safety events. Studies indicate that postmarket safety events were more frequent among drugs receiving accelerated approval,",
               "rationale": "1. Drugs approved via expedited pathways may have greater safety risks to patients. 6,7 In a recent evaluation of 222 novel therapeutic agents approved by the FDA in 2001-2010, postmarket safety events were more frequent among drugs receiving accelerated approval. 7 There is also uncertainty about whether observed effects on surrogate measures ...\n2. Our finding that near-regulatory deadline approvals had higher rates of postmarket safety events is consistent with an earlier study of drugs approved between 1993 and 2004 4 (although the effect we observed was smaller in magnitude) and with prior research demonstrating that safety concerns are a frequent cause of delayed approval. 16 Our ...\n3. Postmarketing studies or clinical trials to demonstrate clinical benefit for drugs approved under the accelerated approval requirements in 21 CFR 314.510 and 21 CFR 601.41\n4. But now, many of them have more than one accelerated approval use, especially if the drug treats cancer. For example, Keytruda, a Merck drug, has more than 30 accelerated approvals.\n5. Near regulatory deadline approval and post-market safety events. There were 44 medicines (27.3%) that were approved before and 117 medicines (72.7%) approved after the 210 days regulatory deadline. ... including approval via the accelerated assessment procedure (0% vs. 31.8%; ... DHPCs represent the best proxy available for post-market drug ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the frequency of post-marketing safety events for therapeutics that receive standard approval?",
               "answer": "The provided evidence does not specify the frequency of post-marketing safety events specifically for therapeutics that receive standard approval. It mentions that 32% of all novel therapeutics approved by the FDA from 2001 through 2010 were affected by postmarket safety events, but it does not differentiate between those that received standard",
               "rationale": "1. This analysis characterizes the frequency of postmarket safety events among all novel therapeutics approved by the FDA from 2001 through 2010 and assesses the associations between 7 characteristics, which describe the novel therapeutics and the regulatory approval process, and postmarket safety events.\n2. Among 222 novel therapeutics approved by the FDA from 2001 through 2010, 32% were affected by a postmarket safety event. Biologics, psychiatric therapeutics, and accelerated and near-regulatory deadline approval were statistically significantly associated with higher rates of events, highlighting th …\n3. Post-market safety events affected 71 (32%) of novel agents, which resulted in 3 withdrawals. The median time to first post-market safety event was 4.2 years (IQR, 2.5-6.0 years). There were 61 ...\n4. IMPORTANCE Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics. These safety events can change how novel therapeutics are used in clinical practice and inform patient and clinician decision making.\n5. Safety & Efficacy. Approval. Postmarket. Phase 4 Safety Surveillance Postmarket Studies . 8 ... - Increased severity or frequency of known reactions - Potential for new \"at-risk\" population. 9 ... Adverse events reported voluntarily by consumers/patients, healthcare providers,",
               "predicate": null
            }
         ],
         "row": 460,
         "id": 338495482802122230
      },
      {
         "claim": "There is a positive correlation between hip fractures and statin use.",
         "label": 0,
         "prediction": 0,
         "rationale": "Statin use appears to have a protective relationship with hip fractures, with longer durations of therapy associated with a reduced risk of major osteoporotic fractures, including hip fractures. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between hip fractures and statin use?",
               "answer": "The relationship between hip fractures and statin use appears to be protective, as evidenced by several findings. A dose-dependent relationship indicates that longer durations of statin therapy are associated with a reduced risk of major osteoporotic fractures, including hip fractures. Specifically, a 1-year increase in statin therapy duration is linked to",
               "rationale": "1. A dose-dependent relationship between statin use and the reduced risk of major osteoporotic fractures was observed. The risk of osteoporotic fracture was decreased by 3% with a 1-year increase in the duration of statin therapy (aOR, 0.97; 95% CI, 0.96-0.99). ... Haque R, Cheetham TC, Kawatkar AA, et al. Statins and hip fracture risk in men: a ...\n2. We did not find any significant difference in statin intake between men and women in the control group. In the case group, those who did not use statins were more likely to undergo a medial hip fracture (28.5% vs 16.1%). Patients from case group also presented a greater mortality (27.9% vs 19.35%) and an higher percentage of previous hip ...\n3. Globally, fracture is known as one of the most frequent disease. Over the past decade, the correlation between statins use and fracture risk, have been extensively investigated, with conflicting results. We conducted the present meta-analysis to explore the correlations between statins use and fracture risk.\n4. The association between adherent use of statins and hip fracture did not change when the outcome was defined as the fracture caused by fall on the same level, or on the snow or ice (Table 5). Using the above end point definition, the HR was 0.69 (0.56-0.86) in the statin versus hypertension cohort comparison and 0.68 (0.52-0.88) in the ...\n5. Purpose: To estimate the association between hydroxymethylglutaryl-CoA inhibitor (statin) use and hip fracture. Methods: We conducted a population-based case-control study. Cases were 6774 male enrollees in a large managed care organization, aged 45 or more years, with an incident hip fracture from 1997 to 2006.",
               "predicate": null
            }
         ],
         "row": 461,
         "id": 304573112557853197
      },
      {
         "claim": "There is a relation between Erythromycin use and hypertrophic pyloric stenosis.",
         "label": 1,
         "prediction": 1,
         "rationale": "Hypertrophic pyloric stenosis is an uncommon condition in infants characterized by the abnormal thickening of the pylorus muscles at the end of the stomach, leading to a narrowing of the pylorus and gastric outlet obstruction. Erythromycin is associated with an increased risk of hypertrophic pyloric stenosis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hypertrophic pyloric stenosis?",
               "answer": "Hypertrophic pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), is an uncommon condition in infants characterized by the abnormal thickening of the pylorus muscles at the end of the stomach. This thickening leads to a narrowing of the pylorus, resulting in gastric outlet obstruction",
               "rationale": "1. Symptoms. Symptoms of pyloric stenosis usually appear within 3 to 5 weeks after birth. Pyloric stenosis is rare in babies older than 3 months. Symptoms include: Vomiting after feeding. The baby may vomit forcefully, ejecting breast milk or formula up to several feet away. This is known as projectile vomiting.\n2. Pyloric stenosis is a condition that affects your infant's pylorus, the muscle at the end of the stomach leading to the small intestine. When their pylorus thickens and narrows, food can't pass through. Pyloric stenosis symptoms include forceful vomiting, which may cause dehydration and malnourishment. Surgery can repair the problem.\n3. Pyloric stenosis is a narrowing of the pylorus, the opening from the stomach, into the small intestine. This type of blockage is also referred to as a gastric outlet obstruction. Normally, food passes easily from the stomach into the duodenum through a valve called the pylorus. In pyloric stenosis, the muscles of the pylorus are abnormally ...\n4. Pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), is an uncommon condition in infants characterized by abnormal thickening of the pylorus muscles in the stomach leading to gastric outlet obstruction. Clinically infants are well at birth. Then, at 3 to 6 weeks of age, the infants present with \"projectile\" vomiting, potentially leading to dehydration and weight loss.[1]\n5. Treatment. Surgery is needed to treat pyloric stenosis. The procedure, called a pyloromyotomy, is often scheduled on the same day as the diagnosis. If your baby is dehydrated or has an electrolyte imbalance, your baby receives fluids [fluid replacement] before surgery. In pyloromyotomy, the surgeon cuts only through the outside layer of the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Erythromycin associated with an increased risk of hypertrophic pyloric stenosis?",
               "answer": "Yes, erythromycin is associated with an increased risk of hypertrophic pyloric stenosis. The evidence indicates that postnatal exposure to erythromycin, particularly within the first 14 days after birth, significantly increases the risk of developing this condition. Specifically, exposure between 3-13 days of life is linked to nearly",
               "rationale": "1. Postnatal exposure to erythromycin has also been associated with an increased risk for the development of pyloric stenosis. Other risk factors include bottle feeding, preterm birth, cesarean section delivery, and first-born infants (30% to 40% of cases). If the mother was a heavy smoker during pregnancy, the risk of hypertrophic pyloric ...\n2. The studies show that the risk of infantile hypertrophic pyloric stenosis following exposure to erythromycin is highest in the first 14 days after birth. Available data suggests an incidence of 2. ...\n3. Exposure to erythromycin between 3-13 days of life was associated with nearly an 8-fold increased risk of pyloric stenosis (adjusted incident rate ratio 7.88; 95% CI, 1.97-31.57). No increased risk of pyloric stenosis was noted in infants exposed after 13 days of life, or in infants...\n4. Introduction. Infantile hypertrophic pyloric stenosis (IHPS) affects 1.9 of every 1000 live births [] making the condition the most common cause of surgical intervention in the first 6 months of life [].IHPS is characterised by hypertrophy of the pylorus resulting in gastric outlet obstruction, leading to the infant presenting with projectile vomiting and severe dehydration.\n5. The causes of pyloric stenosis are unknown, but genetic and environmental factors might play a role. Pyloric stenosis usually isn't present at birth and probably develops afterward. Risk factors. Risk factors for pyloric stenosis include: Sex. Pyloric stenosis is seen more often in boys, especially firstborn children, than in girls. Race and ...",
               "predicate": null
            }
         ],
         "row": 462,
         "id": 999337902692974500
      },
      {
         "claim": "There is no increased risk of hypospadias with clomiphene.",
         "label": 0,
         "prediction": 1,
         "rationale": "Hypospadias is a congenital birth defect in which the urethral opening is located on the underside of the penis instead of at the tip. Clomiphene is not associated with an increased risk of hypospadias. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hypospadias?",
               "answer": "Hypospadias is a congenital birth defect in which the urethral opening is located on the underside of the penis instead of at the tip. This condition can lead to issues with urination, sexual intercourse, and fertility. It occurs due to abnormal development of the urethra and foreskin during pregnancy, specifically",
               "rationale": "1. Hypospadias is a birth defect in which the urethra opening is on the underside of the penis instead of the tip. It can cause abnormal urination and reproduction, and may be genetic or related to hormones or substances. Learn more about diagnosis and treatment options.\n2. Hypospadias is a congenital condition where the urethra and foreskin don't develop properly in a baby's penis. It can cause problems with peeing, sexual intercourse and fertility. Learn about the types, causes, diagnosis and treatment of hypospadias.\n3. Hypospadias is a condition where the urethral opening is not at the tip of the penis, but along the underside. It can cause problems with urination and appearance, and can be corrected with surgery. Learn more about the symptoms, diagnosis and treatment options for hypospadias.\n4. Hypospadias is when the opening of the urethra is not located at the tip of the penis. The urethra is the tube that carries urine from the bladder to the outside of the body. In boys with hypospadias, the urethra forms abnormally during weeks 8-14 of pregnancy. The abnormal opening can form anywhere from just below the end of the penis to the ...\n5. Hypospadias is a condition that affects the penis, causing the urethral opening to be lower than normal and the penis to be curved or incompletely foreskinned. Learn about the possible causes, diagnosis and treatment options for hypospadias at Children's Hospital of Philadelphia.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is clomiphene associated with an increased risk of hypospadias?",
               "answer": "Based on the provided evidence, clomiphene is not associated with an increased risk of hypospadias. The study mentioned indicates an odds ratio of 0.48 for developing hypospadias after exposure to clomiphene, suggesting a lower risk rather than an increased one. Additionally, the evidence notes",
               "rationale": "1. Clomifene was not associated with any increased risk of hypospadias. Several factors should be taken into account when interpreting this study. The full and independent registration of births, birth outcome, and prescriptions prevented selection bias and some types of information bias as this study was based on routinely recorded data.\n2. DES is associated with vaginal cancer and infertility among daughters and with hypospadias among second-generation male offspring. Because clomiphene has a long half-life and metabolites have been found in feces up to 6 weeks after administration, fetal exposure is possible if the mother took this drug prior to becoming pregnant.\n3. But this latest study calculated an odds ratio of developing hypospadias after exposure to clomiphene of only 0.48 (95% CI; 0.15-1.54). Restricting exposure to clomiphene to the first trimester and up to 30 days prior to conception did not alter the result substantially.\n4. Fertility Agents, Female. Gonadotropins. Clomiphene. Progesterone. Metformin. Infertility per se is a risk factor for congenital anomalies. Repeated clomiphene treatment might be associated with a slightly higher risk of hypospadias and neural tube defect. However, the overall increased risk related to various fertility drugs is only 1% to 2%.\n5. Hypospadias is associated with more psychiatric symptoms than controls in adult age (P < 0.05); The most marked difference is depressiveness (15/34 in hypospadias group and 5/36 in the control); more stress reactions are found in the hypospadias patients (P < 0.01).",
               "predicate": null
            }
         ],
         "row": 463,
         "id": 414529051116204376
      },
      {
         "claim": "There is no known interaction between Pioneer factor OCT3/4 and major chromatin remodeling factors.",
         "label": 0,
         "prediction": 1,
         "rationale": "The major chromatin remodeling factors are four families of ATP-dependent chromatin remodeling complexes: SWI/SNF, ISWI, INO80/SWR1, and NuRD. It cannot be determined whether OCT3/4 interacts with SWI/SNF, ISWI, INO80/SWR1, or NuRD based on the provided information. There are no known interactions between OCT3/4 and other chromatin remodeling factors besides SWI/SNF, ISWI, INO80/SWR1, and NuRD. There are no known interactions between OCT3/4 and other chromatin remodeling factors beyond the four families identified in yeast. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are major chromatin remodeling factors?",
               "answer": "The major chromatin remodeling factors are four families of ATP-dependent chromatin remodeling complexes: SWI/SNF, ISWI, INO80/SWR1, and NuRD.",
               "rationale": "1. Chromatin remodeling is the dynamic modification of chromatin architecture to allow access of condensed genomic DNA to the regulatory transcription machinery proteins, and thereby control gene expression.Such remodeling is principally carried out by 1) covalent histone modifications by specific enzymes, e.g., histone acetyltransferases (HATs), deacetylases, methyltransferases, and kinases, and ...\n2. Chromatin remodelers function as gatekeepers and constitute the major determinant of accessibility of DNA-binding factors and to ensure the ... of the chromatin organization and gene expression programs are driven by mutations and aberrant expression of chromatin remodeling factors, which may present crucial triggers of tumorigenesis in at ...\n3. In eukaryotes, DNA is tightly wound into a complex called chromatin. Thanks to the process of chromatin remodeling, this complex can be \"opened\" so that specific genes are expressed. If the DNA ...\n4. Chromatin remodeling is an important mechanism of regulating eukaryotic gene expression, which makes tightly condensed DNA accessible to various regulatory factors, such as transcription factors ...\n5. There are wide varieties of chromatin remodeling complexes that exist and allow for a number of different mechanisms to remodel chromatin. Remodelers can slide nucleosomes, eject histone octamer, remove H2A-H2B dimers, and replace dimmers. Four major families of ATP-dependent chromatin remodeling factors are SWI/SNF, ISWI, INO80/SWR1, and NuRD ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does OCT3/4 interact with SWI/SNF, ISWI, INO80/SWR1, or NuRD?",
               "answer": "The provided evidence snippets do not mention OCT3/4 or its interaction with any of the chromatin remodeling complexes (SWI/SNF, ISWI, INO80/SWR1, or NuRD). Therefore, based on the information given, it cannot be determined whether OCT3/4 interacts with these complexes.",
               "rationale": "1. Although they are frequently mutated in cancer 3, it remains largely unclear how the four mammalian remodeller families (SWI/SNF, ISWI, CHD and INO80) orchestrate the global organization of ...\n2. The ATPase subunits of SWI/SNF, ISWI, CHD1, and SWR1 bind the nucleosomal DNA at superhelical position 2 (SHL + 2). ( C ) Remodeler ATPases make additional contacts through (1) binding to the opposite DNA gyre, ∼90 bp away; (2) contacting the histone core, typically at an acidic patch formed by H2A and H2B; (3) binding the linker DNA; and (4 ...\n3. To date, four types of ATP-dependent chromatin remodelling complexes have been identified in humans, namely SWI/SNF, ISWI, INO80 and NURD/MI2/CHD. SWI/SNF mutations are prevalent in a wide variety of cancerous tissues and cancer-derived cell lines as discovered by next-generation sequencing technologies. SWI/SNF can bind to nucleosomes and use ...\n4. Although isolated INO80 subfamily ATPases have not yet been tested, combined results from SWI/SNF, ISWI and CHD subfamily enzymes converge on a unifying concept: the implementation of DNA ...\n5. This class can be further classified into at least 4 different families (SWI/SNF, ISWI, NURD/Mi-2/CHD and INO80) based on the additional presence of unique domains within or adjacent to the ATPase domain (Figure 2). In this review we will explore the function, the architecture, and the structural implication of the nucleosome remodeling ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Are there any known interactions between OCT3/4 and other chromatin remodeling factors besides SWI/SNF, ISWI, INO80/SWR1, and NuRD?",
               "answer": "The provided evidence snippets do not explicitly mention any interactions between OCT3/4 and chromatin remodeling factors other than SWI/SNF, ISWI, INO80/SWR1, and NuRD. The focus is primarily on the roles of various chromatin remodelers and their mutations in cancer, as well as the",
               "rationale": "1. ATP-dependent chromatin remodelers are commonly mutated in human cancer. Mammalian SWI/SNF complexes comprise three conserved multisubunit chromatin remodelers (cBAF, ncBAF and PBAF) that share ...\n2. Similar to the SWI/SNF, ISWI, and CHD remodelers, the ability of SWR1 to translocate DNA within the nucleosome is dependent on ATP binding . The differences in binding and DNA distortion between SWR1 and the other families of remodelers likely play a role in histone exchange and preventing significant DNA translocation out of the nucleosome.\n3. In this study, we found that the Oct4 linker interface mediates a competing yet balanced Oct4 interactome that is crucial for the biological function of Oct4 in the maintenance of pluripotency in ESCs and embryos. Oct4 contains a bipartite DNA binding domain, a POU-specific domain (POUS) and a POU homeodomain (POUHD) tethered by a linker region.\n4. Genes encoding members of CHD, INO80, SWI/SNF, ATRX and ISWI complexes were mutated in almost 1 in 10 cases in DECIPHER 57,58. In keeping with the themes of non-redundancy, biological specificity ...\n5. For example, addition of the yeast INO80 or the SWI/SNF-type RSC remodeling complex to SGD chromatin without other factors already generated hallmark features of in vivo-like nucleosome ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Are there any known interactions between OCT3/4 and other chromatin remodeling factors besides the four families mentioned?",
               "answer": "The provided evidence snippets do not specifically mention any interactions between OCT3/4 and other chromatin remodeling factors beyond the four families identified in yeast. While they discuss the role of OCT4 as a transcription factor and its function in regulating gene expression and maintaining pluripotency, there is no direct reference to interactions with additional chrom",
               "rationale": "1. Pioneer transcription factors such as OCT4 can target silent genes embedded in nucleosome-dense regions. How nucleosome interaction enables transcription factors to target chromatin and determine ...\n2. Oct-4: a member of the POU family. Oct-4, a transcription factor also known as Oct-3, Oct-3/4, Otf3 or NF-A3, is encoded by the Pou5f1 gene (located on chromosome 6 in human and 17 in mouse) and belongs to the POU (Pit, Oct, Unc) family of DNA binding-proteins. These proteins regulate the expression of target genes by binding to the octamer motif ATGCAAAT within their promoter or enhancer ...\n3. Pluripotency maintenance requires transcription factors (TFs) that induce genes necessary to preserve the undifferentiated state and repress others involved in differentiation. Recent observations ...\n4. Abstract. Chromatin remodelers act to regulate multiple cellular processes, such as transcription and DNA repair, by controlling access to genomic DNA. Four families of chromatin remodelers have been identified in yeast, each with non-redundant roles within the cell. There has been a recent surge in structural models of chromatin remodelers in ...\n5. The POU domain. Oct4 belongs to the family of transcription factors possessing the evolutionary conserved POU domain. The name POU originates from the first letters of the names of the founding members of the family—mammalian Pit1, Oct1, Oct2, and C. elegans Unc86 [].The POU domain itself consists of a POU-specific (POUs) subdomain and a POU-homeo (POUh) subdomain connected by a flexible ...",
               "predicate": null
            }
         ],
         "row": 464,
         "id": 213514326950552340
      },
      {
         "claim": "There is no relation between Erythromycin use and hypertrophic pyloric stenosis.",
         "label": 0,
         "prediction": 0,
         "rationale": "Hypertrophic pyloric stenosis is an uncommon condition in infants characterized by the abnormal thickening of the pylorus muscles at the end of the stomach, leading to a narrowing of the pylorus and causing gastric outlet obstruction. Erythromycin use is associated with hypertrophic pyloric stenosis. There is no available data or studies to support or refute the claim regarding the relationship between Erythromycin use and hypertrophic pyloric stenosis. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hypertrophic pyloric stenosis?",
               "answer": "Hypertrophic pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), is an uncommon condition in infants characterized by the abnormal thickening of the pylorus muscles at the end of the stomach. This thickening leads to a narrowing of the pylorus, causing gastric outlet obstruction,",
               "rationale": "1. Symptoms. Symptoms of pyloric stenosis usually appear within 3 to 5 weeks after birth. Pyloric stenosis is rare in babies older than 3 months. Symptoms include: Vomiting after feeding. The baby may vomit forcefully, ejecting breast milk or formula up to several feet away. This is known as projectile vomiting.\n2. Pyloric stenosis is a condition that affects your infant's pylorus, the muscle at the end of the stomach leading to the small intestine. When their pylorus thickens and narrows, food can't pass through. Pyloric stenosis symptoms include forceful vomiting, which may cause dehydration and malnourishment. Surgery can repair the problem.\n3. Treatment. Surgery is needed to treat pyloric stenosis. The procedure, called a pyloromyotomy, is often scheduled on the same day as the diagnosis. If your baby is dehydrated or has an electrolyte imbalance, your baby receives fluids [fluid replacement] before surgery. In pyloromyotomy, the surgeon cuts only through the outside layer of the ...\n4. Pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), is an uncommon condition in infants characterized by abnormal thickening of the pylorus muscles in the stomach leading to gastric outlet obstruction. Clinically infants are well at birth. Then, at 3 to 6 weeks of age, the infants present with \"projectile\" vomiting, potentially leading to dehydration and weight loss.[1]\n5. Pyloric stenosis is a narrowing of the pylorus, the opening from the stomach, into the small intestine. This type of blockage is also referred to as a gastric outlet obstruction. Normally, food passes easily from the stomach into the duodenum through a valve called the pylorus. In pyloric stenosis, the muscles of the pylorus are abnormally ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Erythromycin use associated with hypertrophic pyloric stenosis?",
               "answer": "Yes, erythromycin use is associated with hypertrophic pyloric stenosis (IHPS). The evidence indicates that exposure to erythromycin between 3-13 days of life is linked to a nearly 8-fold increased risk of developing pyloric stenosis, as shown by an adjusted incident rate ratio of 7.88",
               "rationale": "1. Among 314,029 Medicaid births during this period, 804 (2.6/1,000 infants) met criteria for pyloric stenosis. Exposure to erythromycin between 3-13 days of life was associated with nearly an 8-fold increased risk of pyloric stenosis (adjusted incident rate ratio 7.88; 95% CI, 1.97-31.57).\n2. Pyloric stenosis, also known as infantile hypertrophic pyloric stenosis (IHPS), is an uncommon condition in infants characterized by abnormal thickening of the pylorus muscles in the stomach leading to gastric outlet obstruction. ... Postnatal exposure to erythromycin has also been associated with an increased risk for the development of ...\n3. Infantile hypertrophic pyloric stenosis (IHPS) is a disorder of young infants caused by hypertrophy of the pylorus, which can progress to near-complete obstruction of the gastric outlet, leading to forceful vomiting. The clinical manifestations, diagnosis, and treatment of IHPS are discussed below. The differential diagnosis of vomiting in ...\n4. Macrolide antibiotics, erythromycin, in particular, have been linked to the development of infantile hypertrophic pyloric stenosis (IHPS). Our aim was to conduct a systematic review of the evidence of whether post-natal erythromycin exposure is associated with subsequent development of IHPS.\n5. The studies show that the risk of infantile hypertrophic pyloric stenosis following exposure to erythromycin is highest in the first 14 days after birth. Available data suggests an incidence of 2. ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is the claim \"There is no relation between Erythromycin use and hypertrophic pyloric stenosis\" true?",
               "answer": "The evidence snippet states \"No results found,\" which indicates that there is no available data or studies to support or refute the claim regarding the relationship between Erythromycin use and hypertrophic pyloric stenosis. Therefore, based on the provided evidence, we cannot definitively conclude whether the claim is true or false.",
               "rationale": "No results found.",
               "predicate": null
            }
         ],
         "row": 465,
         "id": 238922043256893645
      },
      {
         "claim": "There was an estimated 30 million cases of pneumonia in young children worldwide in 2010.",
         "label": 1,
         "prediction": 0,
         "rationale": "The exact number of pneumonia cases in young children estimated worldwide in 2010 is not specified. The estimated number of pneumonia cases in young children worldwide in 2010 was 120.4 million cases. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "How many cases of pneumonia in young children were estimated worldwide in 2010?",
               "answer": "The provided evidence does not specify the exact number of pneumonia cases in young children estimated worldwide in 2010. However, it does mention that the annual incidence of clinical pneumonia in young children in developing countries decreased from 329 episodes per 1000 children in 2000 to 231 episodes per 1000 children in",
               "rationale": "1. Pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes around 190,000 newborns. Almost all of these deaths are preventable. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in ...\n2. The chart shows the estimated number of pneumonia deaths caused by different risk factors, in children. Undernutrition is the major contributor to pneumonia mortality The chart shows that childhood undernutrition — especially \" child wasting \" (children who have a weight too low for their height) — is a major risk factor for pneumonia in ...\n3. In parallel, a refined estimate of childhood pneumonia mortality for the same year, based mainly on single-cause studies, was provided by Williams et al. . The first estimate of pneumonia mortality from multi-cause studies was published by Black et al. in CHERG's paper on the causes of global child mortality in the year 2000 . Then ...\n4. On the basis of these data, we estimated that the annual incidence of clinical pneumonia in young children in developing countries decreased from 329 episodes per 1000 children (95% UI 201-537) in 2000 to 231 episodes per 1000 children (141-377) in 2015 . Across developing countries, the number of episodes of clinical pneumonia in children ...\n5. Nevertheless, pneumonia is also important in developed countries, and prior to the introduction of pneumococcal conjugate vaccines there were an estimated 2.6 million cases of pneumonia annually in children aged younger than 5 years, including 1.5 million requiring hospitalisation, and 3,000 deaths .",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What was the estimated number of pneumonia cases in young children worldwide in 2010?",
               "answer": "The estimated number of pneumonia cases in young children worldwide in 2010 was 120.4 million cases.",
               "rationale": "1. The chart shows the estimated number of pneumonia deaths caused by different risk factors, in children. Undernutrition is the major contributor to pneumonia mortality The chart shows that childhood undernutrition — especially \" child wasting \" (children who have a weight too low for their height) — is a major risk factor for pneumonia in ...\n2. We previously published the first global estimates of clinical pneumonia incidence for young children for the year 2000 (155·8 million cases), 2 and subsequently updated these estimates for 2010 (120·4 million cases). 3 However, data on HIV and measles immunisation status (two key risk factors for pneumonia in young children) were not ...\n3. Pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes around 190,000 newborns. Almost all of these deaths are preventable. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in ...\n4. The number of pneumonia cases in each low ... the increase in evidence is only slight: 35 studies in 1990-2010 to estimate global pneumonia incidence, in comparison ... Zhang JS, et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. ...\n5. Epidemiology and etiology of childhood pneumonia in 2010: Estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries ... and influenza virus (flu). We distributed the global and regional- level estimates of the number of cases, severe cases and deaths from childhood pneumonia in 2010 ...",
               "predicate": null
            }
         ],
         "row": 466,
         "id": 201321678855803296
      },
      {
         "claim": "Tirasemtiv targets fast-twitch muscle.",
         "label": 1,
         "prediction": 1,
         "rationale": "Tirasemtiv is a fast skeletal muscle troponin activator that sensitizes the sarcomere to calcium, enhancing the muscle's response to neuromuscular input and producing greater force when nerve input is reduced. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Tirasemtiv?",
               "answer": "Tirasemtiv is a fast skeletal muscle troponin activator that sensitizes the sarcomere to calcium, enhancing the muscle's response to neuromuscular input and producing greater force when nerve input is reduced. It is designed to improve muscle contraction and alleviate muscle weakness and fatigue, particularly in conditions such as",
               "rationale": "1. Objective: To assess the efficacy of tirasemtiv, a fast skeletal muscle troponin activator, vs. placebo in patients with amyotrophic lateral sclerosis. Methods: VITALITY-ALS (NCT02496767) was a multinational, double-blind, randomized, placebo-controlled clinical trial.Participants tolerating 2 weeks of open-label tirasemtiv (125 mg twice daily) were randomized 3:2:2:2 to placebo or one of ...\n2. Tirasemtiv is a fast skeletal troponin activator that sensitizes the sarcomere to calcium; this mechanism of action amplifies the response of muscle to neuromuscular input producing greater force when nerve input is reduced. Here, we demonstrate that a single dose of tirasemtiv significantly increases submaximal isometric force, forelimb grip ...\n3. Tirasemtiv provides only functional improvement, and is not likely to reverse the immunologic processes that drive the pathogenesis of MG or prevent disease progression. In conclusion, this study indicated that tirasemtiv may improve muscle weakness and fatigue associated with MG. The results from this study support further development of ...\n4. Tirasemtiv is a fast activator of the skeletal muscle protein troponin, which forms a complex with another protein called tropomyosin.The binding of the two proteins underlies skeletal muscle contraction and depends on the intracellular levels of calcium. By increasing the sensitivity of fast skeletal muscle to calcium, tirasemtiv improves the force of muscle contraction and, consequently, the ...\n5. Tirasemtiv reduced the slope of decline in SVC by ∼50% during the 12-week treatment phase (Citation 9). Dizziness was the most commonly reported adverse event (AE) (Citation 8). A phase III trial (VITALITY-ALS) was designed to extend and confirm the findings of BENEFIT-ALS. Double-blind treatment was extended to 48 weeks, with the primary ...",
               "predicate": null
            }
         ],
         "row": 467,
         "id": 148850956054640468
      },
      {
         "claim": "Trans-acting factors, such as lncRNAs, influence mRNA translation.",
         "label": 1,
         "prediction": 1,
         "rationale": "Long non-coding RNAs (lncRNAs) are RNA molecules that have a transcript length exceeding 200 nucleotides and are not translated into proteins, playing critical roles in regulating various biological processes. Long non-coding RNAs (lncRNAs) influence mRNA translation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are lncRNAs?",
               "answer": "Long non-coding RNAs (lncRNAs) are defined as RNA molecules that have a transcript length exceeding 200 nucleotides and are not translated into proteins. They play critical roles in regulating various biological processes, including cell differentiation, tissue development, and DNA repair mechanisms. LncRNAs are known to evolve rapidly",
               "rationale": "1. Most lncRNAs evolve more rapidly than protein-coding sequences, are cell type specific and regulate many aspects of cell differentiation and development and other physiological processes. Many ...\n2. A number of lncRNAs are crucial at the different stages of the main pathways of DSB repair in eukaryotic cells: nonhomologous end joining and homology-directed repair . Gene mutations or variation in expression levels of such RNAs can lead to local DNA repair defects, increasing the chromosome aberration frequency. Moreover, it was demonstrated ...\n3. 2.1. The biological question. The lncRNA field is in its infancy yet from what we do know we find that lncRNAs play critical roles in a wide variety of biological processes and diseases from cell differentiation, tissue organ development, flowering in plants, to cancer metastasis to name just a few [, , , , ].We believe that lncRNAs play regulatory roles in many biological processes and diseases.\n4. 1. Introduction. Long non-coding RNAs (lncRNAs) are defined as RNAs that have a transcript length exceeding 200 nucleotides and will not be translated into proteins 1.Although lncRNAs were once thought to be by-products of RNA polymerase II transcription without biological functions, a large repertoire of lncRNAs have been certified to regulate cellular processes, such as chromosome and genome ...\n5. The functions of lncRNAs vary from transcriptional and post-transcriptional gene regulation to the assembly and function of membraneless nuclear bodies, and are relevant to neuronal disorders ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do lncRNAs influence mRNA translation?",
               "answer": "Yes, lncRNAs influence mRNA translation. The evidence indicates that long non-coding RNAs (lncRNAs) regulate gene expression at various levels, including post-transcriptional and translational levels. This suggests that lncRNAs can affect the translation of mRNA.",
               "rationale": "1. 1. Introduction. Gene expression and translation is influenced by messenger RNA (mRNA) stability in almost all living organisms. mRNA from bacterial cells can last from seconds to more than one hour, but on average it stays functional between 1 and 3 min [1,2].Conversely, the lifetime of mammalian mRNA ranges from a couple of minutes to even days, making eukaryotic mRNA more stable than ...\n2. Considering the growing list of cytoplasmic lncRNAs with important roles in modulating mRNA stability, translation and signalling pathways (see below), it will be important to examine how each ...\n3. Long non-coding RNAs (lncRNAs), a group of non-protein coding RNAs with lengths of more than 200 nucleotides, exert their effects by binding to DNA, mRNA, microRNA, and proteins and regulate gene expression at the transcriptional, post-transcriptional, translational, and post-translational levels. Depending on cellular location, lncRNAs are ...\n4. Generally, the influence of lncRNAs on transcriptional regulation of target genes was explored using the following processes: (1) Confirmation of expression correlation. Following knock down or overexpression of lncRNAs, qRT-PCR should be used to investigate the changes in target mRNA expression; (2) Whether lncRNAs recruit transcription ...\n5. Long non-coding RNAs (lncRNAs), a group of non-protein coding RNAs with lengths of more than 200 nucleotides, exert their effects by binding to DNA, mRNA, microRNA, and proteins and regulate gene expression at the transcriptional, post-transcriptional, translational, and post-translational levels. Depending on cellular location, lncRNAs are ...",
               "predicate": null
            }
         ],
         "row": 468,
         "id": 304508986255933192
      },
      {
         "claim": "Transcription factor EB induces transcription of pro-inflammatory cytokines in macrophages infected with Staphylococcus aureus.",
         "label": 1,
         "prediction": 1,
         "rationale": "Transcription factor EB (TFEB) is a protein that functions as a master gene for lysosomal biogenesis and coordinates the expression of lysosomal hydrolases, membrane proteins, and genes involved in autophagy. Transcription factor EB (TFEB) induces the transcription of pro-inflammatory cytokines in macrophages infected with Staphylococcus aureus. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is transcription factor EB?",
               "answer": "Transcription factor EB (TFEB) is a protein encoded by the TFEB gene in humans. It is a master gene for lysosomal biogenesis and functions as a transcription factor that coordinates the expression of lysosomal hydrolases, membrane proteins, and genes involved in autophagy. TFEB is activated by various",
               "rationale": "1. Transcription factor EB is a protein that in humans is encoded by the TFEB gene. Function. TFEB is a master gene for lysosomal biogenesis. It encodes a transcription factor that coordinates expression of lysosomal hydrolases, membrane proteins and genes involved in autophagy. Upon ...\n2. Transcription factor EB is activated by stressors such as nutrition and deprivation of growth factors, hypoxia, lysosomal stress, and mitochondrial injury. To achieve the ultimate functional state, it is controlled in a variety of modes, such as in its rate of transcription, post-transcriptional control, and post-translational alterations. ...\n3. Transcription factor EB (TFEB), a member of the MiT/TFE family of basic helix-loop-helix leucine zipper transcription factors, is an established central regulator of the autophagy/lysosomal-to ...\n4. The transcription factor EB (TFEB) is a member of the microphthalmia family of basic helix-loop-helix- leucine-zipper (bHLH-Zip) transcription factors (MiT family) (Steingrímsson et al., 2004). The role of MiT transcription factors in the regulation of basic cellular processes has only recently become more clear. In particular, recent work ...\n5. Transcription factor EB (TFEB) is a member of the microphthalmia-associated transcription factor/transcription factor E (MiTF/TFE) family and critically involved in the maintenance of structural integrity and functional balance of multiple cells. In this review, we described the effects of post-transcriptional modifications, including ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does transcription factor EB induce transcription of pro-inflammatory cytokines in macrophages infected with Staphylococcus aureus?",
               "answer": "Yes, transcription factor EB (TFEB) induces the transcription of pro-inflammatory cytokines in macrophages infected with Staphylococcus aureus, as indicated by the observation that nuclear localization of TFEB during S. aureus infection is associated with the transcription of these cytokines.",
               "rationale": "1. Recent observations have demonstrated that p53 is also required for the up-regulation of TLR-dependent pro-inflammatory cytokines . It has also been revealed that both p53 and NF-κB co-regulate the transcription of pro-inflammatory genes in human monocytes and macrophages . Further studies are needed to uncover a more comprehensive ...\n2. Transcription factor EB is activated by stressors such as nutrition and deprivation of growth factors, hypoxia, lysosomal stress, and mitochondrial injury. To achieve the ultimate functional state, it is controlled in a variety of modes, such as in its rate of transcription, post-transcriptional control, and post-translational alterations.\n3. During S. aureus infection, nuclear localization of TFEB is associated with the transcription of pro-inflammatory cytokines (Visvikis et al, 2014). Though S. Typhimurium infection prevented TFEB nuclear translocation, TFEB depletion further increased the secretion of pro-inflammatory cytokines underscoring a non-nuclear function of TFEB and ...\n4. In humans, blood Classical CD14 + monocytes contribute to host defense by secreting large amounts of pro-inflammatory cytokines. Their aberrant activity causes hyper-inflammation and life-threatening cytokine storms, while dysfunctional monocytes are associated with 'immunoparalysis', a state of immune hypo responsiveness and reduced pro-inflammatory gene expression, predisposing ...\n5. Abstract. Microphthalmia/TFE (MiT) transcription factors such as TFEB and TFE3, are emerging as key regulators of innate immunity and inflammation. Rapid progress in the field requires a focused update on the latest advances. Recent studies show that TFEB and TFE3 function in innate immune cells to regulate antibacterial and antiviral responses ...",
               "predicate": null
            }
         ],
         "row": 469,
         "id": 162758275221215443
      },
      {
         "claim": "Transplanted human glial progenitor cells can mature in their host animal.",
         "label": 1,
         "prediction": 1,
         "rationale": "Human glial progenitor cells are a type of neural stem and progenitor cell that can differentiate into both oligodendrocytes and astrocytes. Human glial progenitor cells can mature into oligodendrocytes and astrocytes in their host animal. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are human glial progenitor cells?",
               "answer": "Human glial progenitor cells, also known as oligodendrocyte progenitor cells or NG2 cells, are a type of neural stem and progenitor cell that can differentiate into both oligodendrocytes and astrocytes. They are considered promising for therapeutic applications, particularly for restoring myelin in demyel",
               "rationale": "1. Osipovitch, M. et al. Human ESC-derived chimeric mouse models of Huntington's disease reveal cell-intrinsic defects in glial progenitor cell differentiation. Cell Stem Cell 24 , 107-122 (2019).\n2. Human glial progenitor cells - also referred to as either oligodendrocyte progenitor cells or NG2 cells (Nishiyama et al., 2009) - can generate both oligodendrocytes and astrocytes, and as such are promising reagents by which to concurrently restore myelin to demyelinated regions of the diseased or injured CNS, ...\n3. New research from the University of Copenhagen shows that the diseased and aged brain cells can be replaced with new and fresh ones, potentially helping restore normal brain function. \"When we transplant healthy human glial progenitor cells into the brains of mice that have been already colonized by diseased human brain cells, the healthy ...\n4. The human brain undergoes rapid development at mid-gestation from a pool of neural stem and progenitor cells (NSPCs) that give rise to the neurons, oligodendrocytes, and astrocytes of the mature brain. Functional study of these cell types has been hampered by a lack of precise purification methods.\n5. Human astrocytes are larger and more complex than those of infraprimate mammals, suggesting that their role in neural processing has expanded with evolution. To assess the cell-autonomous and species-selective properties of human glia, we engrafted human glial progenitor cells (GPCs) into neonatal i …",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Can human glial progenitor cells mature into oligodendrocytes and astrocytes in their host animal?",
               "answer": "Yes, human glial progenitor cells can mature into oligodendrocytes and astrocytes in their host animal. Evidence 4 indicates that a glial progenitor cell can develop into either an astrocyte or an oligodendrocyte depending on the culture medium, suggesting that these progenitor cells have",
               "rationale": "1. Oligodendrocytes are the myelinating cells of the central nervous system (CNS) that are generated from oligodendrocyte progenitor cells (OPC). OPC are distributed throughout the CNS and represent a pool of migratory and proliferative adult progenitor cells that can differentiate into oligodendrocytes. The central function of oligodendrocytes is ...\n2. Oligodendrocyte progenitor cells (OPCs) account for approximately 5% of the adult brain and have been historically studied for their role in myelination. In the adult brain, OPCs maintain their ...\n3. Oligodendrocytes (OLs) are the myelin sheath-forming cells of the central nervous system responsible for saltatory action potential propagation 1,2,3, neurotransmitter secretion 4 and providing ...\n4. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303 , 390-396 (1983). The discovery of what is now called OPC: a must read!\n5. This strategy has been used in animal models of various demyelinating diseases such as leukodystrophies, hypomyelination, neurodegenerative diseases, and brain or spinal cord injury (Fig. 4) (Table 1 ). Fig. 4. Transplantation of glial-restricted progenitor cells as a therapeutic strategy for central nervous system diseases. Full size image.",
               "predicate": null
            }
         ],
         "row": 470,
         "id": 277918813133854908
      },
      {
         "claim": "Treatment with a protein named FN impairs regenerative abilities of aged muscles.",
         "label": 0,
         "prediction": 0,
         "rationale": "The Fn key is a modifier key on keyboards that triggers alternate functions of the F keys and other keys. The Fn key is not a protein. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is FN?",
               "answer": "The Fn key, short for \"function,\" is a modifier key on keyboards that is used to trigger alternate functions of the F keys (F1-F12) and other keys. It allows users to access special functions such as adjusting volume or screen brightness by holding down the Fn key and pressing the corresponding function key. The",
               "rationale": "1. Windows. On a Windows PC, the special functions of F1-F12 are accessed by holding down the Fn key and then pressing one of the function keys. That can include muting sound or adjusting screen brightness. So, to use the Fn key on a PC: Hold down the Fn key. Simultaneously, press whichever function key you need to use.\n2. Go to the Main tab and then look for the \"Function key behavior\" option and select it. In the new option that will appear, select the Function key to activate the Fn lock. After that, press F10 to save the changes and confirm the prompt by selecting Yes. Knowing how to use the functions keys and Fn key on your keyboard can make your life ...\n3. What Is the Fn Key? Fn is an abbreviation for function. More accurately, it's used to trigger functions. The Fn key is the one we press when we want to do things that are the alternate functions of the F keys at the top of the keyboard.\n4. Fn is a modifier key, and works like other modifiers keys, such as Ctrl, Shift, Alt and AltGr.For a standard modifier key, the microcontroller inside the keyboard sends a scancode for the modifier itself, which is then interpreted by the operating system and combined with other simultaneous key-presses. The Fn key is a form of meta-modifier key, in that it causes the operating system to see ...\n5. Use the Fn key. On keyboards with an Fn key, hold down Fn and press the key to use the alternate commands. Tips. You can also press and hold Fn while moving your finger up and down on the navigation pad to scroll within a document. You can press and hold Fn while pressing keyboard letters M, J, K, L, U, I, O, P, /, ;, and 0 to match the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the Fn key a protein?",
               "answer": "No, the Fn key is not a protein. The evidence provided discusses proteins and their properties, while the Fn key is described as a modifier key on a keyboard used to access special functions.",
               "rationale": "1. Proteins and Polypeptides. Proteins are organic compounds that contain four elements: nitrogen, carbon, hydrogen, and oxygen. To comprehend the full scope of proteins, it is crucial to understand various properties, including the basic biological molecule, peptides, polypeptide chains, amino acids, protein structures, and the processes of protein denaturation.\n2. Fn is a modifier key, and works like other modifiers keys, such as Ctrl, Shift, Alt and AltGr.For a standard modifier key, the microcontroller inside the keyboard sends a scancode for the modifier itself, which is then interpreted by the operating system and combined with other simultaneous key-presses. The Fn key is a form of meta-modifier key, in that it causes the operating system to see ...\n3. Windows. On a Windows PC, the special functions of F1-F12 are accessed by holding down the Fn key and then pressing one of the function keys. That can include muting sound or adjusting screen brightness. So, to use the Fn key on a PC: Hold down the Fn key. Simultaneously, press whichever function key you need to use.\n4. Look for an option labeled \"Function Key Behavior\" or something similar. This option allows you to change how the Fn key operates. It might be called \"Action Keys Mode\" or \"Hotkey Mode\" based on your PC model. Step 5: Change the Function Key Setting. Select the Function Key Behavior option and choose your preferred setting.\n5. Go to the Main tab and then look for the \"Function key behavior\" option and select it. In the new option that will appear, select the Function key to activate the Fn lock. After that, press F10 to save the changes and confirm the prompt by selecting Yes. Knowing how to use the functions keys and Fn key on your keyboard can make your life ...",
               "predicate": null
            }
         ],
         "row": 471,
         "id": 172501172987634596
      },
      {
         "claim": "Treatment with a protein named FN restores regenerative abilities of aged muscles.",
         "label": 1,
         "prediction": 1,
         "rationale": "The Fn key is a modifier key on keyboards that triggers alternate functions of the F keys and other keys, allowing access to special features such as adjusting volume and screen brightness. Fibronectin (FN) is a protein. Fibronectin (FN) can restore regenerative abilities of aged muscles. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is FN?",
               "answer": "The Fn key, short for \"function,\" is a modifier key on keyboards that is used to trigger alternate functions of the F keys (F1-F12) and other keys. It allows users to access special functions such as adjusting volume, screen brightness, and other features by holding down the Fn key while pressing the corresponding",
               "rationale": "1. Windows. On a Windows PC, the special functions of F1-F12 are accessed by holding down the Fn key and then pressing one of the function keys. That can include muting sound or adjusting screen brightness. So, to use the Fn key on a PC: Hold down the Fn key. Simultaneously, press whichever function key you need to use.\n2. Go to the Main tab and then look for the \"Function key behavior\" option and select it. In the new option that will appear, select the Function key to activate the Fn lock. After that, press F10 to save the changes and confirm the prompt by selecting Yes. Knowing how to use the functions keys and Fn key on your keyboard can make your life ...\n3. What Is the Fn Key? Fn is an abbreviation for function. More accurately, it's used to trigger functions. The Fn key is the one we press when we want to do things that are the alternate functions of the F keys at the top of the keyboard.\n4. Fn is a modifier key, and works like other modifiers keys, such as Ctrl, Shift, Alt and AltGr.For a standard modifier key, the microcontroller inside the keyboard sends a scancode for the modifier itself, which is then interpreted by the operating system and combined with other simultaneous key-presses. The Fn key is a form of meta-modifier key, in that it causes the operating system to see ...\n5. Use the Fn key. On keyboards with an Fn key, hold down Fn and press the key to use the alternate commands. Tips. You can also press and hold Fn while moving your finger up and down on the navigation pad to scroll within a document. You can press and hold Fn while pressing keyboard letters M, J, K, L, U, I, O, P, /, ;, and 0 to match the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is FN a protein?",
               "answer": "Yes, fibronectin (FN) is a protein.",
               "rationale": "1. Fibronectin exists as a protein dimer, consisting of two nearly identical polypeptide chains linked by a pair of C-terminal disulfide bonds. [9] Each fibronectin subunit has a molecular weight of ~230-~275 kDa [10] and contains three types of modules: type I, II, and III. All three modules are composed of two anti-parallel β-sheets resulting ...\n2. The extracellular matrix (ECM) plays a key role as both structural scaffold and regulator of cell signal transduction in tissues. In times of ECM assembly and turnover, cells upregulate assembly of the ECM protein, fibronectin (FN). FN is assembled by ...\n3. Fibronectin (FN) Fibronectin is an extracellular glycoprotein that helps organize and maintain homeostasis of the extracellular matrix [93]. Fibronectin binds to collagen, functions in cell adhesion, migration, and differentiation, and regulates cell-matrix and matrix-matrix interactions [94]. Alternative splicing at three major sites, EDA, EDB ...\n4. The extracellular matrix (ECM) plays a key role as both structural scaffold and regulator of cell signal transduction in tissues. In times of ECM assembly and turnover, cells upregulate assembly of the ECM protein, fibronectin (FN). FN is assembled by cells into viscoelastic fibrils that can bind up …\n5. Fibronectin (FN) is a multidomain protein with the ability to bind simultaneously to cell surface receptors, collagen, proteoglycans, and other FN molecules. Many of these domains and interactions are also involved in the assembly of FN dimers into a multimeric fibrillar matrix. When, where, and how FN binds to its various partners must be ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does fibronectin (FN) restore regenerative abilities of aged muscles?",
               "answer": "Yes, fibronectin (FN) can restore regenerative abilities of aged muscles. The evidence indicates that supplementation of fibronectin restores youth-like muscle regeneration in mice, suggesting that increasing FN levels can improve the function and maintenance of muscle stem cells (MuSCs) in the aged stem cell niche.",
               "rationale": "1. During aging, the levels of fibronectin in the muscle stem cell niche decline, contributing to age-related frailty, and supplementation restores youth-like muscle regeneration in mice.\n2. Abstract Age-related changes in the niche have long been postulated to impair the function of somatic stem cells. Here we demonstrate that the aged stem cell niche in skeletal muscle contains substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of muscle stem cells (MuSCs).\n3. During ageing, stem cells decline in their regenerative potential and ability to give rise to differentiated cells in the tissue, which is associated with a deterioration of tissue integrity and ...\n4. The control of protein adsorption at the interface is therefore desirable. Extracellular matrix proteins are of particular interest in this sense, due to their well-known ability to modulate cell behavior. Particularly, fibronectin plays a leading role, being present in both healthy and injured tissues undergoing healing and regeneration.\n5. It is demonstrated that the aged stem cell niche in skeletal muscle contains substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of muscle stem cells (MuSCs), and the loss of stem cell adhesion to FN in the ECM is identified as a previously unknown aging mechanism. Age-related changes in the niche have long been postulated to ...",
               "predicate": null
            }
         ],
         "row": 472,
         "id": 332502528118058895
      },
      {
         "claim": "Tuberculosis incidence occurs at higher rates in more sparsely populated areas in the UK.",
         "label": 0,
         "prediction": 0,
         "rationale": "The trend of tuberculosis incidence in the UK shows a general decline in recent years, particularly in the UK-born population. It is not possible to determine whether tuberculosis incidence is higher in more sparsely populated areas in the UK based on the provided information. The relationship between population density and tuberculosis incidence in the UK is not explicitly detailed in the provided evidence, but high population density is suggested to be a factor that can influence TB transmission and incidence. The population density of areas with high tuberculosis incidence in the UK is unknown based on the provided information. The population density of areas with low tuberculosis incidence in the UK is not specified in the provided evidence. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the trend of tuberculosis incidence in the UK?",
               "answer": "The trend of tuberculosis (TB) incidence in the UK shows a general decline in recent years, particularly in the UK-born population, which experienced a 9.5% decrease in 2022 compared to 2021. After a long period of increasing incidence from 1980 to 2012, TB rates have",
               "rationale": "1. Main messages. In 2021: TB incidence in England was 7.8 per 100,000, below the World Health Organization ( WHO) threshold for a low incidence country (less than or equal to 10 per 100,000 ...\n2. The incidence of active tuberculosis continued to fall in the UK born population (a 9.5% decrease in 2022 compared to 2021), but in the non-UK born population incidence rates remained steady and ...\n3. After three consecutive decades of a relentless increase of the rate of incidence at an average of 1.9%/year between 1980 and 2012, TB resumed its secular decline in England in the past 5 years. However, the future trajectory of TB incidence is uncertain and maintenance of the current favourable trends will require strict adherence to the ...\n4. Data from the UK Health Security Agency ( UKHSA) indicates that cases of TB in England increased by 7% in the first half of 2023 compared to the same timeframe in 2022, with 2,408 notifications ...\n5. In England, the number of people in the drug resistant cohort (confirmed or treated as MDR/RR-TB) has risen to 58 in 2020, a 2.4%. Tuberculosis in England: 2021 report (presenting data to end 2020) 81 of culture confirmed cases. Four of these people had confirmed initial XDR-TB, the same number as in 2019.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is tuberculosis incidence higher in more sparsely populated areas in the UK?",
               "answer": "The provided evidence snippets do not contain specific information regarding the incidence of tuberculosis (TB) in relation to population density in the UK. Therefore, it is not possible to determine whether tuberculosis incidence is higher in more sparsely populated areas in the UK based on the information given. Additional data or studies focusing specifically on TB incidence in",
               "rationale": "1. Tuberculosis (TB) in the United States by the numbers: 8,331: reported TB cases in the United States in 2022 (a rate of 2.5 cases per 100,000 persons) 60: jurisdictions (e.g., states, cities, U.S. territories, and affiliated areas) that report TB data to CDC Up to 13 million: estimated number of people in the United States living with latent TB infection\n2. 2.1 TB incidence. In the late 1800s, tuberculosis (TB) was one of the leading causes of ill health and death in most of the world. With social and economic development - such as improvements in hygiene, incomes, housing and nutrition - numbers of TB cases and deaths started to decline in western Europe, North America and other parts of the ...\n3. We included systematic or scoping reviews published between Jan 1, 2010 and March 8, 2023 reporting the prevalence or incidence of tuberculosis disease (ie, active tuberculosis) among any of the vulnerable populations listed (table 1). If none or few eligible reviews were identified for a population, we additionally considered observational ...\n4. High TB burden country profiles. WHO has published a global tuberculosis (TB) report every year since 1997. The report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease. This set of country profiles are based on data reported by countries and which are ...\n5. If current trends in tuberculosis incidence continue, few countries are likely to meet the SDG target to end the tuberculosis epidemic by 2030. Progress needs to be accelerated by improving the quality of and access to tuberculosis diagnosis and care, by developing new tools, scaling up interventions to prevent risk factors for tuberculosis, and integrating control programmes for tuberculosis ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the relationship between population density and tuberculosis incidence in the UK?",
               "answer": "The provided evidence does not explicitly detail the relationship between population density and tuberculosis (TB) incidence in the UK. However, it does suggest that high population density is a factor that can influence TB transmission and incidence, as indicated in point 2, which discusses the complex relationship between global inequality, domestic socioeconomic status (SES),",
               "rationale": "1. TABLE 1. Key Determinants of Tuberculosis (TB) Transmission and Relevant Interventions Within the Health Care Sector. TB Outcome. Exposure to Infection. Susceptibility to Disease and Disease Outcome. Lack of Timely, Appropriate Treatment Initiation. Poor Treatment Adherence and Success.\n2. This reflects a complex relationship between global inequality, domestic SES, ... high population density, and limited access to care ... P, Yang Z. Race and nativity are major determinants of tuberculosis in the U.S.: evidence of health disparities in tuberculosis incidence in Michigan, 2004-2012. BMC Public Health. 2017; 17 (1) ...\n3. The social determinants of national tuberculosis incidence rates in 116 countries: a longitudinal ecological study between 2005-2015 ... % of total population aged 15-64: World Bank: Included: Under-five-mortality rate, per ... Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol ...\n4. Despite the significant progress over the years, Tuberculosis remains a major public health concern and a danger to global health. This study aimed to analyze the spatial and temporal characteristics of the incidence of tuberculosis and its risk factors and to predict future trends in the incidence of Tuberculosis. This study used secondary data on tuberculosis incidence and tuberculosis risk ...\n5. 2.1 TB incidence. In the late 1800s, tuberculosis (TB) was one of the leading causes of ill health and death in most of the world. With social and economic development - such as improvements in hygiene, incomes, housing and nutrition - numbers of TB cases and deaths started to decline in western Europe, North America and other parts of the ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the population density of areas with high tuberculosis incidence in the UK?",
               "answer": "The provided evidence snippets do not contain specific information regarding the population density of areas with high tuberculosis incidence in the UK. Therefore, I cannot provide an answer based on the given information.",
               "rationale": "1. 2.1 TB incidence. In the late 1800s, tuberculosis (TB) was one of the leading causes of ill health and death in most of the world. With social and economic development - such as improvements in hygiene, incomes, housing and nutrition - numbers of TB cases and deaths started to decline in western Europe, North America and other parts of the ...\n2. The World Health Organization (WHO) today released updated global lists of high burden countries for tuberculosis (TB), HIV-associated TB and multidrug/rifampicin-resistant TB (MDR/RR-TB). The new lists are for 2021-2025 and replace those previously used between 2016 and 2020.The lists provide a focus for global action on TB, HIV-associated TB and drug-resistant TB in the countries where ...\n3. This study used secondary data on tuberculosis incidence and tuberculosis risk factor data from 209 countries and regions worldwide between 2000 and 2021 for analysis. ... In these areas with a high incidence of TB, comprehensive interventions need to be developed, including improving people's health literacy, improving the living environment ...\n4. 2.1 TB incidence. Box 2.1.1 summarizes the methods used to produce estimates of TB incidence between 2000 and 2019, and the new methods that were needed to produce estimates for 2020 and 2021. Estimation of TB incidence during the COVID-19 pandemic is much more difficult than previously. The new methods have been extensively reviewed but rely heavily on country and region-specific dynamic ...\n5. People living with HIV accounted for 6.3% of the total. The TB incidence rate (new cases per 100 000 population per year) rose by 3.9% between 2020 and 2022, reversing declines of about 2% per year for most of the past 2 decades. Globally in 2022, TB caused an estimated 1.30 million (95% UI: 1.18-1.43 million) deaths, including 167 000 people ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the population density of areas with low tuberculosis incidence in the UK?",
               "answer": "The provided evidence snippets do not contain specific information regarding the population density of areas with low tuberculosis incidence in the UK. The evidence discusses the global burden of tuberculosis, its incidence in urban versus rural areas, and general trends in TB cases, but does not provide data on population density in the UK or any specific regions within it",
               "rationale": "1. 2.1 TB incidence. In the late 1800s, tuberculosis (TB) was one of the leading causes of ill health and death in most of the world. With social and economic development - such as improvements in hygiene, incomes, housing and nutrition - numbers of TB cases and deaths started to decline in western Europe, North America and other parts of the ...\n2. TB is more common in urban than in rural areas, and consequently, it is a greater problem in more rapidly urbanizing societies. 65 With almost 1 billion people living in urban slums in developing countries and annual population growth in Asia and Africa projected to be 2.4%, urbanization is one of the largest obstacles to the full ...\n3. Despite the significant progress over the years, Tuberculosis remains a major public health concern and a danger to global health. This study aimed to analyze the spatial and temporal characteristics of the incidence of tuberculosis and its risk factors and to predict future trends in the incidence of Tuberculosis. This study used secondary data on tuberculosis incidence and tuberculosis risk ...\n4. Global TB burden. With 10.6 million estimated new cases, 1.6 million deaths and 1.7 billion latently infected in 2021, TB remains a major global health concern [].Although able to affect anyone anywhere, in low- and middle-income countries TB stands as the eighth and seventh most common cause of death, respectively, and these countries bear the burden of 80% of all TB cases [].\n5. Methods: We conducted a systematic review where the population was all active TB cases in countries with low to medium TB incidence (<40/100,000 population), the exposure was migration to a low or medium TB incidence country and the comparator was non-migrant TB cases in low or medium incidence countries. Overall proportions were compared ...",
               "predicate": null
            }
         ],
         "row": 473,
         "id": 229472611961174175
      },
      {
         "claim": "Tuberculosis-induced granulomas express different immune system protein signatures than the surrounding tissue.",
         "label": 1,
         "prediction": 1,
         "rationale": "A granuloma is a cluster of immune cells that forms in response to infections, inflammation, irritation, or foreign objects in the body, serving as a protective mechanism to contain and isolate these irritants. The typical immune system protein signature of a granuloma includes activated macrophages, helper T-cells, and potentially fibroblasts, along with changes in gene expression and protein concentrations of tissue-damaging matrix metalloproteinases (MMPs). The typical immune system protein signature of the surrounding tissue of a tuberculosis-induced granuloma includes activated macrophages, T cells, and fibroblasts, with the presence of epithelioid macrophages. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is a granuloma?",
               "answer": "A granuloma is a cluster of immune cells, specifically white blood cells and other tissues, that forms in response to infections, inflammation, irritation, or foreign objects in the body. It serves as a protective mechanism to contain and isolate these irritants. Granulomas can develop in various locations and can be associated with different",
               "rationale": "1. A granuloma is a cluster of immune cells that forms around an infection or foreign object in your body. Learn about the types, locations, causes and treatments of granulomas, and how they differ from infections or autoimmune disorders.\n2. A granuloma is a cluster of white blood cells and other tissues that form to protect the body from infection, inflammation, irritation, or foreign objects. Learn about the different types of granulomas, how they develop, and how to treat them.\n3. A granuloma is a tiny cluster of white blood cells and other tissue that forms as a reaction to infections, inflammation, irritants or foreign objects. Learn about the different types of granulomas, how they are diagnosed and treated, and whether they are cancerous.\n4. A lung granuloma is a grain-like nodule of immune cells that forms in response to infection, inflammation, or exposure to toxins in the lungs. Learn about the possible causes, symptoms, diagnosis, and treatment of lung granulomas, and how they differ from cancer.\n5. Similarly, granuloma annulare is a chronic skin disorder characterized by granulomas appearing as small red or yellow bumps in a ring shape on the skin. Finally, granulomatosis with polyangiitis (GPA) is a rare autoimmune-induced vasculitis characterized by granuloma formation, causing inflammation of the blood vessels (primarily small-sized ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the typical immune system protein signature of a granuloma?",
               "answer": "The typical immune system protein signature of a granuloma includes activated macrophages, helper T-cells, and potentially fibroblasts. Additionally, there may be changes in gene expression and protein concentrations of tissue-damaging matrix metalloproteinases (MMPs) associated with the granulomatous response.",
               "rationale": "1. A granuloma is a focal aggregate of immune cells that forms in response to a persistent inflammatory stimulus. It characteristically demonstrates the compact organization of mature macrophages, which may or may not be associated with other inflammatory cell types. Granulomas are evolutionarily ancient structures found throughout both vertebrate and invertebrate species and are likely to have ...\n2. A granuloma is a cluster of immune cells in your body. They form around an infection or foreign object. They can be a symptom of a chronic condition or infection. Locations: ... Granulomas form when cells of your immune system (macrophages) aren't able to destroy something they see as dangerous. This could be an infection (like bacteria or a ...\n3. What is a granuloma? A granuloma is a small area of chronic inflammation, characterized by a collection of macrophages, typically accompanied by helper T-cells. There are two types of immune system responses, innate and active. The innate immune response is non-specific and is the first line of defense to protect the body from invading ...\n4. The typical granuloma in the centre is an organised structure of activated macrophages, T cells, and fibroblasts. ... A short-term intervention of doxycycline for 2 weeks still had significant effects on gene expression and protein concentrations of tissue-damaging matrix metalloproteinases (MMPs) at 8 weeks, demonstrating that, if the immune ...\n5. Granuloma lesions are highly dynamic and depend on continuous cell replacement. This feature provides new therapeutic approaches to treat granulomatous diseases. Keywords: granuloma, cell traffic, VEGF, dendritic cells. Irritants, infectious agents and foreign materials can induce an innate and cognate immune response.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the typical immune system protein signature of the surrounding tissue of a Tuberculosis-induced granuloma?",
               "answer": "The typical immune system protein signature of the surrounding tissue of a tuberculosis-induced granuloma includes activated macrophages, T cells, and fibroblasts. The presence of epithelioid macrophages, which are a specialized form of activated macrophages, is also characteristic. Additionally, the immune-rich composition of the granuloma suggests",
               "rationale": "1. Haematoxylin and eosin staining of a lung nodule that cultured Mycobacterium tuberculosis (Mtb). The typical granuloma in the centre is an organised structure of activated macrophages, T cells, and fibroblasts. Star indicates central caseous necrosis; arrowheads indicate a ring of epithelioid macrophages.\n2. Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However ...\n3. Abstract. Granulomas, organized aggregates of immune cells, are a defining feature of tuberculosis (TB). Granuloma formation is implicated in the pathogenesis of a variety of inflammatory disorders. However, the tuberculous granuloma has been assigned the role of a host protective structure which \"walls-off\" mycobacteria.\n4. Introduction. The granuloma has been recognized by pathologists as the defining pathology of tuberculosis for more than 100 years (1-3).This structure is organized around infecting Mycobacterium tuberculosis, the etiologic agent of tuberculosis, from host immune cells (2, 4).As the location of much of the bacteria within infected individuals, the granuloma pivotally shapes the way that Mtb ...\n5. During tuberculosis (TB) infection, the granuloma provides the microenvironment in which antigen-specific T cells colocate with and activate infected macrophages to inhibit the growth of Mycobacterium tuberculosis.Although the granuloma is the site for mycobacterial killing, virulent mycobacteria have developed a variety of mechanisms to resist this macrophage-mediated killing.",
               "predicate": null
            }
         ],
         "row": 474,
         "id": 284697808896989122
      },
      {
         "claim": "Two variants of chromosome 6q21 are associated with radiation therapy-induced second malignancies in pediatric Hodgkin lymphoma patients.",
         "label": 1,
         "prediction": 1,
         "rationale": "Chromosome 6q21 is linked to pediatric Hodgkin lymphoma patients through specific noncoding single nucleotide polymorphisms (SNPs) between the PRDM1 and ATG1 genes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between chromosome 6q21 and pediatric Hodgkin lymphoma patients?",
               "answer": "The relationship between chromosome 6q21 and pediatric Hodgkin lymphoma patients is linked to the identification of specific noncoding single nucleotide polymorphisms (SNPs), namely rs4946728 and rs1040411, located between the PRDM1 and ATG1 genes. These SNPs have been associated with the",
               "rationale": "1. Hodgkin lymphoma (HL) is a treatable cancer with an incidence peak in adolescent and young adult years. Treatment strategies have been developed to balance the intensity of therapy needed to maintain disease-free survival while simultaneously preserving overall survival. Risk-based, response-adapted frontline therapy has long used a combination of chemotherapy and radiotherapy (RT). Successive ...\n2. Because SMNs after Hodgkin's lymphoma are caused by radiation exposure, we investigated the relationship between ionizing radiation exposure and PRDM1 protein abundance in cell lines homozygous ...\n3. Patients treated successfully for Hodgkin lymphoma (HL) in childhood are at significant risk for radiation therapy-induced second malignant neoplasms (SMNs), with a cumulative incidence of 18.4% by 30 years after treatment and an absolute excess risk of 6.9 per 1,000 person-years of follow-up 1. This high prevalence makes SMNs the second ...\n4. Patients treated successfully for pediatric Hodgkin's lymphoma are known to develop secondary malignancies; care is already taken in treatment to prevent this adverse effect. Recent GWAS study identified rs4946728 and rs1040411 noncoding SNPs located between PRDM1 and ATG1 genes on chromosome 6q21 a …\n5. Abstract. Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation ...",
               "predicate": null
            }
         ],
         "row": 475,
         "id": 764765029999296997
      },
      {
         "claim": "Type 1 Diabetes is associated with subtle perturbations in T reg development.",
         "label": 1,
         "prediction": 1,
         "rationale": "Type 1 diabetes is a chronic autoimmune disease where the immune system destroys insulin-producing beta cells in the pancreas, leading to little or no insulin production and affecting the body's ability to regulate blood sugar levels. T reg development is affected in Type 1 Diabetes, with defects in T reg-mediated suppression despite normal frequency of T regs in the peripheral blood. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Type 1 Diabetes?",
               "answer": "Type 1 diabetes is a chronic autoimmune disease that occurs when the immune system destroys the insulin-producing beta cells in the pancreas, leading to little or no insulin production. This condition affects the body's ability to regulate blood sugar levels, as insulin is necessary for cells to use glucose for energy. Type 1 diabetes can affect both",
               "rationale": "1. Type 1 diabetes is a chronic condition where the pancreas makes little or no insulin. Learn about the symptoms, causes, risk factors and complications of this disease, and how to manage it with insulin, diet and lifestyle.\n2. Type 1 diabetes is a chronic autoimmune disease that prevents your pancreas from making insulin. Learn about the symptoms, diagnosis, management and prevention of this condition that affects children and adults.\n3. Type 1 diabetes is an autoimmune disease that destroys the insulin-producing cells in the pancreas. Learn how to recognize the symptoms, prevent complications, and manage your diabetes with insulin, diet, and exercise.\n4. Learn what type 1 diabetes is, how it affects your body, and how to manage it. Find out the signs, symptoms, causes, risk factors, and treatment options for this autoimmune condition.\n5. Type 1 diabetes ( T1D ), formerly known as juvenile diabetes, is an autoimmune disease that originates when cells that make insulin (beta cells) are destroyed by the immune system. [5] Insulin is a hormone required for the cells to use blood sugar for energy and it helps regulate glucose levels in the bloodstream. [6]",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is T reg development affected in Type 1 Diabetes?",
               "answer": "Yes, T reg development is affected in Type 1 Diabetes (T1D). Evidence suggests that there are defects in T reg-mediated suppression in T1D, despite the frequency of T regs in the peripheral blood of T1D patients being unaltered. Additionally, genetic susceptibility to T1D is linked to",
               "rationale": "1. Regulatory T cells (T regs) are critical regulators of peripheral immune tolerance.T reg insufficiency can lead to autoimmune disorders, including Type 1 Diabetes (T1D). Increasing evidence in mouse models of T1D, as well as other autoimmune disorders, suggest that there are defects in T reg-mediated suppression.Indeed, while T reg frequency in the peripheral blood of T1D patients is unaltered ...\n2. Critical insights into the etiology of type 1 diabetes (T1D) came from genome-wide association studies that unequivocally connected genetic susceptibility to immune cell function. At the top of the susceptibility are genes involved in regulatory T-cell (Treg) function and development. The advances in epigenetic and transcriptional analyses have ...\n3. Abstract. The autoimmune reaction against the beta cells of the pancreatic islets in type 1 diabetes mellitus (T1DM) patients is active in prediabetes and during the development of the clinical manifestation of T1DM, but it decreases within a few years of the clinical manifestation of this disease. A key role in the pathogenesis of T1DM is ...\n4. Type 1 diabetes (T1D), also known as juvenile diabetes, is a chronic autoimmune disorder where a targeted immune response by both T and B cells leads to destruction of insulin producing β cells in the islets of the pancreas ().T1D is one of the most common chronic diseases of children.\n5. The importance of T reg cells in T1D pathology had previously been established in NOD mice (Milestone 4), where the depletion of CD4 + CD25 + T reg cells greatly accelerates the development of T1D.",
               "predicate": null
            }
         ],
         "row": 476,
         "id": 144944997091990239
      },
      {
         "claim": "Ultrasound guidance significantly reduces the number of needle insertion attempts necessary for a given procedure.",
         "label": 1,
         "prediction": 1,
         "rationale": "Ultrasound guidance significantly improves the success rates of needle insertion attempts, reducing the number of attempts needed and complications compared to traditional methods. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of ultrasound guidance on needle insertion attempts?",
               "answer": "Ultrasound guidance significantly improves the success rates of needle insertion attempts for procedures such as arterial catheterization and peripheral intravenous line placement. It has been shown to reduce the number of attempts needed to successfully insert a catheter, leading to higher first and second attempt success rates and a decrease in complications compared to traditional methods like palpation",
               "rationale": "1. Ultrasound guidance has been shown to facilitate arterial catheterization with fewer attempts. Ultrasound guidance for arterial catheterization improves the first and second attempt success rates and decreases the rate of complications compared to palpation or Doppler auditory assistance [ 2 ].\n2. Ultrasonography helps to ensure safe and successful insertion of an arterial catheter. This video demonstrates the use of ultrasound guidance for radial arterial catheterization in adults with the ...\n3. Ultrasound guidance can facilitate the cannulation of superficial peripheral vessels that are typically used during palpation-based PIV placement. They also allow the visualization and guidance to cannulate deeper vessels. A good habit is to try to keep any attempts at the most peripheral vein available to save proximal veins for subsequent ...\n4. Abstract Peripheral intravenous line placement is a common procedure in emergency medicine. Ultrasound guidance has been demonstrated to improve success rates, as well as decrease complications and pain. This paper provides a narrative review of the literature focusing on best practices and techniques to improve performance with this procedure.\n5. We describe our step-by-step approach for teaching ultrasound-guided IV placement at the bedside using short-axis dynamic guidance, with emphasis on advancing the needle and catheter device almost entirely into the vessel before threading the catheter.",
               "predicate": null
            }
         ],
         "row": 477,
         "id": 185257006626713595
      },
      {
         "claim": "Ultrasound guidance significantly reduces the number of traumatic procedures when attempting needle insertion.",
         "label": 1,
         "prediction": 1,
         "rationale": "Ultrasound guidance enhances the safety and success rates of needle insertion procedures by improving the accuracy of needle placement. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of ultrasound guidance on needle insertion procedures?",
               "answer": "The effect of ultrasound guidance on needle insertion procedures is significant, as it enhances the safety and success rates of these procedures. Ultrasound guidance improves the accuracy of needle placement by providing real-time visual aid, which helps in localizing the needle tip relative to adjacent nerves and anatomy. This leads to increased success rates and block quality",
               "rationale": "1. Introduction. The use of ultrasound (US) has made a major impact on the performance of needle-based procedures in anaesthetic practice 1.Ultrasound guidance has been shown to increase the safety and success of central venous cannulation 2, 3 and improves success rate and block quality while reducing occurrence of systemic toxicity for peripheral nerve blocks 4-6.\n2. Other procedures are only possible utilizing image-guidance, due to the required precision of the injection because of delicate local anatomy or depth of the injection; ultrasound is a safe, portable, and widespread modality that can be used to assist the proceduralist in localizing the needle tip in such cases, to ensure safe and accurate ...\n3. Ultrasound-guided needle placement has become an increasingly necessary skill in anesthesiology practice since it was first reported in 1989. 1 Ultrasound provides a real-time visual aid that can decrease reliance on tactile sensations and improve accurate placement of the needle tip relative to adjacent nerves and adjacent anatomy. 2-4 Because of the foreshortened perspective of the needle ...\n4. Ultrasound-guided procedures are safe and convenient, and avoid radiation exposure for patients. The injection clinic uses ultrasound equipment that provides our doctors a live-action display during procedures to ensure accurate needle placement.\n5. Ultrasound is an invaluable technology for the radiologist and other invasive physicians. The technique can be used to localized vessels, fluids and air in many parts of the body. At least 150 to 200 million peripheral intravenous (PIV) catheters are placed each year in the United States, while up to 80% of patients receive a PIV during their ...",
               "predicate": null
            }
         ],
         "row": 478,
         "id": 326114914658727143
      },
      {
         "claim": "Upon developing tyrosine-kinase inhibitor resistance, new mutations in epidermal growth factor receptors emerge and cause treatment failure.",
         "label": 1,
         "prediction": 1,
         "rationale": "Tyrosine-kinase inhibitor resistance refers to the phenomenon where cancer cells develop the ability to evade the effects of tyrosine kinase inhibitors, limiting the effectiveness of TKI therapies and leading to treatment failure. Treatment failure when tyrosine-kinase inhibitor resistance develops is primarily caused by the continued signaling through downstream pathways despite the presence of the inhibitor. New mutations in epidermal growth factor receptors play a critical role in treatment failure when tyrosine kinase inhibitor resistance develops. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is tyrosine-kinase inhibitor resistance?",
               "answer": "Tyrosine-kinase inhibitor (TKI) resistance refers to the phenomenon where cancer cells develop the ability to evade the effects of tyrosine kinase inhibitors, which are designed to disrupt the signaling pathways that promote cancer cell growth and survival. This resistance can limit the effectiveness of TKI therapies, leading to treatment failure",
               "rationale": "1. Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer cell growth and metastasis. During the last two decades, several molecules targeting RTKs were used in oncology as a first or second line therapy in different types of cancer. However, their effectiveness is limited by the appearance of resistance or adverse ...\n2. Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal function is ...\n3. Tyrosine kinase inhibitors (TKI) are a group of pharmacologic agents that disrupt the signal transduction pathways of protein kinases by several modes of inhibition. This activity will review the currently available drugs, their mechanism of action, routes of administration, indications, contraindications, and adverse effects.\n4. 3.8. The FMS-like tyrosine kinase 3 (FLT3) inhibitors. FLT3 is a receptor tyrosine kinase that belongs to the subclass III family [146, 147]. FLT3 is one of the most frequently mutated genes in hematologic malignancies. FLT3 mutations have been found 1-3% of patients with ALL, 5-10% of patients with myelodysplasia and 15-35% of patients ...\n5. Covalent (irreversible) Bruton's tyrosine kinase (BTK) inhibitors have transformed the treatment of multiple B-cell cancers, especially chronic lymphocytic leukemia (CLL). However, resistance ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What causes treatment failure when tyrosine-kinase inhibitor resistance develops?",
               "answer": "Treatment failure when tyrosine-kinase inhibitor (TKI) resistance develops is primarily caused by the continued signaling through downstream pathways despite the presence of the inhibitor. This acquired resistance is a complex phenomenon that allows tumor cells to bypass the inhibitory effects of TKIs, leading to progression of the disease, treatment failure, and",
               "rationale": "1. Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer cell growth and metastasis. During the last two decades, several molecules targeting RTKs were used in oncology as a first or second line therapy in different types of cancer. However, their effectiveness is limited by the appearance of resistance or adverse ...\n2. Acquired resistance to a kinase inhibitor after an initial response develops in most patients. Acquired resistance is a complex and diverse phenomenon, but the end result for each potential mechanism is continued signaling through downstream pathways, despite the continued presence of the inhibitor.\n3. Tyrosine kinase inhibitors (TKIs) are target-specific inhibitors of abnormal PTKs. ... Tumor cells gradually develop resistance during TKIs therapy; however, the time frame for developing acquired drug resistance is not long. ... progression, treatment failure, low compliance and mortality among cancer patients. The mechanisms of TKIs ...\n4. Furthermore, once therapy has been ceased, frequent monitoring is essential, as well as a high degree of vigilance looking for molecular relapse. 3-6 At the opposite end of the response spectrum, treatment failure to at least 2 tyrosine kinase inhibitors (TKIs) or to just 1 second-generation TKI (2G-TKI) requires expert management while still ...\n5. Introduction. Tyrosine kinases are enzymes that are responsible for cell signaling, growth, and division. Tyrosine kinases are often highly and consecutively active in patients with cancer ().ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) rearrangement is observed in approximately 1% to 2% nonsmall cell lung cancer (NSCLC) patients, and the fusion proteins created from such ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the role of new mutations in epidermal growth factor receptors in treatment failure when tyrosine-kinase inhibitor resistance develops?",
               "answer": "New mutations in epidermal growth factor receptors (EGFR) play a critical role in treatment failure when tyrosine kinase inhibitor (TKI) resistance develops. These mutations can alter the structure and function of the EGFR, leading to changes in its signaling pathways that diminish the effectiveness of TKIs. Specifically, point mutations",
               "rationale": "1. 1. Introduction. The epidermal growth factor (EGF) receptor (EGFR) family comprises several isoforms, including ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4 [].When the EGFR extracellular domain binds to its ligands, such as EGF and transforming growth factor-α (TGF-α), it forms dimers with other EGFR family members and leads to autophosphorylation of tyrosine residues, thereby activating several ...\n2. Identification of mechanisms leading to inhibitor resistance has led to new therapeutic modalities, some of which have now been adapted for patients with unsuccessful tyrosine kinase inhibitor treatment. In this review, we describe mechanisms of tyrosine kinase inhibitor resistance and the available strategies to overcoming resistance.\n3. The epidermal growth factor receptor (EGFR) has served as the founding member of the large family of growth factor receptors harboring intrinsic tyrosine kinase function. High abundance of EGFR and large internal deletions are frequently observed in brain tumors, whereas point mutations and small insertions within the kinase domain are common ...\n4. Resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is a significant cause of treatment failure and cancer recurrence in non-small cell lung cancer (NSCLC).\n5. Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal function is ...",
               "predicate": null
            }
         ],
         "row": 479,
         "id": 202913975025173785
      },
      {
         "claim": "Upon viral challenge, influenza-specific memory CD4+ T cells greatly diminish the early production of inflammatory chemokines in the lung.",
         "label": 0,
         "prediction": 1,
         "rationale": "Inflammatory chemokines are small, secreted proteins that facilitate the immune response and contribute to inflammation by signaling the migration of inflammatory leukocytes into damaged areas through cell surface G protein-coupled receptors. The effect of influenza-specific memory CD4+ T cells on the production of inflammatory chemokines in the lung is not explicitly detailed in the provided evidence. The provided evidence does not directly address whether influenza-specific memory CD4+ T cells reduce the early production of inflammatory chemokines in the lung. The provided evidence does not directly address the effect of influenza-specific memory CD4+ T cells on the early production of inflammatory chemokines in the lung. The provided evidence does not directly address whether influenza-specific memory CD4+ T cells diminish the early production of inflammatory chemokines in the lung. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are inflammatory chemokines?",
               "answer": "Inflammatory chemokines are small, secreted proteins that are produced in high concentrations during infection or injury. They play a crucial role in determining the migration of inflammatory leukocytes into damaged areas, thereby facilitating the immune response and contributing to inflammation. These chemokines signal through cell surface G protein-coupled receptors",
               "rationale": "1. Inflammatory: inflammatory chemokines are produced in high concentrations during infection or injury and determine the migration of inflammatory leukocytes into the damaged area.\n2. We will attempt to make a brief summary of the classification and structure of chemokines, highlighting recent advances in the function of the eight most currently reported chemokine axes in cancer progression and cancer immune response. We also summarize the latest understanding of how these chemokine systems operate in inflammatory diseases.\n3. In this review, the authors discuss the properties of chemokines and their receptors and highlight the roles of these chemoattractants in selected clinical disorders.\n4. The chemokines (or chemotactic cytokines) are a large family of small, secreted proteins that signal through cell surface G protein‐coupled heptahelical chemokine receptors. They are best known for their ability to stimulate the migration of cells, ...\n5. Introduction Leukocyte accumulation is a hallmark of inflammation, immune responses and cancer progression and is mediated by a variety of small protein mediators named chemokines that bind to G ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of influenza-specific memory CD4+ T cells on the production of inflammatory chemokines in the lung?",
               "answer": "The provided evidence does not explicitly detail the effect of influenza-specific memory CD4+ T cells on the production of inflammatory chemokines in the lung. However, it suggests that these memory CD4 T cells play a significant role in the immune response following influenza infection, including interactions with various immune cells and their presence in distinct",
               "rationale": "1. Overview of the primary CD4 T cell response and memory generation following Influenza infection. (a) Following Influenza infection, naïve DCs in the lung take up virus and virally-derived particles, driving their maturation and migration to the lung-draining lymph node.(b) Mature, activated DCs activate Influenza-specific naïve CD4 T cells trafficking through the lymph nodes.\n2. IAV-specific CD4 T cells were found throughout the lung at both primary and memory time points. These cells were found near lung airways and in close contact with a range of immune cells including macrophages, dendritic cells, and B cells. Interactions between lung IAV-specific CD4 T cells and major histocompatibility complex (MHC)II+ cells ...\n3. CD4 T cells within and outside lung immune clusters will experience different signals and interact with different cell types suggesting distinct memory niches that may influence the type and function of lung memory CD4 T cells. 52 It will be key for future studies to understand the dynamics of cells within these different environments. For ...\n4. Overview: The contributions of CD4 T cells to protection from influenza virus. CD4 T cells convey a number of discrete functions to protective immunity to influenza, a complexity that distinguishes this arm of adaptive immunity from B cells and CD8 T cells (reviewed in (1-9)).CD4 T cell help for antibody responses is the most generally acknowledged and essential contribution of CD4 T cell ...\n5. Memory CD4 T cells and protection against IAV. The large majority of virus-specific effector CD4 T cells die following viral clearance, leaving a small number of memory cells that persist long-term ( McKinstry et al. 2010b ). In contrast to the naïve CD4 T cell response, the memory CD4 T cell response against IAV can profoundly impact ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do influenza-specific memory CD4+ T cells reduce the early production of inflammatory chemokines in the lung?",
               "answer": "The provided evidence snippet does not directly address whether influenza-specific memory CD4+ T cells reduce the early production of inflammatory chemokines in the lung. While it discusses the role of memory CD4 T cells in protective responses and their interactions with various immune cells, it does not provide specific information about their impact on inflammatory chem",
               "rationale": "1. Overview of the primary CD4 T cell response and memory generation following Influenza infection. (a) Following Influenza infection, naïve DCs in the lung take up virus and virally-derived particles, driving their maturation and migration to the lung-draining lymph node.(b) Mature, activated DCs activate Influenza-specific naïve CD4 T cells trafficking through the lymph nodes.\n2. IAV-specific CD4 T cells were found throughout the lung at both primary and memory time points. These cells were found near lung airways and in close contact with a range of immune cells including macrophages, dendritic cells, and B cells. Interactions between lung IAV-specific CD4 T cells and major histocompatibility complex (MHC)II+ cells ...\n3. In contrast to the current vaccines, natural infection with a strain of IAV is able to protect an individual against a secondary infection with a heterologous IAV strain, displaying different HA and NA molecules ().The T cell compartment is responsible for this heterologous protection (4, 5).This is because T cells recognize internal and more conserved parts of the influenza virus that are far ...\n4. In mouse models, memory CD4 T cells can mediate protective responses to secondary influenza infection independent of B cells or CD8 T cells, and can influence innate immune responses. Importantly, a newly defined, tissue-resident CD4 memory population has been demonstrated to be retained in lung tissue and promote optimal protective responses ...\n5. CD4 T cells within and outside lung immune clusters will experience different signals and interact with different cell types suggesting distinct memory niches that may influence the type and function of lung memory CD4 T cells. 52 It will be key for future studies to understand the dynamics of cells within these different environments. For ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the effect of influenza-specific memory CD4+ T cells on the early production of inflammatory chemokines in the lung?",
               "answer": "The provided evidence does not directly address the effect of influenza-specific memory CD4+ T cells on the early production of inflammatory chemokines in the lung. However, it suggests that these memory CD4 T cells are involved in various interactions within the lung immune environment, which may influence immune responses. Specifically, the presence of",
               "rationale": "1. IAV-specific CD4 T cells were found throughout the lung at both primary and memory time points. These cells were found near lung airways and in close contact with a range of immune cells including macrophages, dendritic cells, and B cells. Interactions between lung IAV-specific CD4 T cells and major histocompatibility complex (MHC)II+ cells ...\n2. Overview of the primary CD4 T cell response and memory generation following Influenza infection. (a) Following Influenza infection, naïve DCs in the lung take up virus and virally-derived particles, driving their maturation and migration to the lung-draining lymph node.(b) Mature, activated DCs activate Influenza-specific naïve CD4 T cells trafficking through the lymph nodes.\n3. In contrast to the current vaccines, natural infection with a strain of IAV is able to protect an individual against a secondary infection with a heterologous IAV strain, displaying different HA and NA molecules ().The T cell compartment is responsible for this heterologous protection (4, 5).This is because T cells recognize internal and more conserved parts of the influenza virus that are far ...\n4. CD4 T cells within and outside lung immune clusters will experience different signals and interact with different cell types suggesting distinct memory niches that may influence the type and function of lung memory CD4 T cells. 52 It will be key for future studies to understand the dynamics of cells within these different environments. For ...\n5. Overview: The contributions of CD4 T cells to protection from influenza virus. CD4 T cells convey a number of discrete functions to protective immunity to influenza, a complexity that distinguishes this arm of adaptive immunity from B cells and CD8 T cells (reviewed in (1-9)).CD4 T cell help for antibody responses is the most generally acknowledged and essential contribution of CD4 T cell ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Do influenza-specific memory CD4+ T cells diminish the early production of inflammatory chemokines in the lung?",
               "answer": "The provided evidence snippets do not directly address whether influenza-specific memory CD4+ T cells diminish the early production of inflammatory chemokines in the lung. The focus of the evidence is primarily on the activation and role of CD4 T cells in the immune response to influenza, their contributions to protective immunity, and the characteristics of",
               "rationale": "1. Overview of the primary CD4 T cell response and memory generation following Influenza infection. (a) Following Influenza infection, naïve DCs in the lung take up virus and virally-derived particles, driving their maturation and migration to the lung-draining lymph node.(b) Mature, activated DCs activate Influenza-specific naïve CD4 T cells trafficking through the lymph nodes.\n2. Overview: The contributions of CD4 T cells to protection from influenza virus. CD4 T cells convey a number of discrete functions to protective immunity to influenza, a complexity that distinguishes this arm of adaptive immunity from B cells and CD8 T cells (reviewed in (1-9)).CD4 T cell help for antibody responses is the most generally acknowledged and essential contribution of CD4 T cell ...\n3. In this review, we will focus on IAV-specific CD4 + and CD8 + memory T cells that are resident within the lung and will discuss factors influencing their induction, function, and persistence. In addition, we will review exciting new experimental vaccination protocols that are being developed to specifically evoke memory T cells in the lung ...\n4. Lastly, lower influenza-specific γδT and MAIT cell responses were associated with more severe patients with higher SOFA scores, but not for NK cells, CD4 + and CD8 + T cells, showing that early ...\n5. There is continued interest in developing novel vaccine strategies that induce establish optimal CD8 + cytotoxic T lymphocyte (CTL) memory for pathogens like the influenza A viruses (IAVs), where the recall of IAV-specific T cell immunity is able to protect against serologically distinct IAV infection. While it is well established that CD4 + T cell help is required for optimal CTL responses ...",
               "predicate": null
            }
         ],
         "row": 480,
         "id": 257795450352007582
      },
      {
         "claim": "Upon viral challenge, influenza-specific memory CD4+ T cells greatly enhance the early production of inflammatory chemokines in the lung.",
         "label": 1,
         "prediction": 1,
         "rationale": "CD4+ T cells, also known as helper T cells, play a crucial role in the immune system by coordinating the immune response against infections and diseases. Influenza-specific memory CD4+ T cells may play a role in influencing innate immune responses, but their specific effect on the production of inflammatory chemokines in the lung is not detailed. The presence of influenza-specific memory CD4+ T cells in the lung drives the production of chemokines that attract innate immune cells, which rapidly control viral spread during a viral challenge. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of CD4+ T cells in the immune system?",
               "answer": "CD4+ T cells, also known as helper T cells, play a crucial role in the immune system by coordinating the immune response against infections and diseases. They interact with and activate various other immune cells, including B lymphocytes and cytotoxic T cells, thereby enhancing the overall immune response. CD4+ T cells are",
               "rationale": "1. CD4+ T cells, or helper T cells, are one type of lymphocyte that helps coordinate the immune response against infection and disease. They interact and activate other cells in the immune system ...\n2. The CD4 + T cells carry out multiple functions, ranging from activation of the cells of the innate immune system, B-lymphocytes, cytotoxic T cells, as well as nonimmune cells, and also play critical role in the suppression of immune reaction. Continuing studies identified new subsets of CD4 + cells besides the classical T-helper 1 (Th1) and T ...\n3. T cells are a type of white blood cell called lymphocytes. They're also called T lymphocytes. Lymphocytes play an essential role in your immune system. Your immune system fights infection-causing pathogens (viruses, bacteria, fungi and parasites) and harmful cells, like cancer cells. Your lymphocytes include T cells and B cells.\n4. As a major arm of the cellular immune response, CD4 + T cells are important in the control and clearance of infections. Primarily described as helpers, CD4 + T cells play an integral role in the development and activation of B cells and CD8 + T cells. CD4 + T cells are incredibly heterogeneous, and can be divided into six main lineages based on ...\n5. Role in HIV Treatment. CD4 T helper cells are a type of white blood cell called a lymphocyte that serves an important role in your immune system. These cells help defend the body against infection by directing other \"killer\" cells to neutralize foreign agents. Without CD4 T helper cells, the immune system cannot recognize and coordinate a ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of influenza-specific memory CD4+ T cells on the production of inflammatory chemokines in the lung?",
               "answer": "The provided evidence does not explicitly detail the effect of influenza-specific memory CD4+ T cells on the production of inflammatory chemokines in the lung. However, it does suggest that these memory CD4 T cells can influence innate immune responses and promote optimal protective responses during secondary influenza infections. This implies that they may play a",
               "rationale": "1. Overview of the primary CD4 T cell response and memory generation following Influenza infection. (a) Following Influenza infection, naïve DCs in the lung take up virus and virally-derived particles, driving their maturation and migration to the lung-draining lymph node.(b) Mature, activated DCs activate Influenza-specific naïve CD4 T cells trafficking through the lymph nodes.\n2. Influenza A virus (IAV) infection leads to the formation of mucosal memory CD4 T cells that can protect the host. An in-depth understanding of the signals that shape memory cell development is required for more effective vaccine design. We have examined the formation of memory CD4 T cells in the lun …\n3. CD4 T cells within and outside lung immune clusters will experience different signals and interact with different cell types suggesting distinct memory niches that may influence the type and function of lung memory CD4 T cells. 52 It will be key for future studies to understand the dynamics of cells within these different environments. For ...\n4. The route of delivery can have a major effect on the induction of T RM cells ... T. M. et al. Preexisting influenza-specific CD4 + T cells ... A. et al. Influenza-specific lung-resident memory T ...\n5. In mouse models, memory CD4 T cells can mediate protective responses to secondary influenza infection independent of B cells or CD8 T cells, and can influence innate immune responses. Importantly, a newly defined, tissue-resident CD4 memory population has been demonstrated to be retained in lung tissue and promote optimal protective responses ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of viral challenge on the production of inflammatory chemokines in the lung when influenza-specific memory CD4+ T cells are present?",
               "answer": "The presence of influenza-specific memory CD4+ T cells in the lung drives the production of chemokines that attract innate immune cells, which rapidly control viral spread during a viral challenge. This indicates that these memory T cells play a crucial role in enhancing the inflammatory response and recruiting additional immune cells to the site of infection,",
               "rationale": "1. The nature of cytokines involved in shifting the Th1/Tfh balance may vary depending on the tissue considered. For instance, TGF-β signaling in the lung mucosa downregulates CD25, making influenza-specific CD4+ T cells less sensitive to IL-2 signaling and driving them towards the Tfh lineage . Thus, multiple mechanisms converge in inhibiting IL ...\n2. In humans, cytotoxic CD4 + T cells are mainly associated with chronic viral infections 68 but influenza virus-specific cytotoxic CD4 + T cells can be induced by short-term culture of T cells from ...\n3. Influenza-specific memory CD8 + T cells persist in the lungs for up to 2 years after infection of mice and these cells remain capable of producing IFN-γ in response to antigen stimulation ( Liang et al. 1994; Doherty et al. 1996; Wu et al. 2014 ). The maintenance of these populations in the lungs is achieved by continuous supply from the ...\n4. Influenza-specific memory CD4 T-cells in the lung drive the production of chemokines that attract innate immune cells that rapidly control viral spread. 51 Similarly, IFN-γ production by L. major-specific CD4 Trm cells drives the recruitment of inflammatory monocytes to the infection site. 15 These recruited monocytes produce nitric oxide and ...\n5. Numbers of influenza-specific CD8+ or CD4+ T cells increase early in disease and retain an activated phenotype during patient recovery. ... the antiviral/inflammatory cytokines and chemokines ...",
               "predicate": null
            }
         ],
         "row": 481,
         "id": 130093005265395688
      },
      {
         "claim": "Upregulation of dynein in Drosophila neurons increases the number of microtubule plus-ends growing toward the cell body of each neuron.",
         "label": 0,
         "prediction": 0,
         "rationale": "Dynein functions in Drosophila neurons primarily in the transport of cellular components along microtubules, particularly towards the microtubule minus end, which is crucial for maintaining the organization and function of neuronal structures. The provided evidence does not directly address whether upregulation of dynein in Drosophila neurons increases the number of microtubule plus-ends growing toward the cell body of each neuron. Upregulation of dynein in Drosophila neurons likely decreases the number of microtubule plus-ends growing toward the cell body of each neuron. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of dynein in Drosophila neurons?",
               "answer": "Dynein functions in Drosophila neurons primarily in the transport of cellular components along microtubules, particularly towards the microtubule minus end. This transport is crucial for maintaining the organization and function of neuronal structures, such as dendrites. Additionally, dynein is involved in the assembly and transport",
               "rationale": "1. The study of Drosophila cytoplasmic dynein has leveraged the awesome power of genetics to isolate mutations in dynein subunits and allow the organism to reveal dynein's essential functions. These studies have relied on an extensive background of literature describing Drosophila development, as well as a tool box of sophisticated technologies ...\n2. Dynein is an essential gene in a number of organisms, including Drosophila melanogaster and mice 6,7, and mutations in the dynein transport machinery have been linked to neurological diseases ...\n3. The dynein assembly pathway is thought to be conserved in humans and other metazoans, including Drosophila 14.The pathway is medically important because defects in it are a frequent cause of the ...\n4. A similar effect was observed for Drosophila FMRP particles in cultured brain neurons derived from Drosophila Khc mutant larvae (Bianco et al., 2010). Microtubule organization is not overtly altered in dendrites of class IV da neurons lacking kinesin or dynein motor activity (Satoh et al., 2008; Zheng et al., 2008; data not shown).\n5. The polarity of microtubules is indicated by plus signs. The arrow depicts the direction of dynein movement towards the microtubule minus end. Note that in some cell types and regions, such as the dendritic arbors of neurons, the microtubule network can have mixed polarity. b | Dynein functions in cilia. Intraflagellar transport (IFT) dynein ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does upregulation of dynein in Drosophila neurons increase the number of microtubule plus-ends growing toward the cell body of each neuron?",
               "answer": "The provided evidence does not directly address whether upregulation of dynein in Drosophila neurons increases the number of microtubule plus-ends growing toward the cell body of each neuron. The evidence discusses the role of dynein in cargo transport, its essential nature in various organisms, and factors influencing",
               "rationale": "1. Dynein is an essential gene in a number of organisms, including Drosophila melanogaster and mice 6, 7, and mutations in the dynein transport machinery have been linked to neurological diseases.\n2. Background: Motor proteins of the minus end-directed cytoplasmic dynein and plus end-directed kinesin families provide the principal means for microtubule-based transport in eukaryotic cells. Despite their opposing polarity, these two classes of motors may cooperate in vivo. In Drosophila circumstantial evidence suggests that dynein acts in the localization of determinants and signaling ...\n3. Here the authors develop a photostable probe that enables long-term single-cargo tracking in living neurons and find the number of active dynein motors per cargo switches between one and five.\n4. The discovery of dynein thus complemented the finding of kinesins 8; microtubule-based motors that typically move towards the plus ends of microtubules and hence the cell periphery.\n5. The precision of dynein-mediated cargo transport is governed by a multitude of factors, including temperature, phosphorylation, the microtubule track, and interactions with a family of activating ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does upregulation of dynein in Drosophila neurons increase the number of microtubule plus-ends growing toward the cell body of each neuron?",
               "answer": "No, the evidence suggests that knockdown of dynein in Drosophila neurons increases the number of plus ends growing toward the cell body. This implies that upregulation of dynein would likely have the opposite effect, potentially decreasing the number of microtubule plus-ends growing toward the cell body",
               "rationale": "1. Background: Motor proteins of the minus end-directed cytoplasmic dynein and plus end-directed kinesin families provide the principal means for microtubule-based transport in eukaryotic cells. Despite their opposing polarity, these two classes of motors may cooperate in vivo. In Drosophila circumstantial evidence suggests that dynein acts in the localization of determinants and signaling ...\n2. Dynein is an essential gene in a number of organisms, including Drosophila ... including localizing dynein to microtubule plus ends, ... during transport toward the cell soma in primary neurons. ...\n3. Dynein first appears at the plus ends of astral microtubules and then at the bud cell cortex, suggesting that dynein is loaded onto the plus end of a growing microtubule and then transferred to ...\n4. Background: The cytoskeleton and associated motors play an important role in the establishment of intracellular polarity. Microtubule-based transport is required in many cell types for the asymmetric localization of mRNAs and organelles. A striking example is the Drosophila oocyte, where microtubule-dependent processes govern the asymmetric positioning of the nucleus and the localization to ...\n5. Indeed, knockdown of dynein in Drosophila neurons increases the number of plus ends growing toward the cell body (Zheng et al., 2008). Moreover, rapid motility (1 μm/s) of MTs has been directly observed after photobleaching long axonal stretches in rat neurons expressing or injected with fluorescent tubulin ( Wang and Brown, 2002 ).",
               "predicate": null
            }
         ],
         "row": 482,
         "id": 212122157487699776
      },
      {
         "claim": "V-9302 inhibits antitumor responses by decreasing cell death and oxidative stress.",
         "label": 0,
         "prediction": 0,
         "rationale": "V-9302 is a novel inhibitor of the glutamine transporter ASCT2, used in research to study its effects on liver cancer cells, decreasing glutamine uptake and having anti-proliferative effects. V-9302 does not decrease cell death and oxidative stress in liver cancer cells, but rather increases them. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is V-9302?",
               "answer": "V-9302 is a novel inhibitor of the glutamine transporter ASCT2, which is used in research to study its effects on liver cancer cells and their sensitivity to other treatments, such as CB-839. It has been shown to decrease glutamine uptake and has anti-proliferative effects in certain liver cancer",
               "rationale": "1. Combining V-9302 with an autophagy inhibitor further decreased the viability of V-9302-sensitive cells, as elevated autophagy was likely a prosurvival response to substrate starvation; this ...\n2. Notably, we found that V-9302, a novel inhibitor of Gln transporter ASCT2 (Schulte et al., 2018), is the most potent agent in sensitizing both SNU398 and HepG2 GD liver cancer cells to CB-839 (Figure 3c and d). To study whether this combination has a broad anti-proliferative effect in liver cancer cells, we tested cell viability and ...\n3. As V-9302 was found to be sufficient to further decease glutamine uptake in ASCT2-depleted cells, the combination of silencing ASCT2 with V-9302 theoretically suppressed the tumour further, which ...\n4. The combination of BPTES and V-9302 showed an anti-proliferation effect in four GD cell lines, but not in two GID cell lines in vitro. Liver cancer cells (four GD and two GID cell lines) were treated with BPTES, V-9302, or the combination at the indicated concentration. Long-term colony formation assays were performed.\n5. Given that glutamine anaplerosis is a key mitochondrial metabolic pathway for cell growth and survival [24], we investigated mitochondrial function in V-9302-treated VSMCs using an XF analyser.As expected, basal and maximal rates of mitochondrial oxygen consumption increased after FBS or PDGF stimulation; however, treatment of VSMCs with V-9302 inhibited basal and maximal oxygen consumption ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does V-9302 decrease cell death and oxidative stress in liver cancer cells?",
               "answer": "No, V-9302 does not decrease cell death and oxidative stress in liver cancer cells. In fact, the evidence indicates that pharmacological blockade of ASCT2 with V-9302 resulted in increased cell death and increased oxidative stress in cancer cells.",
               "rationale": "1. The neutral amino acid glutamine serves as a key intermediate in numerous metabolic processes leveraged by cancer cells, including biosynthesis, cell signaling, and oxidative protection. ... Pharmacological blockade of ASCT2 with V-9302 resulted in attenuated cancer cell growth and proliferation, increased cell death, and increased oxidative ...\n2. Pharmacological blockade of ASCT2 with V-9302 resulted in attenuated cancer cell growth and proliferation, increased cell death, and increased oxidative stress, which collectively contributed to ...\n3. In addition to autophagy, significantly elevated apoptosis was frequently observed in V-9302-treated tumors. Given that autophagy in this setting appeared to be protective, it is likely that the cell death response to V-9302 was mediated at least in part by apoptosis. A third feature of response to V-9302 was elevated oxidative stress.\n4. Given that cancer cells are much more dependent on glutamine than immune cells and that V-9302 does not impair CD8(+) T-cell viability and activation 83, pharmacological inhibitors of SLC1A5 might ...\n5. The combination of BPTES and V-9302 showed an anti-proliferation effect in four GD cell lines, but not in two GID cell lines in vitro. Liver cancer cells (four GD and two GID cell lines) were treated with BPTES, V-9302, or the combination at the indicated concentration. Long-term colony formation assays were performed.",
               "predicate": null
            }
         ],
         "row": 483,
         "id": 221590912081310523
      },
      {
         "claim": "Vaccinating the gastrointestinal tract induces protection of rectal and vaginal mucosa.",
         "label": 1,
         "prediction": 1,
         "rationale": "Vaccinating the gastrointestinal tract's effect is not directly addressed in the provided evidence. Vaccinating the gastrointestinal tract can induce protection of the rectal mucosa. Vaccinating the gastrointestinal tract does not directly induce protection of the vaginal mucosa. The vaginal mucosa has a unique immune environment, but its immune response is not directly compared to that of the rectal mucosa. The immune response of the vaginal mucosa provides protection against pathogens similar to the rectal mucosa. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of vaccinating the gastrointestinal tract?",
               "answer": "The provided evidence does not directly address the effect of vaccinating the gastrointestinal tract specifically. However, it does highlight that the gastrointestinal (GI) tract is significantly affected by COVID-19, as it has a high expression of ACE2 receptors, making it susceptible to damage from the virus. Additionally, it mentions that gastrointestinal symptoms",
               "rationale": "1. Most AEs following COVID-19 vaccination are mild and transient. The common side effects include headache, muscle pain, chills, diarrhea, and pain at the inoculation site. Previous studies reported that digestive symptoms following COVID-19 vaccination were not severe AEs, and they could be managed without medical treatment [17,18]. However ...\n2. Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world, causing a pandemic that has resulted in more than 5 million deaths globally. The gastrointestinal (GI) tract is known to have high expression of angiotensin-converting enzyme 2 (ACE2) receptors in the human body, making it prone to direct damage from the cellular ...\n3. Summary. We comprehensively summarize the latest knowledge of the adverse effects of COVID-19 and therapeutic drugs on the GI system, as well as related disease pathogenesis, and then provide a discussion focusing on the management and vaccination of patients who have inflammatory bowel disease (IBD) and GI cancer.\n4. ROCHESTER, Minnesota — Long COVID syndrome, also known as post-COVID, is more than fatigue and shortness of breath. Symptoms such as headaches, brain fog and ringing in the ears have been reported, and recently, physicians are seeing more patients with gastrointestinal problems. Greg Vanichkachorn, M.D., director of Mayo Clinic's COVID Activity Rehabilitation Program, describes the most ...\n5. Not just a respiratory infection, covid can cause symptoms throughout the body. Gastrointestinal symptoms are common in both acute and long covid, with gut issues often persisting long after initial infection. Katharine Lang investigates Lack of appetite, nausea, vomiting, diarrhoea, and abdominal pain. These may not be the symptoms people expect with covid, but around 50% of people experience ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does vaccinating the gastrointestinal tract induce protection of rectal mucosa?",
               "answer": "Yes, vaccinating the gastrointestinal tract can induce protection of the rectal mucosa. The evidence indicates that the gastrointestinal tract is a significant immunologic organ, and the mucosal immune system plays a crucial role in defending against pathogens. Additionally, the presence of gut-associated lymphoid tissues (GALT) near the rectal",
               "rationale": "1. Mucosal Immune System. The mucosa is the largest organ in humans with a surface area of 400 m 2 [13,14,15].The mucosal surface requires protection because it is the first defense from pathogens that will invade the body [].The mucosal surface is composed of a thin and permeable layer to assist its physiological functions, including gas exchange (in the lungs), absorption of food (in the ...\n2. Mucosal defenses in the gut: activation of the adaptive immune system following oral immunization. The mucosal surface of the gastrointestinal tract, the largest immunologic organ in the human body, is protected by specialized components of the innate and adaptive immune system; the former provides cells that take up and process antigens and secrete pro-inflammatory signals, whereas the latter ...\n3. 3.2.2. Barriers of the gastrointestinal tract mucosa . To effectively induce mucosal immunity in the GI tract, various barriers need to be overcome by oral vaccines (Fig. 2 B). First, the structure of the intestinal epithelium and mucous layer limit the penetration of antigenic substances.\n4. Many viruses infect the mucosal and lymphoid tissues of the lower gastrointestinal (GI) tract (1-4).For example, HIV can be transmitted via the rectal mucosa and spreads to adjacent sites (5, 6).Gut-associated lymphoid tissues (GALT) are near this site of viral entry and are rich with CD4 + T cells that HIV primarily infects (7-9).Other viruses, such as severe acute respiratory syndrome ...\n5. The gastrointestinal tract (oral cavity, oesophagus, stomach, small intestine, colon and rectum) has a large surface area and is the most widely studied of all the mucosal tissues.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does vaccinating the gastrointestinal tract induce protection of vaginal mucosa?",
               "answer": "The provided evidence does not directly address whether vaccinating the gastrointestinal tract induces protection of the vaginal mucosa. The snippets discuss the challenges of inducing mucosal immunity in the gastrointestinal tract and the potential of vaginal vaccines to overcome specific barriers related to the uterine mucosa. While both the gastrointestinal and vaginal mucosa are part of",
               "rationale": "1. 3.2.2. Barriers of the gastrointestinal tract mucosa . To effectively induce mucosal immunity in the GI tract, various barriers need to be overcome by oral vaccines (Fig. 2 B). First, the structure of the intestinal epithelium and mucous layer limit the penetration of antigenic substances.\n2. Introduction. Vaccines are one of the most important inventions in modern medicine and to date have provided protection from various disabilities in more than 750,000 children and the prevention of 3 million deaths each year [].Along with the increasing understanding of the mechanism of the mucosal immune response, one of the promising routes of vaccine administration is vaccination via mucosa ...\n3. Mucosal vaccines offer the potential to trigger robust protective immune responses at the predominant sites of pathogen infection. In principle, the induction of adaptive immunity at mucosal sites ...\n4. Vaginal vaccines should overcome these challenges to effectively induce the immune response 155,156. The uterine mucosa undergoes cyclic changes in response to hormonal fluctuations, and variation ...\n5. Vaccination against STIs is highly desirable for alleviating this global burden of disease. Vaginal immunization is a promising strategy to combat transmission via the vaginal mucosa. The vagina is typically considered a poor inductive site for common correlates of adaptive immunity. However, emerging evidence suggests that immune tolerance may ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does the vaginal mucosa have a similar immune response to the rectal mucosa?",
               "answer": "The provided evidence does not directly compare the immune responses of the vaginal mucosa to those of the rectal mucosa. However, it does indicate that the vaginal mucosa has a unique immune environment characterized by both innate and adaptive immune responses, as well as specific antigen-presenting cells (APCs) that play distinct roles",
               "rationale": "1. The adaptive immune response is defined by specificity, and it plays a role in pathogen removal in the late stages of infection and in the development of immunological memory . The vaginal mucosa, both its tissue layers together with the cervicovaginal fluids, contain both innate and acquired immune responses.\n2. Figure 1. The immunology of the cervicovaginal and non-pregnant uterine mucosae. ( A) The cervicovaginal mucosa maintains homeostasis with the vaginal microbiome, composed primarily of Lactobacillus, while, at the same time, surveying for pathogens. In the human cervicovaginal mucosa, 4 major myeloid APCs were described, with epithelial cvLCs ...\n3. Our understanding of immune responses in the FRT has traditionally lagged behind our grasp of the situation at other mucosal sites, but recently reproductive immunologists have begun to make rapid progress in this challenging area. ... The vaginal mucosa does not contain mucosal-associated lymphoid tissue so priming of adaptive responses takes ...\n4. 3. Vagina. The vagina consists of an inner layer, the mucosa, a middle layer, the muscularis, and an outer layer, the adventitia. The mucosa is composed of a stratified squamous epithelium and its underlying lamina propria. The muscularis is composed of smooth muscle fibers arranged more or less circularly in the inner layer and longitudinally ...\n5. Thus, APCs localized in the two immune systems could display distinct functions in directing the immune responses in the vaginal mucosa. This can be applied to the immune responses in a steady ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does the immune response of the vaginal mucosa provide protection against pathogens similar to the rectal mucosa?",
               "answer": "The evidence provided suggests that the immune response of the vaginal mucosa does offer protection against pathogens, similar to the rectal mucosa. The vaginal mucosa maintains homeostasis with the vaginal microbiome and has various immune components, including vaginal epithelial cells, innate leukocytes, local antibodies, and T cells, which work together",
               "rationale": "1. 2.1. Vaginal Structure . The vagina is an elastic and muscular organ of the female genital tract that connects the uterus and cervix to the outside of the body (Figure 1 A).An outermost mucosa layer, the interstitial muscularis layer, and the deeper adventitia layer are the three different layers that make up the vaginal wall structure (Figure 1 B).The mucosal layer is a structure that ...\n2. The immunology of the cervicovaginal and non-pregnant uterine mucosae (A) The cervicovaginal mucosa maintains homeostasis with the vaginal microbiome, composed primarily of Lactobacillus, while, at the same time, surveying for pathogens.In the human cervicovaginal mucosa, 4 major myeloid APCs were described, with epithelial cvLCs and CD14 − LP-DCs showing gene signatures associated with ...\n3. Vulvovaginal candidiasis (VVC) is a prevalent gynaecological disease characterised by vaginal wall inflammation that is caused by Candida species. VVC impacts almost three-quarters of all women throughout their reproductive years. As the vaginal mucosa is the first point of contact with microbes, vaginal epithelial cells are the first line of defence against opportunistic Candida infection by ...\n4. Vaginal epithelial cells and innate leukocytes provide the first line of cellular defense. Local antibodies and T cells provide long-term protection in the vagina. Vagina entry and residency by effector T cells require unique homing properties. Long-term tissue-resident memory T cells are key for efficient vaccine.\n5. It provides a barrier against foreign particles, captures them in its sticky mucus and clears them out. Immune cells and natural antibiotics in the mucus defend against pathogens, while the lubrication defends against injury. In your stomach and bladder, the mucosa protects from the abrasive effects of your body's own stomach acid and urine.",
               "predicate": null
            }
         ],
         "row": 484,
         "id": 553238402141933332
      },
      {
         "claim": "Varenicline monotherapy is more effective after 26 weeks of treatment compared to combination nicotine replacement therapies with varenicline or bupropion.",
         "label": 0,
         "prediction": 0,
         "rationale": "Varenicline is an oral medication that helps people stop smoking by reducing nicotine cravings and withdrawal symptoms. The effectiveness of varenicline monotherapy after 26 weeks of treatment is not explicitly detailed. Combination nicotine replacement therapies with varenicline or bupropion show no significant differences in confirmed rates of smoking abstinence among adults motivated to quit smoking after 26 weeks of treatment. The provided evidence does not directly address whether varenicline monotherapy is more effective than combination nicotine replacement therapies with varenicline or bupropion after 26 weeks of treatment. The effectiveness of combination nicotine replacement therapies with bupropion after 26 weeks of treatment is not specifically addressed in the provided evidence. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is varenicline?",
               "answer": "Varenicline is an oral medication used to help people stop smoking by reducing nicotine cravings and withdrawal symptoms. It is a nicotinic acetylcholine receptor partial agonist that works by blocking the effects of nicotine on the brain and releasing dopamine in the brain's reward center. Varenicline does not contain nicotine",
               "rationale": "1. Varenicline is an oral medication that helps people stop smoking by reducing nicotine cravings and withdrawal symptoms. It can cause serious side effects such as mental health problems, seizures, heart problems, and allergic reactions.\n2. Varenicline is a prescription pill that does not contain nicotine and helps people quit smoking. Learn how to use it, its pros and cons, side effects, and precautions from the Centers for Disease Control and Prevention.\n3. Varenicline, sold under the brand names Chantix and Champix among others, is a medication used for smoking cessation and for the treatment of dry eye disease. It is a nicotinic acetylcholine receptor partial agonist. When activated, this receptor releases dopamine in the nucleus accumbens, the brain's reward center, thereby reducing cravings and withdrawal symptoms with smoking cessation ...\n4. What is varenicline used for? Varenicline is commonly used to help people quit smoking. Varenicline may also be used for other conditions as determined by your healthcare provider. Varenicline is ...\n5. Varenicline is a medication that helps people stop smoking by blocking the effects of nicotine on the brain. It can be taken with or without counseling and has various dosing options and side effects.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effectiveness of varenicline monotherapy after 26 weeks of treatment?",
               "answer": "The effectiveness of varenicline monotherapy after 26 weeks of treatment is not explicitly detailed in the provided evidence. However, it is noted that no significant treatment condition effects were found for biochemically confirmed point-prevalence abstinence at weeks 4 or 52, or for 26-week prolonged abstinence.",
               "rationale": "1. No significant treatment condition effects were found for biochemically confirmed point-prevalence abstinence at weeks 4 or 52 or for 26-week prolonged abstinence or survival analysis (26-week relapse interval) (eTable 4 in Supplement 2). Of 1086 participants, 917 (84%) provided 12-month follow-up data.\n2. Varenicline is efficacious and cost-effective. Smoking relapse and adverse treatment-related side effects may decrease medication adherence and patient satisfaction with varenicline. In the clinical setting, varenicline treatment can be optimized by reducing doses in patients who experience intolerable side effects, increasing the dose in ...\n3. More intense varenicline protocols, which combined varenicline therapy with the NRT patch or that prolonged treatment exposure to varenicline from 12 weeks to 24 weeks, were found not to be cost-effective options at the threshold recommended by the literature of $100 000/QALY in contrast to standard 12-week varenicline monotherapy. 26 No cost ...\n4. Findings. In this randomized clinical trial that included 1251 participants smoking 5 cigarettes/d or more, treatment with varenicline monotherapy for 12 weeks, varenicline plus nicotine patch for 12 weeks, varenicline monotherapy for 24 weeks, and varenicline plus nicotine patch for 24 weeks resulted in 7-day point prevalence abstinence rates at 52 weeks of 25.1%, 23.6%, 24.4%, and 25.1% ...\n5. Varenicline is the most effective monotherapy treatment for tobacco dependence; however, it is prescribed less often than indicated, and adherence is less than optimal. ... 506 smokers were randomized to 12 weeks of treatment with varenicline + bupropion versus varenicline alone. 50 The primary outcome was carbon monoxide-confirmed 7-day point ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effectiveness of combination nicotine replacement therapies with varenicline or bupropion after 26 weeks of treatment?",
               "answer": "The effectiveness of combination nicotine replacement therapies with varenicline or bupropion after 26 weeks of treatment appears to show no significant differences in confirmed rates of smoking abstinence among adults motivated to quit smoking. The randomized trial indicated that 12 weeks of treatment with either nicotine patch, varenicline, or combination nicotine",
               "rationale": "1. This randomized trial compares the efficacy of varenicline, nicotine patch, and combination nicotine replacement therapy (patch plus lozenges) on smoking abstinence at 26 weeks among adults interested in quitting smoking.\n2. The combination of varenicline plus nicotine replacement therapy has been examined in clinical trials of smokers who do not drink heavily and was shown to be well tolerated but with mixed efficacy. 29 - 31, 44 The precise neuropharmacological mechanism underlying the efficacy of varenicline and nicotine patch is unclear but may be due to ...\n3. Conclusions and Relevance Among adults motivated to quit smoking, 12 weeks of open-label treatment with nicotine patch, varenicline, or combination nicotine replacement produced no significant differences in confirmed rates of smoking abstinence at 26 weeks. The results raise questions about both the relative effectiveness of intense smoking pharmacotherapies in today's smokers and when such ...\n4. To compare the effectiveness of varenicline and combination nicotine replacement therapy (NRT) for treating smokers attempting to stop, as it is unclear which of the 2 is more effective.\n5. Abstract Introduction: Varenicline and combination nicotine replacement treatment (cNRT) have been recommended as the most effective pharmacotherapies, with equal abstinence rate for smoking cessation in a network meta-analysis of randomized trials, but data from real-world long-term follow-up studies are rare. This study aimed to compare the 12-month sustained abstinence rates of smokers ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is varenicline monotherapy more effective than combination nicotine replacement therapies with varenicline or bupropion after 26 weeks of treatment?",
               "answer": "The provided evidence does not directly address whether varenicline monotherapy is more effective than combination nicotine replacement therapies (C-NRT) with varenicline or bupropion after 26 weeks of treatment. However, it does indicate that both varenicline and C-NRT are effective pharmacotherapies for smoking cessation",
               "rationale": "1. C-NRT indicates combination nicotine replacement therapy. Cohort 1 comprises participants recruited from an ongoing longitudinal study of smokers, the Wisconsin Smokers Health Study, 14,16,17 while cohort 2 participants were recruited for this study from the community via media and community outreach. a Exclusion due to diagnosis of or treatment for schizophrenia, a psychotic disorder, or ...\n2. Introduction: Varenicline and combination nicotine replacement treatment (cNRT) have been recommended as the most effective pharmacotherapies, with equal abstinence rate for smoking cessation in a network meta-analysis of randomized trials, but data from real-world long-term follow-up studies are rare. This study aimed to compare the 12-month sustained abstinence rates of smokers using ...\n3. Background and aims: The phase-based model of smoking cessation treatment suggests that treatment needs may vary across phases (e.g. pre-cessation, cessation). This study tested the comparative effects of varenicline and combination nicotine replacement therapy (C-NRT) relative to nicotine patch monotherapy on pre-cessation and cessation phase candidate withdrawal, expectancy and motivation ...\n4. Two pharmacotherapies for smoking seem particularly effective: combination nicotine replacement therapy (C-NRT) and varenicline. A Cochrane meta-analysis 2 showed that both varenicline and C-NRT were superior to NRT monotherapy in increasing the odds of quitting, but did not differ from one another.\n5. PURPOSE: Nicotine replacement therapy (NRT) and varenicline are both effective in helping smokers quit. There is growing interest in combining the two treatments to improve treatment outcomes. None of the available first-line pharmacological therapies to treat tobacco dependence have been labeled for use in combination with other therapies.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the effectiveness of combination nicotine replacement therapies with bupropion after 26 weeks of treatment?",
               "answer": "The provided evidence does not specifically address the effectiveness of combination nicotine replacement therapies with bupropion after 26 weeks of treatment. However, it does indicate that combination nicotine replacement therapy (NRT) and varenicline are generally more effective than bupropion or single therapies for smoking cessation. Additionally, combination therapy",
               "rationale": "1. Nicotine replacement therapy (NRT), varenicline, bupropion and cytisine are the main pharmacological strategies available for smoking cessation. ... Steady-state blood levels are usually achieved after 1-2 weeks of treatment. ... Several meta-analyses showed that both varenicline and combination NRT are more effective than bupropion or single ...\n2. One such recommendation included in these guidelines is the use of combinations of first-line medications in patients who are willing to quit smoking. Combination Nicotine Replacement Therapy (NRT) involves the use of a long acting nicotine formulation (patch) in combination with a short acting formulation (gum, lozenge, inhaler, or nasal spray).\n3. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. ... all smokers use combination smoking cessation pharmacotherapy? using novel analytic methods to detect differential treatment effects over 8 weeks of ...\n4. For the treatment of smokers who drink heavily, varenicline is more effective than other approved monotherapies, such as bupropion or nicotine replacement therapy, for smoking cessation 25-27 or cigarette reduction. 21 However, even with varenicline, quit rates among smokers who drink heavily lag behind those of smokers who do not 11; therefore ...\n5. Combination therapy offers the advantages of increased abstinence rates, enhanced relief of withdrawal symptoms and is well-tolerated. Combination therapy may be most useful for those smokers at highest risk of relapse, e.g., heavy smokers, smokers who have relapsed multiple times, or smokers with psychiatric co-morbidities.",
               "predicate": null
            }
         ],
         "row": 485,
         "id": 281864741086850200
      },
      {
         "claim": "Varying expression levels of EBI2 affect the positioning and migration of B cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "EBI2, also known as GPR183, is a G protein-coupled receptor activated by the oxysterol 7α,25-dihydroxycholesterol and is expressed on the surface of certain immune cells. EBI2 is expressed by human Th17 cells, CD4 T cells, and memory subsets of lymphocytes, including memory T cells and memory B cells. Varying expression levels of EBI2 on B cells affect their localization, migration, and immune responses. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is EBI2?",
               "answer": "EBI2, also known as GPR183 (G-protein coupled receptor 183), is a G protein-coupled receptor that is activated by the oxysterol 7α,25-dihydroxycholesterol (7α25HC). It is expressed on the surface of certain immune cells, particularly",
               "rationale": "1. EBI2 is a G protein-coupled receptor activated by oxysterol 7α, 25-dihydroxycholesterol (7α25HC) and regulates T cell-dependant antibody response and B cell migration. We recently found EBI2 is ...\n2. GPR183. G-protein coupled receptor 183 also known as Epstein-Barr virus-induced G-protein coupled receptor 2 (EBI2) is a protein ( GPCR) expressed on the surface of some immune cells, namely B cells and T cells; in humans it is encoded by the GPR183 gene. [5] Expression of EBI2 is one critical mediator of immune cell localization within lymph ...\n3. The EBI2 receptor (Epstein-Barr virus-induced gene 2, also known as GPR183) was recently shown to be linked to autoimmune disease, and is a critical regulator of the humoral immune response. It ...\n4. Collectively, we suggest that Ebi2-cKO macrophages/myeloid cells enhance chemokine production to shape the microenvironment, which remarkably promotes migration of myeloid and T cells to overcome the effect of EBI2 deficiency on cell migration. 2.7 Ebi2-cKO Lupus Mice Show the Enhanced Lymphocyte Activation\n5. EBI2 and its ligand, 7α,25-dihydroxycholesterol, direct the migration of activated B cells to interfollicular and outer follicular regions of secondary lymphoid tissues. Moreover, modulation of EBI2 expression is crucial for the generation of extrafollicular plasma cell responses and germinal center formation.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What cells express EBI2?",
               "answer": "EBI2 is expressed by human Th17 cells, CD4 T cells, and memory subsets of lymphocytes, including memory T cells and memory B cells.",
               "rationale": "1. Nonetheless, EBI2 was dispensable in active EAE. Human Th17 cells do also express EBI2, and EBI2 expressing cells are abundant within multiple sclerosis (MS) white matter lesions. These findings implicate EBI2 as a mediator of CNS autoimmunity and describe mechanistically its contribution to the migration of autoreactive T cells into inflamed ...\n2. Human Th17 cells do also express EBI2, and EBI2 expressing cells are abundant within multiple sclerosis (MS) white matter lesions. These findings implicate EBI2 as a mediator of CNS autoimmunity and describe mechanistically its contribution to the migration of autoreactive T cells into inflamed organs.\n3. EBI2 (Epstein-Barr virus-induced gene 2, GPR183) is a G protein-coupled receptor that is expressed in peripheral blood mononuclear cells 1,2,3 and activated by the oxysterol 7α25HC (7α, 25 ...\n4. EBI2 is expressed by CD4 T cells 11,12,13,14, but whether it has a role in positioning T cells during the early stages of activation has been unclear.Using an ovalbumin (OVA)-specific T-cell ...\n5. entially express EBI2 in the human setting as well. The highest EBI2 expression was detected in memory subsets of lympho-cytes, with memory T (CD45RA CD4 +) and B (CD27+CD19 ) cells expressing signiﬁcantly more EBI2 compared to their naive counterparts (Figures 1B and S1A). In the B cell subset, CD27 is",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of varying expression levels of EBI2 on B cells?",
               "answer": "Varying expression levels of EBI2 on B cells affect their localization, migration, and immune responses. Increased expression of EBI2 promotes the migration of activated B cells to specific regions within secondary lymphoid tissues, such as the interfollicular and outer follicular areas. This modulation of EBI2 expression",
               "rationale": "1. Here, we demonstrate that B-cell-targeted expression of human EBI2 (hEBI2) in mice reduces GC-dependent immune responses, reduces total immunoglobulin M (IgM) and IgG levels, and leads to increased proliferation and upregulation of cellular oncogenes.\n2. Here, we demonstrate that B-cell-targeted expression of human EBI2 (hEBI2) in mice reduces GC-dependent immune responses, reduces total immunoglobulin M (IgM) and IgG levels, and leads to increased proliferation and upregulation of cellular oncogenes.\n3. EBI2 and its ligand, 7α,25-dihydroxycholesterol, direct the migration of activated B cells to interfollicular and outer follicular regions of secondary lymphoid tissues. Moreover, modulation of EBI2 expression is crucial for the generation of extrafollicular plasma cell responses and germinal center formation.\n4. These studies identify an important role for EBI2 in promoting B cell localization in the outer follicle, and show that differential expression of this receptor helps position B cells ...\n5. Our results show an unexpected causal link between EBI2, an orphan G-protein-coupled receptor controlling B-cell migration, and the known immunological effects of certain oxysterols, thus ...",
               "predicate": null
            }
         ],
         "row": 486,
         "id": 289754747632244882
      },
      {
         "claim": "VgrG (Tssl) protein punctures membranes by forming a spike at the tip of the tube apparatus.",
         "label": 1,
         "prediction": 1,
         "rationale": "The VgrG protein functions as part of the type VI secretion system, ensuring the transition between its intrinsic threefold symmetry and the sixfold symmetry of the base. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of the VgrG (Tssl) protein?",
               "answer": "The VgrG protein functions as part of the type VI secretion system (T6SS), which is a multi-protein complex that injects bacterial effector proteins into target cells. Specifically, VgrG plays a crucial role in ensuring the transition between its intrinsic threefold symmetry and the sixfold symmetry of the base",
               "rationale": "1. The membrane complex is composed of three membrane-associated proteins: TssJ, TssM, and TssL . In contrast, the baseplate forms ... Our previous result suggests that a leucine residue in position 749 plays an important role in canonical VgrG function. A protein alignment analysis revealed that despite considerable levels of divergence among ...\n2. The type VI secretion system (T6SS) is a multi-protein complex that injects bacterial effector proteins into target cells. It is composed of a cell membrane complex anchored to a contractile ...\n3. VgrG thereby ensures the transition between its intrinsic threefold symmetry and the sixfold symmetry of the baseplate and needle, similarly to the phage T4 gp27 protein 15,27,46 or the Tal ...\n4. The minimal core set of conserved membrane proteins required for T6SS function are the inner membrane proteins TssL and TssM as well as the outer membrane lipoprotein TssJ (35 ... VgrG can also be classified as an effector because some VgrG proteins contain additional functional domains beyond the minimal trimeric structure required for T6SS ...\n5. The VgrG protein forms a trimer that structurally resembles the (gp27/gp5) 3 complex of bacteriophage T4 (58, 64). The (gp27/gp5) 3 complex assembles at the tip of the tail, and the β-helical needle-like structure formed by the C-terminal domain of gp5 is used to perforate the outer membrane of the target bacteria . By analogy, it is supposed ...",
               "predicate": null
            }
         ],
         "row": 487,
         "id": 238040793930385483
      },
      {
         "claim": "Vitamin D deficiency effects birth weight.",
         "label": 1,
         "prediction": 1,
         "rationale": "Maternal vitamin D deficiency is associated with an increased risk of low birth weight and small for gestational age infants. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between Vitamin D and birth weight?",
               "answer": "The relationship between Vitamin D and birth weight is that maternal vitamin D deficiency is associated with an increased risk of low birth weight (LBW) and small for gestational age (SGA) infants. Studies indicate that insufficient levels of vitamin D during pregnancy can impair fetal growth, leading to adverse outcomes such as intrauterine",
               "rationale": "1. Low birth weight (LBW) (birth weight < 2500 g) is a common adverse pregnancy outcome, and the recent estimates have shown that there are 18 million babies with LBW born every year [1]. ... The object of the present study was to estimate the relationship between maternal vitamin D deficiency during pregnancy and low birth weight by ...\n2. Most of the evidences suggest a direct relation of insufficient vitamin D on prevailing risk of low birth weight and SGA babies. However, there is still need for adequate randomized clinical trials to determine the underlying pathogenesis and the effect of calcitriol supplementation on fetal outcomes. ... The relationship between vitamin D and ...\n3. Objective: Maternal hypovitaminosis D may impair fetal growth and cause adverse pregnancy outcomes including intrauterine growth restriction and neonatal low birth weight. The aim of this study is to evaluate the relationship between maternal vitamin D status and neonate's birth weight. Materials and methods: A cross-sectional, descriptive analytical study was carried out in the nursery ward ...\n4. In a recent meta-analysis, it was found that pregnant women with vitamin D < 30 nmol/L delivered newborns with lower birth weight and had higher likelihood of SGA compared to women with vitamin D ...\n5. GA and birth weight were positively correlated with 25(OH) D level (r = 0.447, p < 0.001; r = 0.23, p = 0.03, respectively).The distribution of serum vitamin D levels at birth of the 83 study ...",
               "predicate": null
            }
         ],
         "row": 488,
         "id": 653796536711071904
      },
      {
         "claim": "Vitamin D is an important factor in the relationship between calcium and parathyroid hormone.",
         "label": 1,
         "prediction": 1,
         "rationale": "Parathyroid hormone (PTH) regulates calcium levels in the blood by instructing bones to release calcium into the bloodstream when calcium levels are low. Vitamin D is involved in the regulation of calcium levels in the blood. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between calcium and parathyroid hormone?",
               "answer": "The relationship between calcium and parathyroid hormone (PTH) is that PTH is responsible for regulating the levels of calcium in the blood. When calcium levels are low, the parathyroid glands release PTH, which acts to increase calcium levels by instructing the bones to release calcium into the bloodstream and by influencing",
               "rationale": "1. Parathyroid hormone (PTH) is a hormone that your parathyroid glands make and release to control the level of calcium in your blood, not your bones. Calcium is one of the most important and common minerals in your body. PTH also helps control the levels of phosphorus (a mineral) and vitamin D (a hormone) in your blood and bones.\n2. Parathyroid hormone (PTH) is the hormone released by the parathyroid gland to regulate the levels of calcium in the body. The way PTH maintains calcium balance is by: Going to the bones and instructing them to release calcium into the blood (this is the biggest storage area of calcium in the body). Going to the kidneys and making the kidney get ...\n3. In the blood, the sensitive process of calcium and phosphate homeostasis is maintained primarily by an appropriately functioning parathyroid gland. The parathyroid gland is comprised of 4 small glands located posteriorly to the thyroid in the middle aspect of the anterior neck. The parathyroid gland secretes parathyroid hormone (PTH), a polypeptide, in response to low calcium levels detected ...\n4. Calcitonin is a hormone that the C-cells in the thyroid gland produce and release. It opposes the action of the parathyroid hormone, helping to regulate the blood's calcium and phosphate levels. Calcitonin works to control calcium and potassium levels. It does this by inhibiting the activity of the osteoclasts, the cells that break down bone.\n5. Regulation. There are three molecules which regulate the amount of calcium in the blood and ensure it is maintained within the normal range. These are calcitriol (vitamin D), parathyroid hormone and calcitonin. The synthesis of calcitriol is completed in the kidneys, parathyroid hormone (PTH) is secreted by the parathyroid glands, and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is Vitamin D involved in the regulation of calcium levels in the blood?",
               "answer": "Yes, Vitamin D is involved in the regulation of calcium levels in the blood. The evidence indicates that calcitriol (the active form of vitamin D) plays a crucial role in maintaining normal calcium homeostasis, and abnormalities in the vitamin D endocrine system can lead to conditions affecting calcium levels. Additionally, the synthesis of calc",
               "rationale": "1. Regulation. There are three molecules which regulate the amount of calcium in the blood and ensure it is maintained within the normal range. These are calcitriol (vitamin D), parathyroid hormone and calcitonin. The synthesis of calcitriol is completed in the kidneys, parathyroid hormone (PTH) is secreted by the parathyroid glands, and ...\n2. This suggests that cells either accumulate free vitamin D metabolites or that other serum proteins like albumin are involved in cellular vitamin D uptake ... Bone metabolism and regulation of the blood calcium level in rats. Am J Physiol. 1965; 209:887-90. [Google Scholar] Adams ND, et al.\n3. The vitamin D endocrine system plays an important role in the maintenance of normal calcium homeostasis. Abnormalities of this system occur in many conditions, such as rickets, osteomalacia, hypoparathyroidism, and hyperparathyroidism. The diagnosis and treatment of these disorders will be facilitated if the clinician understands the general mechanisms by which defects in vitamin D metabolism ...\n4. Blood vessel flow (calcium) Without enough vitamin D or calcium, your parathyroid glands compensate by producing too much of their hormone, a condition called hyperparathyroidism. That can lead to bone weakening ( osteoporosis) and increased fracture risk. Other problems from calcium and vitamin D deficiencies include:\n5. Organ Systems Involved. Calcium homeostasis is maintained by actions of hormones that regulate calcium transport in the gut, kidneys, and bone. ... If PTH levels are normal, then magnesium, vitamin D, and phosphate levels can be checked to determine if calcium levels are being affected by other electrolyte abnormalities. It is always a good ...",
               "predicate": null
            }
         ],
         "row": 489,
         "id": 215904633313893511
      },
      {
         "claim": "Walking in traffic areas in London did not improve lung function in elderly adults.",
         "label": 1,
         "prediction": 1,
         "rationale": "The study conducted by Sinharay et al. (2018) measured the lung function of elderly adults walking in traffic areas in London. The study by Sinharay et al. (2018) found that walking in a traffic-polluted area did not improve lung function in elderly adults, whereas walking in a traffic-free area led to an increase in lung function. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What study measured the lung function of elderly adults walking in traffic areas in London?",
               "answer": "The study that measured the lung function of elderly adults walking in traffic areas in London is the one conducted by Sinharay et al. (2018), which investigated respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic",
               "rationale": "1. Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study Lancet. 2018 Jan 27;391 (10118):339-349. doi: 10.1016/S0140-6736 (17)32643-0. Epub 2017 Dec 5.\n2. Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study Author links open overlay panel Rudy Sinharay MBBS a b † , Jicheng Gong PhD c d ...\n3. Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study\n4. The study by Sinharay et al. (2018), verified in three groups of older adults, that short periods of exposure to traffic pollution presented beneficial effects of walking that were superior to the harmful effects of air pollutants.\n5. Background: Long-term exposure to pollution can lead to an increase in the rate of decline of lung function, especially in older individuals and in those with chronic obstructive pulmonary disease ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Did the study by Sinharay et al. (2018) find that walking in traffic areas in London improved lung function in elderly adults?",
               "answer": "No, the study by Sinharay et al. (2018) found that walking in a traffic-polluted area (Oxford Street) did not improve lung function; rather, walking in a traffic-free area (Hyde Park) led to an increase in lung function.",
               "rationale": "1. Background: Long-term exposure to pollution can lead to an increase in the rate of decline of lung function, especially in older individuals and in those with chronic obstructive pulmonary disease (COPD), whereas shorter-term exposure at higher pollution levels has been implicated in causing excess deaths from ischaemic heart disease and exacerbations of COPD.\n2. Sinharay R, Gong J, Barratt B, et al. Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants older than 60 years with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study.\n3. Semantic Scholar extracted view of \"Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study\" by R. Sinharay et al.\n4. For example, Sinharay et al. (2018) found that a 2-hour walk in Hyde Park in London (as compared with walking down a busy street, Oxford Street) led to an increase of lung function and a decrease ...\n5. Sinharay, R. et al.Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with ...",
               "predicate": null
            }
         ],
         "row": 490,
         "id": 560348991387463030
      },
      {
         "claim": "Walking in traffic areas in London improves lung function in elderly adults.",
         "label": 0,
         "prediction": 0,
         "rationale": "Walking in traffic areas in London negatively affects lung function in elderly adults. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Does walking in traffic areas in London affect lung function in elderly adults?",
               "answer": "Yes, walking in traffic areas in London negatively affects lung function in elderly adults. Evidence indicates that exposure to traffic-related air pollution during a 2-hour walk in busy areas, such as Oxford Street, consistently reduces forced expiratory volume (FEV1) and forced vital capacity (FVC) in adult asthmatics",
               "rationale": "1. One in five people live with lung conditions in the UK, costing an estimated £11 billion per year [ 4 ]. Lung disease is the second most common cause of disability in older adults behind only musculoskeletal disorders, yet it is often 'hidden' as breathlessness is not immediately obvious.\n2. down a busy street with high levels of pollution compared with walking in a traffic-free area with lower pollution levels in older adults. ... lead to an increase in the rate of decline of lung function in non-smoking adults, ... term exposure to traffic pollution during a 2-h walk in a busy London street compared with those in a nearby park ...\n3. In all participants, irrespective of their disease status, walking in Hyde Park led to an increase in lung function (forced expiratory volume in the first second [FEV 1] and forced vital capacity [FVC]) and a decrease in pulse wave velocity (PWV) and augmentation index up to 26 h after the walk. By contrast, these beneficial responses were ...\n4. 7 December 2017. Results from a study led by Professor Fan Chung, consultant physician at Royal Brompton & Harefield NHS Foundation Trust and professor of respiratory medicine at Imperial College London, have shown that just two hours of exposure to particles of soot or dust, found in traffic fumes on busy roads, appears to counteract the benefits of walking on the heart and lungs of older adults.\n5. In a landmark study in London, traffic-related air pollution exposure immediately induced adverse pulmonary effects in adult asthmatics . Walking for 2 h on Oxford Street consistently reduced forced expiratory volume during the first second (FEV1) and forced vital capacity (FVC). ... Short-term variation in particulate air pollution affects ...",
               "predicate": null
            }
         ],
         "row": 491,
         "id": 244004794155217574
      },
      {
         "claim": "Whole brain radiotherapy increases the occurrence of new brain metastases.",
         "label": 0,
         "prediction": 0,
         "rationale": "Whole brain radiotherapy is a conventional radiation therapy treatment that involves administering radiation to the entire brain to kill tumor cells, particularly in cases of brain metastases. The provided evidence does not directly address whether whole-brain radiotherapy increases the occurrence of new brain metastases. The provided evidence does not directly address whether whole-brain radiotherapy increases the occurrence of new brain metastases. Whole-brain radiotherapy is a treatment option for patients with brain metastases, particularly for those with multiple metastases or uncontrolled primary tumors, and is commonly used in conjunction with corticosteroids to manage symptoms. The provided evidence does not directly address whether whole-brain radiotherapy (WBRT) increases the occurrence of new brain metastases in patients with existing brain metastases. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is whole brain radiotherapy?",
               "answer": "Whole brain radiotherapy (WBRT) is a conventional radiation therapy treatment that involves administering radiation to the entire brain, including both healthy brain tissue and cancer cells. The purpose of WBRT is to kill tumor cells, particularly in cases of brain metastases. Patients typically undergo 10 to 15 treatments over a period of",
               "rationale": "1. As a result, the preferred conventional radiation therapy treatment for brain metastases has been whole brain radiotherapy (WBRT). WBRT is just what it sounds like—giving radiation to the entire brain, even to healthy tissue. In WBRT, both the healthy brain cells and cancer cells receive X-Ray radiation, but the amount of radiation dose that ...\n2. Radiation can be given to treat primary tumors in your brain or tumors that have spread to your brain from another part of your body (metastasized). Your doctor will decide whether you'll receive partial or whole brain radiation. You'll have either external beam radiation therapy or stereotactic radiosurgery depending on your treatment plan.\n3. Whole-brain radiation. Whole-brain radiation applies radiation to the entire brain in order to kill tumor cells. People undergoing whole-brain radiation usually require 10 to 15 treatments over two to three weeks. Side effects may include fatigue, nausea and hair loss. Long-term, whole-brain radiation is associated with cognitive decline.\n4. 2. Compare the risks and benefits of radiation therapy. There are two main types of radiation therapy used at the Comprehensive Brain Tumor Center to treat metastatic brain tumors: Whole-brain radiation therapy targets the entire brain, treating even microscopic tumors that can't be seen on an MRI scan. Common side effects include fatigue ...\n5. Some tumors can be treated with focal radiation, which targets a smaller area than whole brain radiation. Larger treatment areas are generally associated with greater risk of long-term effects. Radiation necrosis. Sometimes dead brain tissue forms at the site of the radiation. This is called radiation necrosis.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does whole brain radiotherapy increase the occurrence of new brain metastases?",
               "answer": "The provided evidence snippets do not directly address whether whole-brain radiotherapy (WBRT) increases the occurrence of new brain metastases. Instead, they focus on the role of WBRT in managing existing brain metastases, its palliative effects, and its historical context in treatment. While WBRT is associated with symptom control",
               "rationale": "1. For patients with multiple brain metastases or presenting with uncontrolled primary tumor or multiple extracerebral metastases, whole-brain radiotherapy (WBRT) is the treatment of choice, associated with corticosteroids as symptomatic treatment. ... a significant increase of the mean score, from 51.11 to 74.92 (p<0.01), which translates into a ...\n2. Whole-brain radiotherapy (WBRT) has been accepted as a palliative treatment for brain metastasis (BM) 1, based on its ability to control neurologic symptoms and reduce disease burden in several clinical trials from the 1980s 2, 3. Stereotactic radiosurgery (SRS) has also recently been found to improve the local control of BM 4 - 6.\n3. Patients with brain metastases (BM) can benefit from radiotherapy (RT), although the long-term benefits of RT remain unclear. We searched a Korean national health insurance claims database and ...\n4. Abstract. An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing.\n5. This guideline provides updated evidence-based recommendations addressing recent developments in the management of patients with brain metastases, including advanced radiation therapy techniques such as stereotactic radiosurgery (SRS) and hippocampal avoidance whole brain radiation therapy and the emergence of systemic therapies with central nervous system activity.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does whole brain radiotherapy increase the occurrence of new brain metastases?",
               "answer": "The provided evidence snippets do not directly address whether whole-brain radiotherapy (WBRT) increases the occurrence of new brain metastases. Instead, they focus on the role of WBRT in treating existing brain metastases, its palliative effects, and its historical context in managing neurological symptoms. While WBRT is acknowledged as",
               "rationale": "1. For patients with multiple brain metastases or presenting with uncontrolled primary tumor or multiple extracerebral metastases, whole-brain radiotherapy (WBRT) is the treatment of choice, associated with corticosteroids as symptomatic treatment. ... a significant increase of the mean score, from 51.11 to 74.92 (p<0.01), which translates into a ...\n2. Whole-brain radiotherapy (WBRT) has been accepted as a palliative treatment for brain metastasis (BM) 1, based on its ability to control neurologic symptoms and reduce disease burden in several clinical trials from the 1980s 2, 3. Stereotactic radiosurgery (SRS) has also recently been found to improve the local control of BM 4 - 6.\n3. Patients with brain metastases (BM) can benefit from radiotherapy (RT), although the long-term benefits of RT remain unclear. We searched a Korean national health insurance claims database and ...\n4. Abstract. An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing.\n5. PURPOSE American Society of Radiation Oncology (ASTRO) has developed a guideline on appropriate radiation therapy for brain metastases. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS \"Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline\"2 was reviewed for ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the relationship between whole brain radiotherapy and the occurrence of new brain metastases?",
               "answer": "Whole-brain radiotherapy (WBRT) is a treatment option for patients with brain metastases, particularly for those with multiple metastases or uncontrolled primary tumors. The evidence suggests that WBRT is commonly used in conjunction with corticosteroids to manage symptoms associated with brain metastases. As the incidence of brain metastases increases,",
               "rationale": "1. For patients with multiple brain metastases or presenting with uncontrolled primary tumor or multiple extracerebral metastases, whole-brain radiotherapy (WBRT) is the treatment of choice, associated with corticosteroids as symptomatic treatment. ... Valicenti R, et al. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain ...\n2. Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.\n3. In the United States, it is estimated that between 8% and 10% of patients with cancer will develop brain metastases representing approximately 200,000 new patients with brain metastases every year. 1 The point prevalence of brain metastases on initial diagnosis varies widely between different cancer histologies. For example, the incidence proportion of patients with metastatic cancer who have ...\n4. Abstract. As novel systemic therapies yield improved survival in metastatic cancer patients, the frequency of brain metastases continues to increase. Over the years, management strategies have continued to evolve. Historically, stereotactic radiosurgery has been used as a boost to whole-brain radiotherapy (WBRT) but is increasingly being used ...\n5. Abstract. An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does whole brain radiotherapy increase the occurrence of new brain metastases in patients with existing brain metastases?",
               "answer": "The provided evidence does not directly address whether whole-brain radiotherapy (WBRT) increases the occurrence of new brain metastases in patients with existing brain metastases. The evidence discusses the treatment of brain metastases, the prevalence of brain metastases in cancer patients, and the historical prognosis for these patients, but it does",
               "rationale": "1. For patients with multiple brain metastases or presenting with uncontrolled primary tumor or multiple extracerebral metastases, whole-brain radiotherapy (WBRT) is the treatment of choice, associated with corticosteroids as symptomatic treatment. ... in the fatigue domain there was a significant increase of the mean score, from 51.11 to 74.92 (p ...\n2. Abstract. An estimated 20% of patients with cancer will develop brain metastases. Approximately 200,000 individuals in the United States alone receive whole-brain radiotherapy (WBRT) each year to treat brain metastases. Historically, the prognosis of patients with brain metastases has been poor; however, with new therapies, this is changing.\n3. Patients with brain metastases (BM) can benefit from radiotherapy (RT), although the long-term benefits of RT remain unclear. We searched a Korean national health insurance claims database and ...\n4. Sahgal A, Aoyama H, Kocher M, et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. Mar 15 2015;91(4):710-717. 61.\n5. The incidence rates of brain metastases (BM) in patients with solid tumor range from 7 to 14 persons per 100,000 population per year across population-based studies [] and shows an increase over time due to improved survival, development of modern therapies and advancing diagnostic technologies [].The primary malignancies that mostly metastasize to the brain are lung, breast, esophageal, skin ...",
               "predicate": null
            }
         ],
         "row": 492,
         "id": 994693290328678335
      },
      {
         "claim": "Women are more susceptible to death due to pneumonia when compared to men.",
         "label": 1,
         "prediction": 0,
         "rationale": "The provided evidence does not indicate whether women are more susceptible to death due to pneumonia. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Are women more susceptible to death due to pneumonia?",
               "answer": "The provided evidence does not specifically address the susceptibility of women to death due to pneumonia. It focuses on age-related risks, general information about pneumonia, symptoms, and statistics regarding hospital admissions and fatalities. Therefore, based on the provided evidence, we cannot conclude whether women are more susceptible to death due to pneumonia.",
               "rationale": "1. People are more likely to get pneumonia at certain ages. For adults, those 65 years or older are at increased risk. Risk continues increasing as age increases: an 80-year-old has a higher risk than a 65-year-old adult. For children, those younger than 5 years old are at increased risk. Risk increases for children at younger ages: a 1-year-old ...\n2. Pneumonia and your lungs Enlarge image. Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.\n3. Signs that indicate a more severe infection are shortness of breath, confusion, decreased urination and lightheadedness. In the U.S., pneumonia accounts for 1.3 visits to the Emergency Department, and 50,000 deaths annually. With the COVID-19 pandemic continuing to affect people around the world, pneumonia has become an even larger health ...\n4. Pneumonia. Pneumonia is an infection of the lungs that can make it hard for the oxygen you breathe to get into your bloodstream. Most cases of pneumonia are caused by bacteria or viruses, but pneumonia can also be caused by fungi. The symptoms of pneumonia can range from mild to severe, and include cough, fever, chills, and trouble breathing.\n5. There are at least 4 million cases of pneumonia every year in the U.S. One out of four will be sick enough to be admitted to a hospital. Adults 65 and older are more likely to be sicker and admitted to a hospital. One out of every 20 cases of pneumonia will be fatal. Pneumonia causes more deaths than HIV/AIDS.",
               "predicate": null
            }
         ],
         "row": 493,
         "id": 247695767878328423
      },
      {
         "claim": "Women with a lower birth weight are more likely to develop breast cancer later in life.",
         "label": 0,
         "prediction": 0,
         "rationale": "There is no clear correlation between birth weight and breast cancer risk. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is there a correlation between birth weight and breast cancer risk?",
               "answer": "The evidence suggests that there is no clear correlation between birth weight and breast cancer risk. While some studies indicate that women with higher birth weights may have an increased risk of breast cancer, particularly in premenopausal women, other analyses show no significant association when comparing different birth weight categories. Specifically, one study reported no association",
               "rationale": "1. Background. The hypothesis that the risk of developing breast cancer in adulthood may be increased by factors that first act in utero—in particular by fetal exposure to higher levels of maternal estrogen—was first proposed in 1990 [].Since then, several observational studies have examined this hypothesis by using birth weight as an index of the effects of intrauterine hormones on fetal ...\n2. Introduction: Birthweight is your weight when you were born. Studies show women who had a higher birthweight have an increased risk of breast cancer compared to women who had a lower birthweight. This is most clearly seen in premenopausal (before menopause) women. Learn more about birthweight and breast cancer risk.\n3. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation Eur J Epidemiol. 2019 Jun;34(6) :591-600. ... Point estimates of the odds ratios from most analyses performed indicated an inverse relationship between genetically-predicted BW and breast cancer, but we are unable to rule out an association ...\n4. Overall, there was no association between birth weight and breast cancer risk comparing women who weighed <3000 g (rate ratio (RR)=0.93) or >3500 g (RR=1.09) with women who weighed 3000-3499 g at birth (P for trend=0.69) (Table 2), and there was no obvious pattern in the association of gestational age with breast cancer incidence (P for trend ...\n5. Results. With summary statistics we identified a positive genetic correlation between fetal-specific birthweight and breast cancer (r g = 0.123 and P = 0.013) as well as a negative but insignificant correlation between maternal-specific birthweight and breast cancer (r g = − 0.068, P = 0.206); and detected 84 pleiotropic genes shared by fetal-specific birthweight and breast cancer, 49 shared ...",
               "predicate": null
            }
         ],
         "row": 494,
         "id": 165637464176125040
      },
      {
         "claim": "YAP/TAZ is required in intestinal regeneration in mouse models of ulcerative colitis.",
         "label": 1,
         "prediction": 1,
         "rationale": "YAP (Yes-associated protein) and TAZ (WWTR1, or Tafazzin) are transcriptional regulators that play crucial roles in various biological processes, including development, tissue homeostasis, and cancer. YAP/TAZ is required in intestinal regeneration in mouse models of ulcerative colitis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is YAP/TAZ?",
               "answer": "YAP (Yes-associated protein) and TAZ (WWTR1, or Tafazzin) are transcriptional regulators that play crucial roles in various biological processes, including development, tissue homeostasis, and cancer. They are involved in the growth of organs, amplification of progenitor cells during tissue renewal and regeneration, and",
               "rationale": "1. The transcriptional regulators YAP and TAZ are the focus of intense interest given their remarkable biological properties in development, tissue homeostasis and cancer. YAP and TAZ activity is key for the growth of whole organs, for amplification of tissue-specific progenitor cells during tissue renewal and regeneration, and for cell proliferation. In tumors, YAP/TAZ can reprogram cancer cells ...\n2. YAP/TAZ lay at the center of a complex regulatory network including cell-autonomous factors but also cell- and tissue-level structural features such as the mechanical properties of the cell microenvironment, the establishment of cell-cell junctions and of basolateral tissue polarity. Enhanced levels and activity of YAP/TAZ are observed in ...\n3. YAP/TAZ are required for growth of embryonic tissues, wound healing and organ regeneration, where they are activated by cell-intrinsic and extrinsic cues. Surprisingly, this activity is dispensable in many adult self-renewing tissues, where YAP/TAZ are constantly kept in check. YAP/TAZ lay at the center of a complex regulatory network including ...\n4. YAP and TAZ function as signaling manifolds in the nucleus and the cytoplasm. The Hippo pathway interacts on multiple levels with many other signaling pathways and organelles. The Hippo network is a potent regulator of tissue regeneration and stem cell biology. Go to:\n5. YAP/TAZ regulation inside and outside the nucleus. a) Regulation of YAP/TAZ transcriptional activities inside the nucleus. YAP/TAZ are transcriptional co-factors that are recruited to enhancer elements on chromatin by TEAD proteins, and act in concert with other transcription factors (e.g. AP-1) to assemble chromatin modifiers and readers ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is YAP/TAZ required in intestinal regeneration in mouse models of ulcerative colitis?",
               "answer": "Yes, YAP/TAZ is required in intestinal regeneration in mouse models of ulcerative colitis. The evidence indicates that YAP is significantly enhanced during epithelial regeneration in a murine colitis model, and it plays a crucial role in maintaining proliferation and preventing premature differentiation of TA cells, which are important for regeneration.",
               "rationale": "1. We conclude that extensive transcriptional rewiring occurs upon regeneration in human ulcerative colitis and following DSS-induced colitis in mouse models. ... we tested the requirement of YAP/TAZ in intestinal organoid engraftment into a damaged epithelium, a proxy of regenerative medicine application for ulcerative colitis. ...\n2. We first observed that YAP was significantly reduced in 62.5% (45/72) of human UC tissues and it was dramatically enhanced during epithelial regeneration in a murine colitis model.\n3. Using a mouse model of stem cell-based incisor renewal, Hsien Hu et al. found that YAP and TAZ were required to maintain proliferation and prevent premature differentiation of TA cells. FAK activates YAP signaling and induces YAP nuclear localization with subsequent activation of mTOR signaling, thereby promoting TA cell proliferation.\n4. Defects in epithelial regeneration, epithelial damage, and excessive intestinal permeability are well-known features of intestinal inflammatory conditions such as celiac disease and IBD [109, 110 ...\n5. Accelerating intestinal epithelial repair to achieve endoscopic mucosal healing has become a key goal in UC. Yes-associated protein (YAP) is a key transcriptional coactivator that regulates organ size, tissue growth and tumorigenesis. Growing studies have focused on the role of YAP in intestinal epithelial regeneration.",
               "predicate": null
            }
         ],
         "row": 495,
         "id": 411678878682498472
      },
      {
         "claim": "aPKCz causes tumour suppression by affecting glutamine metabolism.",
         "label": 1,
         "prediction": 0,
         "rationale": "aPKCz (atypical Protein Kinase C zeta) is a protein that plays a role in establishing cell polarity, particularly in migrating cells, and is involved in the regulation of cell shape and adhesion. It is not possible to determine whether aPKCz affects glutamine metabolism based on the provided information. There is no evidence to suggest that aPKCz causes tumor suppression. The provided evidence does not mention aPKCz or its role in tumor suppression. There is no evidence to suggest that aPKCz is involved in regulating glutamine metabolism in the context of tumor suppression. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is aPKCz?",
               "answer": "aPKCz (atypical Protein Kinase C zeta) is a protein that plays a role in establishing cell polarity, particularly in migrating cells. It is involved in the regulation of cell shape and adhesion, as indicated by its expression in different tissues and its localization in embryos. The evidence suggests that aPK",
               "rationale": "1. Rep. Cori Bush (D-Mo.) vowed revenge on a top pro-Israel PAC after she lost the primary in her reelection campaign Tuesday. The group boosted her opponent in a tightly contested race, knocking off …\n2. aPKCz ¡/ cells were round in shape, and only a few cells adhered tothe substrate.This contrasted withthe control cells, most of which adhered to the substrate, leaving only a few round cells detached. Quantiﬁcation of the number of adherent cells indicated that only 18% of aPKCz ¡/ cells adhered to the dish surface, compared to\n3. Max projections of all confocal sections from a single embryo are shown (n = embryos). (H) aPKCz staining in embryos lacking maternal Wwtr1 and Yap1, either heterozygous for zygotic Wwtr1 and Yap1 or with no zygotic Wwtr1 and Yap1. aPKC is not localized to the apical membrane of embryos with no zygotic Wwtr1 and Yap1 (n = embryos).\n4. At present it is unclear if the two isotypes of aPKC, aPKCz, and aPKCi/l, have separate or overlapping function. To examine which aPKCs are expressed in skin, reverse transcription PCR (RT-PCR) was performed. Both aPKCz and aPKCi/l RNA were found in total skin (Figure 3a). Upon separation of the epidermis and dermis, expression of both\n5. aPKCz in establishing cell polarity in migrating cells.3,4 Front-back polarization of migrating cells results in two deﬁned regions: a pro-trusive area in the direction of migration and a retracting rear (Fig. 2).1 NMIIA and NMIIB reside outside of protrusions and are largely absent from the lamellipo-diuma, acting at a distance to regulate cell",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does aPKCz affect glutamine metabolism?",
               "answer": "The provided evidence snippets do not specifically mention aPKCz or its effects on glutamine metabolism. Therefore, based on the information given, it is not possible to determine whether aPKCz affects glutamine metabolism. Further research or evidence would be needed to answer this question.",
               "rationale": "1. Glutamine has a versatile role in cell metabolism, participating in tricarboxylic acid (TCA) cycle supplementation and the biosynthesis of nucleotides, glutathione (GSH), and other nonessential ...\n2. Among the 20 amino acids detailed in the genetic code, glutamine provides the best example of the versatility of amino acid metabolism and immune function. Glutamine is the most abundant and versatile amino acid in the body, and is of fundamental importance to intermediary metabolism, interorgan nitrogen exchange via ammonia (NH 3) transport ...\n3. The glutamine metabolism goes through glutamate and α-ketoglutarate (AKG). Glutamate can be produced in the mitochondria by glutaminase or transaminases, and in the cytosol through nucleotide synthesis or transaminases. ... This effect does not occur with glutamine, which can feed TCA cycle without NADHc production. More generally, our study ...\n4. The metabolism of amino acids and the cellular energy sensor AMPK are both connected to mTORC1, but the pathway details have not been well defined. Here, the authors show that glutamine metabolism ...\n5. Glutamine, which is a nonessential amino acid (NEAA) due to the endogenous glutamine biosynthesis pathway, is currently considered essential in cancer cells because transformed cells consume glutamine at a rate exceeding that of glutamine biosynthesis 5. Glutamine has a versatile role in cell metabolism, participating in tricarboxylic acid (TCA ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does aPKCz cause tumour suppression?",
               "answer": "The provided evidence snippets do not mention aPKCz or its role in tumor suppression. They focus on tumor suppressor genes, specifically the APC and TP53 genes, and their functions in regulating cell growth and preventing cancer. Therefore, based on the provided evidence, we cannot conclude whether aPKCz causes tumor suppression",
               "rationale": "1. Tumor Suppressor Genes. Tumor suppressor genes help protect your body from cancer. They do that by managing cell growth. When these genes mutate, or change, your cells may multiply uncontrollably and become tumors. Medical researchers are evaluating whether targeted therapy for cancer can reactivate mutated tumor suppressor genes.\n2. The acquisition of biallelic mutations in the APC gene is a rate-limiting step in the development of most colorectal cancers and occurs in the earliest lesions.APC encodes a 312-kDa protein that localizes to multiple subcellular compartments and performs diverse functions. APC participates in a cytoplasmic complex that promotes the destruction of the transcriptional licensing factor β-catenin ...\n3. TP53 is critical for tumour suppression. TP53 functions as a transcription factor that can directly regulate the expression of approximately 500 target genes and indirectly many more.\n4. The acquisition of biallelic mutations in the APC gene is a rate-limiting step in the development of most colorectal cancers and occurs in the earliest lesions. APC encodes a 312-kDa protein that localizes to multiple subcellular compartments and performs diverse functions. APC participates in a cytoplasmic complex that promotes the destruction of the transcriptional licensing factor β ...\n5. Tumor suppressor genes represent the opposite side of cell growth control, normally acting to inhibit cell proliferation and tumor development. In many tumors, these genes are lost or inactivated, thereby removing negative regulators of cell proliferation and contributing to the abnormal proliferation of tumor cells.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is aPKCz involved in tumour suppression?",
               "answer": "The provided evidence snippets do not mention aPKCz (atypical Protein Kinase C zeta) or its role in tumor suppression. The focus is primarily on the APC gene and its protein product, which are involved in tumor suppression, particularly in relation to colorectal cancer. Therefore, based on the provided evidence,",
               "rationale": "1. Adenomatous polyposis coli (APC) has been regarded as a colorectal cancer (CRC) tumor suppressor gene and it is dysregulated at both the germline and somatic level ().The APC gene is located on chromosome 5q21-q22, consists of 8535 nucleotides and spans 21 exons. The APC gene encodes a 310 kDa protein which is composed of 2843 amino acids. . Approximately 75% of the coding sequence is located ...\n2. Molecular pathway. The APC gene codes for the APC protein, a multi-domain protein capable of binding to various cellular proteins. The APC protein is involved in many functions of the cell, with roles in development, tumor suppression, cell adhesion, cellular migration, and chromosome segregation through protein-protein interactions. 46 APC is thought to play a vital role in fetal development.\n3. The APC protein is a negative regulator that controls beta-catenin concentrations and interacts with E-cadherin, which are involved in cell adhesion. Mutations in the APC gene may result in colorectal cancer and desmoid tumors. APC is classified as a tumor suppressor gene. Tumor suppressor genes prevent the uncontrolled growth of cells that may ...\n4. The physical interaction of APC with other proteins such as DLG may also be involved, ... Bienz M. The APC tumour suppressor has a nuclear export function. Nature. 2000; 406 (6799):1009-12. [Google Scholar] 56. Rosin-Arbesfeld R, et al. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription.\n5. The adenomatous polyposis coli (APC) gene is a key tumor suppressor gene. Mutations in the gene have been found not only in most colon cancers but also in some other cancers, such as those of the liver. The APC gene product is a 312 kDa protein that has multiple domains, through which it binds to various proteins, including β-catenin, axin, CtBP, Asefs, IQGAP1, EB1 and microtubules. Studies ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Is aPKCz involved in regulating glutamine metabolism in the context of tumour suppression?",
               "answer": "The provided evidence snippets do not mention aPKCz or its involvement in regulating glutamine metabolism in the context of tumor suppression. The focus of the evidence is primarily on the role of glutamine in cancer metabolism, tumor progression, and immune cell function, but there is no specific reference to aPKCz or its",
               "rationale": "1. In this review, we summarize the mechanism(s) involved at each step of glutamine metabolism, from glutamine transporters to redox homeostasis, and highlight areas that can be exploited for ...\n2. Given its important role in cell metabolism, the ability to monitor and model the glutamine metabolic pathways are highlighted. Novel, label free approaches have the potential to revolutionise metabolic biosensing, laying the foundation for a new paradigm in metabolomics research and addressing the challenges in monitoring metabolic pathways in ...\n3. 2. Effect of glutamine on tumour metastasis through synthesis and metabolism. Since the 1950s, it has been noted that tumour cells consume large amounts of glutamine [].A series of follow-up studies described the role of glutamine in the TCA carbon replenishment pathway, NADPH production, nucleic acid synthesis, and other aspects.\n4. Glutamine metabolism plays a pivotal role in cancer progression, immune cell function, and the modulation of the tumor microenvironment. Dysregulated glutamine metabolism has been implicated in cancer development and immune responses, supported by mounting evidence. Cancer cells heavily rely on glutamine as a critical nutrient for survival and proliferation, while immune cells require ...\n5. Abstract. Metabolic abnormalities are an important feature of tumours. The glutamine-arginine-proline axis is an important node of cancer metabolism and plays a major role in amino acid metabolism. This axis also acts as a scaffold for the synthesis of other nonessential amino acids and essential metabolites.",
               "predicate": null
            }
         ],
         "row": 496,
         "id": 314013102836998481
      },
      {
         "claim": "cSMAC formation represses weak ligand signalling.",
         "label": 0,
         "prediction": 0,
         "rationale": "cSMAC formation refers to the creation of the central supramolecular activation cluster at the immunological synapse, characterized by the clustering of T cell receptors and other signaling molecules. cSMAC formation enhances signaling by weak ligands. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is cSMAC formation?",
               "answer": "cSMAC formation refers to the creation of the central supramolecular activation cluster (cSMAC) at the immunological synapse, which is the interface between a T cell and an antigen-presenting cell. This structure is characterized by the clustering of T cell receptors (TCRs) and other signaling molecules,",
               "rationale": "1. Using manuipulations that enhance cSMAC formation, it was shown that cSMAC formation could enhance signaling by weak ligands (Cemerski et al. 2007). Although the efficiency of cSMAC formation is related to antigen quality, suggesting that cSMACs do not form in the presence of weak ligands, evidence suggests that nonTCR stimuli can allow for ...\n2. Alternatively, cSMAC formation may simply be a consequence of the intensity of TCR signalling, serving to internalize and down-regulate the TCR from the ISs. Accordingly, weak agonists would form cSMACs in which tyrosine phosphorylation persists because the TCR is not internalized.\n3. TCR engagement leads to suppression of T-cell locomotion, formation of a specialized junction, ... Thus, the cSMAC can be divided into two components: the endo-cSMAC in which TCR and CD28 continue to signal and the exo-cSMAC, composed of TCR-enriched extracellular vesicles. We have found that the checkpoint receptor PD-1 is highly enriched in ...\n4. Synapse formation was induced by Staphylococcal enterotoxin E superantigen. In immunology, an immunological synapse (or immune synapse) is the interface between an antigen-presenting cell or target cell and a lymphocyte such as a T cell, B cell, or natural killer cell. The interface was originally named after the neuronal synapse, with which it ...\n5. The formation of the cSMAC has been shown to depend not only on F-actin flow, with inhibitors of F-actin including latrunculin A and jasplakinolide preventing TCR clustering 14,15,16, but also on ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of cSMAC formation on weak ligand signalling?",
               "answer": "The effect of cSMAC formation on weak ligand signaling is that it can enhance signaling despite the weak quality of the ligands. Specifically, manipulations that enhance cSMAC formation have been shown to improve signaling by weak ligands (as indicated in evidence 1). However, it is also noted that the efficiency of",
               "rationale": "1. Only subsequently, would the cSMAC enhance degradation. Using manuipulations that enhance cSMAC formation, it was shown that cSMAC formation could enhance signaling by weak ligands (Cemerski et al. 2007). Although the efficiency of cSMAC formation is related to antigen quality, suggesting that cSMACs do not form in the presence of weak ligands ...\n2. Our computational model of cSMAC function predicted that cSMAC formation has different effects depending on whether the peptide quality is strong versus weak (Cemerski et al., 2007). Previously, we took advantage of our finding that engagement of the receptor NKG2D can induce cSMAC formation regardless of whether antigen is present or not ...\n3. The role of the center of the immunological synapse (the central supramolecular activation cluster or cSMAC) is controversial. One model suggests that the role of the cSMAC depends on antigen quality and can both enhance signaling and receptor downregulation, whereas a second model proposes that the sole function of the cSMAC is to downregulate signaling. An important distinction between the ...\n4. Interestingly, TCR signalling has been detected in microclusters formed in the dSMAC area and it extinguishes as the TCRs reach the cSMAC. Hence, it appears that TCR signalling and full T-cell activation do not require the formation of the cSMAC and that this structure may rather play a role in TCR down-regulation, as well as participating in ...\n5. For instance, extracellular domain size is important for forming and maintaining the conventional IS; proteins with large extracellular domains and no ligand in the cell-cell contact zone, such as the phosphatase CD45, are excluded from the central SMAC (cSMAC) and pushed out into the distal SMAC (dSMAC; Fig. 3) .",
               "predicate": null
            }
         ],
         "row": 497,
         "id": 460413815283693963
      },
      {
         "claim": "mcm 5 s 2 U is required for proper decoding of NNR codons in eukaryotes.",
         "label": 1,
         "prediction": 1,
         "rationale": "Mcm5s2U, or 5-methoxycarbonylmethyl-2-thiouridine, is a modified nucleoside found in tRNA, formed through a complex pathway involving the proteins Trm9 and Trm112. The role of mcm5s2U in eukaryotes is to play a critical part in proper mRNA decoding and efficient protein synthesis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is mcm 5 s 2 U?",
               "answer": "mcm 5 s 2 U, or 5-methoxycarbonylmethyl-2-thiouridine, is a modified nucleoside found in tRNA. It is formed through a complex pathway involving the proteins Trm9 and Trm112, which play a crucial role in the final step",
               "rationale": "1. Unexpected accumulation of ncm 5 U and ncm 5 S 2 U in a trm9 mutant suggests an additional step in the synthesis of mcm 5 U and mcm 5 S 2 U. PLoS One 6: e20783. [PMC free article] [Google Scholar] Chen C, Huang B, Eliasson M, Ryden P, Byström AS. 2011b.\n2. Conclusions. Trm9p and Trm112p function together at the final step in formation of mcm 5 U in tRNA by using the intermediate cm 5 U as a substrate. In tRNA isolated from trm9Δ and trm112Δ strains, ncm 5 U and ncm 5 s 2 U nucleosides accumulate, questioning the order of nucleoside intermediate formation of the mcm 5 side chain.\n3. The Manual for Courts-Martial (MCM), United States (2024 edition) updates the MCM (2019 edition) and MCM (2023 edition). It is a complete republishing and incorporates the ... Justice's website at https://jsc.defense.gov. JOINT SERVICE COMMITTEE ON MILITARY JUSTICE . i\n4. Section 5. art V of the Manual for Courts-Martial, United States is amended and reads as followsS. Part V o. the Manual for Courts-Martial, United States is amended and reads as follows:Ge. era. A. thority.\n5. (mcm 5U) or 5-methoxycarbonylmethyl-2-thiouridine (mcm s2U). The formation of mcm and ncm5 side chains involves a complex pathway, where the last step in formation of mcm 5is a methyl esterification of cm dependent on the Trm9 and Trm112 proteins.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the role of mcm 5 s 2 U in eukaryotes?",
               "answer": "The role of mcm5s2U in eukaryotes is to play a critical part in proper mRNA decoding and efficient protein synthesis. Specifically, the modification of wobble uridines in tRNAs to mcm5s2U enhances the accuracy and efficiency of translation during protein synthesis.",
               "rationale": "1. The post-transcriptional modification of tRNA at the wobble position is a universal process occurring in all domains of life. In eukaryotes, the wobble uridine of particular tRNAs is transformed to the 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) modification ...\n2. The post-transcriptional modification of tRNAs at the wobble position plays a critical role in proper mRNA decoding and efficient protein synthesis. In particular, certain wobble uridines in eukaryotes are converted to 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U). The mcm5s2U modification modulat …\n3. The minichromosome maintenance (or MCM) protein family is composed of six related proteins that are conserved in all eukaryotes. They were first identified by genetic screens in yeast and subsequently analyzed in other experimental systems using molecular and biochemical methods. Early data led to the identification of MCMs as central players ...\n4. ABSTRACT. The exact duplication of a genome once per cell division is required of every proliferating cell. To achieve this goal, eukaryotes adopt a strategy that limits every replication origin to a single initiation event within a narrow window of the cell cycle by temporally separating the assembly of the pre-replication complex (pre-RC) from the initiation of DNA synthesis. A key component ...\n5. The MCM complex controls the once per cell cycle DNA replication in eukaryotic cells. In a process known as DNA replication licensing, it primes chromatin for DNA replication by binding origins of DNA replication during the late M to early G1 phase of the cell cycle. Activated by S phase promoting protein kinases, the origin-bound MCM complexes ...",
               "predicate": null
            }
         ],
         "row": 498,
         "id": 807180679645849126
      },
      {
         "claim": "miR-142-5P is a known regulator of raised body temperature.",
         "label": 1,
         "prediction": 0,
         "rationale": "miR-142-5p is a microRNA involved in regulating cell proliferation, migration, and invasion, particularly in breast cancer, and is characterized as a low-expressed miRNA in this context. miR-142-5p is involved in the regulation of body temperature. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is miR-142-5P?",
               "answer": "miR-142-5p is a microRNA (miRNA) that is involved in the regulation of various biological processes, including cell proliferation, migration, and invasion, particularly in the context of breast cancer. It is characterized as a low-expressed miRNA in breast cancer and has been shown to have a role",
               "rationale": "1. MiR-142-5p Promotes Breast Cancer Cells Proliferation, Migration, and Invasion. In order to explore the effect of miR-142-5p on breast cancer cells, first, we attempted to up-/downregulated miR-142-5p in breast cancer cells with mimics/inhibitors. Quantitative RT-PCR was used to detect the relative expression of miR-142-5p after the cells were ...\n2. MicroRNA-142-5p (miR-142-5p) is a low-expressed miRNA in breast cancer. The role of MKL-1's regulation of DNMT1 in breast cancer cell proliferation and migration is still unclear. MKL-1 (myocardin related transcription factor A) can bind to the conserved cis -regulatory element CC (A/T) 6GG (called CarG box) in the promoter to regulate the ...\n3. MicroRNAs (miRNAs) are a type of non-coding RNA whose dysregulation is frequently associated with the onset and progression of human cancers. miR-142, an ultra-conserved miRNA with both active -3p and -5p mature strands and wide-ranging physiological targets, has been the subject of countless studies over the years. Due to its preferential expression in hematopoietic cells, miR-142 has been ...\n4. So, miR-142-5p overexpression can enhance anti-tumor immunity by blocking PD-L1/PD-1 pathway. Our results identify a novel mechanism by which PD-L1 is regulated by miR-142-5p and overexpression of miR-142-5p could enhance the anti-tumor immunity. Keywords: Pancreatic cancer; Programmed ...\n5. The miR-142-5p expression level was measured using the TaqMan miRNA assay (Applied Biosystems; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. The miRNA expression levels were quantified to RNU48 expression. The relative miR-142-5p expression level was calculated by the 2 −ΔΔCq method . The RT-qPCR reaction ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is miR-142-5p involved in the regulation of body temperature?",
               "answer": "Yes, miR-142-5p is involved in the regulation of body temperature. The evidence indicates that RBM3 regulates temperature-sensitive miR-142-5p, which plays a role in controlling fever and fine-tuning pyrogen levels during fever.",
               "rationale": "1. The increase in body temperature is initiated and regulated by numerous cytokines that act either as pyrogens or antipyretics . ... miR-143 is involved in the regulation of multiple pyrogens including TLR2 , PGE2 ... temperature-sensitive miR-142-5p and miR-143 were shown to be key regulators of pyrexia. When RBM3 levels decrease, the ...\n2. RBM3 regulates temperature sensitive miR-142-5p and miR-143 (thermomiRs), which target immune genes and control fever Nucleic Acids Res. 2016 Apr 7;44(6):2888-97. doi: 10.1093/nar/gkw041. Epub 2016 Jan 28. Authors Justin J-L Wong 1 ... Body Temperature Regulation / genetics\n3. MiR-142 is involved in lineage differentiation of hematopoietic cells. ... This study delineates the molecular aspects involved in regulating body temperature during fever. The RBM3-miR142-5p-cytokine axis fine-tunes pyrogen levels during fever, and dampens the excessive ... RBM3 regulates temperature sensitive miR-142-5p and miR-143 ...\n4. MicroRNAs (miRNAs) are a type of non-coding RNA whose dysregulation is frequently associated with the onset and progression of human cancers. miR-142, an ultra-conserved miRNA with both active -3p and -5p mature strands and wide-ranging physiological targets, has been the subject of countless studies over the years. Due to its preferential expression in hematopoietic cells, miR-142 has been ...\n5. Abstract. Fever is commonly used to diagnose disease and is consistently associated with increased mortality in critically ill patients. However, the molec",
               "predicate": null
            }
         ],
         "row": 499,
         "id": 170867950764845285
      },
      {
         "claim": "miR-142-5P is a temperature-sensitive microRNA (miRNA).",
         "label": 1,
         "prediction": 1,
         "rationale": "miR-142-5p is a microRNA involved in regulating cell proliferation, migration, and invasion, particularly in breast cancer, and is characterized as a low-expressed miRNA in this context. miR-142-5p is temperature-sensitive. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is miR-142-5P?",
               "answer": "miR-142-5p is a microRNA (miRNA) that is involved in the regulation of various biological processes, including cell proliferation, migration, and invasion, particularly in the context of breast cancer. It is characterized as a low-expressed miRNA in breast cancer and has been shown to enhance anti-t",
               "rationale": "1. MiR-142-5p Promotes Breast Cancer Cells Proliferation, Migration, and Invasion. In order to explore the effect of miR-142-5p on breast cancer cells, first, we attempted to up-/downregulated miR-142-5p in breast cancer cells with mimics/inhibitors. Quantitative RT-PCR was used to detect the relative expression of miR-142-5p after the cells were ...\n2. MicroRNA-142-5p (miR-142-5p) is a low-expressed miRNA in breast cancer. The role of MKL-1's regulation of DNMT1 in breast cancer cell proliferation and migration is still unclear. MKL-1 (myocardin related transcription factor A) can bind to the conserved cis -regulatory element CC (A/T) 6GG (called CarG box) in the promoter to regulate the ...\n3. MicroRNAs (miRNAs) are a type of non-coding RNA whose dysregulation is frequently associated with the onset and progression of human cancers. miR-142, an ultra-conserved miRNA with both active -3p and -5p mature strands and wide-ranging physiological targets, has been the subject of countless studies over the years. Due to its preferential expression in hematopoietic cells, miR-142 has been ...\n4. So, miR-142-5p overexpression can enhance anti-tumor immunity by blocking PD-L1/PD-1 pathway. Our results identify a novel mechanism by which PD-L1 is regulated by miR-142-5p and overexpression of miR-142-5p could enhance the anti-tumor immunity. Keywords: Pancreatic cancer; Programmed ...\n5. The miR-142-5p expression level was measured using the TaqMan miRNA assay (Applied Biosystems; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. The miRNA expression levels were quantified to RNU48 expression. The relative miR-142-5p expression level was calculated by the 2 −ΔΔCq method . The RT-qPCR reaction ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is miR-142-5p temperature-sensitive?",
               "answer": "Yes, miR-142-5p is temperature-sensitive. The evidence indicates that when RBM3 levels decrease, the expression of miR-142-5p (along with miR-143) increases dramatically, suggesting its role as a temperature-sensitive microRNA (thermomiR) that regulates pyrex",
               "rationale": "1. Reduced RBM3 expression resulted in increased expression of RBM3-targeted temperature-sensitive miRNAs, we termed thermomiRs. ThermomiRs such as miR-142-5p and miR-143 in turn target endogenous pyrogens including IL-6, IL6ST, TLR2, PGE2 and TNF to complete a negative feedback mechanism, which may be crucial to prevent pathological hyperthermia.\n2. In our model, temperature-sensitive miR-142-5p and miR-143 were shown to be key regulators of pyrexia. When RBM3 levels decrease, the expression of these 'thermomiRs' increases dramatically. In turn these 'thermomiRs' target the pyrogens that cause the increase in body temperature.\n3. In our model, temperature-sensitive miR-142-5p and miR-143 were shown to be key regulators of pyrexia. When RBM3 levels decrease, the expression of these 'thermomiRs' increases dramatically. In turn these 'thermomiRs' target the pyrogens that cause the increase in body temperature.\n4. The classical stem-loop structure of miR142 encodes for two species of mature microRNAs; miR142-5p and miR142-3p. MiR-142 is abundant in cells of hematopoietic origin, and therefore, aptly plays a role in lineage differentiation of hematopoietic cells. ... RBM3 regulates temperature sensitive miR-142-5p and miR-143 (thermomiRs), which ...\n5. Background: Numerous researches have demonstrated that miR-142-5p plays significant roles in several cancers, although the functional characteristic of miR-142-5p in breast cancer has not been determined. This study is designed to explore the biological significance of miR-142-5p in breast cancer clinical implication and mechanism of action.",
               "predicate": null
            }
         ],
         "row": 500,
         "id": 948993292045961312
      },
      {
         "claim": "miRNAs enforce homeostasis by suppressing low-level ''leaky'' transcription.",
         "label": 1,
         "prediction": 1,
         "rationale": "MicroRNAs (miRNAs) are small, single-stranded, non-coding RNA molecules that play a crucial role in the post-transcriptional regulation of gene expression, influencing various cellular activities. MicroRNAs (miRNAs) play a crucial role in regulating gene expression by binding to target mRNAs and controlling their translation. miRNAs counteract \"leaky\" transcription by repressing leaky transcripts and enforcing spatial domains of target gene expression. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are miRNAs?",
               "answer": "MicroRNAs (miRNAs) are small, single-stranded, non-coding RNA molecules that typically contain 21 to 23 nucleotides. They play a crucial role in the post-transcriptional regulation of gene expression, influencing various cellular activities such as cell growth, differentiation, development, and apoptosis. miRNAs",
               "rationale": "1. Pre-miRNA instead of Pri-miRNA in the first point of mechanism. Diagram of microRNA (miRNA) action with mRNA Examples of miRNA stem-loops, with the mature miRNAs shown in red. MicroRNA (miRNA) are small, single-stranded, non-coding RNA molecules containing 21 to 23 nucleotides. Found in plants, animals and some viruses, miRNAs are involved in RNA silencing and post-transcriptional regulation ...\n2. MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function in posttranscriptional regulation of gene expression. They are powerful regulators of various cellular activities including cell growth, differentiation, development, and apoptosis. They have been linked to many diseases, and currently miRNA-mediated clinical trial has shown ...\n3. Biogenesis of miRNAs. miRNA biogenesis starts with the processing of RNA polymerase II/III transcripts post- or co-transcriptionally ().About half of all currently identified miRNAs are intragenic and processed mostly from introns and relatively few exons of protein coding genes, while the remaining are intergenic, transcribed independently of a host gene and regulated by their own promoters ...\n4. As endogenous miRNAs vary widely in their biogenesis efficiency (Fig. 2a-c), including diverse miRNAs in future cryo-EM studies will be informative for both Microprocessor and Dicer substrates.\n5. microRNA - What It Is and How It Works. microRNA is the name of a family of molecules that helps cells control the kinds and amounts of proteins they make. That is, cells use microRNA to help control gene expression. Molecules of microRNA are found in cells and in the bloodstream. (Note: microRNA is abbreviated \"miRNA,\" but here we will use ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What role do miRNAs play in gene expression?",
               "answer": "MicroRNAs (miRNAs) play a crucial role in regulating gene expression. They are small non-coding RNA molecules that do not encode proteins but are involved in the post-transcriptional regulation of a large proportion of the transcriptome. miRNAs are transcribed from DNA sequences and processed into mature forms that can bind to",
               "rationale": "1. MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In ...\n2. This review provides an overview and update on miRNAs biogenesis, regulation of miRNAs expression, their biological functions, and role of miRNAs in epigenetics and cell-cell communication. In addition, alteration of miRNAs following exercise, their association with diseases, and therapeutic potential will be explained.\n3. Abstract. Ever since microRNAs (miRNAs) were first recognized as an extensive gene family >20 years ago, a broad community of researchers was drawn to investigate the universe of small regulatory ...\n4. INTRODUCTION MicroRNAs (miRNAs) are small non-coding ribonucleic acid (RNA) molecules that do not encode proteins. These molecules have drawn attention in the last few years due their role in gene expression regulation and involvement in diseases, such as cancer.\n5. MicroRNAs (miRNAs) are key regulators of gene expression. They are conserved across species, expressed across cell types, and active against a large proportion of the transcriptome. The sequence-complementary mechanism of miRNA activity exploits combinatorial ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of miRNAs on \"leaky\" transcription?",
               "answer": "miRNAs counteract \"leaky\" transcription by repressing leaky transcripts and enforcing spatial domains of target gene expression that are initially defined by transcription factors. They help to reinforce the transcriptional gene expression program and can function within regulatory networks to suppress the effects of transient or weak signaling cues that may lead to leaky transcription",
               "rationale": "1. Signalling cues that are too transient or weak to result in full activation may cause leaky transcription of the target gene (left panel). ... (buffering effect) 49. miRNAs in signalling networks. ...\n2. Through this mechanism, miRNAs are thought to counteract 'leaky' transcription and to enforce spatial domains of target gene expression that are initially defined by transcription factors 110. In ...\n3. The cluster is encoded within about 1 kilo base on chromosome 13 and contains six miRNAs. The transcription of the miRNA cluster can be induced by E2F while some members of the cluster inhibit E2F at the post-transcriptional level, ... (Table 1 preventing leaky transcription). ... Similar effect can be transmitted to Target 2, ...\n4. To gain an understanding of the coordinated effects of TFs and miRNAs, it is critical to delineate and characterize the genome-scale regulatory networks in which these regulators operate. ... Coherent feed-forward loops involving TFs and miRNAs can function to suppress leaky transcription or as toggle switches where an initial signal can be ...\n5. This suggests that miRNAs can act to reinforce the transcriptional gene expression program by repressing leaky transcripts. ... component A activates component B and component B inhibits component A. Genome-wide mapping of interactions between transcription factors and miRNAs in C. elegans ... This noise reduction effect was achieved in ...",
               "predicate": null
            }
         ],
         "row": 501,
         "id": 249865202697676299
      },
      {
         "claim": "siRNA knockdown of A20 accelerates tumor progression in an in vivo murine xenograft model.",
         "label": 0,
         "prediction": 0,
         "rationale": "The Samsung Galaxy A20 is an Android smartphone developed by Samsung Electronics, announced in March 2019 and launched in April 2019, featuring a 6.4-inch display, Exynos 7884 chipset, 4000 mAh battery, 32 GB internal storage, and 3 GB RAM. A20 is a protein. Silencing A20 via siRNA knockdown in an in vivo murine xenograft model promotes a pro-inflammatory environment that inhibits tumor progression. siRNA knockdown of A20 does not accelerate tumor progression in the in vivo murine xenograft model. The siRNA knockdown of A20 expression slowed tumor growth in glioma xenograft mice, suggesting that A20 may act as a tumor suppressor in this context. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is A20?",
               "answer": "The Samsung Galaxy A20 is an Android smartphone developed by Samsung Electronics, announced in March 2019 and launched in April 2019. It features a 6.4-inch display, Exynos 7884 chipset, 4000 mAh battery, 32 GB internal storage, and 3 GB RAM.",
               "rationale": "1. Samsung Galaxy A20 Android smartphone. Announced Mar 2019. Features 6.4″ display, Exynos 7884 chipset, 4000 mAh battery, 32 GB storage, 3 GB RAM, Corning Gorilla Glass 3.\n2. The A20 also trailed the Moto G7 Power and its Snapdragon 632 processor, which scored 4,814 on Geekbench. Operating one app at a time is the only way to prevent lag on the A20.\n3. The Samsung Galaxy A20 is an Android smartphone developed by Samsung Electronics, launched in April 2019. [2] It runs on the Android 9 (Pie) operating system with One UI. The Galaxy A20 model has 32 GB internal storage, 3 GB RAM, and a 4000 mAh battery. [2] It is a successor to the previous smartphone models by Samsung, Galaxy J6 and Galaxy A6. [3]\n4. has built-in optical image stabilization. Samsung Galaxy A15. Samsung Galaxy A20. Optical image stabilization uses gyroscopic sensors to detect the vibrations of the camera. The lens adjusts the optical path accordingly, ensuring that any type of motion blur is corrected before the sensor captures the image.\n5. Brighter displays ensure a screen's contents are easy to read, even in sunny conditions. has branded damage-resistant glass. Samsung Galaxy A20. Samsung Galaxy S20. Damage-resistant glass (such as Corning Gorilla Glass or Asahi Dragontrail Glass) is thin, lightweight, and can withstand high levels of force.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is A20 a protein?",
               "answer": "Yes, A20 is a protein.",
               "rationale": "1. TNFAIP3. Tumor necrosis factor, alpha-induced protein 3 or A20 is a protein that in humans is encoded by the TNFAIP3 gene. [5] [6] This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and a deubiquitinating enzyme, and has been shown ...\n2. A20, also known as TNFAIP3, is a potent regulator of ubiquitin (Ub) dependent signals. A20 prevents multiple human diseases, indicating that the critical functions of this protein are clinically as well as biologically impactful. As revealed by mouse models, cell specific functions of A20 are linked to its ability to regulate diverse signaling ...\n3. A20, also known as TNFAIP3, is a potent regulator of ubiquitin (Ub) dependent signals. A20 prevents multiple human diseases, indicating that the critical functions of this protein are clinically as well as biologically impactful. As revealed by mouse models, cell specific functions of A20 are linked to its ability to regulate diverse signaling ...\n4. A20, also known as TNF-α-induced protein 3 (TNFAIP3), is an anti-inflammatory protein that plays an important part in both immune responses and cell death. Impaired A20 function is associated with several human inflammatory and autoimmune diseases. Although the role of A20 in mediating inflammation has been frequently discussed, its intrinsic link to arthritis awaits further explanation. Here ...\n5. By contrast, the mechanism by which A20 supports cell death in activated B cells may involve A20 inhibiting NF-κB-dependent expression of the anti-apoptotic protein BCL-X.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of siRNA knockdown of A20 on tumor progression in an in vivo murine xenograft model?",
               "answer": "The siRNA knockdown of A20 in an in vivo murine xenograft model enhances the induction of NFκB activity triggered by CpG, which suggests that silencing A20 may promote a more pro-inflammatory environment that could inhibit tumor progression. Specifically, the evidence indicates that A20 silencing leads to increased",
               "rationale": "1. A20 promotes melanoma growth by regulating cell-cycle progression. We then explored the biological function of A20 in melanoma. Lentiviral transfection was employed to obtain stable knockdown of ...\n2. A20-silenced DCs showed spontaneous and enhanced expression of costimulatory molecules and proinflammatory cytokines and had different effects on T cell subsets: they inhibited T reg cells and ...\n3. A20 syngeneic murine model (subcutaneous and metastatic) Chronic lymphocytic leukemia (CLL) is caused by a defect in apoptosis that involves the overexpression of antiapoptotic B-cell lymphoma-2 (BCL-2) family members BCL-2. Preclinical xenograft models are instrumental for investigating novel treatment regimens. The A20 cell line was isolated from a spontaneously developed tumor in a BALB/c ...\n4. In the present study, we demonstrate that a synthetic molecule consisting of a CpG oligonucleotide TLR9 agonist linked to A20-specific siRNAs silences its expression in TLR9+ mouse dendritic cells in vitro and in vivo. In the B16 mouse melanoma tumor model, silencing of A20 enhances the CpG-triggered induction of NFκB activity followed by ...\n5. A20 expression in tumor microenvironment and the knockdown of A20 by si-RNA. (a) The expression of A20 in different cell lines.A20 expression was tested by flow cytometry in E.G7, B16-F10, CT26 ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does siRNA knockdown of A20 accelerate tumor progression in an in vivo murine xenograft model?",
               "answer": "No, siRNA knockdown of A20 does not accelerate tumor progression in the in vivo murine xenograft model. In fact, the evidence suggests that silencing A20 enhances the immune response against the tumor, shifting the balance from immune suppression to immune activation, which is associated with inhibition of tumor growth. Specifically",
               "rationale": "1. In the present study, we demonstrate that a synthetic molecule consisting of a CpG oligonucleotide TLR9 agonist linked to A20-specific siRNAs silences its expression in TLR9+ mouse dendritic cells in vitro and in vivo. In the B16 mouse melanoma tumor model, silencing of A20 enhances the CpG-triggered induction of NFκB activity followed by ...\n2. S3 Fig: Murine melanoma tumor model. B16 melanoma cells (1x10^6) were injected subcutaneously in the right flank of 8-10 week old female C57BL/6 mice. ... As mentioned above, ex vivo A20 knockdown in DCs enhanced stimulatory capacity and inhibitory effects on Tregs. This eventually shifts the balance from immune suppression to immune ...\n3. A20 promotes melanoma growth by regulating cell-cycle progression. We then explored the biological function of A20 in melanoma. Lentiviral transfection was employed to obtain stable knockdown of ...\n4. RNA interference (RNAi) has rapidly become a powerful tool for target discovery and therapeutics. Small interfering RNAs (siRNAs) are highly effective in mediating sequence-specific gene silencing. However, the major obstacle for using siRNAs for cancer therapeutics is their systemic delivery from the administration site to target cells in vivo.\n5. Inhibition in tumor growth of an orthotopic xenograft cancer model has been seen when atelocollagen/siRNA complexes were intratumorally administered . Several factors, such as low toxicity, biodegradability, reduction in immunostimulation, and facile condensation with nucleic acids, contribute to advantages of using natural polymers as delivery ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the effect of siRNA knockdown of A20 on tumor growth in an in vivo murine xenograft model?",
               "answer": "The siRNA knockdown of A20 expression slowed tumor growth in glioma xenograft mice, suggesting that A20 may act as a tumor suppressor in this context.",
               "rationale": "1. There are two widely recognized models of tumor metastasis in terms of time line. One is a linear model, in which metastatic tumor cells colonize different organs at what is widely believed to be ...\n2. A20 expression in tumor microenvironment and the knockdown of A20 by si-RNA. (a) The expression of A20 in different cell lines.A20 expression was tested by flow cytometry in E.G7, B16-F10, CT26 ...\n3. Knockdown of A20 expression slowed tumor growth in glioma xenograft mice [84, 85]. Taken together, the A20 expression profile and the effects of A20 on tumor growth suggest that A20 may act as a tumor suppressor in gliomas. However, in the setting of cancer therapy, A20 displays Janus-like opposing roles.\n4. A20 promotes melanoma growth by regulating cell-cycle progression. We then explored the biological function of A20 in melanoma. Lentiviral transfection was employed to obtain stable knockdown of ...\n5. Inhibition in tumor growth of an orthotopic xenograft cancer model has been seen when atelocollagen/siRNA complexes were intratumorally administered . Several factors, such as low toxicity, biodegradability, reduction in immunostimulation, and facile condensation with nucleic acids, contribute to advantages of using natural polymers as delivery ...",
               "predicate": null
            }
         ],
         "row": 502,
         "id": 902403639670097634
      },
      {
         "claim": "siRNA knockdown of A20 slows tumor progression in an in vivo murine xenograft model.",
         "label": 1,
         "prediction": 1,
         "rationale": "The A20 refers to the Samsung Galaxy A20, an Android smartphone developed by Samsung Electronics, launched in April 2019, featuring a 6.4″ display, Exynos 7884 chipset, 4000 mAh battery, 32 GB storage, and 3 GB RAM. A20 is related to tumor progression. SiRNA knockdown of A20 slows tumor progression in an in vivo murine xenograft model. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is A20?",
               "answer": "The A20 refers to the Samsung Galaxy A20, an Android smartphone developed by Samsung Electronics, launched in April 2019. It features a 6.4″ display, Exynos 7884 chipset, 4000 mAh battery, 32 GB storage, and 3 GB RAM. It runs on",
               "rationale": "1. Samsung Galaxy A20 Android smartphone. Announced Mar 2019. Features 6.4″ display, Exynos 7884 chipset, 4000 mAh battery, 32 GB storage, 3 GB RAM, Corning Gorilla Glass 3.\n2. The A20 also trailed the Moto G7 Power and its Snapdragon 632 processor, which scored 4,814 on Geekbench. Operating one app at a time is the only way to prevent lag on the A20.\n3. The Samsung Galaxy A20 is an Android smartphone developed by Samsung Electronics, launched in April 2019. [2] It runs on the Android 9 (Pie) operating system with One UI. The Galaxy A20 model has 32 GB internal storage, 3 GB RAM, and a 4000 mAh battery. [2] It is a successor to the previous smartphone models by Samsung, Galaxy J6 and Galaxy A6. [3]\n4. has built-in optical image stabilization. Samsung Galaxy A15. Samsung Galaxy A20. Optical image stabilization uses gyroscopic sensors to detect the vibrations of the camera. The lens adjusts the optical path accordingly, ensuring that any type of motion blur is corrected before the sensor captures the image.\n5. The Douglas A-20 Havoc (company designation DB-7) is an American light bomber, attack aircraft, night intruder, night fighter, and reconnaissance aircraft of World War II . Designed to meet an Army Air Corps requirement for a bomber, it was ordered by France for their air force before the USAAC decided it would also meet their requirements.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the A20 in  1 related to tumor progression?",
               "answer": "Yes, A20 is related to tumor progression. The evidence indicates that ectopic expression of A20 is associated with cancer progression, and studies have shown its involvement in various cancers, including its role as an oncogene in breast cancer and its dual roles in solid tumors.",
               "rationale": "1. A20 links glucose metabolism in HCC cell lines. Several studies have shown that ectopic expression of A20 is related to cancer progression. To investigate whether A20 is essential for malignant ...\n2. Several studies have shown that ectopic expression of A20 is related to cancer progression. To investigate whether A20 is essential for malignant progression of HCC, we established A20 overexpressing or knockdown stable Huh7 and LM3 cell lines and their empty vector counterparts (Supplementary Fig. S1a).\n3. Apart from the role in immunity, A20 is also highly related to tumor biology. Up-regulated A20 acted as an oncogene in breast cancer to facilitate epithelial-mesenchymal transition and tumor metastasis via the ubiquitination of Snail1 7. However, the loss of A20 contributed to the progression of MYD88 L265P-driven non-Hodgkin lymphoma 8.\n4. Inflammation-related molecule A20 is closely related to cancer immune response, but the effect of A20 on \"eat-me\" signal and immunotherapy efficacy remains elusive.\n5. A20 is a prototypical anti-inflammatory molecule that is linked to multiple human diseases, including cancers. The role of A20 as a tumor suppressor was first discovered in B cell lymphomas. Subsequent studies revealed the dual roles of A20 in solid cancers. This review focuses on the roles of A20 in different cancer types to demonstrate that ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does siRNA knockdown of A20 slow tumor progression in an in vivo murine xenograft model?",
               "answer": "Yes, the siRNA knockdown of A20 slows tumor progression in an in vivo murine xenograft model. The evidence indicates that silencing A20 enhances the CpG-triggered induction of NFκB activity, which shifts the immune response from suppression to stimulation, thereby potentially slowing tumor progression. Additionally, the",
               "rationale": "1. In the present study, we demonstrate that a synthetic molecule consisting of a CpG oligonucleotide TLR9 agonist linked to A20-specific siRNAs silences its expression in TLR9+ mouse dendritic cells in vitro and in vivo. In the B16 mouse melanoma tumor model, silencing of A20 enhances the CpG-triggered induction of NFκB activity followed by ...\n2. S3 Fig: Murine melanoma tumor model. B16 melanoma cells (1x10^6) were injected subcutaneously in the right flank of 8-10 week old female C57BL/6 mice. ... As mentioned above, ex vivo A20 knockdown in DCs enhanced stimulatory capacity and inhibitory effects on Tregs. This eventually shifts the balance from immune suppression to immune ...\n3. RNA interference (RNAi) has rapidly become a powerful tool for target discovery and therapeutics. Small interfering RNAs (siRNAs) are highly effective in mediating sequence-specific gene silencing. However, the major obstacle for using siRNAs for cancer therapeutics is their systemic delivery from the administration site to target cells in vivo.\n4. A comparison of the biological activities of LNA-modified sisiRNA and siRNA when delivered to cells using a transfection agent showed that sisiRNA suppresses the expression of the target gene by 12% less effectively than siRNA. However, in vivo experiments on the MiaPaca-2 xenograft tumor model in mice showed that LNA-modified sisiRNA and siRNA ...\n5. Atu027 is a siRNA-based lipid nanoparticle that has the ability to knockdown the expression of protein kinase N3 (PKN3). Elevated PKN3 expression is associated with enhanced angiogenesis and tumor metastasis; consequently, silencing PKN3 expression leads to the inhibition of angiogenesis and tumor invasion [ 33, 34 ].",
               "predicate": null
            }
         ],
         "row": 503,
         "id": 331332229230525511
      },
      {
         "claim": "β-sheet opening occurs during pleurotolysin pore formation.",
         "label": 1,
         "prediction": 1,
         "rationale": "Pleurotolysin is a two-component sphingomyelin-specific cytolysin that belongs to the Pleurotolysin Pore-Forming Family, involved in pore formation in membranes, specifically targeting sphingomyelin-cholesterol liposomes. Pleurotolysin pore formation involves β-sheet opening. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is pleurotolysin?",
               "answer": "Pleurotolysin is a two-component sphingomyelin-specific cytolysin that belongs to the Pleurotolysin Pore-Forming Family, which is part of the MACPF superfamily of proteins. It is involved in pore formation in membranes, specifically targeting sphingomyelin-cholesterol liposomes,",
               "rationale": "1. The Pleurotolysin Pore-Forming (Pleurotolysin) Family is a family of pore forming proteins belonging to the MACPF superfamily. Function. Proteins with membrane-attack complex/perforin (MACPF) domains have a variety of biological roles, including defense and attack, organismal development, and cell adhesion and signaling. The distribution of ...\n2. In contrast to other aegerolysins, pleurotolysin is a two-component sphingomyelin-specific cytolysin. 9 Recombinant pleurotolysin A (rPlyA) was expressed in E. coli as a soluble protein with the same molecular mass (17 kDa) and identical N-terminal amino acid sequence as natural PlyA.\n3. Pleurotolysin A specifically bound to sphingomyelin-cholesterol liposomes and caused leakage of the internal carboxyfluorescein in concert with pleurotolysin B. Experiments including solubilization of pleurotolysin-treated erythrocytes with 2% (w/v) SDS at 25 °C and SDS-polyacrylamide gel electrophoresis/Western immunoblotting showed that ...\n4. The pleurotolysin first assembles into rings of 13 subunits, each of which then opens up by about 70° during pore formation. This process is accompanied by refolding and extrusion of two compact regions from each subunit into long hairpins that then zipper together to form an 80-Å wide barrel-shaped channel through the membrane.\n5. Acidic ostreolysin A/pleurotolysin B (OlyA/PlyB, formerly known as ostreolysin (Oly), and basic 20 kDa equinatoxins (EqTs) are cytolytic proteins isolated from the edible mushroom Pleurotus ostreatus and the sea anemone Actinia equina, respectively.Both toxins, although from different sources, share many similar biological activities: (i) colloid-osmotic shock by forming pores in cellular and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does pleurotolysin pore formation involve β-sheet opening?",
               "answer": "Yes, pleurotolysin pore formation involves β-sheet opening. Evidence from the schematic diagram indicates that there are different stages of sheet opening during pore formation, with specific angles of β-sheet opening mentioned (e.g., a 37° rotation angle in the best scoring model and a 70°-opened β-sheet in",
               "rationale": "1. Schematic diagram of sheet opening in pleurotolysin pore formation. (A) PlyA and B monomer structures with coloured shapes indicating the major elements used in flexible fitting. (B) and (C) show the two types of prepore structures found, which can be considered as early and later stages of sheet opening.\n2. The top 20 models (pink for the MACPF β-sheet and grey for HTH region) and best scoring model (red) in the pleurotolysin prepore maps are shown. (B) TMH2 helix lock, in which the best scoring model has a rotation angle (β-sheet opening) of 37° relative to the monomer structure.\n3. (E) Pore model with a 70°-opened β-sheet and membrane-inserted TMH regions. The monomer crystal structure is superimposed on the pore to show the full extent of sheet opening. The colour scheme matches that described in Fig 1, and yellow dashed lines represent disordered TMH regions. This figure has been reproduced from Lukoyanova et al., 2015.\n4. The conserved pore-forming core consists of the bent β-sheet and the TMH domains. (C) PlyB seen edge-on, clearly showing strand β5. Electron microscopy of pleurotolysin pores.\n5. 1. Introduction. Ostreolysin (Oly) and equinatoxins (EqTs) belong to the group of pore-forming proteins with a defined native conformation which, upon an environmental trigger, is changed spontaneously to enable formation of a transmembrane pore consisting of several protein monomers [].Recently, Oly was found to consist of two proteins, ostreolysin A (OlyA) and pleurotolysin B (PlyB ...",
               "predicate": null
            }
         ],
         "row": 504,
         "id": 160712959809024859
      },
      {
         "claim": "1,000 genomes project enables mapping of genetic sequence variation consisting of rare variants with larger penetrance effects than common variants.",
         "label": 1,
         "prediction": 1,
         "rationale": "The 1000 Genomes Project is an international research effort that aimed to create a comprehensive catalogue of human genetic variation by sequencing the genomes of at least 1,000 healthy volunteers from diverse ethnic groups worldwide. The 1000 Genomes Project maps genetic sequence variation, including rare variants. Rare variants have larger penetrance effects than common variants, with rare, penetrant mutations conferring approximately 10-fold larger effects than common variants in the same genes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the 1,000 genomes project?",
               "answer": "The 1000 Genomes Project is an international research effort that aimed to create a comprehensive catalogue of human genetic variation by sequencing the genomes of at least 1,000 healthy volunteers from diverse ethnic groups worldwide. The project, which took place from January 2008 to 2015, utilized whole-genome sequencing and",
               "rationale": "1. The 1000 Genomes Project ( 1KGP ), taken place from January 2008 to 2015, was an international research effort to establish the most detailed catalogue of human genetic variation at the time. Scientists planned to sequence the genomes of at least one thousand anonymous healthy participants from a number of different ethnic groups within the ...\n2. The 1000 Genomes Project created a catalogue of common human genetic variation, using openly consented samples from people who declared themselves to be healthy. The reference data resources generated by the project remain heavily used by the biomedical science community. The International Genome Sample Resource (IGSR) maintains and shares the ...\n3. The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations.\n4. The 1000 Genomes Project is an international research consortium that was set up in 2007 with the aim of sequencing the genomes of at least 1,000 volunteers from multiple populations worldwide in order to improve our understanding of the genetic contribution to human health and disease. Global support was contributed by major institutions ...\n5. The project's goal is to sequence the genomes of at least 1,000 people, discovering both SNPs and structural variants, and to place them in a public database. Creating this unprecedented database is only now possible because of advances in next-generation technologies for sequencing DNA. The map will capture variations in the human genome's ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the 1,000 genomes project map genetic sequence variation consisting of rare variants?",
               "answer": "Yes, the 1000 Genomes Project does map genetic sequence variation, including rare variants. Evidence 4 specifically mentions that the project was designed to bridge the gap of knowledge between rare genetic variants that have a severe effect and common genetic variants that have a mild effect. This indicates that the project encompasses both rare and common",
               "rationale": "1. By characterizing the geographic and functional spectrum of human genetic variation, the 1000 Genomes Project aims to build a resource to help to understand the genetic contribution to disease.\n2. The International Genome Sample Resource The 1000 Genomes Project created a catalogue of common human genetic variation, using openly consented samples from people who declared themselves to be healthy. The reference data resources generated by the project remain heavily used by the biomedical science community.\n3. The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations.\n4. The 1000 Genomes Project was designed to bridge the gap of knowledge between rare genetic variants that have a severe effect predominantly on simple traits (e.g. cystic fibrosis, Huntington disease) and common genetic variants have a mild effect and are implicated in complex traits (e.g. cognition, diabetes, heart disease ).\n5. The 1000 Genomes Project aims to provide a deep characterization of human genome sequence variation as a foundation for investigating the relationship between genotype and phenotype.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do rare variants have larger penetrance effects than common variants?",
               "answer": "Yes, rare variants have larger penetrance effects than common variants. The evidence indicates that rare, penetrant mutations in genes associated with complex traits and common diseases confer approximately 10-fold larger effects than common variants in the same genes.",
               "rationale": "1. A straightforward reconciliation of the effects of rare and common variants supposes that pervasive common variation influences the expression and activity of genes in pathways, establishing the ...\n2. We examined 454,712 exomes for genes associated with a wide spectrum of complex traits and common diseases and observed that rare, penetrant mutations in genes implicated by genome-wide association studies confer ~10-fold larger effects than common variants in the same genes. Consequently, an individual at the phenotypic extreme and at the ...\n3. Joint effects of rare and common variants. A straight forward reconciliation of the effects of rare and common variants supposes that pervasive common variation influences the expression and activity of genes in pathways, establishing the background liability to disease that is then further modified by rare variants with larger effects.\n4. The focus of this review is on the role of rare genetic variants in complex human diseases. Genome-wide association studies (GWASs) have successfully uncovered thousands of robust associations between common variants and complex traits and diseases. As GWAS-based consortia have expanded to include hundreds of thousands of samples [ 1, 2 ], the ...\n5. We examined 454,712 exomes for genes associated with a wide spectrum of complex traits and common diseases and observed that rare, penetrant mutations in genes implicated by genome-wide association studies confer ~10-fold larger effects than common variants in the same genes. Consequently, an individual at the phenotypic extreme and at the ...",
               "predicate": null
            }
         ],
         "row": 505,
         "id": 252914581477601800
      },
      {
         "claim": "1/2000 in UK have abnormal PrP positivity.",
         "label": 1,
         "prediction": 0,
         "rationale": "PrP positivity typically refers to the presence of prion proteins associated with certain diseases, such as prion diseases. The percentage of the UK population with abnormal PrP positivity is not specified. The prevalence of abnormal prion protein positivity in the UK population is estimated to be 237 per million and 493 per million for those exposed to BSE. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PrP positivity?",
               "answer": "The provided evidence snippets do not contain information about \"PrP positivity.\" They focus on platelet-rich plasma (PRP) and its properties, uses, and preparation. \"PrP positivity\" typically refers to the presence of prion proteins (PrP) associated with certain diseases, such as prion diseases, but this",
               "rationale": "1. Platelet-rich plasma (PRP) is a substance that's thought to promote healing when injected. Plasma is a component of your blood that contains special \"factors,\" or proteins, that help your ...\n2. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of plasma protein derived from whole blood, centrifuged to remove red blood cells but retaining platelets. Though promoted for treating various medical conditions, evidence of its benefits was mixed as of 2020 , showing effectiveness in certain conditions ...\n3. What are PRP injections? PRP injections use the patient's blood to stimulate healing, improve pain and restore function after trauma or injury. Blood is drawn from the patient and spun down in a piece of equipment called a centrifuge, so it is composed mostly of a component in the blood called platelets.\n4. \"Platelet-rich plasma (PRP) is an injection derived from the patient's own blood and processed to increase platelet concentration,\" says Michael Baria, M.D., director of the orthobiologics ...\n5. PRP is a substance made from your blood that contains a concentrated number of platelets, the cells that help your blood clot. These platelets also have proteins and growth factors that help repair injuries, encourage healing and improve how your tissue functions. Creating PRP involves spinning a sample of your blood in a machine to separate ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What percentage of the UK population has abnormal PrP positivity?",
               "answer": "The provided evidence does not specify a percentage of the UK population with abnormal PrP positivity. It mentions previous surveys estimating the prevalence of abnormal prion protein (PrP) in the British population exposed to BSE, with figures of 237 per million and 493 per million, but does not provide a specific percentage for",
               "rationale": "1. The Appendix-3 survey was recommended to measure the prevalence of abnormal PrP in population groups thought to have been unexposed to BSE. Immunohistochemistry for abnormal PrP was performed on 29,516 samples from appendices removed between 1962 and 1979 from persons born between 1891 through 1965, and from those born after 1996 that had been ...\n2. Widespread dietary exposure of the population of Britain to bovine spongiform encephalopathy (BSE) prions in the 1980s and 1990s led to the emergence of variant Creutzfeldt-Jakob Disease (vCJD) in humans. Two previous appendectomy sample surveys (Appendix-1 and -2) estimated the prevalence of abnormal prion protein (PrP) in the British population exposed to BSE to be 237 per million and 493 ...\n3. The Appendix-3 survey was recommended to measure the prevalence of abnormal PrP in population groups thought to have been unexposed to BSE. Immunohistochemistry for abnormal PrP was performed on 29,516 samples from appendices removed between 1962 and 1979 from persons born between 1891 through 1965, and from those born after 1996 that had been ...\n4. This followed the observation of PrP positivity in appendix tissue removed from two patients ... The identification of these positive specimens hypothesised that dietary BSE exposure in the UK population may have occurred over a wider time period that initially thought or that there may be a low prevalence of abnormal PrP in lymphoreticular ...\n5. No risk factors for sCJD have been identified, except for ageing and some polymorphisms (for example, codons 129 and 219 of PRNP) 6,20.These polymorphisms might promote the conversion of PrP C ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the prevalence of abnormal PrP positivity in the UK population?",
               "answer": "The prevalence of abnormal prion protein (PrP) positivity in the UK population, based on previous appendectomy sample surveys (Appendix-1 and -2), is estimated to be 237 per million and 493 per million for those exposed to BSE. However, the specific prevalence for the population groups thought to",
               "rationale": "1. The Appendix-3 survey was recommended to measure the prevalence of abnormal PrP in population groups thought to have been unexposed to BSE. Immunohistochemistry for abnormal PrP was performed on 29,516 samples from appendices removed between 1962 and 1979 from persons born between 1891 through 1965, and from those born after 1996 that had been ...\n2. Widespread dietary exposure of the population of Britain to bovine spongiform encephalopathy (BSE) prions in the 1980s and 1990s led to the emergence of variant Creutzfeldt-Jakob Disease (vCJD) in humans. Two previous appendectomy sample surveys (Appendix-1 and -2) estimated the prevalence of abnormal prion protein (PrP) in the British population exposed to BSE to be 237 per million and 493 ...\n3. The Appendix-3 survey was recommended to measure the prevalence of abnormal PrP in population groups thought to have been unexposed to BSE. Immunohistochemistry for abnormal PrP was performed on 29,516 samples from appendices removed between 1962 and 1979 from persons born between 1891 through 1965, and from those born after 1996 that had been ...\n4. Surveys have detected abnormal PrP in the LRS of the UK population [1] [2] [3][4][5], but it remains unclear if these represent carriers of vCJD infection, some other form of prion infection, or ...\n5. The identification of these positive specimens hypothesised that dietary BSE exposure in the UK population may have occurred over a wider time period that initially thought or that there may be a low prevalence of abnormal PrP in lymphoreticular tissues that does not progress to vCJD . There remains some uncertainty over the interpretation of ...",
               "predicate": null
            }
         ],
         "row": 506,
         "id": 213151385792449704
      },
      {
         "claim": "A high microerythrocyte count raises vulnerability to severe anemia in homozygous alpha (+)- thalassemia trait subjects.",
         "label": 0,
         "prediction": 0,
         "rationale": "A microerythrocyte is a red blood cell that is smaller than normal, characteristic of microcytic anemia, where the cells are smaller due to a lack of hemoglobin. The provided evidence does not specifically mention the association of microcytic anemia with severe anemia in homozygous alpha (+)-thalassemia trait subjects. Microcytic anemia is not associated with a high microerythrocyte count. The provided evidence does not specifically mention a high microerythrocyte count in relation to homozygous alpha (+) thalassemia trait. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is a microerythrocyte?",
               "answer": "A microerythrocyte is a term that refers to a red blood cell that is smaller than normal, which is characteristic of microcytic anemia. In microcytic anemia, the red blood cells are smaller due to a lack of hemoglobin, leading to reduced oxygen-carrying capacity and resulting in symptoms",
               "rationale": "1. Microcytic anemia happens when your red blood cells are smaller than usual because they don't have enough hemoglobin. Hemoglobin is a protein in your red blood cells. It helps red blood cells carry oxygen throughout your body. Healthcare providers treat microcytic anemia by identifying and treating the condition that causes microcytic anemia.\n2. Symptoms often appear at an advanced stage when the lack of normal red blood cells is affecting your tissues. Common symptoms of microcytic anemias include: fatigue, weakness, and tiredness. loss ...\n3. Iron is an essential ingredient in hemoglobin. Environmental factors, medical conditions (inherited and acquired) and certain behaviors can also lead to microcytosis. The most common causes of microcytosis include: Iron deficiency: Nutritional deficiencies can prevent you from getting enough iron in your diet.\n4. Microcytic anemia is a blood disorder in which the red blood cells are too small due to a lack of hemoglobin. Hemoglobin, an iron-rich protein, binds to oxygen, delivering it throughout the body. With microcytic anemia, smaller red blood cells carry less oxygen, which leads to low energy and fatigue. Microcytic anemia may develop due to ...\n5. Microcytic anemia is a condition in which the body's tissues and organs do not get enough oxygen. This lack of oxygen can happen because the body does not have enough red blood cells, or because ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is microcytic anemia associated with severe anemia in homozygous alpha (+)- thalassemia trait subjects?",
               "answer": "The provided evidence does not specifically mention the association of microcytic anemia with severe anemia in homozygous alpha (+)-thalassemia trait subjects. It primarily discusses the characteristics and causes of microcytic anemia, including the role of β-thalassemia and other factors. While it mentions that hemoglobinopathies",
               "rationale": "1. In the first evaluation step for a patient with microcytic anemia, the possible presence of a β-thalassemic trait must be excluded. Indeed, microcytosis associated with reduced MCH is the hallmark of β-thalassemia carriers, who usually have normal or very slightly elevated iron parameters and increased HbA2 detected by Hb electrophoresis ...\n2. Microcytic anemia is characterized by smaller-than-normal red cells due to decreased production of hemoglobin. This review discusses diagnosis and treatment of thalassemia, anemia of inflammation, ...\n3. Microcytic anemias are primarily caused by nutritional iron deficiency, iron loss resulting from gastrointestinal disease, iron malabsorption, hemoglobinopathies (including some thalassemia syndromes), and severe anemia resulting from chronic disease.\n4. The most common causes of microcytosis are iron deficiency anemia and thalassemia trait. Other diagnoses to consider include anemia of chronic disease, lead toxicity, and sideroblastic anemia.\n5. Microcytic, hypochromic anemia, as the name suggests, is the type of anemia in which the circulating RBCs are smaller than the usual size of RBCs (microcytic) and have decreased red color (hypochromic). The most common cause of this type of anemia is decreased iron reserves of the body which may be due to multiple reasons.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is microcytic anemia associated with a high microerythrocyte count?",
               "answer": "No, microcytic anemia is not associated with a high microerythrocyte count. In fact, microcytic anemia is characterized by a low mean corpuscular volume (MCV) and may have a normal or low red blood cell count. The evidence indicates that microcytic anemia involves smaller than usual",
               "rationale": "1. Microcytic anemia happens when your red blood cells are smaller than usual because they don't have enough hemoglobin. Hemoglobin is a protein in your red blood cells. It helps red blood cells carry oxygen throughout your body. Healthcare providers treat microcytic anemia by identifying and treating the condition that causes microcytic anemia.\n2. CBC: With microcytic anemia, you may have a normal or low red blood cell count, a low mean corpuscular volume (MCV) that is below 80-100 femtoliters, red cell distribution width (RDW) that is normal or high, and a mean corpuscular hemoglobin concentration (MCHC) that's below 27-31 picograms per cell.; Blood smear: With microcytic anemia, the red blood cells will appear small and often pale ...\n3. Microcytic anemia is a condition in which the body's tissues and organs do not get enough oxygen. This lack of oxygen can happen because the body does not have enough red blood cells, or because ...\n4. Anemia is defined as the reduction in circulating red-cell mass below normal levels. Anemia is a very common condition that is widespread in the human population. Circulating red blood cells (RBCs) contain a protein known as hemoglobin, that protein has four polypeptide chains and one heme ring that contains iron in reduced form. Iron is the main component of hemoglobin and is the prime ...\n5. Microcytosis is a descriptive term for red blood cell (RBC) size smaller than the normal range. The causes are numerous, and the evaluation depends on a synthesis of clinical and laboratory information. This topic discusses causes of microcytosis and microcytic anemia. Additional topics discuss the following:",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is a high microerythrocyte count associated with homozygous alpha (+)- thalassemia trait?",
               "answer": "The provided evidence does not specifically mention a high microerythrocyte count in relation to homozygous alpha (+) thalassemia trait. However, it does discuss the general characteristics of thalassemia, including the imbalance of alpha and beta globin chains and the resulting effects on red blood cell prec",
               "rationale": "1. α-thalassemia is a heterogeneous group of genetic erythrocyte disorders characterized by the absence or deficiency of hemoglobin's α-globin chains. Decreased α-globin synthesis causes a relative excess of β-globin chains, which damages erythroblasts and causes anemia. α-thalassemia has varied presentations, presenting silently in adult ...\n2. Yes, you can have the trait for both alpha- and beta-thalassemia. A 2014 Chinese study found that 17.8% of people with beta-thalassemia trait also had genetic mutations that affected the alpha gene.\n3. The thalassemias are a group of hemoglobinopathies in which the normal ratio of alpha globin to beta globin production is disrupted due to a genetic variant in one or more alpha or beta globin genes. This abnormal alpha chain to beta chain ratio causes the unpaired chains to precipitate, leading to destruction of red blood cell (RBC) precursors ...\n4. Request an Appointment. 410-955-5000 Maryland. 855-695-4872 Outside of Maryland. +1-410-502-7683 International. Find a Doctor. Thalassemia is an inherited blood disorder. It is passed down from one or both parents through their genes. There are two main types of thalassemia: alpha and beta.\n5. beta-thalassemia, and Hb Bart's disease in alpha-thalas- semia major. 10,17 Hb electrophoresis findings are normal in alpha-thalassemia trait and carrier states (Table 4) . 10,20-22",
               "predicate": null
            }
         ],
         "row": 507,
         "id": 719916989896686452
      },
      {
         "claim": "A total of 1,000 people in the UK are asymptomatic carriers of vCJD infection.",
         "label": 0,
         "prediction": 0,
         "rationale": "Variant Creutzfeldt-Jakob disease (vCJD) is a rare and fatal neurological disease caused by prions, linked to consuming beef from cows infected with bovine spongiform encephalopathy (BSE), commonly known as \"mad cow disease.\" There are approximately 16,080 asymptomatic carriers of vCJD infection in the UK. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is vCJD infection?",
               "answer": "Variant Creutzfeldt-Jakob disease (vCJD) is a rare and fatal neurological disease caused by prions, which are infectious proteins. It is linked to consuming beef from cows infected with bovine spongiform encephalopathy (BSE), commonly known as \"mad cow disease.\" vCJD",
               "rationale": "1. And variant Creutzfeldt-Jakob disease (vCJD) has affected people at a much younger age, usually in their late 20s. Genetics. People with familial CJD have genetic changes that cause the disease. To develop this form of the disease, a child must have one copy of the gene that causes CJD. The gene can be passed down from either parent.\n2. Variant Creutzfeldt-Jakob disease (vCJD) is a rare disease caused by a prion, an infectious protein. It is linked to eating beef from cows infected with \"mad cow disease.\" It is always fatal, usually within 14 months of the first symptoms. vCJD illnesses have been very rare since the early 2000s.\n3. Variant Creutzfeldt-Jakob disease (vCJD), commonly referred to as \"mad cow disease\" or \"human mad cow disease\" to distinguish it from its BSE counterpart, is a fatal type of brain disease within the transmissible spongiform encephalopathy family. Initial symptoms include psychiatric problems, behavioral changes, and painful sensations. In the later stages of the illness, patients may exhibit ...\n4. Variant CJD (vCJD). This happens after eating beef from a cow with bovine spongiform encephalopathy (BSE), another disease that happens because of prions. Prions that affect beef cattle with BSE can then pass it to humans and other species, causing vCJD. ... Acquired CJD (infection from a medical procedure, such as a transplant or tissue graft ...\n5. Variant Creutzfeldt-Jakob disease (vCJD) is a relatively new and rare neurological disease, classified as a Transmissible Spongiform Encephalopathy (TSE). ... During infection with prion diseases, infectious titres of prion protein are present in peripheral tissues (particularly lymphoid organs and spleen) before a progressive rise in brain ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "How many people in the UK are asymptomatic carriers of vCJD infection?",
               "answer": "Based on the provided evidence snippet, the estimated prevalence of asymptomatic carriers of vCJD in the UK population is approximately 240 per million. Given the UK population is around 67 million, this would suggest that there are approximately 16,080 asymptomatic carriers of vCJD infection in the UK.",
               "rationale": "1. Variant Creutzfeldt-Jakob disease (vCJD) is a relatively new and rare neurological disease, classified as a Transmissible Spongiform Encephalopathy (TSE). It was first identified in March 1996 in the UK, when 10 cases of a new disease with neurological symptoms were reported and soon associated with the Bovine Spongiform Encephalopathy (BSE ...\n2. However, as of June 2021, the number of clinical cases of vCJD in the UK remains relatively low (n = 178) . Such a discrepancy between the number of vCJD cases reported in the UK and the number of people exposed to the BSE agent raises questions as to the extent of asymptomatic vCJD infection in the UK population.\n3. 'At increased risk' group Identified as 'at increased risk' Total notified Total notified and alive Cases Asymptomatic infections * Recipients of blood from donors who later developed vCJD: 67\n4. prevalence of people that may be in the vCJD carrier state is in the order of 0.05%, (493 cases per one million population) [9]. However, much uncertainty remains around this estimate. The contrast between the estimated prevalence of vCJD-related PrPSc (Pathological 'scrapie' isoform of the prion protein (PrP)) and the reported\n5. The subsequent Appendix III study using immunohistochemical staining of appendices from two birth cohorts (table 2) 70, 71 estimated a central prevalence of asymptomatic carriers of vCJD in the UK population (who had been presumed to be unexposed to BSE) of approximately 240 per million (95% CI 16-492). 56",
               "predicate": null
            }
         ],
         "row": 508,
         "id": 125221761718248788
      },
      {
         "claim": "ADAR1 binds to Dicer to cleave pre-miRNA.",
         "label": 1,
         "prediction": 1,
         "rationale": "ADAR1, or Adenosine Deaminase Acting on RNA 1, is a protein that catalyzes the hydrolytic deamination of adenosine to inosine in RNA. ADAR1 functions to promote the processing of pre-miRNA by forming a heterodimer complex with DICER, and can also antagonize miRNA biogenesis through editing of pri-miRNA or pre-miRNA. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is ADAR1?",
               "answer": "ADAR1, or Adenosine Deaminase Acting on RNA 1, is a protein that plays a crucial role in the regulation of the innate immune response and cellular processes such as senescence. It catalyzes the hydrolytic deamination of adenosine to inosine in RNA, which alters the",
               "rationale": "1. Fig. 1: ADAR1 regulates immune response and senescence through A-to-I RNA editing dependent and independent pathways, respectively. a Mutation of the ADAR1 Zα domain or ADAR1 depletion causes ...\n2. The first hints that ADAR1 was involved in the innate immune response was the discovery of the embryonic lethality of Adar1−/− mice around embryonic day 12.5. This lethality was due to widespread stress-induced apoptosis of liver hematopoietic cells (Hartner et al., 2004; Wang et al., 2004).\n3. The ADAR1 protein is involved in the control of the innate immune response, which is the immune system's early response to foreign invaders (pathogens). The adenosine-to-inosine editing performed by ADAR1 is thought to change certain areas of the body's own RNA that the immune system might interpret as belonging to a virus that should be attacked.\n4. Catalytic function and isoforms of Adenosine Deaminase Acting on RNA 1 (ADAR1). ( A) ADAR1 catalyzes the hydrolytic deamination of adenosine to form inosine, which is recognized by cellular machineries as guanosine; ( B) Gene structures of the two isoforms of ADAR1. Z: Z-DNA binding domain; NES: nuclear export signal; NLS: nuclear localizations ...\n5. Ishizuka et al., 2019. , the Haining group has further characterized the role of ADAR1 in tumor biology, showing that loss of ADAR1 indeed renders tumor cells sensitive to immunotherapy and overcomes resistance to checkpoint blockade. Additionally, a global reshaping of immune cell profile occurs in the ADAR1-null tumors along with increased ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of ADAR1 in relation to pre-miRNA?",
               "answer": "ADAR1 functions to promote the processing of pre-miRNA by forming a heterodimer complex with DICER, which increases the rate of pre-miRNA processing compared to DICER alone. Additionally, ADAR1 can also antagonize miRNA biogenesis through editing of pri-miRNA or pre-miRNA,",
               "rationale": "1. The widespread functions of miRNA mean that ADAR1 may also be implicated indirectly in many cellular pathways, from development to oncogenesis. In most cases, the p110 isoform is associated with pri-miRNA levels and the p150 isoform with pre-miRNA levels, likely due to their different subcellular localizations .\n2. Given that miRNA biogenesis requires the formation of dsRNA intermediates, it is easy to envision the role of ADAR in this process. ADAR can antagonize miRNA biogenesis through editing dependent or independent means. Editing of pri-miRNA or pre-miRNAs can result in many outcomes that depend upon the location and extend of A-to-I editing.\n3. ADAR1 and DICER then form a heterodimer complex that has a higher maximum rate of catalysis than DICER alone, and thus ADAR1 promotes an increased rate of pre-miRNA processing (Figure 5b) (Ota et al., 2013). Besides miRNA, DICER is also able to cleave long dsRNA into smaller endogenous siRNAs. ... Multiple functions of the IKK-related kinase ...\n4. Meanwhile, the abundance of other unaffected miRNAs, such as miR30a and miR30e, remained unaltered at their pri-/pre-miRNA levels after ADAR1 knockdown, indicating that the regulatory effect of ...\n5. ADAR1 appears to interact with Drosha to promote its degradation and thus inhibits the pri- to pre-miRNA processing of miRNAs targeting NF-κB signaling. Drosha and DGCR8 are critical factors for pri- to pre- miRNA processing. 39 Drosha protein expression is attenuated in Ang II-infused mouse aortas . However, ADAR1 deficiency remarkably ...",
               "predicate": null
            }
         ],
         "row": 509,
         "id": 202706270248583998
      },
      {
         "claim": "AIRE is expressed in some skin tumors.",
         "label": 1,
         "prediction": 1,
         "rationale": "AIRE stands for \"Anagrafe degli Italiani Residenti all'Estero,\" or the Registry of Italian Citizens Residing Abroad, a database maintained by Italian municipalities that contains information on all Italian citizens living outside Italy. AIRE is expressed in some skin tumors, specifically in tumor keratinocytes, and its expression is induced in these cells under pathological conditions, promoting skin tumor development. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is AIRE?",
               "answer": "AIRE stands for \"Anagrafe degli Italiani Residenti all'Estero,\" which translates to the Registry of Italian Citizens Residing Abroad. Established by Law No. 470 on October 27, 1988, AIRE is a database maintained by various Italian municipalities that contains information on all Italian citizens living outside",
               "rationale": "1. (Reference Office: D.G.IT.. - DESK II) The Register of Italians living abroad (A.I.R.E.) was established by Law No. 470 of October 27, 1988 and contains the data of Italian citizens living abroad for a period of over twelve months.\n2. AIRE is an acronym which stands for Anagrafe degli Italiani Residenti all'Estero (Registry of Italian (Citizens) Residing Abroad). Launched in 1988, the AIRE is an extension of the record keeping system which helps the Italian government keep track of the vital records of Italian citizens. If you are an Italian citizen originally from Italy ...\n3. AIRE stands for the Anagrafe degli Italiani Residenti all'Estero, which is commonly translated as the Registry of Italians Residing (or Resident) Abroad. Established in 1988, it is basically a database, maintained by the various Italian municipalities, that contains information on all persons with Italian citizenship who live outside Italy.\n4. What is AIRE? AIRE is also known as Anagrafe degli Italiani Residenti all'Estero, which translates to the Registry of Italian Citizens Residing Abroad. It was first introduced in 1988 as a way for the Italian government to keep track of all of its citizens' records, including those who aren't currently living in Italy.\n5. It stands for \"Anagrafe Italiani Residenti all'Estero\" or Registry of Italian Citizens residing Abroad.Who needs to register with AIRE? 1. All Italian citizens who are relocating abroad for more than 12 months.2. Italian citizens who already reside abroad, either because they were born abroad, or because they have acquired Italian ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is AIRE expressed in some skin tumors?",
               "answer": "Yes, AIRE is expressed in some skin tumors, specifically in tumor keratinocytes, and its expression is induced in these cells under pathological conditions, promoting skin tumor development.",
               "rationale": "1. We report that autoimmune regulator (Aire), a transcriptional regulator, is inducibly expressed in human and mouse tumor keratinocytes in a K17-dependent manner and is required for timely onset of Gli2-induced skin tumorigenesis in mice. The induction of Aire mRNA in keratinocytes depends on a functional interaction between K17 and the ...\n2. Autoimmune regulator (AIRE) is a transcriptional regulator that is primarily expressed in medullary epithelial cells, where it induces tissue-specific antigen expression. Under pathological conditions, AIRE expression is induced in epidermal cells and promotes skin tumor development. This study aime …\n3. Aire is induced at low levels in mouse and human tumor keratinocytes, a cell type involved in human skin squamous cell carcinoma, and Aire mRNA induction in keratinocytes (but not mTECs) is dependent on keratin 17 (K17) 76. Furthermore, in keratinocytes, Aire protein interacts with K17 protein, and Aire mRNA interacts with ribonucleoprotein ...\n4. The protein expression data is derived from antibody-based protein profiling using immunohistochemistry. RNA categoryi. A summary of RNA categories for human tissues, cell lines and cancer tissues. Categories for RNA specificity include tissue enriched, group enriched, tissue enhanced, low tissue specificity and not detected. Categories for RNA ...\n5. Pierre Coulombe and colleagues show that the autoimmune regulator Aire is induced in tumor keratinocytes in a keratin 17 (K17)-dependent manner and promotes skin tumorigenesis in mice. They ...",
               "predicate": null
            }
         ],
         "row": 510,
         "id": 186731362421609406
      },
      {
         "claim": "ALDH1 expression is associated with better breast cancer outcomes.",
         "label": 0,
         "prediction": 1,
         "rationale": "ALDH1, or aldehyde dehydrogenase 1, is a protein that belongs to the aldehyde dehydrogenases family and serves as a marker for normal tissue stem cells. The association of ALDH1 expression with breast cancer outcomes is not straightforward and appears to depend on various factors. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is ALDH1?",
               "answer": "ALDH1, or aldehyde dehydrogenase 1, is a protein that belongs to the aldehyde dehydrogenases family and has three main isotypes: ALDH1A1, ALDH1A2, and ALDH1A3. It serves as a marker for normal tissue stem cells",
               "rationale": "1. By contrast, ALDH1-negative tumors may be generated by the transformation of ALDH1-negative progenitor cells. In the ALDH1-positive tumors, the cancer stem cell population may inherit properties of normal stem cells that confer aggressiveness: ability to self-renew, high proliferation potential, resistance to damaging agents and chemoresistance.\n2. Function. This protein belongs to the aldehyde dehydrogenases family of proteins. Aldehyde dehydrogenase is the second enzyme of the major oxidative pathway of alcohol metabolism. Two major liver isoforms of this enzyme, cytosolic and mitochondrial, can be distinguished by their electrophoretic mobilities, kinetic properties, and subcellular ...\n3. Aldehyde dehydrogenase is a polymorphic enzyme responsible for the oxidation of aldehydes to carboxylic acids. There are three different classes of these enzymes in mammals: class 1 (low K m, cytosolic), class 2 (low K m, mitochondrial), and class 3 (high K m, such as those expressed in tumors, stomach, and cornea).In all three classes, constitutive and inducible forms exist.\n4. ALDH1 has three main isotypes, ALDH1A1, ALDH1A2, and ALDH1A3, and is a marker of normal tissue stem cells (SC) and cancer stem cells (CSC), where it is involved in self-renewal, differentiation and self-protection. Experiments with murine and human cells indicate that ALDH1 activity, predominantly attributed to isotype ALDH1A1, is tissue- and ...\n5. ALDH1 (dark gray) and ALDH2 (light gray) are modeled as an overlay with NAD in yellow and blue, respectively. Measurements demonstrate an approximate 5 Å shift of the nicotinamide portion. Key cofactor binding residues are highlighted in red. Residues 241-253 have been omitted for visualisation purposes.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is ALDH1 expression associated with better breast cancer outcomes?",
               "answer": "The association of ALDH1 expression with breast cancer outcomes is not straightforward and appears to depend on various factors, including the context of the expression and the specific subtype of breast cancer. \n\n1. Evidence suggests that ALDH1A1 expression can be linked to both better and worse prognoses. For instance, Sjo",
               "rationale": "1. Aims: Aldehyde dehydrogenase family 1 member A1 (ALDH1A1) is reportedly a key ALDH isozyme linked to the cancer stem cells (CSC) of many solid tumours, where it is involved in self-renewal, differentiation and self-protection. In this study, the prognostic significance of ALDH1A1 expression in early invasive breast cancer (BC) and its role as a BC stem cell (BCSC) were evaluated.\n2. Sjoüstroüm et al. hypothesized that in breast cancer cells, ALDH1A1 overexpression was associated with either a better or a worse prognosis, depending on the cut-off. If weakly stained cells were considered to be positively stained, ALDH1A1 overexpression was associated with a better prognosis in two cohorts.\n3. Another study 49 indicated that ALDH1A1 expression was associated with good outcomes in TNBC. Sjöström et al. 50 reported that stromal ALDH1A1 was associated with better distant disease-free survival in BC. A possible explanation of the survival discrepancy in mRNA expression is that the stromal expression of ALDH1A1 was not completely ...\n4. Although neoadjuvant chemotherapy (NAC) for locally advanced breast cancer can improve operability and local disease control, there is a lack of reliable biomarkers that predict response to chemotherapy or long-term survival. Since expression of aldehyde dehydrogenase-1 (ALDH1) is associated with the stem-like properties of self-renewal and innate chemoresistance in breast cancer, we asked ...\n5. Ginestier et al. reported that high expression of ALDH1A1 mRNA was correlated with poorer overall survival in breast cancer patients, and as a result, ALDH1A1 was the only ALDH1 isozyme capable of serving as a biomarker for predicting poor survival in breast cancer patients . ALDH1A1 might be a major contributor to ALDH1 activity in breast ...",
               "predicate": null
            }
         ],
         "row": 511,
         "id": 309387173203084686
      },
      {
         "claim": "ALDH1 expression is associated with poorer prognosis in breast cancer.",
         "label": 1,
         "prediction": 1,
         "rationale": "ALDH1, or aldehyde dehydrogenase 1, is a marker of both normal tissue stem cells and cancer stem cells, playing a crucial role in self-renewal, differentiation, and self-protection of these cells. ALDH1 expression is associated with poorer prognosis in breast cancer. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is ALDH1?",
               "answer": "ALDH1, or aldehyde dehydrogenase 1, is a member of the aldehyde dehydrogenases family of proteins and is a marker of both normal tissue stem cells and cancer stem cells. It plays a crucial role in self-renewal, differentiation, and self-protection of these cells.",
               "rationale": "1. By contrast, ALDH1-negative tumors may be generated by the transformation of ALDH1-negative progenitor cells. In the ALDH1-positive tumors, the cancer stem cell population may inherit properties of normal stem cells that confer aggressiveness: ability to self-renew, high proliferation potential, resistance to damaging agents and chemoresistance.\n2. Function. This protein belongs to the aldehyde dehydrogenases family of proteins. Aldehyde dehydrogenase is the second enzyme of the major oxidative pathway of alcohol metabolism. Two major liver isoforms of this enzyme, cytosolic and mitochondrial, can be distinguished by their electrophoretic mobilities, kinetic properties, and subcellular ...\n3. ALDH1 (dark gray) and ALDH2 (light gray) are modeled as an overlay with NAD in yellow and blue, respectively. Measurements demonstrate an approximate 5 Å shift of the nicotinamide portion. Key cofactor binding residues are highlighted in red. Residues 241-253 have been omitted for visualisation purposes.\n4. Aldehyde dehydrogenase is a polymorphic enzyme responsible for the oxidation of aldehydes to carboxylic acids. There are three different classes of these enzymes in mammals: class 1 (low K m, cytosolic), class 2 (low K m, mitochondrial), and class 3 (high K m, such as those expressed in tumors, stomach, and cornea).In all three classes, constitutive and inducible forms exist.\n5. ALDH1 has three main isotypes, ALDH1A1, ALDH1A2, and ALDH1A3, and is a marker of normal tissue stem cells (SC) and cancer stem cells (CSC), where it is involved in self-renewal, differentiation and self-protection. Experiments with murine and human cells indicate that ALDH1 activity, predominantly attributed to isotype ALDH1A1, is tissue- and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is ALDH1 expression associated with poorer prognosis in breast cancer?",
               "answer": "Yes, ALDH1 expression is associated with poorer prognosis in breast cancer. The evidence indicates that high immunoexpression of ALDH1A1 is significantly linked to poor breast cancer-specific survival, particularly in certain subtypes like luminal B. Additionally, studies have shown that positive ALDH1 expression correlates with lower",
               "rationale": "1. High ALDH1 expression is associated with poor prognosis in gastric neuroendocrine carcinoma (130, ... and has been associated with poorer prognosis and failure of ... Ziadi S, Saad H, Dhiab MB, Mestiri S, Trimeche M. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer. Breast Cancer ...\n2. In this study, the prognostic significance of ALDH1A1 expression in early invasive breast cancer (BC) and its role as a BC stem cell (BCSC) were evaluated. ... CD24, TWIST, SOX9, EPCAM and CD133. The high immunoexpression of ALDH1A1 was significantly associated with poor BC-specific survival (P < 0.001), and specifically in the luminal B and ...\n3. Background: Many reports suggest that aldehyde dehydrogenase 1 (ALDH1) expression is associated with poorer neoadjuvant chemotherapy (NAC) response in patients with breast cancer; however, the prognostic value of this enzyme in cancer has yet to be confirmed. Therefore, we conducted a meta-analysis of related studies to investigate the relationship between ALDH1 expression and the NAC response ...\n4. Studies also identified a lower survival rate with positive ALDH1 expression. ALDH1 catalyzes endogenous and exogenous aldehyde oxidation into an inactive carboxylic acid. ALDH1 is known to be a cytoplasmic stem cell-related marker that was found in breast cancer, and it was associated with tumor initiating cells.\n5. Impact of ALDH1A1 expression on survival for breast cancer. There were a total of 11 references [11, 18, 19, 21-25, 27, 31, 32] relating to the association between ALDH1A1 expression and breast cancer prognosis. The prognosis was evaluated by the indicators OS/SS/RS and DFS/MFS/RFS.",
               "predicate": null
            }
         ],
         "row": 512,
         "id": 285432129083736819
      },
      {
         "claim": "AMP-activated protein kinase (AMPK) activation increases inflammation-related fibrosis in the lungs.",
         "label": 0,
         "prediction": 0,
         "rationale": "AMP-activated protein kinase (AMPK) is an enzyme that plays a crucial role in cellular energy homeostasis, activated in response to low energy levels in the cell. AMPK activation does not increase inflammation-related fibrosis in the lungs, but rather alleviates it. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is AMP-activated protein kinase (AMPK)?",
               "answer": "AMP-activated protein kinase (AMPK) is an enzyme that plays a crucial role in cellular energy homeostasis. It is activated in response to low energy levels in the cell, indicated by increased AMP (adenosine monophosphate) and decreased ATP (adenosine triphosphate) levels. Once activated",
               "rationale": "No results found.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does AMPK activation increase inflammation-related fibrosis in the lungs?",
               "answer": "No, AMPK activation does not increase inflammation-related fibrosis in the lungs. In fact, the evidence suggests that the activation of AMPK effectively alleviates inflammation-related fibrosis, as indicated by the study that reported its role in preventing an increase in pro-fibrotic markers in pulmonary fibrosis models (Rangarajan et",
               "rationale": "1. Recent study reported that the activation of AMPK effectively alleviated inflammation-related fibrosis in lungs (Rangarajan et al., 2018). Open in a separate window. FIGURE 5. ... and increase the activation of AMPK in the BLM-induced pulmonary fibrosis models, preventing an increase in pro-fibrotic markers such as Col I and α-SAM and ...\n2. AMP-activated protein kinase (AMPK) received its name because AMP binding caused its allosteric activation (Box 1).Since then it has been best known as a sensor of cellular energy status that is ...\n3. In respiratory inflammation, pulmonary AMPK is significantly inhibited, and its activation can prevent lung injury. Recent research reveals that gut microbiota influences ALI, with certain short-chain fatty acids alleviating SAP-ALI via AMPK activation, offering new therapeutic insights. Citation 138 Nrf2 is a key antioxidant pathway. Under ...\n4. The main mechanism of metformin's action is related to its activation of the AMPK enzyme and regulation of the energy balance. ... suppression of oxidative stress and inflammation, and inhibition of the increase in genes encoding proinflammatory ... Also showed that the use of metformin could reduce the risk of lung fibrosis associated with ...\n5. 1. Introduction. For critically ill patients, acute lung injury (ALI) is one the most common causes of morbidity and mortality [1].ALI pathogenesis includes an acute inflammatory response in the lungs with neutrophilic alveolitis, which may lead to long-term respiratory failure, a need for mechanical ventilation, and a high risk of multi-organ failure and fatality [2].",
               "predicate": null
            }
         ],
         "row": 513,
         "id": 359457462927180935
      },
      {
         "claim": "APOE4 expression in iPSC-derived neurons increases AlphaBeta production and tau phosphorylation causing GABA neuron degeneration.",
         "label": 1,
         "prediction": 1,
         "rationale": "APOE4 is a variant of the apolipoprotein E gene associated with an increased risk of developing Alzheimer's disease. APOE4 expression in iPSC-derived neurons increases AlphaBeta production, but not as significantly as in familial Alzheimer's disease neurons. APOE4 expression in iPSC-derived neurons causes GABA neuron degeneration. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is APOE4?",
               "answer": "APOE4 is a variant of the apolipoprotein E gene (APOE) that is associated with an increased risk of developing Alzheimer's disease. It is the strongest genetic risk factor for the disease, with individuals who inherit one copy of the APOE4 gene having a doubled or tripled risk, and those",
               "rationale": "1. One copy of the APOE gene comes from the mother and another from the father. Having at least one APOE e4 gene doubles or triples the risk of getting Alzheimer's disease. Some people have two APOE e4 genes, one from each parent. Having two genes increases the risk of getting Alzheimer's disease even more, about eight- to twelvefold.\n2. APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not mean a person will definitely develop the disease. The study suggests that dementia may be caused by lipid imbalances in brain cells. This illustration shows neurons with amyloid plaques, a hallmark of Alzheimer's disease, in yellow.\n3. A significant risk factor for developing Alzheimer's disease, the APOE4 gene, has widespread effects on brain cells' ability to metabolize lipids and respond to stress, according to MIT research. Experiments also suggest choline, a widely available supplement, might reverse many of these effects.\n4. The apolipoprotein E gene (APOE for short) is linked to Alzheimer's risk because it's involved in the body's process for carrying cholesterol and other fats in the bloodstream. People can have ...\n5. If you have two copies of the APOE4 gene, new research suggests that you're very likely to develop Alzheimer's. Experts break down the findings and share what you can do to lower your risk.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does APOE4 expression in iPSC-derived neurons increase AlphaBeta production?",
               "answer": "The evidence suggests that APOE4 expression in iPSC-derived neurons does have an effect on Aβ production, but the increase is not as significant as in familial Alzheimer's disease (fAD) neurons. Specifically, while APOE4 can increase Aβ production by accelerating APP endocytosis, the increase in Aβ42",
               "rationale": "1. The apolipoprotein E4 ( APOE4) allele represents the major genetic risk factor for Alzheimer's disease (AD). In contrast, APOE2 is known to lower the AD risk, while APOE3 is defined as risk neutral. APOE plays a prominent role in the bioenergetic homeostasis of the brain, and early-stage metabolic changes have been detected in the brains of AD ...\n2. different APOE isoforms - not only the risk-increasing APOE4 but also the protective APOE2 - affect the energy metabolism in human neurons. In the present study, we show that endogenously produced APOE4 increases mitochondrial energy metabolism in pure APOE-isogenic human iPSC-derived neurons (iN cells) but not in the respective iPS cell line.\n3. Interestingly, treating apoE −/− hiPSC-derived neurons with purified recombinant human apoE3 or apoE4 did not significantly alter Aβ production (Supplementary Fig. 10e,f), suggesting that the effect of apoE4 on Aβ production depends on the endogenous expression of apoE. Together, these findings strongly suggest that apoE4 confers a gain ...\n4. ApoE4 can increase Aβ production by accelerating APP endocytosis transport mediated by low-density lipoprotein receptor-related protein ... When the neurons are stressed, the expression of ApoE4 will reduce the generation of ATP (Orr et al. 2019). ... When iPSC-derived neurons were converted from ApoE ε4 to ε3 using zinc finger nucleases, ...\n5. We found that APOE4 iPSC-derived neurons, ... however the increase of Aβ 42 secretion by APOE4 vs. APOE3 neurons is much less than the three-fold increase reported in fAD neurons vs. controls (Paquet et al., ... 2008) was applied to explore gene co-expression pattern in iPSC-derived brain cell types. Briefly, raw count data from 26 RNA-seq ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does APOE4 expression in iPSC-derived neurons cause GABA neuron degeneration?",
               "answer": "Yes, APOE4 expression in iPSC-derived neurons causes GABA neuron degeneration. Evidence 1 specifically states that ApoE4 leads to significantly fewer GABA-positive neurons in hiPSC-derived neuronal cultures compared to ApoE3. Additionally, Evidence 4 mentions that GABAergic neuron degeneration is observed in neurons expressing Apo",
               "rationale": "1. ApoE4 causes GABAergic neuron degeneration/loss in hiPSC-derived neuronal culture. Immunofluorescent staining revealed significantly fewer GABA-positive neurons derived from apoE4/4-hiPSCs than from apoE3/3-hiPSCs, both in individual lines (Supplementary Fig. 2i) and as shown by mean values (Fig. 3a-c).\n2. Human iPSC-derived neurons are generated from individuals with or without&nbsp;Alzheimer's disease carrying different APOE alleles and reveal a toxic, neuron-intrinsic gain&nbsp;of&nbsp;function ...\n3. Lin, Y. T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141-1154.e1147 ...\n4. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector ... and that they displayed GABAergic neuron degeneration. ApoE4 increased Aβ production in human, but not in mouse, neurons. Converting ApoE4 to ApoE3 by gene editing rescued these phenotypes, indicating the specific ...\n5. (A) mEPSCs amplitude (Left) and frequency (Right) in iPSC-derived neurons from APOE4 or APOE3 iPSCs. Scale bar = 20 pA and 200 ms. n=6~8 from three independent cultures. (B) Immunocytochemistry with synaptophysin and PSD-95 antibodies in neurons derived from APOE4 or APOE3 iPSCs. Synaptophysin and PSD-95 signals were analyzed by IMARIS.",
               "predicate": null
            }
         ],
         "row": 514,
         "id": 205582954294879234
      },
      {
         "claim": "APOE4 expression in iPSC-derived neurons increases AlphaBeta production and tau phosphorylation, delaying GABA neuron degeneration.",
         "label": 0,
         "prediction": 1,
         "rationale": "APOE4 is a variant of the apolipoprotein E gene that is linked to an increased risk of developing Alzheimer's disease. APOE4 expression in iPSC-derived neurons increases AlphaBeta production. APOE4 expression in iPSC-derived neurons does not delay GABA neuron degeneration. APOE4 expression in iPSC-derived neurons increases tau phosphorylation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is APOE4?",
               "answer": "APOE4 is a variant of the apolipoprotein E gene (APOE) that is linked to an increased risk of developing Alzheimer's disease. It is the strongest genetic risk factor for the disease, with individuals who have one copy of the APOE4 gene experiencing a doubled or tripled risk, and those",
               "rationale": "1. One copy of the APOE gene comes from the mother and another from the father. Having at least one APOE e4 gene doubles or triples the risk of getting Alzheimer's disease. Some people have two APOE e4 genes, one from each parent. Having two genes increases the risk of getting Alzheimer's disease even more, about eight- to twelvefold.\n2. APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not mean a person will definitely develop the disease. The study suggests that dementia may be caused by lipid imbalances in brain cells. This illustration shows neurons with amyloid plaques, a hallmark of Alzheimer's disease, in yellow.\n3. The apolipoprotein E gene (APOE for short) is linked to Alzheimer's risk because it's involved in the body's process for carrying cholesterol and other fats in the bloodstream. People can have ...\n4. A significant risk factor for developing Alzheimer's disease, the APOE4 gene, has widespread effects on brain cells' ability to metabolize lipids and respond to stress, according to MIT research. Experiments also suggest choline, a widely available supplement, might reverse many of these effects.\n5. If you have two copies of the APOE4 gene, new research suggests that you're very likely to develop Alzheimer's. Experts break down the findings and share what you can do to lower your risk.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does APOE4 expression in iPSC-derived neurons increase AlphaBeta production?",
               "answer": "Yes, APOE4 expression in iPSC-derived neurons increases Aβ production. The evidence states that ApoE4 can increase Aβ production by accelerating APP endocytosis transport.",
               "rationale": "1. The apolipoprotein E4 (APOE4) allele represents the major genetic risk factor for Alzheimer's disease (AD). In contrast, APOE2 is known to lower the AD risk, while APOE3 is defined as risk neutral. APOE plays a prominent role in the bioenergetic homeostasis of the brain, and early-stage metabolic changes have been detected in the brains of AD patients. Although APOE is primarily expressed by ...\n2. ApoE4 can increase Aβ production by accelerating APP endocytosis transport mediated by low-density lipoprotein receptor-related protein ... When the neurons are stressed, the expression of ApoE4 will reduce the generation of ATP (Orr et al. 2019). ... When iPSC-derived neurons were converted from ApoE ε4 to ε3 using zinc finger nucleases, ...\n3. In addition, Wang et al. has shown that p-tau levels were increased in APOE-deficient iPSC-derived neurons when treated with lysates of iPSC-derived neurons with APOE4 19.\n4. To better understand how APOE4 affects major brain cell types involved in AD pathogenesis, we utilized CRISPR/Cas9 to create isogenic iPSC lines harboring homozygous APOE4 alleles from unaffected parental APOE3 cells. We found that APOE4 iPSC-derived neurons, astrocytes, and microglia-like cells recapitulated phenotypes associated with AD at multiple levels.\n5. In the present study, we show that endogenously produced APOE4 increases mitochondrial energy metabolism in pure APOE-isogenic human iPSC-derived neurons (iN cells) but not in the respective iPS cell line. This effect was independent of APOE levels in the different cell lines and did not correlate to levels of mitochondrial fission or fusion ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does APOE4 expression in iPSC-derived neurons delay GABA neuron degeneration?",
               "answer": "The provided evidence suggests that APOE4 expression in iPSC-derived neurons is associated with GABAergic neuron degeneration rather than delaying it. Specifically, the first piece of evidence indicates that APOE4 neurons displayed GABAergic neuron degeneration. Therefore, the answer is that APOE4 expression does not delay GABA neuron degeneration",
               "rationale": "1. Using human neurons derived from induced pluripotent stem cells carrying the major genetic risk factor apolipoprotein E4 (apoE4), we demonstrate that apoE4 neurons have higher levels of tau phosphorylation unrelated to their increased Aβ production and displayed GABAergic neuron degeneration.\n2. Using human neurons derived from induced pluripotent stem cells that expressed apolipoprotein E4 (ApoE4), a variant of the APOE gene product and the major genetic risk factor for AD, we demonstrated that ApoE4-expressing neurons had higher levels of tau phosphorylation, unrelated to their increased production of amyloid-β (Aβ) peptides, and ...\n3. Here, we report that APOE4, but not APOE3, disrupted the cellular lipidomes of human induced pluripotent stem cell (iPSC)-derived astrocytes generated from fibroblasts of APOE4 or APOE3 carriers, and of yeast expressing human APOE isoforms. We combined lipidomics and unbiased genome-wide screens in yeast with functional and genetic ...\n4. Neuronal signature genes whose expression was correlated with APOE4 genotype in both human and iPSC-derived samples were mostly down-regulated and associated with synaptic functions ( Figure 1F and 1G ).\n5. In addition, Wang et al. has shown that p-tau levels were increased in APOE -deficient iPSC-derived neurons when treated with lysates of iPSC-derived neurons with APOE4 19.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does APOE4 expression in iPSC-derived neurons increase tau phosphorylation?",
               "answer": "Yes, APOE4 expression in iPSC-derived neurons increases tau phosphorylation. The evidence indicates that human iPSC-derived neurons expressing ApoE4 show higher levels of tau phosphorylation compared to those expressing ApoE3 (Evidence 1). Additionally, it is noted that p-tau levels were increased in APOE-deficient i",
               "rationale": "1. Another study suggested that human iPSC-derived human ApoE4-expressing neurons show higher levels of tau phosphorylation than those expressing human ApoE3 in mouse models 41. Thus, these results ...\n2. In addition, Wang et al. has shown that p-tau levels were increased in APOE-deficient iPSC-derived neurons when treated with lysates of iPSC-derived neurons with APOE4 19.\n3. Treatment of ApoE4/4-hiPSC-derived neurons with the ApoE4 structure corrector PH002 36,37,38 ameliorated the detrimental effects of ApoE4 on tau phosphorylation, Aβ production and GABAergic ...\n4. Treating apoE4/4 hiPSC-derived neurons with the apoE4 structure corrector PH002 36-38 ameliorated the detrimental effects of apoE4 on tau phosphorylation, Aβ production, and GABAergic neuron degeneration in a dose-dependent manner. These findings warrant further development of apoE4 structure correctors and, ultimately, testing in clinical ...\n5. We found that APOE4 iPSC-derived neurons, ... APOE4 organoids accumulate Aβ and exhibit elevated tau phosphorylation. ... (WGCNA) (Langfelder and Horvath, 2008) was applied to explore gene co-expression pattern in iPSC-derived brain cell types. Briefly, raw count data from 26 RNA-seq samples were processed by edgeR to generate logCPM matrix ...",
               "predicate": null
            }
         ],
         "row": 515,
         "id": 773675429124736929
      },
      {
         "claim": "Activation of PPM1D suppresses p53 function.",
         "label": 1,
         "prediction": 1,
         "rationale": "PPM1D, also known as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase 2C delta (PP2Cδ), is an enzyme encoded by the PPM1D gene in humans. The activation of PPM1D negatively affects p53 function by dephosphorylating p53 at Ser15, a critical modification necessary for p53's transactivation of target genes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PPM1D?",
               "answer": "PPM1D, also known as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase 2C delta (PP2Cδ), is an enzyme encoded by the PPM1D gene in humans. It is a member of the PP2C family of ser",
               "rationale": "1. PPM1D. Protein phosphatase 1D is an enzyme that in humans is encoded by the PPM1D gene. [5] [6] The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. The expression of this gene is induced in a p53-dependent ...\n2. PPM1D, also known as (PPM1D, PPMID, PP2Cδ or IDDGIP), is a wild-type p53-induced phosphatase 1 (Wip1). The PPM1D gene is located at 17q23. The complete protein encoded by PPM1D (605 amino acids) is a member of the PP2C family of Ser/Thr protein phosphatase and a negative regulator of cellular stress response pathway.\n3. A greater understanding of factors causing cancer initiation, progression and evolution is of paramount importance. Among them, the serine/threonine phosphatase PPM1D, also referred to as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase 2C delta (PP2Cδ), is emerging as an important oncoprotein due to its negative regulation on a number of crucial cancer suppressor pathways.\n4. The p53 transcription factor is a master regulator of cellular stress responses inhibited by repressors such as MDM2 and the phosphatase PPM1D. Activation of p53 with pharmacological inhibitors of ...\n5. PPM1D is a known mediator of p53 signalling, and has been linked to treatment resistance in glioma. In this work, the authors utilise genomics, proteomics, and mouse models to determine the role ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of PPM1D activation on p53 function?",
               "answer": "The activation of PPM1D negatively affects p53 function. PPM1D, which is transcriptionally activated by p53, acts as a phosphatase that dephosphorylates p53 at Ser15, a critical modification necessary for p53's transactivation of target genes. By dephosphory",
               "rationale": "1. The p53 transcription factor is a master regulator of cellular stress responses inhibited by repressors such as MDM2 and the phosphatase PPM1D. Activation of p53 with pharmacological inhibitors of ...\n2. A greater understanding of factors causing cancer initiation, progression and evolution is of paramount importance. Among them, the serine/threonine phosphatase PPM1D, also referred to as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase 2C delta (PP2Cδ), is emerging as an important oncoprotein due to its negative regulation on a number of crucial cancer suppressor pathways.\n3. PPM1D encodes for a serine/threonine phosphatase that is transcriptionally activated by p53 and negatively regulates the DDR and p53 signaling via dephosphorylation of numerous substrates upstream of p53, downstream of p53, and p53 itself. Consistent with its function as a suppressor of the DDR/P53, PPM1D is recurrently activated in cancer via amplifications and activating mutations. 5 We and ...\n4. The p53 transcription factor is a master regulator of cellular stress responses inhibited by repressors such as MDM2 and the phosphatase PPM1D. Activation of p53 with pharmacological inhibitors of its repressors is being tested in clinical trials for cancer therapy, but efficacy has been limited by poor induction of tumor cell death.\n5. A major role of PPM1D is to attenuate this activation. P53 in fact transcriptionally activates the expression of PPM1D, which then dephosphorylates p53 at Ser15, which is a critical posttranslational modification required to stimulate transactivation of p53-responsive promoters ; thus, PPM1D dephosphorylation of p53 directly deescalates the DDR ...",
               "predicate": null
            }
         ],
         "row": 516,
         "id": 231738750121507138
      },
      {
         "claim": "All hematopoietic stem cells segregate their chromosomes randomly.",
         "label": 1,
         "prediction": 1,
         "rationale": "Hematopoietic stem cells are rare cells that possess characteristics of pluripotency and self-renewal, allowing them to generate an entire hematopoietic system, which includes all types of blood cells. Hematopoietic stem cells segregate their chromosomes randomly. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are hematopoietic stem cells?",
               "answer": "Hematopoietic stem cells (HSCs) are rare cells that possess characteristics of pluripotency and self-renewal, allowing them to generate an entire hematopoietic system, which includes all types of blood cells. They originate from the ventral endothelial wall of the embryonic aorta and are",
               "rationale": "1. Hematopoietic stem cells ( HSCs) are the stem cells [1] that give rise to other blood cells. This process is called haematopoiesis. [2] In vertebrates, the first definitive HSCs arise from the ventral endothelial wall of the embryonic aorta within the (midgestational) aorta-gonad-mesonephros region, through a process known as endothelial-to ...\n2. Abstract. Hematopoietic stem cells (HSCs) are regarded as one of essential cell sources for treating regenerative diseases. Among many stem cells, the feasibility of using adult-derived hematopoietic stem cells in therapeutic approaches is very diverse, and is unarguably regarded as an important cell source in stem cell biology.\n3. Haematopoietic stem cells are rare cells with characteristics of pluripotency and self-renewal that are capable of generating an entire haematopoeitic system. Haematopoietic stem cells have been ...\n4. Hematopoiesis begins with an originator cell common to all blood cell types. It's called a hematopoietic stem cell (HSC). An HSC develops into a precursor cell, or \"blast\" cell. A precursor cell is on track to become a specific type of blood cell, but it's still in the early stages.\n5. In hematopoietic stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases. Leukemia, lymphoma, neuroblastoma and multiple myeloma often are treated this way. These transplants use adult stem cells or umbilical cord ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do hematopoietic stem cells segregate their chromosomes randomly?",
               "answer": "Yes, hematopoietic stem cells segregate their chromosomes randomly. Evidence from the provided snippets indicates that several studies have demonstrated random chromosome segregation in hematopoietic stem cells, contrary to the immortal strand hypothesis which suggests asymmetric segregation.",
               "rationale": "1. Whereas most cells segregate their chromosomes randomly 1,10, ... M. B. et al. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J. Clin.\n2. Abstract. Stem cells are proposed to segregate chromosomes asymmetrically during self-renewing divisions so that older ('immortal') DNA strands are retained in daughter stem cells whereas newly synthesized strands segregate to differentiating cells. Stem cells are also proposed to retain DNA labels, such as 5-bromo-2-deoxyuridine (BrdU), either ...\n3. The immortal strand hypothesis was proposed as a mechanism by which stem cells could avoid accumulating mutations that arise during DNA replication 2.Whereas most cells segregate their chromosomes randomly 1, 10, it was argued that adult stem cells in steady-state tissues might retain older DNA strands during asymmetric self-renewing divisions, segregating newly synthesized strands to daughter ...\n4. Several studies have demonstrated that epidermal basal cells, hematopoietic stem cells, and intestinal epithelial stem cells segregate their chromosomes randomly Barker et al., 2007 Barker N.\n5. Non-random chromosome segregation and asymmetric cell fate determination. (a) Chromosomes in G 1-phase consist of one older (blue) and one newer (green) strand.The difference in age between strands arises from semi-conservative DNA replication; that is, the older strand served as the template for synthesis of the newer strand during the preceding S-phase (not shown).",
               "predicate": null
            }
         ],
         "row": 517,
         "id": 866439450978836324
      },
      {
         "claim": "Angiotensin converting enzyme inhibitors are associated with increased risk for functional renal insufficiency.",
         "label": 1,
         "prediction": 0,
         "rationale": "Angiotensin-converting enzyme inhibitors (ACE inhibitors) are a class of medications primarily used to treat high blood pressure and heart failure by blocking the production of angiotensin II, thereby relaxing the veins and arteries to lower blood pressure. Angiotensin-converting enzyme inhibitors are not associated with an increased risk for functional renal insufficiency. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Angiotensin converting enzyme inhibitors?",
               "answer": "Angiotensin-converting enzyme inhibitors (ACE inhibitors) are a class of medications primarily used to treat high blood pressure and heart failure. They work by blocking the production of angiotensin II, a substance that narrows blood vessels, thereby relaxing the veins and arteries to lower blood pressure. ACE inhibitors also help decrease blood",
               "rationale": "1. Angiotensin-converting enzyme inhibitors (ACE inhibitors) are a group of medicines that are mainly used to treat certain heart and kidney conditions; however, they may be used in the management of other conditions such as migraine and scleroderma.. They block the production of angiotensin II, a substance that narrows blood vessels and releases hormones such as aldosterone and norepinephrine ...\n2. Angiotensin-converting enzyme (ACE) inhibitors are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.\n3. Angiotensin-converting enzyme inhibitors, often shortened to ACE inhibitors, are a type of medications that lower your blood pressure. They interfere with how your body converts angiotensin into a form that raises your blood pressure. These drugs can treat cardiovascular conditions like high blood pressure, heart failure, kidney problems and more.\n4. Angiotensin-converting enzyme inhibitors have been reported to decrease glomerular capillary pressure by decreasing arterial pressure and selectively dilating efferent arterioles. It has been shown that the use of ACE inhibitors prevents the progression of microalbuminuria to overt proteinuria. Angiotensin-converting enzyme inhibition provides ...\n5. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a class of medication used primarily for the treatment of high blood pressure and heart failure. This class of medicine works by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.. ACE inhibitors inhibit the activity of ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are Angiotensin-converting enzyme inhibitors associated with increased risk for functional renal insufficiency?",
               "answer": "The provided evidence snippets do not indicate that Angiotensin-converting enzyme (ACE) inhibitors are associated with an increased risk for functional renal insufficiency. In fact, they suggest the opposite: ACE inhibitors have been shown to be beneficial in managing conditions such as chronic renal insufficiency, particularly when proteinuria levels are elevated.",
               "rationale": "1. More recently, ACE inhibitors have been shown to reduce the rate of progression in nondiabetic chronic renal insufficiency if the level of proteinuria exceeds 1 to 3 g/d. 9-12 Finally, ACE inhibitors have proved beneficial in treating a range of patients at high risk for cardiovascular events, presumably in relation to an established ability ...\n2. ACE inhibitors are medications used to treat and manage hypertension, which is a significant risk factor for coronary disease, heart failure, stroke, and a host of other cardiovascular conditions. Most cases are primary and not attributable to any specific etiology. This activity reviews the indications, contraindications, activity, adverse events, and other key elements of ACE inhibitor ...\n3. Angiotensin-converting enzyme (ACE) inhibitors1 and angiotensin receptor blockers (ARBs)2 were major therapeutic advances, with strong evidence from large randomized controlled trials supporting the use of renin-angiotensin system (RAS) blockade to lower blood pressure (BP) and prevent-target organ damage in hypertension, reduce mortality in heart failure, and lower proteinuria and slow the ...\n4. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are major therapeutic advances in this respect, as they have been consistently shown to reduce albuminuria ...\n5. By Mayo Clinic Staff. Angiotensin-converting enzyme (ACE) inhibitors are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.",
               "predicate": null
            }
         ],
         "row": 518,
         "id": 131501462000293271
      },
      {
         "claim": "Anthrax spores can be disposed of easily after they are dispersed.",
         "label": 0,
         "prediction": 0,
         "rationale": "Anthrax spores cannot be disposed of easily and require proper disposal methods, such as complete incineration, to effectively destroy them. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Can Anthrax spores be disposed of easily?",
               "answer": "No, anthrax spores cannot be disposed of easily. The evidence indicates that proper disposal methods, such as complete incineration to reduce carcasses to ash, are necessary to effectively destroy spores and decrease environmental contamination. Additionally, there are specific guidelines and precautions that must be followed to prevent exposure and ensure safe disposal, highlighting",
               "rationale": "1. The following guidelines provide information on evaluating disposal efforts and in confirming complete incineration. The goal is to destroy as many spores as possible, thereby decreasing environmental anthrax contamination. A complete burn should be achieved. The carcass should be completely reduced to ash.\n2. Control and Prevention. Infection with Bacillus anthracis, (BA), which causes anthrax, occurs through direct exposure to active bacteria or bacterial spores.Measures for protecting workers from exposure to BA depend on the type of work performed and knowledge of exposure risk, including potential for spore release from an accidental or intentional event.\n3. Anthrax spores are easily transported by rain or surface water from anthrax carcasses because they have a high hydrophobicity and low electronegativity [152, 153, 154]. An understanding of the soil life cycle of B. anthracis is of military medical interest when animals that died of anthrax were only buried and not burnt in some enzootic areas ...\n4. Anthrax is an infection caused by the spore-forming bacteria called Bacillus anthracis. It is a zoonosis (disease transmissible from animals to humans) that typically affects ruminants (such as cows, sheep, and goats). The bacteria produce extremely potent toxins which are responsible for the symptoms, causing a high lethality rate.\n5. Ideally, national policies should ensure that materials known to be contaminated with anthrax spores are appropriately disposed of and are not included in any industrial process. 8.6. Prophylaxis. ... Since, in theory, the vaccine is easy to prepare, many countries undertake their own manufacture (Annex 5, section 2.13). However, it is ...",
               "predicate": null
            }
         ],
         "row": 519,
         "id": 286771033170982901
      },
      {
         "claim": "Antibiotic induced alterations in the gut microbiome reduce resistance against Clostridium difficile",
         "label": 1,
         "prediction": 1,
         "rationale": "Clostridium difficile, or C. difficile, is a bacterium that causes an infection of the colon, leading to symptoms such as diarrhea and colitis. The use of antibiotics disrupts the balance of the gut microbiome. The disruption of the gut microbiome increases susceptibility to Clostridium difficile infection. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Clostridium difficile?",
               "answer": "Clostridium difficile, often referred to as C. difficile or C. diff, is a bacterium that causes an infection of the colon, leading to symptoms such as diarrhea and colitis (inflammation of the colon). It is highly contagious and often occurs after the use of certain antibiotics, which can disrupt the balance",
               "rationale": "1. Clostridioides difficile (klos-TRID-e-oi-deez dif-uh-SEEL) is a bacterium that causes an infection of the colon, the longest part of the large intestine. Symptoms can range from diarrhea to life-threatening damage to the colon. The bacterium is often called C. difficile or C. diff. Illness from C. difficile often occurs after using antibiotic ...\n2. C. diff is a bacterium that causes diarrhea and colitis, often after taking antibiotics. Learn how to prevent, diagnose and treat this contagious and potentially life-threatening infection.\n3. What it is. Clostridioides difficile [klos-TRID-e-OY-dees dif-uh-SEEL], formerly known as Clostridium difficile and often called C. difficile or C. diff., is a germ (bacterium) that causes diarrhea and colitis. Colitis is an inflammation of the colon.\n4. Clostridium difficile (C. diff) is a highly contagious bacterial infection of the colon. It's typically caused by taking certain antibiotics, which can interfere with the balance between good and ...\n5. C. difficile infection is a bacterial infection that causes diarrhea and inflammation of the colon. It can be diagnosed by stool tests, colon exam or imaging tests, and treated with antibiotics, surgery or fecal microbiota transplant.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the use of antibiotics disrupt the balance of the gut microbiome?",
               "answer": "Yes, the use of antibiotics disrupts the balance of the gut microbiome. The evidence indicates that antibiotics can lead to dysbiosis of the microbiota, negatively impacting host health by affecting immune regulation and metabolic activities. Multiple studies have recognized the adverse consequences of antibiotic use on the gut microbiome, highlighting its crucial role",
               "rationale": "1. While non antibiotics such as probiotics contribute to microbiome-facilitated antibiotic resistance, the interactions between drugs and microbiome are found to be bidirectional. Antibiotics can disrupt gut microbiota and microbes as well can modulate the drugs thereby modifying the chemical composition and leads to the antimicrobial resistance.\n2. Antibiotics can have several negative impacts on host health; both direct and indirect effects. The gut microbiota plays a crucial role in host health regulation. Effects of antibiotics on the host through the gut microbiome are immense and can affect various functions including immune regulation, metabolic activities, and thus overall health.\n3. Although antibiotic treatment is crucial for combating infections, its negative effects on the intestinal microbiota and host immunity have been shown to be of the utmost importance. Multiple studies have recognized the adverse consequences of antibiotic use upon the gut microbiome in adults and neonates, causing dysbiosis of the microbiota.\n4. The gut microbiome plays a huge role in maintaining our health, including regulating the immune system and aiding digestion. And experts argue that antibiotics are one of the biggest threats to ...\n5. The main exposure of interest in this review was the effect commonly prescribed antibiotics have on the gut microbiome based on prescriptions advice included in the National Institute for Health and Care Excellence (NICE) guidelines1 8 33-35 and on current use as described in nation reports on antibiotic use.1 34 Of particular interest are ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the disruption of the gut microbiome increase susceptibility to Clostridium difficile infection?",
               "answer": "Yes, the disruption of the gut microbiome increases susceptibility to Clostridium difficile infection (CDI). Evidence indicates that antibiotic treatment induces significant changes in the gut microbial community, which can lead to a breakdown of barrier immunity and make the gut more vulnerable to infections like CDI.",
               "rationale": "1. As such, disruption of the microbiota, as through antibiotic treatment, reduces production of RegIIIγ resulting in a breakdown of barrier immunity. As a consequence, antibiotic-treated mice are highly susceptible to opportunistic infection with enteric pathogens such as vancomycin-resistant enterococcus (VRE) [ 19 ].\n2. Here we show that antibiotic treatment induces substantial changes in the gut microbial community and in the metabolome of mice susceptible to C. difficile infection.\n3. Abstract. Antibiotic-mediated perturbation of the gut microbiome is associated with numerous infectious and autoimmune diseases of the gastrointestinal tract. Yet, as the gut microbiome is a ...\n4. Also, the adverse impact of antibiotics on the gut microbiome is of great importance because when disrupted, it can be associated with a variety of diseases, including susceptibility to infections, autoimmune diseases (such as inflammatory bowel disease), diabetes, depression and obesity.\n5. A disruption in the gut microbiome composition can make the gut more vulnerable to diseases such as Clostridioides difficile infection (CDI), caused by the bacterium C. difficile. CDI management presents a therapeutic dilemma, as it is usually treated with antibiotics that can treat the infection but also can damage the microbiome.",
               "predicate": null
            }
         ],
         "row": 520,
         "id": 269462105221057635
      },
      {
         "claim": "Antiretroviral therapy reduces rates of tuberculosis across a broad range of CD4 strata.",
         "label": 1,
         "prediction": 1,
         "rationale": "Antiretroviral therapy (ART) is a combination of medications used to treat HIV by stopping the virus from reproducing, reducing its levels in the body, and keeping the immune system healthy. Antiretroviral therapy reduces rates of tuberculosis among persons living with HIV. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is antiretroviral therapy?",
               "answer": "Antiretroviral therapy (ART) is a combination of medications used to treat HIV (human immunodeficiency virus). It works by stopping HIV from reproducing, which helps reduce the levels of the virus in the body and keeps the immune system healthy. While ART is not a cure for HIV, it allows many people",
               "rationale": "1. Antiretroviral Therapy. Antiretroviral therapy (ART) is a combination of medications used to treat HIV (human immunodeficiency virus). It works by stopping HIV from reproducing. It can reduce your levels of HIV and keep your immune system healthy. It's not a cure, but many people reach undetectable levels of HIV.\n2. The treatment for HIV is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV treatment regimen) every day. ART is recommended for everyone who has HIV. ART cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives. ART also reduces the risk of HIV transmission.\n3. Antiretroviral therapy is used to control HIV. It relies on drugs that inhibit points of the viral replication cycle so the virus cannot make copies of itself and infect immune system cells. Antiretroviral drugs are usually given daily in the form of a pill, which may contain a combination of drugs.\n4. HIV treatment involves taking highly effective medicines called antiretroviral therapy (ART) that work to control the virus. ART is recommended for everyone with HIV, and people with HIV should start ART as soon as possible after diagnosis, even on that same day. People on ART take a combination of HIV medicines called an HIV treatment regimen.\n5. Treatment with HIV medicines is called antiretroviral therapy (ART).ART is recommended for everyone with HIV, and people with HIV should start ART as soon as possible. People on ART take a combination of HIV medicines (called an HIV treatment regimen) every day or by schedule (injections).A person's initial HIV treatment regimen generally includes three HIV medicines from at least two ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does antiretroviral therapy reduce rates of tuberculosis?",
               "answer": "Yes, antiretroviral therapy (ART) can reduce rates of tuberculosis (TB) among persons living with HIV. The evidence indicates that TB is a leading cause of death in individuals with HIV, and the implementation of TB preventive treatment (TPT) alongside ART has been shown to reduce TB-attributable deaths.",
               "rationale": "1. TPT, when taken with antiretroviral treatment (ART), can reduce TB-attributable deaths among persons with HIV. In 2018, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program committed to offer one course of TPT to all eligible clients receiving ART. ... § rates among persons on antiretroviral treatment, by age, sex ...\n2. Tuberculosis (TB) is the leading cause of death among persons living with human immunodeficiency virus (HIV) infection. In 2018, an estimated 251,000 persons living with HIV infection died from TB, accounting for one third of all HIV-related deaths and one sixth of all TB deaths (1).TB preventive treatment (TPT) is recommended by the World Health Organization (WHO) for persons living with HIV ...\n3. Since tuberculosis incidence rates during early antiretroviral therapy depend highly upon the efficiency of tuberculosis screening prior to antiretroviral ... (2011) When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries. Ann Intern Med 154: 509-515. ...\n4. Key Considerations and Recommendations. Selection of tuberculosis (TB)-preventive treatment for individuals with HIV and latent tuberculosis infection (LTBI) should be based on the individual's antiretroviral (ARV) regimen as noted below. With daily isoniazid alone for 6 or 9 months, any ARV regimen can be used (AIII).\n5. Incidence rates of tuberculosis (TB) by time on antiretroviral treatment (ART) and baseline CD4 count category (< 50, 51-100, 101-200, > 200 cells/mm 3). Numbers in table below figure represent the number of TB cases observed over the total number of people on ART who completed follow up during the respective time periods, by CD4 count ...",
               "predicate": null
            }
         ],
         "row": 521,
         "id": 723772809011703582
      },
      {
         "claim": "Articles published in open access format are less likely to be cited than traditional journals.",
         "label": 0,
         "prediction": 0,
         "rationale": "Open access format refers to a format in which research outputs are distributed online, free of access charges or other barriers, allowing for unrestricted use and reuse of the content. Articles published in open access format are cited more often than articles in traditional journals. The source of the evidence that articles published in open access format are cited more often than articles in traditional journals is a systematic review conducted by Davis and Walters. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of open access format?",
               "answer": "Open access (OA) refers to a format in which research outputs are distributed online, free of access charges or other barriers, allowing for unrestricted use and reuse of the content. It encompasses a range of digital information, including scholarly literature, datasets, and multimedia, and is characterized by less restrictive copyright and licensing compared to traditional",
               "rationale": "1. Open access. Open access ( OA) is a set of principles and a range of practices through which research outputs are distributed online, free of access charges or other barriers. [1] With open access strictly defined (according to the 2001 definition), or libre open access, barriers to copying or reuse are also reduced or removed by applying an ...\n2. Defining Open Access. Open access (OA) refers to freely available, digital, online information. Open access scholarly literature is free of charge and often carries less restrictive copyright and licensing barriers than traditionally published works, for both the users and the authors. While OA is a newer form of scholarly publishing, many OA ...\n3. Open access (OA) means free access to information and unrestricted use of electronic resources for everyone. Any kind of digital content can be OA, from texts and data to software, audio, video, and multi-media. While most of these are related to text only, a growing number are integrating text with images, data, and executable code.\n4. Open access to publications is a component of Open Science, which encompasses a variety of efforts focused on making scientific research more transparent and accessible. Though the term is frequently used to refer to efforts aimed at ensuring access to the products of the research process - journal articles, datasets, code, and other materials - open science also encompasses efforts to ensure ...\n5. Open Access is the free, immediate, online availability of research articles combined with the rights to use these articles fully in the digital environment. Open Access is the needed modern update for the communication of research that fully utilizes the Internet for what it was originally built to do—accelerate research.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are articles published in open access format cited less often than articles in traditional journals?",
               "answer": "No, articles published in open access format are cited more often than articles in traditional journals. Evidence indicates that open access articles are viewed and cited more frequently than those behind a paywall, and a systematic review has been conducted to compare citations of open access and non-open access articles, suggesting a citation advantage for open access publications",
               "rationale": "1. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non-OA ...\n2. 2. Cost. Both traditional and OA journals may charge a small fee at the time of submission to cover editorial and peer review-related costs. The difference arises in the post-acceptance fees. Traditional journals commonly charge per page (often $100-250 each) and/or per color figure ($150-1000 each).\n3. This speed starts with the review process. While journals are reluctant to make promises about the speed of the review process—since qualified reviewers are busy people and meaningful reviews take time—open access journals tend to have faster turn-around times than traditional journals. Once an article is accepted by a reputable journal ...\n4. Increased citation and usage: Studies have shown that open access articles are viewed and cited more often than articles behind a paywall.. Wider collaboration: Open access publications and data enable researchers to carry out collaborative research on a global scale.: Greater public engagement: Content is available to those who can't access subscription content.\n5. The research team analyzed the citations for 19 million scholarly works published from 2010 to 2019, most of them peer-reviewed journal articles. In 2010, about one-third were open access; the proportion steadily rose to more than 50% by 2019. The researchers found that open-access papers consistently scored higher on two widely used scales ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the source of the evidence that articles published in open access format are cited more often than articles in traditional journals?",
               "answer": "The source of the evidence that articles published in open access format are cited more often than articles in traditional journals is a systematic review conducted by Davis and Walters, which found that the majority of studies (47.8%) indicated an open access citation advantage (OACA). Additionally, a longitudinal bibliometric analysis of citations to papers",
               "rationale": "1. In a critical review, Davis and Walters found a notable increase in the number of downloads for articles published OA but no clear evidence of OACA ... used other sources of data, and 24 (17.9%) studies used more than one source of data. The majority of the studies (n = 64, 47.8%) found that there was OACA while 27.6% (n = 37) found that it ...\n2. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non-OA ...\n3. OA is likely to benefit science by accelerating dissemination and uptake of research findings. A longitudinal bibliometric analysis of citations to papers published in the PNAS between June 8, 2004 and December 20, 2004 reveals that the open-access articles were more immediately recognized and cited by peers. Go to:\n4. The research team analyzed the citations for 19 million scholarly works published from 2010 to 2019, most of them peer-reviewed journal articles. In 2010, about one-third were open access; the proportion steadily rose to more than 50% by 2019. The researchers found that open-access papers consistently scored higher on two widely used scales ...\n5. In our times, researchers and authors are more inclined to publish their best articles in influential open-access journals that offer relevant indexing, free access, and wide dissemination of their works.22,23 With the changes in the global research funding, experts believe that full and immediate Open Access will outweigh the role of ...",
               "predicate": null
            }
         ],
         "row": 522,
         "id": 324232439431867125
      },
      {
         "claim": "Articles published in open access format are more likely to be cited than traditional journals.",
         "label": 1,
         "prediction": 0,
         "rationale": "Open access is a set of principles and practices that allow research outputs to be distributed online free of access charges or other barriers, ensuring free access to scholarly literature on the Internet for unrestricted use and reuse by everyone. Articles published in open access format may receive more citations than traditional journals, but the evidence is inconclusive and contradictory. The conclusion of the systematic review comparing citations between OA and non-OA articles is not explicitly stated, with findings on the open access citation advantage being contradictory and inconclusive. The systematic review on the open access citation advantage (OACA) indicates that the quality and heterogeneity of the component studies pose challenges for generalization, with findings regarding the existence of an OACA being contradictory. The existence of an open access citation advantage (OACA) remains inconclusive due to contradictory findings and the poor quality and heterogeneity of existing studies. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of open access format?",
               "answer": "Open access (OA) is defined as a set of principles and practices that allow research outputs, such as journal articles, to be distributed online free of access charges or other barriers. It ensures free access to scholarly literature on the Internet, allowing unrestricted use and reuse of digital content for everyone. The aim of open access is",
               "rationale": "1. Open access. Open access ( OA) is a set of principles and a range of practices through which research outputs are distributed online, free of access charges or other barriers. [1] With open access strictly defined (according to the 2001 definition), or libre open access, barriers to copying or reuse are also reduced or removed by applying an ...\n2. The Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities. Open access (OA) means free access to information and unrestricted use of electronic resources for everyone. Any kind of digital content can be OA, from texts and data to software, audio, video, and multi-media. While most of these are related to text only, a ...\n3. Open Access is the free, immediate, online availability of research articles combined with the rights to use these articles fully in the digital environment. Open Access is the needed modern update for the communication of research that fully utilizes the Internet for what it was originally built to do—accelerate research.\n4. Open access (OA) is a set of principles and practices through which research outputs like journal articles are distributed online, free of cost or other access barriers.. In \"traditional\" scholarly publishing, the publisher owns the rights to the articles in their journals. Individuals looking to read these articles may encounter a paywall, requiring them to pay a fee for access.\n5. Definition. In a nutshell: open access means free access to scholarly literature on the Internet. The most commonly invoked definition of open access comes from the so-called Budapest Declaration (2002). Thus, the aim of open access is to make scholarly literature freely accessible and reusable for everyone - that is, free of charge and, as ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do articles published in open access format have more citations than traditional journals?",
               "answer": "The evidence suggests that there is ongoing research into the citation impact of open access (OA) articles compared to traditional subscription-based journals. While some studies indicate that OA articles may receive more citations, the findings have been contradictory and inconclusive. Specifically, the systematic review mentioned aims to compare citations between OA and non-OA articles",
               "rationale": "1. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non-OA ...\n2. This study aims to investigate the research and citation impact of open access (OA) journals versus non-OA journals being published in the spectrum of library and information science (LIS) across the world and to further ascertain whether OA journals have greater citation counts than subscription-based journals in LIS discipline.,A total of 116 ...\n3. A breakthrough in the analysis of the relationship between citations and open access status came with the study performed by Schwarz and Kennicutt (2004) on articles published in Astrophysical Journal (ApJ) in 1999 or 2002 with a matching pre-print version deposited in the astrophysics section of arXiv.These authors were among the first to recognize that citation counting begins earlier for ...\n4. 2. Cost. Both traditional and OA journals may charge a small fee at the time of submission to cover editorial and peer review-related costs. The difference arises in the post-acceptance fees. Traditional journals commonly charge per page (often $100-250 each) and/or per color figure ($150-1000 each).\n5. In this study, we compare the difference in the impact between open access (OA) and non-open access (non-OA) articles. 1761 Nature Communications articles published from 1 January 2012 to 31 August 2013 are selected as our research objects, including 587 OA articles and 1174 non-OA articles. Citation data and daily updated article-level metrics data are harvested directly from the platform of ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the conclusion of the systematic review comparing citations between OA and non-OA articles?",
               "answer": "The conclusion of the systematic review comparing citations between OA and non-OA articles is not explicitly stated in the provided evidence snippets. However, it is indicated that there has been substantial research on the open access citation advantage (OACA), but findings have been contradictory and inconclusive. The systematic review aimed to compare studies on citations",
               "rationale": "1. A 2007 critical review by Craig et al. looked at three non-exclusive postulates when examining citation differences between both OA and non-OA articles: that the advantage is due to 1) OA status of the article; 2) selection bias (i.e., authors select their best works to share openly), and 3) early view effects (i.e., the extra time that an ...\n2. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non-OA ...\n3. studies of citations to OA and non-OA articles. Methods A systematic search of 17 databases attempted to capture all relevant studies authored since 2001. The protocol was registered in Open Science Framework. We included studies with a direct comparison between OA and non-OA items and reported article-level citation as an outcome.\n4. We conducted a systematic review to compare studies of citations to OA and non-OA articles. Methods A systematic search of 17 databases attempted to capture all relevant studies authored since 2001.\n5. Since Lawrence in 2001 proposed the open access (OA) citation advantage, the potential benefit of OA in relation to citation impact has been discussed in depth. The methodology to test this postulate ranges from comparing the impact factors of OA journals versus traditional ones, to comparing citations of OA versus non-OA articles published in the same non-OA journals. However, conclusions are ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the outcome of the systematic review on the open access citation advantage (OACA)?",
               "answer": "The outcome of the systematic review on the open access citation advantage (OACA) indicates that the quality and heterogeneity of the component studies pose challenges for generalization. The review suggests that there is a need for reporting guidelines for bibliometric studies, highlighting that the findings regarding the existence of an OACA have been contradictory and",
               "rationale": "1. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non-OA ...\n2. A systematic review of studies of citations to OA and non-OA articles concluded that quality and heterogeneity of the component studies pose challenges for generalization and suggest the need for reporting guidelines for bibliometrics studies. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access ...\n3. RESEARCH ARTICLE Is the open access citation advantage real? A systematic review of the citation of open access and subscription-based articles Allison Langham-Putrow ID 1☯*, Caitlin Bakker2☯, Amy Riegelman ID 1☯ 1 University of Minnesota Libraries, University of Minnesota, Minneapolis, MN, United States of America, 2 University of Minnesota Health Sciences Libraries, Minneapolis MN ...\n4. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion.\n5. Aims: Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive. We conducted a systematic review to compare studies of citations to OA and non ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the final conclusion of the systematic review regarding the existence of an open access citation advantage (OACA)?",
               "answer": "The final conclusion of the systematic review regarding the existence of an open access citation advantage (OACA) is that the findings are contradictory and inconclusive, and that the quality and heterogeneity of the studies pose challenges for generalization. The review suggests the need for reporting guidelines for bibliometrics studies.",
               "rationale": "1. Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion. While there has been substantial research to address this question, findings have been contradictory and inconclusive.\n2. A systematic review of studies of citations to OA and non-OA articles concluded that quality and heterogeneity of the component studies pose challenges for generalization and suggest the need for reporting guidelines for bibliometrics studies. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access ...\n3. Aims Over the last two decades, the existence of an open access citation advantage (OACA)—increased citation of articles made available open access (OA)—has been the topic of much discussion.\n4. The 2006 publication quoted in the article was one of 134 included in a 2021 systematic review of studies of citation rates of ... one supported the existence of the open-access advantage, one did ...\n5. Since Lawrence in 2001 proposed the open access (OA) citation advantage, the potential benefit of OA in relation to citation impact has been discussed in depth. The methodology to test this postulate ranges from comparing the impact factors of OA journals versus traditional ones, to comparing citations of OA versus non-OA articles published in the same non-OA journals. However, conclusions are ...",
               "predicate": null
            }
         ],
         "row": 523,
         "id": 187611894853461237
      },
      {
         "claim": "Assembly of invadopodia is triggered by focal generation of phosphatidylinositol-3,4-biphosphate and the activation of the nonreceptor tyrosine kinase Src.",
         "label": 1,
         "prediction": 1,
         "rationale": "Src functions as a non-receptor protein tyrosine kinase that transduces signals involved in the control of various cellular processes, including proliferation, differentiation, motility, and adhesion. The activation of Src is involved in the assembly of invadopodia. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the function of Src in cellular processes?",
               "answer": "Src functions as a non-receptor protein tyrosine kinase that transduces signals involved in the control of various cellular processes, including proliferation, differentiation, motility, and adhesion. It is typically maintained in an inactive state but can be activated transiently during events such as mitosis or constitutively in certain conditions",
               "rationale": "1. Src is the representative member of the Src-family kinases (SFKs), a group of tyrosine kinases involved in several cellular processes. Its main function has been for long confined to the plasma membrane/cytoplasm compartment, being a myristoylated protein anchored to the cell membrane and functioning downstream to receptors, most of them lacking intrinsic kinase activity.\n2. View/Edit Mouse. Proto-oncogene tyrosine-protein kinase Src, also known as proto-oncogene c-Src, or simply c-Src (cellular Src; pronounced \"sarc\", as it is short for sarcoma ), is a non-receptor tyrosine kinase protein that in humans is encoded by the SRC gene. It belongs to a family of Src family kinases and is similar to the v-Src (viral Src ...\n3. Src is the representative member of the Src-family kinases (SFKs), a group of tyrosine kinases involved in several cellular processes. Its main function has been for long confined to the plasma membrane/cytoplasm compartment, being a myristoylated protein anchored to the cell membrane and functioning downstream to receptors, most of them lacking intrinsic kinase activity.\n4. With the discovery that v-Src is a constitutively activated form of c-Src, and that v-Src is capable of eliciting many dramatic biological responses within cells, including cellular transformation ...\n5. Src is a non-receptor protein tyrosine kinase that transduces signals that are involved in the control of a variety of cellular processes such as proliferation, differentiation, motility, and adhesion. Src is normally maintained in an inactive state, but can be activated transiently during cellular events such as mitosis, or constitutively by ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is the activation of Src involved in the assembly of invadopodia?",
               "answer": "Yes, the activation of Src is involved in the assembly of invadopodia. Evidence from the snippets indicates that Src is activated by extracellular stimulation (e.g., by EGFR) and plays a crucial role in the assembly and stabilization of invadopodium precursors by recruiting and phosphorylating Tks5.",
               "rationale": "1. Definition and description. Podosomes and invadopodia constitute a class of cell-matrix contacts that have been studied mostly in the context of 2D migration on planar substrates classically ...\n2. Pyk2-mediated signaling in invadopodia. Extracellular stimulation by EGFR and integrins leads to activation of Pyk2, which tyrosine phosphorylates cortactin both directly and indirectly by activating Src and Arg kinases. Activation of Src leads to invadopodium precursor assembly and stabilization by recruiting and phosphorylating Tks5.\n3. Invadopodia initially form as precursors in response to EGF or other stimuli (e.g. TGF-β or PDGF). Src is activated either directly by EGFR or by PTP1B (Cortesio et al., 2008). These stimuli induce Cdc42 activation, leading to assembly of the precursor core structure (red text within circle; Razidlo et al., 2014; Yamaguchi et al., 2005).\n4. The initiation phase includes the assembly of actin-based precursor complexes and cortactin-dependent actin polymerization that extends plasma membrane and drives elongation of cellular protrusions. ... MT1-MMP was found to be involved in the activation of MMP2 and possibly MMP8 and MMP13 (70 ... The SRC substrate Tks5, podosomes (invadopodia ...\n5. The family member Tks4 also localizes to invadopodia in Src-transformed cells and is required for invadopodia assembly. 29 However, Tks4 and Tks5 seem to have non-redundant roles in invadopodia ...",
               "predicate": null
            }
         ],
         "row": 524,
         "id": 198837821797473937
      },
      {
         "claim": "Asymptomatic visual impairment screening in elderly populations does not lead to improved vision.",
         "label": 1,
         "prediction": 1,
         "rationale": "Asymptomatic visual impairment refers to a condition where an individual has a reduction in visual acuity or visual function but does not experience noticeable symptoms or difficulties in daily activities. Screening for asymptomatic visual impairment in elderly populations does not show a clear improvement in vision outcomes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of asymptomatic visual impairment?",
               "answer": "The provided evidence snippets do not specifically define \"asymptomatic visual impairment.\" However, based on general knowledge, asymptomatic visual impairment refers to a condition where an individual has a reduction in visual acuity or visual function but does not experience noticeable symptoms or difficulties in daily activities. This means that the impairment may not be apparent",
               "rationale": "1. It is the spatial resolving capacity of the visual system and measures the sharpness of vision. Visual acuity is usually measured using a Snellen's chart at a distance of 6 metres or 20 feet. Several other charts are available for specialised conditions. Normal vision is denoted as a visual acuity of 6/6 or 20/20.\n2. Definition of Visual Impairment. Visual impairment is defined as a condition that results in a loss or reduction in an individual's ability to see. It can be caused by various factors, including genetics, injury, or disease. The impact of visual impairment on daily life can vary depending on the severity and type of impairment.\n3. Visual impairment, or vision impairment, usually means that someone's eyesight is reduced (impaired) to the extent that it can't be corrected to a normal level. This means full correction is not even possible with the help of glasses, contact lenses, medication or vision surgery. The definition of visual impairment can vary depending on who ...\n4. Globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these, vision impairment could have been prevented or is yet to be addressed. The leading causes of vision impairment and blindness at a global level are refractive errors and cataracts. It is estimated that globally only 36% of people with ...\n5. Profound Visual Impairment: Snellen visual acuity = 20/500 to 20/1000; OR visual field of 10 degrees or less; Like the term \"legal blindness,\" \"visual impairment\" is not a functional definition that tells us very much about what a person can and cannot see. It is a classification system, rather than a definition. ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does screening for asymptomatic visual impairment in elderly populations improve vision?",
               "answer": "Based on the provided evidence snippets, the answer is that screening for asymptomatic visual impairment in elderly populations does not show a clear improvement in vision outcomes. The largest trial indicated that while universal vision screening identified significantly more patients with impaired visual acuity and correctable impairment compared to targeted screening, there was no significant difference in the",
               "rationale": "1. In the largest (n = 3249) trial, universal vision screening identified about 10 times as many patients with impaired visual acuity and correctable impairment compared with targeted screening, but there was no significant difference in the likelihood of visual acuity worse than 20/60 at 3- to 5-year follow-up (relative risk [RR], 1.07 [95% CI, 0 ...\n2. The prevalence of cataracts increases sharply with age; an estimated 50% of U.S. adults 80 years or older have cataracts. 1 The prevalence of hyperopia requiring a correction of +3.0 diopters or ...\n3. This report updates a 2016 review for the U.S. Preventive Services Task Force (USPSTF)1,2 on screening for impaired visual acuity in older adults (defined as persons 65 years of age or older). It will be used by the USPSTF to update its 2016 recommendation.3 In 2016, the Task Force concluded that the current evidence was insufficient to assess the balance of benefits and harms of screening for ...\n4. This recommendation statement applies to adults 65 years or older. Assessment of risk. Older age is an important risk factor for most types of visual impairment. Additional risk factors for ...\n5. The US Preventive Services Task Force (USPSTF) has published an updated recommendation statement on screening for impaired visual acuity in older adults 1 and an updated evidence report and systematic review. 2 The USPSTF analyzed the evidence for screening adults older than 65 years in the primary care setting and concluded that \"the current evidence is insufficient to assess the balance of ...",
               "predicate": null
            }
         ],
         "row": 525,
         "id": 156914113410040468
      },
      {
         "claim": "Auditory entrainment is strengthened when people see congruent visual and auditory information.",
         "label": 1,
         "prediction": 1,
         "rationale": "Auditory entrainment is a fundamental neural mechanism that involves the synchronization of brain activity with auditory rhythms, facilitating auditory perception and enhancing the processing of task-relevant information. Seeing congruent visual and auditory information strengthens auditory entrainment. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is auditory entrainment?",
               "answer": "Auditory entrainment is a fundamental neural mechanism that involves the synchronization of brain activity with auditory rhythms. It facilitates auditory perception by aligning neural oscillations with rhythmic auditory stimuli, which can enhance the processing of task-relevant information. This phenomenon can be observed in various contexts, such as listening to sounds or speaking, where different",
               "rationale": "1. Auditory stimuli are often rhythmic in nature. Brain activity synchronizes with auditory rhythms via neural entrainment, and entrainment seems to be beneficial for auditory perception. However, it is not clear to what extent neural entrainment in the auditory system is reliable over time, which is a necessary prerequisite for targeted intervention.\n2. Listening to a voice message leads to entrainment of brain rhythms in auditory (and other) brain areas. This is an example of a clear unidirectional coupling. However, the situation is more complex when speaking yourself since your motor cortex and auditory cortex are phase locked to the rhythm of your speech. There is coupling from motor areas ...\n3. Auditory entrainment is a fundamental neural mechanism subserving auditory perception. It has been deployed to study a wide range of problems in temporal processing. We examine the concept of entrainment, compare it to similar phenomena, and then take a systemic view, examining the functional roles of auditory entrainment at the cortical level. ...\n4. When tracing entrainment back to auditory neurophysiology, it becomes clear how entrainment may facilitate the selection of task-relevant, attended information. The important delineation of true oscillatory entrainment versus entrainment in a broad sense notwithstanding, researchers can make use of the same analytical tools at different levels ...\n5. Synopsis Auditory entrainment is a fundamental neural mechanism subserving auditory perception. It has been deployed to study a wide range of problems in temporal processing. We examine the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does seeing congruent visual and auditory information strengthen auditory entrainment?",
               "answer": "Yes, seeing congruent visual and auditory information strengthens auditory entrainment. The evidence indicates that auditory entrainment is enhanced when individuals are presented with congruent audiovisual information, and this process is influenced by attention and top-down signals from the frontal cortex.",
               "rationale": "1. Congruent audiovisual speech enhances our ability to comprehend a speaker, even in noise-free conditions. When incongruent auditory and visual information is presented concurrently, it can hinder a listener's perception and even cause him or her to perceive information that was not presented in either modality.\n2. Auditory entrainment is strengthened when people see congruent visual and auditory information (11, 12) and is modulated by attention and by top-down signals from frontal cortex (4, 14). Cortical entrainment is proposed to perform a key role in speech comprehension, such as segmenting out syllables from a continuous speech stream ( 1 , 2 , 15 ...\n3. Congruent audiovisual speech enhances our ability to comprehend a speaker, even in noise-free conditions. When incongruent auditory and visual information is presented concurrently, it can hinder a listener's perception and even cause him or her to perceive information that was not presented in either modality.\n4. Studies of memory in the elderly have previously focused on a single sensory modality, although multisensory encoding has been shown to improve memory performance in children and young adults. In this study, we investigated how audiovisual encoding affects auditory recognition memory in older (mean age 71 years) and younger (mean age 23 years ...\n5. Congruent visual speech enhances cortical entrainment to continuous auditory speech in noise-free conditions. J. Neurosci. 2015; 35 ... Our data provide evidence that one role for the early integration of visual information into auditory cortex is to resolve competition between multiple sound sources within an auditory scene and that these ...",
               "predicate": null
            }
         ],
         "row": 526,
         "id": 989501298830854389
      },
      {
         "claim": "Autologous transplantation of mesenchymal stem cells causes a higher rate of opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies.",
         "label": 0,
         "prediction": 0,
         "rationale": "Autologous transplantation of mesenchymal stem cells is a procedure where mesenchymal stem cells are harvested from a patient's own body and then used for transplantation, offering advantages such as reduced risk of incompatibility. It is not possible to determine whether autologous transplantation of mesenchymal stem cells causes a higher rate of opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies based on the provided evidence. The rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells is not specified in the provided evidence. The rate of opportunistic infections associated with induction therapy using anti-interleukin-2 receptor antibodies is not specified in the provided information. The rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells is lower compared to induction therapy with anti-interleukin-2 receptor antibodies. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is autologous transplantation of mesenchymal stem cells?",
               "answer": "Autologous transplantation of mesenchymal stem cells refers to a procedure where mesenchymal stem cells (MSCs) are harvested from a patient's own body and then used for transplantation. This type of transplantation offers advantages such as reduced risk of incompatibility since the cells are derived from the same individual. The harvested MSCs",
               "rationale": "1. An autologous stem cell transplant is also called an autologous bone marrow transplant. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor. For example, you don't need to worry about incompatibility between the donor's cells and your own cells if you have an autologous stem cell ...\n2. An autologous stem cell transplant may be a treatment option for some blood cancers. It works by using your own healthy stem cells to replace cells that cancer treatment kills. It may be an option when other treatments aren't effective, or cancer comes back. Research shows it may put a specific blood cancer into long-term remission.\n3. With a stem cell transplant, the stem cells are taken from either the bone marrow or the bloodstream. Understanding Your Autologous Stem Cell Transplant. When you have an autologous stem cell transplant, your stem cells are harvested (collected) from your body and frozen. \"Autologous\" means that the stem cells come from yourself.\n4. One type of transplant, called an allogeneic transplant, uses stem cells from a donor. But in many cases, a transplant may use stem cells from a patient's own body. This is called an autologous stem cell transplant. We talked with Partow Kebriaei, M.D., to learn more about what happens when a patient becomes their own donor.\n5. Abstract. The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell population of multipotential stem/progenitor cells commonly referred to as mesenchymal stem cells ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does autologous transplantation of mesenchymal stem cells cause a higher rate of opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The provided evidence does not contain information regarding the rates of opportunistic infections associated with autologous transplantation of mesenchymal stem cells compared to induction therapy with anti-interleukin-2 receptor antibodies. Therefore, it is not possible to determine whether autologous transplantation causes a higher rate of opportunistic infections based on the",
               "rationale": "1. An autologous stem cell transplant procedure harvests blood-forming cells from your own blood or bone marrow to infuse back after cancer treatment.\n2. This guide will help you and your family understand what to expect throughout your autologous stem cell transplant journey.\n3. An autologous stem cell transplant uses healthy blood stem cells from your own body to replace bone marrow that's not working properly. An autologous stem cell transplant is also called an autologous bone marrow transplant. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor.\n4. In autologous stem cell transplantation, your healthy blood stem cells are the foundation for a new supply of healthy cells after cancer treatment. An autologous stem cell transplant isn't a solution for every kind of cancer or an option for everyone with blood cancer.\n5. Autologous stem cell transplants are an option for patients whose cancer is in remission or has stabilized. This type of transplant is used most frequently to treat multiple myeloma and lymphoma. Leukemia patients usually receive an allogeneic stem cell transplant. That's because research has shown that stem cells from donors help prevent ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells?",
               "answer": "The provided evidence snippets do not contain specific information regarding the rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells. The focus is primarily on autologous hematopoietic stem cell transplantation (ASCT) and its implications for hematologic malignancies and autoimmune diseases, as well as the",
               "rationale": "1. Introduction Autologous hematopoietic stem cell transplantation (ASCT) is a well-established treatment option for hematologic malignancies, especially malignant lymphoma and multiple myeloma (MM). With the advances in medicine, the success rate of ASCT has improved; however, infection is still an important complication related to the prognosis of ASCT and can affect the quality of life and ...\n2. However, since immune reconstitution is a process that occurs in both autologous and allogeneic stem cell transplantation, it is thought to be related to opportunistic infections in ASCT after ...\n3. In the past 20 years, autologous hematopoietic stem cell transplantation (ASCT) has opened new avenues in the treatment of patients with severe, treatment-resistant autoimmune diseases with the aim of resetting the patient's immune system. Over the years, this has led to increased safety and efficacy of the procedure however it is still associated with morbidity and mortality. We evaluated the ...\n4. The development of \"Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients\" represents several years of collaborative efforts of the Centers for Disease Control and Prevention (CDC), the Infectious Diseases Society of America (IDSA), the American Society for Blood and Marrow Transplantation (ASBMT), and two dozen other scholarly societies and ...\n5. Autologous hematopoietic stem cell transplantation (HSCT) has been used as a treatment for severe and therapy-refractory autoimmune diseases (ADs) for more than 15 years.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the rate of opportunistic infections associated with induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The provided evidence snippet does not contain specific information regarding the rate of opportunistic infections associated with induction therapy using anti-interleukin-2 receptor antibodies. Therefore, I cannot provide an answer based on the given information.",
               "rationale": "1. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV A-7. References . 1. Kaplan JE, Masur H, Holmes KK, et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview.\n2. As an example, in a meta-analysis of 70 randomized controlled trials that included over 32,000 patients with rheumatoid arthritis, use of a biologic agent (tumor necrosis factor [TNF]-alpha inhibitors, anakinra, tocilizumab, abatacept, and rituximab) was associated with higher incidence of opportunistic infections compared with placebo (odds ...\n3. Opportunistic infections (OI) are a significant cause of morbidity and mortality in patients with HIV/AIDS. Although the incidence of OI has reduced since the introduction of highly active antiretroviral therapy (ART) in 1995, it continues to add to the burden of HIV-related hospitalizations and deaths in patients. This is particularly true in patients who have not received HAART therapy or ...\n4. The. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. document is published in an electronic format and updated as relevant changes in prevention and treatment recommendations occur. All changes are developed by the subject-matter groups listed in the document.\n5. To confirm the relevance of anti-interleukin-23 to infection susceptibility, we sought a cohort of patients with thymoma, in whom the likelihood of the presence of autoantibodies against both ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells compared to induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The rate of opportunistic infections associated with autologous transplantation of mesenchymal stem cells (MSCs) is lower compared to induction therapy with anti-interleukin-2 receptor antibodies. In a trial involving 159 patients undergoing renal transplantation, the use of autologous MSCs resulted in a decreased risk of opportun",
               "rationale": "1. Several guidelines classify autologous stem cell transplantation (ASCT) as a low to intermediate risk group for infection. In a nationwide population-based study, using the Korean Health Insurance Review and Assessment Service database, patients with lymphoma and multiple myeloma (MM) who underwent ASCT from 2002 to 2016 were retrospectively analyzed.\n2. Context: Antibody-based induction therapy plus calcineurin inhibitors (CNIs) reduce acute rejection rates in kidney recipients; however, opportunistic infections and toxic CNI effects remain challenging. Reportedly, mesenchymal stem cells (MSCs) have successfully treated graft-vs-host disease. Objective: To assess autologous MSCs as replacement of antibody induction for patients with end-stage ...\n3. In a trial among 159 patients undergoing renal transplantation, the use of autologous MSCs compared with anti-IL-2 receptor antibody induction therapy resulted in lower incidence of acute rejection, decreased risk of opportunistic infection and better estimated renal function at 1 year . Moreover, in a clinical pilot study allogeneic MSCs were ...\n4. However, since immune reconstitution is a process that occurs in both autologous and allogeneic stem cell transplantation, it is thought to be related to opportunistic infections in ASCT after ...\n5. To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT), evidence-based recommendations on infectious complications after HDC/ASCT are given. This guideline not only focuses on patients with haematological malignancies but also addresses the specifics of HDC/ASCT patients with solid tumours or autoimmune disorders. In addition to HBV and HCV, HEV ...",
               "predicate": null
            }
         ],
         "row": 527,
         "id": 303244969042843578
      },
      {
         "claim": "Autologous transplantation of mesenchymal stem cells causes fewer opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies.",
         "label": 1,
         "prediction": 0,
         "rationale": "Autologous transplantation of mesenchymal stem cells refers to a procedure where stem cells are harvested from a patient's own body and then used for transplantation. Induction therapy with anti-interleukin-2 receptor antibodies refers to the use of non-depleting immunosuppressive agents to reduce the risk of acute rejection and improve graft survival in the early post-transplant period. It is not possible to determine whether autologous transplantation of mesenchymal stem cells causes fewer opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies based on the provided evidence. The rate of opportunistic infections in patients undergoing autologous transplantation of mesenchymal stem cells is not specified in the provided evidence. The rate of opportunistic infections in patients undergoing induction therapy with anti-interleukin-2 receptor antibodies is not specified in the provided evidence snippets. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is autologous transplantation of mesenchymal stem cells?",
               "answer": "Autologous transplantation of mesenchymal stem cells (MSCs) refers to a procedure where stem cells are harvested from a patient's own body and then used for transplantation. In this context, \"autologous\" indicates that the stem cells come from the same individual, eliminating concerns about compatibility that can arise with donor cells",
               "rationale": "1. An autologous stem cell transplant is also called an autologous bone marrow transplant. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor. For example, you don't need to worry about incompatibility between the donor's cells and your own cells if you have an autologous stem cell ...\n2. An autologous stem cell transplant may be a treatment option for some blood cancers. It works by using your own healthy stem cells to replace cells that cancer treatment kills. It may be an option when other treatments aren't effective, or cancer comes back. Research shows it may put a specific blood cancer into long-term remission.\n3. One type of transplant, called an allogeneic transplant, uses stem cells from a donor. But in many cases, a transplant may use stem cells from a patient's own body. This is called an autologous stem cell transplant. We talked with Partow Kebriaei, M.D., to learn more about what happens when a patient becomes their own donor.\n4. Abstract. The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell population of multipotential stem/progenitor cells commonly referred to as mesenchymal stem cells ...\n5. With a stem cell transplant, the stem cells are taken from either the bone marrow or the bloodstream. Understanding Your Autologous Stem Cell Transplant. When you have an autologous stem cell transplant, your stem cells are harvested (collected) from your body and frozen. \"Autologous\" means that the stem cells come from yourself.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "Induction therapy with anti-interleukin-2 receptor antibodies (IL-2RA) refers to the use of non-depleting immunosuppressive agents, such as basiliximab or daclizumab, in the early post-transplant period to reduce the risk of acute rejection and improve graft survival in",
               "rationale": "1. Interleukin-2 receptor (IL-2R) antibody, a non-depleting immunosuppressive agent, has been authorized for induction therapy since 2000, with the aim of reducing the risk of acute rejection and improving graft survival .\n2. Induction therapy with antilymphocyte biological agents is widely used after kidney transplantation, most commonly T lymphocyte-depleting rabbit-derived antithymocyte globulin (rATG) or an IL-2 receptor antagonist (IL2RA). Early randomized trials showed that rATG or IL2RA induction reduces early acute rejection, prompting recommendations by Kidney Disease Improving Global Outcomes that IL2RA ...\n3. The use of antibody induction after kidney transplantation has increased from 25% to 63% in the past decade and roughly one half of the induction agent used is anti-interleukin-2 receptor antibody (IL-2RA, ie, basiliximab or daclizumab).\n4. Background: Although the utility of antibody induction therapy has been demonstrated in clinical trials, the ideal regimen to use based on patient risk factors has not been fully elucidated. The objectives of this study were to determine the impact of either anti-interleukin-2 receptor antibodies (IL-2RA) or thymoglobulin induction therapies versus no induction therapy on acute rejection rates ...\n5. Induction therapy with antilymphocyte biological agents is widely used after kidney transplantation, most commonly T lymphocyte‐depleting rabbit‐derived antithymocyte globulin (rATG) or an IL ‐2 receptor antagonist (IL 2 RA).Early randomized trials showed that rATG or IL 2 RA induction reduces early acute rejection, prompting recommendations by Kidney Disease Improving Global Outcomes ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does autologous transplantation of mesenchymal stem cells cause fewer opportunistic infections than induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The provided evidence snippets do not contain specific information regarding the comparison of opportunistic infections between autologous transplantation of mesenchymal stem cells and induction therapy with anti-interleukin-2 receptor antibodies. Therefore, based on the evidence given, it is not possible to determine whether autologous transplantation of mesenchymal stem",
               "rationale": "1. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor. For example, you don't need to worry about incompatibility between the donor's cells and your own cells if you have an autologous stem cell transplant.\n2. An autologous stem cell transplant procedure harvests blood-forming cells from your own blood or bone marrow to infuse back after cancer treatment.\n3. Autologous HSC-based gene therapy encompasses and broadens the indications for allogeneic hematopoietic cell transplantation (allo-HSCT); in addition to blood-specific diseases [e.g., primary immunodeficiencies (PIDs), hemoglobinopathies, congenital forms of cytopenia, and stem cell defects], metabolic diseases can also benefit from the cross ...\n4. This guide will help you and your family understand what to expect throughout your autologous stem cell transplant journey.\n5. In autologous stem cell transplantation, your healthy blood stem cells are the foundation for a new supply of healthy cells after cancer treatment. An autologous stem cell transplant isn't a solution for every kind of cancer or an option for everyone with blood cancer.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the rate of opportunistic infections in patients undergoing autologous transplantation of mesenchymal stem cells?",
               "answer": "The provided evidence snippets do not specifically mention the rate of opportunistic infections in patients undergoing autologous transplantation of mesenchymal stem cells. The information focuses on cytomegalovirus infection after autologous stem cell transplantation, guidelines regarding infection risk in ASCT patients, and recommendations for managing infectious complications, but does not",
               "rationale": "1. Rossini, F. et al. Cytomegalovirus infection after autologous stem cell transplantation: Incidence and outcome in a group of patients undergoing a surveillance program.\n2. Several guidelines classify autologous stem cell transplantation (ASCT) as a low to intermediate risk group for infection. In a nationwide population-based study, using the Korean Health Insurance Review and Assessment Service database, patients with ...\n3. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce ...\n4. To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT), evidence-based recommendations on infectious complications after HDC/ASCT are given. This guideline not only focuses on patients with haematological malignancies but also addresses the specifics of HDC/ASCT patients with solid tumours or autoimmune disorders. In addition to HBV and HCV, HEV ...\n5. Procedures such as the transfer of autologous haematopoietic stem cells after ... the risk of opportunistic infections, ... lifelong monitoring for patients undergoing treatment with genetically ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the rate of opportunistic infections in patients undergoing induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The provided evidence snippets do not contain specific information regarding the rate of opportunistic infections in patients undergoing induction therapy with anti-interleukin-2 receptor antibodies. The snippets discuss the use of lymphocyte-depleting therapies such as alemtuzumab and anti-thymocyte globulin, as well as the general context of",
               "rationale": "1. Introduction. Kidney transplantation is the best kidney replacement therapy for patients with stage 5 chronic kidney disease. Induction therapy is an important component of transplant immunosuppression that reduces biopsy-proven acute rejection (BPAR), which in turn affects long-term graft survival. 1 The role of induction in low-risk, living-donor kidney transplant recipients in the present ...\n2. Antibody induction therapy is routinely employed in kidney transplantation to decrease the risk of early rejection. Lymphocyte-depleting therapies alemtuzumab and anti-thymocyte globulin are being used with increasing frequency because of their ability to minimize the early rejection risk when compared to basiliximab [1, 2], although they may increase the risk of infectious complications [3].\n3. Opportunistic infections occur in situations of dysbiosis, predisposing the individual to exogenous and endogenous infections. They occur in the context of autoimmunity or show reactions of varying intensity, both increased (in allergic reactions and conditions of chronic inflammation) and decreased (in cases of immunodeficiency and cancer). 1.\n4. Cryptococcal Disease in Diverse Hosts. The fungus cryptococcus is the most common cause of adult meningitis in parts of the world with high rates of human immunodeficiency virus (HIV) infection ...\n5. Cancer therapy is a dynamically evolving field. Chemotherapy and biologic agents impact the magnitude and duration of immunosuppression in the already-immunocompromised cancer hosts who are then susceptible to a broad spectrum of infectious complications ranging from mild opportunistic infections to severe, fatal neutropenic sepsis. Numerous bacterial, fungal, and viral organisms have been ...",
               "predicate": null
            }
         ],
         "row": 528,
         "id": 327188364198100946
      },
      {
         "claim": "Autologous transplantation of mesenchymal stem cells has lower rates of rejection than induction therapy with anti-interleukin-2 receptor antibodies.",
         "label": 1,
         "prediction": 1,
         "rationale": "Autologous transplantation of mesenchymal stem cells involves using stem cells harvested from the patient's own body for therapeutic purposes, offering advantages such as reduced risk of immune rejection. The rate of rejection for autologous transplantation of mesenchymal stem cells is not specified, but using autologous stem cells is likely to have a lower likelihood of rejection due to avoiding incompatibility issues. The rate of rejection for induction therapy with anti-interleukin-2 receptor antibodies is 6.25%. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is autologous transplantation of mesenchymal stem cells?",
               "answer": "Autologous transplantation of mesenchymal stem cells (MSCs) involves using stem cells that are harvested from the patient's own body for therapeutic purposes. This type of transplantation offers several advantages, such as a reduced risk of immune rejection since the cells are the patient's own. Autologous MSCs can be used to treat",
               "rationale": "1. An autologous stem cell transplant is also called an autologous bone marrow transplant. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor. For example, you don't need to worry about incompatibility between the donor's cells and your own cells if you have an autologous stem cell ...\n2. An autologous stem cell transplant may be a treatment option for some blood cancers. It works by using your own healthy stem cells to replace cells that cancer treatment kills. It may be an option when other treatments aren't effective, or cancer comes back. Research shows it may put a specific blood cancer into long-term remission.\n3. Abstract. The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell population of multipotential stem/progenitor cells commonly referred to as mesenchymal stem cells ...\n4. Autologous vs allogeneic: clinical implications. In general, autologous stem cells have several advantages. A match. First, since they are the patient's own cells, they have little to no risk of being rejected by the immune system. This means that an autologous stem cell transplant is more likely to \"take\", which we scientists call ...\n5. Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of using autologous vs. allogeneic MSCs are inconclusive. Transplanted MSCs within the body interact with ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the rate of rejection for autologous transplantation of mesenchymal stem cells?",
               "answer": "The provided evidence does not specify the rate of rejection for autologous transplantation of mesenchymal stem cells (MSCs). However, it does mention that using cells from one's own body (autologous stem cell transplant) offers advantages such as avoiding incompatibility issues, which suggests a lower likelihood of rejection compared to all",
               "rationale": "1. The drug is based on expanded adipose-derived stem cells 26. In both cases the drugs are allogeneic, which provides strong advantage other autologous products due to possibility of detailed testing regarding both safety and potency before release. Nowadays other sources of MSCs are also used for clinical therapies.\n2. An autologous stem cell transplant is also called an autologous bone marrow transplant. Using cells from your own body during your stem cell transplant offers some advantages over stem cells from a donor. For example, you don't need to worry about incompatibility between the donor's cells and your own cells if you have an autologous stem cell ...\n3. Transplant Process. After the Procedure. An autologous stem cell transplant (ASCT) is one that uses healthy hemopoietic stem cells (those that form the blood cells) from a person's own body—instead of taking stem cells from a donor—to replace diseased bone marrow or bone marrow damaged by cancer treatment. Another method of autologous ...\n4. Abstract. The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell population of multipotential stem/progenitor cells commonly referred to as mesenchymal stem cells ...\n5. Transplantation of allogeneic cells from healthy donors has been suggested as a potential solution, but no definitive population of SG stem cells, capable of regenerating the gland, has been ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the rate of rejection for induction therapy with anti-interleukin-2 receptor antibodies?",
               "answer": "The rate of rejection for induction therapy with anti-interleukin-2 receptor antibodies (IL2RAs) is indicated in the evidence as follows: in a study involving 16 subjects, one suffered rejection within the year, resulting in a rejection rate of 0.0625 (or 6.25%). Additionally",
               "rationale": "1. Background: Antibody induction therapy aims at preventing acute cellular rejection by reducing T-cell proliferation and activation. We evaluated the efficacy and side effects of two anti-interleukin-2 receptor antibodies (IL2RAs), basiliximab and daclizumab, for prevention of liver transplant rejection in adult patients.\n2. Background: Although the utility of antibody induction therapy has been demonstrated in clinical trials, the ideal regimen to use based on patient risk factors has not been fully elucidated. The objectives of this study were to determine the impact of either anti-interleukin-2 receptor antibodies (IL-2RA) or thymoglobulin induction therapies versus no induction therapy on acute rejection rates ...\n3. Induction therapy with IL-2 receptor antagonist (IL2-RA) is recommended as a first-line agent in low immunological risk kidney transplant recipients. ... These number 16 subjects and from whom one suffered rejection within the year, i.e., a rate of 0.0625. A margin of non-inferiority is proposed such that the true rejection rate among those ...\n4. Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver ... IL2RA-based induction therapy reduces rate of acute rejection events but does not reduce mortality. However, optimal regimen relating to IL2RA-based induction therapy remains ... analysis were the acute rejection rate and mortality rate, respectively. Odds ratio ...\n5. Anti-CD25 antibodies are effective nondepleting induction agents that have gained widespread use in kidney transplantation. These monoclonal antibodies bind to the α chain of the interleukin 2 (IL-2) receptor and prevent binding and activation by circulating IL-2 . Thus, they often are referred to as anti-IL-2 receptor antibodies.",
               "predicate": null
            }
         ],
         "row": 529,
         "id": 287678932847248442
      },
      {
         "claim": "Autophagy declines in aged organisms.",
         "label": 1,
         "prediction": 1,
         "rationale": "Autophagy is a natural process in which the body breaks down and recycles damaged or dysfunctional cells to repair and maintain cellular health. Autophagy declines with age, leading to a loss of cellular homeostatic control and contributing to various age-related issues. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is autophagy?",
               "answer": "Autophagy is a natural process in which the body breaks down and recycles damaged or dysfunctional cells to repair and maintain cellular health. It involves cleaning out unwanted or damaged components of cells and is triggered by conditions such as nutrient deprivation, oxygen scarcity, or cellular damage. Autophagy helps the body make the most of",
               "rationale": "1. Autophagy is a natural process where the body breaks down and recycles damaged or dysfunctional cells for repair and survival. Learn how autophagy can help prevent or treat diseases, and how to boost it with fasting, ketosis, and exercise.\n2. Autophagy occurs when your body's cells are deprived of nutrients or oxygen or if they're damaged in some way. Think of it this way: Autophagy is a recycling process that makes the most of a cell's already-existing energy resources. The process ramps up when your body has to make the most of these resources because your cells aren't ...\n3. Autophagy is a natural process that cleans out unwanted or damaged components of cells. Learn how autophagy may affect various health conditions, how to induce it by fasting or other methods, and what are the potential side effects.\n4. Autophagy is a natural process in which your body breaks down and cleans out damaged cells. It is triggered by fasting and has been promoted for weight loss and longevity, although there is no ...\n5. Autophagy is a natural process that occurs as your body clears out and replaces damaged cell parts with new ones. It occurs within your body at all times.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does autophagy decline with age?",
               "answer": "Yes, autophagy declines with age. The evidence indicates that there is an age-induced decline in autophagy, which leads to a loss of cellular homeostatic control and is associated with various age-related issues, including the accumulation of lipid droplets and defects in cellular processes.",
               "rationale": "1. Similarly, the age‐induced decline in autophagy leads to the loss of cellular homeostatic control. Paradoxically, such a valuable mechanism is hijacked by diseases, during tumor progression and by senescence, presumably due to high levels of metabolic demand. Here, we review both the role of autophagy in preventing cellular decline in aging ...\n2. Further, age-dependent accrual of lipid droplets and ectopic fat deposition are highly interconnected with the age-dependent decline in autophagy and/or autophagic defects 105,106.\n3. Macroautophagy (autophagy) is a conserved lysosomal degradation process essential for cellular homeostasis and adaption to stress. Accumulating evidence indicates that autophagy declines with age ...\n4. As almost all of them decline with age, the modulation of mitophagy regulatory proteins could be a novel anti-aging therapeutic approach in the future. ... LC3 and Atg5 promoter regions, compared with those of young mice, downregulating the protein levels and promoting aging decline of autophagy . The natural polyphenol resveratrol, an ...\n5. Autophagy has an essential role in maintaining cellular homeostasis in response to intracellular stress; however, the efficiency of autophagy declines with age and overnutrition can interfere with ...",
               "predicate": null
            }
         ],
         "row": 530,
         "id": 136684748296024909
      },
      {
         "claim": "Bariatric surgery has a positive impact on mental health.",
         "label": 1,
         "prediction": 1,
         "rationale": "Bariatric surgery, also known as weight loss surgery, is a category of surgical operations intended to help people with obesity lose weight by making changes to their digestive system. Bariatric surgery's impact on mental health is not directly addressed by the provided evidence. Bariatric surgery is associated with lower rates of depression and a decrease in the severity of depressive symptoms after the operation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of bariatric surgery?",
               "answer": "Bariatric surgery, also known as weight loss surgery, is a category of surgical operations intended to help people with obesity lose weight by making changes to their digestive system. It is recommended when other weight loss methods have failed and when obesity poses a greater risk to health than the surgery itself.",
               "rationale": "1. Types of bariatric surgery. Each type of bariatric surgery has pros and cons. Be sure to talk to your doctor about them. Here's a look at common types of bariatric surgery: Roux-en-Y (roo-en-wy) gastric bypass. This procedure is the most common method of gastric bypass. This surgery is typically not reversible.\n2. Bariatric surgery, also called weight loss surgery, is a category of surgical operations intended to help people with obesity lose weight. Healthcare providers may recommend bariatric surgery if other weight loss methods have failed and if obesity appears to pose a greater risk to your health than surgery. Bariatric surgery procedures work by ...\n3. Weight-loss surgery encompasses a group of operations that help you lose weight by making changes to your digestive system. It is also known as metabolic and bariatric surgery (\"metabolic\" means \"related to how your body gets energy\" and \"bariatric\" means \"related to treatment for heavy weight\"). Some types of weight-loss surgery make your ...\n4. Bariatric surgery is a term used to describe weight loss surgeries like gastric bypass and gastric sleeve. These surgeries work to treat obesity by altering the structure of your digestive tract.\n5. Bariatric surgery is an option that can help achieve weight loss. It's usually tried when a person has developed risks or complications of excess weight and other weight-reduction methods such as lifestyle adjustments and medications haven't worked. There are several types of bariatric procedures, and a surgeon will choose the right one ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does bariatric surgery improve mental health?",
               "answer": "The provided evidence does not directly address the impact of bariatric surgery on mental health. It focuses on the relationship between weight loss surgery and diabetes management, the necessity of lifestyle changes post-surgery, and the types of bariatric surgery. To determine whether bariatric surgery improves mental health, additional research or evidence specifically discussing mental",
               "rationale": "1. PNN New Delhi [India], August 7: In recent years, the intersection of weight loss surgery and diabetes management has garnered significant attention in the medical community.The prevalence of obesity and diabetes continues to rise globally, despite several people embracing fitness routines, healthy eating, and practices like yoga.There have been plenty of innovations in the medical sector, and ...\n2. Bariatric surgery gives you a tool for long-term weight management, but it requires a commitment to lifestyle changes, including a balanced, nutritious diet and regular exercise.\n3. Two of the most common types of bariatric surgery are a gastric bypass, in which the top part of the stomach is isolated from the rest, and a sleeve gastrectomy, in which 80 percent of the stomach ...\n4. Purpose With the global epidemic of obesity, the importance of metabolic and bariatric surgery (MBS) is greater than ever before. Performing these surgeries requires academic training and the completion of a dedicated fellowship training program. This study aimed to develop guidelines based on expert consensus using a modified Delphi method to create the criteria for metabolic and bariatric ...\n5. Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville 10753 Falls Road, Pavilion II, STE 305 , Lutherville , MD 21093 phone: 410-955-0670",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does bariatric surgery reduce symptoms of depression?",
               "answer": "Yes, bariatric surgery is associated with lower rates of depression and a decrease in the severity of depressive symptoms after the operation. However, it is important to note that post-surgical depression can still occur in some patients, and careful monitoring is necessary.",
               "rationale": "1. However, the success of bariatric surgery also relies on the improvement of mental health status. Therefore, the current meta-analysis was carried out to reveal the prevalence of depressive symptoms and their subsequent impact on bariatric surgery outcomes.\n2. The researchers found that bariatric surgery was consistently associated with lower rates of depression and a decrease in the severity of symptoms of depression after the operation.\n3. Key points Post-surgical depression is a common experience. Mental health screenings and realistic expectations can help reduce post-surgical depression. Patients can plan ahead to prevent ...\n4. Bariatric surgery was associated with a greater risk of post-operative incident depression treatment and greater persistence of post-operative depression treatment. Depression may worsen for some patients after bariatric surgery, so clinicians should carefully monitor their patients for depression post-operatively.\n5. Abstract Background: Although bariatric surgery has been shown to reduce weight loss and obesity-related conditions, an improvement in depression remains unclear. The aim of this study was to determine whether bariatric surgery is associated with a resolution of depression, and the prevention of its onset.",
               "predicate": null
            }
         ],
         "row": 531,
         "id": 133374044746609369
      },
      {
         "claim": "Basophils counteract disease development in patients with systemic lupus erythematosus (SLE).",
         "label": 0,
         "prediction": 0,
         "rationale": "Basophils play a vital role in the immune system as a type of white blood cell, acting as frontline defenders against diseases, contributing to immune responses, and being involved in allergic reactions and inflammation. Basophils are involved in the development of systemic lupus erythematosus (SLE) and may have a deleterious role in the disease. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of Basophils in the human body?",
               "answer": "Basophils play a vital role in the immune system as a type of white blood cell known as a granulocyte. They are part of the innate immune system and act as frontline defenders against diseases, including infections and parasites. Basophils contribute to immune responses and can be involved in allergic reactions and inflammation. They help",
               "rationale": "1. Basophils are a type of white blood cell. There are three types of white blood cells, each with its own function to boost your immune system, including granulocytes, monocytes and lymphocytes. Basophils are one of three granulocytes, along with neutrophils and eosinophils. They are the smallest in number of granulocytes but the largest in cell ...\n2. Basophils are types of white blood cells that play a vital role in keeping the immune system functioning. Basophil tests can help diagnose many health concerns.\n3. The normal range of absolute basophil count is 0 to 300 microliters. Basophils normally constitute just 0.5% to 1% of the total white blood cell (WBC) count. The absolute basophil count is derived by taking the total white cell count and calculating the percentage of basophils in them. Abnormal basophil levels can be detected with a complete ...\n4. Basophils are a type of white blood cell called a granulocyte. As part of the innate immune system, basophils are one of the frontline defenders against diseases, including parasites. High basophils (basophilia) may be caused by infections, autoimmune diseases, and cancer, while low basophils (basopenia) may be caused by acute infection, hives ...\n5. The role of basophils was poorly understood for a long time. ... These are white blood cells that are found in the connective tissues throughout your body. Basophils play a part in \"immune ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are Basophils involved in the development of systemic lupus erythematosus (SLE)?",
               "answer": "Yes, basophils are involved in the development of systemic lupus erythematosus (SLE). The evidence indicates that basophils may have a deleterious role in SLE, as they are implicated in the disease's mechanisms, including the amplification of autoantibody production and the activation of autoreactive",
               "rationale": "1. The selected studies supported a potential immunomodulatory activity of basophils in systemic lupus erythematosus (possibly by influencing some aspects of the adaptive immune response), but additional basic research and clinical studies are needed to clarify the relevance of their contribution and the precise immunopathological mechanisms.\n2. Here, we summarize what we have learned about the deleterious role of basophils in lupus both in a mouse model and in SLE patients. We discuss which possible pathways could be involved in basophil activation and recruitment to secondary lymphoid organs during SLE, and how basophils may amplify autoantibody production.\n3. Basophils have been implicated in systemic lupus erythematosus (SLE), as evidenced by the fact that basophil-deficient mice do not develop the disease. Here, the authors demonstrate that PD-L1 and ...\n4. In the mouse model of systemic lupus erythematosus (SLE) and in patients with SLE, autoreactive IgE antibodies can be detected in the blood. Autoreactive IgE antibodies form immune complexes with corresponding autoantigens and activate blood-circulating basophils.\n5. In this review, we summarize the progress in understanding the roles of basophils in mediating immune responses with an emphasis on autoimmune diseases, particularly systemic lupus erythematosus and rheumatoid arthritis.",
               "predicate": null
            }
         ],
         "row": 532,
         "id": 110494892956138991
      },
      {
         "claim": "Birth-weight is positively associated with breast cancer.",
         "label": 1,
         "prediction": 1,
         "rationale": "Higher birth weight is associated with an increased risk of breast cancer, particularly in premenopausal women. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is there a correlation between birth-weight and breast cancer?",
               "answer": "Yes, there is a correlation between birth weight and breast cancer. The evidence indicates that higher birth weight is associated with an increased risk of breast cancer, particularly in premenopausal women. Additionally, a positive genetic correlation between fetal-specific birth weight and breast cancer was identified, further supporting the link between the two.",
               "rationale": "1. Background. The hypothesis that the risk of developing breast cancer in adulthood may be increased by factors that first act in utero—in particular by fetal exposure to higher levels of maternal estrogen—was first proposed in 1990 [].Since then, several observational studies have examined this hypothesis by using birth weight as an index of the effects of intrauterine hormones on fetal ...\n2. Micro-AbstractA literature search was conducted to clarify the dose-response relationship between birth weight and breast cancer. We assessed 16 prospective studies describing 16,000 cases among 553,644 participants. Higher birth weight was associated with an increased risk of breast cancer in premenopausal women.\n3. The link between excess weight and increased cancer risk is well established. Being overweight or obese increases your risk for 12 cancers, including uterine, kidney, liver and colorectal cancer. When it comes to breast cancer, the story isn't so clear. Being overweight does affect your breast cancer risk. But that effect is different before ...\n4. Introduction: Birthweight is your weight when you were born. Studies show women who had a higher birthweight have an increased risk of breast cancer compared to women who had a lower birthweight. This is most clearly seen in premenopausal (before menopause) women. Learn more about birthweight and breast cancer risk.\n5. Results. With summary statistics we identified a positive genetic correlation between fetal-specific birthweight and breast cancer (r g = 0.123 and P = 0.013) as well as a negative but insignificant correlation between maternal-specific birthweight and breast cancer (r g = − 0.068, P = 0.206); and detected 84 pleiotropic genes shared by fetal-specific birthweight and breast cancer, 49 shared ...",
               "predicate": null
            }
         ],
         "row": 533,
         "id": 151300078692589234
      },
      {
         "claim": "Blocking the interaction between TDP-43 and respiratory complex I proteins ND3 and ND6 leads to increased TDP-43-induced neuronal loss.",
         "label": 0,
         "prediction": 0,
         "rationale": "TDP-43 is a conserved heterogeneous nuclear ribonucleoprotein that plays a critical role in RNA-related metabolism, functioning as an RNA/DNA binding protein and a transcriptional repressor. Blocking the interaction between TDP-43 and respiratory complex I proteins ND3 and ND6 does not lead to increased neuronal loss, but rather suppresses TDP-43-induced neuronal loss. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TDP-43?",
               "answer": "TDP-43 is a conserved heterogeneous nuclear ribonucleoprotein (hnRNP) that consists of 414 amino acids and is encoded by the TARDBP gene. It plays a critical role in RNA-related metabolism, functioning as an RNA/DNA binding protein and a transcriptional repressor. TDP-",
               "rationale": "1. The accumulation of TDP-43 aggregates in the central nervous system is a common feature of many neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia ...\n2. Structure and function of TDP-43. TDP-43 is a conserved hnRNP containing 414 amino acids and encoded by the TARDBP gene (1.p36.22). 7 The protein structure is comprised of an N-terminal region, nuclear localisation signal (NLS), two RNA recognition motifs: RRM1 and RRM2, nuclear export signal (NES), a C-terminal region encompassing a prion-like glutamine/asparagine-rich (Q/N) domain and a ...\n3. While TDP-43 is an essential RNA/DNA binding protein critical for RNA-related metabolism, determining the pathophysiological mechanisms through which TDP-43 mediates neurodegeneration appears complex, and unravelling these molecular processes seems critical for the development of effective therapies. This review highlights the key physiological ...\n4. TDP-43 is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. In particular, TDP-43 is a splicing factor binding to the intron8/exon9 junction of the CFTR gene and to the intron2/exon3 region of the apoA-II gene.\n5. This type of dementia usually affects those over age 80 and causes memory and thinking problems. Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a type of dementia that affects memory, thinking and social skills. When people think about memory problems, Alzheimer's disease comes to mind. But LATE is a different disease and has ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does blocking the interaction between TDP-43 and respiratory complex I proteins ND3 and ND6 lead to increased neuronal loss?",
               "answer": "No, blocking the interaction between TDP-43 and respiratory complex I proteins ND3 and ND6 does not lead to increased neuronal loss. In fact, the evidence suggests that blocking such an interaction can suppress TDP-43-induced neuronal loss.",
               "rationale": "1. Here we have found that TDP-43 accumulates in the mitochondria of neurons in subjects with ALS or frontotemporal dementia (FTD). Disease-associated mutations increase TDP-43 mitochondrial localization. In mitochondria, wild-type (WT) and mutant TDP-43 preferentially bind mitochondria-transcribed messenger RNAs (mRNAs) encoding respiratory ...\n2. The correlation between TDP-43 inclusion and neuronal loss is relatively high ... It has been reported that TDP-43 preferentially locates to the mitochondria and interacts with respiratory complex I proteins ND3 and ND6 to induce a complex disassembly; thus, blocking such an interaction can suppress TDP-43-induced neuronal loss .\n3. (a,b) Representative images of TOM20 and TDP-43 in human motor neurons in lumbar spinal cords of sporadic ALS (n = 6) (a) or human cortical neurons in cortices of sporadic FTD (n = 4) (b).\n4. Intriguingly, the interaction between TDP-43 aggregation and oxidative stress appears to amplify the cellular TDP-43 toxicity as well as the deleterious effects of TDP-43 on mitochondrial function. 1 Importantly, blocking the mitochondrial localisation of TDP-43 has been shown to mitigate its cellular toxicity and to improve the clinical ...\n5. Cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP43; also known as TARDBP or TDP-43) is a key pathological feature of several neurodegenerative diseases, including amyotrophic lateral ...",
               "predicate": null
            }
         ],
         "row": 534,
         "id": 662586514612088305
      },
      {
         "claim": "Bone marrow cells contribute to adult macrophage compartments.",
         "label": 0,
         "prediction": 1,
         "rationale": "Adult macrophage compartments consist of various tissue-specific populations that originate from both embryonic sources and adult bone marrow-derived monocytes, exhibiting diversity based on their ontogenetic origin, organ context, and microbial signals. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are adult macrophage compartments?",
               "answer": "Adult macrophage compartments include various tissue-specific populations that originate from both embryonic sources (such as yolk sac and fetal liver) and adult bone marrow-derived monocytes. These compartments are present in all body tissues and exhibit diversity based on their ontogenetic origin, the organ context, and the signals they receive from microbial",
               "rationale": "1. Interestingly, the ventricular macrophage compartment is more heterogenous in its ontogeny. ... thereby driving the diversification of tissue-specific macrophages observed in adult stages 2,124,125.\n2. Macrophages are a diverse set of cells present in all body compartments. Diversity is imprinted by their different ontogenetic origin (embryonal versus adult bone marrow-derived cells), by the organ context and by activation or deactivation signals from microbial invasion, tissue damage, dismetabolism and polarized adaptive T cell responses.\n3. The next step is to truly understand the kinetic changes within each compartment of the body, that is bone marrow, blood and tissue, in addition to the cues that skew the lifespan of these cells during pathology, which may allow for future targeting to promote an adequate response. ... Yolk Sac macrophages, fetal liver, and adult monocytes can ...\n4. Macrophages are a diverse set of cells present in all body compartments. This diversity is imprinted by their ontogenetic origin (embryonal versus adult bone marrow-derived cells); the organ context; by their activation or deactivation by various signals in the contexts of microbial invasion, tissue damage, and metabolic derangement; and by polarization of adaptive T cell responses.\n5. Tissue macrophage populations in the adult mouse are of mixed embryonic and bone marrow monocyte origin in the steady state and after inflammatory and infectious stimulation. ... illustrating the distinct adaptations of macrophages in each compartment. Red pulp macrophages clear effete blood cells by incompletely understood mechanisms, which ...",
               "predicate": null
            }
         ],
         "row": 535,
         "id": 255986236100915559
      },
      {
         "claim": "Breast cancer development is determined exclusively by genetic factors.",
         "label": 0,
         "prediction": 0,
         "rationale": "Genetic factors are not the only factors that determine breast cancer development. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Are genetic factors the only factors that determine breast cancer development?",
               "answer": "No, genetic factors are not the only factors that determine breast cancer development. While the evidence highlights the role of genetic predisposition, particularly mutations in genes like BRCA1 and BRCA2, it also implies that there are other risk factors associated with breast cancer that vary from those of other cancers. Additionally, the mention",
               "rationale": "1. Abstract As the most commonly occurring cancer in women worldwide, breast cancer poses a formidable public health challenge on a global scale. Breast cancer consists of a group of biologically and molecularly heterogeneous diseases originated from the breast. While the risk factors associated with this cancer varies with respect to other cancers, genetic predisposition, most notably mutations ...\n2. The genetic factors known to be involved in breast cancer risk comprise about 30 genes. These include the high-penetrance early-onset breast cancer genes, BRCA1 and BRCA2, a number of rare cancer syndrome genes, and rare genes with more moderate penetrance. A larger group of common variants has more recently been identified through genome-wide ...\n3. Talk to your doctor, radiologist, and genetic counselor about developing a specialized program for early detection that addresses your breast cancer risk, meets your individual needs, and gives you peace of mind.\n4. Breast cancer gene mutations like BRCA raise your risk of getting breast and other cancers. Find out what these genes mean for you and whether you should be tested.\n5. Breast Cancer Genetics. Everyone has genes that pass along hereditary information from generation to generation. Sometimes changes occur in the gene code, and these changes are called mutations. Learn how gene mutations can affect breast cancer risk, as well as about how genetic testing works. Other Breast Cancer Genes Family history is one of ...",
               "predicate": null
            }
         ],
         "row": 536,
         "id": 302028065157891288
      },
      {
         "claim": "CHEK2 is not associated with breast cancer.",
         "label": 1,
         "prediction": 0,
         "rationale": "CHEK2 is associated with breast cancer. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is CHEK2 associated with breast cancer?",
               "answer": "Yes, CHEK2 is associated with breast cancer. The evidence indicates that mutations in the CHEK2 gene are linked to an increased risk of breast cancer, and specific mutations, such as the 1100delC variant, have been confirmed as causes of breast cancer in various populations. Additionally, studies have shown that",
               "rationale": "1. Mutations of CHEK2 or TP53 have been associated with resistance to anthracycline-based chemotherapy in patients with breast cancer. 33 Another study in Chinese women with breast cancer demonstrated that H371Y carriers may have better response to neoadjuvant chemotherapy (p=0.031). 34 In contrast, there was no difference observed in response to ...\n2. There is increasing interest in the use of germline cancer susceptibility testing for patient risk stratification and precision medicine. This work highlights the potential interaction between obesity and CHEK2-associated cancer risk.The findings also suggest that CHEK2 gene carriers with breast cancer may have a poorer outcome compared with noncarriers.\n3. Protein-truncating variants in 5 genes (ATM, BRCA1, BRCA2, CHEK2, and PALB2) were associated with a risk of breast cancer overall with a P value of less than .0001.Protein-truncating variants in ...\n4. A CHEK2 gene mutation increases your risk for certain types of cancers. Your cancer risk may be different depending on the specific CHEK2 mutation you have. Most CHEK2 mutations increase your risk for breast cancer. Some of the most common CHEK2 mutations slightly increase your risk for colorectal (colon and rectal) cancer.\n5. The CHEK2 gene has been found to be a breast cancer-predisposing gene in several populations. In 2002, a single recurrent mutation in the CHEK2 gene (1100delC) was first reported as a cause of breast cancer, and numerous studies have confirmed this association. 1-21 In Eastern and Northern Europe, the population frequency of the 1100delC allele ranges from 0.2% to 1.4%, 1-4 but the ...",
               "predicate": null
            }
         ],
         "row": 537,
         "id": 177378746794589938
      },
      {
         "claim": "CR is associated with higher methylation age.",
         "label": 0,
         "prediction": 0,
         "rationale": "CR can stand for several things, including \"Child Rider\" (insurance), \"Corporate Repository,\" \"Cryptography Research, Inc.,\" and \"Croydon\" (postcode, United Kingdom). CR stands for Caloric Restriction in the context of methylation age. Caloric restriction is not directly associated with higher methylation age, but rather is linked to extended lifespan and involves changes in molecular processes related to aging, including DNA methylation. Caloric restriction is not directly associated with higher methylation age, but rather with extended lifespan and changes in molecular processes related to aging, including DNA methylation. Caloric restriction is associated with a reduction in methylation age, reflected in changes to DNA methylation patterns that correlate with gene expression and may mitigate age-related methylation drift. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CR?",
               "answer": "CR can stand for several things, including \"Child Rider\" (insurance), \"Corporate Repository,\" \"Cryptography Research, Inc.,\" and \"Croydon\" (postcode, United Kingdom). It is also noted that CR is an abbreviation listed in various authoritative dictionaries and databases.",
               "rationale": "1. High creatinine levels can mean kidney damage or dehydration. A high creatinine level is typically anything over 1.3 (depending on age, race, gender, and body size). Certain conditions may cause a person to have higher than normal levels of creatinine. People with only one kidney may have a normal creatinine level of about 1.8 or 1.9.\n2. What does the abbreviation CR stand for? Meaning: center.\n3. Looking for online definition of CR or what CR stands for? CR is listed in the World's most authoritative dictionary of abbreviations and acronyms The Free Dictionary\n4. The World's most comprehensive professionally edited abbreviations and acronyms database All trademarks/service marks referenced on this site are properties of their respective owners.\n5. Child Rider (insurance) CR. Corporate Repository. CR. Cryptography Research, Inc. CR. Croydon (postcode, United Kingdom) showing only Business & Finance definitions ( show all 236 definitions) Note: We have 144 other definitions for CR in our Acronym Attic.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What does CR stand for in the context of methylation age?",
               "answer": "CR stands for Caloric Restriction in the context of methylation age.",
               "rationale": "1. The genomic context of age-related changes in DNA methylation. ... (500 bp) of the genome that were differentially methylated (DMRs) with age or the anti-aging manipulations. CR increased methylation in the age-associated hypomethylated DMRs (45% to 55%) and decreased methylation in the age-associated hypermethylated DMRs (62% to 58%) in the ...\n2. Abstract. DNA methylation is a major control program that modulates gene expression in a plethora of organisms. Gene silencing through methylation occurs through the activity of DNA methyltransferases, enzymes that transfer a methyl group from S -adenosyl- l -methionine to the carbon 5 position of cytosine.\n3. Importantly, methylation age has recently also been associated with cancer risk (Levine et al., 2015; Lu et al., 2019a; Yu et al., 2020). In this article, we will review studies of global methylation alterations that occur with advancing age and cancer risk, compare the development and features of first- and second-generation epigenetic clocks ...\n4. Recent research efforts provided compelling evidence of genome-wide DNA methylation alterations in aging and age-related disease. It is currently well established that DNA methylation biomarkers can determine biological age of any tissue across the entire human lifespan, even during development. There is growing evidence suggesting epigenetic ...\n5. Abstract. DNA methylation is currently the most promising molecular marker for monitoring aging and predicting life expectancy. However, the mechanisms underlying age-related DNA methylation changes remain mostly undiscovered. Here we discuss the current knowledge of the dynamic nature of DNA epigenome landscape in mammals, and propose putative ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is Caloric Restriction associated with higher methylation age?",
               "answer": "The provided evidence does not directly indicate that caloric restriction (CR) is associated with higher methylation age. Instead, it suggests that caloric restriction is linked to extended lifespan and involves changes in molecular processes related to aging, including DNA methylation. The evidence mentions that there is a drift in DNA methylation associated with",
               "rationale": "1. In mammals, caloric restriction consistently results in extended lifespan. Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age ...\n2. Abstract. In mammals, caloric restriction consistently results in extended lifespan. Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age that includes both gains and losses of DNA methylation at various sites. Here, we report that epigenetic drift is conserved across species and ...\n3. Caloric restriction (CR), defined as lessening caloric intake without depriving essential nutrients4, results in changes in molecular processes that have been associated with aging, including DNA ...\n4. Conversely, in non-proliferative tissues, age-related methylation loss could be seen in the exon- and high-expression-associated transcription state TxEx4 (OR = 12.9, P = 1.6 × 10 −52 in the ...\n5. Caloric restriction. Caloric restriction (CR), the decrease in nutrient intake above the level of starvation and below what an organism would consume ad libitum, is one of the most robust and consistent means of increasing life span across a spectrum of organisms. 59,60 Both caloric intake and DNMT3A play a role in neuronal aging, with DNMT3A ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is caloric restriction associated with higher methylation age?",
               "answer": "The provided evidence does not directly indicate that caloric restriction (CR) is associated with higher methylation age. Instead, it suggests that caloric restriction is linked to extended lifespan and changes in molecular processes related to aging, including DNA methylation. However, it also mentions that there is a drift in DNA methylation associated",
               "rationale": "1. In mammals, caloric restriction consistently results in extended lifespan. Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age ...\n2. Abstract. In mammals, caloric restriction consistently results in extended lifespan. Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age that includes both gains and losses of DNA methylation at various sites. Here, we report that epigenetic drift is conserved across species and ...\n3. Caloric restriction (CR), defined as lessening caloric intake without depriving essential nutrients4, results in changes in molecular processes that have been associated with aging, including DNA ...\n4. Conversely, in non-proliferative tissues, age-related methylation loss could be seen in the exon- and high-expression-associated transcription state TxEx4 (OR = 12.9, P = 1.6 × 10 −52 in the ...\n5. Caloric restriction. Caloric restriction (CR), the decrease in nutrient intake above the level of starvation and below what an organism would consume ad libitum, is one of the most robust and consistent means of increasing life span across a spectrum of organisms. 59,60 Both caloric intake and DNMT3A play a role in neuronal aging, with DNMT3A ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the relationship between caloric restriction and methylation age?",
               "answer": "Caloric restriction (CR) is associated with a reduction in methylation age, which is reflected in the effects of CR on DNA methylation patterns. The evidence suggests that caloric restriction leads to changes in DNA methylation that correlate with gene expression and may mitigate age-related methylation drift. This drift, characterized by both",
               "rationale": "1. The effects of caloric restriction on DNA methylation were detectable across different tissues and correlated with gene expression. We propose that epigenetic drift is a determinant of lifespan in mammals. Caloric restriction has been shown to increase lifespan in mammals. Here, the authors provide evidence that age-related methylation drift ...\n2. Abstract. In mammals, caloric restriction consistently results in extended lifespan. Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age that includes both gains and losses of DNA methylation at various sites. Here, we report that epigenetic drift is conserved across species and ...\n3. Caloric restriction. Caloric restriction (CR), the decrease in nutrient intake above the level of starvation and below what an organism would consume ad libitum, is one of the most robust and consistent means of increasing life span across a spectrum of organisms. 59,60 Both caloric intake and DNMT3A play a role in neuronal aging, with DNMT3A ...\n4. Long-range co-methylation relationships also exist 118,122,123, ... In humans, calorie restriction reduces the risk of age-associated diseases, including T2D, cancer and CVD, ...\n5. Participants in the CR group were prescribed a 25% restriction in calorie intake based on energy requirements estimated from two DLW measurement periods at baseline. ... S. DNA methylation age of ...",
               "predicate": null
            }
         ],
         "row": 538,
         "id": 229358742558972745
      },
      {
         "claim": "CX3CR1 on the Th2 cells impairs T cell survival",
         "label": 0,
         "prediction": 0,
         "rationale": "CX3CR1 is a transmembrane protein that belongs to the G protein-coupled receptor 1 family and is the only known member of the CX3C chemokine receptor family. CX3CR1 provides a survival signal through Bcl-2 for Th2 cells, which is important for their persistence in airway disease, particularly in asthma models. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CX3CR1?",
               "answer": "CX3CR1, also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein that belongs to the G protein-coupled receptor 1 (GPCR1) family. It is the only known member of the CX3C chemok",
               "rationale": "1. CX3C motif chemokine receptor 1 (CX3CR1), also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein of the G protein-coupled receptor 1 (GPCR1) family and the only known member of the CX3C chemokine receptor subfamily.. As the name suggests, this receptor binds the inflammatory chemokine CX3CL1 (also called neurotactin in mice or fractalkine in ...\n2. CX 3 CR1-CX 3 CL1 signaling pathway and migration process of immune cells via their interactions. (A) CX 3 CL1/fractalkine, a transmembrane protein with O-glycosylated mucin-like stem, is expressed on the surface of immune cells and non-immune cells. Soluble forms of CX 3 CL1 can be made after proteolytic cleavage by metalloprotease ADAM 10/17. Both membrane bound and soluble forms of CX 3 CL1 ...\n3. CX3CR1 is a chemokine receptor that is present on early myeloid lineage cells, including osteoclast precursors. It plays a role in the migration of osteoclast precursors to the bone surface and is involved in osteoclast formation. AI generated definition based on: Osteoporosis (Fourth Edition), 2013.\n4. Together with CXCR4, CX3CR1 was the most broadly expressed chemokine receptor on myeloid cells. However, CX3CR1 was also prominent on the predominant myeloid cell cluster of healthy kidneys. CX3CR1 expression is consistent with the fact that renal monocytic cells were rather similar to non-classical than classical monocytes.\n5. Collectively, these data support T-cell CX3CR1 expression as a blood-based dynamic early on-treatment predictor of response to ICI therapy. There is an urgent need to discover blood-based ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of CX3CR1 on Th2 cells?",
               "answer": "The effect of CX3CR1 on Th2 cells includes providing a survival signal through Bcl-2, which is important for their persistence in the context of airway disease in asthma models. Additionally, CX3CR1 is expressed on a fraction of CD4+ T cells in individuals with asthma, indicating its involvement in",
               "rationale": "1. It can induce mast cell chemotaxis and increase CX 3 CR1 function in Th2 cells . ... Verrier B, Combadière C, Combadière B. Cutting edge: Protective effect of CX3CR1+ dendritic cells in a vaccinia virus pulmonary infection model. ... Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T. Exclusive increase ...\n2. Recent evidence indicates that receptor expression determines the spectrum of action of chemokines in Th1 and Th2 cells and that CX 3 CR1 is preferentially expressed on the former, which is ...\n3. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4+ T cells and effector CD8+ T cells. CXCR3 is activated by three interferon-inducible ...\n4. Whether this is due to an effect of CX3CR1 on the differentiation of the Th1 cells or an effect on the survival of the more differentiated effectors was not investigated in this study. However, in the literature CX3CR1, which is required for airway disease in asthma models, was shown to provide a survival signal to Th2 cells through Bcl-2 .\n5. Allergic asthma is a T helper type 2 (T H 2)-dominated disease of the lung. In people with asthma, a fraction of CD4 + T cells express the CX3CL1 receptor, CX3CR1, and CX3CL1 expression is ...",
               "predicate": null
            }
         ],
         "row": 539,
         "id": 737479916495112789
      },
      {
         "claim": "CX3CR1 on the Th2 cells promotes T cell survival",
         "label": 1,
         "prediction": 1,
         "rationale": "CX3CR1 is a transmembrane protein that belongs to the G protein-coupled receptor 1 family and is the only known member of the CX3C chemokine receptor family. CX3CR1 on Th2 cells promotes their survival in inflamed tissues and is important for their maintenance and function in inflammatory conditions. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CX3CR1?",
               "answer": "CX3CR1, also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein that belongs to the G protein-coupled receptor 1 (GPCR1) family. It is the only known member of the CX3C chemok",
               "rationale": "1. CX3C motif chemokine receptor 1 (CX3CR1), also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein of the G protein-coupled receptor 1 (GPCR1) family and the only known member of the CX3C chemokine receptor subfamily.. As the name suggests, this receptor binds the inflammatory chemokine CX3CL1 (also called neurotactin in mice or fractalkine in ...\n2. CX3CR1 is a chemokine receptor that is present on early myeloid lineage cells, including osteoclast precursors. It plays a role in the migration of osteoclast precursors to the bone surface and is involved in osteoclast formation.\n3. CX 3 CR1-CX 3 CL1 signaling pathway and migration process of immune cells via their interactions. (A) CX 3 CL1/fractalkine, a transmembrane protein with O-glycosylated mucin-like stem, is expressed on the surface of immune cells and non-immune cells. Soluble forms of CX 3 CL1 can be made after proteolytic cleavage by metalloprotease ADAM 10/17. Both membrane bound and soluble forms of CX 3 CL1 ...\n4. Collectively, these data support T-cell CX3CR1 expression as a blood-based dynamic early on-treatment predictor of response to ICI therapy. There is an urgent need to discover blood-based ...\n5. The receptor CX3CR1 is essential in myeloid phagocyte homing to the kidney at homeostasis, after acute cell depletion and in inflammation. CX3CR1 and its ligand are highly regulated in human kidney diseases such as IgA nephritis, systemic lupus erythematosus, and inflammatory conditions such as transplant rejection.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of CX3CR1 on Th2 cells?",
               "answer": "The function of CX3CR1 on Th2 cells includes promoting their survival in inflamed tissues, such as the lungs. CX3CR1 signaling is important for the maintenance and function of Th2 cells in inflammatory conditions.",
               "rationale": "1. It can induce mast cell chemotaxis and increase CX 3 CR1 function in Th2 cells . ... Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis. 2007; 13:837-846.\n2. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4+ T cells and effector CD8+ T cells. CXCR3 is activated by three interferon-inducible ...\n3. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4 (+) T cells and effector CD8 (+) T cells. CXCR3 is activated by three interferon ...\n4. This Review describes our current understanding of the mechanisms regulating T helper 2 (TH2) cell development and function. The authors discuss how our increasing comprehension of these pathways ...\n5. We found that CX3CR1 signaling promoted TH2 survival in the inflamed lungs, and injection of B cell leukemia/lymphoma-2 protein (BCl-2)-transduced CX3CR1-deficient TH2 cells into CX3CR1-deficient ...",
               "predicate": null
            }
         ],
         "row": 540,
         "id": 118571517720484589
      },
      {
         "claim": "CX3CR1 on the Th2 cells promotes airway inflammation.",
         "label": 1,
         "prediction": 1,
         "rationale": "CX3CR1 is a transmembrane protein that belongs to the G protein-coupled receptor 1 family and is the only known member of the CX3C chemokine receptor. CX3CR1 on Th2 cells increases its function and induces mast cell chemotaxis. CX3CR1 on Th2 cells promotes airway inflammation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CX3CR1?",
               "answer": "CX3CR1, also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein that belongs to the G protein-coupled receptor 1 (GPCR1) family and is the only known member of the CX3C chemokine",
               "rationale": "1. CX3C motif chemokine receptor 1 (CX3CR1), also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein of the G protein-coupled receptor 1 (GPCR1) family and the only known member of the CX3C chemokine receptor subfamily.. As the name suggests, this receptor binds the inflammatory chemokine CX3CL1 (also called neurotactin in mice or fractalkine in ...\n2. CX 3 CR1-CX 3 CL1 signaling pathway and migration process of immune cells via their interactions. (A) CX 3 CL1/fractalkine, a transmembrane protein with O-glycosylated mucin-like stem, is expressed on the surface of immune cells and non-immune cells. Soluble forms of CX 3 CL1 can be made after proteolytic cleavage by metalloprotease ADAM 10/17. Both membrane bound and soluble forms of CX 3 CL1 ...\n3. CX3CR1 is a chemokine receptor that is present on early myeloid lineage cells, including osteoclast precursors. It plays a role in the migration of osteoclast precursors to the bone surface and is involved in osteoclast formation. AI generated definition based on: Osteoporosis (Fourth Edition), 2013.\n4. Together with CXCR4, CX3CR1 was the most broadly expressed chemokine receptor on myeloid cells. However, CX3CR1 was also prominent on the predominant myeloid cell cluster of healthy kidneys. CX3CR1 expression is consistent with the fact that renal monocytic cells were rather similar to non-classical than classical monocytes.\n5. Regulation of the CX3CL1-CX3CR1 axis. The CX3CL1-CX3CR1 axis has several levels of regulation, including cytokine stimulation, hypoxia, activation of transcription factors, posttranscriptional modifications and proteolytic shedding. CX3CL1 is a target for the enzymes ADAM 10 and 17, Cathepsin S and some metalloproteinases, such as MMP-3.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of CX3CR1 on the Th2 cells?",
               "answer": "The function of CX3CR1 on Th2 cells, as indicated in the evidence snippet, is to increase its function and induce mast cell chemotaxis. Specifically, the presence of CX3CR1+CD28-CD4+ T cells is noted in inflammatory bowel disease, suggesting that CX3CR1 plays a",
               "rationale": "1. It can induce mast cell chemotaxis and increase CX 3 CR1 function in Th2 cells . ... Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis. 2007; 13:837-846.\n2. This Review describes our current understanding of the mechanisms regulating T helper 2 (TH2) cell development and function. The authors discuss how our increasing comprehension of these pathways ...\n3. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4 (+) T cells and effector CD8 (+) T cells. CXCR3 is activated by three interferon ...\n4. Differentiation of naive CD4(+) T cells into T helper (Th) cells is a defining event in adaptive immunity. The cytokines and transcription factors that control Th cell differentiation are understood, but it is not known how this process is orchestrated within lymph nodes (LNs). ... and both functions contribute to Th1 cell differentiation.\n5. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4+ T cells and effector CD8+ T cells. CXCR3 is activated by three interferon-inducible ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does CX3CR1 on the Th2 cells promote airway inflammation?",
               "answer": "Yes, CX3CR1 on the Th2 cells promotes airway inflammation. The evidence indicates that CX3CR1 signaling is involved in the survival of Th2 cells in inflamed lungs, and that blocking CX3CR1 can prevent airway inflammation when wild-type Th2 cells are transferred into CX3CR1-deficient",
               "rationale": "1. Allergic asthma is a T helper type 2 (T(H)2)-dominated disease of the lung. In people with asthma, a fraction of CD4(+) T cells express the CX3CL1 receptor, CX3CR1, and CX3CL1 expression is increased in airway smooth muscle, lung endothelium and epithelium upon allergen challenge. Here we found that …\n2. We found that CX3CR1 signaling promoted TH2 survival in the inflamed lungs, and injection of B cell leukemia/lymphoma-2 protein (BCl-2)-transduced CX3CR1-deficient TH2 cells into CX3CR1-deficient ...\n3. Transfer of wild-type CD4-positive T cells into CX3CR1-deficient mice restored the cardinal features of asthma, and CX3CR1-blocking reagents prevented airway inflammation in CX3CR1-deficient recipients injected with wild-type Th2 cells. We found that CX3CR1 signaling promoted Th2 survival in the inflamed lungs, and injection of B cell leukemia ...\n4. Role of T H 2 cells and IL-4, IL-5 and IL-13. At the beginning of our investigations into the pathophysiology of asthma (in early 1992), asthma was understood as a chronic disease of the airways, characterized clinically by reversible airways obstruction, enhanced bronchial responsiveness to spasmogens (also known as airways hyperresponsiveness, or AHR) and airways inflammation.\n5. Prophylactic injection of IL-27 reduced the concentration of Th2 cytokines and increased the number of type 1 regulatory T cells in mice, thereby reducing the lung inflammatory environment and improving asthma . In this study, there was no evidence that asthma development could increase or decrease the levels of these cytokines, and whether the ...",
               "predicate": null
            }
         ],
         "row": 541,
         "id": 202678785301285905
      },
      {
         "claim": "CX3CR1 on the Th2 cells suppresses airway inflammation.",
         "label": 0,
         "prediction": 0,
         "rationale": "CX3CR1 is a transmembrane protein that belongs to the G protein-coupled receptor 1 family and is the only known member of the CX3C chemokine receptor family. The function of CX3CR1 on Th2 cells is not specifically mentioned in the provided evidence snippets. CX3CR1 on Th2 cells does not suppress airway inflammation, but instead promotes their survival in inflamed lungs and is associated with increased airway inflammation. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CX3CR1?",
               "answer": "CX3CR1, also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein that belongs to the G protein-coupled receptor 1 (GPCR1) family. It is the only known member of the CX3C chemok",
               "rationale": "1. CX3C motif chemokine receptor 1 (CX3CR1), also known as the fractalkine receptor or G-protein coupled receptor 13 (GPR13), is a transmembrane protein of the G protein-coupled receptor 1 (GPCR1) family and the only known member of the CX3C chemokine receptor subfamily.. As the name suggests, this receptor binds the inflammatory chemokine CX3CL1 (also called neurotactin in mice or fractalkine in ...\n2. CX3CR1 is a chemokine receptor that is present on early myeloid lineage cells, including osteoclast precursors. It plays a role in the migration of osteoclast precursors to the bone surface and is involved in osteoclast formation.\n3. CX 3 CR1-CX 3 CL1 signaling pathway and migration process of immune cells via their interactions. (A) CX 3 CL1/fractalkine, a transmembrane protein with O-glycosylated mucin-like stem, is expressed on the surface of immune cells and non-immune cells. Soluble forms of CX 3 CL1 can be made after proteolytic cleavage by metalloprotease ADAM 10/17. Both membrane bound and soluble forms of CX 3 CL1 ...\n4. The receptor CX3CR1 is essential in myeloid phagocyte homing to the kidney at homeostasis, after acute cell depletion and in inflammation. CX3CR1 and its ligand are highly regulated in human kidney diseases such as IgA nephritis, systemic lupus erythematosus, and inflammatory conditions such as transplant rejection.\n5. Collectively, these data support T-cell CX3CR1 expression as a blood-based dynamic early on-treatment predictor of response to ICI therapy. There is an urgent need to discover blood-based ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of CX3CR1 on Th2 cells?",
               "answer": "The provided evidence snippets do not specifically mention the function of CX3CR1 on Th2 cells. However, they do discuss the roles of CX3CR1 in immune cell signaling and migration, as well as its involvement in pro-inflammatory and anti-inflammatory responses depending on environmental conditions. To determine the specific function of CX3",
               "rationale": "1. CX 3 CR1-CX 3 CL1 signaling pathway and migration process of immune cells via their interactions. (A) CX 3 CL1/fractalkine, a transmembrane protein with O-glycosylated mucin-like stem, is expressed on the surface of immune cells and non-immune cells. Soluble forms of CX 3 CL1 can be made after proteolytic cleavage by metalloprotease ADAM 10/17. Both membrane bound and soluble forms of CX 3 CL1 ...\n2. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4+ T cells and effector CD8+ T cells. CXCR3 is activated by three interferon-inducible ...\n3. This Review describes our current understanding of the mechanisms regulating T helper 2 (TH2) cell development and function. The authors discuss how our increasing comprehension of these pathways ...\n4. CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4 (+) T cells and effector CD8 (+) T cells. CXCR3 is activated by three interferon ...\n5. CX 3 CR1 expressing immune cells have a main role in either pro-inflammatory or anti-inflammatory response depending on environmental condition. In a given tissue such as bone marrow, brain, lung, liver, gut, and cancer, CX 3 CR1 expressing cells can maintain tissue homeostasis. Under pathologic conditions, however, CX 3 CR1 expressing cells ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does CX3CR1 on Th2 cells suppress airway inflammation?",
               "answer": "No, CX3CR1 on Th2 cells does not suppress airway inflammation. Instead, the evidence suggests that CX3CR1 provides a selective advantage to Th2 cells, promotes their survival in inflamed lungs, and is associated with increased airway inflammation. The presence of CX3CR1+ CD4+ T cells",
               "rationale": "1. Allergic asthma is a T helper type 2 (T(H)2)-dominated disease of the lung. In people with asthma, a fraction of CD4(+) T cells express the CX3CL1 receptor, CX3CR1, and CX3CL1 expression is increased in airway smooth muscle, lung endothelium and epithelium upon allergen challenge. Here we found that …\n2. CX3CR1 provides a selective advantage to T H 2 cells. The key role of CX3CR1 in airway inflammation and the presence of CX3CR1 + CD4 + T cells in the airways could reflect the preferential ...\n3. It can induce mast cell chemotaxis and increase CX 3 CR1 function in Th2 cells ... Lacoeuille Y, Hessel E, Coffman R, et al. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. ... Imai T, Goto H, Hibi T. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and ...\n4. Transfer of wild-type CD4-positive T cells into CX3CR1-deficient mice restored the cardinal features of asthma, and CX3CR1-blocking reagents prevented airway inflammation in CX3CR1-deficient recipients injected with wild-type Th2 cells. We found that CX3CR1 signaling promoted Th2 survival in the inflamed lungs, and injection of B cell leukemia ...\n5. SB010 successfully penetrated cells and inhibited airway inflammation in mouse models of lung inflammation. ... A. et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 ...",
               "predicate": null
            }
         ],
         "row": 542,
         "id": 256676616546271096
      },
      {
         "claim": "Carriers of the alcohol aldehyde dehydrogenase deficiency mutation drink less that non-carries.",
         "label": 1,
         "prediction": 1,
         "rationale": "The alcohol aldehyde dehydrogenase deficiency mutation, specifically the ALDH2 mutation, leads to impaired enzyme activity and the accumulation of acetaldehyde when alcohol is consumed, resulting in unpleasant physical reactions such as flushing, nausea, and palpitations. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of the alcohol aldehyde dehydrogenase deficiency mutation on drinking behavior?",
               "answer": "The alcohol aldehyde dehydrogenase deficiency mutation, specifically the ALDH2 mutation, leads to impaired enzyme activity and the accumulation of acetaldehyde when alcohol is consumed. This results in a condition known as Alcohol Flushing Syndrome or Asian Glow, which causes unpleasant physical reactions such as flushing, nausea, and palpit",
               "rationale": "1. Most variants have very small effects on risk. This critical review will focus on the set of genes with the strongest effect on risk for AUD, the alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) genes. There is very strong evidence that variations in ADH and ALDH genes affect alcohol consumption and the risk for AUD.\n2. The primary enzymes involved in alcohol metabolism are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Both enzymes occur in several forms that are encoded by different genes; moreover, there are variants (i.e., alleles) of some of these genes that encode enzymes with different characteristics and which have different ethnic distributions.\n3. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme of alcohol metabolism and it is involved in the cellular mechanism of alcohol liver disease. ALDH2 gene mutations exist in about 8% of the world's population, with the incidence reaching 45% in East Asia. The mutations will result in impairment of enzyme activity and accumulation of acetaldehyde, facilitating the progression of other liver ...\n4. ALDH2 deficiency, more commonly known as Alcohol Flushing Syndrome or Asian Glow, is a genetic condition that interferes with the metabolism of alcohol. As a result, people with ALDH2 deficiency have increased risks of developing esophageal and head & neck cancers . Globally, this deficiency affects 540 million people — 8% of the world ...\n5. Alcohol-related liver disease (ALD) is a common medical complication caused by excessive alcohol consumption and comprises around 50% of the global burden of liver disease 1,2,3,4.The most widely ...",
               "predicate": null
            }
         ],
         "row": 543,
         "id": 166950473585026490
      },
      {
         "claim": "Cell autonomous sex determination in somatic cells does not occur in Galliformes.",
         "label": 0,
         "prediction": 1,
         "rationale": "Galliformes, which include birds such as chickens and turkeys, typically use a ZW sex-determination system, where females are heterogametic (ZW) and males are homogametic (ZZ). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the sex determination mechanism in Galliformes?",
               "answer": "The provided evidence does not specifically mention the sex determination mechanism in Galliformes. However, it is known that Galliformes, which include birds such as chickens and turkeys, typically use a ZW sex-determination system. In this system, females are heterogametic (ZW) and males are homog",
               "rationale": "1. A sex-determination system is a biological system that determines the development of sexual characteristics in an organism. [1] Most organisms that create their offspring using sexual reproduction have two common sexes and a few less common intersex variations. In some species, there are hermaphrodites. [2]\n2. Sexual reproduction: the mixing of genomes via meiosis and fusion of gametes. Sex: the sexual phenotype of an individual. Sex determination: the mechanism by which the sexual phenotype of an individual is established in a given species. Sex chromosome: a chromosome involved with determining the sex of an individual.\n3. The XY sex-determination system is a sex-determination system used to classify many mammals, including humans, some insects (), some snakes, some fish (), and some plants (Ginkgo tree).. In this system, the sex of an individual usually is determined by a pair of sex chromosomes.Typically, females have two of the same kind of sex chromosome (XX), and are called the homogametic sex.\n4. Sex Determination in Mammals. Figure 1: Location of the sex-determining region Y (SRY) gene on the Y-chromosome. The SRY gene (blue band) on the male Y chromosome regulates sex determination in ...\n5. The Genetics of Sex Determination. Sex determination is an intricate series of physiological events and patterns that are often controlled through hormonal expression. Sexual characteristics can also be triggered by a change in hormonal balance, sometimes determined by an environmental change. In some organisms such as fruitflies sex is ...",
               "predicate": null
            }
         ],
         "row": 544,
         "id": 242833549576823997
      },
      {
         "claim": "Cell autonomous sex determination in somatic cells occurs in Passeriformes.",
         "label": 1,
         "prediction": 1,
         "rationale": "Passeriformes is the largest order of birds, commonly known as passerines or perching birds, which includes more than half of all bird species, with over 5,000 members. Passerines exhibit cell autonomous sex determination in somatic cells. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Passeriformes?",
               "answer": "Passeriformes is the largest order of birds, commonly known as passerines or perching birds. This order includes more than half of all bird species, with over 5,000 members, such as crows, finches, flycatchers, nightingales, swallows, tanagers, vireos",
               "rationale": "1. passeriform, (order Passeriformes), any member of the largest order of birds and the dominant avian group on Earth today. The passeriform birds are true perching birds, with four toes, three directed forward and one backward. Considered the most highly evolved of all birds, passerines have undergone an explosive evolutionary radiation in relatively recent geological time and now occur in ...\n2. A passerine (/ ˈ p æ s ə r aɪ n /) is any bird of the order Passeriformes (/ ˈ p æ s ə r ɪ f ɔːr m iː z /; from Latin passer 'sparrow' and formis '-shaped') which includes more than half of all bird species. Sometimes known as perching birds, passerines generally have an anisodactyl arrangement of their toes (three pointing forward and one back), which facilitates perching.\n3. The order of Passeriformes, commonly called passerines (PASS-ur-eenz), are the largest and most unique family of birds. A few of the many birds in the passerine order are crows, finches, flycatchers, nightingales, swallows, tanagers, vireos, shrikes, wrens, and warblers. They are sometimes called \"perching birds\" and (less accurately) \"song birds.\"\n4. Passeriform - Flight, Adaptations, Foraging: The single feature distinguishing passerines from all similar birds is their \"perching\" foot. A number of species are largely terrestrial and have feet modified for walking and running. The bills are extraordinarily diverse in size, shape, and proportions. Passerine bills may be broadly classified into eight morphological and functional types.\n5. A passerine is a perching bird that is a member of the order Passeriformes and accounts for more than half of all bird species, with over 5,000 belonging to this bird category. This includes all songbirds, finches, thrushes, larks, and sparrows. Passerines are often referred to as songbirds, although this is not entirely correct as not all of ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do passerines exhibit cell autonomous sex determination in somatic cells?",
               "answer": "Yes, passerines exhibit cell autonomous sex determination in somatic cells. The evidence indicates that avian somatic cells, including those in birds like passerines, possess an inherent sex identity and that sexual differentiation is substantively cell autonomous, meaning it occurs independently of hormonal influences.",
               "rationale": "1. The discordance between chicken gonadal sex and somatic sex shows that somatic cells have a degree of cell autonomous sexual differentiation that is unaffected by hormones. DMRT1 is only expressed in the urogenital system. ... Cell-autonomous sex determination outside of the gonad. Dev. Dyn. 2013; 242: 371-379. View in Article Scopus (57) PubMed;\n2. Our study demonstrates that avian somatic cells possess an inherent sex identity and that, in birds, sexual differentiation is substantively cell autonomous. You have full access to this article ...\n3. The discordance between chicken gonadal sex and somatic sex shows that somatic cells have a degree of cell autonomous sexual differentiation that is unaffected by hormones. DMRT1 is only expressed in the ... Cell-autonomous sex determination outside of the gonad. Dev. Dyn., 242 (2013), pp. 371-379. CrossRef View in Scopus Google Scholar. Cited ...\n4. In birds, sex is determined through cell-autonomous mechanisms and various factors, such as the dosage of DMRT1. While the sex-determination mechanism in gonads is well known, the mechanism in ...\n5. Our study demonstrates that avian somatic cells possess an inherent sex identity and that, in birds, sexual differentiation is substantively cell autonomous. Sexual development in vertebrates is thought to be governed by general principles defined in the early to mid-twentieth century 1, 2.",
               "predicate": null
            }
         ],
         "row": 545,
         "id": 236565774357213638
      },
      {
         "claim": "Cellular aging closely links to an older appearance.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cellular aging is the process of cellular senescence, characterized by the cessation of cell division in response to damage or stress, which serves to protect the surrounding tissue from harmful replication errors. Cellular aging affects physical appearance, leading to visible signs of aging such as changes in the skin, including thinning, wrinkling, sagging, and loss of elasticity, as well as degenerative physical changes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is cellular aging?",
               "answer": "Cellular aging is the process of cellular senescence, characterized by the cessation of cell division in response to damage or stress, which serves to protect the surrounding tissue from harmful replication errors. It is integrated with metabolism and proteostasis, where metabolic disorders that affect proteostasis can enhance aging. Cellular aging is marked by various indicators",
               "rationale": "1. Cellular aging is a process integrated with metabolism and proteostasis and their mutual interactions. Thereby, all metabolic disorders that affect proteostasis can enhance aging via feed-forward connectivity .\n2. Cellular senescence, specifically, is the process of cellular aging. A senescent cell is generally larger than its non-senescent counterparts. Senescent cells no longer divide in an effort to protect themselves and the tissue surrounding them from inaccurate or harmful replication errors.\n3. The cytoskeleton is critical in maintaining cell shape and integrity, and its dysregulation is an indicator of cellular aging (Gourlay and Ayscough, 2005). In yeast, actin turnover increases with increased ROS (Gourlay et al., 2004) and disruption of the Ras pathway with age (Ho and Bretscher, 2001).\n4. Senescence as a central hallmark of aging. Telomere damage, epigenetic dysregulation, DNA damage, and mitochondrial dysfunction are primary drivers of damage in aging. Several of these drivers of damage can induce senescence. Senescence can in turn drive the consequential aging hallmarks in response to damage: stem cell exhaustion and chronic ...\n5. Aging is a gradual and irreversible pathophysiological process. It presents with declines in tissue and cell functions and significant increases in the risks of various aging-related diseases ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does cellular aging affect physical appearance?",
               "answer": "Yes, cellular aging affects physical appearance. Evidence 3 and 4 specifically highlight how aging leads to changes in the skin, such as thinning, wrinkling, sagging, and loss of elasticity, which are all visible signs of aging. Additionally, evidence 5 mentions that aging results in degenerative physical changes in",
               "rationale": "1. Cellular aging is a process integrated with metabolism and proteostasis and their mutual interactions. Thereby, all metabolic disorders that affect proteostasis can enhance aging via feed-forward connectivity . In ... Direct physical interaction between different organelles occurs at membrane contact sites, including vacuole-mitochondria ...\n2. The aging of a cell is one trigger. Old cells must die to make room for new cells. Other triggers include an excess number of cells and possibly damage to a cell. Old cells also die because they can divide only a limited number of times. This limit is programmed by genes. When a cell can no longer divide, it grows larger, exists for a while ...\n3. Reviewed/Revised Jan 2024. Aging results in thinning of the dermis and epidermis. The underlying fat layer can be lost as well. The decrease in volume and overall effectiveness of all three skin layers results in a number of changes. The skin loses some of its elasticity. It becomes drier because of impaired barrier function and decreased ...\n4. Aging induces marked alterations in biochemical, structural and physical properties of the skin, which results in an impairment of biological functions and a diversity of diseases ( Diridollou et al. 2001; Harn et al. 2019 ). Clear visual skin changes during aging include thinning, wrinkling, sagging, and also the greying of hair.\n5. Aging is a chronic, complicated process that leads to degenerative physical and biological changes in living organisms. Aging is associated with permanent, gradual physiological cellular decay that affects all aspects of cellular mechanobiological features, including cellular cytoskeleton structures, mechanosensitive signaling pathways, and forces in the cell, as well as the cell's ability ...",
               "predicate": null
            }
         ],
         "row": 546,
         "id": 267679459368096405
      },
      {
         "claim": "Chenodeosycholic acid treatment increases whole-body energy expenditure.",
         "label": 1,
         "prediction": 1,
         "rationale": "Chenodeoxycholic acid is a naturally occurring bile acid that plays a role in the digestion and absorption of fats, dissolving cholesterol gallstones, and inhibiting cholesterol production in the liver. Chenodeoxycholic acid treatment increases whole-body energy expenditure. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Chenodeosycholic acid?",
               "answer": "Chenodeoxycholic acid (CDCA) is a naturally occurring bile acid that plays a role in the digestion and absorption of fats. It is one of the main bile acids found in the body and is involved in dissolving cholesterol gallstones and inhibiting cholesterol production in the liver. CDCA is used therapeutically",
               "rationale": "1. Chenodeoxycholic acid (CDCA; also known as chenodesoxycholic acid, chenocholic acid and 3α,7α-dihydroxy-5β-cholan-24-oic acid) is a bile acid.Salts of this carboxylic acid are called chenodeoxycholates.Chenodeoxycholic acid is one of the main bile acids. It was first isolated from the bile of the domestic goose, which gives it the \"cheno\" portion of its name (Greek: χήν = goose).\n2. severe or ongoing diarrhea; or. liver problems--loss of appetite, upper stomach pain, tiredness, easy bruising or bleeding, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes). Common side effects of chenodiol may include: mild stomach cramps; or. abnormal blood tests (low white blood cells, high cholesterol or triglycerides).\n3. Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of gallstones. It can also reduce the amount of other bile acids that can be harmful to liver ...\n4. Chenodeoxycholic acid or chenodiol (kee\" noe dye' ol) is a naturally occurring bile acid that is used therapeutically to dissolve cholesterol gallstone in patients with a functioning gall bladder who have contraindications to cholecystectomy or refuse surgery. Chenodiol is the major bile acid synthesized by the liver and is usually the bile ...\n5. Chenodal (chenodeoxycholic acid) is a naturally occurring human bile acid indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Chenodeoxycholic acid treatment increase whole-body energy expenditure?",
               "answer": "Yes, chenodeoxycholic acid (CDCA) treatment increases whole-body energy expenditure. Evidence from the studies indicates that treatment with CDCA resulted in increased brown adipose tissue (BAT) activity and also led to an increase in whole-body energy expenditure in healthy female subjects.",
               "rationale": "1. New treatment approaches to weight loss and weight loss maintenance in humans are critical. Given its potential role in stimulating energy expenditure, brown adipose tissue (BAT) activation has become a trending topic as an anti-obesity treatment.Most ...\n2. Broeders et al. show that the bile acid chenodeoxycholic acid (CDCA) promotes mitochondrial uncoupling via TGR5 in human brown adipocytes and increases brown fat activity and energy expenditure in women.\n3. Here we examined the effects of oral supplementation of the bile acid chenodeoxycholic acid (CDCA) on human BAT activity. Treatment of 12 healthy female subjects with CDCA for 2 days resulted in increased BAT activity. Whole-body energy expenditure was also increased upon CDCA treatment.\n4. A deeper understanding of the role of BAT in human metabolic health and its interrelationship with body fat distribution and deciphering proper strategies to increase energy expenditure, by either increasing functional BAT mass or inducing white adipose browning, holds the promise for possible therapeutic avenues for the treatment of obesity ...\n5. The bile acid, chenodeoxycholic acid (CDCA), is another steroid molecule that is essential for metabolism and thought to increase human whole-body energy expenditure.",
               "predicate": null
            }
         ],
         "row": 547,
         "id": 237525299555132980
      },
      {
         "claim": "Chenodeosycholic acid treatment reduces whole-body energy expenditure.",
         "label": 0,
         "prediction": 0,
         "rationale": "Chenodeoxycholic acid is a primary bile acid synthesized in the liver, present in high concentrations in bile, and used therapeutically to dissolve cholesterol gallstones by dissolving cholesterol and inhibiting its production. Chenodeoxycholic acid treatment affects whole-body energy expenditure. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Chenodeosycholic acid?",
               "answer": "Chenodeoxycholic acid (CDCA), also known as chenodiol, is a primary bile acid synthesized in the liver. It is present in high concentrations in bile and is used therapeutically to dissolve cholesterol gallstones. CDCA works by dissolving the cholesterol that forms gallstones and inhibiting cholesterol production in",
               "rationale": "1. Chenodiol Generic name: chenodiol (chenodeoxycholic acid) [ KEE-noe-DYE-ol ] Brand name: Chenodal Dosage form: oral tablet (250 mg) Drug class: Gallstone solubilizing agents Medically reviewed by Drugs.com on Apr 8, 2024. Written by Cerner Multum.\n2. Chenodeoxycholic acid (CDCA; also known as chenodesoxycholic acid, chenocholic acid and 3α,7α-dihydroxy-5β-cholan-24-oic acid) is a bile acid. Salts of this carboxylic acid are called chenodeoxycholates.\n3. Chenodeoxycholic acid (chenodiol) is a primary bile acid, synthesized in the liver and present in high concentrations in bile that is used therapeutically to dissolve cholesterol gallstones. Chronic therapy is associated with transient elevations in serum aminotransferase levels in up to 30% of patients, but chenodiol has been linked to only rare instances of clinically apparent liver injury ...\n4. Chenodeoxycholic acid (or Chenodiol) is an epimer of ursodeoxycholic acid (DB01586). Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of ...\n5. Chenodeoxycholic acid (CDCA), 3α,7α-dihydroxy-5β-cholan-24-oic acid, is a primary bile acid generated in the liver from cholesterol. In liver cells CDCA is conjugated with glycine or taurine to form two bile salts, Glyco-CDCA and Tauro-CDCA, before being released into the bile ducts. In the intestin …",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Chenodeoxycholic acid treatment affect whole-body energy expenditure?",
               "answer": "Yes, chenodeoxycholic acid treatment does affect whole-body energy expenditure. The evidence indicates that alterations in bile acid synthesis, such as increased synthesis of chenodeoxycholic acid due to the inability to synthesize cholic acid, are associated with increased whole-body energy expenditure. Additionally, the treatment with bile acids",
               "rationale": "1. These mice are unable to synthesize cholic acid, resulting in increased synthesis of chenodeoxycholic acid and enlarged bile acid pool. Cy … Increased whole body energy expenditure and protection against diet-induced obesity in Cyp8b1-deficient mice is accompanied by altered adipose tissue features ...\n2. In line with induction of energy expenditure by bile acids, lowering of the bile acid pool via treatment with the FXR-agonist GW4064 was shown to result in decreased energy expenditure, weight gain and insulin resistance [Citation 14]. Increased energy expenditure following treatment with bile acids has been demonstrated also in humans.\n3. Introduction. Obesity has reached epidemic proportions around the world and poses a severe threat to global public health. Driven by a chronic energy imbalance between excess energy (food) intake and/or reduced energy expenditure (physical activity), obesity in the United States reached 35.0% of men and 40.4% of women in 2013-2014 [] with the yearly cost of obesity to the US public health ...\n4. Introduction. The obesity epidemic has become a major public health crisis, contributing to an upsurge in cases of hypertension, coronary heart disease and diabetes ().Obesity, defined as the excess accumulation of white adipose tissue (WAT), develops when energy intake exceeds expenditure ().Weight reduction and increased physical activity are recommended as the most effective treatments for ...\n5. Perino and Schoonjans summarize the most recent literature on the receptor-mediated role of bile acid signalling in the control of peripheral and central energy homeostasis.",
               "predicate": null
            }
         ],
         "row": 548,
         "id": 202612161670325954
      },
      {
         "claim": "Chronic aerobic exercise alters endothelial function, improving vasodilating mechanisms mediated by NO.",
         "label": 1,
         "prediction": 1,
         "rationale": "NO is a negative term used to express dissent, denial, or refusal, meaning \"not any\" or \"not at all,\" and can also indicate that something is not allowed. Nitric oxide (NO) plays several crucial roles in the human body, including vasodilation and acting as a signaling molecule. Chronic aerobic exercise alters endothelial function. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is NO?",
               "answer": "NO is a negative term used to express dissent, denial, or refusal. It means \"not any\" or \"not at all,\" and can also indicate that something is not allowed. It serves as a response to questions or requests, emphasizing a negative stance.",
               "rationale": "1. The meaning of NO is not. How to use no in a sentence. With no itchy seams and a blended no-static material, this shirt is designed for running and reduces chafing, retains shape, stretches further than other fabrics, and uses mesh to maximize breathability during cardio heavy training. — Stephanie Osmanski, Southern Living, 27 Mar. 2024 The offensive line needs three new starters and more ...\n2. NO definition: 1. not any; not one; not a: 2. used in signs and on notices to show that something is not allowed…. Learn more.\n3. No definition: (a negative used to express dissent, denial, or refusal, as in response to a question or request). See examples of NO used in a sentence.\n4. No is the ultimate negative: it means \"not any,\" or \"not at all,\" and it's also used to express a generally negative response. If there's no milk for your cereal in the morning, there's not a drop left.\n5. No definition: Used to express refusal, denial, disbelief, emphasis, or disagreement.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the role of NO in the human body?",
               "answer": "Nitric oxide (NO) plays several crucial roles in the human body, including:\n\n1. **Vasodilation**: NO relaxes the walls of blood vessels, leading to their widening, which allows for increased blood flow to the heart and other organs.\n2. **Signaling Molecule**: It acts",
               "rationale": "1. Biological functions of nitric oxide are roles that nitric oxide plays within biology.. Nitric oxide (nitrogen monoxide) is a molecule and chemical compound with chemical formula of N O.In mammals including humans, nitric oxide is a signaling molecule involved in several physiological and pathological processes. It is a powerful vasodilator with a half-life of a few seconds in the blood.\n2. Nitric oxide, abbreviated as NO, is a chemical compound that plays a key role in cell metabolism. It is also crucial in coordinating tissue energy demand with supply. The body naturally produces nitric oxide as a free radical. It is the end product of a conversion process of dietary nitrates and vitamin C. One of nitric oxide's prominent ...\n3. NO has many important biological functions. It relaxes the walls of blood vessels, which causes vasodilation (widening of the vessels). This allows more blood to flow into the heart and other organs. It also acts as a signaling molecule between nerve cells. In addition, it plays an important role in our immune system and helps it to fight ...\n4. Nitric oxide (NO) is a gaseous molecule that has a central role in signaling pathways involved in numerous physiological processes (e.g., vasodilation, neurotransmission, inflammation, apoptosis, and tumor growth). Due to its gaseous form, NO has a short half‐life, and its physiology role is concentration dependent, often restricting its ...\n5. The following work presents the most important information on the NOS isoforms and their role in the human body, including NO synthesis in various tissues and cells, intercellular signaling and activities supporting the immune system and regulating blood vessel functions. The role of NOS in pathological conditions such as obesity, diabetes and ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does chronic aerobic exercise alter endothelial function?",
               "answer": "Yes, chronic aerobic exercise does alter endothelial function. The evidence suggests that continuous aerobic exercise can improve vascular endothelial function, particularly in individuals with conditions such as obesity and hypertension. It has been shown to increase levels of beneficial microRNAs (like miR-126 and miR-214) and improve various endothelial function markers,",
               "rationale": "1. Background: Current research suggests that continuous aerobic exercise can be effective in improving vascular endothelial function, while the effect between different intensities and durations of exercise is unclear. The aim of this study was to explore the effect of different durations and intensities of aerobic exercise on vascular endothelial function in different populations.\n2. Aerobic exercise can increase the miR-126 level and RHI index and decrease serum risk factors such as ox-LDL and blood glucose in obese adolescents . miR-214 has been found to be involved in endothelial protection and angiogenesis and was reported to protect against endothelial cell apoptosis possibly by targeting cyclooxygenase-2 (COX-2) [114 ...\n3. Endothelial Function and Physical Exercise. The endothelium is considered an active and dynamic tissue with important properties such as maintenance of blood circulation, regulation of vascular tone, microvascular permeability, signaling, and vascular angiogenesis and inflammatory response. 1 The endothelium allows the connection among ...\n4. Indeed, it is well known that aerobic exercise improves endothelial function both in animal models of hypertension and in patients with hypertension. 5, 6 A balance between ambient levels of ...\n5. The present results are consistent with the notion that aerobic exercise training elicits favorable adaptations in endothelial function in individuals with overweight and obesity.",
               "predicate": null
            }
         ],
         "row": 549,
         "id": 260324473229680412
      },
      {
         "claim": "Combination nicotine replacement therapies with varenicline or bupropion lead to significantly higher long-term abstinence rates at 52 weeks than varenicline monotherapy.",
         "label": 0,
         "prediction": 1,
         "rationale": "Varenicline is an oral medication used to help people stop smoking by reducing nicotine cravings and withdrawal symptoms. Varenicline monotherapy leads to lower long-term abstinence rates at 52 weeks compared to combination nicotine replacement therapies with varenicline or bupropion. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is varenicline?",
               "answer": "Varenicline is an oral medication used to help people stop smoking by reducing nicotine cravings and withdrawal symptoms. It is a prescription pill that does not contain nicotine and works as a nicotinic acetylcholine receptor partial agonist, which activates receptors in the brain to release dopamine, thereby reducing cravings. Varenic",
               "rationale": "1. Varenicline is an oral medication that helps people stop smoking by reducing nicotine cravings and withdrawal symptoms. It can cause serious side effects such as mental health problems, seizures, heart problems, and allergic reactions.\n2. Varenicline is a prescription pill that does not contain nicotine and helps people quit smoking. Learn how to use it, its pros and cons, side effects, and precautions from the Centers for Disease Control and Prevention.\n3. Varenicline, sold under the brand names Chantix and Champix among others, is a medication used for smoking cessation and for the treatment of dry eye disease. It is a nicotinic acetylcholine receptor partial agonist. When activated, this receptor releases dopamine in the nucleus accumbens, the brain's reward center, thereby reducing cravings and withdrawal symptoms with smoking cessation ...\n4. What is varenicline used for? Varenicline is commonly used to help people quit smoking. Varenicline may also be used for other conditions as determined by your healthcare provider. Varenicline is ...\n5. Varenicline is a medication that helps people stop smoking by blocking the effects of nicotine on the brain. It can be taken with or without counseling and has various dosing options and side effects.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does varenicline monotherapy lead to lower long-term abstinence rates at 52 weeks compared to combination nicotine replacement therapies with varenicline or bupropion?",
               "answer": "Yes, varenicline monotherapy leads to lower long-term abstinence rates at 52 weeks compared to combination therapies. The evidence indicates that combination therapy with varenicline and bupropion resulted in a continuous abstinence rate of 55.0%, while varenicline monotherapy had a rate of 32",
               "rationale": "1. Nicotine replacement therapy, bupropion, and varenicline are proven to be efficacious pharmacological aids, doubling the chances of success in quitting smoking [4-6]. To date, 3 randomized controlled trials (RCTs) have compared varenicline, bupropion, and placebo [6-8]. The primary outcome measure was continuous abstinence rates (CARs) at ...\n2. Research to date suggests that varenicline (as monotherapy) and combination NRT are the most effective smoking cessation therapies that are currently available to assist in achieving abstinence. 4 Even these, however, result in only modest increases in abstinence rates of approximately 30%-40% at 6 months compared with placebo. 5 10-12 A ...\n3. The retrospective study displayed higher success rates (continuous abstinence rates at 52 weeks) with combination varenicline and bupropion (55.0%; compared to varenicline monotherapy (32.1%), p < 0.001). Subgroup analyses suggest that this combination may be more beneficial in males and patients with higher baseline nicotine dependence.\n4. In another study of combination therapy with varenicline and the 21 mg nicotine patch, combination therapy did not increase smoking abstinence rates compared to varenicline alone. 49 In this randomized study of 341 smokers, participants started the nicotine patch at a quit date 1 week after the participants began a varenicline titration. No ...\n5. Two studies suggest that the combination of varenicline and bupropion can improve short-term abstinence rates, but the effect seems to diminish over time. In one trial, 506 smokers received varenicline plus bupropion, or varenicline plus placebo Citation 71. There was a significant effect of combination treatment on abstinence at 12 weeks (53.0 ...",
               "predicate": null
            }
         ],
         "row": 550,
         "id": 203855316692674884
      },
      {
         "claim": "Combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors is effective at treating KRAS mutant tumors.",
         "label": 1,
         "prediction": 1,
         "rationale": "The effect of combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors on KRAS mutant tumors is not directly addressed in the provided evidence snippets. Both PI3K and MEK pathways are often activated in KRAS mutant tumors. Combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors may be effective at treating KRAS mutant tumors. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the effect of combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors on KRAS mutant tumors?",
               "answer": "The provided evidence snippets do not directly address the specific effects of combining phosphatidylinositide 3-kinase (PI3K) and MEK 1/2 inhibitors on KRAS mutant tumors. However, it is known from broader scientific literature that both PI3K and MEK pathways are often activated",
               "rationale": "1. Phosphatidylinositol 3-kinase (PI3K) is involved in multiple cell processes, including insulin signaling, cell growth, immunity, and brain development. It is activated in a wide variety of cancers ...\n2. Abstract Thrombopoietin (TPO) enhances platelet activation through activation of the tyrosine kinase; JAK2 and the lipid kinase phosphatidylinositide 3-kinase (PI3K). The aim of our study was to identify the PI3K isoforms involved in mediating the effect of TPO on platelet function and elucidate the underlying mechanism.\n3. Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which regulates cell growth, motility, survival, metabolism, and angiogenesis [ 1, 2 ]. Activation of the PI3K/AKT/mTOR pathway contributes to the development of tumor and resistance to anticancer ...\n4. Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that regulate diverse cellular processes including proliferation, adhesion, survival, and motility. Dysregulated PI3K pathway signaling occurs in one-third of human tumors. Aberrantly activated PI3K signaling also confers sensitivity and resistance to conventional therapies.\n5. Thrombopoietin (TPO) enhances platelet activation through activation of the tyrosine kinase; JAK2 and the lipid kinase phosphatidylinositide 3-kinase (PI3K).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are both PI3K and MEK pathways often activated in KRAS mutant tumors?",
               "answer": "Yes, both PI3K and MEK pathways are often activated in KRAS mutant tumors. Evidence 5 indicates that many cell lines with KRAS mutations also harbor mutations in the PI3K pathway, suggesting that both pathways are frequently activated in these tumors. Additionally, evidence 2 highlights the complexity of the RAS",
               "rationale": "1. In KRAS mutant cancers, a mutant selective KRAS inhibitor might combine well with a PI3K inhibitor because both pathways will be suppressed specifically in cancer cells, but the MEK/ERK pathway will remain intact in the normal cells of the body, increasing significantly the tolerability of the combination.\n2. The RAS signaling network gets more complex because PI3K is also directly activated by receptor tyrosine kinases (RTKs) or G protein-coupled receptors (GPCRs). Besides, there are several points in which the MAPK and PI3K pathways cross talk, leading to either activation or inhibition at different levels.\n3. Introduction. Colorectal cancer (CRC) is a heterogeneous disease with multiple underlying causative genetic mutations. Activating genetic mutations in the phosphatidylinositol-3 kinase (PI3K) and the mitogen activated protein kinase (MAPK) pathways have been implicated in CRC. Insulin-like growth factor-1 receptor (IGF-1R) is a key activator of ...\n4. Activated KRAS protein can activate multiple signalling pathways, including the rapidly accelerated fibrosarcoma (RAF)-mitogen-activated protein kinase (MEK)-extracellular regulated protein ...\n5. Given the frequent co-occurrence of KRAS and PI3K pathway lesions, many of these cell lines harbored both KRAS and PI3K pathway mutations . As expected, cell lines that are wild-type for KRAS were generally insensitive to PD0325901 (Fig. 1A,, black columns). However, the sensitivity of the 11 KRAS mutant cell lines to the MEK1/2 inhibitor ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is combining phosphatidylinositide 3-kinase and MEK 1/2 inhibitors effective at treating KRAS mutant tumors?",
               "answer": "Yes, combining phosphatidylinositide 3-kinase (PI3K) and MEK 1/2 inhibitors may be effective at treating KRAS mutant tumors. The evidence indicates that PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers. Therefore, targeting both pathways",
               "rationale": "1. Bladder cancer is characterized by aberrant activation of the phosphatidylinositol-3-OH kinase (PI3K) signaling, underscoring the significance of directing therapeutic efforts toward the PI3K ...\n2. Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance ... There is evidence emerging from clinical trials that PI3K inhibitors may be more active in PIK3CA mutant tumors, where PI3K is driving tumor ... PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers ...\n3. Abstract. Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that regulate diverse cellular processes including proliferation, adhesion, survival, and motility. Dysregulated PI3K pathway signaling occurs in one-third of human tumors. Aberrantly activated PI3K signaling also confers sensitivity and resistance to conventional therapies.\n4. Introduction: The phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway plays a central role in regulating cell growth and proliferation and thus has been considered as effective anticancer drug targets.Many PI3K inhibitors have been developed and progressed to various stages of clinical trials, and some have been approved as anticancer ...\n5. Background Lung cancer, accounting for a significant proportion of global cancer cases and deaths, poses a considerable health burden. Non-small cell lung cancer (NSCLC) patients have a poor prognosis and limited treatment options due to late-stage diagnosis and drug resistance. Dysregulated of the mitogen-activated protein kinase (MAPK) pathway, which is implicated in NSCLC pathogenesis ...",
               "predicate": null
            }
         ],
         "row": 551,
         "id": 278376982430444212
      },
      {
         "claim": "Commelina yellow mottle virus' (ComYMV) genome consists of 7489 baise pairs.",
         "label": 1,
         "prediction": 1,
         "rationale": "The genome size of Commelina yellow mottle virus (ComYMV) is 7489 bp. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the genome size of Commelina yellow mottle virus (ComYMV)?",
               "answer": "The genome size of Commelina yellow mottle virus (CoYMV) is 7489 bp.",
               "rationale": "1. Commelina yellow mottle virus (CoYMV) is a double-stranded DNA virus that infects the monocot Commelina diffusa. Although CoYMV and cauliflower mosaic virus (CaMV; another double-stranded DNA virus) probably replicate by a similar mechanism, the particle morphology and host range of CoYMV place it in a distinct group.\n2. Commelina yellow mottle virus (CoYMV) is a double-stranded DNA virus that infects the monocot Commelina diffusa. Although CoYMV and cauliflower mosaic virus (CaMV; another double-stranded DNA virus) probably replicate by a similar mechanism, the particle morphology and host range of CoYMV place it in a distinct group. ...\n3. Commelina yellow mottle virus: ComYMV: Commelina (Commelinaceae) Caribbean: X52938: Dioscorea bacilliform virus: DBV: Yam (Dioscoreaceae) ... viruses, nonenveloped, flexuous, filamentous, 470-1000 nm long and 12-13 nm in diameter with a linear ssRNA(+) genome of 5.8-9 kb in size, polyadenylated at the 3′ terminus and sometimes capped at ...\n4. Properties of Commelina yellow mottle virus's complete DNA sequence, genomic discontinuities and transcript suggest that it is a pararetrovirus Scott L ... Analysis of the genome sequence indicates that the genome is 7489 bp in size and that the transcribed strand contains three open reading frames capable of encoding proteins of 23, 15 and 216 ...\n5. Properties of Commelina yellow mottle virus's complete DNA sequence, genomic discontinuities and transcript suggest that it is a pararetrovirus. S L Medberry, B E ... Analysis of the genome sequence indicates that the genome is 7489 bp in size and that the transcribed strand contains three open reading frames capable of encoding proteins of 23 ...",
               "predicate": null
            }
         ],
         "row": 552,
         "id": 242402941157467275
      },
      {
         "claim": "Crosstalk between dendritic cells (DCs) and innate lymphoid cells (ILCs) is important in the regulation of intestinal homeostasis.",
         "label": 1,
         "prediction": 1,
         "rationale": "Dendritic cells play a crucial role in the regulation of intestinal homeostasis by acting as sentinel cells that prime and polarize T cell responses, maintaining immune balance and preventing destructive inflammatory responses. Innate lymphoid cells (ILCs) play a crucial role in the regulation of intestinal homeostasis by acting as immune sentinels within mucosal surfaces, surveying tissues to counter inappropriate immune reactions and maintain homeostasis. Dendritic cells (DCs) and innate lymphoid cells (ILCs) interact with each other in the regulation of intestinal homeostasis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of dendritic cells (DCs) in the regulation of intestinal homeostasis?",
               "answer": "Dendritic cells (DCs) play a crucial role in the regulation of intestinal homeostasis by acting as sentinel cells that prime and polarize T cell responses. They are involved in maintaining immune balance within the intestinal environment, preventing destructive inflammatory responses. DCs, including conventional DCs (cDCs) and plasm",
               "rationale": "1. Abstract. Dendritic cells (DCs), including conventional DCs (cDCs) and plasmacytoid DCs (pDCs), serve as the sentinel cells of the immune system and are responsible for presenting antigen information. Moreover, the role of DCs derived from monocytes (moDCs) in the development of inflammation has been emphasized.\n2. Intestinal dendritic cells (DCs) play a central role in these functions as sentinel cells able to prime and polarize the T cell responses. ... Intestinal dendritic cells (DCs) play a central role ...\n3. Rimoldi, M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunol. 6, 507-514 (2005). This study emphasised the ...\n4. Antigen-presenting cells of the intestine. The intestine and associated lymphoid tissues are home to an extensive network of innate immune cells with antigen presenting function, including macrophages, conventional CD11c hi DCs and plasmacytoid DCs (pDCs) 1, 2.Adaptations to the intestinal environment that prevent the generation of destructive inflammatory responses have been demonstrated in ...\n5. There may also be a release from the regulatory mechanisms that normally limit effector function within the mucosa, due, for instance to a loss of response to regulatory cytokines like IL-10 or TGFβ or a failure to interact with CX3CR1+ cells that promote regulation (E). The role of DCs on determining responsiveness to these local control ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the role of innate lymphoid cells (ILCs) in the regulation of intestinal homeostasis?",
               "answer": "Innate lymphoid cells (ILCs) play a crucial role in the regulation of intestinal homeostasis by acting as immune sentinels within mucosal surfaces. They help survey tissues to counter inappropriate immune reactions and maintain homeostasis. ILCs are involved in various immune defense mechanisms, tissue remodeling, and the regulation of",
               "rationale": "1. Innate lymphoid cells (ILCs) are innate lymphocytes that play important roles in immune defense against microbes, regulation of adaptive immunity, tissue remodeling, and repair and homeostasis of hematopoietic and nonhematopoietic cell types. ILCs are present in all tissues, but they are particularly enriched in mucosal surfaces.\n2. Introduction. Innate lymphoid cells (ILCs) is the collective term for a group of lymphoid cells lacking rearranged antigen-specific receptors [] of which the natural killer (NK) cells are the most well characterized.However, in addition to cytotoxic NK cells, a number of non-cytotoxic, so-called helper ILCs, have been identified, initially in the mouse [2-7] and later also in humans [8-11].\n3. Abstract. Since their discovery, innate lymphoid cells (ILCs) have been described as the innate counterpart of the T cells. Indeed, ILCs and T cells share many features including their common progenitors, transcriptional regulation, and effector cytokine secretion. Several studies have shown complementary and redundant roles for ILCs and T ...\n4. The emplacement of innate lymphoid cells (ILCs) as immune sentinels within mucosal surfaces allows them to survey tissues to help counter inappropriate immune reactions and maintain homeostasis ...\n5. Key Points. Innate lymphoid cells (ILCs) are involved in many inflammatory disorders but appear to be redundant for protective immunity in humans under modern conditions of hygiene and medicine ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do dendritic cells (DCs) and innate lymphoid cells (ILCs) interact with each other in the regulation of intestinal homeostasis?",
               "answer": "Yes, dendritic cells (DCs) and innate lymphoid cells (ILCs) interact with each other in the regulation of intestinal homeostasis. The evidence indicates that ILCs, particularly group 3 innate lymphoid cells (ILC3s), play significant roles in tissue homeostasis and immunity, responding to",
               "rationale": "1. Disruption of leukaemia inhibitory factor production from group 2 innate lymphoid cells prevents immune cells leaving the lungs to migrate to lymph nodes, leading to plasmacytoid dendritic cells ...\n2. Cell Biology and Toxicology (2024) Dendritic cells (DCs) are the key link between innate immunity and adaptive immunity and play crucial roles in both the promotion of immune defense and the ...\n3. ABSTRACT. Group 3 innate lymphoid cells (ILC3s) have emerged as significant regulators of tissue homeostasis, immunity and inflammation through various effector molecules in response to signals within the tissue microenvironment. Multiple signals derived from the tissue microenvironment have been illustrated in recent years, which could either ...\n4. Innate lymphoid cells (ILCs) have emerged as an expanding family of effector cells particularly enriched in the mucosal barriers. ILCs are promptly activated by stress signals and multiple epithelial- and myeloid-cell-derived cytokines. In response, ILCs rapidly secrete effector cytokines, which allow them to survey and maintain the mucosal ...\n5. T cells are an essential element that regulates the balance in immunity, by killing infected cells, helping antibody formation and suppressing autoimmune responses. However, T cells are incapable of recognizing native antigens. Instead, they recognize processed peptides presented by MHC molecules. Dendritic cells (DCs) are professional antigen ...",
               "predicate": null
            }
         ],
         "row": 553,
         "id": 811435368736853827
      },
      {
         "claim": "Cytochrome c is released from the mitochondrial intermembrane space to cytosol during apoptosis.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cytochrome c is located loosely associated with the inner membrane of the mitochondrion during normal cellular function. Cytochrome c is released from mitochondria into the cytosol during apoptosis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the location of cytochrome c during normal cellular function?",
               "answer": "During normal cellular function, cytochrome c is located loosely associated with the inner membrane of the mitochondrion.",
               "rationale": "1. Cytochrome c (Cytc) is essential in mitochondrial electron transport and intrinsic type II apoptosis.Mammalian Cytc also scavenges reactive oxygen species (ROS) under healthy conditions, produces ROS with the co-factor p66 Shc, and oxidizes cardiolipin during apoptosis.The recent finding that Cytc is phosphorylated in vivo underpins a model for the pivotal role of Cytc regulation in making ...\n2. Abstract. Cytochrome c is primarily known for its function in the mitochondria as a key participant in the life-supporting function of ATP synthesis. However, when a cell receives an apoptotic ...\n3. The cytochrome complex, or cyt c, is a small hemeprotein found loosely associated with the inner membrane of the mitochondrion where it plays a critical role in cellular respiration. It transfers electrons between Complexes III (Coenzyme Q - Cyt c reductase) and IV (Cyt c oxidase). Cytochrome c is highly water-soluble, unlike other cytochromes.\n4. Cellular respiration is the process of oxidizing food molecules, like glucose, to carbon dioxide and water. C6H12O6 + 6O2 + 6H2O → 12H2O + 6CO2 (4.5.1) (4.5.1) C 6 H 12 O 6 + 6 O 2 + 6 H 2 O → 12 H 2 O + 6 C O 2. The energy released is trapped in the form of ATP for use by all the energy-consuming activities of the cell.\n5. During apoptosis, cytochrome c is released through the outer mitochondrial membrane (see Figure 1 ). This allows it to interact with Apaf-1 (apoptosis protease activating factor-1), which activates pro-caspase-9. Caspase-9 then triggers other caspases. In other words, ectopic cytochrome c unleashes the killer caspases, which leads to ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Where is cytochrome c released to during apoptosis?",
               "answer": "Cytochrome c is released from mitochondria into the cytosol during apoptosis.",
               "rationale": "1. Release of cytochrome c from mitochondria is a central event in apoptotic signaling. In this study, we utilized a cytochrome c fusion that binds fluorescent biarsenical ligands (cytochrome c-4CYS (cyt. c-4CYS)) as well as cytochrome c-green fluorescent protein (cyt. c-GFP) to measure its release from mitochondria in different cell types during apoptosis.\n2. Goldstein JC, Waterhouse NJ, Juin P, Evan GI and Green DR (2000) The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2 : 156-162.\n3. Release of cytochrome c from mitochondria is a major event during apoptosis. Released cytochrome c has been shown to activate caspase-dependent apoptotic signals. In this report, we provide evidence for a novel role of cytochrome c in caspase-independent nuclear apoptosis. We showed that cytochrome c, released from mitochondria upon apoptosis induction, gradually accumulates in the nucleus as ...\n4. Cytochrome c (Cytc) is a multifunctional protein, acting as an electron carrier in the electron transport chain (ETC), where it shuttles electrons from bc 1 complex to cytochrome c oxidase (COX ...\n5. CA69381/CA/NCI NIH HHS/United States. Release of cytochrome c from mitochondria triggers activation of caspase proteases and death of a cell by apoptosis. However, the mechanism and kinetics of cytochrome c release remain unknown. Here we study this event by using green fluorescent protein (GFP)-tagged cytochrome c, and find that the re ….",
               "predicate": null
            }
         ],
         "row": 554,
         "id": 153586702211636910
      },
      {
         "claim": "Deamination of cytidine to uridine on the minus strand of viral DNA results in catastrophic G-to-A mutations in the viral genome.",
         "label": 1,
         "prediction": 1,
         "rationale": "Deamination of cytidine to uridine is a biochemical process catalyzed by the enzyme cytidine deaminase, involving the irreversible hydrolytic conversion of cytidine into uridine. The deamination of cytidine to uridine contributes to the inhibition of retroviral infection and is vital to host defense mechanisms. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is deamination of cytidine to uridine?",
               "answer": "Deamination of cytidine to uridine is a biochemical process catalyzed by the enzyme cytidine deaminase (CDA). This process involves the irreversible hydrolytic conversion of cytidine (and its deoxy form, deoxycytidine) into uridine (and deoxyuridine, respectively)",
               "rationale": "1. Cytidine deaminase is an enzyme that in humans is encoded by the CDA gene.. This gene encodes an enzyme involved in pyrimidine salvaging. The encoded protein forms a homotetramer that catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. It is one of several deaminases responsible for maintaining the cellular pyrimidine pool.\n2. The deamination of cytidine to uridine contributes, on the one hand, to maintaining nucleotide pool balance for DNA and RNA synthesis. On the other hand, such conversion is also necessary for the catabolism of the pyrimidine cycle, a source of carbon and nitrogen, which results in the formation of β-alanine .\n3. The molecular landmark of CDA is its deaminase function, which catalyzes the transformation of cytidines and deoxycytidines into uridines and deoxyuridines, respectively, 18 by hydrolyzing the amine moiety into ketone with ammonia release (Figure 2). 11 The deamination of cytidine to uridine contributes, on the one hand, to maintaining nucleotide pool balance for DNA and RNA synthesis.\n4. Cytidine deaminase (CDA, cytidine/2′-deoxycytidine aminohydrolase; EC 3.5.4.5, gene map locus 1p36.2-p35) is an enzyme of the pyrimidine salvage pathways, which catalyzes the formation of uridine and 2′-deoxyuridine by hydrolytic deamination of cytidine and 2′deoxycytidine, respectively.\n5. Cytidine deamination results in the generation of uracil-containing viral DNA, which likely becomes targeted by DNA repair/degradation enzymes. ... (APOBEC) family, which can recode both RNA and DNA by changing cytidine and deoxycytidine to uridine and deoxyuridine, respectively (Navaratnam and Sarwar, 2006).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of deamination of cytidine to uridine on the viral genome?",
               "answer": "The deamination of cytidine to uridine has a significant effect on the viral genome as it contributes to the inhibition of retroviral infection. This process is vital to host defense mechanisms, as it diversifies immunoglobulin (Ig) genes and helps in the defense against viral pathogens. The action of cytidine deamin",
               "rationale": "1. The deamination of cytidine to uridine contributes, on the one hand, to maintaining nucleotide pool balance for DNA and RNA synthesis. On the other hand, such conversion is also necessary for the catabolism of the pyrimidine cycle, a source of carbon and nitrogen, which results in the formation of β-alanine ( Figure 2 ).\n2. Abstract Cytidine deamination of nucleic acids underlies diversification of Ig genes and inhibition of retroviral infection, and thus, it would appear to be vital to host defense. The host defense properties of cytidine deamination require two distinct but homologous cytidine deaminases—activation-induced cytidine deaminase and apolipoprotein B-editing cytidine deaminase, subunit 3G ...\n3. The deamination mediated by these enzymes involves the hydrolytic removal of the amino group at the C4 position of a cytidine (C) or deoxycytidine (dC), generating a uridine (U) or deoxyuridine (dU) ( Figure 1) [ 11 ]. Figure 1 Structure and function of human APOBEC proteins. (a) Schematic representation of APOBEC proteins.\n4. The molecular landmark of CDA is its deaminase function, which catalyzes the transformation of cytidines and deoxycytidines into uridines and deoxyuridines, respectively, 18 by hydrolyzing the amine moiety into ketone with ammonia release ( Figure 2 ). 11 The deamination of cytidine to uridine contributes, on the one hand, to maintaining ...\n5. Two major families of polynucleotide editing enzymes, the AID/APOBEC cytidine deaminases (which catalyze the deamination of cytidine to uridine) and the adenosine deaminases acting on RNA (ADARs, which catalyze the deamination of adenosine to inosine), function in a variety of host defense mechanisms.",
               "predicate": null
            }
         ],
         "row": 555,
         "id": 966810323319243932
      },
      {
         "claim": "Deletion of αvβ8 does not result in a spontaneous inflammatory phenotype.",
         "label": 1,
         "prediction": 1,
         "rationale": "αvβ8 is an integrin that functions as a receptor for transforming growth factor β (TGF-β), modulating cell-extracellular matrix (ECM) adhesion and signaling events, particularly in the cancer microenvironment. Deletion of αvβ8 does not result in a spontaneous inflammatory phenotype. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is αvβ8?",
               "answer": "Integrin αvβ8 is a type of integrin that functions as a receptor for transforming growth factor β (TGF-β). It plays a crucial role in modulating cell-extracellular matrix (ECM) adhesion and signaling events, particularly in the cancer microenvironment. αvβ8 integrin",
               "rationale": "1. Integrin αvβ8 modulates cell-ECM adhesion and signaling events in the cancer microenvironment. αvβ8 integrin expressed in cancer cells (shown here is an example of the brain cancer GBM) mediates the activation of ECM-bound latent TGFβs in the tumor microenvironment. Active TGFβ subsequently engages with its receptors to coordinately ...\n2. αvβ8 integrin in CNS development. The brain is the most vascularized organ in the mammalian body with its complex network of blood vessels that interact with neurons and glia in multicellular complexes termed neurovascular units (Paredes et al., 2018).Growth factors, ECM proteins and adhesion receptors regulate communication between cells of the neurovascular unit in a coordinated manner to ...\n3. Integrin αvβ8 is a receptor for TGF-β, which activates TGF-β signal transduction by binding with TGF-β. 73 Integrin αvβ8-mediated TGF-β activation is involved in regulating neurovascular ...\n4. αvβ8 integrin, a key activator of transforming growth factor β (TGF-β), inhibits anti-tumor immunity. We show that a potent blocking monoclonal antibody against αvβ8 (ADWA-11) causes growth suppression or complete regression in syngeneic models of squamous cell carcinoma, mammary cancer, colon cancer, and prostate cancer, especially when combined with other immunomodulators or ...\n5. Integrin αVβ8, which like αVβ6 functions to activate TGF-βs, is atypical. Its β8 subunit binds to a distinctive cytoskeleton adaptor and does not exhibit large changes in conformation upon ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does deletion of αvβ8 result in a spontaneous inflammatory phenotype?",
               "answer": "No, deletion of αvβ8 does not result in a spontaneous inflammatory phenotype. The evidence indicates that Treg-cell-specific deletion of integrin αvβ8 does not lead to spontaneous inflammation, suggesting that this pathway is not crucial for the maintenance of immune homeostasis.",
               "rationale": "1. Treg-cell-specific deletion of integrin αvβ8 did not result in a spontaneous inflammatory phenotype, suggesting that this pathway is not important in Treg-cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin αvβ8 were unable to suppress pathogenic T cell responses during active inflammation.\n2. Treg-cell-specific deletion of integrin αvβ8 did not result in a spontaneous inflammatory phenotype, suggesting that this pathway is not important in Treg-cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin αvβ8 were unable to suppress pathogenic T cell responses during active inflammation.\n3. Treg-specific deletion of αvβ8 inhibits suppression of T cell-dependent inflammation in a transfer colitis model, but does not result in a spontaneous inflammatory phenotype, probably because immune suppression by Tregs is regulated by an αvβ8-independent pathway during homeostasis\n4. In this Review, I will summarize adhesion and signaling functions for a specific integrin, αvβ8, in development, physiology and disease. αvβ8 integrin is a member of the αv subfamily of integrins, which comprises αvβ1, αvβ3, αvβ5 and αvβ6 (Weis and Cheresh, 2011).These integrins bind with high specificity to RGD peptide, a motif that is present in many ECM proteins, including ...\n5. factor-b(TGF-b). Treg-cell-speciﬁc deletion of integ-rin avb8 did not result in a spontaneous inﬂamma-tory phenotype, suggesting that this pathway is not important in Treg-cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin avb8 were unable to suppress",
               "predicate": null
            }
         ],
         "row": 556,
         "id": 107088240248879927
      },
      {
         "claim": "Dexamethasone decreases risk of postoperative bleeding.",
         "label": 0,
         "prediction": 0,
         "rationale": "Dexamethasone is a corticosteroid medication that reduces inflammation and immune response, used to treat various conditions including allergies, skin disorders, asthma, arthritis, cancer, and adrenal insufficiency. Dexamethasone may increase the risk of postoperative bleeding rather than decrease it. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Dexamethasone?",
               "answer": "Dexamethasone is a corticosteroid medication that reduces inflammation and immune response. It is used to treat various conditions, including allergies, skin disorders, asthma, arthritis, cancer, and adrenal insufficiency. It can also be used in the treatment of COVID-19 and other severe allergic reactions. Dexamethas",
               "rationale": "1. Dexamethasone is a corticosteroid that prevents inflammation and treats various conditions such as allergies, skin disorders, and breathing problems. Learn about the warnings, interactions, and how to take dexamethasone safely and effectively.\n2. Dexamethasone is a steroid medication that can treat inflammation, allergic reactions, adrenal insufficiency, and other conditions. Learn about its side effects, interactions, warnings, and how it works for COVID-19.\n3. Dexamethasone is a corticosteroid drug that reduces inflammation and immune response. It is used to treat various conditions such as arthritis, asthma, cancer, and allergies, but it can also cause serious side effects and interactions.\n4. Dexamethasone is a corticosteroid that reduces inflammation, allergic reactions, and immune system activity. It is used to treat various conditions, such as asthma, arthritis, multiple sclerosis, and multiple myeloma.\n5. Dexamethasone is a fluorinated glucocorticoid medication used to treat rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, superior vena cava syndrome (a complication of some forms of cancer), and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it may be used ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Dexamethasone decrease the risk of postoperative bleeding?",
               "answer": "The evidence suggests that dexamethasone may increase the bleeding risk through inhibition of wound healing, as noted in point 3. Therefore, it is uncertain whether dexamethasone decreases the risk of postoperative bleeding. In fact, the evidence implies a potential increase in bleeding risk rather than a decrease.",
               "rationale": "1. The mechanism of action of dexamethasone for postoperative nausea and vomiting is poorly understood, but it is likely to result from both nongenomic and genomic anti-inflammatory actions. 2-6 Surgery typically includes tissue injury and induces an inflammatory response, 7,8 both of which result in postoperative pain. Corticosteroids have potent anti-inflammatory actions that likely mitigate ...\n2. The rate of the primary outcome ranged from 15% to 25% in recent studies. 3 4 20 24 In studies including participants at high risk of postoperative complications, dexamethasone was associated with a relative reduction in mortality of 20%, 25 respiratory complications of 31% to 53%, 14 and wound infection of 20%. 16 We thus hypothesised that ...\n3. As there is some evidence that dexamethasone may increase the bleeding risk through inhibition of wound healing, 8 any case of reoperation due to bleeding, rehospitalisation due to bleeding or need for blood transfusion within 30 days postoperatively was recorded. Finally, signs of infection (culture of surgical site, antibiotic treatment ...\n4. A single dose of dexamethasone probably does not increase the risk for postoperative infection. It is uncertain whether dexamethasone has an effect on delayed wound healing in the general surgical population owing to imprecision in trial results. ... A single dose of 4 mg of dexamethasone has been shown to decrease the time to discharge after ...\n5. Background: In the perioperative period, dexamethasone is widely and effectively used for prophylaxis of postoperative nausea and vomiting (PONV), for pain management, and to facilitate early discharge after ambulatory surgery.Long-term treatment with steroids has many side effects, such as adrenal insufficiency, increased infection risk, hyperglycaemia, high blood pressure, osteoporosis, and ...",
               "predicate": null
            }
         ],
         "row": 557,
         "id": 176365623904647585
      },
      {
         "claim": "Diabetic patients with acute coronary syndrome experience increased short-term and long-term risk for bleeding events.",
         "label": 1,
         "prediction": 0,
         "rationale": "The relationship between diabetes and bleeding events in patients with acute coronary syndrome is not explicitly detailed in the provided evidence. The provided evidence does not directly address whether diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients. The risk of bleeding events in diabetic patients with acute coronary syndrome compared to non-diabetic patients is not directly addressed by the provided evidence. The provided evidence does not directly address whether diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients. The provided evidence does not directly address whether diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between diabetes and bleeding events in patients with acute coronary syndrome?",
               "answer": "The provided evidence does not explicitly detail the relationship between diabetes and bleeding events in patients with acute coronary syndrome (ACS). However, it does mention that in post-ACS patients with a high risk of ischemic events and without bleeding risk, certain antithrombotic therapies, such as aspirin and low-dose Ticagrel",
               "rationale": "1. Background. Acute coronary syndrome (ACS) is the acute manifestation of ischemic heart disease. Despite optimal antithrombotic therapies and timely revascularization, ACS remains a major cause of morbidity and mortality worldwide, and can lead to the development of de novo acute heart failure (HF) or worsening of chronic HF. 1 Diabetes mellitus (DM) is a complex, chronic metabolic disease ...\n2. Introduction. Within the last 2 decades, the number of patients with diabetes quadrupled from 108 million to 422 million in 2014. 1 It is estimated that the burden of diabetes will continue to grow owing to the increase in the prevalence of obesity, high caloric diet, and physical inactivity worldwide. The link between diabetes and cardiovascular disease is strong as diabetes increases the ...\n3. Factors promoting increased incidence and poorer outcomes of acute coronary syndromes in patients with diabetes. ... In post ACS patients with a high risk of ischemic events and without bleeding risk, when therapy is continued without interruption or with short interruption after ACS, aspirin, and low dose of Ticagrelor is preferred ...\n4. Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients with diabetes mellitus. 1-3 Patients with diabetes are more likely to experience acute myocardial infarction (AMI) and heart failure, and are at greater risk for dying after an acute cardiac event, than patients without diabetes. 4-14 These differences may ...\n5. Numerous trials have demonstrated a worse outcome for diabetic patients with acute coronary syndromes (ACS) compared with their nondiabetic counterparts. 1 Because our knowledge of the influence of diabetes mellitus on ACS outcomes is based on subgroup analyses of randomized trials that are often post hoc and underpowered, most clinicians have not entertained the concept that we might consider ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients?",
               "answer": "The provided evidence snippets do not directly address the risk of bleeding events in diabetic patients with acute coronary syndrome (ACS) compared to non-diabetic patients. However, they highlight the increased overall risk associated with diabetes in the context of ACS and the challenges in managing these patients. \n\nWhile it is known that diabetic patients often have",
               "rationale": "1. European guidelines on the management of chronic coronary syndromes recommend the continuation of more aggressive antithrombotic therapy beyond 12 months in patients at high risk of ischemic events (class IIa) or a moderate risk (class IIb) who have well-tolerated DAPT in the first year after MI, suggesting in addition to Aspirin 75-100 mg /d ...\n2. Introduction. Within the last 2 decades, the number of patients with diabetes quadrupled from 108 million to 422 million in 2014. 1 It is estimated that the burden of diabetes will continue to grow owing to the increase in the prevalence of obesity, high caloric diet, and physical inactivity worldwide. The link between diabetes and cardiovascular disease is strong as diabetes increases the ...\n3. Background. Acute coronary syndromes (ACS) in diabetic patients are associated with increased overall risk compared to the general ACS population despite unquestionable advances in treating these patients [].Most patients are treated with percuatenous intervention (PCI) with stent implantation [] while a minority are referred for coronary artery bypass grafting (CABG).\n4. Abstract. Type 2 diabetes mellitus (T2DM) and its complications are seriously affecting public health worldwide. Myocardial infarction (MI) is the primary cause of death in patients with T2DM. T2DM patients without a history of coronary artery disease (CAD) have the same risk of major coronary events as those with CAD; T2DM patients with a ...\n5. Background. Acute coronary syndrome (ACS) is the acute manifestation of ischemic heart disease. Despite optimal antithrombotic therapies and timely revascularization, ACS remains a major cause of morbidity and mortality worldwide, and can lead to the development of de novo acute heart failure (HF) or worsening of chronic HF. 1 Diabetes mellitus (DM) is a complex, chronic metabolic disease ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients?",
               "answer": "The provided evidence snippets do not directly address the risk of bleeding events in diabetic patients with acute coronary syndrome (ACS) compared to non-diabetic patients. While the evidence highlights that diabetic patients with ACS have a greater prevalence of cardiovascular risk factors, receive different treatments, and experience worse outcomes, it does not specifically mention bleeding events",
               "rationale": "1. The results of this large multinational observational study suggest that diabetic patients with an ACS present with a greater prevalence of cardiovascular risk factors, receive different treatments, and have a higher rate of adverse hospital outcomes than patients without diabetes.\n2. In the past decade advancement in both percutaneous coronary intervention (PCI) and coronary artery by-pass graft (CABG) techniques and more potent antiplatelet drugs like prasugrel and ticagrelor improved outcomes of diabetic patients with ACS, but this population still experiences worse outcomes compared to non-diabetic patients.\n3. The global prevalence of diabetes mellitus (DM) has led to a pandemic, with significant microvascular and macrovascular complications including coronary artery disease (CAD), which worsen clinical outcomes and cardiovascular prognosis. Patients with both acute coronary syndrome (ACS) and DM have worse prognosis and several pathophysiologic ...\n4. Patients with ESKD may experience a higher risk of acute coronary syndrome, mortality rate, and have worse prognosis after myocardial infarction (MI) than non‐ESKD patients (Dai et al., 2017). Therefore, detecting CAD early in diabetics and ESKD patients is critical and beneficial in order to alleviate mortality and morbidity in these patients.\n5. A study by Li et al. including 4,419 patients with diabetes and chronic coronary syndrome from the PRospective Observational Multi-center cohort for ISchemic and hEmorrhage risk in coronary artery ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Do diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients?",
               "answer": "The provided evidence snippets do not directly address the risk of bleeding events in diabetic patients with acute coronary syndrome (ACS) compared to non-diabetic patients. However, they highlight the increased overall risk associated with ACS in diabetic patients and the complexities of managing these patients. \n\nTo determine whether diabetic patients have a higher risk of bleeding",
               "rationale": "1. European guidelines on the management of chronic coronary syndromes recommend the continuation of more aggressive antithrombotic therapy beyond 12 months in patients at high risk of ischemic events (class IIa) or a moderate risk (class IIb) who have well-tolerated DAPT in the first year after MI, suggesting in addition to Aspirin 75-100 mg /d ...\n2. Introduction. Within the last 2 decades, the number of patients with diabetes quadrupled from 108 million to 422 million in 2014. 1 It is estimated that the burden of diabetes will continue to grow owing to the increase in the prevalence of obesity, high caloric diet, and physical inactivity worldwide. The link between diabetes and cardiovascular disease is strong as diabetes increases the ...\n3. Background There are limited data describing the presenting characteristics, management, and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS).. Objective To examine differences in these factors, patients with ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction, and unstable angina were enrolled in a large ...\n4. Background. Acute coronary syndromes (ACS) in diabetic patients are associated with increased overall risk compared to the general ACS population despite unquestionable advances in treating these patients [].Most patients are treated with percuatenous intervention (PCI) with stent implantation [] while a minority are referred for coronary artery bypass grafting (CABG).\n5. Abstract. Type 2 diabetes mellitus (T2DM) and its complications are seriously affecting public health worldwide. Myocardial infarction (MI) is the primary cause of death in patients with T2DM. T2DM patients without a history of coronary artery disease (CAD) have the same risk of major coronary events as those with CAD; T2DM patients with a ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Do diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients?",
               "answer": "The provided evidence snippets do not directly address whether diabetic patients with acute coronary syndrome have a higher risk of bleeding events compared to non-diabetic patients. However, snippet 3 mentions that there were no significant differences in cardiovascular events or major bleeding between patients assigned to different doses of aspirin, which suggests that the risk of major bleeding",
               "rationale": "1. European guidelines on the management of chronic coronary syndromes recommend the continuation of more aggressive antithrombotic therapy beyond 12 months in patients at high risk of ischemic events (class IIa) or a moderate risk (class IIb) who have well-tolerated DAPT in the first year after MI, suggesting in addition to Aspirin 75-100 mg /d ...\n2. Background There are limited data describing the presenting characteristics, management, and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS).. Objective To examine differences in these factors, patients with ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction, and unstable angina were enrolled in a large ...\n3. 10.21 In patients with diabetes at higher risk, ... is reasonable for a year after an acute coronary syndrome and may have benefits beyond this period. A. ... there were no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily . In the U.S., the most ...\n4. Introduction. Within the last 2 decades, the number of patients with diabetes quadrupled from 108 million to 422 million in 2014. 1 It is estimated that the burden of diabetes will continue to grow owing to the increase in the prevalence of obesity, high caloric diet, and physical inactivity worldwide. The link between diabetes and cardiovascular disease is strong as diabetes increases the ...\n5. Introduction. Over the past few decades, clinical trials have indicated that patients with diabetes and coronary artery disease (CAD) have suboptimal outcomes after revascularisation when compared with patients without diabetes1.Patients with diabetes typically exhibit disruptions in metabolic processes that can potentially contribute to increased platelet reactivity, leading to early ...",
               "predicate": null
            }
         ],
         "row": 558,
         "id": 195131238782025909
      },
      {
         "claim": "Enhanced early production of inflammatory chemokines improves viral control in the lung.",
         "label": 1,
         "prediction": 1,
         "rationale": "Inflammatory chemokines play a crucial role in directing leukocyte recruitment into infected or damaged tissues during processes such as infection and inflammation. Enhanced early production of inflammatory chemokines may play a crucial role in controlling viral infections, but the relationship between this and viral control is complex. The provided evidence does not directly indicate whether enhanced early production of inflammatory chemokines in the lung reduces viral load. The early production of inflammatory chemokines in the lung improves the clearance of respiratory pathogens. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the context of the claim about inflammatory chemokines?",
               "answer": "The context of the claim about inflammatory chemokines is that they play a crucial role in directing leukocyte recruitment into infected or damaged tissues during processes such as infection and inflammation. Inflammatory chemokines are produced in large quantities in response to various infectious and inflammatory stimuli, highlighting their importance in coordinating immune responses and regulating interactions",
               "rationale": "1. Chemokines are a large family of small secreted proteins that have fundamental roles in organ development, normal physiology, and immune responses upon binding to their corresponding receptors. The primary functions of chemokines are to coordinate and recruit immune cells to and from tissues and to participate in regulating interactions between ...\n2. Infection, inflammation, and immunopathology. Chemokines, along with an array of other proteins, peptides, lipids, and microbial products, direct leukocyte recruitment into infected or damaged tissues 66, 285. Many chemokines are highly inducible and produced in large quantities in response to a broad array of infectious and inflammatory stimuli.\n3. During tumorigenesis, chemokines regulate the activation, recruitment, phenotype, and function of immune cells within the TME. Therefore, chemokines and their receptors have a significant impact on the quality of pro- and anti-tumorigenic immune responses. Figure 1 Chemokines in pro-tumor immunity. Show full caption.\n4. For the past twenty years, chemokines have emerged as a family of critical mediators of cell migration during immune surveillance, development, inflammation and cancer progression. Chemokines bind ...\n5. Chemokines are generally categorized as homeostatic and inflammatory chemokines or receptors based on their major in vivo functionalities. 3,11 However, some chemokines and GPCRs display both ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does enhanced early production of inflammatory chemokines improve viral control in the lung during infection?",
               "answer": "The provided evidence suggests that chemokines play a crucial role in the immune response during viral infections, including COVID-19. While chemokines are essential mediators of inflammation and contribute to controlling viral infections, the relationship between enhanced early production of inflammatory chemokines and viral control is complex. \n\nEvidence point 1",
               "rationale": "1. 4. Summary and outlook. Chemokines and their receptors are vital players during an immune response, yet tight regulation of their functions is mandated to prevent excessive inflammation. In COVID-19 patients, chemokines serve various roles in the different phases of the disease.\n2. Potential mechanisms include high rates of viral replication that could be responsible for enhanced host cell cytolysis and the strong production of inflammatory cytokines and chemokines by infected epithelial cells and the delayed induction of antiviral IFN responses owing to virus escape mechanisms such as the production of IFN inhibitory ...\n3. Recognition of viral genome during infection plays an important role in limiting virus replication at the early stages of infection. During the process, the Nod-like receptor family, pyrin domain-containing 3 (NLRP3), is activated . Currently, there is a gap in knowledge regarding the host innate immune response to SARS-CoV-2.\n4. Genetic variants of chemokines and receptors in viral infection. ... in lung inflammation, and CCL2 ... changes that activate their associated genes during early inflammatory responses ...\n5. Chemokines are essential mediators of inflammation and important for control of viral infections. The profile of chemokine expression contributes to shaping the immune response during viral infection, whereas viral subversion of the chemokine system allows the virus to evade antiviral activities of the host.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does enhanced early production of inflammatory chemokines in the lung reduce viral load?",
               "answer": "The provided evidence does not directly indicate whether enhanced early production of inflammatory chemokines in the lung reduces viral load. While it mentions that chemokines play a role in immune responses and that regulatory cytokine activity can hamper the clearance of respiratory pathogens, it does not explicitly state the relationship between the early production of inflammatory chem",
               "rationale": "1. Abstract. Chemokines are a large family of small secreted proteins that have fundamental roles in organ development, normal physiology, and immune responses upon binding to their corresponding receptors. The primary functions of chemokines are to coordinate and recruit immune cells to and from tissues and to participate in regulating ...\n2. Potential mechanisms include high rates of viral replication that could be responsible for enhanced host cell cytolysis and the strong production of inflammatory cytokines and chemokines by infected epithelial cells and the delayed induction of antiviral IFN responses owing to virus escape mechanisms such as the production of IFN inhibitory ...\n3. Chemokines in the generation, delivery, and function of pro- and anti-tumor immune cells. Tumors develop from normal cells through the acquisition of genetic changes that enable their uncontrolled proliferation (Hanahan and Weinberg, 2011).Tumor progression is often supported by tissue-resident immune cells, fibroblasts, endothelial cells, and neurons that are co-opted by cancer for its benefit.\n4. Fig. 2. Regulatory cytokine function during respiratory infection. a Regulatory cytokine activity can hamper clearance of respiratory pathogens. Influenza A virus (IAV) increases expression of ...\n5. In these responses, chemokines are secreted downstream of the cellular recognition of pathogen-associated molecules and the first wave of production of inflammatory cytokines, such as interleukin-1.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does the early production of inflammatory chemokines in the lung improve the clearance of respiratory pathogens?",
               "answer": "Yes, the early production of inflammatory chemokines in the lung improves the clearance of respiratory pathogens. The evidence indicates that inflammatory monocytes are recruited to the lungs in response to chemokines such as CCL7 and CCL2, and these monocytes play a central role in pathogen clearance. Additionally, their recruitment",
               "rationale": "1. Inflammatory monocytes are recruited to the lungs of infected mice in response to CCL7 and CCL2 (Ref. 24,86) and play a central role in pathogen clearance. Recruited monocytes can serve as a major secondary source of cytokines including type I IFNs, TNF and IL-6, and their recruitment enhances subsequent neutrophil recruitment to the lung 87 , 88 .\n2. The early innate immune response not only shapes the adaptive immune response but also determines the extent of the damage to the lungs and upper respiratory tract. The initial damage caused by the innate immune response may have adverse effects after viral clearance like increased susceptibility for bacterial superinfections.\n3. Fig. 2. Regulatory cytokine function during respiratory infection. a Regulatory cytokine activity can hamper clearance of respiratory pathogens. Influenza A virus (IAV) increases expression of ...\n4. Abstract. Pulmonary epithelial cells are widely considered to be the first line of defence in the lung and are responsible for coordinating the innate immune response to injury and subsequent repair. Consequently, epithelial cells communicate with multiple cell types including immune cells and fibroblasts to promote acute inflammation and ...\n5. Respiratory epithelial cells have an essential important role in the initial recognition and amplitude of the inflammatory responses to microbial pathogens through activation of TLRs and receptors ...",
               "predicate": null
            }
         ],
         "row": 559,
         "id": 161421708908481523
      },
      {
         "claim": "Epigenetic modulating agents (EMAs) modulate antitumor immune response in a cancer model system.",
         "label": 1,
         "prediction": 1,
         "rationale": "Epigenetic modulating agents (EMAs) are therapeutic agents that target and modify epigenetic alterations in cancer cells to restore immunological fitness and enhance treatment outcomes by altering the expression of genes involved in tumor biology. Epigenetic modifying agents (EMAs) can modulate the antitumor immune response in a cancer model system. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are Epigenetic modulating agents (EMAs)?",
               "answer": "Epigenetic modulating agents (EMAs) are therapeutic agents that target and modify epigenetic alterations in cancer cells. They are being utilized as anti-neoplastic and immunomodulatory agents to restore immunological fitness and enhance treatment outcomes. EMAs work by altering the expression of genes involved in tumor biology, such as",
               "rationale": "1. Epigenetic alterations are central to cancer cell biology and cancer immune evasion. Accordingly, epigenetic modulating agents (EMAs) are being exploited as anti-neoplastic and immunomodulatory agents to restore immunological fitness.\n2. Epigenetic alterations are central to cancer cell biology and cancer immune evasion. Accordingly, epigenetic modulating agents (EMAs) are being exploited as anti-neoplastic and immunomodulatory agents to restore immunological fitness. By simultaneously acting on cancer cells, e.g. by changing expression of tumor antigens, immune checkpoints ...\n3. Epigenetic modulators thus serve to transduce signals from environmental agents, injury, inflammation, ageing and other cellular stressors towards modifiers to alter the chromatin states at tumour ...\n4. Unlike genetic changes, epigenetic changes are reversible, and by modulating these epigenetic marks, it is possible to restore normal gene expression patterns. For example, by targeting epigenetic marks, it is possible to inhibit tumor growth and reverse drug resistance, leading to enhanced treatment outcomes [ 3 ].\n5. Targeting epigenetic modifications is an effective cancer therapeutic approach and can be combined with other therapeutics for maximal effect.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do Epigenetic modulating agents (EMAs) modulate antitumor immune response in a cancer model system?",
               "answer": "Yes, epigenetic modifying agents (EMAs) can modulate the antitumor immune response in a cancer model system. The evidence indicates that EMAs enhance various aspects of the immune response against tumors, such as boosting tumor antigen expression, improving antigen processing, increasing the display of cancer/testis antigens (CT",
               "rationale": "1. Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also in the activation, differentiation and effector function(s) of immune cells. In this review, we summarize current literature related to epigenomic dynamics in immune cells impacting immune cell fate and fu …\n2. Epigenetic modifying agents can enhance multiple aspects of an antitumor immune response. EMAs may boost tumor antigen expression, endogenous antigen processing, increase surface CTA display in context of MHC molecules, and boost presentation to T cells by increasing expression of co-stimulatory molecules. EMAs may also enhance both cellular ...\n3. Cancer-Immunity Cycle and Cancer Immunotherapy. The human immune system should theoretically be capable of eradicating cancer cells through an acquired immune response executed by T cells. A series of stepwise events, called the 'cancer-immunity cycle', is required for tumor cell clearance by the immune system (Figure 2). This self ...\n4. The ability to evade destruction by the immune system is a cancer hallmark ... Epigenetic modifying agents (EMAs) can enhance multiple aspects of the antitumor immune response. Full size image ...\n5. Recent studies have shown that epigenetic regulation affects all cancer hallmarks, including all aspects of the interaction between tumor cells and the immune system. As a result, epigenetic modulation can elicit robust antitumor immune responses. Although some changes are broad, others are more restricted to certain cells and/or tissues.",
               "predicate": null
            }
         ],
         "row": 560,
         "id": 282758709750687311
      },
      {
         "claim": "Errors in peripheral IV drug administration are most common during bolus administration and multiple-step medicine preparations.",
         "label": 1,
         "prediction": 1,
         "rationale": "The most common time for errors in peripheral IV drug administration to occur is not specified. The most common time for errors in peripheral IV drug administration to occur is during the medication administration phase. The most common type of administration during which errors in peripheral IV drug administration occur is related to the wrong intravenous rate, specifically the administration of intravenous drugs at a faster rate than recommended. The most common type of administration during which errors in peripheral IV drug administration occur is during the administration stage. The most common type of administration during which errors in peripheral IV drug administration occur is the Direct Intermittent Injection (Intravenous Push or Bolus) method. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the most common time for errors in peripheral IV drug administration to occur?",
               "answer": "The provided evidence snippet suggests that there may be a correlation between the incidence of errors in peripheral IV drug administration and the time of day (day versus night) or the day of the week (weekday versus weekend). However, it does not specify which time is the most common for errors to occur. Therefore, based on the",
               "rationale": "1. To determine the type and frequency of errors associated with prescribing, documenting, and administering IV infusions, and to also determine if a correlation exists between the incidence of errors and either the time of day (day versus night) or the day of the week (weekday versus weekend) in an academic medicosurgical intensive care unit ...\n2. Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care 2010;19:341-5.\n3. Systemic errors were identified most frequently during medication administration, prescribing and preparation, with common errors involving knowledge gaps, calculation errors, failure to double-check, and confusion between look-alike, sound-alike medications. More research focused on IV medication safety is needed.\n4. Identify and gain consensus on the most common risks associated with IV push administration of medications to adults. Standardize and simplify the safe administration of parenteral medications to adults through the IV push administration route. Develop and communicate safe practices associated with the use of IV push medications for adults.\n5. Preparation and intravenous (IV) administration of medications is a crucial clinical activity in provision of health care for hospitalized patients. 1, 2 In health care systems, the medication administration processes represent an advanced technology and a complex process. 3, 4 Infusion therapy is one of the medication administration processes ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the most common time for errors in peripheral IV drug administration to occur during the process of administration?",
               "answer": "The most common time for errors in peripheral IV drug administration to occur during the process is during the medication administration phase. This is supported by evidence indicating that systemic errors were most frequently identified during medication administration, as well as the mention that preparation and administration errors are the most common types of IV medication errors.",
               "rationale": "1. Clinical intravenous errors. Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable Drugs Handbook (AIDH).15 Administration of intravenous bolus or intravenous infusion ≥15% faster than recommended.. Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable Drugs Handbook (AIDH).15\n2. Although only a few medications are administered IV in the hospital setting, the IV drugs account for the majority of medication errors. 15, 16 A high incidence of medication errors related to IV therapy was found in Germany, where 23% of the total medication errors occur during IV administration. 16, 17 In Ethiopia, the prevalence of ...\n3. The DRPs seen in our study population receiving IV medications were incompatibilities, rate of administration errors, dilution errors, and complications. Incompatibilities were dominant than all other DRPs. Among the 110 patients, nearly half of the patients (46.3%, n = 51) were reported with DRPs.\n4. Intravenous (IV) medication administration errors can cause severe patient harm. In this systematic review, researchers identified eleven studies characterizing the systemic causes of in-hospital IV medication errors. Systemic errors were identified most frequently during medication administration, prescribing and preparation, with common errors involving knowledge gaps, calculation errors ...\n5. Studies have found preparation and administration errors to be the most common IV ME types, probably due to these phases of the MMU process being the most widely studied. 4,16,17 However, the number of IV prescribing errors is likely to be higher as, when also considering other administration routes, prescribing and monitoring are associated ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the most common type of administration during which errors in peripheral IV drug administration occur?",
               "answer": "The most common type of administration during which errors in peripheral IV drug administration occur is related to the wrong intravenous rate, specifically the administration of intravenous drugs at a faster rate than recommended.",
               "rationale": "1. Here are a few examples of the benefits of preventing medication errors in nursing. 1. Increased Patient Safety: The ethical imperative for all patient safety efforts is, \"First, do no harm.\" When nurses implement safe nursing practices, including measures to decrease medication errors, patient safety increases. 2.\n2. Dispensing. Administering. Monitoring. Medication errors most commonly occur during the prescribing, ordering, and administration stages. Nearly 50% of all medication errors occur when a medication is prescribed or ordered. Studies reveal that nurses and pharmacists identify 30% to 70% of medication-ordering errors.\n3. Medication administration errors are typically thought of as a failure in one of the five \"rights\" of medication administration (right patient, medication, time, dose, and route). These five \"rights\" have been historically incorporated into the nursing curriculum as the standard processes to ensure safe medication administration.\n4. Clinical intravenous errors. Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable Drugs Handbook (AIDH).15 Administration of intravenous bolus or intravenous infusion ≥15% faster than recommended.. Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable Drugs Handbook (AIDH).15\n5. Medication reconciliation is a process that involves (1) verification of the patient's medication history, (2) clarification that the medications are appropriate for the patient, and (3) reconciliation of any discrepancies. 40. Medication reconciliation has received much attention from health care organizations.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the most common type of administration during which errors in peripheral IV drug administration occur in terms of the method of administration?",
               "answer": "The most common type of administration during which errors in peripheral IV drug administration occur, based on the provided evidence snippet, is during the \"administration\" stage. This is highlighted in point 3, which states that medication errors most commonly occur during the prescribing, ordering, and administration stages, with a significant portion of errors",
               "rationale": "1. You are given the order to administer 0.01 mg/kg of epinephrine, 1:1000, IM to a 35-pound pediatric patient. Epinephrine 1:1000 is supplied in a concentration of 1 mg/mL. The correct dosage for this patient would be: 0.16 mL. A route of drug administration is a way in which the drug gains access to the body.\n2. Here are a few examples of the benefits of preventing medication errors in nursing. 1. Increased Patient Safety: The ethical imperative for all patient safety efforts is, \"First, do no harm.\" When nurses implement safe nursing practices, including measures to decrease medication errors, patient safety increases. 2.\n3. Dispensing. Administering. Monitoring. Medication errors most commonly occur during the prescribing, ordering, and administration stages. Nearly 50% of all medication errors occur when a medication is prescribed or ordered. Studies reveal that nurses and pharmacists identify 30% to 70% of medication-ordering errors.\n4. The median age was 30 with IQR (28-34) years and the majority of them (83.8%) had BSc qualification in nursing. The prevalence of MAE in this study was 57.7% and 30.4% of them made it more than three times. Wrong time (38.6%), wrong assessment (27.5%), and wrong evaluation (26.1%) were the most frequently perpetuated medication administration ...\n5. Clinical intravenous errors. Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable Drugs Handbook (AIDH).15 Administration of intravenous bolus or intravenous infusion ≥15% faster than recommended.. Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable Drugs Handbook (AIDH).15",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the most common type of administration during which errors in peripheral IV drug administration occur in terms of the method of administration, such as bolus or multiple-step medicine preparations?",
               "answer": "The most common type of administration during which errors in peripheral IV drug administration occur is likely during the **Direct Intermittent Injection (Intravenous Push or Bolus)** method. This method is specifically mentioned in the context of intravenous administration and is associated with the potential for errors, as indicated by the information provided about medication",
               "rationale": "1. You are given the order to administer 0.01 mg/kg of epinephrine, 1:1000, IM to a 35-pound pediatric patient. Epinephrine 1:1000 is supplied in a concentration of 1 mg/mL. The correct dosage for this patient would be: 0.16 mL. A route of drug administration is a way in which the drug gains access to the body.\n2. Clinical intravenous errors. Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable Drugs Handbook (AIDH).15 Administration of intravenous bolus or intravenous infusion ≥15% faster than recommended.. Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable Drugs Handbook (AIDH).15\n3. Medication errors are the most common and preventable cause of patient injury.[1] These errors typically involve administering the wrong drug or dose, using the wrong route, administering it incorrectly, or giving medication to the wrong patient. The reported incidence of medication errors in acute hospitals is approximately 6.5 per 100 admissions.[1]\n4. Peripheral venous cannulation, among the most common medical procedures, has revolutionized the practice of medicine. Peripheral intravenous (IV) catheters allow for the safe infusion of medications, hydration fluids, blood products, and nutritional supplements. First-time success rate for peripheral IV placement ranges from 65 to 86 percent [ 1 ].\n5. 10. After Administration of an IV Medicine 14 11. Methods of Intravenous Administration 11.1 Direct Intermittent Injection (Intravenous Push or Bolus) 11.2 Peripheral Intravenous Administration 11.3 Administration via a Central Venous Line 15 15 15 12. Complications of Intravenous Drug Administration 12.1 Infiltration or Tissuing",
               "predicate": null
            }
         ],
         "row": 561,
         "id": 265722866560684312
      },
      {
         "claim": "Exposure to fine particulate air pollution is relate to anxiety prevalence.",
         "label": 1,
         "prediction": 1,
         "rationale": "Exposure to fine particulate air pollution is related to anxiety prevalence, with higher exposure to PM2.5 associated with increased symptoms of anxiety. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is exposure to fine particulate air pollution related to anxiety prevalence?",
               "answer": "Yes, exposure to fine particulate air pollution (PM2.5) is related to anxiety prevalence. The evidence indicates that higher exposure to PM2.5 is associated with increased symptoms of anxiety, particularly with more recent exposures being more relevant. Additionally, the systematic review mentioned suggests a growing interest in the potential link between particulate",
               "rationale": "1. Exposure to fine particulate matter (PM2.5) was associated with high symptoms of anxiety, with more recent exposures potentially more relevant than more distant exposures. Research evaluating whether reductions in exposure to ambient PM2.5 would reduce the population level burden of clinically relev …\n2. Objective To determine whether higher past exposure to particulate air pollution is associated with prevalent high symptoms of anxiety.Design Observational cohort study.Setting Nurses' Health Study.Participants 71 271 women enrolled in ...\n3. Background: Particulate air pollution's physical health effects are well known, but associations between particulate matter (PM) exposure and mental illness have not yet been established. However, there is increasing interest in emerging evidence supporting a possible etiological link. Objectives: This systematic review aims to provide a comprehensive overview and synthesis of the ...\n4. The causes of the development of depression and anxiety involve a variety of genetic and environmental factors, of which ambient air pollution, particularly particulate matter exposure, maybe a prominent issue.\n5. Background Recent epidemiological evidence suggests associations between air pollution exposure and major depressive disorders, but the literature is inconsistent for other mental illnesses. We investigated the associations of several air pollutants and road traffic noise with the incidence of different categories of mental disorders in a large population-based cohort.",
               "predicate": null
            }
         ],
         "row": 562,
         "id": 180921821668817689
      },
      {
         "claim": "Female carriers of the Apolipoprotein E4 (APOE4) allele have increased risk for dementia.",
         "label": 1,
         "prediction": 1,
         "rationale": "The Apolipoprotein E4 (APOE4) allele is a variant of the apolipoprotein E gene that is associated with an increased risk of developing Alzheimer's disease. The Apolipoprotein E4 (APOE4) allele is the strongest genetic risk factor for Alzheimer's disease, affecting individuals regardless of sex. The provided evidence does not specifically address whether the Apolipoprotein E4 (APOE4) allele increases the risk of dementia in females more than in males. The provided evidence does not specifically address whether the Apolipoprotein E4 (APOE4) allele increases the risk of dementia in females more than in males due to sex-specific factors. The relationship between the Apolipoprotein E4 (APOE4) allele and the risk of dementia in females due to hormonal or reproductive factors is not specifically addressed in the provided evidence. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the Apolipoprotein E4 (APOE4) allele?",
               "answer": "The Apolipoprotein E4 (APOE4) allele is a variant of the apolipoprotein E gene that is associated with an increased risk of developing Alzheimer's disease. Individuals who carry at least one copy of the APOE4 gene have a doubled or tripled risk of Alzheimer's, while those with",
               "rationale": "1. Biomarkers Abound in APOE4 Markers. The apolipoprotein E gene (APOE for short) is linked to Alzheimer's risk because it's involved in the body's process for carrying cholesterol and other fats ...\n2. One copy of the APOE gene comes from the mother and another from the father. Having at least one APOE e4 gene doubles or triples the risk of getting Alzheimer's disease. Some people have two APOE e4 genes, one from each parent. Having two genes increases the risk of getting Alzheimer's disease even more, about eight- to twelvefold.\n3. From NIH Research Matters. Certain genes can increase the risk of developing dementia, including Alzheimer's disease. One of the most significant genetic risk factors is a form of the apolipoprotein E gene called APOE4.About 25% of people carry one copy of APOE4, and 2 to 3% carry two copies.APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not ...\n4. Apolipoprotein E (Apo-E) is a protein ... The first allele to emerge was E4. After the primate-human split, there were four amino acid changes in the human lineage, three of which had no effect on protein function (V174L, A18T, A135V). ... The APOE4 allele has an even stronger effect in East Asian populations, ...\n5. The human gene for APOE, or apolipoprotein E, comes in three versions. While APOE4 is linked to higher risk for Alzheimer's, APOE2 is considered protective, and APOE3, the most common variant, is neutral. APOE is known to be involved in lipid metabolism, but its role in the development of Alzheimer's has been unclear, Tsai says.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the Apolipoprotein E4 (APOE4) allele increase the risk of dementia in females?",
               "answer": "The provided evidence does not specify whether the Apolipoprotein E4 (APOE4) allele increases the risk of dementia specifically in females. However, it does indicate that APOE4 is the strongest genetic risk factor for Alzheimer's disease in general, affecting individuals regardless of sex. Therefore, while it is known that",
               "rationale": "1. Certain genes can increase the risk of developing dementia, including Alzheimer's disease. One of the most significant genetic risk factors is a form of the apolipoprotein E gene called APOE4. About 25% of people carry one copy of APOE4, and 2 to 3% carry two copies. APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not mean a person will ...\n2. Lipid dysregulation The human gene for APOE, or apolipoprotein E, comes in three versions. While APOE4 is linked to higher risk for Alzheimer's, APOE2 is considered protective, and APOE3, the most common variant, is neutral.\n3. The ɛ4 allele of the apolipoprotein E gene (APOE), which translates to the APOE4 isoform, is the strongest genetic risk factor for late-onset Alzheimer disease (AD). Within the CNS, APOE is ...\n4. Since pivotal genetic studies in 1993, the ε4 allele of the apolipoprotein E gene (APOE ε4) has remained the strongest single genome-wide associated risk variant in AD.\n5. Abstract Alzheimer's disease (AD) is the leading cause of dementia affecting almost 50 million people worldwide. The ε4 allele of Apolipoprotein E (APOE) is the strongest known genetic risk factor for late-onset AD cases, with homozygous APOE4 carriers being approximately 15-times more likely to develop the disease.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does the Apolipoprotein E4 (APOE4) allele increase the risk of dementia in females more than in males?",
               "answer": "The provided evidence snippets do not specifically address whether the Apolipoprotein E4 (APOE4) allele increases the risk of dementia in females more than in males. While they highlight that APOE4 is a significant genetic risk factor for Alzheimer's disease and its association with amyloid deposition and early onset, they do",
               "rationale": "1. March 16, 2021. Genetics Alzheimer's Disease Dementias. From NIH Research Matters. Certain genes can increase the risk of developing dementia, including Alzheimer's disease. One of the most significant genetic risk factors is a form of the apolipoprotein E gene called APOE4. About 25% of people carry one copy of APOE4, and 2 to 3% carry two ...\n2. Abstract. APOE-ε4 is the strongest genetic risk factor for Alzheimer's disease (AD), and is associated with an increase in the levels of amyloid deposition and an early age of onset. Recent data demonstrate that AD pathological changes occur decades before clinical symptoms, raising questions about the precise onset of the disease.\n3. Targeting the E4 isoform of apolipoprotein E (APOE4) produced by neurons may be an effective way to reduce Alzheimer disease (AD) risk (Fig. 6b ), because neuronal APOE4 promotes all major ...\n4. The Apolipoprotein E ε4 (ApoE ε4) allele, encoding ApoE4, is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD). Emerging epidemiological evidence indicated that ApoE4 contributes to AD through influencing β-amyloid (Aβ) deposition and clearance. However, the molecular mechanisms of ApoE4 involved in AD pathogenesis remains unclear.\n5. While AD dementia is more prevalent among ... support the idea that ApoE3 and ApoE4 increase AD pathology ... E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does the Apolipoprotein E4 (APOE4) allele increase the risk of dementia in females more than in males due to sex-specific factors?",
               "answer": "The provided evidence snippets do not specifically address whether the Apolipoprotein E4 (APOE4) allele increases the risk of dementia in females more than in males due to sex-specific factors. While they highlight that APOE4 is the strongest genetic risk factor for Alzheimer's disease and mention its prevalence and impact on disease",
               "rationale": "1. From NIH Research Matters. Certain genes can increase the risk of developing dementia, including Alzheimer's disease. One of the most significant genetic risk factors is a form of the apolipoprotein E gene called APOE4.About 25% of people carry one copy of APOE4, and 2 to 3% carry two copies.APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not ...\n2. Targeting the E4 isoform of apolipoprotein E (APOE4) produced by neurons may be an effective way to reduce Alzheimer disease (AD) risk (Fig. 6b ), because neuronal APOE4 promotes all major ...\n3. The Apolipoprotein E ε4 (ApoE ε4) allele, encoding ApoE4, is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD). Emerging epidemiological evidence indicated that ApoE4 contributes to AD through influencing β-amyloid (Aβ) deposition and clearance. However, the molecular mechanisms of ApoE4 involved in AD pathogenesis remains unclear.\n4. Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its prevalence is rapidly increasing due to extended lifespans. Among the increasing number of genetic risk factors identified, the apolipoprotein E (APOE) gene remains the strongest and most prevalent, impacting more than half of all AD cases. While the ε4 allele of the APOE gene significantly increases AD risk ...\n5. Alzheimer's disease (AD) is the leading cause of dementia affecting almost 50 million people worldwide. The ε4 allele of Apolipoprotein E (APOE) is the strongest known genetic risk factor for late-onset AD cases, with homozygous APOE4 carriers being approximately 15-times more likely to develop the disease. With 25% of the population being APOE4 carriers, understanding the role of this allele ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does the Apolipoprotein E4 (APOE4) allele increase the risk of dementia in females due to hormonal or reproductive factors?",
               "answer": "The provided evidence snippets do not specifically address the relationship between the Apolipoprotein E4 (APOE4) allele and the risk of dementia in females due to hormonal or reproductive factors. The evidence primarily focuses on the genetic risk associated with APOE4 and its role in Alzheimer's disease, particularly in terms of its",
               "rationale": "1. Certain genes can increase the risk of developing dementia, including Alzheimer's disease. One of the most significant genetic risk factors is a form of the apolipoprotein E gene called APOE4. About 25% of people carry one copy of APOE4, and 2 to 3% carry two copies. APOE4 is the strongest risk factor gene for Alzheimer's disease, although inheriting APOE4 does not mean a person will ...\n2. The ɛ4 allele of the apolipoprotein E gene (APOE), which translates to the APOE4 isoform, is the strongest genetic risk factor for late-onset Alzheimer disease (AD). Within the CNS, APOE is ...\n3. The Apolipoprotein E ε4 ( ApoE ε4) allele, encoding ApoE4, is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD). Emerging epidemiological evidence indicated that ApoE4 contributes to AD through influencing β-amyloid (Aβ) deposition and clearance.\n4. 2. APOE GENOTYPE EFFECTS ON ALZHEIMER'S DISEASE The greatest genetic risk for late onset Alzheimer's disease is associated with alleles of the apolipoprotein E (APOE) gene. APOE encodes for three isoforms of a secreted 299 amino acid protein (apoE2, apoE3, apoE4) that differ in amino acid sequence at positions 112 and 158 [ 5 ]. With an allele frequency of 14%, APOE-ε4 is present in ...\n5. Since pivotal genetic studies in 1993, the ε4 allele of the apolipoprotein E gene (APOE ε4) has remained the strongest single genome-wide associated risk variant in AD.",
               "predicate": null
            }
         ],
         "row": 563,
         "id": 182078143019095583
      },
      {
         "claim": "FoxO3a activation in neuronal death is mediated by reactive oxygen species (ROS).",
         "label": 1,
         "prediction": 1,
         "rationale": "FoxO3a is a transcription factor encoded by the FOXO3 gene that regulates various biological processes, including stress resistance, metabolism, cell cycle arrest, and apoptosis. Reactive oxygen species (ROS) play a significant role in neuronal death, as they are implicated in both apoptotic and necrotic cell death. FOXO3a activation in neuronal death is mediated by reactive oxygen species (ROS). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is FoxO3a?",
               "answer": "FoxO3a is a transcription factor encoded by the FOXO3 gene, which is a member of the FOXO subclass of transcription factors. It plays a crucial role in regulating various biological processes, including stress resistance, metabolism, cell cycle arrest, and apoptosis. FoxO3a is involved in translating environmental stimuli,",
               "rationale": "1. Deregulation of FOXO3a is involved in tumorigenesis, for example translocation of this gene with the MLL gene is associated with secondary acute leukemia. Downregulation of FOXO3a activity is often seen in cancer (e.g. by increase in Akt activity resulting from loss of PTEN). FOXO3 is known as a tumour suppressor.\n2. FoxOs are master regulators that translate environmental stimuli arising from insulin, growth factors, nutrients and oxidative stress into specific gene expression programs. The role of FoxO3 in longevity may involve upregulation of target genes involved in stress resistance, metabolism, cell cycle arrest, and apoptosis.\n3. Abstract. Background: The gene FOXO3, encoding the transcription factor forkhead box O-3 (FoxO3), is one of only two for which genetic polymorphisms have exhibited consistent associations with longevity in diverse human populations. Objective: Here, we review the multitude of actions of FoxO3 that are relevant to health, and thus healthy ageing ...\n4. The forkhead box O3 (FOXO3, or FKHRL1) protein is a member of the FOXO subclass of transcription factors. FOXO proteins were originally identified as regulators of insulin-related genes; however, they are now established regulators of genes involved in vital biological processes, including substrate metabolism, protein turnover, cell survival, and cell death.\n5. A significant association has been shown between human longevity and several FOXO3 variants located in intron 2. This haplotype block forms a putative aging chromatin hub in which FOXO3 has a central role, as it modulates the physical connection and activity of neighboring genes involved in age-related processes.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the role of reactive oxygen species (ROS) in neuronal death?",
               "answer": "Reactive oxygen species (ROS) play a significant role in neuronal death, as they are implicated in both apoptotic and necrotic cell death. The evidence indicates that the production of ROS, such as superoxide anions, is associated with neuronal apoptotic death. Additionally, the study mentioned evaluates the role of different ROS",
               "rationale": "1. In this review, we summarize classical and modern concepts regarding ROS physiology, with an emphasis on the role of the NADPH oxidase (NOX) complex, the main enzymatic and regulated source of ROS in the nervous system. We discuss how ROS and redox state contribute to neurogenesis, polarization and maturation of neurons, providing a context for ...\n2. Reactive oxygen species (ROS) form a family of molecules derived from molecular oxygen (O 2) present in the atmosphere. The most common ROS members are the superoxide anion (O 2 _ ), the hydroxyl radical (HO) and hydrogen peroxide (H 2 O 2) [1]. Both superoxide anions and hydroxyl radicals are free radical molecules, with one electron missing ...\n3. Neuronal apoptotic death involves the participation of reactive oxygen species (ROS), which have also been implicated in necrotic cell death. In this study we evaluated the role of different ROS in neuronal death. Superoxide anion was produced by incubating cells with xanthine and xanthine oxidase plus catalase, singlet oxygen was generated ...\n4. 'Reactive oxygen species' (ROS) is an umbrella term for an array of derivatives of molecular oxygen that occur as a normal attribute of aerobic life. Elevated formation of the different ROS ...\n5. Introduction. Cellular reactive oxygen species (ROS) are tightly controlled to dictate different cell fates, such as differentiation or cell survival. When ROS are produced in excess, such as in cells under metabolic stress, this leads to cell death. This suggests that a \"ROS rheostat\" exists in cells controlling cellular survival.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is FoxO3a activation in neuronal death mediated by reactive oxygen species (ROS)?",
               "answer": "Yes, FOXO3a activation in neuronal death is mediated by reactive oxygen species (ROS). The evidence indicates that FOXO3a plays a role in the detoxification of ROS and is involved in the cellular response to oxidative stress, which is relevant to neuronal death. Specifically, the activation of FOXO3a after",
               "rationale": "1. FOXO3a has been previously implicated in the detoxification of reactive oxygen species (ROS) through induction of manganese-containing superoxide dismutase (SOD2).\n2. FOXO3a has been previously implicated in the detoxification of reactive oxygen species (ROS) through induction of manganese-containing superoxide dismutase (SOD2). We observed that reduction in ROS levels following FOXO3a activation was independent of SOD2, but required c-Myc inhibition. Hypoxia increases ROS production from the mitochondria ...\n3. Cell metabolism generates potentially harmful reactive oxygen species (ROS). ... and of the important role of FOXO activation after exposure to ROS in neuronal death (Lehtinen et al., 2006). They also shed light into an important aspect of ROS-mediated neurodegeneration, namely, whether the pathological mechanisms set in motion by chronic ...\n4. The well-established role of FOXO proteins in the elimination of reactive oxygen species is largely mediated by directly upregulating the expression of manganese superoxide dismutase (MnSOD or ...\n5. It has been found to be a negative regulator of cardiac hypertrophy by activating FOXO3a-dependent antioxidants, i.e., MnSOD and CAT, as well as by suppressing ROS-mediated Ras activation and the downstream MAPK/ERK and PI3K/AKT signaling pathways . The SIRT3-FOXO3a pathway has been widely reported to maintain mitochondrial homeostasis and ...",
               "predicate": null
            }
         ],
         "row": 564,
         "id": 121976340601785050
      },
      {
         "claim": "Free histones are degraded by a Rad53-dependent mechanism once DNA has been replicated.",
         "label": 1,
         "prediction": 1,
         "rationale": "Rad53 is an essential protein kinase in the budding yeast Saccharomyces cerevisiae that plays a critical role in DNA damage and DNA replication checkpoint pathways. Rad53 plays multiple roles in safeguarding DNA replication forks during replication stress, including restraining CMG helicase activity, phosphorylating key proteins, limiting histone levels, and coupling leading- and lagging-strand DNA synthesis. Once DNA has been replicated, the free histones are involved in the immediate packaging of the newly synthesized DNA into nucleosomes. Free histones are degraded by a mechanism dependent on Rad53. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Rad53?",
               "answer": "Rad53 is an essential protein kinase in the budding yeast Saccharomyces cerevisiae that plays a critical role in DNA damage and DNA replication checkpoint pathways. It is involved in controlling and transmitting responses to DNA damage through phosphorylation of target proteins, amplifying initial signals from proteins that recognize DNA damage and replication blocks. Rad",
               "rationale": "1. Rad53 is recruited to replisomes in vivo even after disruption of its interaction with both Mrc1 and Cdc45 (ref. 53), indicating that Rad53 interacts with yet other replisome components.\n2. Saccharomyces cerevisiae Rad53, the ortholog of mammalian Chk2, is an essential protein kinase in DNA damage and DNA replication checkpoint pathways. Consecutive phosphatidyl inositol kinase-like kinase (PIKK)-dependent and PIKK-independent steps in activation of Rad53 are key steps for controlling and transmitting diverse downstream responses to DNA damage.\n3. RAD53 encodes an essential protein kinase required for cell cycle checkpoint function. By modifying the phosphorylation state of protein targets, Rad53p amplifies initial signals from proteins that recognize DNA damage and replication blocks ( 11, 14, and reviewed in 16 ).\n4. Rad53-Spt21 mutants display severe glucose dependence, caused by excess histones through two separable mechanisms: dampening of acetyl-coenzyme A-dependent carbon metabolism through histone hyper ...\n5. The Rad53 DNA checkpoint protein kinase plays multiple roles in the budding yeast cell response to DNA replication stress. Key amongst these is its enigmatic role in safeguarding DNA replication forks. Using DNA replication reactions reconstituted with purified proteins, we show Rad53 phosphorylatio …",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of Rad53 in DNA replication?",
               "answer": "Rad53 plays multiple roles in safeguarding DNA replication forks during replication stress. It restrains CMG helicase activity to prevent DNA unwinding and collapse of stalled forks, phosphorylates key proteins involved in the replication process, limits histone levels in the absence of DNA damage, and couples leading- and lagging-strand DNA",
               "rationale": "1. In vitro assays using a fully reconstituted DNA replication system reveal that the checkpoint kinase Rad53 restrains CMG helicase activity to prevent DNA unwinding and collapse of stalled forks in ...\n2. Abstract. The Rad53 DNA checkpoint protein kinase plays multiple roles in the budding yeast cell response to DNA replication stress. Key amongst these is its enigmatic role in safeguarding DNA replication forks. Using DNA replication reactions reconstituted with purified proteins, we show Rad53 phosphorylation of Sld3/7 or Dbf4-dependent kinase ...\n3. Here we provide evidence of a non-canonical function of the Rad53 kinase in limiting histone levels in the absence of DNA damage insults, and of a baseline activity of the Rad53-Spt21 axis in ...\n4. Furthermore, depletion of either Mrc1 or its partner, Tof1, suppresses the asymmetric DNA synthesis in rad53-1 mutant cells. Thus, the DNA replication checkpoint pathway couples leading- and lagging-strand DNA synthesis by attenuating the replication function of Mrc1-Tof1 under replication stress.\n5. The FHA1 Domain Functions in the Replication Checkpoint Pathway—An alternative explanation for the DNA damage sensitivity phenotypes could be that the Rad53 FHA1 domain has important RAD9-and RAD17-independent DNA damage response functions in the replication checkpoint. DNA is most susceptible to damage during S phase (41). The DNA ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What happens to free histones once DNA has been replicated?",
               "answer": "Once DNA has been replicated, the free histones are likely involved in the immediate packaging of the newly synthesized DNA into nucleosomes. As indicated in point 4, newly synthesized histones are transported into the nucleus at the beginning of the S phase and are used to form nucleosomes around the replicated DNA. This process ensures",
               "rationale": "1. Anatomy of the nucleosome and histone chaperones. A. Unraveling of the nucleosomal DNA to indicate which regions of the 147 bp of DNA are organized by which histone proteins. The surface of the histones closest to the DNA is the one that binds to the DNA. The interactions within the stable dimer units have been maintained, but all other histone-histone interactions have been dissolved.\n2. Fig. 3. Histone dynamics during replication stress. Selected functions of histone modifications and variants in resolving replication stress are shown. Histone marks and the corresponding catalytic protein (s) are listed along with their main function in resolving certain types of replication stress.\n3. Nuclear DNA is tightly packaged into chromatin, which profoundly influences DNA replication, transcription, repair, and recombination. The extensive interactions between the basic histone proteins and acidic DNA make the nucleosomal unit of chromatin a highly stable entity. For the cellular machinery to access the DNA, the chromatin must be unwound and the DNA cleared of histone proteins ...\n4. Yes, they have to. But that is just half of the story. The (canonical) histones which are used in DNA replication are synthesized at the beginning of the S phase, and subsequently transported into the nucleus. Studies have shown that newly synthesized DNA is immediately packed into nucleosomes.\n5. Histone dynamics. Histone modifications. Histone variants. Accurate and complete replication of the genome is essential not only for genome stability but also for cell viability. However, cells face constant threats to the replication process, such as spontaneous DNA modifications and DNA lesions from endogenous and external sources.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Are free histones degraded by a mechanism dependent on Rad53?",
               "answer": "Yes, free histones are degraded by a mechanism dependent on Rad53. The evidence indicates that excess (non-chromatin bound) histones are rapidly degraded in a Rad53-dependent manner, suggesting that only free histones can be targeted for degradation by Rad53.",
               "rationale": "1. Taken together, our data suggest the existence of a Rad53-dependent surveillance mechanism that balances the rates of DNA replication and histone synthesis during S phase and in response to DNA damage. ... Hir proteins, or Asf1 may also protect newly synthesized histones from degradation and perhaps only free histones can be degraded by Rad53.\n2. Although chromosomal histones are stable, excess (non-chromatin bound) histones are rapidly degraded in a Rad53 (radiation sensitive 53) kinase-dependent manner in Saccharomyces cerevisiae.\n3. Taken together, our data suggest the existence of a Rad53-dependent surveillance mechanism that balances the rates of DNA replication and histone synthesis during S phase and in response to DNA damage. ... Hir proteins, or Asf1 may also protect newly synthesized histones from degradation and perhaps only free histones can be degraded by Rad53.\n4. Rad53-Spt21 mutants display severe glucose dependence, caused by excess histones through two separable mechanisms: dampening of acetyl-coenzyme A-dependent carbon metabolism through histone hyper ...\n5. A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell 115 , 537-549 (2003). Article CAS PubMed Google Scholar",
               "predicate": null
            }
         ],
         "row": 565,
         "id": 201343597300708473
      },
      {
         "claim": "GATA-3 is important for hematopoietic stem cell (HSC) function.",
         "label": 1,
         "prediction": 1,
         "rationale": "GATA-3 is a transcription factor that plays a crucial role in the differentiation of breast epithelia, urothelia, and subsets of T lymphocytes, and is highly expressed in the Luminal A subtype of breast cancer, associated with favorable pathologic features, such as positive estrogen receptor status. GATA-3 is important for hematopoietic stem cell function. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is GATA-3?",
               "answer": "GATA-3 is a transcription factor that plays a crucial role in the differentiation of breast epithelia, urothelia, and subsets of T lymphocytes. It is highly expressed in the Luminal A subtype of breast cancer and is associated with favorable pathologic features, such as positive estrogen receptor (ER) status",
               "rationale": "1. GATA3 variant 1 is a linear protein consisting of 444 amino acids.GATA3 variant 2 protein is an identically structured isoform of, but 1 amino acid shorter than, GATA3 variant 1. Differences, if any, in the functions of these two variants have not been reported. With respect to the best studied variant, variant 1, but presumably also variant 2, one of the zinc finger structural motifs, ZNF2 ...\n2. GATA-3 is almost exclusively expressed in ER+ patients and is also associated with lower tumor grade, older age at diagnosis, and the absence of Her2 overexpression. In univariate analysis, the presence of GATA-3 is a marker of good prognosis and predicted for superior breast cancer-specific survival, relapse-free survival, and overall survival.\n3. In the breast, GATA 3 is mainly expressed in luminal epithelia and it has been reported frequently expressed in breast carcinomas and as a potential marker for mammary origin of metastatic carcinoma. 13-16 In this study, GATA3 was detected in 92% of primary ductal carcinomas of the breast. Furthermore, it was retained with a high percentage (96 ...\n4. GATA3 is a transcription factor important in the differentiation of breast epithelia, urothelia, and subsets of T lymphocytes. It has been suggested to be useful in the evaluation of carcinomas of mammary or urothelial origin or metastatic carcinomas, but its distribution in normal and neoplastic tissues is incompletely mapped.\n5. Abstract. Background: GATA-3 is a transcription factor involved in human growth and differentiation. Gene expression profiling has shown that GATA-3 is highly expressed in the Luminal A subtype of breast cancer. A recent study found GATA-3 to be associated with favorable breast cancer pathologic features, including negative lymph node and positive estrogen receptor (ER) status. GATA-3 levels ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is GATA-3 important for hematopoietic stem cell function?",
               "answer": "Yes, GATA-3 is important for hematopoietic stem cell function. The evidence indicates that GATA-3 plays a role in the transition of hemogenic endothelial cells into fully functional hematopoietic cells and is required for the maintenance of a normal number of long-term hematopoietic stem cells (",
               "rationale": "1. Ottersbach and colleagues demonstrate that Gata3 marks hemogenic endothelial cells and early hematopoietic stem cell precursors where its expression correlates with other early drivers of the endothelial-to-hematopoietic transition and a quiescent cell cycle state. Importantly, they show that GATA3 facilitates the transition of hemogenic endothelial cells into fully functional hematopoietic ...\n2. Furthermore, Gata3 mutant hematopoietic progenitor cells fail to be recruited into an increased cycling state after 5-fluorouracil-induced myelosuppression. Therefore, GATA-3 is required for the maintenance of a normal number of LT-HSCs and for their entry into the cell cycle. Go to:\n3. GATA3 regulates T cell development, proliferation and maintenance. Furthermore, recent studies have demonstrated important roles for GATA3 in innate lymphoid cells. Thus GATA3 emerges as a factor with diverse functions in immune regulation, which are in some cases cell-type specific and in others shared by multiple cell types.\n4. Although GATA-3 is expressed in hematopoietic stem cells, its function there remains unclear. Iscove and colleagues show that GATA-3 inhibits the self-renewal potential of long-term hematopoietic ...\n5. Introduction GATA1, GATA2 and GATA3 are expressed at distinct stages in the hematopoietic hierarchy. GATA1 is required for erythropoiesis, megakaryocytes, and eosinophils, 1-3 GATA2 for primitive hematopoietic stem/progenitor cells, 4, 5 and GATA3 for multiple stages of T-cell development. 6-8 However, Gata3 is expressed already in hematopoietic stem cells (HSCs), 9 multipotent progenitors, 10 ...",
               "predicate": null
            }
         ],
         "row": 566,
         "id": 177268060028625477
      },
      {
         "claim": "Gene expression does not vary appreciably across genetically identical cells.",
         "label": 0,
         "prediction": 0,
         "rationale": "Gene expression is the process by which the information encoded in a gene is utilized to synthesize functional products, primarily proteins or non-coding RNA molecules. Genetically identical cells do not have the same gene expression, due to variability referred to as cellular noise. Cellular noise is appreciable and affects action potential timing, leading to variability in biological processes. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is gene expression?",
               "answer": "Gene expression is the process by which the information encoded in a gene is utilized to synthesize functional products, primarily proteins or non-coding RNA molecules. This process involves the transcription of RNA from DNA, which serves as a template for producing proteins or functional RNA that can influence an organism's phenotype. Gene expression can be thought",
               "rationale": "1. Gene expression is the process by which the information encoded in a gene is turned into a function. This mostly occurs via the transcription of RNA molecules that code for proteins or non-coding RNA molecules that serve other functions. Gene expression be thought of as an \"on/off switch\" to control when and where RNA molecules and proteins ...\n2. Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product that enables it to produce end products, proteins or non-coding RNA, and ultimately affect a phenotype.These products are often proteins, but in non-protein-coding genes such as transfer RNA (tRNA) and small nuclear RNA (snRNA), the product is a functional non-coding RNA.\n3. Gene expression is the process our cells use to convert the instructions in our DNA into a functional product, such as a protein. Our DNA stores the information our cells need to function. It is organised into small sections, called genes, which contain instructions for making a specific product, usually a protein.\n4. Gene expression is how cells produce proteins according to a DNA-based recipe. Learn about the transcription and translation steps, the differences between eukaryotic and prokaryotic gene expression, and the methods of gene expression analysis.\n5. Learn how genes in DNA provide instructions for proteins through transcription and translation. Explore the central dogma of molecular biology and the genetic code with examples and diagrams.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do genetically identical cells have the same gene expression?",
               "answer": "No, genetically identical cells do not have the same gene expression. The evidence indicates that even though cells contain the same DNA, they can produce varying amounts of the same protein associated with the same gene, leading to differences in gene expression. This variability is referred to as cellular noise, and it contributes to the diverse functions and",
               "rationale": "1. Summary: Researchers have taken an important step toward explaining why genetically identical cells can produce varying amounts of the same protein associated with the same gene. Researchers ...\n2. This process is thought to regulate a vast number of cell behaviors, including cell fate decisions during embryogenesis, cell function, and chemotaxis. In addition, gene expression changes can ...\n3. Key points: Gene regulation is the process of controlling which genes in a cell's DNA are expressed (used to make a functional product such as a protein). Different cells in a multicellular organism may express very different sets of genes, even though they contain the same DNA. The set of genes expressed in a cell determines the set of ...\n4. The different cell types in a multicellular organism differ dramatically in both structure and function. If we compare a mammalian neuron with a lymphocyte, for example, the differences are so extreme that it is difficult to imagine that the two cells contain the same genome (Figure 7-1). For this reason, and because cell differentiation is often irreversible, biologists originally suspected ...\n5. Nearly every cell in a person's body contains the same DNA, the master set of genetic instructions for making the complex proteins that do most of the biological work. DNA segments called genes encode specific proteins. ... That fluctuation in gene expression between identical cells is called cellular noise.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is cellular noise appreciable?",
               "answer": "Yes, cellular noise is appreciable. The evidence indicates that motor neurons, like other neurons, are subject to cellular noise, which affects action potential (AP) timing and can lead to variability in biological processes. This suggests that the effects of cellular noise are significant enough to be observed and measured in various contexts, such as",
               "rationale": "1. Second, motor neurons are subject to the same sources of cellular noise as any other neuron, making noise appreciable in AP timing in myelinated motor axons of 10 μm diameter 106 and at the ...\n2. Second, motor neurons are subject to the same sources of cellular noise as any other neuron, making noise appreciable in AP timing in myelinated motor axons of 10 μm diameter 108 and at the neuromuscular junction 109. The resulting AP timing variability will reduce the periodicity of the force and thus increase its variability.\n3. Cellular noise is random variability in quantities arising in cellular biology. For example, cells which are genetically identical, even within the same tissue, are often observed to have different expression levels of proteins, different sizes and structures. [1] [2] These apparently random differences can have important biological and medical ...\n4. Cellular noise is a generic term designating random fluctuations in the rates of biochemical reactions, which can cause non-deterministic heterogeneity among genetically identical cells.\n5. But for the cells that make up all living things, noise — meaning random variability in the outside environment, including fluctuating food sources, pathogens and deadly toxins, or random ...",
               "predicate": null
            }
         ],
         "row": 567,
         "id": 258240159461115795
      },
      {
         "claim": "Glycolysis is one of the primary glycometabolic pathways in cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "Glycolysis is a metabolic pathway that converts glucose into pyruvate, producing energy in the form of ATP and NADH. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is glycolysis?",
               "answer": "Glycolysis is a metabolic pathway that converts glucose (C6H12O6) into pyruvate, producing energy in the form of adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide (NADH) in the process. It occurs in the cyt",
               "rationale": "1. Glycolysis is the breakdown of glucose into two pyruvates, with two ATP and two NADH produced. Learn the ten steps of glycolysis, the enzymes that catalyze them, and how they are regulated.\n2. Glycolysis is the metabolic pathway that converts glucose (C 6 H 12 O 6) into pyruvate and, in most organisms, occurs in the liquid part of cells (the cytosol). The free energy released in this process is used to form the high-energy molecules adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide (NADH).\n3. Glycolysis is the process of breaking down glucose into pyruvate and ATP in the cytoplasm of cells. Learn the stages, enzymes and end products of glycolysis with examples and quiz at BYJU'S website.\n4. Glycolysis is a metabolic process that converts glucose into pyruvate and produces energy. Learn the definition, formula, steps, and examples of glycolysis in the cell cytosol.\n5. Glycolysis is a metabolic pathway and an anaerobic energy source that has evolved in nearly all types of organisms. Another name for the process is the Embden-Meyerhof pathway, in honor of the major contributors towards its discovery and understanding.[1] Although it doesn't require oxygen, hence its purpose in anaerobic respiration, it is also the first step in cellular respiration.",
               "predicate": null
            }
         ],
         "row": 568,
         "id": 906854219944358909
      },
      {
         "claim": "Headaches are not correlated with cognitive impairment.",
         "label": 1,
         "prediction": 0,
         "rationale": "There is a correlation between headaches, particularly migraines, and cognitive impairment, with evidence suggesting an association with lower general cognitive function and an increased risk of dementia and Alzheimer's disease. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is there a correlation between headaches and cognitive impairment?",
               "answer": "Yes, there appears to be a correlation between headaches, particularly migraines, and cognitive impairment. The evidence suggests that migraine is associated with lower general cognitive function and language function, as well as an increased risk of dementia, vascular dementia (VaD), and Alzheimer's disease (AD). While there is limited data on tension-type headaches",
               "rationale": "1. There is little data regarding the potential association between tension-type headaches and cognitive impairment. Given the high lifetime prevalence of tension-type headaches, uncovering a specific risk would be methodologically challenging and presumably very nonspecific [ 50 ].\n2. Conclusions. In conclusion, the meta-analysis demonstrated lower general cognitive function and language function in migraine. In addition, migraine is associated with an increased risk of all-cause dementia, VaD and AD. These results suggest a significant association between migraine and cognitive impairment.\n3. Cognitive dysfunction has recently gained attention as a significant problem among migraine sufferers. All of the clinical studies show poor cognitive performance during migraine attacks, though, the interictal data are conflicting. Migraineurs show impaired cognitive function interictally in most of the clinic-based studies. Population-based studies did not reveal a difference in cognitive ...\n4. Abstract. Migraine and other types of headaches have several symptoms associated with them. The association between migraine and dementia has been considered. It is a topic of discussion and appears to be multifactorial. Dementia is a cluster of symptoms, with memory loss and cognitive dysfunction being the prominent symptoms.\n5. Objective: In the present article, we aim to provide a comprehensive review of existing data concerning the link between headache and cognitive decline. Methods: We undertook a systematic literature review to report articles that focus on headaches (including all types of headaches) and neurocognitive disorders of degenerative causes.",
               "predicate": null
            }
         ],
         "row": 569,
         "id": 629471890586197289
      },
      {
         "claim": "High cardiopulmonary fitness causes increased mortality rate.",
         "label": 0,
         "prediction": 0,
         "rationale": "High cardiopulmonary fitness is associated with a lower risk of all-cause mortality and cardiovascular disease, not an increased mortality rate. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is high cardiopulmonary fitness associated with increased mortality rate?",
               "answer": "No, high cardiopulmonary fitness (CRF) is not associated with increased mortality rate. In fact, the evidence suggests that higher levels of CRF are associated with a lower risk of all-cause mortality and cardiovascular disease. The studies indicate a strong inverse relationship between CRF and mortality risk, meaning that as",
               "rationale": "1. Conclusion Aggregate analysis of observational cohort studies confirms a strong inverse and independent association between CRF and all-cause mortality risk. The results suggest that guideline bodies should consider the inclusion of CRF in standard risk panels for mortality risk assessment. Abbreviations and Acronyms: CPX ( cardiopulmonary exercise testing ), CRF ( cardiorespiratory fitness ...\n2. The beneficial health effects and prognostic significance of regular moderate-to-vigorous physical activity (PA), increased cardiorespiratory fitness (CRF), or both are often underappreciated by the medical community and the patients they serve. Individuals with low CRF have higher annual health care costs, higher rates of surgical complications, and are two to three times more likely to die ...\n3. Mounting evidence has firmly established that low levels of cardiorespiratory fitness (CRF) are associated with a high risk of cardiovascular disease, all-cause mortality, and mortality rates attributable to various cancers. A growing body of epidemiological and clinical evidence demonstrates not only that CRF is a potentially stronger predictor of mortality than established risk factors such ...\n4. Physical activity and cardiorespiratory fitness (fitness) are known to be associated with enhanced health and quality of life, 1 and even small improvements in fitness have been associated with reduced cardiovascular and all-cause mortality. 2 - 4 The current physical activity guidelines recognize the importance of fitness and activity ...\n5. Cardiorespiratory fitness (CRF) is inversely associated with mortality in apparently healthy subjects and in some clinical populations, but evidence for the association between CRF and all-cause and/or cardiovascular disease (CVD) mortality in patients ...",
               "predicate": null
            }
         ],
         "row": 570,
         "id": 646621513932296121
      },
      {
         "claim": "High levels of CRP reduces the risk of exacerbations in chronic obstructive pulmonary disease (COPD).",
         "label": 0,
         "prediction": 0,
         "rationale": "C-reactive protein (CRP) is a protein produced by the liver that serves as a marker of inflammation in the body. C-reactive protein (CRP) levels are raised in patients with chronic obstructive pulmonary disease (COPD), which may be related to systemic inflammation associated with the disease or other factors such as ischaemic heart disease (IHD) or smoking status. High CRP levels do not reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD). Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CRP?",
               "answer": "C-reactive protein (CRP) is a protein produced by the liver that serves as a marker of inflammation in the body. It is measured in the blood, and elevated levels indicate the presence of inflammation, which can be caused by various conditions such as infections, autoimmune disorders, or lung diseases.",
               "rationale": "1. C-reactive protein is measured in milligrams per liter (mg/L). Results equal to or greater than 8 mg/L or 10 mg/L are considered high. Range values vary depending on the lab doing the test. A high test result is a sign of inflammation. It may be due to serious infection, injury or chronic disease. Your health care provider may recommend other ...\n2. C-reactive protein (CRP) is a marker of inflammation in the body. Learn why a CRP test is done, how to prepare for it, and what the results mean for your health.\n3. A CRP test measures the level of a protein in your blood that indicates inflammation. Learn why healthcare providers order this test, how to prepare for it and what the results mean.\n4. A CRP test measures the level of CRP in your blood, a protein that your liver makes when you have inflammation. Inflammation can be acute or chronic and caused by various conditions, such as infections, autoimmune disorders, or lung diseases.\n5. C-reactive protein (CRP) is a marker of inflammation in the body. Learn why a CRP test is done, how to prepare, what the results mean, and what to do if you have high levels.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is CRP associated with chronic obstructive pulmonary disease (COPD)?",
               "answer": "The evidence suggests that C-reactive protein (CRP) levels are raised in patients with chronic obstructive pulmonary disease (COPD), which may be related to systemic inflammation associated with the disease or other factors such as ischaemic heart disease (IHD) or smoking status. However, the conclusion indicates that in stable",
               "rationale": "1. The prognostic role of baseline C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) is controversial. In order to clarify this issue, we performed a systematic review and meta-analysis to assess the predictive effect of baseline CRP level in COPD patients. 15 eligible articles focusing on late mortality in COPD were included in our study. We performed a random-effects meta ...\n2. Introduction Chronic obstructive pulmonary disease (COPD) is currently the third most frequent cause of disability and mortality globally in patients older than 40, with an estimated prevalence of 174 million affected and 3.2 million mortalities worldwide in 2015, even though many studies postulate that these figures are likely understated [ 1, 2 ]. The disorder is associated with preserved ...\n3. Abstract Background: Patients with chronic obstructive pulmonary disease (COPD) have raised serum levels of C reactive protein (CRP). This may be related directly to COPD and its associated systemic inflammation or secondary to other factors such as concomitant ischaemic heart disease (IHD) or smoking status. The aim of this study was to evaluate IHD and smoking as potential causes of raised ...\n4. Chronic obstructive pulmonary disease (COPD) constitutes a set of heterogeneous symptoms affecting millions of people worldwide. The associated comorbidities developing in COPD involve dysregulation in physiological pathways resulting from systemic inflammation ...\n5. Conclusion The levels of CRP in the stable COPD patients were not significantly different when compared to those in the control subjects. Female sex and FVC (% predicted) were associated with CRP levels greater than 3 mg/dL in the COPD group. Keywords: case-control study, chronic obstructive pulmonary disease, C-reactive protein, comorbidity Go to:",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does high CRP level reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD)?",
               "answer": "The provided evidence does not support the conclusion that high CRP levels reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD). In fact, the second snippet mentions that the prognostic role of baseline C-reactive protein (CRP) in COPD is controversial, indicating that there is uncertainty regarding its predictive",
               "rationale": "1. Introduction. Chronic obstructive pulmonary disease (COPD) is currently the third most frequent cause of disability and mortality globally in patients older than 40, with an estimated prevalence of 174 million affected and 3.2 million mortalities worldwide in 2015, even though many studies postulate that these figures are likely understated [1,2].The disorder is associated with preserved ...\n2. The prognostic role of baseline C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) is controversial. In order to clarify this issue, we performed a systematic review and meta-analysis to assess the predictive effect of baseline CRP level in COPD patients. 15 eligible articles focusing on late mortality in COPD were included in our study. We performed a random-effects meta ...\n3. Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD exacerbations are associated with a worsening of lung function, increased disease burden, and mortality, and, therefore, preventing their occurrence is an important goal of COPD management. This review was conducted to identify the evidence base regarding risk factors and predictors of ...\n4. In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized by an acute deterioration in respiratory symptoms, are fundamental events impacting negatively upon disease progression, comorbidities, wellbeing and mortality. ECOPD also represent the largest component of the soc …\n5. Introduction. Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are episodes of symptom worsening 1 that have significant adverse consequences for patients. 2 The important causes of exacerbations include airway bacteria, viruses, and pollution; however, the interplay of these triggers must also be considered. It is recognized that defects in immunity and host defense lead ...",
               "predicate": null
            }
         ],
         "row": 571,
         "id": 585004758663285506
      },
      {
         "claim": "High-sensitivity cardiac troponin T (HSCT-T) dosage may not be diagnostic if the onset of symptoms occurs less than 3 hours before acute myocardial injury (AMI).",
         "label": 1,
         "prediction": 1,
         "rationale": "The relationship between HSCT-T dosage and acute myocardial injury (AMI) is not directly addressed in the provided evidence snippets. The minimum time required for HSCT-T dosage to be diagnostic for acute myocardial injury (AMI) cannot be determined based on the provided information. The minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI) is not specified. The minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI) is not specified. The minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI) is typically at least 2 hours after the onset of symptoms. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between HSCT-T dosage and acute myocardial injury (AMI)?",
               "answer": "The provided evidence snippets do not directly address the relationship between HSCT-T (Hematopoietic Stem Cell Transplantation with a specific dosage) and acute myocardial injury (AMI). However, they do indicate that HSCT can be associated with complications such as thrombotic microangiopathy (TA-TMA) and",
               "rationale": "1. The diagnosis of myocardial infarction is applied when acute myocardial injury occurs in a patient with symptoms or signs of myocardial ischaemia on the electrocardiogram (ECG), or new imaging evidence of a regional wall motion abnormality in a coronary territory. Myocardial infarction is further stratified into five main subtypes ( Figure 1 ...\n2. However, cTn is actually more often elevated in patients who do not have acute coronary syndromes. , , , , , , , Such patients are defined as having myocardial injury and are becoming more common with the introduction of high-sensitivity cardiac troponin (hs-cTn) assays.\n3. Abstract Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-TMA) is now a well-recognized and potentially severe complication of HSCT that carries a high risk of death. In those who survive, TA-TMA may be associated with long-term morbidity and chronic organ injury.\n4. Myocardial injury after noncardiac surgery is defined by elevated postoperative cardiac troponin concentrations that exceed the 99th percentile of the upper reference limit of the assay and are attributable to a presumed ischemic mechanism, with or without concomitant symptoms or signs. Myocardial injury after noncardiac surgery occurs in ≈20% of patients who have major inpatient surgery ...\n5. However, the association between HSCT and early- and late-onset cardiotoxicity remains controversial as these cardiac complications, including acute heart failure and arrhythmia, such as atrial ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the minimum time required for HSCT-T dosage to be diagnostic for acute myocardial injury (AMI)?",
               "answer": "The provided evidence snippets do not contain specific information regarding the minimum time required for HSCT-T dosage to be diagnostic for acute myocardial injury (AMI). Therefore, based on the given information, it is not possible to determine the minimum time required for HSCT-T dosage to be diagnostic for AMI.",
               "rationale": "1. In the High-STEACS study, the risk of subsequent cardiovascular death or myocardial infarction in patients with acute myocardial injury and chronic myocardial injury was four-fold higher than in those without myocardial injury (cause specific hazard ratios 4.38, 95% CI 3.80 to 5.05) and (3.88, 95% CI 3.31 to 4.55), respectively.\n2. Myocardial injury after noncardiac surgery is defined by elevated postoperative cardiac troponin concentrations that exceed the 99th percentile of the upper reference limit of the assay and are attributable to a presumed ischemic mechanism, with or without concomitant symptoms or signs. Myocardial injury after noncardiac surgery occurs in ≈20% of patients who have major inpatient surgery ...\n3. 1 B-NR 1. Patients with acute chest pain and a 30-day risk of death or MACE <1% should be designated as low risk. 2a B-R 2. In patients with acute chest pain and suspected ACS who are deemed low-risk (<1% 30-day risk of death or MACE), it is reasonable to discharge home without admission or urgent cardiac testing.\n4. Kidney injury, both acute (AKI) and chronic (CKD), is a well documented consequence of TA-TMA. In general, AKI and CKD remain as significant complications for many HSCT recipients, regardless of whether they develop TA-TMA or not . For example, Rajpal et al. recently compared the incidence of dialysis-requiring AKI in the first 100 days after ...\n5. Type 2 MI may arise in the context of various acute medical and surgical conditions that are similarly associated with nonischemic myocardial injury, making the differentiation between type 2 MI and acute nonischemic myocardial injury challenging in common clinical settings. 4,24 Some investigators have simply reported the prevalence and ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the minimum time required for high-sensitivity cardiac troponin T (HSCT-T) dosage to be diagnostic for acute myocardial injury (AMI)?",
               "answer": "The provided evidence snippet does not specify the minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI). Therefore, based on the information given, it is not possible to determine the exact time frame for hs-cTnT to be",
               "rationale": "1. This evidence-based, multidisciplinary, critical appraisal of the acute chest pain and high-sensitivity cardiac troponin (hs-cTn) recommendations from the 2021 American Heart Association (AHA)/American College of Cardiology (ACC)/American Society of Echocardiography/American College of Chest Physicians/Society for Academic Emergency Medicine ...\n2. The definition of high-sensitivity assays is that it is able to detect troponin in healthy subjects without myocardial injury (i.e a few nanograms of troponin per liter blood).\n3. Despite uneasiness among clinicians about the increasing sensitivity of assays for cardiac troponin (cTn), it is rare that clinical algorithms for laboratory-based tests have as much data to guide decision making as do high-sensitivity assays for cTn (hsTn) for diagnosis (rule-in) or exclusion (rule-out) of myocardial infarction (MI).\n4. This primer discusses the use of high-sensitivity cardiac troponin (hs-cTn) testing in context of the 2021 multisociety guidelines for the evaluation and diagnosis of acute chest pain, with a notable focus on analytical aspects of the hs-cTn assays and their implications.\n5. Abstract High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin concentrations and resolve minor changes in biomarker concentrations. Clinically, this allows for the ability to rapidly identify or exclude acute myocardial injury in the setting of acute chest discomfort—thus providing more rapid evaluation for acute myocardial infarction—but the ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI)?",
               "answer": "The provided evidence snippets do not specify the minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI). Therefore, based on the information given, I cannot provide a definitive answer to that question. For accurate information, it would be best",
               "rationale": "1. This evidence-based, multidisciplinary, critical appraisal of the acute chest pain and high-sensitivity cardiac troponin (hs-cTn) recommendations from the 2021 American Heart Association (AHA)/American College of Cardiology (ACC)/American Society of Echocardiography/American College of Chest Physicians/Society for Academic Emergency Medicine/Society of Cardiovascular Computed Tomography ...\n2. Assays for cTn, namely cTnI and cardiac troponin T (cTnT), are the preferred diagnostic tests for ACS, in particular non-ST-segment-elevation myocardial infarction, because of the tissue-specific expression of cTnI and cTnT in the myocardium. The results of cTn testing often guide the decision for coronary intervention. However, although the increasing sensitivity of cTn assays lowers the ...\n3. Abstract High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin concentrations and resolve minor changes in biomarker concentrations. Clinically, this allows for the ability to rapidly identify or exclude acute myocardial injury in the setting of acute chest discomfort—thus providing more rapid evaluation for acute myocardial infarction—but the ...\n4. This primer discusses the use of high-sensitivity cardiac troponin (hs-cTn) testing in context of the 2021 multisociety guidelines for the evaluation and diagnosis of acute chest pain, with a notable focus on analytical aspects of the hs-cTn assays and their implications.\n5. Despite uneasiness among clinicians about the increasing sensitivity of assays for cardiac troponin (cTn), it is rare that clinical algorithms for laboratory-based tests have as much data to guide decision making as do high-sensitivity assays for cTn (hsTn) for diagnosis (rule-in) or exclusion (rule-out) of myocardial infarction (MI). Rather, the proliferation of research evaluating variations ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI)?",
               "answer": "The minimum time required for high-sensitivity cardiac troponin T (hs-cTnT) dosage to be diagnostic for acute myocardial injury (AMI) is typically at least 2 hours after the onset of symptoms. This is supported by the evidence indicating that 0/1-hour testing appears reasonable in otherwise low-risk",
               "rationale": "1. Rubini Gimenez M, Twerenbold R, Reichlin T, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014 Sep 7;35(34):2303-11. Gore MO, Seliger SL, Defilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.\n2. 1. Clinical assessment of the probability of MI and timing of onset of symptoms. 2. Serial testing at presentation and at 1 to 3 hours later; 0/1-hour testing appears reasonable in otherwise low-risk patients who have presented >2 hours after symptom onset.\n3. Cardiac troponin (cTn) testing is an essential component of the diagnostic workup and management of acute coronary syndromes (ACS). Although over the past 15 years the diagnostic performance of the previous gold-standard assay, creatine kinase-MB, has not changed appreciably, the ever-increasing sensitivity of cTn assays has had a dramatic impact on the use of cTn testing to diagnose ACS. 1 ...\n4. Figure 1. Use of optimized thresholds with high-sensitivity cardiac troponin assays. Extensive data including observational studies, meta-analyses, and the largest high-sensitivity cardiac troponin (hs-cTn) randomized trial (HiSTORIC [High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction]) show that optimized rule-out thresholds (for selected hs-cTn assays thus ...\n5. Cardiac troponin is the preferred biomarker for the diagnosis of acute myocardial infarction (AMI). The recent development of a high-sensitive cardiac troponin T (hs-cTnT) assay permits detection of very low levels of cTnT. Using the hs-cTnT assay improves the overall diagnostic accuracy in patients with suspected AMI, while a negative result ...",
               "predicate": null
            }
         ],
         "row": 572,
         "id": 194240120415271661
      },
      {
         "claim": "Histone demethylase recruitment and a transient decrease in histone methylation is necessary for ligand-dependent induction of transcription by nuclear receptors.",
         "label": 1,
         "prediction": 1,
         "rationale": "Histone demethylase is an enzyme that removes methyl groups from histones, playing a crucial role in regulating gene expression by dynamically controlling histone methylation and influencing chromatin structure and transcriptional activity. Histone demethylase recruitment affects ligand-dependent induction of transcription by nuclear receptors. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is histone demethylase?",
               "answer": "Histone demethylase is an enzyme that removes methyl (CH3) groups from histones, which are proteins that help package DNA in the nucleus. These enzymes play a crucial role in regulating gene expression and are important for various physiological processes by dynamically controlling histone methylation, thereby influencing chromatin structure and transcriptional",
               "rationale": "1. Histone demethylases are important for both chromatin structure and transcription. The insights being gained into their regulation and target specificity have important implications for both ...\n2. Demethylase. Demethylases are enzymes that remove methyl (CH 3) groups from nucleic acids, proteins (particularly histones ), and other molecules. Demethylases are important epigenetic proteins, as they are responsible for transcriptional regulation of the genome by controlling the methylation of DNA and histones, and by extension, the ...\n3. Histone methylation plays fundamental roles in regulating chromatin‐based processes. With the discovery of histone demethylases over a decade ago, it is now clear that histone methylation is dynamically regulated to shape the epigenome and regulate important nuclear processes including transcription, cell cycle control and DNA repair. In addition, recent observations suggest that these ...\n4. Histone demethylases (KDMs) regulate gene expression and play essential roles in numerous physiological processes by removing methyl groups from lysine residues on target proteins.\n5. Numerous studies have shown that mutation or misregulation of histone methylation, methyltransferases, demethylases and methyl-lysine-binding proteins are associated with various diseases. 16 ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does histone demethylase recruitment affect ligand-dependent induction of transcription by nuclear receptors?",
               "answer": "Yes, histone demethylase recruitment affects ligand-dependent induction of transcription by nuclear receptors. The evidence indicates that LSD1, a histone demethylase, is recruited to active promoters and is necessary for the activation of gene targets in response to ligands. This suggests that the presence of histone demethylases like",
               "rationale": "1. The major enhancer regulator lysine-specific histone demethylase 1A (LSD1) is required for mammalian embryogenesis and is implicated in human congenital diseases and multiple types of cancer ...\n2. Lysine-specific histone demethylase 1 (LSD1) represents the first example of an identified nuclear protein with histone demethylase activity. In particular, it plays a special role in the ...\n3. Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone ...\n4. Histone demethylases are important for both chromatin structure and transcription. The insights being gained into their regulation and target specificity have important implications for both ...\n5. Regulated transcription by nuclear receptors is mediated by ligands binding to the C-terminal domain, ... Here we report an unexpectedly widespread recruitment of the histone demethylase LSD1 to active promoters, including most ER α gene targets in MCF7 cells, and we find that LSD1 is needed for activation and is required to oppose the ...",
               "predicate": null
            }
         ],
         "row": 573,
         "id": 153855592406886420
      },
      {
         "claim": "Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) patients produce Immunoglobulin G (IgG) antibodies which cross-react with an immunodominant epitope in Tax.",
         "label": 1,
         "prediction": 1,
         "rationale": "Tax is an oncoprotein produced by the Human T-lymphotropic virus type 1 (HTLV-1) that plays a crucial role in viral gene expression and the pathogenesis of diseases associated with the virus, such as adult T-cell leukemia (ATL), by transactivating the viral promoter. Immunoglobulin G (IgG) antibodies produced by HAM/TSP patients cross-react with an immunodominant epitope in Tax. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Tax in the context of Human T-lymphotropic virus type-I?",
               "answer": "Tax is an oncoprotein produced by the Human T-lymphotropic virus type 1 (HTLV-1) that plays a crucial role in viral gene expression and the pathogenesis of diseases associated with the virus, such as adult T-cell leukemia (ATL). It functions by transactivating the viral promoter",
               "rationale": "1. Human T-cell lymphotropic virus type 1 (HTLV-1) Tax oncoprotein is required for viral gene expression. Tax transactivates the viral promoter by recruiting specific transcription factors but also by interfering with general transcription factors involved in the preinitiation step, such as TFIIA and TFIID.\n2. Human T-cell lymphotropic virus type 1 (HTLV-1) has been identified as the causative agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The virus infects between 15 and 20 million people worldwide of which approximately 2-5% develop ATL. The past 35 years of research have yielded ...\n3. HTLV-1 is the etiological agent of adult T-cell leukemia (ATL), the neurological syndrome TSP/HAM and certain other clinical disorders. The viral Tax protein is considered to play a central role in the process leading to ATL. Tax modulates the expression of many viral and cellular genes through the CREB/ATF-, SRF- and NF-kappaB-associated ...\n4. Adult T-cell leukemia/lymphoma (ATLL) is caused by human T-cell leukemia virus type 1 (HTLV-1). HTLV-1-associated mRNA, including HBZ and tax, is deeply involved in the pathogenesis of ATLL. Using ...\n5. Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma (ATL), a malignancy of CD4 + T cells whose etiology is thought to be associated with the viral trans-activator Tax.We have shown recently that Tax can drastically upregulate the expression of p27 Kip1 and p21 CIP1/WAF1 through protein stabilization and mRNA trans-activation and stabilization ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Immunoglobulin G (IgG) antibodies produced by HAM/TSP patients cross-react with an immunodominant epitope in Tax?",
               "answer": "Yes, Immunoglobulin G (IgG) antibodies produced by HAM/TSP patients cross-react with an immunodominant epitope in Tax. The evidence indicates that HAM/TSP immunoglobulin G identified hnRNP A1 as the autoantigen, and tax monoclonal antibodies (MAbs)",
               "rationale": "1. In neuronal extracts, HAM/TSP immunoglobulin G identified heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as the autoantigen. Importantly, tax MAbs reacted with hnRNP A1. To identify the epitope recognized by the tax MAbs, the fine epitope specificity of the antibodies was determined using overlapping peptides.\n2. Immunoglobulin G (IgG) is the predominant glycoprotein present in human serum, constituting about 75-80% of total immunoglobulin in humans which accounts for 10 to 16mg/ml serum concentration and is produced as part of the secondary immune response to an antigen. IgG is usually found as monomers and has an average half-life of 23 days and is ...\n3. This test checks the amount of certain antibodies called immunoglobulins in your body. Antibodies are proteins that your immune cells make to fight off bacteria, viruses, and other harmful ...\n4. Immunoglobulins (Ig) or antibodies are glycoproteins produced by plasma cells. B cells are instructed by specific immunogens, for example, bacterial proteins, to differentiate into plasma cells. Plasma cells are protein-making cells participating in humoral immune responses against bacteria, viruses, fungi, parasites, cellular antigens, chemicals, and synthetic substances.[1] Immunoglobulins ...\n5. The water-accessible surface area of an IgG antibody. Immunoglobulin G ( IgG) is a type of antibody. Representing approximately 75% of serum antibodies in humans, IgG is the most common type of antibody found in blood circulation. [1] IgG molecules are created and released by plasma B cells. Each IgG antibody has two paratopes .",
               "predicate": null
            }
         ],
         "row": 574,
         "id": 173228348975752121
      },
      {
         "claim": "Hyperfibrinogenemia decreases rates of femoropopliteal bypass thrombosis.",
         "label": 0,
         "prediction": 0,
         "rationale": "Hyperfibrinogenemia is a condition characterized by elevated levels of fibrinogen in the blood, specifically defined as fibrinogen levels between 400 - 600 mg/dl in adults. Hyperfibrinogenemia does not decrease the rate of thrombosis in femoropopliteal bypass. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hyperfibrinogenemia?",
               "answer": "Hyperfibrinogenemia is a condition characterized by elevated levels of fibrinogen in the blood. Specifically, mild hyperfibrinogenemia is defined as fibrinogen levels between 400 - 600 mg/dl in adults. This condition can be associated with various underlying causes, including menstruation or drug",
               "rationale": "1. Recently described genetically altered mice with chronically increased plasma fibrinogen levels in the absence of underlying inflammation provide a novel experimental tool to investigate the cause-effect relationship between hyperfibrinogenemia and vascular disease. 18 The mutant mouse strain (hereafter referred to as Hifib mice) was derived by pronuclear oocyte microinjection of the entire ...\n2. Hyperfibrinogenemia or a high fibrinogen level in the blood means: Mild hyperfibrinogenemia (400 - 600 mg/dl in adults): When there is a mild hyperfibrinogenemia is recommended to visit your doctor and study the possible underlying causes. It may be due to menstruation or drug interference. Therefore, it is advisable to make a new test in a few ...\n3. Fibrinogen plays a pivotal role in hemostasis and host defense and facilitates wound healing. Fibrinogen disorders can have both hemorrhagic and thrombotic manifestations, as well as effects on pregnancy. This topic describes the pathophysiology, clinical presentation, diagnosis, and treatment of inherited and acquired fibrinogen disorders.\n4. A piece of the \"cause-and-effect\" puzzle has been answered. However, it is still unclear whether modest hyperfibrinogenemia contributes to the development of atherothrombotic diseases—in particular, coronary heart disease and myocardial infarction. Further studies are necessary to resolve this important question.\n5. Congenital dysfibrinogenemia (CD) is caused by structural changes in fibrinogen that modify its function. Diagnosis is based on discrepancy between decreased fibrinogen activity and normal fibrinogen antigen levels and is confirmed by genetic testing. CD is caused by monoallelic mutations in fibrinogen genes that lead to clinically heterogenous ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does hyperfibrinogenemia decrease the rate of thrombosis in femoropopliteal bypass?",
               "answer": "The provided evidence does not support the conclusion that hyperfibrinogenemia decreases the rate of thrombosis in femoropopliteal bypass. In fact, it suggests the opposite. Evidence 1 indicates that hyperfibrinogenemia is correlated with both arterial and venous thrombosis. Evidence 2 discusses",
               "rationale": "1. The shear rates between arteries and veins differ significantly; in humans, large arteries, such as the carotid, have wall shear rates of 300 to 800 inverse seconds, whereas venous shear rates are in the range of 20 to 200 inverse seconds. 46 Interestingly, hyperfibrinogenemia has been correlated with both arterial and venous thrombosis ...\n2. The effect of hyperfibrinogenemia on stasis-induced thrombus formation was investigated by employing an established experimental protocol that reduces blood flow in the common carotid artery to a residual, pulsatile mode and induces reproducible alterations of arterial wall function by a combination of neointimal hyperplasia and vascular ...\n3. The 5-year patency rates of femoropopliteal bypass grafts are reported as ... Patients undergoing surgical bypass for lower extremity ischemia should be entered into a clinical surveillance program that consists of ... Prins MH. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database ...\n4. Elevated plasma levels of fibrinogen are strongly associated with human vascular disease. The Northwick Park Heart Study, which prospectively followed more than 1500 men for a mean of 10 years, found that elevated plasma fibrinogen at recruitment was independently associated with subsequent cardiovascular risk, with an increase in baseline ...\n5. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood . 2011; 117 :4953-4963. doi: 10.1182/blood-2010-11-316885. Crossref",
               "predicate": null
            }
         ],
         "row": 575,
         "id": 234645170785885167
      },
      {
         "claim": "Hyperfibrinogenemia increases rates of femoropopliteal bypass thrombosis.",
         "label": 1,
         "prediction": 0,
         "rationale": "Hyperfibrinogenemia is a condition characterized by elevated levels of fibrinogen in the blood, specifically defined as mild hyperfibrinogenemia when levels are between 400 - 600 mg/dl in adults. Hyperfibrinogenemia is associated with an increased risk of thrombosis. Femoropopliteal bypass surgery's proneness to thrombosis is not explicitly mentioned in the provided evidence. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hyperfibrinogenemia?",
               "answer": "Hyperfibrinogenemia is a condition characterized by elevated levels of fibrinogen in the blood, specifically defined as mild hyperfibrinogenemia when levels are between 400 - 600 mg/dl in adults. It may be associated with various underlying causes, including menstruation or drug interference, and it",
               "rationale": "1. Hyperfibrinogenemia or a high fibrinogen level in the blood means: Mild hyperfibrinogenemia (400 - 600 mg/dl in adults): When there is a mild hyperfibrinogenemia is recommended to visit your doctor and study the possible underlying causes. It may be due to menstruation or drug interference. Therefore, it is advisable to make a new test in a few ...\n2. Fibrinogen plays a pivotal role in hemostasis and host defense and facilitates wound healing. Fibrinogen disorders can have both hemorrhagic and thrombotic manifestations, as well as effects on pregnancy. This topic describes the pathophysiology, clinical presentation, diagnosis, and treatment of inherited and acquired fibrinogen disorders.\n3. Congenital dysfibrinogenemia (CD) is caused by structural changes in fibrinogen that modify its function. Diagnosis is based on discrepancy between decreased fibrinogen activity and normal fibrinogen antigen levels and is confirmed by genetic testing. CD is caused by monoallelic mutations in fibrinogen genes that lead to clinically heterogenous ...\n4. Recently described genetically altered mice with chronically increased plasma fibrinogen levels in the absence of underlying inflammation provide a novel experimental tool to investigate the cause-effect relationship between hyperfibrinogenemia and vascular disease. 18 The mutant mouse strain (hereafter referred to as Hifib mice) was derived by pronuclear oocyte microinjection of the entire ...\n5. What is the treatment for hyperfibrinogenemia? —James Patel, MD, Stockton, Calif. Plasma fibrinogen is increasingly recognized as an independent risk factor for stroke and ischemic heart disease ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is hyperfibrinogenemia associated with an increased risk of thrombosis?",
               "answer": "Yes, hyperfibrinogenemia is associated with an increased risk of thrombosis. The evidence indicates that elevated plasma fibrinogen levels are linked to cardiovascular disease and both arterial and venous thrombosis. Additionally, studies have shown a dose effect, where the risk of death or thrombosis increases in individuals with higher",
               "rationale": "1. Introduction. Elevated plasma fibrinogen is associated with risk of cardiovascular disease and arterial and venous thrombosis. 1 -9 Several studies have detected dose effects, with increased risk of death or thrombosis in subjects with the highest plasma fibrinogen concentrations. 6 -9 The Framingham 7 and Fragmin During Instability in Coronary Artery Disease 8 studies positively ...\n2. The disease risk associated with hyperfibrinogenemia is disproportionally augmented in those individuals with the highest fibrinogen levels, indicating a threshold effect. ... Hifib/TMPro mice therefore allowed us to investigate the consequences of hyperfibrinogenemia in animals that displayed increased susceptibility to thrombosis.\n3. Previous in vivo studies have produced contradictory results regarding the role of elevated fibrinogen in thrombosis. Several of these studies were based on a murine transgenic model with raised (murine) fibrinogen (1.5- to 2-fold) levels. 4 The fibrinogen used in the study by Machlus and colleagues was of both human and murine origin. Human fibrinogen is known to contain variations that are ...\n4. Epidemiologic studies have correlated elevated plasma fibrinogen (hyperfibrinogenemia) with risk of cardiovascular disease and arterial and venous thrombosis. However, it is unknown whether hyperfibrinogenemia is merely a biomarker of the proinflammatory disease state or is a causative mechanism in …\n5. Fibrinogen plays a pivotal role in hemostasis and host defense and facilitates wound healing. Fibrinogen disorders can have both hemorrhagic and thrombotic manifestations, as well as effects on pregnancy. This topic describes the pathophysiology, clinical presentation, diagnosis, and treatment of inherited and acquired fibrinogen disorders.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is femoropopliteal bypass a type of surgery that is prone to thrombosis?",
               "answer": "The provided evidence does not explicitly mention whether femoropopliteal bypass surgery is prone to thrombosis. However, it does describe the procedure and its purpose, which is to improve blood flow in the leg by bypassing narrowed or blocked arteries. While the risk of thrombosis can be a concern in any surgical procedure",
               "rationale": "1. Femoral popliteal bypass surgery is used to treat a blocked femoral artery. The femoral artery is the largest artery in the thigh. It supplies oxygen-rich blood to the leg. ... Once the surgeon has attached the graft onto the diseased artery, a type of X-ray called an arteriogram may be done to make sure that blood flow has been restored to the ...\n2. A femoropopliteal bypass is a type of surgery. It is also called a fem-pop or leg artery bypass. This type of surgery redirects blood around a narrowed or blocked blood vessel in your leg. So it may improve the blood flow in your leg. This can decrease leg pain, numbness, and cramping. Your doctor will use something...\n3. Popliteal bypass surgery, more commonly known as femoropopliteal bypass (FPB, fem-pop, etc.) or more generally as lower extremity bypass surgery, is a surgical procedure used to treat diseased leg arteries above or below the knee. It is used as a medical intervention to salvage limbs that are at risk of amputation and to improve walking ability in people with severe intermittent claudication ...\n4. Femoropopliteal (fem-pop) bypass surgery is used to bypass narrowed or blocked arteries above or below the knee. The bypass improves blood flow to the leg. To bypass a narrowed or blocked artery, blood is redirected through a graft. The graft is either a healthy blood vessel that has been transplanted or a human-made material.\n5. Femoral popliteal (also called femoropopliteal or Fem-Pop) bypass surgery is a procedure used to treat femoral artery disease. It is performed to bypass the blocked portion of main artery in the leg using a piece of another blood vessel. Femoral popliteal bypass surgery: Conditions treated.",
               "predicate": null
            }
         ],
         "row": 576,
         "id": 136418042673721845
      },
      {
         "claim": "Hypocretin neurones induce panicprone state in rats.",
         "label": 1,
         "prediction": 1,
         "rationale": "Hypocretin neurons, also known as orexin neurons, are specialized neurons located exclusively in the lateral hypothalamic area of the brain that produce neuropeptides called orexin A and orexin B, regulating arousal. Hypocretin (orexin) neurons induce a panic-prone state in rats. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are hypocretin neurones?",
               "answer": "Hypocretin neurons, also known as orexin neurons, are specialized neurons located exclusively in the lateral hypothalamic area of the brain. They produce neuropeptides called orexin A and orexin B (or hypocretin 1 and hypocretin 2), which play crucial roles in regulating arousal",
               "rationale": "1. Orexin (/ ɒ ˈ r ɛ k s ɪ n /), also known as hypocretin, is a neuropeptide that regulates arousal, wakefulness, and appetite. It exists in the forms of orexin-A and orexin-B.The most common form of narcolepsy, type 1, in which the individual experiences brief losses of muscle tone (\"drop attacks\" or cataplexy), is caused by a lack of orexin in the brain due to destruction of the cells that ...\n2. Hypocretin/orexin neurons are distributed restrictively in the hypothalamus, a brain region known to orchestrate diverse functions including sleep, reward processing, food intake, thermogenesis, and mood. Since the hypocretins/orexins were discovered more than two decades ago, extensive studies have accumulated concrete evidence showing the ...\n3. The neuropeptides orexin A and orexin B (also known as hypocretin 1 and hypocretin 2), produced in hypothalamic neurons, are crucial regulators of sleep and wakefulness.\n4. Hypocretin cells are sensitive to glucose and food deprivation 46,47,48,49,50: the activity of hypocretin neurons and their expression of hypocretin mRNA and c-Fos increases during hypoglycaemia ...\n5. Hypocretin (Hcrt) neurons are located exclusively in the lateral hypothalamic area (pale pink) and project widely across the brain. Hcrt-1 and Hcrt-2 interact with both receptors (Hcrt-R1 and Hcrt-R2), Hcrt-1 with equal, high affinity for Hcrt-R1 and R2, Hcrt-2 with a similar high affinity for Hcrt-R2 but lower (∼10-fold) for Hcrt-R1.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do hypocretin neurons induce a panic-prone state in rats?",
               "answer": "Yes, hypocretin (orexin) neurons induce a panic-prone state in rats. Evidence from the provided snippets indicates that activation of orexin-synthesizing neurons is necessary for developing a panic-prone state in a rat panic model.",
               "rationale": "1. In addition to the circuitry that modulates energy balance, hypocretin neurons contact several hypothalamic nuclei involved in sleep and wakefulness, including the ventrolateral preoptic nucleus (VLPO), the dorsomedial hypothalamus (DMH), and the tuberomammilary nucleus (TMN). Hypocretin neurons only account for 4% of the lateral hypothalamic ...\n2. Abstract. Hypocretin/orexin neurons are distributed restrictively in the hypothalamus, a brain region known to orchestrate diverse functions including sleep, reward processing, food intake, thermogenesis, and mood. Since the hypocretins/orexins were discovered more than two decades ago, extensive studies have accumulated concrete evidence ...\n3. Abstract. The lateral hypothalamus is comprised of a heterogeneous mix of neurons that serve to integrate and regulate sleep, feeding, stress, energy balance, reward, and motivated behavior. Within these populations, the hypocretin/orexin neurons are among the most well studied. Here, we provide an overview on how these neurons act as a central ...\n4. The dorsomedial-perifornical hypothalamus is enriched in neurons containing orexin (ORX, also known as hypocretin), which have a crucial role in arousal, vigilance and central autonomic mobilization, all of which are key components of panic. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state ...\n5. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state in the rat panic model, and either silencing of the hypothalamic gene encoding ORX (Hcrt ...",
               "predicate": null
            }
         ],
         "row": 577,
         "id": 253445261972349094
      },
      {
         "claim": "Hypoglycemia increases the risk of dementia.",
         "label": 1,
         "prediction": 1,
         "rationale": "Hypoglycemia is a condition characterized by abnormally low blood sugar levels, typically defined as being below 70 mg/dL. There is a link between hypoglycemia and dementia, with evidence suggesting that hypoglycemia increases the risk of developing dementia and dementia can also increase the risk of hypoglycemia. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is hypoglycemia?",
               "answer": "Hypoglycemia is a condition characterized by abnormally low blood sugar levels, typically defined as being below 70 mg/dL. It can occur in individuals with diabetes or those without diabetes due to various factors such as medications, diseases, or lifestyle choices. Symptoms may include fast heartbeat, shaking, confusion, and seizures,",
               "rationale": "1. Hypoglycemia is a condition in which your blood sugar level is lower than the standard range. Learn about the signs, causes and treatment of hypoglycemia, and how to prevent it.\n2. Hypoglycemia is when the level of sugar in your blood drops below the healthy range. It can be common in people with diabetes and requires immediate treatment with carbohydrates. Learn about the causes, symptoms, diagnosis and prevention of low blood sugar.\n3. Hypoglycemia is a condition caused by low blood glucose levels. It can affect people with diabetes or those who don't have diabetes due to certain medications, diseases, or lifestyle factors. Learn how to recognize, treat, and prevent hypoglycemia.\n4. Hypoglycemia is when your blood glucose levels are too low and need to be raised quickly. Learn the causes, signs, and how to treat it with the 15-15 rule or glucagon.\n5. Low blood sugar is when your blood sugar level is below 70 mg/dL. It can be dangerous if left untreated and cause symptoms like fast heartbeat, shaking, confusion, or seizures. Learn how to prevent, identify, and treat low blood sugar.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is there a link between hypoglycemia and dementia?",
               "answer": "Yes, there is a link between hypoglycemia and dementia. The evidence suggests that hypoglycemia increases the risk of developing dementia, and conversely, dementia can increase the risk of hypoglycemia due to difficulties in managing diabetes treatment. This reciprocal association highlights the intricate relationship between the two conditions, indicating that both can",
               "rationale": "1. In light of new evidence, a deeper understating of the relationship between hypoglycemia and dementia can help to inform and guide preventative strategies. In this review, we discuss the epidemiology of dementia among patients with diabetes, and the emerging mechanisms thought to underlie the association between hypoglycemia and dementia.\n2. Another factor relates to the episodes of hypoglycemia that commonly occur in diabetes. Although tight control of blood sugars has been proven to reduce the long-term risks of heart disease and strokes, tight control can also lead to hypoglycemia, memory loss, and dementia.\n3. Furthermore, there exists a reciprocal association between hypoglycemia and dementia [ 5 ], wherein hypoglycemia increases the risk of dementia, and dementia in turn increases the risk of hypoglycemia due to difficulty in managing complex DM treatment regimens.\n4. It also examines critical factors such as early-stage diabetes, hypoglycemia, diabetes control, glycated hemoglobin, and fasting blood sugar, enhancing our understanding of the intricate link between diabetes and dementia.\n5. In this study, we aim to examine the association between dementia and the risk of developing hypoglycaemia among the DM population, and our findings might support and extend the previous literature that dementia is an important risk factor for the development of hypoglycaemia.",
               "predicate": null
            }
         ],
         "row": 578,
         "id": 332922128661115318
      },
      {
         "claim": "Hypothalamic glutamate neurotransmission is crucial to energy balance.",
         "label": 1,
         "prediction": 1,
         "rationale": "Glutamate neurotransmission plays a crucial role in the brain as the principal excitatory neurotransmitter, essential for functions such as learning and memory, and is involved in over 90% of synaptic connections in the vertebrate nervous system. Glutamate neurotransmission in the hypothalamus is related to energy balance. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of glutamate neurotransmission in the body?",
               "answer": "Glutamate neurotransmission plays a crucial role in the brain as the principal excitatory neurotransmitter. It is essential for various functions, including learning and memory, and is involved in over 90% of synaptic connections in the vertebrate nervous system. Glutamate is stored in synaptic vesicles and released by",
               "rationale": "1. Glutamate is the most abundant excitatory neurotransmitter released by nerve cells in your brain. It plays a major role in learning and memory. For your brain to function properly, glutamate needs to be present in the right concentration in the right places at the right time. Too much glutamate is associated with such diseases as Parkinson's ...\n2. The important role of glutamate uptake in the control of the excitatory action of glutamate was recognized ... A third topic is why the body needs several different glutamate transporters, and how they can be pharmacologically modulated. ... Wiessner M. Glia-neuron interaction by high-affinity glutamate transporters in neurotransmission. Adv ...\n3. Storage and Transmission. Over the past three decades, researchers have learned that glutamate is the major excitatory neurotransmitter of the healthy mammalian brain, as the most profuse free amino acid that happens to sit at the intersection between several metabolic pathways (Watkins and Jane, 2006; Zhou and Danbolt, 2014).Glutamate is stored in synaptic vesicles of nerve terminals until it ...\n4. In neuroscience, glutamate is the anion of glutamic acid in its role as a neurotransmitter (a chemical that nerve cells use to send signals to other cells). It is by a wide margin the most abundant excitatory neurotransmitter in the vertebrate nervous system. It is used by every major excitatory function in the vertebrate brain, accounting in total for well over 90% of the synaptic connections ...\n5. Glutamate is the principal excitatory neurotransmitter in brain. Our knowledge of the glutamatergic synapse has advanced enormously in the last 10 years, primarily through application of molecular biological techniques to the study of glutamate receptors and transporters. There are three families of ionotropic receptors with intrinsic cation permeable channels [N-methyl-D-aspartate (NMDA), α ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is glutamate neurotransmission in the hypothalamus related to energy balance?",
               "answer": "Yes, glutamate neurotransmission in the hypothalamus is related to energy balance. The hypothalamus is a primary center for the regulation of energy balance, and while the role of glutamate in this context has received less attention compared to neuropeptides, it is still significant. Glutamate is a neurotransmitter",
               "rationale": "1. Energy homeostasis is tightly regulated by the central nervous system, and the hypothalamus is the primary center for the regulation of energy balance. The hypothalamus exerts its effect through ...\n2. It took a long time to realize that glutamate is a neurotransmitter in part because of its abundance in brain tissue and in part because it is at the crossroad of multiple metabolic pathways (e.g. Erecinska and Silver 1990; Broman et al. 2000; McKenna 2007; Hertz 2013 ). There is 5-15 mmol glutamate per kg brain tissue, depending on the ...\n3. The role of GABA and glutamate in regulating energy balance has received less attention in comparison to neuropeptides. ... A primary central nervous site for control of energy balance is the hypothalamus. This region is also intimately associated with the regulation of basic functions such as thirst, reproduction, temperature, hormonal ...\n4. The past 20 years witnessed an enormous leap in understanding of the central regulation of whole-body energy metabolism. Genetic tools have enabled identification of the region-specific expression of peripheral metabolic hormone receptors and have identified neuronal circuits that mediate the action of these hormones on behavior and peripheral tissue functions.\n5. Neurotransmitter Agents. During the last two decades attention has been focussed on the role of different neuropeptides in hypothalamic control of feeding behavior. Several hypothalamic peptides that participate in the control of ingestive behavior are produced in neuronal cell bodies of the arcuate nucleus and/or the later ….",
               "predicate": null
            }
         ],
         "row": 579,
         "id": 303170993541713138
      },
      {
         "claim": "IRG1 has antiviral effects against neurotropic viruses.",
         "label": 1,
         "prediction": 1,
         "rationale": "IRG1, or Immune-responsive gene 1, encodes aconitate decarboxylase (ACOD1), an enzyme that catalyzes the production of itaconic acid (ITA) from cis-aconitate, a metabolite in the tricarboxylic acid (TCA) cycle. IRG1 has antiviral effects against neurotropic viruses, particularly in neurons, as shown by its activity against distinct neurotropic flaviviruses such as Zika virus. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is IRG1?",
               "answer": "IRG1, or Immune-responsive gene 1, encodes aconitate decarboxylase (ACOD1), an enzyme that catalyzes the production of itaconic acid (ITA) from cis-aconitate, a metabolite in the tricarboxylic acid (TCA) cycle",
               "rationale": "1. Immune-responsive gene 1 (IRG1) encodes aconitate decarboxylase (ACOD1) that catalyzes the production of itaconic acids (ITAs). The anti-inflammatory function of IRG1/ITA has been established in multiple pathogen models, but very little is known in cancer. Here, we show that IRG1 is expressed in tum …\n2. Immune-responsive gene 1 (IRG1) encodes aconitate decarboxylase (ACOD1) that catalyzes the production of itaconic acids (ITAs). The anti-inflammatory function of IRG1/ITA has been established in multiple pathogen models, but very little is known in cancer.\n3. The host Immune-Responsive Gene 1 (Irg1; also called Acod1) is a mitochondrial enzyme induced under inflammatory conditions that produces the metabolite itaconate by decarboxylating cis-aconitate, a TCA cycle intermediate (Michelucci et al., 2013).Because itaconate production in myeloid cells reportedly inhibits bacterial ICLs, it has gained interest as an endogenous antibacterial effector ...\n4. Mucosal Immunology - Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation.\n5. Immunoresponsive gene 1 (Irg1) is highly expressed in mammalian macrophages during inflammation, but its biological function has not yet been elucidated. Here, we identify Irg1 as the gene coding for an enzyme producing itaconic acid (also known as methylenesuccinic acid) through the decarboxylation of cis-aconitate, a tricarboxylic acid cycle ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does IRG1 have antiviral effects against neurotropic viruses?",
               "answer": "Yes, IRG1 has antiviral effects against neurotropic viruses, as indicated by several studies. While overexpression of IRG1 did not affect RSV infection in certain cell lines, it has been shown to exert antiviral activity against distinct neurotropic flaviviruses, such as Zika virus, particularly in neurons.",
               "rationale": "1. Cho et al. reported that IRG1 was among three upregulated ISGs with antiviral effects against different neurotropic viruses . Although RSV infection promotes IRG1 expression, our data show that overexpression of IRG1 had no effect on RSV infection in 293T or A549 cells.\n2. Most studies describing DNA sensor mediated antiviral effects with neurotropic viruses have been performed with HSV. One cytoplasmic viral DNA sensor is cGAMP synthase (cGAS), which signals through an adaptor molecule, stimulator of IFN genes (STING). ... (Irg1 and Ifi27l2a) reportedly have antiviral activity in neurons against multiple viruses ...\n3. These data demonstrate that IRG1 exerts antiviral activity against distinct neurotropic flaviviruses in ... these data suggest that the antiviral effects of itaconate do not arise from changes to the infectious potential of ZIKV particles; rather, changes to neuronal metabolism appear to exert a global suppression on replication of the viral ...\n4. While studies of itaconate have predominantly focused on macrophages and models of bacterial infection, IRG1 was also identified in a screen for genes whose overexpression restricted RNA virus replication in neurons (Cho et al., 2013). However, a role for the IRG1-itaconate axis in antiviral defense in vivo has not been described.\n5. For example, the receptor-interacting protein kinase (RIPK)-dependent antiviral responses are coupled to Irg1 as deletion of Irg1 shows increased neuronal viral load and mortality rate in zika ...",
               "predicate": null
            }
         ],
         "row": 580,
         "id": 291807342836554654
      },
      {
         "claim": "In adult tissue, most T cells are memory T cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "Memory T cells are a specialized subset of T cells that develop from naïve T cells in response to antigen exposure, playing a crucial role in the adaptive immune system. The percentage of T cells in adult tissue that are memory T cells is not specified, but it is noted that memory T cell frequency in the blood underestimates the total frequency and numbers of memory T cells in the whole body. The exact percentage of T cells in adult tissue that are memory T cells cannot be determined based on the provided information. The exact percentage of T cells in adult tissue that are memory T cells is not specified in the provided evidence snippet. The percentage of T cells in adult tissue that are memory T cells is not specified in the provided information and would require consultation of a reliable immunological source for accurate data. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are memory T cells?",
               "answer": "Memory T cells are a specialized subset of T cells that develop from naïve T cells in response to antigen exposure, playing a crucial role in the adaptive immune system. They are capable of responding more rapidly and robustly to secondary infections without the need for further differentiation. Memory T cells accumulate throughout an individual's life, undergoing dynamic",
               "rationale": "1. Memory T cells undergo different changes and play different roles in different life stages for humans. At birth and early childhood, T cells in the peripheral blood are mainly naïve T cells. Through frequent antigen exposure, the population of memory T cells accumulates. This is the memory generation stage, which lasts from birth to about 20 ...\n2. The generation of effective adaptive T-cell memory is a cardinal feature of the adaptive immune system. The establishment of protective T-cell immunity requires the differentiation of CD8 + T cells from a naive state to one where pathogen-specific memory CD8 + T cells are capable of responding to a secondary infection more rapidly and robustly without the need for further differentiation.\n3. Memory T cell accumulation throughout life. The frequency of memory T cells undergoes dynamic changes throughout an individual's lifetime that can be divided into three phases: memory generation, memory homeostasis, and immunosenescence (Fig. 1).At birth, all T cells in peripheral blood are naïve, and memory T cells develop over time in response to diverse antigen exposure.\n4. Memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body. Estimates of the number of T cells in human tissues are 2 × ...\n5. GZMK + memory T (T PEX) cells coexpress markers of T cell exhaustion and are committed to give rise to T cells with an exhausted phenotype. GZMK - memory T (T STEM /T CM) cells have the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What percentage of T cells in adult tissue are memory T cells?",
               "answer": "The provided evidence does not specify an exact percentage of T cells in adult tissue that are memory T cells. However, it does indicate that memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body. To determine the percentage of memory T cells in adult tissue",
               "rationale": "1. Memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body. Estimates of the number of T cells in human tissues are 2 × ...\n2. CD103 is expressed by a subset of CD69 + memory CD8 + T cells in barrier and oral-gastro mucosal sites, but not significantly by lymphoid memory CD8 + T cells or by CD4 + memory T cells in any tissue (Kumar et al., 2017; Thome et al., 2014; Watanabe et al., 2015), suggesting that CD69 is the primary marker distinguishing tissue from circulating ...\n3. Generation of T RM cells. The generation of antigen-specific T RM cells is essential for rapid and long-lasting immunological protection. It is now known that the commitment to the memory lineage occurs early after infection, 27,28 when a fraction of naive T cells activated by local DCs differentiate into memory T cell precursors. These precursors can be divided into distinct subsets according ...\n4. The restriction of one memory T cell per stromal cell implies that (1) the population size of the tissue-resident memory is determined by the number of available IL-7 + stromal cells, which in turn is determined by the volume of bone marrow and strictly related to the size of the individual, and (2) that once all niches are hosting a memory T ...\n5. The distinction between permanent and transient tissue-resident T cells will need to be addressed for both CD4 + and CD8 + memory T cell populations. Furthermore, it is becoming apparent that ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What percentage of T cells in adult tissue are memory T cells?",
               "answer": "The provided evidence snippets do not specify the exact percentage of T cells in adult tissue that are memory T cells. Therefore, based on the information given, it is not possible to determine that percentage.",
               "rationale": "1. Here, we review studies focused on human memory T cells that reveal key properties including subset heterogeneity and diverse tissue residence in multiple mucosal and lymphoid tissue sites. We also discuss how the function and adaptability of human memory T cells depend on spatial and temporal compartmentalization. Go to:\n2. In this Review, we discuss studies focused on human memory T cells that reveal key properties of these cells, including subset heterogeneity and diverse tissue residence in multiple mucosal and ...\n3. Considerable advances have been made in recent years in understanding the generation and function of memory T cells. In this review, we consider new developments in the field and focus on how emerging differences between memory cells with respect to their ...\n4. We also discuss how anatomic compartments undergo distinct age-associated changes in T cell subset composition and function over a lifetime. Considering age and tissue influences on human T cells is important for developing targeted strategies to modulate T cell-mediated immunity in vaccines and immunotherapies.\n5. The recent discovery that some memory T cells can become tissue resident after infection warrants further study into the mechanisms and therapeutic implications of such enhanced regional immunity.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What percentage of T cells in adult tissue are memory T cells according to immunological studies?",
               "answer": "The provided evidence snippet does not specify the exact percentage of T cells in adult tissue that are memory T cells. It mentions that memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body, but it does not provide a specific percentage. Therefore, based on",
               "rationale": "1. Memory T cell accumulation throughout life. The frequency of memory T cells undergoes dynamic changes throughout an individual's lifetime that can be divided into three phases: memory generation, memory homeostasis, and immunosenescence (Fig. 1).At birth, all T cells in peripheral blood are naïve, and memory T cells develop over time in response to diverse antigen exposure.\n2. Memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body. Estimates of the number of T cells in human tissues are 2 × ...\n3. Generation of T RM cells. The generation of antigen-specific T RM cells is essential for rapid and long-lasting immunological protection. It is now known that the commitment to the memory lineage occurs early after infection, 27,28 when a fraction of naive T cells activated by local DCs differentiate into memory T cell precursors. These precursors can be divided into distinct subsets according ...\n4. The restriction of one memory T cell per stromal cell implies that (1) the population size of the tissue-resident memory is determined by the number of available IL-7 + stromal cells, which in turn is determined by the volume of bone marrow and strictly related to the size of the individual, and (2) that once all niches are hosting a memory T ...\n5. The discovery of T cells resident in diverse tissues has altered our understanding of adaptive immunity to encompass site-specific responses mediated by tissue-adapted memory T cells throughout the body. Here, we discuss the key phenotypic, transcriptional, and functional features of these tissue-resident memory T cells (T RM) as established in ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What percentage of T cells in adult tissue are memory T cells according to a reliable immunological source?",
               "answer": "The provided evidence snippets do not contain specific information regarding the percentage of T cells in adult tissue that are memory T cells. Therefore, I cannot provide an answer based on the given information. For accurate data on the percentage of memory T cells in adult tissue, it would be necessary to consult a reliable immunological source or study",
               "rationale": "1. Here, we review studies focused on human memory T cells that reveal key properties including subset heterogeneity and diverse tissue residence in multiple mucosal and lymphoid tissue sites. We also discuss how the function and adaptability of human memory T cells depend on spatial and temporal compartmentalization. Go to:\n2. In this Review, we discuss studies focused on human memory T cells that reveal key properties of these cells, including subset heterogeneity and diverse tissue residence in multiple mucosal and ...\n3. Considerable advances have been made in recent years in understanding the generation and function of memory T cells. In this review, we consider new developments in the field and focus on how emerging differences between memory cells with respect to their ...\n4. At its most basic mechanistic level, T cell vaccine efficacy can be defined as the ability of the vaccine to generate large, effective, long-lived populations of memory T cells. In this paper we will take a dynamic view of how long-term T cell memory may be generated and maintained in humans and review the implications of a kinetic perspective ...\n5. Summary Memory T cells form an essential part of immunological memory, which can last for years or even a lifetime. Much experimental work has shown that the individual cells that make up the memory T-cell pool are in fact relatively short-lived. Memory T cells isolated from the blood of humans, or the lymph nodes and spleen of mice, live about 5-10 fold shorter than naive T cells, and much ...",
               "predicate": null
            }
         ],
         "row": 581,
         "id": 671208457893843578
      },
      {
         "claim": "In mouse models, the loss of CSF1R facilitates MOZ-TIF2-induced leuekmogenesis.",
         "label": 0,
         "prediction": 0,
         "rationale": "CSF1R, or Colony Stimulating Factor 1 Receptor, is a cell-surface protein encoded by the human CSF1R gene that can be activated by two ligands: colony stimulating factor 1 (CSF-1) and interleukin-34 (IL-34). The loss of CSF1R impairs MOZ-TIF2-induced leukemogenesis in mouse models, suppressing the induction of AML and delaying the development of MOZ-TIF2-induced acute myeloid leukemia. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CSF1R?",
               "answer": "CSF1R, or Colony Stimulating Factor 1 Receptor, is a cell-surface protein encoded by the human CSF1R gene (also known as c-FMS). It is a receptor that can be activated by two ligands: colony stimulating factor 1 (CSF-1) and inter",
               "rationale": "1. Colony stimulating factor 1 receptor (CSF1R), also known as macrophage colony-stimulating factor receptor (M-CSFR), and CD115 (Cluster of Differentiation 115), is a cell-surface protein encoded by the human CSF1R gene (known also as c-FMS). CSF1R is a receptor that can be activated by two ligands: colony stimulating factor 1 (CSF-1) and interleukin-34 (IL-34).\n2. The CSF1R gene provides instructions for making a protein called the colony stimulating factor 1 receptor (CSF-1 receptor). This protein is found in the outer membrane of certain cell types. When a specific protein called colony stimulating factor 1 attaches (binds) to it, the receptor turns on (activates) a series of proteins inside the cell that are part of multiple signaling pathways.\n3. CSF1R and cd68 gene expression is an independent predictor for progression-free survival of Hodgkin lymphoma patients. Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.\n4. The spectrum of CSF1R-related disorder ranges from early-onset disease (age <18 years) to late-onset disease (age ≥18 years). Early-onset disease is associated with hypotonia, delayed acquisition of developmental milestones, and non-neurologic manifestations (such as skeletal abnormalities); both early- and late-onset disease have similar neurodegenerative involvement.\n5. CSF1R (Colony Stimulating Factor 1 Receptor) is a Protein Coding gene. Diseases associated with CSF1R include Leukoencephalopathy, Hereditary Diffuse, With Spheroids 1 and Brain Abnormalities, Neurodegeneration, And Dysosteosclerosis.Among its related pathways are GPCR Pathway and ERK Signaling.Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of the loss of CSF1R on MOZ-TIF2-induced leuekmogenesis in mouse models?",
               "answer": "The loss of CSF1R impairs MOZ-TIF2-induced leukemogenesis in mouse models. Specifically, studies indicate that CSF1R-deficient mice show suppressed induction of AML, and the use of CSF1R inhibitors delays the development of MOZ-TIF2-induced acute myeloid leukemia (AML",
               "rationale": "1. MOZ-TIF2 interacted with PU.1 to stimulate the expression of M-CSFR, and PU.1 is required for the establishment and maintenance of LSCs by MOZ-TIF2. Loss of CSF1R impairs MOZ-TIF2-induced leuekmogenesis in mouse models and CSF1R inhibitors delay the development of MOZ-TIF2-induced AML . MOZ-TIF2 can cooperate with FLT3-ITD to ...\n2. To investigate the role of CSF1R in the development of MOZ-TIF2-induced AML, we infected wild-type and Csf1r −/− (ref. 12) mouse fetal liver cells of embryonic day 16.5 (E16.5) littermate ...\n3. CSF1R promoter, we cured AML by ablation of CSF1Rhigh cells. Moreover, induction of AML was suppressed in CSF1R-deficient mice and CSF1R inhibitors slowed the progression of MOZ-TIF2-induced ...\n4. The MOZ fusion proteins MOZ-TIF2 and MOZ-CBP interacted with the transcription factor PU.1 to stimulate the expression of macrophage colony-stimulating factor receptor (CSF1R, also known as M-CSFR, c-FMS or CD115). Studies using PU.1-deficient mice showed that PU.1 is essential for the ability of MOZ-TIF2 to establish and maintain AML stem ...\n5. CSF1R high cells show potent leukemia-initiating activity (a) The BM cells from MOZ-TIF2-induced AML mice were analyzed by FACS for expression of GFP and CSF1R.(b) CSF1R high and CSF1R low/− cells were sorted by flow cytometry, and MOZ-TIF2 expression was investigated by immunoblot analysis using an anti-MOZ antibody.(c, d) The indicated numbers of flow-sorted CSF1R high (c) and CSF1R low ...",
               "predicate": null
            }
         ],
         "row": 582,
         "id": 318831309367851515
      },
      {
         "claim": "In young and middle-aged adults, current or remote uses of ADHD medications do not increase the risk of serious cardiovascular events.",
         "label": 1,
         "prediction": 1,
         "rationale": "ADHD medications include stimulants, non-stimulants, clonidine, and antidepressants, with stimulants being the most commonly prescribed type that work by increasing dopamine and norepinephrine levels. ADHD medications do not increase the risk of serious cardiovascular events in young and middle-aged adults. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are ADHD medications?",
               "answer": "ADHD medications include stimulants, non-stimulants, clonidine, and antidepressants. Stimulants are the most commonly prescribed type and work by increasing dopamine and norepinephrine levels. These medications are available in both immediate-release (short-acting) and extended-release forms.",
               "rationale": "1. ADHD medications include stimulants and non-stimulants. Healthcare providers often prescribe antidepressants, as well. Stimulants. Stimulants are the most common type of prescription medication healthcare providers use to treat ADHD. Despite their name, stimulants don't work by increasing your stimulation.\n2. Pharmacological treatments for ADHD include stimulants, non-stimulants, clonidine, and antidepressants. Stimulants. These are the most commonly prescribed treatments and work by increasing dopamine and norepinephrine levels. Available in immediate-release (short-acting) and extended-release forms.\n3. ADHD is commonly treated with prescription medications. See a full list of drugs, including stimulants, nonstimulants, and more.\n4. Treatment for attention deficit hyperactivity disorder (ADHD) has advanced by leaps and bounds over the last few decades. This means parents and adults have more options than ever when it comes to ADHD medication — but it also means that the plethora of medication choices can be confusing, overwhelming, and time-consuming to sort through when ...\n5. ADHD Medication. Medication may be an important part of your treatment plan for attention deficit hyperactivity disorder. Doctors can choose from many types of drugs to control your symptoms.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do ADHD medications increase the risk of serious cardiovascular events in young and middle-aged adults?",
               "answer": "No, ADHD medications do not increase the risk of serious cardiovascular events in young and middle-aged adults. The evidence suggests that there is no statistically significant association between the use of ADHD medications and the risk of cardiovascular events in this population.",
               "rationale": "1. 223-2005-20006C/PHS HHS/United States. Among young and middle-aged adults, current or new use of ADHD medications, compared with nonuse or remote use, was not associated with an increased risk of serious cardiovascular events. Apparent protective associations likely represent healthy-user bias.\n2. Adverse-event reports from North America have raised concern that the use of drugs for attention deficit-hyperactivity disorder (ADHD) increases the risk of serious cardiovascular events. We ...\n3. Findings This systematic review and meta-analysis based on 19 observational studies with more than 3.9 million participants suggested that there was no statistically significant association between ADHD medications and the risk of cardiovascular events among children and adolescents, young and middle-aged adults, or older adults.\n4. This systematic review and meta-analysis based on 19 observational studies with more than 3.9 million participants suggested that there was no statistically significant association between ADHD medications and the risk of cardiovascular events among children and adolescents, young and middle-aged adults, or older adults.\n5. Perspective: In this population-based cohort of young and middle-aged adults, including more than 150,000 users of ADHD medications identified through filled prescriptions, the investigators found no evidence of an increased risk of MI, SCD, or stroke associated with current use compared with nonuse or remote use of ADHD medications.",
               "predicate": null
            }
         ],
         "row": 583,
         "id": 128973766638500717
      },
      {
         "claim": "Incidence of heart failure decreased by 10% in women since 1979.",
         "label": 1,
         "prediction": 1,
         "rationale": "The source of the data on heart failure incidence in women since 1979 is not specified. The incidence of heart failure in women in 1979 is not specified. The prevalence of heart failure in women in the United States has increased to 6.5 million in Americans aged 20 years and older, according to the 2017 American Heart Association statistics. The incidence of heart failure in women in 1979 compared to the most recent year available cannot be determined based on the provided information. The percentage decrease in the incidence of heart failure in women from 1979 to the most recent year available cannot be determined based on the provided information. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the source of the data on heart failure incidence in women since 1979?",
               "answer": "The provided evidence snippet does not explicitly mention the source of the data on heart failure incidence in women since 1979. It discusses trends in heart failure epidemiology, the AHA's statistical updates, and the overall burden of heart failure, but does not specify the source for the historical data on incidence in women. Therefore",
               "rationale": "1. 1. Preamble Trends in the epidemiology and outcomes for heart failure (HF) are critically important and have not been explicated and compiled in a comprehensive contemporary document. There have been concerning trends in the incidence, prevalence, mortality, and HF hospitalization rates over the past decade.\n2. At-a-Glance This document contains key statistics about heart disease, stroke, other cardiovascular diseases and their risk factors, in addition to commonly cited statistics about the American Heart Association (AHA)'s research program. This At-a-Glance document is based on the association's 2024 Heart Disease and Stroke Statistics Update: A Report of US and Global Data From the AHA, which ...\n3. Prevalence, incidence and survival for heart failure varied widely across countries and studies, reflecting a range of study design. Heart failure remains a high prevalence disease among older adults with a high risk of death at 1 year. This review synthesises all available published estimates of heart failure burden.\n4. Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. HF affects more than 64 million people worldwide. Therefore, attempts to decrease its social and economic burden have become a major global public health priority.\n5. METHODS: The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the incidence of heart failure in women in 1979?",
               "answer": "The provided evidence does not specify the incidence of heart failure in women in 1979. It mentions trends and statistics from various years, but does not give a specific figure for that year. Therefore, based on the provided evidence snippet, the answer is: **The incidence of heart failure in women in 1979 is",
               "rationale": "1. Incidence of All Heart Failure: 1990-1999: 19.7 per 1.000PY 2000-2009: ... All Heart Failure: Black Women: 17.2/1,000 PY; Black Men: 19.9/1000PY; White Women: 10.8/1000 PY; White Men: 14/1000 PY: Inpatient or outpatient ICD 9 and 10 codes: ... between 1979 and 2002, the prevalence of hypertension, obesity, and smoking increased over time ...\n2. Temporal trends in heart failure incidence among Medicare beneficiaries across risk factor strata, 2011 to 2016. ... between 1979 and 2002, the prevalence of hypertension, obesity, and smoking increased over time. ... hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ ...\n3. Age: The mortality of heart failure increases as you age; those over age 65 represent over 90% of deaths attributed to the condition. Among Medicare patients, the survival rate at one year was found to be about 70%. Sex: Studies have found that women with heart failure have better survival at 5 years than men, though fatality rates are similar at 30 days and 90 days.\n4. Heart failure affects over 2.6 million women and 3.4 million men in the United States with known sex differences in epidemiology, management, response to treatment, and outcomes across a wide spectrum of cardiomyopathies that include peripartum cardiomyopathy, hypertrophic cardiomyopathy, stress cardiomyopathy, cardiac amyloidosis, and sarcoidosis. Some of these sex-specific considerations are ...\n5. Heart failure (HF) is a major public health problem, with a prevalence of more than 5.8 million in the United States and more than 23 million worldwide. In 1997, HF was singled out as an emerging epidemic. 1 An epidemic can reflect increased incidence, increased survival leading to increased prevalence, or both factors combined.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the incidence of heart failure in women in the most recent year available?",
               "answer": "The most recent year available indicates that the prevalence of heart failure (HF) in women in the United States has increased to 6.5 million in Americans aged 20 years and older, according to the 2017 American Heart Association (AHA) Heart Disease and Stroke Statistics Update. By 2030, the",
               "rationale": "1. The GBD (Global Burden of Diseases, Injuries, and Risk Factors Study) project is a systematic analysis to compare the magnitude of health loss attributable to diseases, injuries, and risk factors by age, sex, and geography for specific points in time. 8 The GBD 2019 study 9 is the newest update of the GBD 2017 study, 10 comprising newly available data sets that enhance method performance and ...\n2. Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. HF affects more than 64 million people worldwide. Therefore, attempts to decrease its social and economic burden have become a major global public health priority.\n3. Abstract. Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has stabilised worldwide and seems to be declining in developed countries, the prevalence is increasing due to the ageing of the population, improved survival after MI and improved ...\n4. Overall, HF affects approximately 56.2 million people globally; based on estimates from the 2019 Global Burden of Disease Study, 5-year mortality ranges from 45% to 75% in North America; and the ...\n5. EPIDEMIOLOGY OF HEART FAILURE IN WOMEN. According to the 2017 American Heart Association (AHA) Heart Disease and Stroke Statistics Update, heart failure (HF) prevalence has increased to 6.5 million in Americans ≥ 20 years of age. 1 By 2030, the incidence of HF is projected to rise by 46%, affecting more than 8 million individuals. Heart ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the incidence of heart failure in women in 1979 compared to the most recent year available?",
               "answer": "The provided evidence does not include specific data on the incidence of heart failure in women for the year 1979 or the most recent year available. Therefore, it is not possible to determine the incidence of heart failure in women in 1979 compared to the most recent year based on the information given.",
               "rationale": "1. Incidence of All Heart Failure: 1990-1999: 19.7 per 1.000PY 2000-2009: ... In the US, the incidence of HF is greater in women compared with men, but the prevalence is less in women when age includes all patients 20 years of age or older. ... From Ni H, Xu J. Recent trends in heart failure-related mortality: United States, 2000-2014. NCHS ...\n2. Women tend to develop HF at an older age compared to men. 10 Heart failure with preserved ejection fraction is more common in women than in men, and it accounts for at least half the cases of HF in women. 10 When men and women with HF and a low LV ejection fraction are compared, the women are more symptomatic and have a similarly poor outcome.\n3. Abstract. Designated as an emerging epidemic in 1997, heart failure (HF) remains a major clinical and public health problem. This review focuses on the most recent studies identified by searching the Medline database for publications with the subject headings HF, epidemiology, prevalence, incidence, trends between 2010 and present.\n4. Heart failure occurred in 1075 subjects (51 percent of whom were women). As compared with the rate for the period from 1950 through 1969, the incidence of heart failure remained virtually ...\n5. Abstract. Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has stabilised worldwide and seems to be declining in developed countries, the prevalence is increasing due to the ageing of the population, improved survival after MI and improved ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the percentage decrease in the incidence of heart failure in women from 1979 to the most recent year available?",
               "answer": "The provided evidence snippets do not contain specific data regarding the percentage decrease in the incidence of heart failure in women from 1979 to the most recent year available. Therefore, it is not possible to determine the percentage decrease based on the information given.",
               "rationale": "1. Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has stabilised worldwide and seems to be declining in developed countries, the prevalence is increasing ...\n2. Heart failure remains a major health problem, with increased trends possible in the future. Efforts for prevention and control of heart failure should focus more on less‐developed regions. It is essential to prevent and treat primary diseases such as ischemic heart disease and hypertensive heart disease for the control of heart failure.\n3. Abstract Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. HF affects more than 64 million people worldwide. Therefore, attempts to decrease its social and economic burden have become a major global public health priority. While the incidence of HF has ...\n4. Prevalence, incidence and survival for heart failure varied widely across countries and studies, reflecting a range of study design. Heart failure remains a high prevalence disease among older adults with a high risk of death at 1 year. This review synthesises all available published estimates of heart failure burden.\n5. The writing group members reviewed and synthesized available published data regarding HF epidemiology, incidence, prevalence, rates of HF and all-cause mortality and hospitalizations, and differences according to sex, race/ethnicity, and age. A succinct and high-level summary is included for each section.",
               "predicate": null
            }
         ],
         "row": 584,
         "id": 149247602754931657
      },
      {
         "claim": "Incidence rates of cervical cancer have decreased.",
         "label": 1,
         "prediction": 1,
         "rationale": "The current incidence rate of cervical cancer is 7.6 new cases per 100,000 women per year. The incidence rates of cervical cancer before 2017 are not specified in the provided evidence. The exact incidence rates of cervical cancer before 2017 are not specified. The incidence rates of cervical cancer in the years preceding 2017 showed a significant decline, with age-adjusted incidence rates decreasing by 54% from 13.07 per 100,000 women in 1973-1975 to 6.01 per 100,000 women. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are the current incidence rates of cervical cancer?",
               "answer": "The current incidence rate of cervical cancer is 7.6 new cases per 100,000 women per year. This rate is age-adjusted and based on cases from 2017-2021.",
               "rationale": "1. Cancer Statistics At a Glance: See rates or numbers of new cervical cancers or cervical cancer deaths for the entire United States and individual states. Also, see the top 10 cancers. Cancers by Age, Sex, Race, and Ethnicity: See rates or numbers of new cervical cancers or cervical cancer deaths by race/ethnicity and age group. Trends: See how ...\n2. Rates of new cases are also referred to as incidence rates. Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017-2021 cases and 2018-2022 deaths.\n3. Incidence rates for cervical cancer. Cervical cancer incidence rates decreased by more than half from the mid-1970s to the mid-2000s, largely because of the increased use of screening, but they have stabilized over the past decade. However, in women ages 30-44, rates have increased 1.7% each year from 2012 to 2019. ...\n4. Globally, cervical cancer is the fourth most common cancer in women, with around 660 000 new cases in 2022. In the same year, about 94% of the 350 000 deaths caused by cervical cancer occurred in low- and middle-income countries. The highest rates of cervical cancer incidence and mortality are in sub-Saharan Africa (SSA), Central America and ...\n5. A clear and strong socioeconomic gradient was observed between cervical cancer incidence and mortality rates and the mean national HDI values, with progressively lower rates observed as HDI increased. ... The existing discrepancies in cancer screening, diagnosis, and treatment services as reflected in the current allocation of funding for ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What were the incidence rates of cervical cancer before 2017?",
               "answer": "The provided evidence does not include specific incidence rates of cervical cancer before 2017. It only mentions that the rate of new cases of cervical cancer was 7.6 per 100,000 women per year based on data from 2017-2021. Therefore, we cannot determine the incidence rates of cervical cancer",
               "rationale": "1. The American Cancer Society's estimates for cervical cancer in the United States for 2024 are: About 13,820 new cases of invasive cervical cancer will be diagnosed. About 4,360 women will die from cervical cancer. Cervical pre-cancers are diagnosed far more often than invasive cervical cancer. Cervical cancer is most frequently diagnosed in ...\n2. Rates of new cases are also referred to as incidence rates. Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017-2021 cases and 2018-2022 deaths.\n3. Cancer Statistics At a Glance: See rates or numbers of new cervical cancers or cervical cancer deaths for the entire United States and individual states. Also, see the top 10 cancers. Cancers by Age, Sex, Race, and Ethnicity: See rates or numbers of new cervical cancers or cervical cancer deaths by race/ethnicity and age group. Trends: See how ...\n4. Squamous cell carcinoma incidence rates. The rate of getting squamous cell carcinoma cervical cancer dropped from 1999 to 2017 for all age groups. The rate dropped almost 13% per year on average in girls and women who were 15 to 20 years old. The largest decline was from 2011 to 2017, when the rate dropped nearly 23% per year on average.\n5. Globally, cervical cancer is the fourth most common cancer in women, with around 660 000 new cases in 2022. In the same year, about 94% of the 350 000 deaths caused by cervical cancer occurred in low- and middle-income countries. The highest rates of cervical cancer incidence and mortality are in sub-Saharan Africa (SSA), Central America and ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What were the incidence rates of cervical cancer before 2017?",
               "answer": "The provided evidence does not specify the exact incidence rates of cervical cancer before 2017. It mentions that the rate of new cases of cervical cancer was 7.6 per 100,000 women per year for the period of 2017-2021, but does not provide historical data or specific rates for the",
               "rationale": "1. Rates of new cases are also referred to as incidence rates. Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017-2021 cases and 2018-2022 deaths.\n2. Cancer Statistics At a Glance: See rates or numbers of new cervical cancers or cervical cancer deaths for the entire United States and individual states. Also, see the top 10 cancers. Cancers by Age, Sex, Race, and Ethnicity: See rates or numbers of new cervical cancers or cervical cancer deaths by race/ethnicity and age group.\n3. More than 20% of cervical cancers are found in women over 65. However, these cancers rarely occur in women who have been getting regular tests to screen for cervical cancer before they were 65. See Can Cervical Cancer Be Prevented? and Cervical Cancer Screening Tests to learn more about tests used to screen for cervical cancer.\n4. Methods For this analysis, we used the GLOBOCAN 2020 database to estimate the age-specific and age-standardised incidence and mortality rates of cervical cancer per 100 000 women-years for 185 countries or territories aggregated across the 20 UN-defined world regions, and by four-tier levels of the Human Development Index (HDI). Time trends (1988-2017) in incidence were extracted from the ...\n5. The rate of getting squamous cell carcinoma cervical cancer dropped from 1999 to 2017 for all age groups. The rate dropped almost 13% per year on average in girls and women who were 15 to 20 years old.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What were the incidence rates of cervical cancer in the years preceding 2017?",
               "answer": "The incidence rates of cervical cancer in the years preceding 2017 showed a significant decline. Specifically, age-adjusted incidence rates for all invasive cervical cancer decreased by 54% from 13.07 per 100,000 women in 1973-1975 to 6.01 per 100,000 women",
               "rationale": "1. Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017-2021 cases and 2018-2022 deaths. Lifetime Risk of Developing Cancer: Approximately 0.6 percent of women will be diagnosed ...\n2. Incidence rates for cervical cancer. Cervical cancer incidence rates decreased by more than half from the mid-1970s to the mid-2000s, largely because of the increased use of screening, but they have stabilized over the past decade. However, in women ages 30-44, rates have increased 1.7% each year from 2012 to 2019. In contrast, rates declined ...\n3. Over the 35-year period, age-adjusted incidence rates for all invasive cervical cancer decreased by 54% from 13.07/100,000 women in 1973-1975 to 6.01/100,000 women in 2006-2007. Join-point analysis showed that, on an annual basis, invasive cervical cancer declined by 6.4% between 1973 and 2007. This rate of change was not constant over the ...\n4. Cancer Statistics At a Glance: See rates or numbers of new cervical cancers or cervical cancer deaths for the entire United States and individual states. Also, see the top 10 cancers. Cancers by Age, Sex, Race, and Ethnicity: See rates or numbers of new cervical cancers or cervical cancer deaths by race/ethnicity and age group. Trends: See how ...\n5. Cancer Stat Facts: Cervical Cancer. Reports on Cancer. Annual Report to the Nation; Cancer Stat Facts; Cancer Statistics Review. Archive; Preliminary Incidence Rates for 2017.",
               "predicate": null
            }
         ],
         "row": 585,
         "id": 660569376041468074
      },
      {
         "claim": "Incidence rates of cervical cancer have increased due to nationwide screening programs based primarily on cytology to detect uterine cervical cancer.",
         "label": 0,
         "prediction": 1,
         "rationale": "Nationwide screening programs based primarily on cytology have been implemented to detect uterine cervical cancer. Incidence rates of cervical cancer have increased in women ages 30-44, with rates rising by 1.7% each year from 2012 to 2019. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Have nationwide screening programs based primarily on cytology been implemented to detect uterine cervical cancer?",
               "answer": "Yes, nationwide screening programs based primarily on cytology have been implemented to detect uterine cervical cancer, as indicated by the evidence that France recently implemented a nationwide organized screening program using cytology for detection of cervical cancer. Additionally, high-income countries have integrated cytology screening services into their medical and public health systems, achieving high",
               "rationale": "1. The currently available tests for cervical cancer screening detect lesions at different stages in the process of carcinogenesis (Panel C). ... a population-based, nationwide program have compared ...\n2. Two in three women aged 30-49 years have never been screened for cervical cancer. Roll-out of screening is very low in low-income and middle-income countries, where the burden of disease is highest. The priority of the WHO elimination campaign should be to increase both screening coverage and treatment of detected lesions; however, expanding the efforts of surveillance systems in both ...\n3. Only six of 11 countries assessed have population-based screening programs in place. ... France recently implemented a nationwide organized screening ... cytology for detection of cervical cancer ...\n4. The most widely used cervical screening test is cytology. High-income countries have integrated cytology screening services in medical and public health services and have achieved high coverage through better program organization. This has resulted in substantial declines in cervical cancer incidence and mortality over time.\n5. In 2020, an estimated 604,000 women were diagnosed with cervical cancer, and 342,000 women died from the disease, with 47% of these deaths occurring in low- and lower-middle-income countries ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Have incidence rates of cervical cancer increased?",
               "answer": "Yes, incidence rates of cervical cancer have increased in women ages 30-44, with rates rising by 1.7% each year from 2012 to 2019. While overall incidence rates decreased significantly from the mid-1970s to the mid-2000s due to increased screening, they have",
               "rationale": "1. Incidence rates for cervical cancer. Cervical cancer incidence rates decreased by more than half from the mid-1970s to the mid-2000s, largely because of the increased use of screening, but they have stabilized over the past decade. However, in women ages 30-44, rates have increased 1.7% each year from 2012 to 2019. ...\n2. Cancer Statistics At a Glance: See rates or numbers of new cervical cancers or cervical cancer deaths for the entire United States and individual states. Also, see the top 10 cancers. Cancers by Age, Sex, Race, and Ethnicity: See rates or numbers of new cervical cancers or cervical cancer deaths by race/ethnicity and age group. Trends: See how ...\n3. Rates of new cases are also referred to as incidence rates. Rate of New Cases and Deaths per 100,000: The rate of new cases of cervical cancer was 7.6 per 100,000 women per year. The death rate was 2.2 per 100,000 women per year. These rates are age-adjusted and based on 2017-2021 cases and 2018-2022 deaths.\n4. Between 2005 and 2019, the analysis showed, the rates of timely cervical cancer screening fell overall. ... the expansion of Medicaid in many states and certain provisions of the Affordable Care Act have increased coverage of recommended screenings. ... (31%). Although the reasons for that aren't clear, the incidence of cervical cancer among ...\n5. Researchers also found that Black women have an overall higher rate of late-stage cervical cancer, at 1.55 per 100,000, versus 0.92 per 100,000 in white women. Shots - Health News She was already ...",
               "predicate": null
            }
         ],
         "row": 586,
         "id": 169794552446774693
      },
      {
         "claim": "Increased microtubule acetylation repairs LRRK2 Roc-COR domain mutation induced locomotor deficits.",
         "label": 1,
         "prediction": 1,
         "rationale": "The LRRK2 Roc-COR domain mutation refers to genetic alterations within the Roc and COR domains of the LRRK2 protein, associated with familial forms of Parkinson's disease. Increased microtubule acetylation can repair locomotor deficits induced by LRRK2 Roc-COR domain mutations. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is LRRK2 Roc-COR domain mutation?",
               "answer": "The LRRK2 Roc-COR domain mutation refers to genetic alterations that occur within the Roc (Ras of Complex) and COR (C-terminal of Roc) domains of the LRRK2 protein. These mutations are significant because they are associated with familial forms of Parkinson's disease (PARK8) and tend",
               "rationale": "1. The central portion of LRRK2 contains a Ras of Complex (Roc) GTPase and a C-terminus of Roc (COR) domain, followed by serine-threonine kinase domains. The ROC-COR bidomain and kinase region together constitute the catalytic core of LRRK2, which therefore encompasses two enzymatic activities [20, 21].\n2. LRRK2 was identified as a member of the Ras of complex proteins (ROCO) family 4 and thus it also contains a Ras-like GTPase domain (ROC) followed by a C-terminal of ROC (COR) domain.\n3. Mutations in PARK8, encoding LRRK2, are the most common known cause of Parkinson's disease.The LRRK2 Roc-COR tandem domain exhibits GTPase activity controlling LRRK2 kinase activity via an intramolecular process. We report the interaction of LRRK2 with the dishevelled family of phosphoproteins (DVL1-3), key regulators of Wnt (Wingless/Int) signalling pathways important for axon guidance ...\n4. An interesting feature of LRRK2 is that it contains two distinct enzymatic domains, a Ras of complex (ROC) GTPase domain and a serine/threonine kinase domain, separated by a C-terminal of ROC (COR) domain. Familial mutations tend to cluster within the catalytic domains of LRRK2.\n5. This construct consists of the ROC, COR, kinase and WD40 domains of LRRK2 (Fig. 1a), which we refer to as LRRK2 RCKW. The COR domain was previously defined as consisting of two subdomains, COR-A ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does increased microtubule acetylation repair locomotor deficits induced by LRRK2 Roc-COR domain mutation?",
               "answer": "Yes, increased microtubule acetylation can repair locomotor deficits induced by LRRK2 Roc-COR domain mutations. The evidence indicates that increasing microtubule acetylation rescues both axonal transport and locomotor deficits caused by these mutations.",
               "rationale": "1. Godena, V., Brookes-Hocking, N., Moller, A. et al. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat Commun 5 , 5245 ...\n2. increasing microtubule acetylation can rescue LRRK2 Roc-COR mutant-induced axonal transport defects. Finally, we asked whether treatment with TSA would be able to\n3. Leucine-rich repeat kinase 2 ( LRRK2) is the most commonly mutated gene in familial Parkinson's disease 1 and is also linked to its idiopathic form 2. LRRK2 has been proposed to function in ...\n4. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations October 2014 Nature Communications 5(1):5245\n5. Similarly, transport defects caused by Lrrk-R1069C or Y1383C expression were also restored by feeding TSA (Supplementary Fig. 3). Thus, both genetic and pharmacological approaches in vitro and in vivo show that increasing microtubule acetylation can rescue LRRK2 Roc-COR mutant-induced axonal transport defects.",
               "predicate": null
            }
         ],
         "row": 587,
         "id": 241326248504941031
      },
      {
         "claim": "Increased vessel density along with a reduction in fibrosis decreases the efficacy of chemotherapy treatments.",
         "label": 0,
         "prediction": 1,
         "rationale": "The relationship between vessel density and chemotherapy efficacy is complex, with higher vessel density potentially enhancing drug delivery and treatment outcomes. Increased vessel density can decrease the efficacy of chemotherapy treatments. A reduction in fibrosis may not necessarily decrease the efficacy of chemotherapy treatments, as the provided evidence does not directly address this relationship. The provided evidence does not directly address whether a reduction in fibrosis increases the efficacy of chemotherapy treatments. There is no direct evidence to suggest that increased vessel density combined with a reduction in fibrosis decreases the efficacy of chemotherapy treatments. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between vessel density and chemotherapy efficacy?",
               "answer": "The relationship between vessel density and chemotherapy efficacy is complex and can significantly impact treatment outcomes. Evidence suggests that dysfunctional blood vessels in tumors impair the delivery and distribution of therapeutic agents, leading to reduced treatment efficacy. Specifically, the efficacy of chemotherapy can be modulated by the density of blood vessels; higher vessel density may enhance drug delivery",
               "rationale": "1. In this work we propose to model chemotherapy taking into account the mutual interaction between tumour growth and the development of tumour vasculature. By adopting a simple model for this interaction, and assuming that the efficacy of a drug can be modulated by the vessel density, we study the con …\n2. Blood vessels in tumors are often dysfunctional. This impairs the delivery of therapeutic agents to and distribution among the cancer cells. Subsequently, treatment efficacy is reduced, and dose ...\n3. Fig. 6 shows how the average asymptotic tumour volume depends on T for different values of χ, both in the case of constant γ, and in the case of drug efficacy changing with ρ.In the case of γ constant, V m is an increasing function of T for all the values of χ tested, i.e. there is full metronomic effect (upper panel of Fig. 6).Quite different is the behaviour in case of non-constant γ ...\n4. In contrast to VEGF inhibitors, which prune immature tumour vessels, vessel density is increased and vessels are more uniformly distributed in RGS5-deficient tumours (Figs 2b,3b,c). Coverage of ...\n5. Clinical trials involving breast cancer patients who received a single dose of bevacizumab followed by chemotherapy showed that the microvessel density prior to bevacizumab treatment could be used ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does increased vessel density decrease the efficacy of chemotherapy treatments?",
               "answer": "Yes, increased vessel density can decrease the efficacy of chemotherapy treatments. The evidence suggests that tumor vasculature, which is often disorganized and 'leaky' due to cancer-induced angiogenesis, can reduce treatment efficacy and increase the chance of metastasis. In contrast, exercise-induced angiogenesis leads to a normalization of tumor",
               "rationale": "1. Importantly, exercise induces a normalization of tumour vasculature due to shear stress-induced angiogenesis, as compared with angiogenesis as a hallmark of cancer which produces 'leaky' and disorganised pathological vessels which reduce treatment efficacy and increase the chance of metastasis . Therefore, exercise may protect from vascular ...\n2. The greater efficacy of dose-dense chemotherapy was not compromised by increased toxicity. Grade 3 or 4 neutropenia was significantly more common with conventional therapy than with dose-dense therapy (33% vs. 6%; p<0.0001), and cycle delays due to neutropenia were significantly more frequent with conventional than with dose-dense therapy (38% ...\n3. Multiple studies and long term follow-up data confirm the benefit of dose dense therapy for treatment of early stage breast cancer (ESBC). Breast cancer is know to have a \"dose response\" effect meaning that higher doses of chemotherapy tend to destroy more breast cancer cells than lower doses. 1-9. CancerConnect.\n4. Dose-dense chemotherapy pushes treatments closer together in time and allows for greater benefit for patients, with no increase in side effects. Compared with a standard plan, dose-dense chemotherapy controls cancer growth more effectively, improves overall survival for patients, and does not add any long-term side effects.\n5. Advancements in the treatment of cancer have improved the prognosis of patients with a wide range of malignancies, 1 to the extent that treatment is now often given with curative intent. 2 In tandem with the improved survival from cancer, there has been increasing focus on cardiovascular actions of chemotherapeutic agents. In addition to acute toxic vascular effects of chemotherapeutic agents ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does a reduction in fibrosis decrease the efficacy of chemotherapy treatments?",
               "answer": "The provided evidence snippets do not directly address the relationship between a reduction in fibrosis and the efficacy of chemotherapy treatments. They primarily focus on the effects of radiation-induced fibrosis, its impact on quality of life, and the general implications of fibrosis in cancer patients. Therefore, based on the information given, we cannot conclude whether a reduction",
               "rationale": "1. Radiation-induced fibrosis (RIF) is a long-term side effect of external beam radiation therapy for the treatment of cancer. It results in a multitude of symptoms that significantly impact quality of life. Understanding the mechanisms of RIF-induced changes is essential to developing effective strategies to prevent long-term disability and ...\n2. The term \"fibrosis\" refers to a spectrum of connective tissue disorders characterized by the excessive accumulation of extracellular matrix leading to organ dysfunction and, ultimately, failure. Fibrosis affects millions of patients worldwide and often manifests itself as a late-stage pathological condition associated with poor prognostic outcome. Although the aetiology and clinical course ...\n3. Abstract. Cancer and its therapies including surgeries, radiation therapy, and chemotherapy, have a significant influence on the body of the patient. Tissue fibrosis is one of the most significant adverse efects noticed in cancer patients. Fibrosis caused by any tissue damage or various intracellular mechanisms can result in physical and ...\n4. Radiation therapy can affect normal tissues in patients with breast cancer, causing adverse effects such as fibrosis. Although there are several interventions for radiation-induced fibrosis, the efficacy of these procedures is still unclear. The purpose of this review is to evaluate the efficacy of interventions for radiation-induced fibrosis in patients with breast cancer.\n5. Abstract. Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the industrialized world. It has long been thought to be relentlessly progressive and irreversible, but ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does a reduction in fibrosis increase the efficacy of chemotherapy treatments?",
               "answer": "The provided evidence snippets do not directly address whether a reduction in fibrosis increases the efficacy of chemotherapy treatments. However, they do highlight that fibrosis is a common complication of cancer therapies, including chemotherapy and radiation, and can lead to significant morbidity and poor prognostic outcomes. While the evidence suggests that fibrosis is a detrimental effect of cancer",
               "rationale": "1. Fibrosis is a common, persistent and potentially debilitating complication of chemotherapy and radiation regimens used for the treatment of cancer. The molecular mechanisms underlying fibrosis have been well studied and reveal overall processes that are largely ubiquitous. However, it is important to note that although the processes are similar ...\n2. Abstract. Cancer and its therapies including surgeries, radiation therapy, and chemotherapy, have a significant influence on the body of the patient. Tissue fibrosis is one of the most significant adverse efects noticed in cancer patients. Fibrosis caused by any tissue damage or various intracellular mechanisms can result in physical and ...\n3. Cancer remains the leading cause of death around the world. In cancer treatment, over 50% of cancer patients receive radiotherapy alone or in multimodal combinations with other therapies. One of the adverse consequences after radiation exposure is the occurrence of radiation-induced tissue fibrosis (RIF), which is characterized by the abnormal activation of myofibroblasts and the excessive ...\n4. Introduction. Fibrosis is a widely recognized cause of disease-related morbidity and mortality worldwide [1].Despite the diverse array of etiologies and affected organs, common mechanisms underlying the development and progression of fibrosis exist [2].Specifically, these include a hyperactive inflammatory response, excessive activation of fibroblasts, and aberrant tissue remodeling following ...\n5. The term \"fibrosis\" refers to a spectrum of connective tissue disorders characterized by the excessive accumulation of extracellular matrix leading to organ dysfunction and, ultimately, failure. Fibrosis affects millions of patients worldwide and often manifests itself as a late-stage pathological condition associated with poor prognostic outcome. Although the aetiology and clinical course ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does increased vessel density combined with a reduction in fibrosis decrease the efficacy of chemotherapy treatments?",
               "answer": "The provided evidence snippets do not directly address the relationship between increased vessel density, reduced fibrosis, and the efficacy of chemotherapy treatments. While there are mentions of vascular changes in pulmonary fibrosis, such as increased capillary density and endothelial proliferation, as well as conflicting findings regarding endothelial apoptosis and reduced capillary density, there is no specific",
               "rationale": "1. Introduction. Fibrosis is a widely recognized cause of disease-related morbidity and mortality worldwide [1].Despite the diverse array of etiologies and affected organs, common mechanisms underlying the development and progression of fibrosis exist [2].Specifically, these include a hyperactive inflammatory response, excessive activation of fibroblasts, and aberrant tissue remodeling following ...\n2. Over the years, the literature describing the vasculature in pulmonary fibrosis has demonstrated potentially conflicting findings. There have been reports of heterogeneously increased sprouting angiogenesis [], increased capillary density and endothelial proliferation [33, 34], as well as contrasting observations of endothelial apoptosis and reduced capillary density [33,34,35,36].\n3. The main complications of pulmonary fibrosis are acute exacerbations and pulmonary hypertension; comorbidities are also of prognostic relevance. Treatment of pulmonary fibrosis depends on the subtype and clinical behavior. For IPF, antifibrotic therapy is indicated; fHP, on the other hand, is mainly treated by antigen avoidance and immune ...\n4. 1. INTRODUCTION. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis, inflammation, and destruction of lung architecture. 1 , 2 , 3 Damage to the alveolar epithelium and abnormal wound repair are theorized to be key factors in the development of this disease. IPF is thus far incurable with average onset at about age 65 years and a survival rate ...\n5. A common pharmaceutical therapy for radiation fibrosis is combined treatment with pentoxifylline and α-tocopherol (vitamin E). 40 Pentoxifylline is a methylxanthine derivative that induces vasodilation, increases erythrocyte membrane flexibility, and decreases platelet aggregation to enhance blood flow. Vitamin E has antioxidant properties ...",
               "predicate": null
            }
         ],
         "row": 588,
         "id": 265878349421907412
      },
      {
         "claim": "Inositol lipid 3-phosphatase PTEN converts Ptdlns(3,4)P 2 into phosphatidylinositol 4-phosphate.",
         "label": 1,
         "prediction": 0,
         "rationale": "PTEN (phosphatase and tensin homolog) is a gene that encodes an enzyme found in almost all tissues in the body, acting as a tumor suppressor to regulate cell division. PTEN converts PtdIns(3,4,5)P3 into PtdIns(4,5)P2. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PTEN?",
               "answer": "PTEN (phosphatase and tensin homolog) is a gene that encodes an enzyme found in almost all tissues in the body. This enzyme acts as a tumor suppressor, helping to regulate cell division by preventing cells from growing and dividing too rapidly or in an uncontrolled manner. Mutations in the PTEN",
               "rationale": "1. PTEN. (gene) Space-filling model of the PTEN protein (blue) complexed with tartaric acid (brown). [5] Phosphatase and tensin homolog ( PTEN) is a phosphatase in humans and is encoded by the PTEN gene. [6] Mutations of this gene are a step in the development of many cancers, specifically glioblastoma, lung cancer, breast cancer, and prostate cancer.\n2. The PTEN gene provides instructions for making an enzyme that is found in almost all tissues in the body. The enzyme acts as a tumor suppressor, which means that it helps regulate cell division by keeping cells from growing and dividing (proliferating) too rapidly or in an uncontrolled way. To function, the PTEN enzyme attaches (binds) to ...\n3. PTEN Hamartoma Tumor syndrome (PHTS) is a rare genetic condition that causes an increased risk for certain cancers, benign growths, and neurodevelopmental disorders.Â PHTS describes any person who is found to have a change, or mutation, in the PTENÂ gene; some persons may also carry diagnoses of Cowden syndrome or Bannayan-Riley-Ruvalcaba syndrome, which are based on their personal medical ...\n4. Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a phosphatase that is frequently altered in cancer. PTEN has phosphatase-dependent and - independent roles; and genetic alterations in PTEN lead to deregulation of protein synthesis, cell cycle, migration, growth, DNA repair, and survival signaling. PTEN localization, stability, conformation, and phosphatase activity are ...\n5. What is PTEN hamartoma tumor syndrome (PHTS)?. PTEN hamartoma tumor syndrome (PHTS) refers to a group of syndromes that involve a mutation, or change, in your PTEN gene. PTEN is a tumor suppressor gene.It makes an enzyme that prevents uncontrolled cell growth that causes tumors.Cells can grow out of control when there's a mutation, causing hamartomas.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What does PTEN convert Ptdlns(3,4)P 2 into?",
               "answer": "PTEN converts PtdIns(3,4,5)P 3 into PtdIns(4,5)P 2.",
               "rationale": "1. A hypothetical model of the interfacial activation of PTEN at a membrane surface rich in PtdIns(4,5)P 2 is shown. PTEN is proposed to undergo a conformational change on interaction with PtdIns(4,5 ...\n2. Model for the inhibition of PI 3-kinase signalling by PTEN and SHIP at the plasma membrane. The lipid second messenger PtdIns(3,4,5)P 3 is produced from the abundant cellular PI PtdIns(4,5)P 2 by the action of class I PI 3-kinase (PI3K) enzymes, which phosphorylate the 3-position of the inositol ring. PI 3-kinases are activated by diverse stimuli, including many that act through transmembrane ...\n3. Class I PI3K generates PtdIns (3,4,5)P 3 at the plasma membrane in response to growth factor stimulation, leading to AKT activation to drive cell proliferation, survival and migration. PTEN negatively regulates PI3K/AKT signalling by dephosphorylating PtdIns (3,4,5)P 3 to form PtdIns (4,5)P 2. PtdIns (3,4,5)P 3 can also be hydrolysed by the ...\n4. G9403619/MRC_/Medical Research Council/United Kingdom. The PTEN tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (PI3K)-dependent signalling by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PtdInsP (3)). Here, we discuss the concept of PTEN as an 'interfacial enzyme', which exists in a ...\n5. PTEN localizes to the apical plasma membrane during epithelial morphogenesis and catalyses the conversion of PtdIns(3,4,5)P 3 to PtdIns(4,5)P 2; PtdIns(4,5)P 2 recruits annexin 2 (ANXA2), which in ...",
               "predicate": null
            }
         ],
         "row": 589,
         "id": 163264275160650003
      },
      {
         "claim": "Insomnia can be effectively treated with cognitive behavioral therapy.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cognitive behavioral therapy (CBT) is a type of psychotherapeutic treatment that helps individuals identify and change destructive or disturbing thought patterns that negatively influence their behavior and emotions. Cognitive behavioral therapy for insomnia (CBT-I) is effective in treating insomnia. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is cognitive behavioral therapy?",
               "answer": "Cognitive behavioral therapy (CBT) is a type of psychotherapeutic treatment that helps individuals identify and change destructive or disturbing thought patterns that negatively influence their behavior and emotions. It combines cognitive therapy, which focuses on changing negative thinking, with behavioral therapy, which addresses maladaptive behaviors. CBT is a structured form of talk",
               "rationale": "1. CBT is a form of psychological treatment that helps people cope with various problems by changing their thinking and behavior. Learn about the core principles, strategies, and evidence of CBT from the American Psychological Association.\n2. Cognitive behavioral therapy (CBT) is a common type of talk therapy (psychotherapy). You work with a mental health counselor (psychotherapist or therapist) in a structured way, attending a limited number of sessions. CBT helps you become aware of inaccurate or negative thinking so you can view challenging situations more clearly and respond to ...\n3. Cognitive behavioral therapy (CBT) is a type of psychotherapeutic treatment that helps people learn how to identify and change the destructive or disturbing thought patterns that have a negative influence on their behavior and emotions. Cognitive behavioral therapy combines cognitive therapy with behavior therapy by identifying maladaptive ...\n4. Cognitive behavioral therapy (CBT) is one of the most common and best studied forms of psychotherapy. It is a combination of two therapeutic approaches, known as cognitive therapy and behavioral therapy. The exact treatment approaches used will depend on the illness or problem to be treated. But the basic idea behind the therapy is always the ...\n5. CBT is a type of talk therapy that helps you change negative thoughts and behaviors to improve your mental and emotional health. Learn how CBT works, what conditions it can treat, and how to find a therapist.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is cognitive behavioral therapy effective in treating insomnia?",
               "answer": "Yes, cognitive behavioral therapy for insomnia (CBT-I) is effective in treating insomnia. The evidence indicates that CBT-I is the most effective nonpharmacological treatment for chronic insomnia, with studies showing significant reductions in sleep latency and time awake after sleep onset. Additionally, CBT-I employs various techniques that help individuals improve their",
               "rationale": "1. The most effective nonpharmacological treatment for chronic insomnia is cognitive-behavioral therapy for insomnia (CBT-i). A 2015 meta-analysis of 20 randomized controlled studies of CBT-i for patients with chronic insomnia found average reductions of 19 minutes in sleep latency and 26 minutes in time awake after sleep onset.\n2. Therapy techniques involve stimulus control, sleep restriction, and relaxation training. Most individuals who try CBT-I experience improvements to their insomnia and better quality sleep. CBT-I is considered effective for both short-term insomnia and chronic insomnia. Living with insomnia can be a challenge.\n3. Cognitive behavioral therapy, sometimes called CBT, can effectively treat long-term sleep problems like insomnia. Generally, it's the first treatment recommended. CBT helps you find out which thoughts and behaviors cause sleep problems or make them worse. You learn how to replace these thoughts and behaviors with habits that support sound sleep.\n4. Fortunately, there is a well-studied and proven treatment for insomnia that generally works in eight sessions or less: cognitive behavioral therapy for insomnia, or C.B.T.- I. If you cannot find a ...\n5. Cognitive behavioral therapy for insomnia (CBT-I) is a treatment program that can help people who have difficulty falling asleep, staying asleep, or find that sleep is unrefreshing. It offers benefits in dealing with chronic insomnia, defined as three episodes of sleep difficulty per week for three months without another cause.",
               "predicate": null
            }
         ],
         "row": 590,
         "id": 148443592151098292
      },
      {
         "claim": "LDL cholesterol has no involvement in the development of cardiovascular disease.",
         "label": 0,
         "prediction": 0,
         "rationale": "LDL cholesterol is involved in the development of cardiovascular disease. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "Is LDL cholesterol involved in the development of cardiovascular disease?",
               "answer": "Yes, LDL cholesterol is involved in the development of cardiovascular disease. The evidence indicates that low-density lipoprotein cholesterol (LDL-C) is a major causal factor in the pathophysiology of atherosclerotic cardiovascular disease (ASCVD) and is clearly established as a risk factor for the development of cardiovascular disease",
               "rationale": "1. Abstract. For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the ...\n2. Low-density lipoprotein (LDL) as the primary driver of atherogenesis. Key features of the influx and retention of LDL in the arterial intima, with ensuing pathways of modification leading to (i) extracellular cholesterol accumulation and (ii) formation of cholesteryl ester droplet-engorged macrophage foam cells with transformation to an inflammatory and prothrombotic phenotype.\n3. Low‐density lipoprotein cholesterol (LDL‐C) is a major causal factor in the pathophysiology of atherosclerotic cardiovascular disease (ASCVD). 1 Epidemiological studies have consistently demonstrated a dose‐dependent log‐linear relationship between plasma LDL‐C concentrations and risk of ASCVD events; this relationship is replicated in Mendelian randomization studies. 1 In addition ...\n4. Elevated low-density lipoprotein (LDL, or \"bad\") cholesterol is a clearly established risk factor for the development of cardiovascular disease (CVD). Lowering LDL with medications and/or lifestyle changes has been shown to lower CVD risk. Just how far to lower LDL, however, has remained controversial.\n5. (1) The study was a prospective cohort study, (2) the exposure was total serum cholesterol, HDL-cholesterol, and LDL-cholesterol levels measured before the cardiovascular event, and (3) the outcome was cardiovascular disease (CVD) mortality, including coronary heart disease (CHD) mortality. We excluded studies if they did not meet these criteria.",
               "predicate": null
            }
         ],
         "row": 591,
         "id": 110976805926991457
      },
      {
         "claim": "Leuko-increased blood increases infectious complications in red blood cell transfusion.",
         "label": 0,
         "prediction": 1,
         "rationale": "Leuko-increased blood refers to leukocytosis, a condition characterized by an increased level of leukocytes in the blood, often signaling an inflammatory response. Leukocytosis itself is a common sign of infection and should prompt further evaluation for potential infectious complications, but its direct relationship with the risk of infectious complications in red blood cell transfusion is not addressed. The provided evidence does not directly address whether leukocytosis increases the risk of infectious complications specifically in red blood cell transfusions. Leukocytosis can increase the risk of infectious complications. There is no direct evidence that leukocytosis increases the risk of infectious complications specifically related to red blood cell transfusions. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is leuko-increased blood?",
               "answer": "Leuko-increased blood refers to leukocytosis, which is a condition characterized by an increased level of leukocytes (white blood cells) in the blood. This condition often signals an inflammatory response, commonly due to infection, but can also result from other factors such as parasitic infections, bone tumors, leukemia, strenuous",
               "rationale": "1. Leukopenia is a low white blood cell count. It doesn't always cause symptoms, but it can lead to serious complications. This article takes a closer look at leukopenia, including its causes ...\n2. A high white blood count most often signals an infection in the body, especially when there are also other symptoms. ‌. Other conditions that can cause leukocytosis include: lifestyle factors ...\n3. Leukopenia is a low white blood cell (leukocyte) count that indicates a decrease in disease-fighting cells in your body. Leukopenia can indicate a variety of health complications, including serious infections, diseases, and cancer. Leukopenia can involve one or more types of white blood cells and may include neutropenia, monocytopenia, and more.\n4. Leukocytosis is condition characterized by increased levels of leukocytes in the blood. Leukocytes are a type of white blood cell that help protect your body against illness and infection ...\n5. Leukocytosis is a condition in which the white cell count is above the normal range in the blood. It is frequently a sign of an inflammatory response, most commonly the result of infection, but may also occur following certain parasitic infections or bone tumors as well as leukemia.It may also occur after strenuous exercise, convulsions such as epilepsy, emotional stress, pregnancy and labor ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does leukocytosis increase the risk of infectious complications in red blood cell transfusion?",
               "answer": "Based on the provided evidence snippets, it can be inferred that leukocytosis itself is a common sign of infection and should prompt further evaluation for potential infectious complications. However, the specific evidence regarding the relationship between leukocytosis and the risk of infectious complications in red blood cell transfusion is not directly addressed. \n\nSnippet",
               "rationale": "1. Infections Associated with Blood Products Blood products transfusion can cause infectious complications through three mechanisms: (a) transfusion of microbes present in asymptomatic donor blood [mainly viruses]; (b) contamination of stored blood products [primarily bacteria in platelets]; and (c) transfusion-related immunosuppression predisposing to postoperative infections and others. The ...\n2. Continuing Education Activity Leukocytosis, characterized by an elevation in the white blood cell count, is a common clinical finding with various potential causes, encompassing infections, inflammation, malignancies, and hereditary disorders. The threshold for leukocytosis varies with age and pregnancy status, with significant deviations from typical values prompting further evaluation ...\n3. In patients who are at risk of developing transfusion-associated circulatory overload or who need to have offending substances removed from cell-free fluid in cellular blood products (similar to ...\n4. Leukocytosis is a common sign of infection, particularly bacterial, and should prompt physicians to identify other signs and symptoms of infection.\n5. In the septic group, no significant post-transfusion leukocytosis occurred. In 11 nonseptic patients requiring more than one unit of packed red cells, a significant increase in mean white blood cell count occurred 2 hrs after transfusion with non-filtered packed red cells, whereas transfusion with pre-storage-filtered packed red cells did not ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does leukocytosis increase the risk of infectious complications in red blood cell transfusion?",
               "answer": "The provided evidence does not directly address whether leukocytosis increases the risk of infectious complications specifically in red blood cell transfusions. However, it does mention that blood transfusions carry significant risks, including the transmission of infectious agents and immune suppression. While leukocytosis itself is defined as an elevated white blood cell count, the",
               "rationale": "1. Infections Associated with Blood Products. Blood products transfusion can cause infectious complications through three mechanisms: (a) transfusion of microbes present in asymptomatic donor blood [mainly viruses]; (b) contamination of stored blood products [primarily bacteria in platelets]; and (c) transfusion-related immunosuppression predisposing to postoperative infections and others.\n2. Blood transfusion safety has progressed significantly in modern times. However, infectious complications of blood transfusions can still be encountered from time to time. Although any intravenously administered fluid can transmit infection, blood is a unique medium and is an exceptional mode for transmitting infection. Only through modern blood banking procedures have infectious complications ...\n3. Leukocytosis denotes an age-appropriate rise in the white blood cell (WBC) count. Typically, a WBC count surpassing 11,000 cells/µL in adults is deemed leukocytosis, and a WBC count >100,000 cells/µL is termed hyperleukocytosis.[1] However, the threshold varies with age and pregnancy; for instance, 30,000 cells/µL in adults would be abnormal but within the normal range for a newborn.[2]\n4. Major Red Cell Products for Transfusion. (±10%) mL of whole bloodfrom volunteer donors and removal of the plasma by ce. trifugation (see Table 1). After removal of the plasma, the resulting product is red blood cells (referred to informally as \". acked red blood cells\").The most commonly available US RBC product has a 42-day blood bank.\n5. Blood transfusions remain common practice in the critical care and surgical settings. Transfusions carry significant risks, including risks for transmission of infectious agents and immune suppression. Transmission of bacterial infections, although rare, is the most common adverse event with transfusion. The risk for transmission of viral infections has decreased over time, clearly because ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Does leukocytosis increase the risk of infectious complications in general?",
               "answer": "Yes, leukocytosis can increase the risk of infectious complications. The evidence indicates that a WBC count in excess of 100,000/μL constitutes a medical emergency due to the risk of leukostasis, which can lead to profound and prolonged cytopenias, ultimately resulting in infectious complications.",
               "rationale": "1. In clinical practice, leukocytosis is often overlooked after infectious and hematologic disease are ruled out, particularly in patients with solid tumors. This is unfortunate, as the mechanisms that mediate paraneoplastic leukocytosis may play a significant role in the underlying pathophysiology of cancer progression and prognosis.\n2. Leukocytosis denotes an age-appropriate rise in the white blood cell (WBC) count. Typically, a WBC count surpassing 11,000 cells/µL in adults is deemed leukocytosis, and a WBC count >100,000 cells/µL is termed hyperleukocytosis.[1] However, the threshold varies with age and pregnancy; for instance, 30,000 cells/µL in adults would be abnormal but within the normal range for a newborn.[2]\n3. Patient characteristic Normal total leukocyte count. Newborn infant 13,000 to 38,000 per mm3. (13.0 to 38.0 × 109per L) Infant two weeks of age 5,000 to 20,000 per mm3. (5.0 to 20.0 × 109per L ...\n4. Leukocytosis is an increase of the white blood cell (WBC, or leukocyte) count; for adults, this is usually more than 11,000/μL. ... WBC counts in excess of 100,000/μL constitute a medical emergency because of the risk of leukostasis (described earlier). ... The resultant profound and prolonged cytopenias may result in infectious complications ...\n5. Practice Essentials. Leukocytosis refers to an increase in the total number of white blood cells (WBCs) due to any cause. From a practical standpoint, leukocytosis is traditionally classified according to the component of white cells that contribute to an increase in the total number of WBCs. Therefore, leukocytosis may be caused by an increase ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "Does leukocytosis increase the risk of infectious complications in red blood cell transfusions specifically?",
               "answer": "The provided evidence does not directly address whether leukocytosis increases the risk of infectious complications specifically related to red blood cell transfusions. While it mentions that transfusion-related immunosuppression can predispose patients to postoperative infections and other infections, it does not establish a clear link between leukocytosis and increased risk of infectious",
               "rationale": "1. Infections Associated with Blood Products. Blood products transfusion can cause infectious complications through three mechanisms: (a) transfusion of microbes present in asymptomatic donor blood [mainly viruses]; (b) contamination of stored blood products [primarily bacteria in platelets]; and (c) transfusion-related immunosuppression predisposing to postoperative infections and others.\n2. Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. ... blood screening process; the risk of contracting an infection from transfusion has decreased ...\n3. Leukocytosis denotes an age-appropriate rise in the white blood cell (WBC) count. Typically, a WBC count surpassing 11,000 cells/µL in adults is deemed leukocytosis, and a WBC count >100,000 cells/µL is termed hyperleukocytosis.[1] However, the threshold varies with age and pregnancy; for instance, 30,000 cells/µL in adults would be abnormal but within the normal range for a newborn.[2]\n4. Over 11 million red blood cells (RBCs) are transfused annually in the United States, making transfusion the most common procedure completed during a given hospitalization. 1,2 Transfusion threshold studies have shown that restrictive hemoglobin thresholds are as safe as or safer than liberal hemoglobin thresholds for many patient populations and indications, leading to a decline in transfused ...\n5. Non-infectious complications are a group of adverse events associated with blood transfusions, some of which could be life-threatening. Therefore, knowledge of these complications is essential for an interprofessional team. This activity describes various non-infectious blood transfusion complications, symptoms, and potential mitigation ...",
               "predicate": null
            }
         ],
         "row": 592,
         "id": 220423103883426868
      },
      {
         "claim": "Leuko-reduced blood reduces infectious complications in red blood cell transfusion.",
         "label": 1,
         "prediction": 0,
         "rationale": "Leuko-reduced blood is blood or blood components from which white blood cells have been removed through a process known as leukoreduction. Leuko-reduced blood is intended to reduce the risk of adverse reactions associated with blood transfusions, including infectious complications, although its potential benefits in decreasing both infectious and non-infectious complications remain unclear. Leukoreduction does not significantly reduce the risk of infectious complications in red blood cell transfusion. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is leuko-reduced blood?",
               "answer": "Leuko-reduced blood refers to blood or blood components from which white blood cells (leukocytes) have been removed through a process known as leukoreduction. This process is typically achieved using filtration techniques, such as leukocyte reduction filters, which are integrated into blood collection systems. The purpose of leukoreduction is",
               "rationale": "1. Leukoreduction. Leukoreduction is the removal of white blood cells (or leukocytes) from the blood or blood components supplied for blood transfusion. After the removal of the leukocytes, the blood product is said to be leukoreduced .\n2. Guidelines for the statistical process control of leukoreduced blood components have been published. [26-28] 10 6 WBCs per unit translates into 3.3 WBCs/μl, hence the enumeration of residual WBCs in the leukoreduced blood components is a challenging task. The traditional automated cell counters do not give accurate results at leukocyte ...\n3. The process of removing white blood cells from a blood product prior to transfusion, primarily by filtration. So-called \"leukocyte reduction filters\" are part of a whole blood collection bag set, so that after a unit of blood is collected, it can be quickly filtered without breaking the sterility of the product. Modern apheresis equipment ...\n4. Leucoreduction (LR) is the reduction of white blood cell (WBC) concentration in blood components, namely red blood cell concentrates (RBC), platelet concentrates (PC) and plasma obtained from the fractionation of whole blood or apheresis. There are many methods of LR but, currently, this process may be performed using selective LR filters ...\n5. Leucoreduction is a filtration technique used to remove white blood cells, or leukocytes, from platelet and red blood cell products. White blood cells are known for the critical role they play in the body's immune response, and part of the reason they can protect you so well is that white blood cells contain human leukocyte antigens.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does leuko-reduced blood reduce infectious complications in red blood cell transfusion?",
               "answer": "The evidence suggests that leukoreduction is intended to reduce the risk of adverse reactions associated with blood transfusions, including infectious complications. However, it also indicates that the potential benefits of leukoreduced packed red blood cells (PRBCs) in decreasing both infectious and non-infectious complications remain unclear. Therefore, while",
               "rationale": "1. A majority of them become alloimmune to various red blood cell, platelet, and HLA antigens during the course of their transfusion therapy. ... transfusion of leukoreduced blood components assumes a lot of significance in these patients. Historical Aspects ... and the risk of perioperative infection in which some of them showed an increased ...\n2. However, blood transfusions have adverse events, some of them potentially related to immune modulation or to a direct transmission of infectious agents (e.g. cytomegalovirus). Leukoreduction is a process in which the white blood cells are intentionally reduced in packed red blood cells (PRBCs) in order to reduce the risk of adverse reactions.\n3. Introduction. Leucocytes and leucocyte-derived cytokines are associated with several adverse outcomes of transfusion therapy 1. Leucoreduction (LR) is the reduction of white blood cell (WBC) concentration in blood components, namely red blood cell concentrates (RBC), platelet concentrates (PC) and plasma obtained from the fractionation of whole ...\n4. Leukoreduction is a process in which the white blood cells are intentionally reduced in packed red blood cells (PRBCs) in order to reduce the risk of adverse reactions. The potential benefits of leukoreduced PRBCs in all types of transfused patients for decreasing infectious and non-infectious complications remain unclear.\n5. The transfusion threshold of plasma for most adults should be an international normalized ratio > 1.5 to 1.6 in patients with active bleeding or at high risk of bleeding. 4 - 8. , 11. C ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does leukoreduction decrease the risk of infectious complications in red blood cell transfusion?",
               "answer": "Based on the provided evidence snippet, leukoreduction does not significantly reduce the risk of infectious complications in red blood cell transfusion. Although leukoreduction aims to reduce adverse reactions by filtering out white blood cells, several reviews and meta-analyses indicate that it does not have a significant impact on the risk of infectious complications",
               "rationale": "1. Leukoreduction. Leukoreduction (LR) aims to attenuate transfusion-associated reactions by filtering donor leukocytes from packed RBC units. In order to achieve leukoreduction, freshly collected RBC units are passed through a filter (Figure 1) that operates by two mechanisms: barrier filtration and cell adhesion.Barrier filtration partitions cell types based on size.\n2. However, blood transfusions have adverse events, some of them potentially related to immune modulation or to a direct transmission of infectious agents (e.g. cytomegalovirus). Leukoreduction is a process in which the white blood cells are intentionally reduced in packed red blood cells (PRBCs) in order to reduce the risk of adverse reactions.\n3. Several reviews and meta-analyses on postoperative infection and death related to the leukoreduction of blood products have been ... does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. ... Randomized trial comparing packed red cell blood transfusion with and without leukocyte ...\n4. Introduction. Pre-storage leukoreduction (LR) of whole blood (WB) or red blood cells (RBC) reduces white blood cell (WBC) and platelet contamination and decreases febrile non-hemolytic transfusion reactions, alloimmunization, and the accumulation of biologic response modifiers (BRMs), including: soluble CD40 ligand, cytokines, chemokines, and lysophosphatidylcholines (lyso-PCs) some of which ...\n5. Leukoreduction is a process in which the white blood cells are intentionally removed from donated blood in order to reduce the risk of adverse reactions in people receiving the blood transfusion. The benefits of removing white blood cells with the intent of reducing infectious and non-infectious complications in all types of transfused patients ...",
               "predicate": null
            }
         ],
         "row": 593,
         "id": 271747157109773478
      },
      {
         "claim": "Low nucleosome occupancy correlates with low methylation levels across species.",
         "label": 0,
         "prediction": 1,
         "rationale": "Nucleosome occupancy refers to the fraction of cells in which a specific position along the genome is occupied by a nucleosome. The relationship between nucleosome occupancy and methylation levels is complex and not fully understood, with ongoing debate about whether DNA methylation reliably indicates high nucleosome occupancy. The relationship between low nucleosome occupancy and low methylation levels across species is not definitively established. There is no consistent correlation between nucleosome occupancy and methylation levels across different species. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is nucleosome occupancy?",
               "answer": "Nucleosome occupancy refers to the fraction of cells in which a specific position along the genome is occupied by a nucleosome. It is a measure of how many nucleosomes are present at a given location in the DNA, which can influence the accessibility of that region for various biological processes. Nucleosome occupancy is characterized by",
               "rationale": "1. Mapping nucleosome occupancy. Nucleosome locations are mapped genome-wide through a variety of methods, each of which has advantages and disadvantages . The key steps include chromosome ...\n2. Kinetics of nucleosome release from chromatin. Each position x along the genome is characterized by a nucleosome occupancy (i.e., the fraction of cells in which position x is occupied by a nucleosome), a rate of nucleosome release (rate constant k 1 (x)), and a rate of nucleosome decay (over-digestion, rate constant k 2 (x)).Digesting a population of C cells with a concentration [E] of MNase ...\n3. To account for local context of nucleosome occupancy, the estimation of significance of the nucleosome occupancy changes within bins was performed independently in 25 kb segments with a 12.5 kb ...\n4. Definition of nucleosome occupancy and positioning. We define the term \"nucleosome positioning\" broadly to indicate where nucleosomes are located with respect to the genomic DNA sequence. Although nucleosome positioning is a dynamic process, sequencing-based mapping approaches identify the positions of individual nucleosomes in a single ...\n5. Nucleosome occupancy and positioning are principal determinants of accessibility and are differentially regulated by sequence-specific TFs and chromatin remodellers, which are thought to bias the ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the relationship between nucleosome occupancy and methylation levels?",
               "answer": "The relationship between nucleosome occupancy and methylation levels is complex and not fully understood. Evidence suggests that DNA methylation is enriched in heterochromatin and depleted at active promoters and enhancers, but there is ongoing debate about whether DNA methylation reliably indicates high nucleosome occupancy. Some studies indicate that nucleosome occupancy can",
               "rationale": "1. To investigate methylation levels and nucleosome occupancy in the human genome, we use data from the NOME-seq method (Kelly et al., 2012), ... the complex relationship between nucleosome occupancy and DNA methylation should be tested further. Ideally, experimental studies should attempt measurements that can simultaneously access DNA ...\n2. DNA methylation is an epigenetic modification that is enriched in heterochromatin but depleted at active promoters and enhancers. However, the debate on whether or not DNA methylation is a reliable indicator of high nucleosome occupancy has not been settled. For example, the methylation levels of DNA flanking CTCF sites are higher in linker DNA ...\n3. Background: DNA methylation is an epigenetic modification that is enriched in heterochromatin but depleted at active promoters and enhancers. However, the debate on whether or not DNA methylation is a reliable indicator of high nucleosome occupancy has not been settled. For example, the methylation levels of DNA flanking CTCF sites are higher ...\n4. In other regions along the genome nucleosome occupancy is statistically independent of the positioning of CpGs or their methylation levels. Anti-correlation between CpG density and methylation level is however similarly strong in both regions. On promoters, nucleosome occupancy is more strongly affected by the level of gene expression than CpG ...\n5. Indeed, genome-wide nucleosome-positioning data suggest that exons also show increased nucleosome occupancy levels compared to introns 66 and nucleosomes are preferential sites for DNA methylation 67.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does low nucleosome occupancy correlate with low methylation levels across species?",
               "answer": "The provided evidence does not definitively establish a correlation between low nucleosome occupancy and low methylation levels across species. While it mentions that DNA methylation is depleted at active promoters and enhancers (which may suggest lower nucleosome occupancy in these regions), it also indicates that the relationship between nucleosome occupancy and methylation levels",
               "rationale": "1. Previously, nucleosome depleted regions were observed upstream of transcription start sites and nucleosome occupancy was reported to correlate both with CpG density and the level of CpG methylation. Several studies imply a causal link where CpG methylation might induce nucleosome formation, whereas others argue the opposite, i.e., that ...\n2. DNA methylation is an epigenetic modification that is enriched in heterochromatin but depleted at active promoters and enhancers. However, the debate on whether or not DNA methylation is a reliable indicator of high nucleosome occupancy has not been settled. For example, the methylation levels of DNA flanking CTCF sites are higher in linker DNA ...\n3. Abstract. Background: DNA methylation is an epigenetic modification that is enriched in heterochromatin but depleted at active promoters and enhancers. However, the debate on whether or not DNA methylation is a reliable indicator of high nucleosome occupancy has not been settled. For example, the methylation levels of DNA flanking CTCF sites ...\n4. In other regions along the genome nucleosome occupancy is statistically independent of the positioning of CpGs or their methylation levels. Anti-correlation between CpG density and methylation level is however similarly strong in both regions. On promoters, nucleosome occupancy is more strongly affected by the level of gene expression than CpG ...\n5. Prominent exceptions to the positive correlation between mCpG density and nucleosome occupancy included CpG islands marked by H3K27me3 and CpG-poor heterochromatin marked by H3K9me3, and these modifications, along with DNA methylation, are the major silencing mechanisms of the human genome.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Is there a consistent correlation between nucleosome occupancy and methylation levels across different species?",
               "answer": "The provided evidence does not indicate a consistent correlation between nucleosome occupancy and methylation levels across different species. It highlights that while there are correlations observed in certain contexts, such as near promoter sites, the relationship can vary significantly in other regions of the genome. For instance, it mentions that in some areas, nucleosome occupancy",
               "rationale": "1. DNA methylation and nucleosome occupancy at the genome level. A common strategy used to study chromatin from genome-wide high-throughput sequencing data involves designating boundary elements and then characterizing the markers surrounding these sites [].An example of this approach is given in Additional file 1: Figure S1, which displays average DNA methylation and nucleosome occupancy levels ...\n2. Several studies imply a causal link where CpG methylation might induce nucleosome formation, whereas others argue the opposite, i.e., that nucleosome occupancy might influence CpG methylation. Correlations are indeed evident between nucleosomes, CpG density and CpG methylation—at least near promoter sites.\n3. Abstract. Background: DNA methylation is an epigenetic modification that is enriched in heterochromatin but depleted at active promoters and enhancers. However, the debate on whether or not DNA methylation is a reliable indicator of high nucleosome occupancy has not been settled. For example, the methylation levels of DNA flanking CTCF sites ...\n4. In other regions along the genome nucleosome occupancy is statistically independent of the positioning of CpGs or their methylation levels. Anti-correlation between CpG density and methylation level is however similarly strong in both regions. On promoters, nucleosome occupancy is more strongly affected by the level of gene expression than CpG ...\n5. Prominent exceptions to the positive correlation between mCpG density and nucleosome occupancy included CpG islands marked by H3K27me3 and CpG-poor heterochromatin marked by H3K9me3, and these modifications, along with DNA methylation, are the major silencing mechanisms of the human genome.",
               "predicate": null
            }
         ],
         "row": 594,
         "id": 240874657188434650
      },
      {
         "claim": "Lupus-prone mice infected with curliproducing bacteria have higher autoantibody titers compared to controls.",
         "label": 1,
         "prediction": 1,
         "rationale": "Curli-producing bacteria are certain strains of enterobacteria, such as E. coli and Salmonella spp., that produce curli proteins, which are involved in biofilm formation, promote cell community behavior, and can mediate host cell adhesion and invasion. Lupus-prone mice infected with curli-producing bacteria have higher autoantibody titers compared to controls. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are curliproducing bacteria?",
               "answer": "Curli-producing bacteria are certain strains of enterobacteria, such as E. coli and Salmonella spp., that produce curli proteins, which are a type of amyloid fiber. These fibers are involved in biofilm formation, promote cell community behavior, and can mediate host cell adhesion and invasion.",
               "rationale": "1. Curli. The Curli protein is a type of amyloid fiber produced by certain strains of enterobacteria. They are extracellular fibers located on bacteria such as E. coli and Salmonella spp. [2] These fibers serve to promote cell community behavior through biofilm formation in the extracellular matrix. Amyloids are associated with several human ...\n2. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone.\n3. Presented here is a systematic study of the effects of curli on bacteria-clay interactions. The aggregation trends of curli-producing and curli-deficient bacteria with clay minerals were followed using gradient-sedimentation experiments, Lumisizer measurements, bright-field and electron microscopy.\n4. Curli also mediate host cell adhesion and invasion, and they are potent inducers of the host inflammatory response. The structure and biogenesis of curli are unique among bacterial fibers that have been described to date. Structurally and biochemically, curli belong to a growing class of fibers known as amyloids.\n5. Curli provide a unique system to study macromolecular assembly in bacteria and in vivo amyloid fiber formation. Here, we review curli biogenesis, regulation, role in biofilm formation, and role in pathogenesis.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do lupus-prone mice infected with curli-producing bacteria have higher autoantibody titers compared to controls?",
               "answer": "Yes, lupus-prone mice infected with curli-producing bacteria have higher autoantibody titers compared to controls (curli-deficient bacteria). The evidence indicates that the infection with curli-producing bacteria triggers higher autoantibody levels in lupus-prone mice.",
               "rationale": "1. We also found that the infection of lupus-prone mice with curli-producing bacteria triggered higher autoantibody titers compared to curli-deficient bacteria. These data provide a mechanism by which the microbiome and biofilm-producing enteric infections may contribute to the progression of SLE and point to a potential molecular target for ...\n2. When given systemically, curli/DNA complexes trigger immune activation and production of type I interferons as well as autoantibodies in SLE-prone and wild-type mice . It was also found that infection of SLE-prone mice with curli-producing bacteria triggers higher autoantibody titers than do curli-deficient bacteria ( 41 ).\n3. We also found that the infection of lupus-prone mice with curli-producing bacteria triggered higher autoantibody titers compared to curli-deficient bacteria. These data provide a mechanism by which the microbiome and biofilm-producing enteric infections may contribute to the progression of SLE and point to a potential molecular target for ...\n4. Although most research efforts focus on the genetic and environmental factors of systemic lupus erythematosus (SLE), novel new research highlights the effect bacterial infections can have on lupus activation and flares. The article, \"Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity,\" explains how researchers identified the amyloid protein curli, a component of bacterial ...\n5. When given systemically, curli/DNA complexes trigger immune activation and production of type I interferons as well as autoantibodies in SLE-prone and wild-type mice . It was also found that infection of SLE-prone mice with curli-producing bacteria triggers higher autoantibody titers than do curli-deficient bacteria ( 41 ).",
               "predicate": null
            }
         ],
         "row": 595,
         "id": 566132714753734545
      },
      {
         "claim": "Ly49Q directs the organization of neutrophil migration to inflammation sites by regulating membrane raft functions.",
         "label": 1,
         "prediction": 1,
         "rationale": "Ly49Q is an inhibitory receptor expressed exclusively on myeloid cells, associated with SHP-1/2 upon cross-linking. Ly49Q plays a crucial role in neutrophil migration by regulating polarization and membrane raft functions, influencing neutrophil migration towards chemoattractants through its interaction with MHC class I. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Ly49Q?",
               "answer": "Ly49Q is an inhibitory receptor that is expressed exclusively on myeloid cells and is not found on natural killer (NK), invariant natural killer T (iNKT), or gamma delta (γδ) T cells. It is associated with SHP-1/2 upon cross-linking and is primarily detected on",
               "rationale": "1. One family member, Ly49Q, is expressed only on myeloid cells and is not found on NK, iNKT, or γδ T cells. There is growing evidence that these receptors may regulate not just the immune response to viruses, but other intracellular pathogens as well. Thus, this review's primary goal is to provide a guide for researchers first encountering ...\n2. Ly49Q may, as do other ITIM-bearing receptors on myeloid lineage cells, play an inhibitory function on these cells. Ly49Q is the only known example of a Ly49 family member that is not expressed on NK and NKT cells. IL-2 stimulation of NK and NKT cells fails to induce expression of Ly49Q on their surface (data not shown).\n3. Ly49Q is an inhibitory receptor and has been shown to associate with SHP-1/2 upon cross-linking . Its expression was detected on Gr-1 + cells in mouse fetal liver and adult BM and spleen. Expression was found to be higher on immature myeloid precursors and IFN-γ-treated macrophages . Ly49Q ...\n4. One family member, Ly49Q, is expressed only on myeloid cells and is not found on NK, iNKT, or γδ T cells. There is growing evidence that these receptors may regulate not just the immune response to viruses, but other intracellular pathogens as well. Thus, this review's primary goal is to provide a guide for researchers first encountering the ...\n5. One family member, Ly49Q, is expressed only on myeloid cells and is not found on NK, iNKT, or γδ T cells. There is growing evidence that these receptors may regulate not just the immune response to viruses, but other intracellular pathogens as well. Thus, this review's primary goal is to provide a guide for researchers first encountering ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of Ly49Q in neutrophil migration?",
               "answer": "Ly49Q plays a crucial role in neutrophil migration by regulating polarization and membrane raft functions. It is involved in switching neutrophils to a polarized morphology, which is essential for their rapid migration during inflammation. The interaction of Ly49Q with MHC class I influences neutrophil migration towards chemoattractants",
               "rationale": "1. The migration of B2m −/− neutrophils to the chemoattractants was significantly (p < 0.001) reduced (Figure 1I), suggesting that the Ly49Q-MHC class I interaction plays an important role in neutrophil migration. Taken together, these results indicated that Ly49Q plays an important role in the polarity formation and migration of neutrophils.\n2. opposite functions appeared to be mediated by distinct use of effector phosphatase SHP-1 and SHP-2. Ly49Q-dependent polarization and migration were affected by Ly49Q regulation of membrane raft functions. We propose that Ly49Q is pivotal in switching neutrophils to their polarized morphology and rapid migration upon inﬂammation, through its\n3. The Ly49Q receptor plays a crucial role in neutrophil polarization and migration by regulating raft trafficking. ... Vidal SM, et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med (2008) 205 (13):3187-99 10.1084/jem.20080718 [PMC free article] [Google Scholar] 114. Rahim ...\n4. Semantic Scholar extracted view of \"The Ly49Q receptor plays a crucial role in neutrophil polarization and migration by regulating raft trafficking.\" by S. Sasawatari et al. ... in pulmonary infection and structure function analysis in vitro and in vivo demonstrated that different domains of Ly49Q are important for its function. Expand. 8.\n5. Ly49Q-dependent neutrophil polarization and migration were affected by Ly49Q regulation of membrane raft functions (14). However, the significance of phosphatase recruitment in pDC function is ...",
               "predicate": null
            }
         ],
         "row": 596,
         "id": 174834433315322920
      },
      {
         "claim": "Ly6C hi monocytes have a lower inflammatory capacity than Ly6C lo monocytes.",
         "label": 0,
         "prediction": 0,
         "rationale": "The difference between Ly6C hi and Ly6C lo monocytes lies in their surface marker expression, functional roles, and transcriptional profiles, with Ly6C hi monocytes primarily promoting inflammation. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the difference between Ly6C hi and Ly6C lo monocytes?",
               "answer": "The difference between Ly6C hi and Ly6C lo monocytes lies in their surface marker expression, functional roles, and transcriptional profiles. Ly6C hi monocytes (Gr1 Hi CCR2 + CX3CR1 Lo) are primarily associated with promoting inflammation, while Ly6C lo monocytes (Gr",
               "rationale": "1. Macrophages originating from the yolk sac or bone marrow play essential roles in tissue homeostasis and disease. Bone marrow-derived monocytes differentiate into Ly6C hi and Ly6C lo macrophages according to the differential expression of the surface marker protein Ly6C. Ly6C hi and Ly6C lo cells possess diverse functions and transcriptional profiles and can accelerate the disease process or ...\n2. In-depth lineage-tracing experiments from Yona et al 35 suggest that Ly6C hi monocytes are the precursors to Ly6C low monocytes in the blood and in the bone marrow during the steady state. This concept is further supported by adoptive transfer experiments, where fluorescently labeled Ly6C hi monocytes become Ly6C low monocytes in the blood and bone marrow of the recipient mouse. 15,36 However ...\n3. Among blood monocytes, specific identifiable subsets with distinct effector functions have now been identified. 34,35 For instance, Ly6C Hi (Gr1 Hi CCR2 + CX3CR1 Lo) have been shown to promote inflammation, whereas Ly6C Lo (Gr1 Lo CCR2 − CX3CR1 Hi) monocytes are more regenerative. 13,21 - 23,30 - 32,34,36 Human correlates for these cells ...\n4. Differentially expressed genes between Ly6c Hi classical monocytes and Ly6c Lo non-classical monocytes, determined by a ≥ 0.5 log fold change and p < 0.05, were identified using the Wilcoxon ...\n5. The frequency and the number of Ly6C hi PD-L2 lo classical monocytes and Ly6C hi PD-L2 hi early CMDMs increased until the ... respectively. The value of Δear thickness, the differences in ear ...",
               "predicate": null
            }
         ],
         "row": 597,
         "id": 935069069495204584
      },
      {
         "claim": "Lymphadenopathy is observed in knockin mouse lacking the SHP-2 MAPK pathway.",
         "label": 1,
         "prediction": 1,
         "rationale": "SHP-2 is a ubiquitous tyrosine phosphatase that plays a crucial role in the MAPK pathway by promoting its activation in response to various growth factors, hormones, or cytokines. The effect of lacking the SHP-2 MAPK pathway in knockin mice is not directly addressed, but SHP-2 is known to play a significant role in regulating the MAPK signaling pathway. Lymphadenopathy is observed in knockin mice lacking the SHP-2 MAPK pathway. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is SHP-2 MAPK pathway?",
               "answer": "SHP-2 is a ubiquitous tyrosine phosphatase that plays a crucial role in the MAPK (Mitogen-Activated Protein Kinase) pathway by promoting the activation of this signaling cascade in response to various growth factors, hormones, or cytokines. It is involved in dephosphorylating negative",
               "rationale": "1. Shp-2 has therefore been proposed to dephosphorylate negative regulators of the MAPK pathway 12. Along these lines, SHP-2 overactivation is involved in cancer development and novel inhibitors have ...\n2. Shp2 is a ubiquitous tyrosine phosphatase containing Src Homology 2 domains which plays major biological functions in response to various growth factors, hormones or cytokines. This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway. Recent progresses have been made in the ...\n3. The addition of SHP2is improves G12Ci efficacy in several ways. First, G12Cis target the GDP-bound state of KRAS (KRAS-GDP). Effectively, then, G12Ci action is opposed by RAS-GEF activity. By preventing SOS1/2 action, SHP2is increase the amount of KRAS-GDP and thus the \"target\" of G12Cis [13, 22].\n4. Scaffolds also facilitate tighter control of MAPK signaling. 150 KSR is a scaffold protein in the MAPK pathway that assembles B/CRAF, MEK1/2, and ERK1/2. 167 In addition, both KSR and MEK partner ...\n5. Targeting SHP2 plays multiple roles in cancer. ① SHP2 is a critical regulator of RAS-MAPK pathway. SHP2i may inhibit cancers driven by RTK or KRAS alteration. ② SHP2 is a critical downstream effector for PD-1/PD-L1 and CD28 pathway. ... PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of lacking the SHP-2 MAPK pathway in knockin mice?",
               "answer": "The provided evidence snippets do not directly address the specific effects of lacking the SHP-2 MAPK pathway in knockin mice. However, they do indicate that SHP-2 plays a significant role in regulating the MAPK signaling pathway, particularly in relation to cancer development and the activation of various signaling pathways. \n\nFrom",
               "rationale": "1. Shp-2 has therefore been proposed to dephosphorylate negative regulators of the MAPK pathway 12. Along these lines, SHP-2 overactivation is involved in cancer development and novel inhibitors have ...\n2. SHP2 is a key protein tyrosine phosphatase in the oncogenic signaling pathway, and several related regulatory mechanisms have been proposed. One mechanism involves a positive regulatory effect of SHP2 on the activation of the RAS-ERK and PI3K-AKT signaling pathways and a negative regulatory effect on the JAK-STAT3 signaling pathway (Fig. 3) [48 ...\n3. 2. Physiological Roles of the MAPK Signaling Pathway. The framework of a signaling cascade such as MAPK is complex, with many interacting pathways and constant crosstalk, which are each subjected to fine-tuning and switch-like activations of regulatory factors (Figure 1).As an overview, the MAPK pathways converge in the amplification of key molecules that sustain cell proliferation, growth ...\n4. 2. Mechanisms of Drug Resistance in the ERK Pathway. The RAS-RAF-MEK-ERK pathway is altered in ~40% of all human cancers, mainly due to mutations in BRAF (~10%) and its upstream activator RAS (~30%) [].MEK inhibitors were the first drugs developed, but despite their high potency and selectivity largely disappointed in the clinic [4,15].This failure is attributable to the negative feedback ...\n5. At the same time, both IVT4 and inhibition of EGFR/MAPK signaling had a similar effect on the induction of IRF1 but only direct RIG-I activation led to robust PARP cleavage either alone or in ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Is lymphadenopathy observed in knockin mice lacking the SHP-2 MAPK pathway?",
               "answer": "Yes, lymphadenopathy is observed in knockin mice lacking the SHP-2 MAPK pathway, specifically in the gp130 F759/F759 mouse, which exhibits splenomegaly and lymphadenopathy from an early age.",
               "rationale": "1. We observed that a knockin mouse lacking the SHP-2 MAPK pathway (named the gp130 F759/F759 mouse) has splenomegaly and lymphadenopathy from an early age . In this study, we analyzed the role of IL-6 on DC activation/maturation in vivo, using several mutant mice, including the IL-6 knockout (IL-6 KO) and gp130 knockin mice.\n2. No cells of SHP-2 −/− origin could be detected in bone marrow or thymus of the SHP-2 −/− RAG-2 −/− chimeras, indicating the requirement for SHP-2 in early lymphopoiesis. To bypass the early developmental steps, transgenic mice were generated that express the putative dominant negative mutant SHP-2 C/S in the T-cell lineage at a ...\n3. However, Shp-2 deficiency does not phenocopy the NK cell defects observed in IL-15- and PI3K-deficient mice or in mice conditionally deficient for mTORC1 and mTORC2 in the NK lineage 30,34,43,56 ...\n4. Upon FGF-2, EGF and insulin stimulation SHP-2 regulates MAPK pathway activation. In addition, SHP-2 is involved in the regulation of cell survival by influencing the PI3-K/Akt pathway upon EGF, IGF and PDGF stimulation. Due to these properties, SHP-2 function has recently gained more interest in vascular processes, such as in the ...\n5. In a CD40 dose-dependent manner, SHP-1 modulates CD40-induced phosphorylation of p38 MAPK and ERK1/2 to favor ERK1/2-dependent IL-10 expression and parasite survival (Figure Figure2 2). Xin et al. (2008) and Boggiatto et al. (2009 , 2014 ) also demonstrated the importance of the CD40/MAPK signaling pathway in L. amazonensis infection.",
               "predicate": null
            }
         ],
         "row": 598,
         "id": 976283697593701738
      },
      {
         "claim": "Macrolides have no protective effect against myocardial infarction.",
         "label": 1,
         "prediction": 1,
         "rationale": "Macrolides are a class of antibiotics that inhibit protein synthesis in bacteria by binding to the P site of the 50S unit of the ribosome, primarily targeting gram-positive cocci and intracellular pathogens such as mycoplasma, chlamydia, and legionella. Macrolides do not have a protective effect against myocardial infarction and are associated with an increased risk of cardiovascular events. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are macrolides?",
               "answer": "Macrolides are a class of antibiotics that inhibit protein synthesis in bacteria by binding to the P site of the 50S unit of the ribosome. They primarily target gram-positive cocci and intracellular pathogens such as mycoplasma, chlamydia, and legionella. Commonly used macrolides include eryth",
               "rationale": "1. Macrolides inhibit protein synthesis in bacteria by reversibly binding to the P site of the 50S unit of the ribosome. Macrolides mainly affect gram-positive cocci and intracellular pathogens such as mycoplasma, chlamydia, and legionella. Erythromycin was the first macrolide discovered; other macrolides include azithromycin, clarithromycin, and ...\n2. Macrolides are a class of drugs used to manage and treat various bacterial infections. Azithromycin, clarithromycin, and erythromycin are commonly used to treat infections like pneumonia, sinusitis, pharyngitis, and tonsillitis. They are also used in uncomplicated skin infections and otitis media in pediatric patients. Clarithromycin is used to treat Helicobacter pylori infections in standard ...\n3. The macrolide ring is the lactone (cyclic ester) at upper left. Clarithromycin Roxithromycin. Macrolides are a class of mostly natural products with a large macrocyclic lactone ring to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. The lactone rings are usually 14-, 15-, or 16-membered.\n4. Macrolides are antibiotics used for infections caused by gram-positive bacteria (streptococcal and pneumococcal infections).. Macrolide antibiotics inhibit protein synthesis by targeting the bacterial ribosomes (responsible for the synthesis of cellular proteins) and occluding the nascent peptide exit tunnel of the bacterial ribosome.. Therefore, macrolides are often referred to as \"tunnel ...\n5. Macrolides should be taken during pregnancy only when the benefits of treatment outweigh the risks. Erythromycin is considered among the safest antibiotics to use during pregnancy. It is considered safer than azithromycin because it has been used more, and thus more is known about it.. clarithromycin except when there is no alternative medication. (See also Safety of Medications During Pregnancy.)",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do macrolides have a protective effect against myocardial infarction?",
               "answer": "No, macrolides do not have a protective effect against myocardial infarction. In fact, the evidence suggests that macrolide use is associated with an increased risk of cardiovascular events, including myocardial infarction, cardiovascular death, and arrhythmias.",
               "rationale": "1. The findings of this meta-analysis indicate that macrolide use increases the risk of CVD death, VA or SCD, and myocardial infarction, although not increasing all-cause death. Both azithromycin and clarithromycin increase the incidence of VA or SCD, and azithromycin tends to increase the risk of CVD death and MI.\n2. However, Yang et al. showed that cangrelor and clopidogrel protected hearts against infarction in rabbit model of myocardial I/R. This protective effect was independent of its antiaggregatory properties.\n3. 4.1 Cardiovascular Risk. In general, we found a short-term increased risk of cardiovascular mortality, myocardial infarction, and arrhythmia associated with the use of macrolides. However, we did not find any long-term cardiovascular risk except for a weak association with myocardial infarction.\n4. Background Some studies have found that antimicrobials, especially macrolides, increase the risk of cardiovascular death. We investigated potential cardiac‐related events associated with antimicrobial use in a population of patients with acute myocardial infarction.\n5. Therefore, we conducted a meta-analysis to examine the link between macrolides and CV risk, including SCD or ventricular tachyarrhythmias (VTA), cardiovascular death, death from any cause, myocardial infarction (MI), stroke, and any cardiovascular events.",
               "predicate": null
            }
         ],
         "row": 599,
         "id": 323197440321644240
      },
      {
         "claim": "Macrolides protect against myocardial infarction.",
         "label": 0,
         "prediction": 0,
         "rationale": "Macrolides are a class of antibiotics that inhibit protein synthesis in bacteria by reversibly binding to the P site of the 50S unit of the ribosome, primarily targeting gram-positive cocci and intracellular pathogens. Macrolides have an effect on myocardial infarction, with evidence suggesting an increased risk of myocardial infarction, particularly with erythromycin and clarithromycin, but also a potential reduction in all-cause mortality. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are macrolides?",
               "answer": "Macrolides are a class of antibiotics that inhibit protein synthesis in bacteria by reversibly binding to the P site of the 50S unit of the ribosome. They primarily target gram-positive cocci and intracellular pathogens such as mycoplasma, chlamydia, and legionella. Commonly used macrolides",
               "rationale": "1. Macrolides inhibit protein synthesis in bacteria by reversibly binding to the P site of the 50S unit of the ribosome. Macrolides mainly affect gram-positive cocci and intracellular pathogens such as mycoplasma, chlamydia, and legionella. Erythromycin was the first macrolide discovered; other macrolides include azithromycin, clarithromycin, and ...\n2. Macrolides are a class of drugs used to manage and treat various bacterial infections. Azithromycin, clarithromycin, and erythromycin are commonly used to treat infections like pneumonia, sinusitis, pharyngitis, and tonsillitis. They are also used in uncomplicated skin infections and otitis media in pediatric patients. Clarithromycin is used to treat Helicobacter pylori infections in standard ...\n3. Erythromycin.The macrolide ring is the lactone (cyclic ester) at upper left. Clarithromycin Roxithromycin. Macrolides are a class of mostly natural products with a large macrocyclic lactone ring to which one or more deoxy sugars, usually cladinose and desosamine, may be attached.The lactone rings are usually 14-, 15-, or 16-membered. Macrolides belong to the polyketide class of natural products.\n4. Macrolides are antibiotics used for infections caused by gram-positive bacteria (streptococcal and pneumococcal infections).. Macrolide antibiotics inhibit protein synthesis by targeting the bacterial ribosomes (responsible for the synthesis of cellular proteins) and occluding the nascent peptide exit tunnel of the bacterial ribosome.. Therefore, macrolides are often referred to as \"tunnel ...\n5. Macrolides should be taken during pregnancy only when the benefits of treatment outweigh the risks. Erythromycin is considered among the safest antibiotics to use during pregnancy. It is considered safer than azithromycin because it has been used more, and thus more is known about it.. clarithromycin except when there is no alternative medication. (See also Safety of Medications During Pregnancy.)",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do macrolides have any effect on myocardial infarction?",
               "answer": "Yes, macrolides have an effect on myocardial infarction. The evidence suggests that macrolides, particularly erythromycin and clarithromycin, are associated with an increased risk of myocardial infarction. However, some studies also indicate that macrolide use may reduce all-cause mortality compared to no macrolide use",
               "rationale": "1. Macrolides increase the risk of myocardial infarction, among which erythromycin and clarithromycin have been associated with a greater risk of myocardial infarction . Of note, previous meta-analyses have suggested that macrolide use can reduce all-cause death compared to no macrolide use ( 11 , 12 ).\n2. People with established coronary heart disease have a high risk of subsequent cardiovascular events including myocardial infarction, stroke, and cardiovascular death. Antibiotics might prevent such outcomes due to their antibacterial, antiinflammatory, and antioxidative effects. ... Trials assessing the effects of macrolides (28 trials; 22,059 ...\n3. No difference between the two groups was seen with respect to the primary outcome (i.e., composite of all-cause mortality, myocardial infarction, or unstable angina at 3 yr) or secondary outcome (i.e., composite of cardiovascular mortality myocardial infarction or unstable angina at 3 yr), and none of the prespecified outcomes was significantly ...\n4. BackgroundSome studies have found that antimicrobials, especially macrolides, increase the risk of cardiovascular death. We investigated potential cardiac‐related events associated with antimicrobial use in a population of patients with acute myocardial infarction. Methods and ResultsFor 185&nbsp;010 Medicare beneficiaries, we recorded prescriptions for azithromycin, clarithromycin ...\n5. We aimed to review the evidence of cardiovascular risk associated with macrolides regarding duration of effect and risk factors; and to explore the potential effect of statins for the prevention of cardiovascular events as a result of macrolide use. ... myocardial infarction, and arrhythmia associated with macrolides but no risk was found in ...",
               "predicate": null
            }
         ],
         "row": 600,
         "id": 271376614742271660
      },
      {
         "claim": "Macropinocytosis contributes to a cell's supply of amino acids via the intracellular uptake of protein.",
         "label": 1,
         "prediction": 1,
         "rationale": "Macropinocytosis is a unique and regulated form of endocytosis characterized by the nonspecific internalization of large volumes of extracellular fluid, solutes, and membrane into large endocytic vesicles known as macropinosomes. Macropinocytosis serves several functions in cells, including antigen capture in dendritic cells, allowing them to continuously capture antigens and function as sentinel cells in the immune response. Macropinocytosis contributes to a cell's supply of amino acids by internalizing extracellular proteins that are then degraded to release essential amino acids, including glutamine. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is macropinocytosis?",
               "answer": "Macropinocytosis is a unique and regulated form of endocytosis characterized by the nonspecific internalization of large volumes of extracellular fluid, solutes, and membrane into large endocytic vesicles known as macropinosomes. This process is initiated by the activation of growth factor signaling pathways and involves the extension",
               "rationale": "1. Macropinocytosis is a unique pathway of endocytosis characterised by the nonspecific internalisation of large amounts of extracellular fluid, solutes and membrane in large endocytic vesicles known as macropinosomes. Macropinocytosis is important in a range of physiological processes, including antigen presentation, nutrient sensing, recycling ...\n2. Macropinocytosis is a form of endocytosis which provides an effective way for non-selective uptakes of extracellular proteins, liquids, and particles. The endocytic process is initiated by the activation of the growth factors signaling pathways. After activation of the biochemical signal, the cell starts internalizing extracellular solutes and ...\n3. Macropinocytosis is the uptake of large volumes of medium into digestive vesicles. •. Evolutionarily conserved and used for feeding by amoebae and cancers. •. Used by viruses and drugs to enter cells, and the immune system to detect invaders. •. Performed by cups extended from cell surface by actin polymerization. •.\n4. Macropinocytosis is a form of endocytosis performed by ruffles and cups of the plasma membrane. These close to entrap droplets of medium into micron-sized vesicles, which are trafficked through the endocytic system, their contents digested and useful products absorbed. Macropinocytosis is constituti …\n5. Macropinocytosis is a regulated form of endocytosis that mediates the non-selective uptake of solute molecules, nutrients and antigens. It is an actin-dependent process initiated from surface membrane ruffles that give rise to large endocytic vacuoles called macropinosomes. Macropinocytosis is impor …",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the function of macropinocytosis in cells?",
               "answer": "Macropinocytosis serves several functions in cells, including:\n\n1. **Antigen Capture**: In dendritic cells (DCs), macropinocytosis is a constitutive process that allows these immune cells to continuously capture antigens, enabling them to function as sentinel cells in the immune response.\n\n2.",
               "rationale": "1. In contrast to many other cell types, macropinocytosis in DCs is a constitutive process, which enables them to function as sentinel cells that constitutively capture antigens [12,13,14]. Constitutive macropinocytosis in the absence of defined stimulatory factors has been demonstrated for both mouse BMDCs and mouse splenic DCs .\n2. Macropinocytosis is an evolutionarily conserved form of endocytosis that mediates non-selective uptake of extracellular fluid and the solutes contained therein. In mammalian cells, macropinocytosis is initiated by growth factor-mediated activation of the Ras and PI3-kinase signalling pathways. In malignant cells, oncogenic activation of growth ...\n3. Introduction. Cancer macropinocytosis is an endocytic uptake process by which cancer cells internalize extracellular proteins or necrotic cell debris and deliver them to lysosomes for further degradation [1-4].The decomposition of these macropinocytic cargos contributes to the supply of the desperately needed amino acids that support cancer cells' survival and growth.\n4. Macropinocytosis is a form of endocytosis performed by ruffles and cups of the plasma membrane. These close to entrap droplets of medium into micron-sized vesicles, which are trafficked through the endocytic system, their contents digested and useful products absorbed. Macropinocytosis is constitutive in certain immune cells and stimulated in ...\n5. Macropinocytosis is a unique pathway of endocytosis characterised by the nonspecific internalisation of large amounts of extracellular fluid, solutes and membrane in large endocytic vesicles known as macropinosomes. Macropinocytosis is important in a range of physiological processes, including antigen presentation, nutrient sensing, recycling ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does macropinocytosis contribute to a cell's supply of amino acids?",
               "answer": "Yes, macropinocytosis contributes to a cell's supply of amino acids. The evidence indicates that Ras-transformed cells utilize macropinocytosis to internalize extracellular proteins, which are then degraded to release amino acids, including glutamine, that are essential for cellular metabolism. Additionally, macropinocytosis",
               "rationale": "1. Labelling with fluid-phase markers has the limitation in that uptake by other endocytic processes can also contribute. For ... through the acquisition of amino acids, macropinocytosis of extracellular nutrients can also act as a ... of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013; 497:633-637. doi: 10. ...\n2. Oncogenic Ras has previously been shown to promote macropinocytosis; here it is demonstrated that this process allows tumour cells to use extracellular proteins to generate amino acids necessary ...\n3. Here we show that Ras-transformed cells use macropinocytosis to transport extracellular protein into the cell. The internalized protein undergoes proteolytic degradation, yielding amino acids including glutamine that can enter central carbon metabolism. Accordingly, the dependence of Ras-transformed cells on free extracellular glutamine for ...\n4. Metabolic benefits of macropinocytosis. (a) Biomass composition of human plasma.Of note, most biomass in circulation is contained within proteins. (b) Macropinocytosis internalizes nutrients according to their extracellular concentration.Proteins are a major cargo of macropinosomes and supply amino acids, and possibly bound lipids, sugar residues and micronutrients.\n5. Macropinocytosis could also allow other cells to use the nutritional content of extracellular macromolecules to buffer fluctuations in the supply of amino acids and other nutrients. In this context, the relative contribution of macropinocytosis and autophagy remains to be addressed.",
               "predicate": null
            }
         ],
         "row": 601,
         "id": 261789206571215663
      },
      {
         "claim": "Many proteins in human cells can be post-translationally modified at lysine residues via acetylation.",
         "label": 1,
         "prediction": 1,
         "rationale": "Acetylation is a chemical reaction that introduces an acetyl functional group into a chemical compound, typically involving the substitution of a hydrogen atom with an acetyl group. Acetylation can occur at lysine residues in human cells. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is acetylation?",
               "answer": "Acetylation is a chemical reaction that introduces an acetyl functional group (CH3C=O) into a chemical compound. This process typically involves the substitution of a hydrogen atom in a compound with an acetyl group, resulting in the formation of products that may contain an acetoxy functional group. Acetyl",
               "rationale": "1. Acetylation. In chemistry, acetylation is an organic esterification reaction with acetic acid. It introduces an acetyl group into a chemical compound. Such compounds are termed acetate esters or simply acetates. Deacetylation is the opposite reaction, the removal of an acetyl group from a chemical compound.\n2. What is Acetylation? Acetylation is a chemical reaction in which a hydrogen atom is substituted for an acetyl group (CH 3 C=O group) in a compound. The products formed in acetylation reactions typically have an acetoxy functional group.When the hydrogen atom belonging to an alcohol group replaced with an acetyl group in an acetylation reaction, an ester is formed as the product.\n3. Acetylation is a chemical reaction that describes a reaction that introduces an acetyl functional group into a chemical compound.\n4. Acetylation and its role in human diseases. Acetylation is a metabolic and chemical process, during which the acetyl group is attached to the protein/peptide or messenger RNA. 2,60 In protein ...\n5. Acetylation is a reversible modification on proteins that can also contribute to protein localization and function. Acetylation of lysine residues in histone proteins can control the secondary structure of chromatin as well as gene expression levels from certain loci, and chromatin remodeling and its consequences in a variety of molecular and ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Can acetylation occur at lysine residues in human cells?",
               "answer": "Yes, acetylation can occur at lysine residues in human cells. The evidence indicates that acetylation of lysine residues is an important modification that affects protein function, and it is noted that acetylation occurs on most lysine residues in cells.",
               "rationale": "1. Abstract. Posttranslational acetylation modifications of proteins have important consequences for cell biology, including effects on protein trafficking and cellular localization as well as on the interactions of acetylated proteins with other proteins and macromolecules such as DNA. Experiments to uncover and characterize protein acetylation ...\n2. Acetylation of lysine (K) residues is an important modification in defining protein function through altering its structure, activity, stability or ability to interact with other biomolecules. Addition of an acetyl group to lysine residues is reversible and was initially described as an epigenetic modification of histones regulating chromatin ...\n3. This bias is found in every acetylome dataset that we have examined (Supplementary Figure 2a) 9,10,11,12, and indicates that acetylation occurs on most lysine residues in cells and that protein ...\n4. Histone acetylation is an active mark characteristic of open chromatin, but acetylation on specific lysine residues and histone variants occurs in different biological contexts and can confer various outcomes. The significance of acetylation events is indicated by the associations of lysine acetyltransferases, deacetylases, and acetyl-lysine ...\n5. Abstract. Lysine acetylation regulates the function of soluble proteins in vivo, yet it remains largely unexplored whether lysine acetylation regulates membrane protein function. Here, we use ...",
               "predicate": null
            }
         ],
         "row": 602,
         "id": 287269939418205419
      },
      {
         "claim": "Mathematical models predict that using Artemisinin-based combination therapy over nongametocytocidal drugs have a dramatic impact in reducing malaria transmission.",
         "label": 0,
         "prediction": 1,
         "rationale": "Artemisinin-based combination therapy (ACT) is a treatment for malaria that combines an artemisinin derivative with a partner drug, recommended by the World Health Organization (WHO) as the first- and second-line treatment. Artemisinin-based combination therapy has been effective in reducing malaria transmission in endemic regions. The effect of using nongametocytocidal drugs on malaria transmission according to mathematical models is not explicitly stated, but it can be inferred that such drugs can influence malaria transmission dynamics. The effect of using Artemisinin-based combination therapy compared to nongametocytocidal drugs on malaria transmission according to mathematical models is not directly addressed, but ACTs are implied to potentially lower malaria transmission by reducing parasite density. The effect of using nongametocytocidal drugs on malaria transmission according to mathematical models is not explicitly mentioned in the provided evidence snippets. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Artemisinin-based combination therapy?",
               "answer": "Artemisinin-based combination therapy (ACT) is a treatment for malaria that combines an artemisinin derivative (such as artesunate, artemether, or dihydroartemisinin) with a partner drug. ACTs are recommended by the World Health Organization (WHO) as the first- and second-line treatment",
               "rationale": "1. Artemisinin-based combination treatments (ACTs) are now generally accepted as the best treatments for uncomplicated falciparum malaria. They are rapidly and reliably effective. Efficacy is determined by the drug partnering the artemisinin derivative and, for artesunate-mefloquine, artemether-lumefantrine, and dihydroartemisinin-piperaquine, this usually exceeds 95%. Artesunate ...\n2. Artemisinin-based combination therapies (ACTs) are recommended by WHO as the first- and second-line treatment for uncomplicated P. falciparum malaria as well as for chloroquine-resistant P. vivax malaria. ACTs combine an artemisinin derivative (artemisinin derivatives include artesunate, artemether and dihydroartemisinin) with a partner drug.\n3. Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria therapy in endemic countries worldwide. This systematic review aims at presenting the current scenario of drug resistance molecular markers, either selected or involved in treatment failures (TF) during in vivo ACT efficacy studies from sub-Saharan Africa (sSA) and India.\n4. Artemisinin-based combination therapy (ACT) was deployed in 2005 as an alternative to chloroquine and is considered the most efficacious treatment currently available for uncomplicated falciparum malaria. While widespread artemisinin resistance has not been reported to date in Africa, recent studies have reported partial resistance in Rwanda.\n5. Triple artemisinin-based combination therapies have shown high efficacy for treatment of malaria in preliminary studies. Here, the authors use mathematical modelling to assess whether these ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of using Artemisinin-based combination therapy on malaria transmission according to mathematical models?",
               "answer": "The provided evidence does not explicitly mention the effects of using Artemisinin-based combination therapy (ACT) on malaria transmission according to mathematical models. However, it does state that ACT has proven more effective in treating uncomplicated Plasmodium falciparum malaria and has been effective in reducing transmission in endemic regions. Therefore, while the",
               "rationale": "1. The adverse effect profiles of the artemisinin-based combination treatments are determined by the partner drug. Most malaria endemic countries have now adopted artemisinin-based combination treatments as first-line treatment of falciparum malaria, but in most of these only a minority of the patients that need artemisinin-based combination ...\n2. The World Health Organization recommends uncomplicated P. falciparum malaria is treated using Artemisinin‐based Combination Therapy (ACT). This review aims to assist the decision making of malaria control programmes by providing an overview of the relative benefits and harms of the available options.\n3. Artemisinin-based combination therapy (ACT) was deployed in 2005 as an alternative to chloroquine and is considered the most efficacious treatment currently available for uncomplicated falciparum malaria. While widespread artemisinin resistance has not been reported to date in Africa, recent studies have reported partial resistance in Rwanda.\n4. Background Artemisinin-based combination therapy (ACT) has been adopted by the World Health Organization as a first-line treatment for uncomplicated Plasmodium falciparum malaria. In endemic regions, it has proven more effective in treating the disease, and even in reducing its transmission. Nonetheless, there is a scarcity of studies carried out in non-endemic areas on imported uncomplicated ...\n5. Abstract. Plasmodium falciparum resistance to chloroquine and sulphadoxine-pyrimethamine has led to the recent adoption of artemisinin-based combination therapies (ACTs) as the first line of treatment against malaria. ACTs comprise semisynthetic artemisinin derivatives paired with distinct chemical classes of longer acting drugs.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of using nongametocytocidal drugs on malaria transmission according to mathematical models?",
               "answer": "The provided evidence snippets do not explicitly mention the effect of using nongametocytocidal drugs on malaria transmission according to mathematical models. However, it can be inferred that the use of antimalarial drugs, including those that may not target gametocytes, can influence malaria transmission dynamics. Specifically, the third snippet discusses how",
               "rationale": "1. Mathematical models have been used to provide an explicit framework for understanding malaria transmission dynamics in human population for over 100 years. With the disease still thriving and threatening to be a major source of death and disability due to changed environmental and socio-economic conditions, it is necessary to make a critical assessment of the existing models, and study their ...\n2. As a result of the interplay between many factors, the control of this disease can be challenging. However, few studies have demonstrated malaria's complexity, control, and modeling although this perspective could lead to effective policy recommendations. This paper aims to be a didactic material providing the reader with an overview of malaria.\n3. Mathematical models of the dynamics of a drug within the host are now frequently used to guide drug development. These generally focus on assessing the efficacy and duration of response to guide patient therapy. Increasingly, antimalarial drugs are used at the population level, to clear infections, provide chemoprevention, and to reduce onward ...\n4. Hence, this study developed mathematical and computational models to study the effect of malaria importation as well as WHO-approved and traditional malaria control usage levels on malaria transmission dynamics using Covenant University environment which is a low malaria-endemic region in Nigeria, as case study (Adegbite et al., 2022).\n5. Plasmodium vivax poses a unique challenge for malaria elimination worldwide. Here, White et al. develop an individual-based mathematical model of P. vivax transmission and evaluate intervention ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the effect of using Artemisinin-based combination therapy compared to nongametocytocidal drugs on malaria transmission according to mathematical models?",
               "answer": "The provided evidence snippets do not directly address the specific effects of using Artemisinin-based combination therapy (ACT) compared to nongametocytocidal drugs on malaria transmission according to mathematical models. However, it is implied that ACTs are effective in reducing parasite density, which could potentially lower malaria transmission. The mention of mathematical modeling",
               "rationale": "1. Artemisinin-based combination treatments (ACTs) are now generally accepted as the best treatments for uncomplicated falciparum malaria. They are rapidly and reliably effective. Efficacy is determined by the drug partnering the artemisinin derivative and, for artesunate-mefloquine, artemether-lumefantrine, and dihydroartemisinin-piperaquine, this usually exceeds 95%. Artesunate ...\n2. Artemisinin-based combination therapy (ACT) is a combination of artemisinin family of drugs and other non-artemisinin partners. Even though both the artemisinin and non-artemisinin components are essential for the antimalarial efficacy, the artemisinin component is vital to decrease parasite density in the early days of treatment.\n3. Triple artemisinin-based combination therapies have shown high efficacy for treatment of malaria in preliminary studies. Here, the authors use mathematical modelling to assess whether these ...\n4. Plasmodium falciparum resistance to chloroquine and sulphadoxine-pyrimethamine has led to the recent adoption of artemisinin-based combination therapies (ACTs) as the first line of treatment against malaria. ACTs comprise semisynthetic artemisinin derivatives paired with distinct chemical classes of longer acting drugs. These artemisinins are exceptionally potent against the pathogenic ...\n5. The WHO recommends Artemisinin-based combination therapy (ACTs) as the first-line treatment for malaria. This meta-analysis aims to analyze the effects of artemisinin and its derivatives as well as non-artemisinin drugs on the gametophytes in the host during the treatment of falciparum malaria. Four …",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the effect of using nongametocytocidal drugs on malaria transmission according to mathematical models?",
               "answer": "The provided evidence snippets do not explicitly mention the effect of using nongametocytocidal drugs on malaria transmission according to mathematical models. However, it can be inferred that mathematical models are utilized to assess various aspects of malaria transmission dynamics, including the impact of different types of antimalarial drugs. Specifically, the third snippet indicates",
               "rationale": "1. As a result of the interplay between many factors, the control of this disease can be challenging. However, few studies have demonstrated malaria's complexity, control, and modeling although this perspective could lead to effective policy recommendations. This paper aims to be a didactic material providing the reader with an overview of malaria.\n2. Mathematical models have been used to provide an explicit framework for understanding malaria transmission dynamics in human population for over 100 years. With the disease still thriving and threatening to be a major source of death and disability due to changed environmental and socio-economic conditions, it is necessary to make a critical assessment of the existing models, and study their ...\n3. Mathematical models of the dynamics of a drug within the host are now frequently used to guide drug development. These generally focus on assessing the efficacy and duration of response to guide patient therapy. Increasingly, antimalarial drugs are used at the population level, to clear infections, provide chemoprevention, and to reduce onward ...\n4. Hence, this study developed mathematical and computational models to study the effect of malaria importation as well as WHO-approved and traditional malaria control usage levels on malaria transmission dynamics using Covenant University environment which is a low malaria-endemic region in Nigeria, as case study (Adegbite et al., 2022).\n5. Plasmodium vivax poses a unique challenge for malaria elimination worldwide. Here, White et al. develop an individual-based mathematical model of P. vivax transmission and evaluate intervention ...",
               "predicate": null
            }
         ],
         "row": 603,
         "id": 169898465999489305
      },
      {
         "claim": "Metastatic colorectal cancer treated with a single agent fluoropyrimidines resulted in reduced efficacy and lower quality of life when compared with oxaliplatin-based chemotherapy in elderly patients.",
         "label": 1,
         "prediction": 0,
         "rationale": "The efficacy of single-agent fluoropyrimidines in treating metastatic colorectal cancer is not specifically addressed in the provided evidence snippets. Oxaliplatin-based chemotherapy is a treatment option for metastatic colorectal cancer in elderly patients. The quality of life of elderly patients treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer is not directly addressed in the provided evidence, but concerns are raised regarding treatment benefits, risks, adherence, and toxicity patterns in older patients. The quality of life of elderly patients treated with single agent fluoropyrimidines for metastatic colorectal cancer is not specifically addressed in the provided evidence. There is no direct comparison of quality of life between elderly patients treated with single-agent fluoropyrimidines and those treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer in the provided evidence snippets. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the efficacy of single agent fluoropyrimidines in treating metastatic colorectal cancer?",
               "answer": "The provided evidence snippets do not specifically address the efficacy of single-agent fluoropyrimidines in treating metastatic colorectal cancer (mCRC). However, they indicate that fluoropyrimidines, particularly 5-fluorouracil (5-FU), are considered the backbone of systemic treatment for mCRC, often",
               "rationale": "1. Micro-AbstractWe retrospectively evaluated 3136 individuals who did not respond to treatment with fluoropyrimidine and oxaliplatin plus bevacizumab and were then treated with one of five chemotherapy regimens consisting of fluoropyrimidine, irinotecan, and an angiogenesis inhibitor for metastatic colorectal cancer. Data were collected from a medical claim database provided by Medical Data ...\n2. PURPOSE To develop recommendations for treatment of patients with metastatic colorectal cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. RESULTS Five systematic reviews and 10 randomized controlled trials met the systematic review inclusion criteria. RECOMMENDATIONS Doublet chemotherapy ...\n3. The treatment options for patients with metastatic colorectal cancer (mCRC) have expanded significantly over the last decades. For many years, intravenous 5-fluorouracil (5-FU) with or without leucovorin (5-FU/LV) was the only available treatment for these patients. Fluoropyrimidines are still considered as the backbone of systemic treatment in ...\n4. Notwithstanding recent treatment advances in metastatic colorectal cancer (mCRC), chemotherapy with a combination of a fluoropyrimidine and a folate agent, often 5-fluorouracil (5-FU) and leucovorin, remains the backbone of treatment regimens for the majority of patients with mCRC. This is despite a recent focus on molecular-targeted treatments ...\n5. Never resectable disease: In case of metastases not completely resectable with surgery, treatment goal is disease control rate and intensive protocols is not necessary. In this setting, a doublet chemotherapy plus a biologic agent is the standard of care, according to tumour molecular profile and 'sideness'.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the efficacy of oxaliplatin-based chemotherapy in treating metastatic colorectal cancer in elderly patients?",
               "answer": "The efficacy of oxaliplatin-based chemotherapy in treating metastatic colorectal cancer in elderly patients is supported by its use as a treatment option for this demographic. Oxaliplatin, as a member of the platinum-based chemotherapeutic class, is indicated for the management of metastatic colorectal cancer and is often used in combination with inf",
               "rationale": "1. Colorectal cancer is one of the leading causes of cancer death. The mainstay of chemotherapy in colorectal cancer patients for the past 40 years has been fluorouracil (5-FU). Oxaliplatin (Eloxatin) is a novel platinum compound with promising activity in colorectal cancer. As a single agent, oxaliplatin has produced response rates of 12% to 24% in patients with previously untreated advanced ...\n2. 1. Introduction. Colorectal cancer (CRC) is the third most common cancer in Western countries. As mortality from other non-cancer causes declines with a corresponding lengthening of the average life, CRC incidence has been increasing in older patients—so much so that it has a median age of onset of 71 years at present and more than 30% of patients with new diagnoses are aged at least 75 ...\n3. Perioperative chemotherapy is recommended for a total preoperative and postoperative duration of 6 months, on the basis of total duration of chemotherapy in the EORTC 40983 trial. 64. Table 10. Perioperative Chemotherapy Versus Surgery Alone for Patients With Liver Metastases From Colorectal Cancer 22. Open in viewer.\n4. Oxaliplatin is a medication used to manage and treat metastatic colorectal cancer. It is a member of the platinum-based chemotherapeutic class of drugs and is indicated in the adjunctive treatment of stage III colorectal cancer after resection of the primary tumor and for the treatment of metastatic colorectal cancer. It is FDA-approved in combination with infusional 5-fluorouracil and leucovorin.\n5. Background: The real-world effectiveness of oxaliplatin in stage III colon cancer has not been determined in a large-scale population. We aimed to assess the real-world impact of adjuvant oxaliplatin treatment on the survival of these patients. Methods: Based on Taiwan cancer registry, we evaluated 17,801 patients with resected stage III colon cancer, including 14,168 patients receiving ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the quality of life of elderly patients treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer?",
               "answer": "The provided evidence snippets do not directly address the quality of life (QOL) of elderly patients treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer. However, they do highlight concerns regarding the benefits and risks of such treatments in older patients, particularly in relation to treatment adherence and toxicity patterns. The evidence suggests that",
               "rationale": "1. PURPOSE A number of studies suggest that older patients may have reduced or no benefit from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III colon cancer (CC). MATERIALS AND METHODS We studied the prognostic impact of age, as well as treatment adherence/toxicity patterns according to age, in patients with stage III CC who received 3 or 6 months of ...\n2. If patients with high-risk colon cancer benefit from fluorouracil (FU)-based therapy across all age groups, the use of more intensive agents (oxaliplatin) is controversial and debated. 1 Large observational databases revealed little or no benefit from oxaliplatin implementation. 2 However, in a pooled analysis of four oxaliplatin-based trials ...\n3. Abstract. Colorectal cancer has a high incidence, and approximately 60% of colorectal cancer patients are older than 70, with this incidence likely increasing in the near future. Elderly patients (> 70-75 years of age) are a very heterogeneous group, ranging from the very fit to the very frail. Traditionally, these patients have often been ...\n4. Postoperative (adjuvant) systemic chemotherapy is recommended for high-risk patients to eradicate these micrometastases, thereby increasing the cure rate. This topic review will cover the benefits, risks, and choice of adjuvant chemotherapy for older adult patients with resected colon cancer. A general discussion of the benefits of adjuvant ...\n5. With the aging of the global population, the number of older patients with cancer will continue to rise in the coming years. 1 Despite this demographic shift, current oncologic practices are still based on trials in which older patients are underrepresented, 2 and relevant end points for older patients, such as quality of life (QOL) and ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the quality of life of elderly patients treated with single agent fluoropyrimidines for metastatic colorectal cancer?",
               "answer": "The provided evidence does not specifically address the quality of life (QoL) of elderly patients treated with single-agent fluoropyrimidines for metastatic colorectal cancer. However, it does indicate that elderly patients often face unique challenges and may experience different outcomes compared to younger patients. The systematic review mentioned in the evidence focuses on Qo",
               "rationale": "1. Around 60% of people living with cancer are aged 65years or older. Older cancer patients face a unique set of age-associated changes, comorbidities and circumstances that impact on their quality of life (QoL) in ways that are different from those affecting younger patients. A Task Force of the International Society of Geriatric Oncology recommends and encourages all healthcare professionals ...\n2. The incidence of most types of cancers is age-dependent and the progressive ageing is rapidly increasing the number of elderly people who need treatment for cancer. Elderly patients present peculiar characteristics that make the choice of the correct treatment more difficult and these patients are often undertreated. Moreover, elderly patients are largely underrepresented in cancer treatment ...\n3. The aim of this systematic review was to summarize and assess the literature on quality of life (QoL) among cancer patients 80 years and older admitted to hospitals and what QoL instruments have been used. We searched systematically in Medline, Embase and Cinahl. Eligibility criteria included studies with any design measuring QoL among cancer patients 80&nbsp;years and older hospitalized for ...\n4. Chemotherapy is used in the treatment of colon cancer in the elderly population in adjuvant settings for Stage 3 cancers, including in palliative settings in metastatic cancer. Studies have shown improvement in progression-free survival and overall survival in both settings. However, elderly patients are also at the risk of experiencing more ...\n5. Single-agent treatment is often recommended for elderly patients [9. ... QoL was assessed by the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-C30 and the supplementary lung-cancer-specific module QLQ-C13, before, during (day 1 and 8 of each cycle) and after chemotherapy (week 12, 15 and 18 ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the comparison of quality of life between elderly patients treated with single agent fluoropyrimidines and those treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer?",
               "answer": "The provided evidence snippets do not directly address the comparison of quality of life between elderly patients treated with single-agent fluoropyrimidines and those treated with oxaliplatin-based chemotherapy for metastatic colorectal cancer. While there is mention of treatment efficacy and toxicity in elderly patients, specific data or findings regarding quality of life outcomes in",
               "rationale": "1. Micro-AbstractWe retrospectively evaluated 3136 individuals who did not respond to treatment with fluoropyrimidine and oxaliplatin plus bevacizumab and were then treated with one of five chemotherapy regimens consisting of fluoropyrimidine, irinotecan, and an angiogenesis inhibitor for metastatic colorectal cancer. Data were collected from a medical claim database provided by Medical Data ...\n2. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).\n3. Background Irinotecan (IRI) and oxaliplatin (Ox) are standard therapeutic agents of the first-line treatments for metastatic colorectal cancer (mCRC). Previous meta-analyses of randomized controlled trials (RCTs) showed that treatment with Ox-based compared with IRI-based regimens was associated with better overall survival (OS). However, these reports did not include trials of molecular ...\n4. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).\n5. The burden of colorectal cancer (CRC) morbidity and mortality falls largely on the elderly, who make up more than 70% of CRC patients. Recent evidence from pooled analyses suggests that both adjuvant and palliative chemotherapy are as efficacious in fit older patients as in younger patients. Although severe hematologic toxicity is increased in ...",
               "predicate": null
            }
         ],
         "row": 604,
         "id": 261986589382935683
      },
      {
         "claim": "Mice that lack Interferon-γ or its receptor exhibit high resistance to experimental autoimmune myocarditis.",
         "label": 0,
         "prediction": 0,
         "rationale": "Interferon-γ is a dimerized soluble cytokine that is primarily produced by natural killer cells and T cells, playing a crucial role as an antiviral cytokine and an activator of macrophages. Lacking Interferon-γ or its receptor can lead to an exacerbation of experimental autoimmune myocarditis in mice. Mice lacking Interferon-γ or its receptor do not have evidence to suggest high resistance to experimental autoimmune myocarditis. Lacking Interferon-γ (IFN-γ) or its receptor in mice results in reduced antiviral activity, diminished macrophage activation, and an altered balance between Th1 and Th2 immune responses, compromising the overall immune system's function. The effect of lacking Interferon-γ or its receptor on the susceptibility of mice to experimental autoimmune myocarditis is not directly addressed, but it can be inferred that it may involve the promotion of Th1 responses. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Interferon-γ?",
               "answer": "Interferon-γ (IFN-γ) is a dimerized soluble cytokine and the only member of the type II class of interferons. It is produced primarily by natural killer (NK) cells and T cells and plays a crucial role as an antiviral cytokine and an activator of macrophages.",
               "rationale": "1. Interferon gamma (IFNG or IFN-γ) is a dimerized soluble cytokine that is the only member of the type II class of interferons. The existence of this interferon, which early in its history was known as immune interferon, was described by E. F. Wheelock as a product of human leukocytes stimulated with phytohemagglutinin, and by others as a product of antigen-stimulated lymphocytes.\n2. Interferon-γ. Interferon-γ (IFN-γ) is an important cytokine that is found in decreased amounts in patients with IPF. IFN-γ is produced by NK and T cells and is an important antiviral cytokine and activator of macrophages. It has been shown to inhibit fibroblast proliferation 140 and to suppress proinflammatory Th2 signaling.\n3. The IFN-γ Protein. The IFN-γ polypeptides from both mice and humans are approximately 160 amino acids long, but share only 40% sequence homology, a result that explains the strict species specificity displayed by the mouse and human proteins for their respective target cells (Gray and Goeddel 1982, 1983; Farrar and Schreiber 1993).Biologically active IFN-γ is a noncovalently linked ...\n4. Interferon type II (IFN-γ in humans): This is also known as immune interferon and is activated by Interleukin-12. Type II interferons are also released by cytotoxic T cells and type-1 T helper cells. However, they block the proliferation of type-2 T helper cells.\n5. Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin's lymphoma, and autoimmune diseases such as multiple sclerosis. This activity outlines the different types of interferons, namely interferon alpha, beta, and gamma. It discusses the pharmacological properties of different interferons, their medical uses, methods of ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of lacking Interferon-γ or its receptor on experimental autoimmune myocarditis in mice?",
               "answer": "The provided evidence snippets do not directly address the specific effects of lacking Interferon-γ or its receptor on experimental autoimmune myocarditis in mice. However, it is known from broader research that the absence of Interferon-γ or its receptor can lead to an exacerbation of autoimmune conditions, including myocarditis, due",
               "rationale": "1. Background— Interleukin (IL)-12 exerts a potent proinflammatory effect by stimulating T-helper (Th) 1 responses. This effect is believed to be mediated primarily through the activation of STAT4 and subsequent production of interferon (IFN)-γ. Methods and Results— We examined the role of IL-12 receptor (IL-12R) signaling in the development of murine experimental autoimmune myocarditis (EAM ...\n2. Cumulative evidence has established that Interferon (IFN)-γ has both pathogenic and protective roles in Multiple Sclerosis and the animal model, Experimental Autoimmune Encephalomyelitis (EAE). However, the underlying mechanisms to the beneficial effects of IFN-γ are not well understood. In this stu …\n3. Background—Activation of innate pattern-recognition receptors promotes CD4+ T-cell-mediated autoimmune myocarditis and subsequent inflammatory cardiomyopathy. Mechanisms that counterregulate exaggerated heart-specific autoimmunity are poorly understood. Methods and Results—Experimental autoimmune myocarditis was induced in BALB/c mice by immunization with α-myosin heavy chain peptide ...\n4. Immune checkpoint inhibitor (ICI)-induced myocarditis involves intensive immune/inflammation activation; however, its molecular basis is unclear. Here, we show that gasdermin-E (GSDME), a ...\n5. Crosses to mice lacking TLR7 rescued all ... Effects of Toll-like receptor 9-ligand complexes ... Zhenjun, L., Takada, Y. & Sugai, S. Involvement of the interferon-γ-induced T cell ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do mice lacking Interferon-γ or its receptor exhibit high resistance to experimental autoimmune myocarditis?",
               "answer": "The provided evidence does not specifically address whether mice lacking Interferon-γ (IFN-γ) or its receptor exhibit high resistance to experimental autoimmune myocarditis. However, it does indicate that mice lacking IFN-γ or its receptor have decreased defense against various infectious agents and tumors, suggesting a compromised immune response.",
               "rationale": "1. Abstract. Interferon-γ (IFN-γ) exerts pleiotropic effects, including antiviral activity, stimulation of macrophages and natural killer cells, and increased expression of major histocompatibility complex antigens. Mice without the IFN-γ receptor had no overt anomalies, and their immune system appeared to develop normally.\n2. The IFN-γ Protein. The IFN-γ polypeptides from both mice and humans are approximately 160 amino acids long, but share only 40% sequence homology, a result that explains the strict species specificity displayed by the mouse and human proteins for their respective target cells (Gray and Goeddel 1982, 1983; Farrar and Schreiber 1993).Biologically active IFN-γ is a noncovalently linked ...\n3. Interferon-γ (IFN-γ) is an important cytokine for control of infectious agents and regulation of the immune system (1-3).Mice that lack production of IFN-γ or the IFN-γ receptor have decreased defense against parasites, bacteria, viruses, and tumors (4-6).IFN-γ is thought to exert its effects largely by activation of IFN-γ-responsive genes, over 200 of which have been identified ().\n4. Inflammation promotes insulin resistance in adipocytes, but the mechanism is unclear. Here, the authors show that the inflammatory transcription factor IRF3 drives expression of AIG1, which ...\n5. Abstract. Interferon-gamma (IFN-gamma) exerts pleiotropic effects, including antiviral activity, stimulation of macrophages and natural killer cells, and increased expression of major histocompatibility complex antigens. Mice without the IFN-gamma receptor had no overt anomalies, and their immune system appeared to develop normally.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the effect of lacking Interferon-γ or its receptor on the immune response of mice?",
               "answer": "Lacking Interferon-γ (IFN-γ) or its receptor in mice leads to significant impairments in the immune response. Specifically, it results in reduced antiviral activity, diminished macrophage activation, and an altered balance between Th1 and Th2 immune responses. This deficiency can compromise the overall immune system's",
               "rationale": "1. IFNγ is a cytokine with important roles in tissue homeostasis, immune and inflammatory responses and tumour immunosurveillance. Signalling by the IFNγ receptor activates the Janus kinase (JAK ...\n2. Interferon-γ (IFNγ) is a pleiotropic cytokine with multiple effects on the inflammatory response and on innate and adaptive immunity. Overproduction of IFNγ underlies several, potentially fatal ...\n3. Abstract. The interferons (IFNs) were originally described over 50 years ago, identified by their ability to confer viral resistance to cells. We now know that they are much more than just anti‐viral cytokines collectively having roles in both innate and adaptive immune responses, in tumor surveillance and defense, and modulation of immune ...\n4. IFN-γ binding to its receptor activates ... The contribution of these sensors to the overall immune response is key and depends on their subcellular localization in the cytosol or in endosomes ...\n5. Interferon-gamma (IFN-γ) is a pleiotropic cytokine that plays a critical role in mediating an array of immune responses including promotes antiviral activity, facilitates macrophage activation, controls Th1/Th2 balance, and regulates cellular apoptosis and proliferation. A few articles have previous …",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the effect of lacking Interferon-γ or its receptor on the susceptibility of mice to experimental autoimmune myocarditis?",
               "answer": "The provided evidence snippets do not directly address the specific effect of lacking Interferon-γ (IFN-γ) or its receptor on the susceptibility of mice to experimental autoimmune myocarditis (EAM). However, it can be inferred from the general role of IFN-γ in promoting Th1 responses and its involvement",
               "rationale": "1. Background— Interleukin (IL)-12 exerts a potent proinflammatory effect by stimulating T-helper (Th) 1 responses. This effect is believed to be mediated primarily through the activation of STAT4 and subsequent production of interferon (IFN)-γ. Methods and Results— We examined the role of IL-12 receptor (IL-12R) signaling in the development of murine experimental autoimmune myocarditis (EAM ...\n2. Immune checkpoint inhibitor (ICI)-induced myocarditis involves intensive immune/inflammation activation; however, its molecular basis is unclear. Here, we show that gasdermin-E (GSDME), a ...\n3. The IFN-γ Protein. The IFN-γ polypeptides from both mice and humans are approximately 160 amino acids long, but share only 40% sequence homology, a result that explains the strict species specificity displayed by the mouse and human proteins for their respective target cells (Gray and Goeddel 1982, 1983; Farrar and Schreiber 1993).Biologically active IFN-γ is a noncovalently linked ...\n4. This hypothesis is consistent with mice models that exhibit susceptibility to the development of experimental autoimmune myocarditis. In a study by Chen et al., a more susceptible mouse strain was shown to have higher percentage of CD4 + T cells along with a tendency to differentiate into the Th17 phenotype and a lower frequency of T reg cells ...\n5. Background—Activation of innate pattern-recognition receptors promotes CD4+ T-cell-mediated autoimmune myocarditis and subsequent inflammatory cardiomyopathy. Mechanisms that counterregulate exaggerated heart-specific autoimmunity are poorly understood. Methods and Results—Experimental autoimmune myocarditis was induced in BALB/c mice by immunization with α-myosin heavy chain peptide ...",
               "predicate": null
            }
         ],
         "row": 605,
         "id": 300410489540986682
      },
      {
         "claim": "MicroRNA is involved in the regulation of Neural Stem Cell (NSC) differentiation and proliferation dynamic homeostasis",
         "label": 1,
         "prediction": 1,
         "rationale": "MicroRNA is involved in the posttranscriptional regulation of gene expression, affecting cellular activities such as cell growth, differentiation, development, and apoptosis, and regulating protein production, with links to various diseases. MicroRNA is involved in the regulation of neural stem cell differentiation and proliferation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is MicroRNA involved in?",
               "answer": "MicroRNA (miRNA) is involved in the posttranscriptional regulation of gene expression, which affects various cellular activities including cell growth, differentiation, development, and apoptosis. Additionally, miRNAs play a role in regulating the kinds and amounts of proteins that cells produce. They are also linked to many diseases and have been",
               "rationale": "1. However, genes involved in functions common to all cells, such as gene expression, have relatively fewer microRNA target sites and seem to be under selection to avoid targeting by microRNAs. There is a strong correlation between ITPR gene regulations and mir-92 and mir-19.\n2. MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function in posttranscriptional regulation of gene expression. They are powerful regulators of various cellular activities including cell growth, differentiation, development, and apoptosis. They have been linked to many diseases, and currently miRNA-mediated clinical trial has shown ...\n3. microRNA - What It Is and How It Works. microRNA is the name of a family of molecules that helps cells control the kinds and amounts of proteins they make. That is, cells use microRNA to help control gene expression. Molecules of microRNA are found in cells and in the bloodstream. (Note: microRNA is abbreviated \"miRNA,\" but here we will use ...\n4. MicroRNAs are small RNA molecules that regulate gene expression in cells. These small molecules comprise 17 to 25 nucleotides and are able to recognize target messenger RNAs by sequence complementarity and regulate their protein translation. Different microRNAs are expressed in all human cells. There is over 2,500 microRNAs described in humans ...\n5. Introduction. The discovery of the first microRNA (miRNA), lin-4, in 1993 by the Ambros and Ruvkun groups in Caenorhabditis elegans (1, 2) has revolutionized the field of molecular biology.Years before, lin-4 was characterized by the Horvitz's lab as one of the genes that regulate temporal development of C. elegans larvae (3, 4).Later in 1987, the same group found that a mutation in lin-4 had ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is MicroRNA involved in the regulation of Neural Stem Cell differentiation and proliferation?",
               "answer": "Yes, microRNA is involved in the regulation of neural stem cell differentiation and proliferation. The evidence indicates that microRNAs play a central role in controlling the balance between stem cell self-renewal and fate determination, and they are involved in multiple steps of neurogenesis, particularly in the proliferation and differentiation of neural stem cells",
               "rationale": "1. MicroRNAs are a class of small RNA regulators that are involved in numerous cellular processes, including development, proliferation, differentiation, and plasticity. The emerging concept is that microRNAs play a central role in controlling the balance between stem cell self-renewal and fate determi …\n2. MicroRNA, short non-coding RNA that regulates gene expression at the post-transcriptional level, appears to be involved in multiple steps of neurogenesis. This review summarizes the emerging role of microRNAs in regulating embryonic and adult neurogenesis, with a particular emphasis on the proliferation and differentiation of neural stem cells.\n3. MicroRNAs interact with gene regulatory motifs to regulate neural induction and neuronal differentiation. Many of the miRNAs expressed in the CNS are dynamically regulated both during physiological brain development and in vitro neural differentiation of stem cells, indicating a significant contribution to neural development and function (Krichevsky et al. 2003, 2006; Sempere et al. 2004 ...\n4. The functions of microRNAs discussed in this review are listed in Table 1. Fig 1. MicroRNAs regulate different aspects of cell differentiation. MicroRNAs can promote cell proliferation, differentiation, and regulate cell fates during asymmetric cell division.\n5. Transcription factors and microRNA involved in NSC differentiation ... The regulation of the fate of neural stem cells is a finely controlled process relying on a complex regulatory network that extends from the epigenetic to the translational level and involves extracellular matrix components. Thus, a better understanding of the mechanisms ...",
               "predicate": null
            }
         ],
         "row": 606,
         "id": 184601577492927892
      },
      {
         "claim": "Mitochondria are uninvolved in apoptosis.",
         "label": 0,
         "prediction": 0,
         "rationale": "Mitochondria play a crucial role in apoptosis by regulating the process of programmed cell death through mechanisms such as mitochondrial outer membrane permeabilization (MOMP). Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the role of mitochondria in apoptosis?",
               "answer": "Mitochondria play a crucial role in apoptosis by regulating the process of programmed cell death through mechanisms such as mitochondrial outer membrane permeabilization (MOMP). This process is driven by pro-apoptotic members of the Bcl-2 family, which facilitate the release of proteins from the intermembrane space of",
               "rationale": "1. The role of mitochondria in apoptosis in three model systems. In Caenorhabditis elegans, Ced-4 is constantly bound by Ced-9 on the mitochondrial outer membrane in healthy cells. Ced-3 is bound by Csp-3, a caspase homolog without the large subunit to prevent inadvertent Ced-3 auto-activation. Egl-1, a BH3-only protein, is transcriptionally ...\n2. The role of mitochondria in cell death is unequivocally established in apoptosis, where mitochondrial outer membrane permeabilization (MOMP) driven by effector pro-apoptotic members of the B cell ...\n3. Most Cited. Mitochondria play key roles in activating apoptosis in mammalian cells. Bcl-2 family members regulate the release of proteins from the space between the mitochondrial inner and outer membrane that, once in the cytosol, activate caspase proteases that dismantle cells and signal efficient phagocytosis of cell corpses.\n4. While the role of mitochondria in apoptosis is well established, mitochondria can, at least in specific contexts, contribute to other cell death modalities. Equally important is the emerging ...\n5. Apoptosis (programmed cell death) is a cellular self-destruction mechanism that is essential for a variety of biological events, such as developmental sculpturing, tissue homeostasis, and the removal of unwanted cells. Mitochondria play a crucial role in regulating cell death. Ca2+ has long been recognized as a participant in apoptotic pathways.",
               "predicate": null
            }
         ],
         "row": 607,
         "id": 155071927039554707
      },
      {
         "claim": "Monoclonal antibody targeting of N-cadherin inhibits metastasis.",
         "label": 1,
         "prediction": 1,
         "rationale": "N-cadherin is a transmembrane protein encoded by the CDH2 gene in humans, mediating cell-cell adhesion as a member of the calcium-dependent adhesion molecule family of classical cadherins. Monoclonal antibody targeting of N-cadherin inhibits metastasis. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is N-cadherin?",
               "answer": "N-cadherin, also known as Cadherin-2 or Neural cadherin, is a transmembrane protein encoded by the CDH2 gene in humans. It is a member of the calcium-dependent adhesion molecule family of classical cadherins, which mediate cell-cell adhesion. N-cadher",
               "rationale": "1. Cadherin-2 also known as Neural cadherin (N-cadherin), is a protein that in humans is encoded by the CDH2 gene. CDH2 has also been designated as CD325 (cluster of differentiation 325). Cadherin-2 is a transmembrane protein expressed in multiple tissues and functions to mediate cell-cell adhesion.\n2. N-cadherin is a member of the calcium-dependent adhesion molecule family of classical cadherins which directly mediate homotypic and heterotypic cell-cell adhesion. N-cadherin is a classical type I cadherin consisting of 5 extracellular domains linked to a functional intracellular domain.\n3. N-cadherin is overexpressed in invasive and metastatic breast cancer and induces metastasis by potentiating signaling by the FGF receptor in humans . There are various factors which modulate N-cadherin expression in tumor cells such as TGF-β1, Wnt/β-catenin, EGFR and NF-κB. Abnormal expression of N-cadherin has also been found in many other ...\n4. For instance, N-cadherin is specifically required for mediating contact inhibition of locomotion in neural crest cells . Other adhesion molecules, such as the atypical cadherins Fat and Dachs, or cadherin-associated proteins, such as nectins and DDR1, also seem to control cell-cell contact formation by regulating actomyosin contractility at ...\n5. N-cadherin expression in null embryonal stem cells with genetically ablated E-cadherin and human embryonic kidney cells cause an increase in STAT3 activity . The homophilic interactions between Cadherin-11 and N-cadherin was responsible for the upregulation of STAT3, which subsequently leads to cell proliferation, survival, and migration .",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does monoclonal antibody targeting of N-cadherin inhibit metastasis?",
               "answer": "Yes, monoclonal antibody targeting of N-cadherin inhibits metastasis. The evidence indicates that N-cadherin-specific antibodies reduced the growth of established tumors, inhibited localized muscle invasion, and decreased distant lymph node metastasis in a prostate cancer mouse model. Additionally, these antibodies delayed the emergence of castration",
               "rationale": "1. Two additional monoclonal antibodies, 1H7 (targeting N-cadherin EC1-3) and 2A9 (targeting N-cadherin EC4), have shown efficacy in a subcutaneous xenograft prostate cancer mouse model, whereby both antibodies reduced the growth of established tumours and inhibited localised muscle invasion and distant lymph node metastasis . ADH-1\n2. N-cadherin-specific antibodies markedly delayed the time to emergence of castration resistance, markedly affected tumor histology and angiogenesis, and reduced both AKT serine-threonine kinase activity and serum interleukin-8 (IL-8) secretion. These data indicate that N-cadherin is a major cause of both prostate cancer metastasis and castration ...\n3. N-cadherin as a therapeutic target in cancer. As N-cadherin is widely implicated in cancer metastasis, the utility of N-cadherin antagonists as therapeutic drugs is being investigated in the oncology setting. Notably, N-cadherin-targeting agents have been shown to inhibit cell adhesion and to modulate cell signalling.\n4. The finding that N-cadherin-targeted antibodies delay castration-resistant progression and inhibit growth, invasion and metastasis raises the possibility that these antibodies may be ...\n5. Mimicking the natural HAVD sequence of N-cadherin: Inhibit angiogenesis, metastasis, cell proliferation and tumor growth Cause apoptosis of multiple myeloma: ... (targeting N-cadherin EC4) are newfound antibodies targeting N-cadherin and have been proved effectiveness in treating prostate cancer in mouse model.",
               "predicate": null
            }
         ],
         "row": 608,
         "id": 238854748202161684
      },
      {
         "claim": "Most termination events in Okazaki fragments are sequence specific.",
         "label": 1,
         "prediction": 1,
         "rationale": "Okazaki fragments are short sequences of DNA nucleotides, approximately 150 to 200 base pairs long in eukaryotes, that are synthesized discontinuously during DNA replication on the lagging strand. Most termination events in Okazaki fragments are not definitively known to be sequence specific based on the provided evidence. The termination events in Okazaki fragments are determined by the localization of replication termination zones, which are generally found midway between origins of replication and are influenced by the activity of the origins. The termination events in Okazaki fragments are influenced by both sequence specificity and stochastic processes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are Okazaki fragments?",
               "answer": "Okazaki fragments are short sequences of DNA nucleotides, approximately 150 to 200 base pairs long in eukaryotes, that are synthesized discontinuously during DNA replication on the lagging strand. They are produced as the DNA unwinds and splits into two strands, with the leading strand being built continuously and",
               "rationale": "1. Okazaki fragments. Okazaki fragments are short sequences of DNA nucleotides (approximately 150 to 200 base pairs long in eukaryotes) which are synthesized discontinuously and later linked together by the enzyme DNA ligase to create the lagging strand during DNA replication. [1] They were discovered in the 1960s by the Japanese molecular ...\n2. Okazaki fragments are short lengths of DNA that are produced by the discontinuous replication of the lagging strand during cell division. Learn how they are formed, discovered, and processed by DNA polymerases and ligases in this NEET biology guide.\n3. Okazaki fragments are short pieces of DNA synthesized on the lagging strand during DNA replication. Learn how they are made, what role they play, and how they are joined together by DNA ligase.\n4. Okazaki fragments are short DNA sequences with RNA primers that are synthesized discontinuously and joined to form the lagging strand during DNA replication. Learn how they were discovered, how they are formed, and why they are important for cell growth and DNA integrity.\n5. Leading and lagging strands in DNA replication. DNA replication is a precise process where DNA unwinds and splits into two strands. Each strand then serves as a template for a new DNA molecule. The leading strand is built continuously, while the lagging strand is built in fragments, called Okazaki fragments. Created by Sal Khan.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are most termination events in Okazaki fragments sequence specific?",
               "answer": "The provided evidence does not definitively answer whether most termination events in Okazaki fragments are sequence specific. It raises the question of whether termination events are sequence specific or stochastic, but does not provide a conclusion or evidence to support one mode over the other. Therefore, based on the evidence given, we cannot determine if most",
               "rationale": "1. All of these catenanes have to be decatenated (resolved) prior to chromosome segregation ( Figure 1F-G ). Another important issue is whether most termination events are sequence-specific or stochastic, and whether these two modes are mechanistically distinct. Furthermore, the exact order of these processes during termination remains unclear.\n2. Another important issue is whether most termination events are sequence specific or stochastic, and whether these two modes are mechanistically distinct. Furthermore, the exact order of these ...\n3. Another important issue is whether most termin ation events are sequence specific or stochastic, and whether these two modes are mechanistically dis-tinct. Furthermore, the exact order of these processes during termination remains unclear.\n4. Okazaki fragments. Okazaki fragments are short sequences of DNA nucleotides (approximately 150 to 200 base pairs long in eukaryotes) which are synthesized discontinuously and later linked together by the enzyme DNA ligase to create the lagging strand during DNA replication. [1] They were discovered in the 1960s by the Japanese molecular ...\n5. Here we describe a detailed protocol for isolating and sequencing Okazaki fragments from asynchronously growing mammalian cells, termed Okazaki fragment sequencing (Ok-seq), for the purpose of ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What determines the termination events in Okazaki fragments?",
               "answer": "The termination events in Okazaki fragments are determined by the localization of replication termination zones, which are generally found midway between origins of replication. Additionally, the analysis indicates that the more active the two origins are, the better defined the termination zone between them becomes. This suggests that the dynamics of replication initiation and the activity of",
               "rationale": "1. Formation of the Okazaki fragments. The work of Kiwako Sakabe, Reiji Okazaki and Tsuneko Okazaki provided experimental evidence supporting the hypothesis that DNA replication is a discontinuous process. Previously, it was commonly accepted that replication was continuous in both the 3' to 5' and 5' to 3' directions. 3' and 5' are specifically numbered carbons on the deoxyribose ring in nucleic ...\n2. The small fragments are called Okazaki fragments, named for the Japanese scientist who discovered them. The leading strand can be extended from one primer alone, whereas the lagging strand needs a new primer for each of the short Okazaki fragments. ... Pray, L. A. (2008). Major molecular events of DNA replication. Nature Education, 1(1), 99 ...\n3. More recently, Okazaki fragments were mapped genome-wide in unsynchronized budding yeast cells to identify fork merger zones 47. This analysis showed that termination events generally occur midway between origins and that the more active two origins are, the better defined the termination zone between them.\n4. The change in Okazaki fragment strand bias in the vicinity of TTS showed a sharp trough immediately adjacent to the TTS itself, indicating that the peak of replication termination is localized, on ...\n5. (B) Schematic representation of Okazaki fragment distributions arising from replication termination at TTS. (C) Replication initiation frequency, calculated as the first derivative of Okazaki fragment strand bias as in Fig. 1h, around TTS binned by total RNA-seq read density in the gene body as in (A). Negative initiation frequencies correspond ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Are the termination events in Okazaki fragments determined by sequence specificity or stochastic processes?",
               "answer": "The termination events in Okazaki fragments are influenced by both sequence specificity and stochastic processes. While the evidence does not explicitly state the mechanisms behind termination, it implies that the interactions between DNA polymerase (specifically Pol δ) and the Okazaki fragments, as well as the processes involved in the maturation of these fragments",
               "rationale": "1. Chapter 11: DNA Replication. Define and indicate the significance of (a) Okazaki fragments, (b) DNA ligase, and (c) primer RNA during DNA replication. (a) Okazaki fragments are relatively short (1000 to 2000 bases in prokaryotes) DNA fragments that are synthesized in a discontinuous fashion on the lagging strand during DNA replication.\n2. Formation of the Okazaki fragments. The work of Kiwako Sakabe, Reiji Okazaki and Tsuneko Okazaki provided experimental evidence supporting the hypothesis that DNA replication is a discontinuous process. Previously, it was commonly accepted that replication was continuous in both the 3' to 5' and 5' to 3' directions. 3' and 5' are specifically numbered carbons on the deoxyribose ring in nucleic ...\n3. Why do Okazaki fragments (the primers at least) need to be removed? ... Dna2? pre-catanenes?? replication origin efficiency how does passing lead to the termination processes? Share. Students also viewed. Lipids. 13 terms. GracieFitzsimons. Preview. Disruption of the metabolism . 22 terms. HBleackley. ... what logical sequence of events is ...\n4. DNA polymerase (pol) δ is essential for both leading and lagging strand DNA synthesis during chromosomal replication in eukaryotes. Pol δ has been implicated in the Okazaki fragment maturation process for the extension of the newly synthesized fragment and for the displacement of the RNA/DNA segment of the preexisting downstream fragment generating an intermediate flap structure that is the ...\n5. A previous report determined that Pol δ collision with the 5′-end of an Okazaki fragment reduces the affinity of the polymerase for DNA, designated \"collision release\" 24. Since we find that the whole process should be complete within just a few seconds, our data do not disagree with that study, which was carried out at a time scale of ...",
               "predicate": null
            }
         ],
         "row": 609,
         "id": 113530777195057899
      },
      {
         "claim": "Mutant mice lacking SVCT2 have greatly increased ascorbic acid levels in both brain and adrenals.",
         "label": 0,
         "prediction": 0,
         "rationale": "SVCT2 is a transporter that is preferentially expressed in neurons and neural precursor cells, playing a crucial role in protecting metabolically active cells against oxidative stress and accumulating vitamin C at needed sites. In mutant mice lacking SVCT2, ascorbic acid levels are severely reduced in tissues, leading to significant physiological consequences and ultimately resulting in the death of the mice shortly after birth. The lack of SVCT2 in mutant mice leads to drastically diminished ascorbate levels in the brain. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is SVCT2?",
               "answer": "SVCT2 is a transporter that is preferentially expressed in neurons and neural precursor cells. It plays a crucial role in protecting metabolically active cells against oxidative stress and is involved in the accumulation of vitamin C (ascorbate) at sites where it is needed. In developmental stages, SVCT2 is concentrated in the",
               "rationale": "1. SVCT1 is involved in whole-body homeostasis of vitamin C, while SVCT2 protects metabolically active cells against oxidative stress. Regulation at mRNA or protein level may serve for preferential accumulation of ascorbic acid at sites where it is needed. This review will summarize the present knowledge on structure, function and regulation of ...\n2. SVCT1 is involved in whole-body homeostasis of vitamin C, while SVCT2 protects metabolically active cells against oxidative stress. Regulation at mRNA or protein level may serve for preferential accumulation of ascorbic acid at sites where it is needed. This review will summarize the present knowledge on structure, function and regulation of ...\n3. SVCT2 expression was analyzed in femora from mice 12- and 24-months of age, along with other known bone markers. We found that relative expression of the SVCT2 gene in bone was markedly decreased with age. Compared to 12 month mice, SVCT2 expression was down regulated two-fold in 24 month old mice (Fig. 8). The Collagen type 1, BMP-2 and RUNX-2 ...\n4. Vitamin C (ascorbate) is an essential water-soluble micronutrient in humans and is obtained through the diet, primarily from fruits and vegetables. In vivo, vitamin C acts as a cofactor for numerous biosynthetic enzymes required for the synthesis of amino acid-derived macromolecules, neurotransmitters, and neuropeptide hormones, and is also a ...\n5. SVCT2 is a transporter preferentially expressed in neurons and in neural precursor cells. In developmental stages, it is concentrated in the apical region of the radial glia, and in adult life, it is expressed preferentially in motor neurons of the cerebral cortex, starting on postnatal day 1.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What happens to ascorbic acid levels in mutant mice lacking SVCT2?",
               "answer": "In mutant mice lacking SVCT2, ascorbic acid levels are severely reduced in tissues. This deficiency leads to significant physiological consequences, including a decrease in tissue catecholamine levels in the adrenals and ultimately results in the death of the mice shortly after birth.",
               "rationale": "1. Mutant mice lacking the plasma membrane ascorbic acid transporter (SVCT2) have severely reduced tissue levels of ascorbic acid and die soon after birth. There is a significant decrease of tissue catecholamine levels in the adrenals. On the ultrastructural level, adrenal chromaffin cells in SVCT2 null mice show depletion of catecholamine storage ...\n2. Ascorbic acid (vitamin C) is a cofactor required in catecholamine synthesis for conversion of dopamine to norepinephrine by dopamine β-hydroxylase. Mutant mice lacking the plasma membrane ascorbic acid transporter (SVCT2) have severely reduced tissue levels of ascorbic acid and die after birth.\n3. Abstract. Vitamin C, or ascorbic acid, is important as an antioxidant and participates in numerous cellular functions. Although it circulates in plasma in micromolar concentrations, it reaches millimolar concentrations in most tissues. These high ascorbate cellular concentrations are thought to be generated and maintained by the SVCT2 (Slc23a2 ...\n4. Vitamin C (L-ascorbic acid) is an essential nutrient for human health, and its deficiency has long been known to cause scurvy. Sodium-dependent vitamin C transporters (SVCTs) are responsible for ...\n5. 1. Introduction. In recent years, it has been postulated that vitamin C has a functional role in neuronal and progenitor cell differentiation [1,2,3,4,5,6,7].Sodium-dependent vitamin C transporter 2 (SVCT2) has been detected in neurons of the cerebral cortex, cerebellum, hippocampus, entorhinal cortex and hypothalamus [1,3,8,9,10,11].SVCT2 has also been detected in glial cells, such as ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the effect of lacking SVCT2 on ascorbic acid levels in the brain and adrenals of mutant mice?",
               "answer": "The lack of SVCT2 in mutant mice leads to drastically diminished ascorbate levels in the brain, as indicated by the observation that SVCT2 knockout (KO) mice exhibit significantly reduced ascorbate levels. The evidence does not explicitly mention the effect on ascorbic acid levels in the adrenals, but",
               "rationale": "1. To demonstrate the effect of ascorbic acid on SVCT2 expression, SVCT2 protein levels were measured in the mPFC of mice that received intraperitoneal injection of ascorbic acid ranging from 10 mg/kg to 1000 mg/kg.\n2. The recycling activity begins at the cerebral postnatal cortex when neurons increase SVCT2 expression and concomitantly, GLUT1 is expressed in glial cells. Keywords: SVCT2, vitamin C, ascorbic acid, dehydroascorbic acid, cortical neurons, neurospheres, vitamin C recycling, neuronal branching, neurites, SIM superresolution, bystander effect\n3. Radioactive uptake assays using 14 C-labelled ascorbic acid showed a significant increase of ascorbic acid uptake into the brain after stroke. Taken together, these results provide evidence for the expression and transport activity of SVCT2 in brain capillary endothelial cells after transient ischemia in mice.\n4. The sodium-dependent vitamin C transporter-2 (SVCT2) is the only ascorbic acid (ASC) transporter significantly expressed in brain. It is required for life and is critical during brain development to supply adequate levels of ASC. To assess SVCT2 function in the developing brain, we studied time-depe …\n5. The brains of the SVCT2 KO mice exhibit drastically diminished ascorbate levels and extensive and specific brain hemorrhage. Besides the brain, only the lungs showed macroscopic abnormalities, which raises the question: Did pup death occur due to brain hemorrhage or lung defects?",
               "predicate": null
            }
         ],
         "row": 610,
         "id": 321689463201858849
      },
      {
         "claim": "N348I mutations cause resistance to zidovudine (AZT).",
         "label": 1,
         "prediction": 1,
         "rationale": "Zidovudine (AZT) is an antiretroviral medication used to prevent and treat HIV/AIDS. The N348I mutation in HIV-1 reverse transcriptase confers resistance to zidovudine (AZT) by decreasing the frequency of secondary ribonuclease H (RNase H) cleavages, reducing the RNA/DNA duplex length of the template. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is zidovudine (AZT)?",
               "answer": "Zidovudine (AZT) is an antiretroviral medication used to prevent and treat HIV/AIDS. It is a nucleoside reverse transcriptase inhibitor (NRTI) that helps slow the progression of HIV infection in patients, whether they have advanced symptoms, early symptoms, or no symptoms at all",
               "rationale": "1. Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS.It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and ...\n2. Zidovudine (also known as AZT) is used together with other medicines for the treatment of human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Zidovudine is used to slow the progression of disease in patients infected with HIV who have advanced symptoms, early symptoms, or no ...\n3. AZT, drug used to delay development of AIDS (acquired immunodeficiency syndrome) in patients infected with HIV (human immunodeficiency virus). AZT belongs to a group of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). In 1987 AZT became the first of these drugs to be approved by the U.S. Food and Drug Administration for the purpose of prolonging the lives of AIDS patients.\n4. Zidovudine is a medication used in the management and treatment of HIV-1. It is in the nucleoside reverse transcriptase inhibitor class of medications. This activity reviews the indications, mechanism of action, and contraindications for zidovudine as a valuable agent in the treatment of HIV-1. This activity will highlight the mechanism of action, adverse event profile, and other key factors ...\n5. AZT, or azidothymidine, was originally developed in the 1960s by a U.S. researcher as way to thwart cancer; the compound was supposed to insert itself into the DNA of a cancer cell and mess with ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of N348I mutations on zidovudine (AZT)?",
               "answer": "The N348I mutation in HIV-1 reverse transcriptase (RT) confers resistance to zidovudine (AZT). It indirectly increases AZT resistance by decreasing the frequency of secondary ribonuclease H (RNase H) cleavages, which reduces the RNA/DNA duplex length of the template",
               "rationale": "1. Patients treated with zidovudine and nevirapine were 2.6 times more likely to have the N348I mutation than patients not treated with these drugs. Furthermore, the appearance of the N348I mutation often coincided with an increase in viral load, although other mutations that appeared at a similar time could have contributed to this increase.\n2. Patients treated with zidovudine and nevirapine were 2.6 times more likely to have the N348I mutation than patients not treated with these drugs. Furthermore, the appearance of the N348I mutation often coincided with an increase in viral load, although other mutations that appeared at a similar time could have contributed to this increase.\n3. Phenotypic analyses revealed that N348I in subtype C RT decreases susceptibility to NVP, EFV, ETV, and AZT or reduces hypersusceptibility to AZT when in the context of polymerase domain mutations. The frequent emergence and phenotypic effects of N348I warrant further efforts to characterize its effects on virologic response to second- and third ...\n4. Background: N348I in HIV-1 reverse transcriptase (RT) confers resistance to zidovudine (AZT) and nevirapine. Biochemical studies demonstrated that N348I indirectly increases AZT resistance by decreasing the frequency of secondary ribonuclease H (RNase H) cleavages that reduce the RNA/DNA duplex length of the template/primer (T/P) and diminish the efficiency of AZT-monophosphate (MP) excision.\n5. Background. N348I in HIV-1 reverse transcriptase (RT) confers resistance to zidovudine (AZT) and nevirapine. Biochemical studies demonstrated that N348I indirectly increases AZT resistance by decreasing the frequency of secondary ribonuclease H (RNase H) cleavages that reduce the RNA/DNA duplex length of the template/primer (T/P) and diminish the efficiency of AZT-monophosphate (MP) excision.",
               "predicate": null
            }
         ],
         "row": 611,
         "id": 310946676635229392
      },
      {
         "claim": "NFAT4 activation requires IP3R-mediated Ca2+ mobilization.",
         "label": 1,
         "prediction": 1,
         "rationale": "NFAT4 is a transcription factor involved in cytokine and early response gene expression in activated lymphocytes, specifically expressed in double-positive thymocytes and crucial for CD4 development. NFAT4 activation requires IP3R-mediated Ca2+ mobilization in DP thymocytes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is NFAT4?",
               "answer": "NFAT4 is a member of the nuclear factor of activated T cells (NFAT) family of transcription factors, which are involved in cytokine and early response gene expression in activated lymphocytes. NFAT4 is specifically expressed in double-positive (DP) thymocytes and plays a crucial role in the development of CD4",
               "rationale": "1. Cell-specific differences in expression levels (for example, NFAT4 is the main NFAT protein that is expressed by thymocytes, but its expression by peripheral T cells is low compared with that of ...\n2. NFAT1-NFAT4 are regulated by intracellular Ca 2+ signalling 9,10, but NFAT5 — the primordial member of the NFAT family — is activated in response to osmotic stress 21,22.\n3. Nfat4-null mice exhibit abnormal development of myofibres, as well as reduced thymocyte numbers owing to suppression of BCL-2 (Ref. 101). Only when more than one NFAT isoform is eliminated are ...\n4. Nuclear factor of activated T cells (NFAT) is a family of four related transcription factors implicated in cytokine and early response gene expression in activated lymphocytes. Here we report that NFAT4, in contrast to NFATp and NFATc, is preferentially expressed in DP thymocytes. Mice lacking NFAT4 have impaired development of CD4 and CD8 SP thymocytes and peripheral T cells as well as ...\n5. Abstract. The nuclear factor of activated T cells (NFAT) family of transcription factors, which includes NFAT1, NFAT2, and NFAT4, are well-known to play important roles in T cell activation. Most of NFAT proteins are controlled by calcium influx upon T cell receptor and costimulatory signaling results increase of IL-2 and IL-2 receptor.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does NFAT4 activation require IP3R-mediated Ca2+ mobilization in DP thymocytes?",
               "answer": "Yes, NFAT4 activation requires IP3R-mediated Ca2+ mobilization in DP thymocytes. Evidence 2 mentions that the adaptor protein Tespa1 facilitates Ca2+ ion mobilization following TCR activation, which is likely linked to the activation of NFAT4 as indicated in Evidence 1, where distinct",
               "rationale": "1. Here, we show that two Ca 2+-dependent transcription factor isoforms, NFAT1 and NFAT4, require distinct sub-cellular InsP 3 and Ca 2+ signals for physiologically sustained activation. NFAT1 is stimulated by sub-plasmalemmal Ca 2+ microdomains, whereas NFAT4 additionally requires Ca 2+ mobilization from the inner nuclear envelope by nuclear InsP ...\n2. We have recently discovered a new TCR signaling regulatory mechanism in DP thymocytes mediated by the adaptor protein Tespa1. ... (IP3R) following TCR activation and facilitates its Ca2+ ion ...\n3. The association of these 2 different pathways leads to the early activation of NFκB and the late activation of interferon regulatory factor-3 responses. 32 CD14 activation after LPS engagement is mediated by lipid rafts and leads to Src kinase activation. 33 The resultant Ca 2+ mobilization leads to the dephosphorylation of NFAT by calcineurin ...\n4. 2285. Fig. 1 Mobilizing ER IP3Rs as a mechanism to facilitate calcium signaling: Several IP3R binding proteins, including Tespa1, BANK1, and SLAT, have been found in T and B cells. Upon TCR or BCR ...\n5. A pivotal component of the calcium (Ca2+) signaling toolbox in cells is the inositol 1,4,5-triphosphate (IP3) receptor (IP3R), which mediates Ca2+ release from the endoplasmic reticulum (ER ...",
               "predicate": null
            }
         ],
         "row": 612,
         "id": 143709091553751492
      },
      {
         "claim": "NR5A2 is important in development of endometrial tissues.",
         "label": 1,
         "prediction": 0,
         "rationale": "NR5A2, also known as liver receptor homolog-1 (LRH-1), is a key pioneer factor and a member of the nuclear receptor family of intracellular transcription factors that plays a critical role in various biological processes. NR5A2 is not directly indicated to be involved in the development of endometrial tissues, but it plays a role in embryonic development and is distributed in endodermal tissues. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is NR5A2?",
               "answer": "NR5A2, also known as liver receptor homolog-1 (LRH-1), is a key pioneer factor and a member of the nuclear receptor family of intracellular transcription factors. It plays a critical role in various biological processes, including zygotic genome activation, pluripotency in embryonic stem cells, and",
               "rationale": "1. Nr5a2 is a key pioneer factor that regulates zygotic genome activation in totipotent embryos, pluripotency in embryonic stem cells and metabolism in adult tissues, but the mechanism of its pioneer ...\n2. Nr5a2 is essential for early embryogenesis and regulates the expression of Pou5f1 in the epiblast. 22,23,24 In mouse ESCs (mESCs), NR5A2 is regulated by canonical Wnt/β-Catenin signaling and in ...\n3. The liver receptor homolog-1 (LRH-1) also known as totipotency pioneer factor NR5A2 (nuclear receptor subfamily 5, group A, member 2) is a protein that in humans is encoded by the NR5A2 gene. LRH-1 is a member of the nuclear receptor family of intracellular transcription factors.. LRH-1 plays a critical role in the regulation of development, cholesterol transport, bile acid homeostasis and ...\n4. NR5A2 is a member of NR5A subfamily having four members (Nr5a1-Nr5a4). NR5A2 shows involvement in diverse biological processes like reverse cholesterol transport, embryonic stem cell pluripotency, steroidogenesis, development and differentiation of embryo, and adult homeostasis. NR5A2 haploinsufficiency has been seen associated with chronic ...\n5. We provide evidence that the orphan nuclear receptor Nr5a2 is a pivotal pioneer factor that activates up to 72% of major ZGA genes in mouse embryos. Nr5a2 binds to SINE B1/Alu retrotransposable elements in the cis-regulatory regions of nearly half of all ZGA genes, and this binding correlates with transcriptional changes. The genome-wide ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is NR5A2 involved in the development of endometrial tissues?",
               "answer": "The provided evidence does not directly indicate that NR5A2 is involved specifically in the development of endometrial tissues. However, it does mention that NR5A2 plays a significant role in various physiological processes, including embryonic development and is distributed in endodermal tissues like the intestine and liver. While it",
               "rationale": "1. Nr5a2 is a key pioneer factor that regulates zygotic genome activation in totipotent embryos, pluripotency in embryonic stem cells and metabolism in adult tissues, but the mechanism of its pioneer ...\n2. The expression levels of MYC, NR5A2, SNAI1, TWIST1, and STK11 were significantly higher in tumor-adjacent tissues than in the matched EC samples, and this difference was not influenced by the content of cancer cells in cancer-adjacent tissues. The expression of MYC, NR5A2, and SNAI1 was also higher in EC-adjacent tissues than in samples from ...\n3. Furthermore, knockout of Nr5a2 leads to arrest of the embryo at the morula stage 24,25, suggesting that it may play a much earlier role in embryo development. A major obstacle in understanding TF ...\n4. NR5A2 gene encodes transcription factor NR5A2 or LRH-1 which plays a significant role in multiple physiological processes like normal physiology, homeostasis, embryonic development, lipid metabolism, anti-inflammatory activities, cancer development, regulation of steroidogenesis and progesterone synthesis [12, 13].In adults, NR5A2 is distributed in endodermal tissues like intestine, liver, and ...\n5. KD or KO of Nr5a2 leads to developmental arrest at the morula stage. To ask which NR TF plays a more critical role in early development, we removed each one of the 4 siRNAs in the combined siRNAs ...",
               "predicate": null
            }
         ],
         "row": 613,
         "id": 108007243655634991
      },
      {
         "claim": "Nanoparticles can be targeted against specific cell types by incorporating aptamers into lipid nanoparticles.",
         "label": 1,
         "prediction": 1,
         "rationale": "Aptamers are short, single-stranded oligonucleotide molecules that can recognize and bind to specific target molecules or cellular receptors with high affinity and specificity. Aptamers can be incorporated into lipid nanoparticles. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are aptamers?",
               "answer": "Aptamers are short, single-stranded oligonucleotide molecules (DNA, RNA, or XNA) that can recognize and bind to specific target molecules or cellular receptors with high affinity and specificity. They are often referred to as \"chemical antibodies\" or \"antibody mimics\" due to their ability to fold",
               "rationale": "1. A typical aptamer is a synthetically generated ligand exploiting the combinatorial diversity of DNA, RNA, XNA, or peptide to achieve strong, specific binding for a particular target molecule or family of target molecules. Aptamers are occasionally classified as \"chemical antibodies\" or \"antibody mimics\". However, most aptamers are small, with a molecular weight of 6-30 kDa, in contrast to the ...\n2. Aptamer. Aptamers are macromolecules that can recognize specific cellular receptors or biomolecules. They are composed of single-stranded oligonucleotide chains and offer advantages such as resistance to degradation, ease of synthesis, low immunogenicity, and small size. They can be conjugated to other entities on the surface of nanoparticles ...\n3. First, therapeutic aptamers should be highly stable in the body. Since natural RNA and DNA are susceptible to endogenous nucleases, chemical modifications on the sugar and/or phosphodiester backbone should be adequately included ( Figure 2 ). Second, the nucleotide length should be sufficiently shortened.\n4. Abstract. Aptamers are nucleic acid molecules that mimic antibodies by folding into complex 3D shapes that bind to specific targets. Although some aptamers exist naturally as the ligand-binding ...\n5. Aptamers are short, single-stranded oligonucleotides that bind to specific target molecules. The shape-forming feature of single-stranded oligonucleotides provides high affinity and excellent specificity toward targets. Hence, aptamers can be used as analogs of antibodies. In December 2004, the US F …",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Can aptamers be incorporated into lipid nanoparticles?",
               "answer": "Yes, aptamers can be incorporated into lipid nanoparticles. The evidence indicates that aptamers can be modified and inserted into preformed liposomes, which are a type of lipid nanoparticle. Additionally, aptamers can serve as targeting ligands for drug delivery systems, including those involving lipid nanoparticles.",
               "rationale": "1. To date, aptamers have been incorporated into different biological materials including antibodies, RNAi reagents, DNA origami, and microsomes, to enhance their activities and functions. ... You Y.M., Im C.S., Song I.H., Lee T.S., Park Y.S. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted ...\n2. Aptamers can bind to the receptors on the cell membrane and mediate themselves or conjugated nanoparticles to enter into cells. Therefore, aptamers can be served as ideal targeting ligands for drug delivery. Since their excellent properties, different aptamer-mediated drug delivery systems had been developed for cancer therapy.\n3. The utilization of antibody-conjugated lipid nanoparticles in anticancer drug delivery is discussed below, with several examples organized by nanoparticle type. 3.1. Antibody-Functionalized SLN. The lipids used to produce SLN are solid at both room temperature and human body temperature [ 28 ].\n4. Aptamer modification can be achieved either into the scaffold of selected aptamers through standard solid-phase synthesis (post-selection modification) or by using modified nucleoside triphosphates (NTPs) directly in the selection process [54,55,56]. The common chemical modification approaches of nucleic acid aptamers for the development of ...\n5. Post-insertion methods involve the incorporation of aptamers into preformed liposomes, either by using lipid moieties linked to the aptamer or by hybridizing complementary DNA strands to the liposomes [79]. Cholesterol-tagged aptamers can spontaneously insert into liposomes based on the tag [Fig. 3 D] [79]. Aptamers can be added to liposomes ...",
               "predicate": null
            }
         ],
         "row": 614,
         "id": 238918155318566561
      },
      {
         "claim": "Neutrophil extracellular traps (NETs) are released by ANCA-stimulated neutrophils.",
         "label": 1,
         "prediction": 1,
         "rationale": "ANCA-stimulated neutrophils are neutrophils that have been activated by antineutrophil cytoplasmic antibodies (ANCAs), undergoing activation in response to these proteins produced by the immune system that mistakenly target neutrophils. ANCA-stimulated neutrophils' release of Neutrophil extracellular traps (NETs) is not specifically mentioned in the provided evidence snippets. Activated neutrophils release Neutrophil extracellular traps (NETs). Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are ANCA-stimulated neutrophils?",
               "answer": "ANCA-stimulated neutrophils are neutrophils that have been activated by antineutrophil cytoplasmic antibodies (ANCAs). These neutrophils undergo activation in response to ANCAs, which are proteins produced by the immune system that mistakenly target neutrophils. Once activated, these neutrophils",
               "rationale": "1. Under normal circumstances, neutrophils are in an inactive state and move slowly in the direction of the peripheral blood circulation. Once the body is stimulated to enter into an inflammatory state, neutrophils will be activated, released quickly from the neutrophil storage pool, and stimulated to undergo proliferation in the bone marrow.\n2. They activate neutrophils and express target antigens on their cell surface. Meanwhile, the alternative-complement pathway also activates neutrophils via binding C5a to its surface receptors . At the same time, neutrophils stimulated by antigens form neutrophil-extracellular traps (NETs) . MPO and PR3 antigens are released into the ...\n3. ANCA Test. An antineutrophil cytoplasmic antibodies (ANCA) test is a blood test that detects ANCAs in your blood. ANCAs are proteins made by the immune system that mistakenly target neutrophils, infection-fighting white blood cells. ANCA testing helps healthcare providers diagnose and monitor certain types of vasculitis and inflammatory bowel ...\n4. ANCA-activated neutrophils also release BLyS, which could contribute to the amplification of ANCA responses by inducing B-cell survival and plasma cell differentiation . NETs are produced by ANCA-stimulated neutrophils and have been reported in glomeruli and in the interstitium of kidney biopsies from patients with AASV.\n5. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affects systemic small vessels and is accompanied by the presence of ANCAs in the serum. ... When stimulated by bacteria ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do ANCA-stimulated neutrophils release Neutrophil extracellular traps (NETs)?",
               "answer": "The provided evidence snippets do not specifically mention ANCA-stimulated neutrophils releasing Neutrophil extracellular traps (NETs). However, they do indicate that activated neutrophils can release NETs in response to various stimuli, and that NETs play a role in the immune response. To definitively answer whether",
               "rationale": "1. In addition, neutrophils can also release neutrophil extracellular traps (NETs) under pathological conditions or in vitro stimulation. The structure of NETs released from neutrophils under phorbol myristate acetate (PMA) or lipopolysaccharide (LPS) stimulation was first observed by Brinkmann et al. in 2004 using electron microscopy . NETs carry ...\n2. Neutrophil extracellular traps (NETs) protect against infection, but they are also implicated in the pathology associated with various immune-mediated conditions. This Review describes when and ...\n3. Activated neutrophils release neutrophil extracellular traps (NETs) in response to a variety of stimuli. NETosis is driven by protein-arginine deiminase type 4, with the release of intracellular granule components that function by capturing and destroying microbes, including viral, fungal, bacterial, and protozoal pathogens.\n4. At the frontline of the host defence response, neutrophil antimicrobial functions have adapted to combat infections and injuries of different origins and magnitude. The release of web-like DNA structures named neutrophil extracellular traps (NETs) constitutes an important mechanism by which neutrophils prevent pathogen dissemination or deal ...\n5. Neutrophils have specialized in the formation of neutrophil extracellular traps (NETs), which are the most studied type of DNA trap. ... neutrophils are stimulated to form NETs and the binding of ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do activated neutrophils release Neutrophil extracellular traps (NETs)?",
               "answer": "Yes, activated neutrophils release Neutrophil extracellular traps (NETs).",
               "rationale": "1. Activated neutrophils release neutrophil extracellular traps (NETs) in response to a variety of stimuli. NETosis is driven by protein-arginine deiminase type 4, with the release of intracellular granule components that function by capturing and destroying microbes, including viral, fungal, bacterial, and protozoal pathogens.\n2. Neutrophil extracellular traps (NETs) protect against infection, but they are also implicated in the pathology associated with various immune-mediated conditions. This Review describes when and ...\n3. Neutrophils are the principal trouper of the innate immune system. Activated neutrophils undergo a noble cell death termed NETosis and release a mesh-like structure called neutrophil extracellular traps (NETs) as a part of their defensive strategy against microbial pathogen attack.\n4. Activated neutrophils release neutrophil extracellular traps (NETs) in response to a variety of stimuli. NETosis is driven by protein-arginine deiminase type 4, with the release of intracellular granule components that function by capturing and destroying microbes, including viral, fungal, bacterial, and protozoal pathogens.\n5. In addition, activated neutrophils release neutrophil extracellular traps (NETs), which are complex networks comprised of DNA, histones, and granule proteins . NETs effectively capture pathogens and secrete antimicrobial proteins to kill them ( 7 , 8 ).",
               "predicate": null
            }
         ],
         "row": 615,
         "id": 939568880916569008
      },
      {
         "claim": "New drugs for tuberculosis often do not penetrate the necrotic portion of a tuberculosis lesion in high concentrations.",
         "label": 0,
         "prediction": 0,
         "rationale": "The necrotic portion of a tuberculosis lesion is referred to as caseous necrosis, characterized by a central area of necrotic tissue with a cheese-like appearance surrounded by a granulomatous inflammatory response. New drugs for tuberculosis may not necessarily penetrate caseous necrosis in high concentrations, but certain treatments can be effective against caseum at relatively high concentrations. New drugs for tuberculosis penetrate the caseous necrosis in high concentrations. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the necrotic portion of a tuberculosis lesion?",
               "answer": "The necrotic portion of a tuberculosis lesion is referred to as caseous necrosis. This type of necrosis is characterized by a central area of necrotic tissue that has a cheese-like appearance, surrounded by a granulomatous inflammatory response, which includes epitheloid macrophages and lymphocytes.",
               "rationale": "1. Tuberculosis (TB) is the most common cause of caseous necrosis. TB is a bacterial disease of the lungs (pulmonary). It can also spread to other organs and systems throughout your body. TB can be latent or active. In latent TB infection, the bacteria lie dormant in your lungs but don't cause symptoms. In some people, TB will stay dormant for ...\n2. Summary. Necrosis is the death of tissues of the body. It can be caused by many factors like insufficient oxygen, infection, trauma, or radiation therapy. Necrosis has been categorized into different types based on distinct features, including appearance. Symptoms include pain, swelling, and fever, along with notable skin issues.\n3. Pott's disease, or Pott disease, named for British surgeon Percivall Pott who first described the symptoms in 1799, is tuberculosis of the spine, usually due to haematogenous spread from other sites, often the lungs. The lower thoracic and upper lumbar vertebrae areas of the spine are most often affected.. It causes a kind of tuberculous arthritis of the intervertebral joints.\n4. Necrosis. Necrosis is the medical term for the death of your body tissue. When the cells in your tissues die, it can affect many different areas of your body, including your bones, skin and organs. Necrosis can occur because of illness, infection, injury, disease or lack of blood flow to your tissues. Contents Overview Additional Common Questions.\n5. Primary tuberculosis. Primary tuberculosis occurs in previously uninfected individuals with competent immune responses 2, 6.The characteristic lesion, a caseating granuloma, is a localized lesion in tissue consisting of a central area of caseous necrosis surrounded by epitheloid macrophages and then lymphocytes, Figure 1.Caseation necrosis was termed 'fatty metamorphosis' by Virchow ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do new drugs for tuberculosis penetrate the caseous necrosis in high concentrations?",
               "answer": "The evidence suggests that caseum (the necrotic debris associated with tuberculosis) is vulnerable to certain treatments, particularly at relatively high concentrations (50 to 100 μM). However, it does not explicitly state that new drugs for tuberculosis penetrate caseous necrosis in high concentrations. It indicates that for successful treatment, drugs",
               "rationale": "1. Caseous necrosis is a hallmark of pulmonary TB pathology. The soft necrotic debris that accumulates in the center of TB granulomas resembles cheese, earning its Latin name, \"caseum.\" ... albeit at relatively high concentrations (50 to 100 μM). This suggests that caseum M. tuberculosis is vulnerable to RpoB inhibition, at least via the ...\n2. Mycobacterium tuberculosis ( M. tb ), the causative agent of TB, is a recalcitrant pathogen that is rife around the world, latently infecting approximately a quarter of the worldwide population. The asymptomatic status of the dormant bacteria escalates to the transmissible, active form when the host's immune system becomes debilitated.\n3. Introduction. The United Nations (UN) convened an unprecedented high-level meeting for highlighting tuberculosis (TB) epidemic and for strategizing a global response toward ending TB by 2030. 1 The UN declaration acknowledges that TB is still amongst the top 10 causes of death worldwide, the leading cause of death in patients with HIV, responsible for one-third of global antimicrobial ...\n4. For the successful treatment of pulmonary tuberculosis, drugs need to penetrate complex lung lesions and permeate the mycobacterial cell wall in order to reach their intracellular targets ...\n5. The intensive biomedical research effort to develop new vaccination approaches and shorter treatment regimens for tuberculosis have not yet resulted in significant changes to disease management [], suggesting that paradigms of pathogenesis may be incomplete.The pathophysiological hallmark of tuberculosis is caseous necrosis, which is thought to result from Mycobacterium tuberculosis-mediated ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do new drugs for tuberculosis penetrate the caseous necrosis in high concentrations?",
               "answer": "Yes, the evidence suggests that caseum M. tuberculosis is vulnerable to RpoB inhibition at relatively high concentrations (50 to 100 μM), indicating that new drugs may penetrate the caseous necrosis effectively.",
               "rationale": "1. Mycobacterium tuberculosis ( M. tb ), the causative agent of TB, is a recalcitrant pathogen that is rife around the world, latently infecting approximately a quarter of the worldwide population. The asymptomatic status of the dormant bacteria escalates to the transmissible, active form when the host's immune system becomes debilitated.\n2. Caseous necrosis is a hallmark of pulmonary TB pathology. The soft necrotic debris that accumulates in the center of TB granulomas resembles cheese, earning its Latin name, \"caseum.\" ... albeit at relatively high concentrations (50 to 100 μM). This suggests that caseum M. tuberculosis is vulnerable to RpoB inhibition, at least via the ...\n3. INTRODUCTION. In 2014, tuberculosis (TB) surpassed HIV as the leading infectious cause of death. According to the World Health Organization (WHO), there were 10 million incident cases of TB in 2017 with 1.3 million deaths. 1 Treatment success was 82%, a number that seems to be decreasing. This is alarming given that small changes in treatment efficacy meaningfully affect population-level ...\n4. Introduction. The United Nations (UN) convened an unprecedented high-level meeting for highlighting tuberculosis (TB) epidemic and for strategizing a global response toward ending TB by 2030. 1 The UN declaration acknowledges that TB is still amongst the top 10 causes of death worldwide, the leading cause of death in patients with HIV, responsible for one-third of global antimicrobial ...\n5. For the successful treatment of pulmonary tuberculosis, drugs need to penetrate complex lung lesions and permeate the mycobacterial cell wall in order to reach their intracellular targets ...",
               "predicate": null
            }
         ],
         "row": 616,
         "id": 253069929267080774
      },
      {
         "claim": "Non-invasive ventilation use should be decreased if there is inadequate response to conventional treatment.",
         "label": 0,
         "prediction": 0,
         "rationale": "Non-invasive ventilation refers to the administration of ventilatory support without the use of invasive artificial airways, delivered through a face mask, nasal mask, or helmet, with air often supplemented with oxygen. The conventional treatment for non-invasive ventilation is pharmacological treatment, used alongside NIV to decrease respiratory muscle work, improve ventilation, reduce dyspnoea, and avoid intubation and invasive mechanical ventilation. If there is an inadequate response to pharmacological treatment, it may indicate adherence issues, such as poor compliance due to drug-related issues like side effects. If there is inadequate response to conventional treatment, non-invasive ventilation (NIV) may be considered as an alternative approach to provide ventilatory support. If there is inadequate response to conventional treatment, non-invasive ventilation may be utilized as an alternative to mechanical ventilation for patients with respiratory failure. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is non-invasive ventilation?",
               "answer": "Non-invasive ventilation (NIV) refers to the administration of ventilatory support without the use of invasive artificial airways, such as endotracheal tubes or tracheostomy tubes. It involves the use of breathing support delivered through a face mask, nasal mask, or helmet, where air, often with added oxygen",
               "rationale": "1. Overview. Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). The use of noninvasive ventilation (see the video below) has markedly increased over the past two decades, and noninvasive ventilation has now become an integral tool ...\n2. Non-invasive ventilation (NIV) is the use of breathing support administered through a face mask, nasal mask, or a helmet. Air, usually with added oxygen, is given through the mask under positive pressure; generally the amount of pressure is alternated depending on whether someone is breathing in or out.\n3. Non-invasive ventilation (NIV) was first reported in the mid-eighteen century by a Scottish physician, John Dalziel.[1] In 1864, Alfred F. Jones' patented the first American tank respirator in the iron lung, known as non-invasive negative pressure ventilation. In 1938 a new form of NIV was described by Barach et al. as a treatment for pulmonary edema.[2] However, Oertel described the use of ...\n4. Noninvasive ventilation (NIV) is a critical technique in respiratory care that delivers ventilatory assistance without the need for invasive procedures like endotracheal intubation. This method is widely used in clinical settings to manage patients with acute and chronic respiratory failure, offering numerous advantages such as reduced risk of infection, improved patient comfort, and shorter ...\n5. Noninvasive positive pressure ventilation (NPPV) is a type of mechanical ventilation that can be used at home to assist with taking a full breath and maintaining adequate oxygen supply in the body, especially while sleeping. If you have a health condition that causes you to have trouble breathing, such as sleep apnea or chronic obstructive ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the conventional treatment for non-invasive ventilation?",
               "answer": "The conventional treatment for non-invasive ventilation (NIV) is pharmacological treatment, which is used alongside NIV to decrease respiratory muscle work, improve ventilation, reduce the sensation of dyspnoea, and ultimately avoid intubation and invasive mechanical ventilation.",
               "rationale": "1. Non-invasive ventilation (NIV) was first reported in the mid-eighteen century by a Scottish physician, John Dalziel. In 1864, Alfred F. Jones' patented the first American tank respirator in the iron lung, known as non-invasive negative pressure ventilation. In 1938 a new form of NIV was described by Barach et al. as a treatment for pulmonary edema.\n2. Noninvasive ventilation (NIV) refers to the delivery of positive pressure ventilation through a noninvasive interface (eg, nasal mask, face mask, or nasal plugs), rather than an invasive interface (endotracheal tube, tracheostomy). NIV can be used as ventilatory support for patients with acute or chronic respiratory failure.\n3. Noninvasive ventilation (NIV) is a critical technique in respiratory care that delivers ventilatory assistance without the need for invasive procedures like endotracheal intubation. This method is widely used in clinical settings to manage patients with acute and chronic respiratory failure, offering numerous advantages such as reduced risk of infection, improved patient comfort, and shorter ...\n4. Overview. Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). The use of noninvasive ventilation (see the video below) has markedly increased over the past two decades, and noninvasive ventilation has now become an integral tool ...\n5. NIV is used, together with conventional pharmacological treatment, with the aim to decrease the respiratory muscle work that is much increased during the episodes of acute bronchoconstriction, to improve ventilation, decrease the sensation of dyspnoea, and ultimately avoid intubation and invasive mechanical ventilation. ... Early use of non ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What happens if there is inadequate response to pharmacological treatment?",
               "answer": "If there is an inadequate response to pharmacological treatment, it may indicate several issues that need to be addressed. These can include:\n\n1. **Adherence Issues**: Poor adherence to treatment can significantly impact the effectiveness of pharmacological interventions. Factors contributing to noncompliance may include drug-related issues (such as side effects",
               "rationale": "1. In psychiatry, one of the main factors contributing to poor response to pharmacological treatment is adherence. Noncompliance with maintenance treatments for chronic illnesses such as schizophrenia and affective disorders can exceed 50%, Poor adherence can be due to drug-related factors (tolerance, complexity of prescription, side effects, or cost), patient-related variables (illness symptoms ...\n2. Prediction of response. A priori indicators of response to treatment would be useful because it would decrease the need to wait for 4 weeks of antidepressant therapy to conclude whether the patient is a responder or not. OCD patients need to be treated for 6 to 8 weeks before concluding that they are nonresponders.\n3. Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder which does not respond to traditional and first-line therapeutic options. There are several definitions and staging models of TRD and a consensus for each has not yet been established. However, in common for each model is the inadequate response to at least 2 trials ...\n4. Cost may play a part. 38 There is a tendency to avoid treatment in older people, 39, 40 and this can lead to unwanted effects, 28 including the so-called risk-treatment mismatch, in which those who are at greatest risk are less aggressively treated, an effect that may be partly associated with age. 41 However, other factors may contribute to ...\n5. An apparent poor response to treatment, whether pharmacological or psychosocial, may, on closer examination, be due to an inadequate dose and/or duration of treatment. Assessing past treatment trials in terms of their dose and duration, and associated tolerability and benefit, will help plan a logical sequence of future treatments.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What happens to non-invasive ventilation use if there is inadequate response to conventional treatment?",
               "answer": "If there is inadequate response to conventional treatment, non-invasive ventilation (NIV) may be considered as an alternative approach to provide ventilatory support. The evidence suggests that NIV is a critical technique in managing respiratory problems, and it can be used to assess patient tolerance and potential improvement in respiratory distress. If patients do not respond",
               "rationale": "1. In this narrative review, non-invasive ventilation (NIV) is discussed in terms of modes of delivery, interface and patient selection, as well as practical considerations. 1. Introduction. As emergency physicians, we encounter patients suffering from either hypoxemic and/or hypercarbic respiratory problems on a daily basis.\n2. Noninvasive ventilation (NIV) is a critical technique in respiratory care that delivers ventilatory assistance without the need for invasive procedures like endotracheal intubation. This method is widely used in clinical settings to manage patients with acute and chronic respiratory failure, offering numerous advantages such as reduced risk of infection, improved patient comfort, and shorter ...\n3. A benefit of BVM ventilation is the ability to quickly discover if a patient will tolerate non-invasive ventilation and if so, whether there's improvement in their respiratory distress, heart rate, saturation and WOB. Deciding to use invasive ventilation is risky but completely warranted in some patients.\n4. Overview. Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). The use of noninvasive ventilation (see the video below) has markedly increased over the past two decades, and noninvasive ventilation has now become an integral tool ...\n5. Noninvasive ventilation (NIV) has become a standard practice in the hospital and at home for several acute and chronic respiratory diseases. While the routine use of humidification in invasive ventilation has become a standard of care, there is no consensus or standard approach to guide the use of humidification in NIV.",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What happens to non-invasive ventilation use if there is inadequate response to conventional treatment?",
               "answer": "If there is inadequate response to conventional treatment, non-invasive ventilation (NIV) may be utilized as an alternative to mechanical ventilation for patients with respiratory failure. This suggests that NIV can be considered when traditional methods do not yield sufficient improvement in the patient's condition.",
               "rationale": "1. The term noninvasive positive‑pressure ventilation (abbreviated NPPV or NIPPV) was previously used to distinguish it from noninvasive negative-pressure ventilation, but given the latter's rarity nowadays, the simpler term NIV is more convenient. As there is now a range of ventilators available for NIV, use of the product name BIPAP (Bilevel positive airway pressure) as a generic term for NIV ...\n2. Nasal masks, non-rebreather masks with a reservoir, high flow nasal cannula (HFNC) and mechanical ventilation with either invasive or non-invasive methods are the procedures that can be performed during the ED course of a patient presenting with acute respiratory failure. The history of the non-invasive ventilation (NIV) dates back to the 1940s.\n3. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomized controlled trial.\n4. Non-invasive ventilation (NIV) is an alternative to mechanical ventilation for patients with respiratory failure. The equipment, indications for use, advantages and disadvantages are discussed below.\n5. The update of this clinical practice guideline is based on 184 clinical trials and systematic reviews, and 10 articles investigating humidification during invasive and noninvasive mechanical ventilation.",
               "predicate": null
            }
         ],
         "row": 617,
         "id": 103467401334602667
      },
      {
         "claim": "Normal expression of RUNX1 has tumor-promoting effects.",
         "label": 0,
         "prediction": 0,
         "rationale": "RUNX1 is a gene located on chromosome 21 that encodes a protein involved in the regulation of blood cell development. Normal expression of RUNX1 can have both tumor-promoting and tumor-suppressive effects, depending on the context. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is RUNX1?",
               "answer": "RUNX1 is a gene located on chromosome 21 that encodes a protein involved in the regulation of blood cell development (hematopoiesis). It can be transcribed from two alternative promoters, leading to various isoforms through alternative splicing. RUNX1 is crucial for the development of hematopoietic stem",
               "rationale": "1. In humans, the gene RUNX1 is 260 kilobases (kb) in length, and is located on chromosome 21 (21q22.12). The gene can be transcribed from 2 alternative promoters, promoter 1 (distal) or promoter 2 (proximal). As a result, various isoforms of RUNX1 can be synthesized, facilitated by alternative splicing. The full-length RUNX1 protein is encoded by ...\n2. The RUNX1 protein turns on (activates) genes that help control the development of blood cells (hematopoiesis). In particular, it plays an important role in development of hematopoietic stem cells, early blood cells that have the potential to develop into all types of mature blood cells such as white blood cells, red blood cells, and platelets.\n3. Genetic counseling. RUNX1-FPDMM is inherited in an autosomal dominant manner. Most individuals diagnosed with RUNX1-FPDMM inherited the causative pathogenic variant from a parent who may or may not have recognized manifestations of the disorder. If a parent of the proband is affected and/or is known to have the pathogenic variant identified in the proband, the risk to sibs of inheriting the ...\n4. Abstract. RUNX1 is a member of the core-binding factor family of transcription factors and is indispensable for the establishment of definitive hematopoiesis in vertebrates. RUNX1 is one of the most frequently mutated genes in a variety of hematological malignancies. Germ line mutations in RUNX1 cause familial platelet disorder with associated ...\n5. RUNX1 Familial Platelet Disorder (RUNX1-FPD) is a rare condition that can affect many parts of the body and results in higher risk for developing certain cancers. This condition is caused by harmful changes in the RUNX1 gene. A parent can pass down these genetic changes to their children, which means that multiple people in the same family can ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does normal expression of RUNX1 have tumor-promoting effects?",
               "answer": "Based on the provided evidence snippets, normal expression of RUNX1 appears to have both tumor-promoting and tumor-suppressive effects, depending on the context. The evidence suggests that RUNX1 expression is dysregulated in almost all tumors and can have positive or negative effects on clinical outcomes. Additionally, increased levels of RUN",
               "rationale": "1. Background Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, there is no evidence from pan-cancer analysis. Methods We comprehensively investigated the effect of RUNX1 expression on tumor prognosis across human malignancies by analyzing ...\n2. Our results suggest that RUNX1 expression is dysregulated in almost all tumors and may have positive or negative effects on the clinical outcomes of patients with cancer. Additionally, an increased level of RUNX1 is associated with the immune infiltrate levels of CAFs and the activation of oncogenic signaling pathways in human cancers, which ...\n3. Runt-related transcription factor 1 (RUNX1) is frequently involved in the progression of acute leukemia. However, emerging and discoverable RUNX1 somatic mutations, RUNX1 expressional signatures in normal tissues and cancers, and RUNX1's clinical significance in many cancer types have attracted attention for considering RUNX1 as a biomarker for ...\n4. RUNX1 plays an important role in the regulation of normal hematopoiesis. RUNX1 mutations are frequently found and have been intensively studied in hematological malignancies. Germline mutations in RUNX1 cause familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). Somatic mutations of RUNX1 are observed in various types of hematological malignancies, such as AML ...\n5. The impact of normal RUNX1 on other hematologic malignancies is still unclear. There was a recent study suggesting that high RUNX1 expression is associated with poor prognosis in CN-AML. 187 The authors analyzed several publicly available datasets and determined that RUNX1 expression is",
               "predicate": null
            }
         ],
         "row": 618,
         "id": 335824210667934762
      },
      {
         "claim": "Obesity is determined solely by environmental factors.",
         "label": 0,
         "prediction": 0,
         "rationale": "Obesity is determined by excessive fat deposits that can impair health, commonly assessed using the Body Mass Index (BMI), which compares a person's weight to their height. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What determines obesity?",
               "answer": "Obesity is determined by excessive fat deposits that can impair health, and it is commonly assessed using the Body Mass Index (BMI), which compares a person's weight to their height. Healthcare providers use BMI along with additional risk factors to evaluate a person's risk for developing weight-related diseases.",
               "rationale": "1. Obesity makes you more likely to have high blood pressure and unhealthy cholesterol levels, which are risk factors for heart disease and strokes. Type 2 diabetes. Obesity can affect the way the body uses insulin to control blood sugar levels. This raises the risk of insulin resistance and diabetes. Certain cancers.\n2. People with obesity need to get at least 150 minutes a week of moderate-intensity physical activity. This can help prevent further weight gain or maintain the loss of a modest amount of weight. You'll probably need to gradually increase the amount you exercise as your endurance and fitness improve. Keep moving.\n3. Obesity is a chronic complex disease defined by excessive fat deposits that can impair health. Obesity can lead to increased risk of type 2 diabetes and heart disease, it can affect bone health and reproduction, it increases the risk of certain cancers. Obesity influences the quality of living, such as sleeping or moving.\n4. The most common way to determine if a person is affected by overweight or obesity is to calculate BMI, which is an estimate of body fat that compares a person's weight to their height. Healthcare providers use BMI, along with information about additional risk factors, to determine a person's risk for developing weight-related diseases.\n5. Diagnosing obesity can help a doctor estimate a person's risk of developing obesity-related conditions. The most common way to determine obesity is by calculating someone's BMI. However, BMI ...",
               "predicate": null
            }
         ],
         "row": 619,
         "id": 155580620541779427
      },
      {
         "claim": "Occupancy of ribosomes by IncRNAs do not make functional peptides.",
         "label": 0,
         "prediction": 1,
         "rationale": "Long non-coding RNAs (lncRNAs) are RNA transcripts that exceed 200 nucleotides in length and are not translated into proteins, playing significant roles in regulating various cellular processes. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are IncRNAs?",
               "answer": "Long non-coding RNAs (lncRNAs) are defined as RNA transcripts that exceed 200 nucleotides in length and are not translated into proteins. They are found in many species and have been shown to play significant roles in regulating various cellular processes, including transcriptional and post-transcriptional gene regulation, as",
               "rationale": "1. lncRNAs have been arbitrarily defined as non-coding transcripts of more than 200 nucleotides (200 nt), which is a convenient size cut-off in biochemical and biophysical RNA purification protocols ...\n2. Long non-coding transcripts are found in many species. Large-scale complementary DNA (cDNA) sequencing projects such as FANTOM reveal the complexity of these transcripts in humans. The FANTOM3 project identified ~35,000 non-coding transcripts that bear many signatures of messenger RNAs, including 5' capping, splicing, and poly-adenylation, but have little or no open reading frame (ORF).\n3. 1. Introduction. Long non-coding RNAs (lncRNAs) are defined as RNAs that have a transcript length exceeding 200 nucleotides and will not be translated into proteins 1.Although lncRNAs were once thought to be by-products of RNA polymerase II transcription without biological functions, a large repertoire of lncRNAs have been certified to regulate cellular processes, such as chromosome and genome ...\n4. The functions of lncRNAs vary from transcriptional and post-transcriptional gene regulation to the assembly and function of membraneless nuclear bodies, and are relevant to neuronal disorders ...\n5. LncRNAs Can Regulate the Transcription of Target Genes Alone or in Combination With Transcription Factors . Whether lncRNAs regulate gene transcription through the cis or trans action mode depends on its relative position tothe target genes. Numerous databases provide valuable information regarding the combination of lncRNAs and transcription ...",
               "predicate": null
            }
         ],
         "row": 620,
         "id": 637412331027357317
      },
      {
         "claim": "Occupancy of ribosomes by IncRNAs mirror 5 0-UTRs",
         "label": 1,
         "prediction": 0,
         "rationale": "Long non-coding RNAs (lncRNAs) are RNA transcripts that exceed 200 nucleotides in length and are not translated into proteins, playing critical roles in various biological processes and diseases. The provided evidence does not explicitly state whether lincRNAs occupy ribosomes, but suggests that they are generally not translated into protein. 5' UTRs do not occupy ribosomes, but instead play a crucial role in the recruitment of ribosomes to the mRNA for translation. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are IncRNAs?",
               "answer": "Long non-coding RNAs (lncRNAs) are defined as RNA transcripts that exceed 200 nucleotides in length and are not translated into proteins. They are widely expressed across many species and have been shown to play critical roles in various biological processes and diseases, including gene regulation, cell differentiation, tissue development,",
               "rationale": "1. lncRNAs have been arbitrarily defined as non-coding transcripts of more than 200 nucleotides (200 nt), which is a convenient size cut-off in biochemical and biophysical RNA purification protocols ...\n2. Long non-coding transcripts are found in many species. Large-scale complementary DNA (cDNA) sequencing projects such as FANTOM reveal the complexity of these transcripts in humans. The FANTOM3 project identified ~35,000 non-coding transcripts that bear many signatures of messenger RNAs, including 5' capping, splicing, and poly-adenylation, but have little or no open reading frame (ORF).\n3. Evidence accumulated over the past decade shows that long non-coding RNAs (lncRNAs) are widely expressed and have key roles in gene regulation. Recent studies have begun to unravel how the ...\n4. 1. Introduction. Long non-coding RNAs (lncRNAs) are defined as RNAs that have a transcript length exceeding 200 nucleotides and will not be translated into proteins 1.Although lncRNAs were once thought to be by-products of RNA polymerase II transcription without biological functions, a large repertoire of lncRNAs have been certified to regulate cellular processes, such as chromosome and genome ...\n5. 2.1. The biological question. The lncRNA field is in its infancy yet from what we do know we find that lncRNAs play critical roles in a wide variety of biological processes and diseases from cell differentiation, tissue organ development, flowering in plants, to cancer metastasis to name just a few [, , , , ].We believe that lncRNAs play regulatory roles in many biological processes and diseases.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do IncRNAs occupy ribosomes?",
               "answer": "The provided evidence does not explicitly state whether long intergenic non-coding RNAs (lincRNAs) occupy ribosomes. However, it does indicate that lincRNAs and long non-coding RNAs (lncRNAs) are generally not translated into protein, which suggests that they do not function in the same way",
               "rationale": "1. Long intergenic non-coding RNAs (lincRNAs) do not overlap protein-coding genes, although some lincRNA genes have minimal coding potential and can include small open reading frames that encode ...\n2. This Consensus Statement addresses the definition, nomenclature and classification of long non-coding RNAs, and provides a shared viewpoint on their features and functions. The authors also ...\n3. Long non-coding RNAs ( long ncRNAs, lncRNA) are a type of RNA, generally defined as transcripts more than 200 nucleotides that are not translated into protein. [2] This arbitrary limit distinguishes long ncRNAs from small non-coding RNAs, such as microRNAs (miRNAs), small interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small ...\n4. Recent studies have provided novel insight into the biogenesis of long non-coding RNAs (lncRNAs) and their specific functions. The functions of lncRNAs vary from transcriptional and post ...\n5. A lncRNA can also regulate a mRNA transcript co-transcriptionally 'Part III' by affecting either the stability, change the splicing activity, editing of modifications, or even the capping of the mature mRNA. Finally, post-transcriptionally a lncRNA can function to regulate the mRNA in several ways.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do 5' UTRs occupy ribosomes?",
               "answer": "No, 5' UTRs do not occupy ribosomes. Instead, they play a crucial role in the recruitment of ribosomes to the mRNA for translation. The evidence indicates that the 5' UTR contains regulatory elements that facilitate ribosome recruitment and translation initiation, but the UTR itself is not where",
               "rationale": "1. As it is well known, messenger RNA has many regulatory regions along its sequence length. One of them is the 5′ untranslated region (5'UTR), which itself contains many regulatory elements such as upstream ORFs (uORFs), internal ribosome entry sites (IRESs), microRNA binding sites, and structural components involved in the regulation of mRNA stability, pre-mRNA splicing, and translation ...\n2. Internal ribosome entry sites (IRESs) recruit ribosomes to 5′ UTRs in a cap-independent manner. Many cellular IRESs are activated upon stress, whereas some are required in regular physiological ...\n3. The 5′ untranslated region (also known as 5′ UTR, leader sequence, transcript leader, or leader RNA) is the region of a messenger RNA (mRNA) that is directly upstream from the initiation codon.This region is important for the regulation of translation of a transcript by differing mechanisms in viruses, prokaryotes and eukaryotes.While called untranslated, the 5′ UTR or a portion of it is ...\n4. The length of 5′ untranslated regions (UTRs) has increased in eukaryotes during evolution, with median lengths ranging between 53-218 nucleotides (nt). We compared RefSeq-annotated 5′ UTR lengths of reviewed and validated transcripts ( n) between species for which at least 100 5′ UTRs are annotated.\n5. The crucial role of the 5′ UTR in mRNA translation encompasses ribosome recruitment, scanning and start-codon selection. With only 10-nucleotide sequence variation in the 5′ UTR, the massively ...",
               "predicate": null
            }
         ],
         "row": 621,
         "id": 309495867747859502
      },
      {
         "claim": "Omnivores produce less trimethylamine N-oxide from dietary I-carnitine than vegetarians.",
         "label": 0,
         "prediction": 1,
         "rationale": "Trimethylamine N-oxide (TMAO) is a small colorless amine oxide produced from the metabolism of choline, betaine, and carnitine by gut bacteria. The production of trimethylamine N-oxide from dietary L-carnitine depends on diet. Omnivores have different gut bacteria than vegetarians. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is trimethylamine N-oxide?",
               "answer": "Trimethylamine N-oxide (TMAO) is a small colorless amine oxide with the chemical formula (CH3)3NO. It is produced from the metabolism of choline, betaine, and carnitine by gut bacteria. TMAO is typically encountered as a dihydrate and is a",
               "rationale": "1. Trimethylamine N-oxide (TMAO) is a small colorless amine oxide generated from choline, betaine, and carnitine by gut microbial metabolism. It accumulates in the tissue of marine animals in high concentrations and protects against the protein-destabilizing effects of urea. Plasma level of TMAO is determined by a number of factors including diet ...\n2. Trimethylamine N-oxide (TMAO) is an organic compound with the formula (CH 3) 3 NO. It is in the class of amine oxides. Although the anhydrous compound is known, trimethylamine N-oxide is usually encountered as the dihydrate. Both the anhydrous and hydrated materials are white, water-soluble solids.\n3. Trimethylamine N-oxide (TMAO) is a dietary component that belongs to the class of amine oxides with the formula (CH 3) 3 NO. TMAO is an oxidized form of trimethylamine (TMA) (Gessner et al., 2020; Subramaniam and Fletcher, 2018; Ufnal et al., 2015). One of the functions of TMAO is the ability to affect the structure and activity of a large ...\n4. A substance called trimethylamine N-oxide, which is produced when your body digests red meat, may raise the risk of cardiovascular problems. Experts used to think that red meat raised your risk of heart disease simply because it was high in saturated fat. But today that picture has gotten more complicated thanks to the discovery of a metabolite ...\n5. TMAO, or trimethylamine-N-oxide, is a toxic compound produced by human gut bacteria. Its production can have a major impact on the development of chronic disease and overall health. In fact, the effects of TMAO are so significant that it's being used as a medical indicator to help predict risk for heart attack, stroke, and death.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does the production of trimethylamine N-oxide from dietary L-carnitine depend on diet?",
               "answer": "Yes, the production of trimethylamine N-oxide (TMAO) from dietary L-carnitine does depend on diet. The evidence indicates that TMAO is produced from the metabolism of dietary choline and L-carnitine by intestinal microbiota, which suggests that the presence of these dietary components",
               "rationale": "1. Trimethylamine N-oxide (TMAO) is produced from the metabolism of dietary choline and L-carnitine by intestinal microbiota, and many studies have shown that this important product inhibits cholesterol metabolism, induces platelet aggregation and thrombosis, and promotes atherosclerosis.\n2. The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison ... lecithin and l-carnitine, and these in turn are mostly present in red meat, deep water fish, ... The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease. Toxins. 2018; 10:\n3. Background—Trimethylamine N-oxide (TMAO), a gut microbe-dependent metabolite of dietary choline and other trimethylamine-containing nutrients, is both elevated in the circulation of patients having heart failure and heralds worse overall prognosis. In animal studies, dietary choline or TMAO significantly accelerates atherosclerotic lesion development in ApoE-deficient mice, and reduction ...\n4. Introduction. Trimethylamine N-oxide (TMAO) is a dietary component that belongs to the class of amine oxides with the formula (CH 3) 3 NO. TMAO is an oxidized form of trimethylamine (TMA) (Gessner et al., 2020[]; Subramaniam and Fletcher, 2018[]; Ufnal et al., 2015[]).One of the functions of TMAO is the ability to affect the structure and activity of a large group of biologically important ...\n5. TMAO production results from the fermentation by the gut microbiota of dietary nutrients such as choline and carnitine, which are transformed to trimethylamine (TMA) and converted into TMAO in the liver by flavin-containing monooxygenase 1 and 3 (FMO1 and FMO3). Considering that TMAO is involved in the development of many chronic diseases ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Do omnivores have different gut bacteria than vegetarians?",
               "answer": "Yes, omnivores have different gut bacteria than vegetarians. The evidence indicates that vegetarians have a different gut microbiota composition compared to omnivores, with a diminished capacity to produce trimethylamine (TMA), which is a precursor to TMAO. Additionally, studies have shown differences in microbiota composition",
               "rationale": "1. Higher TMAO levels have also been observed with red meat intake, increasing risk for cardiovascular disease and inflammatory bowel disease ( 54, 66 ). Vegetarians have a different gut microbiota composition than omnivores with a diminished capacity to produce trimethylamine (TMA), the precursor to TMAO.\n2. The diversity and functions of the gut microbiota are influenced by many different factors, including age, use of antibiotics, consumption of pro- or prebiotics, and also by dietary habits . Observational studies in healthy subjects have shown that there are differences in the microbiota composition between omnivores, vegetarians, and vegans ...\n3. Initially, fecal microbiota analysis was performed by culture. However, more than 60% of fecal bacteria cannot be cultured. ... and Faecalibacterium prausnitzii (P < 0.01) were noted in vegetarians and vegans than omnivores ... comparison, and still, others compared vegans, vegetarian, and omnivores. Different study designs make interpretation ...\n4. Meat eating and weight. A study looking at the 'Risk of overweight and obesity among semi-vegetarian, lacto-vegetarian, and vegan women 6 found that 40% of the omnivores had a BMI over 25 (obese), compared to 29% of semi vegetarians and vegans and 25% lacto-vegetarians. They concluded that even if vegetarians consume some animal products ...\n5. In conclusion, the available literature suggests that a vegetarian/vegan diet is effective in promoting a diverse ecosystem of beneficial bacteria to support both human gut microbiome and overall health. This review will focus on effects of different diets and nutrient contents, particularly plant-based diets, on the gut microbiota composition ...",
               "predicate": null
            }
         ],
         "row": 622,
         "id": 262220209151745994
      },
      {
         "claim": "PD-1 triggering on monocytes reduces IL-10 production by monocytes.",
         "label": 0,
         "prediction": 0,
         "rationale": "PD-1, or Programmed cell death protein 1, is a cell surface receptor found on T cells and B cells that plays a crucial role in regulating the immune system's response by down-regulating it and promoting self-tolerance. PD-1 triggering on monocytes impairs Bruton's tyrosine kinase signaling, decreases glycolysis, and reduces phagocytosis, but this metabolic dysfunction can be reverted by PD-1 pathway blockade. PD-1 triggering on monocytes stimulates the production of IL-10 by monocytes. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PD-1?",
               "answer": "PD-1, or Programmed cell death protein 1, is a cell surface receptor found on T cells and B cells that plays a crucial role in regulating the immune system's response. It is encoded by the PDCD1 gene in humans and functions to down-regulate the immune system, promoting self-tolerance by",
               "rationale": "1. Programmed cell death protein 1 (PD-1), (CD279 cluster of differentiation 279). PD-1 is a protein encoded in humans by the PDCD1 gene. PD-1 is a cell surface receptor on T cells and B cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity.\n2. Immune Checkpoint Inhibitors. Checkpoint proteins, such as PD-L1 on tumor cells and PD-1 on T cells, help keep immune responses in check. The binding of PD-L1 to PD-1 keeps T cells from killing tumor cells in the body (left panel). Blocking the binding of PD-L1 to PD-1 with an immune checkpoint inhibitor (anti-PD-L1 or anti-PD-1) allows the T ...\n3. Immunotherapy harnesses the power of the immune system — the body's defender against infection and disease — to fight cancer. Some of the most effective immunotherapy agents for cancer are drugs known as checkpoint inhibitors, which, by blocking PD-1, PD-L1 and related proteins, give the immune system a go-ahead to attack tumor cells.\n4. PD-L1. PD-1 ligand (PD-L1; also referred to as CD279 and B7-H1), belongs to the B7 series and is a 33-kDa type 1 transmembrane glycoprotein that contains 290 amino acids with Ig- and IgC domains in its extracellular region [].PD-L1 is usually expressed by macrophages, some activated T cells and B cells, DCs and some epithelial cells, particularly under inflammatory conditions [].\n5. PD-1 and PD-L1 inhibitors PD-1 is a checkpoint protein on immune cells called T cells . It normally acts as a type of \"off switch\" that helps keep the T cells from attacking other cells in the body.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the effect of PD-1 triggering on monocytes?",
               "answer": "The effect of PD-1 triggering on monocytes includes impaired Bruton's tyrosine kinase (BTK) signaling, decreased glycolysis, and reduced phagocytosis. Additionally, PD-1 pathway blockade can revert this metabolic dysfunction.",
               "rationale": "1. Programmed cell death protein 1 (PD1) is an inhibitory receptor that is expressed by all T cells during activation. It regulates T cell effector functions during various physiological responses ...\n2. Effect of PD-1 signaling in T cells. PD-1 signaling dephosphorylates proximal signaling molecules and augments PTEN expression, inhibiting PI3K and AKT activation. The consequences include decreased T cell proliferation, cytokine production and cell survival. ... For example, PD-1 ligation in monocytes has been shown to stimulate the production ...\n3. Metabolic effects of PD-1 in myeloid cells. ( A) PD-1 triggering on monocytes results in impaired Bruton's tyrosine kinase (BTK) signaling, glycolysis and phagocytosis. PD-1 pathway blockade reverts this metabolic dysfunction. TLR: Toll-Like Receptor.\n4. INTRODUCTION. Under normal physiological conditions, the major function of PD-1 is to inhibit effector T-cell activity and enhance the function and development of Tregs, which inhibit T-cell responses and prevent overstimulation of immune responses in peripheral tissues [1, 2].The PD-1 pathway can protect the host against autoimmunity [].PD-1 pathway plays a key role in the regulation of ...\n5. The immune regulation mechanism of the PD-1/PD-L1 axis. Antigen-presenting cells (APCs) deliver tumor antigens to the T-cell receptor (TCR) via the major histocompatibility complex(MHC), and when the MHC-antigen complex specifically binds to the TCR, it triggers a series of signal transductions, including the phosphatidylinositol signaling and mitogen- activated protein kinases signaling ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Does PD-1 triggering on monocytes reduce IL-10 production by monocytes?",
               "answer": "No, PD-1 triggering on monocytes does not reduce IL-10 production by monocytes. In fact, the evidence suggests that PD-1 ligation on monocytes stimulates the production of IL-10, which contributes to reducing T cell function.",
               "rationale": "1. Triggering of PD-1 expressed on monocytes by PD-L1 expressed on various cell types induced IL-10 production and led to reversible CD4+ T cell dysfunction. We describe a new function for PD-1 whereby microbial products inhibit T cell expansion and function by upregulating PD-1 levels and IL-10 production by monocytes after binding of PD-1 by PD-L1.\n2. Programmed death-1 (PD-1) and interleukin-10 (IL-10) impair T cell function during chronic viral infections. Microbial products are now found to inhibit T cell function during HIV infection by ...\n3. For example, PD-1 ligation in monocytes has been shown to stimulate the production of IL-10 during HIV infection, which in turn contributes to reducing T cell function . These findings demonstrate that PD-1 expression on a non-lymphocyte population also may influence T cell immune function in HIV infection and this finding may extend to other ...\n4. PD-1 AND THE REGULATION OF PD-1 EXPRESSION. PD-1 (also called CD279) was first isolated from 2B4.11 (a murine T-cell hybridoma) and interleukin-3 (IL-3)-deprived LyD9 (a murine hematopoietic progenitor cell line) by using subtractive hybridization technique [].PD-1 is encoded by the Pdcd1, which is located on chromosome 2 (2q37) [25-27].PD-1 is one of the member of B7/CD28 family [28, 29].\n5. In our study, PD-1 expression in CD4 + lymphocytes and PD-L1 expression in CD14 + monocytes were correlated with peripheral lymphocyte count and plasma IL-10 concentration, suggesting that the PD-1/PD-L1 system takes part in the development of immunosuppression in AP by regulating lymphocyte proliferation and IL-10 production. Increased PD-1 ...",
               "predicate": null
            }
         ],
         "row": 623,
         "id": 168209033689838222
      },
      {
         "claim": "PDPN promotes efficient motility along stromal surfaces by activating the C-type lectin receptor to rearrange the actin cytoskeleton in dendritic cells.",
         "label": 1,
         "prediction": 1,
         "rationale": "Podoplanin (PDPN) is a transmembrane receptor glycoprotein that serves as a specific marker for lymphatic vessels and is involved in various biological processes related to cancer progression. Podoplanin promotes efficient motility along stromal surfaces in dendritic cells. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PDPN?",
               "answer": "Podoplanin (PDPN) is a transmembrane receptor glycoprotein that serves as a specific marker for lymphatic vessels and is involved in various biological processes related to cancer progression. It is upregulated in transformed cells, cancer-associated fibroblasts, and inflammatory macrophages, contributing to tumor cell clonal",
               "rationale": "1. PDPN has been studied extensively in the cancer field. It is a specific lymphatic vessel marker, and since lymphangiogenesis levels are correlated with poor prognosis in cancer patients, it can be used as a diagnostic marker. [8]\n2. Podoplanin ( PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression. In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migration, invasion, metastasis and inflammation.\n3. Podoplanin (PDPN) is a well-conserved, mucin-type transmembrane protein expressed in multiple tissues during ontogeny and in adult animals, including the brain, heart, kidney, lungs, osteoblasts, and lymphoid organs. Studies of PDPN-deficient mice have demonstrated that this molecule plays a critical role in development of the heart, lungs, and ...\n4. Podoplanin (PDPN) is a cell-surface mucin-like glycoprotein that plays a critical role in tumor development and normal development of the lung, kidney, and lymphatic vascular systems. PDPN is overexpressed in several tumors and is involved in their malignancy. ...\n5. Podoplanin (PDPN) is a small mucin-like transmembrane protein that is involved in cancer progression [103,104]. Ma and colleagues investigated podoplanin levels in ESCC tissues ( n = 107) by immunohistochemistry and noted that cancer recurrence, presence of lymph node metastasis and poorer prognosis of patients with ESCC was correlated with ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Podoplanin promote efficient motility along stromal surfaces in dendritic cells?",
               "answer": "Yes, podoplanin promotes efficient motility along stromal surfaces in dendritic cells. The evidence indicates that activation of CLEC-2 by podoplanin rearranges the actin cytoskeleton in dendritic cells, facilitating their movement along stromal scaffolds.",
               "rationale": "1. To initiate adaptive immunity, dendritic cells (DCs) move from parenchymal tissues to lymphoid organs by migrating along stromal scaffolds that display the glycoprotein podoplanin (PDPN). PDPN is expressed by lymphatic endothelial and fibroblastic reticular cells and promotes blood-lymph separation during development by activating the C-type ...\n2. Abstract. Cell motility is crucial for leukocytes to traffic between tissues and to interact with one another and their microenvironment. Stromal cells provide\n3. Podoplanin (PDPN) is a 36- to 43-kDa mucin-type transmembrane protein. It has homologues in humans, mice, rats, dogs, and hamsters and is relatively well conserved between species. PDPN has a wide variety of functions including regulation of organ development, cell motility, and tumorigenesis and metastasis ( Wicki and Christofori, 2007; Suzuki ...\n4. Thus, activation of CLEC-2 by PDPN rearranges the actin cytoskeleton in DCs to promote efficient motility along stromal surfaces. AB - To initiate adaptive immunity, dendritic cells (DCs) move from parenchymal tissues to lymphoid organs by migrating along stromal scaffolds that display the glycoprotein podoplanin (PDPN).\n5. The podoplanin-CLEC-2 interaction endows DCs with the capacity to crawl along stromal cell scaffolds of secondary lymphoid organs and to find and properly activate T cells.",
               "predicate": null
            }
         ],
         "row": 624,
         "id": 514841934924849030
      },
      {
         "claim": "PKG-la plays an essential role in expression of pain hypersensitivity in PGK-la knockout mice.",
         "label": 1,
         "prediction": 0,
         "rationale": "PKG-la is a specific application or package related to the PKG file format, possibly within a particular operating system or environment. The provided evidence does not directly address the role of PKG-la in PGK-la knockout mice. The relationship between PKG-la and pain hypersensitivity in PKG-la knockout mice cannot be determined based on the provided information. The relationship between PKG-Ia and pain hypersensitivity in PKG-Ia knockout mice is not explicitly mentioned in the provided evidence. Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PKG-la?",
               "answer": "The provided evidence does not specifically mention \"PKG-la.\" However, based on the context of PKG files, it can be inferred that \"PKG-la\" may refer to a specific application or package related to the PKG file format, possibly within a particular operating system or environment. To provide a more accurate answer",
               "rationale": "1. A PKG file may also be an application that can be run on a Nintendo 3DS or Switch using SmileBASIC and Midori-OS. It contains an app that is written using the BASIC (Beginners' All-purpose Symbolic Instruction Code) programming language and compiled for use with Midori-OS. PKG files are loaded in Midori-OS using the LOAD command and PKG Loader.\n2. Decisional means that it requires manual review. Current employment is always decisional for 2 reasons. Reason 1, so that the hiring manager can decide whether or not your current employment is a conflict of interest with the position you've been offered, or that the position they offered you won't give you access to special training, company ...\n3. How to open PKG files. Important: Different programs may use files with the PKG file extension for different purposes, so unless you are sure which format your PKG file is, you may need to try a few different programs. While we have not verified the apps ourselves yet, our users have suggested ten different PKG openers which you will find ...\n4. DMG and PKG Files Serve Different Purposes. While both are commonly used, their intended purpose is a bit different. DMG files are much more flexible and suitable for distribution, while PKG files offer greater options for specific install instructions. In addition, they are both compressed, so the original file size is reduced.\n5. .pkg (package) is a filename extension used for several file formats that contain packages of software and other files to be installed onto a certain device, operating system, or filesystem, such as macOS, iOS, the PlayStation Vita, the PlayStation 3, the PlayStation 4 and the PlayStation 5.. The macOS and iOS operating systems made by Apple use .pkg extensions for Apple software packages ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the role of PKG-la in PGK-la knockout mice?",
               "answer": "The provided evidence snippets do not directly address the role of PKG-la in PGK-la knockout mice. However, they do mention the involvement of the NO/cGMP/PKG signaling pathway in various biological processes, including osteoblast proliferation and differentiation. To determine the specific role of PKG-la in PGK-la",
               "rationale": "1. Unlike Gapdhs(-/-) males, the Pgk2(-/-) males also sired occasional pups. Alternative pathways that bypass the PGK step of glycolysis exist. We determined that one of these bypass enzymes, acylphosphatase, is active in mouse sperm, perhaps contributing to phenotypic differences between mice lacking GAPDHS or PGK2.\n2. Analysis of knockout animals indicates that 3′,5′cyclic guanosine monophosphate (cGMP) has an important role in gut homeostasis but the signaling mechanism is not known. The goals of this ...\n3. The most common application of gene targeting is to produce knockout mice, where a drug resistance marker replaces an essential coding region in a genetic locus. In the majority of cases, the importance of a gene cannot be determined by simply recognizing amino acid motifs in the protein (Iredale, 1999). Additionally, the role of a gene often ...\n4. KI Mouse Technology. The KI of a mutant allele in the mouse genome can be achieved using homologous recombination (HR) in embryonic stem (ES) cells (Thomas and Capecchi 1987), similar to the methods used to generate conditional knockout mice.However, rather than deleting a portion of a target gene, specific mutations can be introduced into endogenous genes and transmitted throughout the mouse ...\n5. We previously showed that the NO/cGMP/protein kinase G (PKG) signaling pathway positively regulates osteoblast proliferation, differentiation, and survival in vitro, and that cGMP-elevating agents have bone-anabolic effects in mice. Here, we generated mice with an osteoblast-specific (OB) knockout ( …",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the relationship between PKG-la and pain hypersensitivity in PGK-la knockout mice?",
               "answer": "The provided evidence snippets do not directly mention PKG-la or its relationship to pain hypersensitivity in PKG-la knockout mice. Therefore, based on the information given, we cannot determine the relationship between PKG-la and pain hypersensitivity in PKG-la knockout mice. Further specific studies or data regarding PKG-la would be",
               "rationale": "1. We find that both mice and people become hypersensitive to acute, thermal nociception when tested in an environment previously associated with an aversive tonic pain experience. This sensitization persisted for at least 24 hr and was only present in males of both species. In mice, context-dependent pain hypersensitivity was abolished by ...\n2. Male mice (Figure 4C) and male humans (Figure 7C) exhibited evidence of increased stress on the second day of testing, and for mice, stress measured as plasma corticosterone seemed to be respon-sible for the observed stress-induced hypersensitivity [36] in males only. Future work might explicitly test cortisol in human.\n3. Pain memories are hypothesized to be critically involved in the transition of pain from an acute to a chronic state. To help elucidate the underlying neurobiological mechanisms of pain memory, we developed novel paradigms to study context-dependent pain hypersensitivity in mouse and human subjects, respectively. We find that both mice and people become hypersensitive to acute, thermal ...\n4. Recently,73 context was found to influence pain behaviors in male mice and humans after a single conditioning trial (Martin 74 et al., 2019). Both male mice and men exhibited stress-induced ...\n5. In states of chronic pain, particularly in the context of inflammation and cancer, nociceptive and non-nociceptive sensory afferents are sensitized. Peripheral sensitization represents a reduction in the threshold and/or an increase in magnitude of responsiveness at the peripheral ends of sensory nerve fibers.",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the relationship between PKG-la and pain hypersensitivity in PGK-la knockout mice?",
               "answer": "The provided evidence does not explicitly mention PKG-Ia or its relationship to pain hypersensitivity in PKG-Ia knockout mice. However, it does discuss the role of a cGMP-dependent kinase (likely referring to PKG-I) in amplifying neurotransmitter release from peripheral pain sensors and potentiating spinal synapses",
               "rationale": "1. We find that both mice and people become hypersensitive to acute, thermal nociception when tested in an environment previously associated with an aversive tonic pain experience. This sensitization persisted for at least 24 hr and was only present in males of both species. In mice, context-dependent pain hypersensitivity was abolished by ...\n2. Pain memories are hypothesized to be critically involved in the transition of pain from an acute to a chronic state. To help elucidate the underlying neurobiological mechanisms of pain memory, we developed novel paradigms to study context-dependent pain hypersensitivity in mouse and human subjects, respectively. We find that both mice and people become hypersensitive to acute, thermal ...\n3. To help elucidate the underlying neurobiological mechanisms of pain memory, we developed novel paradigms to study context-dependent pain hypersensitivity in mouse and human subjects, respectively. We find that both mice and people become hypersensitive to acute, thermal nociception when tested in an environment previously associated with an ...\n4. Electrophysiological and behavioral experiments in mice reveal that a cGMP-dependent kinase amplifies neurotransmitter release from peripheral pain sensors, potentiates spinal synapses, and leads to exaggerated pain.Synaptic long-term potentiation (LTP) ...\n5. (b) Schematic diagram showing SNS-PKG-I À/À mice with a selective deletion of PKG-I in nociceptive DRG neurons in the ascending pain pathways, but without any change of PKG-I expression in the ...",
               "predicate": null
            }
         ],
         "row": 625,
         "id": 268874593800691213
      },
      {
         "claim": "Participating in six months of physical activity improves cognitive functioning.",
         "label": 1,
         "prediction": 1,
         "rationale": "Cognitive functioning refers to a person's thought processes and ways of learning and remembering, encompassing mental processes such as perception, memory, learning, attention, decision making, and language abilities. Participating in six months of physical activity improves perception, memory, learning, attention, decision making, and language abilities. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of cognitive functioning?",
               "answer": "Cognitive functioning refers to a person's thought processes and ways of learning and remembering. It encompasses a variety of mental processes involved in the acquisition of knowledge, manipulation of information, and reasoning, including perception, memory, learning, attention, decision making, and language abilities.",
               "rationale": "1. Cognitive functioning refers to a person's thought processes and ways of learning and remembering. However, cognitive function is just one part of how a brain works. Other aspects include motor ...\n2. In psychological health research, a person's ability to think, otherwise known as their cognitive functions, is a crucial subject of research. The cognitive functions are a variety of different ...\n3. In psychology, the term 'cognitive' refers to all of the different mental events involved in thinking, learning, and comprehending. Cognitive processes such as learning, attention, perception, and memory are important parts of the human experience. Understanding how they function can provide insight into normal human thought and behavior and ...\n4. The underlying mechanisms are called cognitive processes. They govern cognitive functions like attention, pattern-matching, problem-solving, memory, learning, decision-making, language, mental processing, perception, imagination, logic, strategic thinking, etc. The word cognition comes from the Latin word cognoscere which means \"get to know\".\n5. Definition. Cognitive function is a broad term that refers to mental processes involved in the acquisition of knowledge, manipulation of information, and reasoning. Cognitive functions include the domains of perception, memory, learning, attention, decision making, and language abilities.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does participating in six months of physical activity improve perception, memory, learning, attention, decision making, and language abilities?",
               "answer": "Yes, participating in six months of physical activity is likely to improve perception, memory, learning, attention, decision making, and language abilities. The evidence indicates that regular physical activity enhances cognitive functions such as attention, focus, memory, cognition, and language fluency. Additionally, exercise can improve mood and sleep, which are",
               "rationale": "1. Of the 617 results, 58 articles strictly connected to the main topics of physical activity and cognitive functioning were then reviewed. The areas of attention, thinking, language, learning, and memory were analyzed relative to sports and childhood.\n2. It has been shown that exercise can improve attention, focus, memory, cognition, language fluency, and decision-making for up to two hours [ 11 ]. Researchers state that regular physical activity improves the functioning of the hypothalamus-pituitary-adrenal (HPA) axis, lowering cortisol secretion and restoring the balance of leptin and ghrelin ...\n3. Physical activity (PA) is known to improve cognitive and brain function, but debate continues regarding the consistency and magnitude of its effects, populations and cognitive domains most affected, and parameters necessary to achieve the greatest improvements ...\n4. Exercise can also boost memory and thinking indirectly by improving mood and sleep, and by reducing stress and anxiety. Problems in these areas frequently cause or contribute to cognitive impairment.\n5. While, both cardio and motor skill activities improve overall brain function, they activate children's brains differently so we need each of these to plan and make decisions from simple to most complex (2). Physical activity can affect how we learn, remember, problem-solve, and pay attention (3).",
               "predicate": null
            }
         ],
         "row": 626,
         "id": 301006465662090984
      },
      {
         "claim": "Patients in stable partnerships have a faster progression from HIV to AIDS.",
         "label": 0,
         "prediction": 0,
         "rationale": "HIV (Human Immunodeficiency Virus) is a virus that can lead to AIDS (Acquired Immunodeficiency Syndrome), which is the late stage of HIV infection. Being in a stable partnership affects the progression from HIV to AIDS, with patients in stable partnerships experiencing a slower rate of progression to AIDS or death, particularly when receiving highly active antiretroviral therapy (HAART). Therefore, the final answer is: False.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the relationship between HIV and AIDS?",
               "answer": "HIV (Human Immunodeficiency Virus) is a virus that can lead to AIDS (Acquired Immunodeficiency Syndrome), which is the late stage of HIV infection. While HIV can be transmitted through bodily fluids and can be managed with treatment, untreated HIV can weaken the immune system over time, potentially progressing to AIDS.",
               "rationale": "1. What is the difference between HIV and AIDS? HIV is a virus that can be transmitted in various ways, through bodily fluids. With treatment, a person can live a long and normal life. However ...\n2. HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It is not spread by kisses, hugs or sharing food. It can also spread from a mother to her baby. HIV can be prevented and treated with antiretroviral therapy (ART). Untreated HIV can progress to AIDS, often after many years.\n3. AIDS is the late stage of HIV infection that occurs when the body's immune system is badly damaged because of the virus. In the U.S., most people with HIV do not develop AIDS because taking HIV medicine as prescribed stops the progression of the disease. A person with HIV is considered to have progressed to AIDS when: the number of their CD4 ...\n4. HIV and AIDS are related, but they're not the same. HIV is a virus. It may cause AIDS after you've been infected for several years and it's weakened your immune system. Not everyone who has ...\n5. HIV is a virus, and AIDS is the condition the virus may cause. An HIV infection doesn't necessarily progress to stage 3. In fact, many people with HIV live for years without developing AIDS.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does being in a stable partnership affect the progression from HIV to AIDS?",
               "answer": "Yes, being in a stable partnership affects the progression from HIV to AIDS. The evidence indicates that patients with HIV who have a stable partner experience a slower rate of progression to AIDS or death, particularly when receiving highly active antiretroviral therapy (HAART). Studies have shown that a significant percentage of HIV-positive patients in",
               "rationale": "1. A stable partnership is associated with a slower rate of progression to AIDS or death in patients with HIV receiving highly active antiretroviral therapy In the absence of a stable partnership an HIV infected patient may progress more rapidly through clinical latency to the later stages of the disease\n2. A stable partnership seems to slow progression to AIDS or death for patients receiving highly active antiretroviral treatment (HAART), a Swiss cohort study has shown. Exactly how such partnerships might affect outcome is purely speculative but warrants further study, especially of the mechanisms suitable for intervention, say its authors. The …\n3. In people infected with HIV, having a stable partner slows the progression of disease. During three years' follow up of 3736 HIV positive Swiss patients who had received highly active antiretroviral therapy, Young and colleagues ( p 15) found that 80% of the patients had a stable partner at some time, and these patients had a slower rate of progression to AIDS or death. Though having a stable ...\n4. Conclusions Partnership patterns strongly influence the transmission of HIV and do so differentially by stage of infection. Dynamic partnerships need to be taken into account to make a robust inference on the role of different stages of HIV infection.\n5. A stable partnership is associated with a slower rate of progression to AIDS or death in HIV infected patients receiving HAART.",
               "predicate": null
            }
         ],
         "row": 627,
         "id": 287574262288601337
      },
      {
         "claim": "Peroxynitrite is required for nitration of TCR/CD8.",
         "label": 1,
         "prediction": 1,
         "rationale": "TCR/CD8 refers to the T-cell receptor and CD8, a protein complex and transmembrane glycoprotein, respectively, that work together to recognize fragments of antigens as peptides bound to major histocompatibility complex (MHC) molecules. Peroxynitrite is required for the nitration of T-cell receptors. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is TCR/CD8?",
               "answer": "TCR (T-cell receptor) is a protein complex found on the surface of T cells that recognizes fragments of antigens as peptides bound to major histocompatibility complex (MHC) molecules. CD8 is a transmembrane glycoprotein that serves as a co-receptor for the TCR, playing",
               "rationale": "1. The T-cell receptor ( TCR) is a protein complex found on the surface of T cells, or T lymphocytes, [1] that is responsible for recognizing fragments of antigen as peptides bound to major histocompatibility complex (MHC) molecules. The binding between TCR and antigen peptides is of relatively low affinity and is degenerate: that is, many TCRs recognize the same antigen peptide and many antigen ...\n2. CD8. CD8 ( cluster of differentiation 8) is a transmembrane glycoprotein that serves as a co-receptor for the T-cell receptor (TCR). Along with the TCR, the CD8 co-receptor plays a role in T cell signaling and aiding with cytotoxic T cell - antigen interactions. Like the TCR, CD8 binds to a major histocompatibility complex (MHC) molecule, but ...\n3. Abstract. Interaction of the T cell receptor (TCR) with an MHC-antigenic peptide complex results in changes at the molecular and cellular levels in T cells. The outside environmental cues are ...\n4. The TCR recognizes antigens on major histocompatibility complex molecules with the cooperation of CD4 or CD8 coreceptors.\n5. A defining feature of CD8 + T-cell memory is the ability to persist in the long term and respond quickly upon reactivation. Unlike naive T cells, once formed, memory CD8 + T cells do not require TCR contact with self-peptide/major histocompatibility complex (MHC) and subsequent tonic signaling ( Tanchot et al. 1997; Takada and Jameson 2009 ).",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Is peroxynitrite required for the nitration of T-cell receptors?",
               "answer": "Yes, peroxynitrite is implicated in the nitration of T-cell receptors. The evidence suggests that peroxynitrite can alter protein function through nitration, which includes the T cell receptor. Specifically, it is mentioned that peroxynitrite can limit T cell responses by nitrating the T cell",
               "rationale": "1. To elucidate the production of peroxynitrite in T cells, we investigated the expression of 3-NT in self-antigen specific T cell subsets including Th1, Th17 and Treg cells. The subsets of CD4 + Th cells were isolated from the lymph nodes and lumbar spinal cord (LSC) in the active EAE mice at 0, 11, 18, and 30 dpi, corresponding to the stages of ...\n2. To elucidate the production of peroxynitrite in T cells, we investigated the expression of 3-NT in self-antigen specific T cell subsets including Th1, Th17 and Treg cells. The subsets of CD4 + Th cells were isolated from the lymph nodes and lumbar spinal cord (LSC) in the active EAE mice at 0, 11, 18, and 30 dpi, corresponding to the stages of ...\n3. The underlying mechanisms are related to induce the nitration of IL-2R and inhibit the RAS/JNK-AP-1 signalling pathway in Treg cells. The study highlights that targeting peroxynitrite-mediated peripheral IL-2R nitration in Treg cells could be a novel therapeutic strategy to restore Treg/Th17 balance and ameliorate MS/EAE pathogenesis.\n4. Peroxynitrite — the product of the reaction of nitric oxide with superoxide radical — is a potent inducer of cell death. Szabó and colleagues review the biochemistry and pathophysiology of ...\n5. Peroxynitrite inhibition in combination with immune checkpoint blockade enhances efficacy preclinically. ... data suggest that PNT can limit T cell responses and intratumoral infiltration by altering protein function through nitration of the T cell receptor and chemokines. 4. Nagaraj S. Gupta K. Pisarev V. ... the protease complex required for ...",
               "predicate": null
            }
         ],
         "row": 628,
         "id": 243714062189178409
      },
      {
         "claim": "Podocytes are motile and migrate in the presence of injury.",
         "label": 1,
         "prediction": 1,
         "rationale": "Podocytes are highly specialized cells in the kidney glomerulus that play a crucial role in glomerular filtration by forming a barrier with filtration slits that prevent plasma proteins from entering the urinary ultrafiltrate. The provided evidence does not explicitly state whether podocytes migrate in the presence of injury. There is ongoing debate regarding the motility of podocytes, with some evidence suggesting they can migrate in vitro, but uncertainties about their motility in vivo. Podocytes are highly differentiated cells with limited capability to undergo cell division in the adult, and their function relies on the dynamic regulation of their complex cell architecture, but it is unclear if they are capable of migration in vivo. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What are podocytes?",
               "answer": "Podocytes are highly specialized cells located in the kidney glomerulus that wrap around the capillaries and are adjacent to the cells of Bowman's capsule. They play a crucial role in glomerular filtration by forming a barrier with filtration slits that prevent plasma proteins from entering the urinary ultrafiltrate. Podocytes have",
               "rationale": "1. Podocyte. Renal corpuscle structure Blood flows in the afferent arteriole at the top, and out the efferent arteriole at the bottom. Blood flows through the capillaries of the glomerulus, where it is filtered by pressure. The podocytes (green) are wrapped around the capillaries. Blood is filtered through the slit diaphragm (or filtration slit ...\n2. Podocytes are highly specialized cells of the kidney glomerulus that wrap around capillaries and that neighbor cells of the Bowman's capsule. When it comes to glomerular filtration, podocytes play an active role in preventing plasma proteins from entering the urinary ultrafiltrate by providing a barrier comprising filtration slits between ...\n3. Podocytes are highly differentiated cells with limited capability to undergo cell division in the adult, and the loss of podocytes is a hallmark of progressive kidney disease. The function of podocytes is based largely on the dynamic regulation of their complex cell architecture, in particular the FP structure.\n4. Podocytes are highly specialized cells of the kidney glomerulus that wrap around capillaries and that neighbor cells of the Bowman's capsule. When it comes to glomerular filtration, podocytes play an active role in preventing plasma proteins from entering the urinary ultrafiltrate by providing a barrier comprising filtration slits between foot ...\n5. Glomerular podocytes are highly specialized cells with a complex cytoarchitecture. Their most prominent features are interdigitated foot processes with filtration slits in between. These are bridged by the slit diaphragm, which plays a major role in establishing the selective permeability of the glomerular filtration barrier. Injury to podocytes leads to proteinuria, a hallmark of most ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Do podocytes migrate in the presence of injury?",
               "answer": "The provided evidence does not explicitly state whether podocytes migrate in the presence of injury. However, it does highlight the crucial role of podocytes in maintaining the glomerular filtration barrier and suggests that their loss leads to glomerular disease. Additionally, it mentions that abnormalities in podocyte molecules can lead to proteinuria,",
               "rationale": "1. Abstract. Podocytes are the key target cells for injury across the spectrum of primary and secondary proteinuric kidney disorders, which account for up to 90% of cases of kidney failure worldwide ...\n2. The function of podocytes is based on their intricate cell architecture. (a) A glomerulus contains a capillary tuft that receives primary structural support from the glomerular basement membrane (GBM).Glomerular endothelial cells (E) lining the capillary lumen (CL) and mesangial cells (M) are located on the blood side of the GBM, whereas podocyte foot processes (FP) cover the outer part of the ...\n3. Podocytes have a crucial role in maintaining the glomerular filtration barrier and their loss leads to glomerular disease. This Review discusses the role of podocyte actin dynamics in health and ...\n4. Podocytes maintain the glomerular filtration barrier, and the stability of this barrier depends on their highly differentiated postmitotic phenotype, which also defines the particular vulnerability of the glomerulus. Recent podocyte biology and gene disruption studies in vivo indicate a causal relationship between abnormalities of single podocyte molecules and proteinuria and ...\n5. Older mutant mice develop mild proteinuria suggesting that α2β1 protects against renal injury. 81 ... Ptk2 in podocytes do not display ... features even in the presence of the endogenous ...",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "Are podocytes motile?",
               "answer": "The evidence suggests that there is ongoing debate regarding the motility of podocytes. While some studies indicate that podocytes can migrate in vitro, particularly in wound assays, there are uncertainties about their motility in vivo. The presence of factors that affect podocyte motility and the role of their intricate architecture also contribute to this",
               "rationale": "1. Podocytes, the postmitotic and highly branched epithelial cells of the glomerulus, play a pivotal role for the function of the glomerular filtration barrier and the development of chronic kidney disease. It has long been discussed whether podocytes in vivo are motile and can laterally migrate in a c …\n2. Podocytes, the postmitotic and highly branched epithelial cells of the glomerulus, play a pivotal role for the function of the glomerular filtration barrier and the development of chronic kidney disease. It has long been discussed whether podocytes in vivo are motile and can laterally migrate in a coordinated way along the capillaries until they reach the position of naked glomerular basement ...\n3. dissociation inhibitor, affect the motility of podocytes in vitro and lead to severe kidney diseases in vivo [18, 20]. Imaging of podocyte morphology and motility Based on the ability of cultured podocytes to migrate in vitro as it was demonstrated in wound assays, it was expected that podocytes are motile in vivo and do migrate along the GBM\n4. Podocytes (or visceral epithelial cells) are terminally differentiated cells lining the outer surface of the glomerular capillaries. ... (CD80) with cytoskeletal protein talin and thereby stabilizes β1-integrin activity and prevents podocyte motility 359. However, these results have been subjected to criticism since uncertainties still remain, ...\n5. The function of podocytes is based on their intricate cell architecture. (a) A glomerulus contains a capillary tuft that receives primary structural support from the glomerular basement membrane (GBM).Glomerular endothelial cells (E) lining the capillary lumen (CL) and mesangial cells (M) are located on the blood side of the GBM, whereas podocyte foot processes (FP) cover the outer part of the ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "Are podocytes capable of migration in vivo?",
               "answer": "The provided evidence does not explicitly state whether podocytes are capable of migration in vivo. However, it does highlight that podocytes are highly differentiated cells with limited capability to undergo cell division in the adult, and their function relies on the dynamic regulation of their complex cell architecture. This suggests that while podocytes may have some degree",
               "rationale": "1. Podocytes are highly differentiated cells with limited capability to undergo cell division in the adult, and the loss of podocytes is a hallmark of progressive kidney disease. The function of podocytes is based largely on the dynamic regulation of their complex cell architecture, in particular the FP structure.\n2. Podocytes are highly specialized cells of the kidney glomerulus that wrap around capillaries and that neighbor cells of the Bowman's capsule. When it comes to glomerular filtration, podocytes play an active role in preventing plasma proteins from entering the urinary ultrafiltrate by providing a barrier comprising filtration slits between ...\n3. Tran et al. performed single-cell RNA sequencing to provide an understanding of human podocyte development. Insights from the in vivo analysis was applied to extensively evaluate the formation of podocytes in vitro, highlighting autonomous programs of development and those requiring an interplay with adjacent cell types. Go to:\n4. Tran et al. performed single-cell RNA sequencing to provide an understanding of human podocyte development. Insights from the in vivo analysis was applied to extensively evaluate the formation of podocytes in vitro, highlighting autonomous programs of development and those requiring an interplay with adjacent cell types.\n5. However, in the context of podocytes in vivo, all three proteins are heavily involved in the morphological and biomechanical properties of the actin-rich terminal foot processes that interdigitate ...",
               "predicate": null
            }
         ],
         "row": 629,
         "id": 271410555592616700
      },
      {
         "claim": "Polymeal nutrition reduces cardiovascular mortality.",
         "label": 1,
         "prediction": 1,
         "rationale": "Polymeal nutrition is a diet-based approach that aims to reduce the risk of cardiovascular disease by incorporating specific foods with heart health benefits. The Polymeal nutrition is suggested to reduce the risk of cardiovascular disease. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is Polymeal nutrition?",
               "answer": "Polymeal nutrition refers to a diet-based approach aimed at reducing the risk of cardiovascular disease by incorporating specific foods that have been shown to have heart health benefits. Proposed by Oscar Franco and his colleagues in 2004, the Polymeal includes ingredients selected based on the best available evidence regarding their effectiveness in lowering heart disease risk.",
               "rationale": "1. Food for thought: The polymeal. Cardiovascular disease is common in the industrial world, and as globalization spreads the Western lifestyle, the epidemic of heart disease is following in its wake. In the United States alone, heart disease and stroke are the first and third leading causes of death, taking about 800,000 lives annually.\n2. The Polymeal is a diet-based approach to combatting heart disease, proposed in December 2004 by Oscar Franco, a Colombian public health scientist at the University Medical Centre in Rotterdam, Netherlands. Franco and his colleagues suggest the \"Polymeal\" as a natural alternative to the \"Polypill\", a multi-drug-based strategy for reducing heart ...\n3. The recipe. To optimise the Polymeal ingredients we used an evidence based diet conceptual framework, which follows similar principles to evidence based medicine.4 The constituting elements of a meal or recipe are selected on the basis of the best available evidence; the evidence available for each ingredient is graded according to the level of evidence.\n4. Classic Foods for Heart Health. In 2004, the British Medical Journal designed most heart-healthy meal imaginable, and called it the \"polymeal.\"(1) Based on the results of the Framingham Heart Study, which surveyed more than 5000 subjects and followed them for 46 years, the polymeal was shown to reduce heart disease by a staggering 76%.Nothing has ever come close to that!\n5. The \"polymeal\" concept, published in the December 18/25, 2004 issue of the British Medical Journal, advocates eating foods that have been shown to decrease the risk of cardiovascular disease.It would include drinking about 2/3 of a cup of wine daily, which has been shown to reduce heart disease by 32 percent; eating fish four times a week, which lowers the risk by 14 percent; eating about 3.5 ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does Polymeal nutrition reduce the risk of cardiovascular disease?",
               "answer": "Yes, the Polymeal nutrition is suggested to reduce the risk of cardiovascular disease. The evidence indicates that the Polymeal can lead to a significant reduction in cardiovascular disease events and may improve life expectancy while being a tastier and safer alternative to the Polypill. The study highlights the potential benefits of the Polymeal in managing",
               "rationale": "1. coronary heart disease and stroke separated) on the basis of current recommendations in the European guidelines on cardiovascular disease prevention.19 Effects of the Polymeal on life expectancy and time with cardiovascular disease To translate the effects of the Polymeal on reduction of cardiovascular disease events (table 1) in terms of\n2. Objective Although the Polypill concept (proposed in 2003) is promising in terms of benefits for cardiovascular risk management, the potential costs and adverse effects are its main pitfalls. The objective of this study was to identify a tastier and safer alternative to the Polypill: the Polymeal. Methods Data on the ingredients of the Polymeal were taken from the literature.\n3. Nutrition-related chronic diseases are prevalent over the life course, with growing evidence of maternal-fetal nutritional origins. 9 Excess gestational weight gain, especially among women who experience overweight or obesity at conception, can lead to adverse pregnancy outcomes, subclinical CVD and CVD risk factors in mothers, and an increased risk for pediatric obesity in the offspring. 10 ...\n4. Food for thought: The polymeal. Cardiovascular disease is common in the industrial world, and as globalization spreads the Western lifestyle, the epidemic of heart disease is following in its wake. In the United States alone, heart disease and stroke are the first and third leading causes of death, taking about 800,000 lives annually.\n5. Franco OH et al. (2004) The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%. BMJ 329: 1447-1450. Following ...",
               "predicate": null
            }
         ],
         "row": 630,
         "id": 324400830681669396
      },
      {
         "claim": "Pretreatment with the Arp2/3 inhibitor CK-666 affects lamelliopodia formation.",
         "label": 1,
         "prediction": 1,
         "rationale": "CK-666 is a cell-permeable inhibitor of the actin-related protein 2/3 (Arp2/3) complex. CK-666 affects lamellipodia formation, decreasing the percentage of cells forming lamellipodia and increasing bleb formation. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is CK-666?",
               "answer": "CK-666 is a cell-permeable inhibitor of the actin-related protein 2/3 (Arp2/3) complex. It has an IC50 of 12 μM and works by binding to the Arp2/3 complex, stabilizing its inactive state and blocking the movement of the Ar",
               "rationale": "1. The actin-related protein 2/3 (Arp 2/3) complex nucleates branched actin filaments important for many cellular functions. Hetrick et al. determine the mechanism of small molecule inhibitors CK-666 and CK-869, showing they inhibit Arp2/3 complex by blocking an activating conformational change that is induced by nucleation promoting factors and actin monomer binding.\n2. Actin-related protein 2/3 (Arp2/3) complex is a seven-subunit assembly that nucleates branched actin filaments. Small molecule inhibitors CK-666 and CK-869 bind to Arp2/3 complex and inhibit nucleation, but their modes of action are unknown. Here, we use biochemical and structural methods to determi …\n3. CK-666 is a cell-permeable actin-related protein Arp2/3 complex inhibitor (IC50=12 μM). CK-666 binds to Arp2/3 complex, stabilizes the inactive state of the complex, blocking movement of the Arp2 and Arp3 subunits into the activated filament-like (short pitch) conformation. - Mechanism of Action & Protocol.\n4. CK-666 and CK-869 are commercially available compounds derived from CK-636 and CK-548, respectively (Nolen et al., 2009; Figure 1 B). The recently reported crystal structure of CK-666 bound to Arp2/3 complex showed that, like CK-636, it binds to a pocket at the interface of Arp2 and Arp3, suggesting both inhibitors may block formation of the ...\n5. CK-666 stabilizes the inactive state of the ARP2/3 complex, blocking movement of the Arp2 and Arp3 subunits into the activated filament-like (short pitch) conformation. In other words, CK-666 is a ARP 2/3 complex inhibitor. It acts as a cell-permeable selective inhibitor of actin assembly mediated by actin-related protein Arp2/3 complex.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Does CK-666 affect lamelliopodia formation?",
               "answer": "Yes, CK-666 affects lamellipodia formation. The evidence indicates that pretreatment with CK-666, an Arp2/3 inhibitory compound, impacts lamellipodia formation, leading to a decrease in the percentage of cells forming lamellipodia and an increase in bleb formation.",
               "rationale": "1. Filopodia Formation in 2xKD Cells upon ... Transient depletion of either the Cdc42 or Rac1 small GTPase or both does not affect the ability of fibroblasts to ... AlexaFluor647 dye conjugated phalloidin was from Invitrogen. Arp2/3 complex inhibitor CK-666 and the inactive control CK-689 are from EMD4Biosciences. Latrunculin B, (-)-Blebbistatin ...\n2. In contrast, pretreatment with the Arp2/3 inhibitory compound CK-666, shown to affect lamelliopodia formation ... Cdc42 regulates filopodial growth and localization of FMNL2, but does not affect junction formation. (A) MCF10A cells co-expressing GFP-Fascin and mCherry-PA-Rac1. (B) ...\n3. CK-666, CK-689, and PD0325901 were dissolved in DMSO to make a 10 mM stock. Inhibitors were diluted to varying concentrations in embryo medium. ... As there was no effect on the formation of lamellipodia-like protrusions, these observations imply that Ras-Erk pathway acts either downstream of the molecular machinery responsible for FAs ...\n4. Effect of CK-666 Analogs on Lamellipodium Formation and Cell Migration. Arp2/3 activity is most established to generate membrane protrusions, called lamellipodia, that mediate a type of cell motility, referred to as mesenchymal. ... We studied the effect of CK-666 and its analogs 15, 59, 69, and 71 over a longer period, up to the four-arm mid ...\n5. We thus inhibited Arp2/3 activity using the small molecule inhibitor CK-666 . Treatment with CK-666 led to an instantaneous and dose-dependent decrease of the percentage of adhSL cells forming lamellipodia, and strongly increased bleb formation (Fig. 3 A and B and Movie S5). To rule out nonspecific effects of the inhibitor, we decreased Arp2/3 ...",
               "predicate": null
            }
         ],
         "row": 631,
         "id": 161422656829523302
      },
      {
         "claim": "Primary cervical cancer screening with HPV detection has higher longitudinal sensitivity than conventional cytology to detect cervical intraepithelial neoplasia grade 2.",
         "label": 1,
         "prediction": 1,
         "rationale": "Longitudinal sensitivity in the context of cervical cancer screening refers to the ability of a screening test to accurately detect cervical cancer or its precursors over time, considering the changes in a woman's health status and risk factors. The longitudinal sensitivity of conventional cytology in detecting cervical intraepithelial neoplasia grade 2 (CIN 2) is not specified. The longitudinal sensitivity of primary cervical cancer screening with HPV detection in detecting cervical intraepithelial neoplasia grade 2 (CIN 2) is not explicitly stated in the provided evidence snippets. The longitudinal sensitivity of primary cervical cancer screening with HPV detection compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2 (CIN2) is not directly specified in the provided evidence snippets. The longitudinal sensitivity of primary cervical cancer screening with HPV detection is higher compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the definition of longitudinal sensitivity in the context of cervical cancer screening?",
               "answer": "The provided evidence snippets do not explicitly define \"longitudinal sensitivity\" in the context of cervical cancer screening. However, in general terms, longitudinal sensitivity in screening refers to the ability of a screening test to accurately detect cervical cancer or its precursors over time, considering the changes in a woman's health status and risk factors.",
               "rationale": "1. HPV DNA based screening programmes have a much higher impact in reducing cervical cancer morbidity and mortality compared to VIA based screening and are more cost-effective. They also require fewer screening visits and generate fewer precancer treatments event and associated harms, in both the general population of women and in the population ...\n2. Guidelines process will selectively incorporate new technologies and approaches with adequate supportive data to more effectively improve cancer prevention for high-risk individuals and decrease unnecessary procedures in low-risk individuals. This manuscript describes the structure, process, and methods of the Enduring Guidelines effort. Using systematic literature reviews and primary data ...\n3. Abstract. Cervical cancer is one of the leading causes of cancer death among females worldwide and its behavior epidemiologically likes a venereal disease of low infectiousness. Early age at first intercourse and multiple sexual partners have been shown to exert strong effects on risk. The wide differences in the incidence among different ...\n4. Cervical cancer is largely preventable through both vaccination and screening for precursor lesions, with appropriate follow-up and treatment. 7 As a secondary objective, screening may lead to ...\n5. Cervical cancer is a leading cause of mortality among women. In 2020, an estimated 604 000 women were diagnosed with cervical cancer worldwide and about 342 000 women died from the disease. Cervical cancer is the most commonly diagnosed cancer in 23 countries and is the leading cause of cancer death in 36 countries.",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "What is the longitudinal sensitivity of conventional cytology in detecting cervical intraepithelial neoplasia grade 2?",
               "answer": "The provided evidence snippets do not specify the longitudinal sensitivity of conventional cytology in detecting cervical intraepithelial neoplasia grade 2 (CIN 2). They mention that the longitudinal sensitivity of repeated cytology is higher and provide information about the sensitivity of high-risk HPV (hrHPV) testing, but do",
               "rationale": "1. It is these women who are at risk of developing high‐grade cervical intraepithelial neoplasia (CIN) grades ... even though the longitudinal sensitivity of repeated cytology is higher. ... when HC2 was assessed at the threshold of 2 pg/mL for the detection of CIN 3+ was nearly identical to the test for detection of CIN 2+ (sensitivity was 95% ...\n2. Only fully paired-design screening studies of cytology and hrHPV testing, either opportunistic or organized screening, aimed at detecting cervical intraepithelial neoplasia ≥ grade 2 (CIN2+) in ...\n3. Liquid-based cytology is superior to conventional cytology for the detection of epithelial cell lesions. ... lesions as compared to CS that included 3 cases of high-grade squamous intraepithelial lesion (HSIL) [Figure 1], 5 ... population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous ...\n4. J Low Genit Tract Dis. 2020;24(2):102-131. Risk-Based Framework. The new guidelines provide risk thresholds for clinical action (Table 1) and establish risk estimates for the development of cervical intraepithelial neoplasia grade 3 (CIN 3), adenocarcinoma in situ, or cancer (ie, CIN 3+) for different combinations of test results.\n5. Early diagnosis and treatment of preinvasive lesions have made cervical cytology one of the most effective methods of cancer screening in industrialized nations, which have seen a sharp decline in the incidence and death of invasive cancer. The aim of this study is to compare liquid-based cytology (LBC) and conventional Pap on cervical smears.",
               "predicate": null
            },
            {
               "round": 2,
               "target_entity": "",
               "generated_question": "What is the longitudinal sensitivity of primary cervical cancer screening with HPV detection in detecting cervical intraepithelial neoplasia grade 2?",
               "answer": "The provided evidence snippets do not explicitly state the longitudinal sensitivity of primary cervical cancer screening with HPV detection for detecting cervical intraepithelial neoplasia grade 2 (CIN 2). However, they indicate that systematic reviews and studies have been conducted to assess the diagnostic accuracy of HPV testing, including comparisons with cytological",
               "rationale": "1. To determine the diagnostic accuracy of HPV testing for detecting histologically confirmed cervical intraepithelial neoplasias (CIN) of grade 2 or worse (CIN 2+), including adenocarcinoma in situ, in women participating in primary cervical cancer screening; and how it compares to the accuracy of cytological testing (liquid‐based and ...\n2. Asthana S, Labani S. Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia. Cancer ...\n3. We did a systematic review to assess the cross-sectional clinical accuracy to detect cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) or 3 or worse (CIN3+) of hrHPV mRNA versus DNA testing in primary cervical cancer screening; the longitudinal clinical performance of cervical cancer screening using hrHPV mRNA versus DNA assays; and the clinical accuracy of hrHPV mRNA testing on ...\n4. Cervical cancer screening is no longer required in low-risk patients older than 65 years who have not been diagnosed with grade 2 or greater cervical intraepithelial neoplasia within the past 25 ...\n5. To compare all available accuracy data on screening strategies for identifying cervical intraepithelial neoplasia grade ≥ 2 in healthy asymptomatic women, we performed a systematic review and ...",
               "predicate": null
            },
            {
               "round": 3,
               "target_entity": "",
               "generated_question": "What is the longitudinal sensitivity of primary cervical cancer screening with HPV detection compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2?",
               "answer": "The provided evidence snippets do not directly specify the longitudinal sensitivity of primary cervical cancer screening with HPV detection compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2 (CIN2). However, they indicate that studies have been conducted to assess the diagnostic accuracy of HPV testing and its comparison with cyt",
               "rationale": "1. The main objective of this review was to determine the diagnostic accuracy of HPV testing for detecting histologically confirmed CIN 2 or worse (CIN 2+), including adenocarcinoma in situ, in women participating in primary cervical cancer screening; and how it compares to the accuracy of cytological testing (liquid‐based and conventional) at ...\n2. This article reviews recent evidence from the International Agency for Research on Cancer on the best methods of screening for cervical cancer, including by means of conventional cytology, visual i...\n3. This randomized clinical trial compares the effects of cervical HPV vs cytology (Pap smear) screening on the cumulative incidence of high-grade cervical intraepithelial neoplasia (CIN3+) detected at 48 months.\n4. We have followed the cohort to 2015 through national cancer registration for CIN3 (cervical intraepithelial neoplasia grade 3) and cancer, and through linkage to the cervical screening call-recall system to obtain lifetime cytology records.\n5. Methods We did a systematic review to assess the cross-sectional clinical accuracy to detect cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) or 3 or worse (CIN3+) of hrHPV mRNA versus DNA testing in primary cervical cancer screening; the longitudinal clinical performance of cervical cancer screening using hrHPV mRNA versus DNA assays; and the clinical accuracy of hrHPV mRNA ...",
               "predicate": null
            },
            {
               "round": 4,
               "target_entity": "",
               "generated_question": "What is the longitudinal sensitivity of primary cervical cancer screening with HPV detection compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2?",
               "answer": "The longitudinal sensitivity of primary cervical cancer screening with HPV detection is higher compared to conventional cytology in detecting cervical intraepithelial neoplasia grade 2 (CIN 2). Evidence indicates that HPV testing is more sensitive and reproducible than cytological testing, allowing for extended screening intervals and improved detection of cervical abnormalities",
               "rationale": "1. To determine the diagnostic accuracy of HPV testing for detecting histologically confirmed cervical intraepithelial neoplasias (CIN) of grade 2 or worse (CIN 2+), including adenocarcinoma in situ, in women participating in primary cervical cancer screening; and how it compares to the accuracy of cytological testing (liquid‐based and ...\n2. Secondary prevention of cervical cancer relies on the accurate diagnosis and treatment of its high-grade precursors, cervical intraepithelial neoplasia (CIN) 2 and CIN3, to prevent progression to ...\n3. Human papillomavirus (HPV) causes cervical cancer. The latest scientific evidence shows that screening for HPV is better than screening for abnormal cytology with a 'smear' test, so HPV testing is being rolled out nationally. The main disadvantage is that more women will test positive and be referred for further tests.\n4. Based on solid evidence, screening every 5 years with the Pap test and the HPV DNA test (cotesting) in women aged 30 years and older is more sensitive in detecting cervical abnormalities, compared with the Pap test alone. Screening with the Pap test and HPV DNA test reduces the incidence of cervical cancer. [ 3]\n5. The performance of cytology to detect cervical precancer and cancer has been studied largely among women from Europe and North America. There is ample evidence and agreement that HPV testing is a more sensitive and reproducible test for primary screening than cytology, which allows extension of screening intervals and can be self-collected.",
               "predicate": null
            }
         ],
         "row": 632,
         "id": 200194967979571000
      },
      {
         "claim": "Proteins synthesized at the growth cone are ubiquitinated at a higher rate than proteins from the cell body.",
         "label": 1,
         "prediction": 1,
         "rationale": "The growth cone is a large, actin-supported extension of a developing or regenerating neurite that plays a crucial role in driving axon growth. Proteins synthesized at the growth cone are ubiquitinated at a higher rate than proteins from the cell body. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is the growth cone?",
               "answer": "The growth cone is a large, actin-supported extension of a developing or regenerating neurite that plays a crucial role in driving axon growth. It is a highly motile structure that forms specifically in extending axons and dendrites, responding to various signals by advancing, pausing, and turning until it reaches its",
               "rationale": "1. A growth cone is a large actin-supported extension of a developing or regenerating neurite seeking its synaptic target. It is the growth cone that drives axon growth. Their existence was originally proposed by Spanish histologist Santiago Ramón y Cajal based upon stationary images he observed under the microscope.\n2. Proteomic identification of the molecular basis of mammalian CNS growth cones. Michihiro Igarashi, in Neuroscience Research, 2014. 1 Introduction. The growth cone is a highly motile structure that specifically forms in the developing and extending axons and dendrites. Historically, this structure was discovered by a distinguished Spanish anatomist, Santiago Ramón y Cajal, more than a century ...\n3. The growth cone responds to these signs by advancing, pausing and turning until it reaches its proper destination. Growth cone history The Spanish neuroscientist Santiago Ramon y Cajal discovered growth cones in his anatomical studies of embryos, and in 1890 he published the first report and pictures of axonal growth cones .\n4. The growth cone structure (A) and its behaviors are regulated by second messengers (B). The growth cone is divided into two regions; one is the central (C-) domain in which MTs and vesicles are enriched; the other is the peripheral (P-) domain in which dynamic F-actin bundles are enriched, forming lamellipodia and filopodia.\n5. What are growth cones? Of all animal cells, neurons have the most diverse and remarkable shapes. They vary in appearance from the simple, unipolar cells of invertebrate ganglia to the highly complex pyramidal cells of the human cerebral cortex with their profusion of processes and thousands of synapses. The basis for this diversity of shape is ...",
               "predicate": null
            },
            {
               "round": 1,
               "target_entity": "",
               "generated_question": "Are proteins synthesized at the growth cone ubiquitinated at a higher rate than proteins from the cell body?",
               "answer": "Yes, proteins synthesized at the growth cone are ubiquitinated at a higher rate than proteins from the cell body. The evidence suggests that the growth cone has a higher rate of protein ubiquitination compared to other parts of the neuron, including the cell body.",
               "rationale": "1. The remaining proteins are synthesized in the cell body and trafficked into axons. ... These data suggest that the growth cone has a higher rate of protein ubiquitination than other parts of the ...\n2. Insights into ubiquitinated proteins using Ub tagging-based approaches. To profile protein ubiquitination in a high-throughput manner, the ubiquitinated proteins were enriched after the expression of Ub tags in living cells. There are two kinds of tags used for purifying ubiquitination substrates, termed epitope tags and protein/domain tags.\n3. The remaining proteins are synthesized in the cell body and trafficked into axons. In the present study, we examine the basis for the requirement for local translation of RhoA in Sema3A-induced growth cone collapse. ... These data suggest that the growth cone has a higher rate of protein ubiquitination than other parts of the neuron ...\n4. Identification of ubiquitinated proteins and lysine residues can help researchers better understand the physiological roles of ubiquitin modification in different biological systems.\n5. The obtained information on protein ubiquitination helps to crack the molecular mechanism of ubiquitination in numerous pathologies. In this review, we summarize the recent advances in protein ubiquitination analysis to gain updated knowledge in this field. In addition, the current and future challenges and barriers are also reviewed and discussed.",
               "predicate": null
            }
         ],
         "row": 633,
         "id": 131999404904497427
      },
      {
         "claim": "Pseudogene PTENP1 regulates the expression of PTEN by functioning as an miRNA decoy.",
         "label": 1,
         "prediction": 1,
         "rationale": "PTENP1, or Phosphatase and Tensin Homolog Pseudogene 1, is a human pseudogene that shares high sequence homology with the tumor suppressor gene PTEN and has a partial reactivated function as a competing endogenous RNA, regulating PTEN expression. Therefore, the final answer is: True.",
         "context": [
            {
               "round": 0,
               "target_entity": "",
               "generated_question": "What is PTENP1?",
               "answer": "PTENP1, or Phosphatase and Tensin Homolog Pseudogene 1, is a human pseudogene that shares high sequence homology with the tumor suppressor gene PTEN. It has a partial reactivated function as a competing endogenous RNA, regulating PTEN expression. PTENP1 is",
               "rationale": "1. 2.9 PTENP1. LncRNA PTENP1 is the pseudogene of the phosphatase and tensin homolog (PTEN), which shares high sequence homology with PTEN [86 ]. Xin proved that PTENP1 rs7853346 (OR = 0.81) was correlated with the risk of OSCC [ 87 ]. Recent evidence has shown that PTENP1 is down-regulated or eliminated in different cancers, including GC [ 86 ].\n2. Phosphatase and tensin homolog (mutated in multiple advanced cancers 1), pseudogene 1, also known as PTENP1, is a human pseudogene. [3] which has a partial reactivated function as a competing endogenous RNA regulating the tumor suppressor gene PTEN.\n3. GeneCards Summary for PTENP1 Gene PTENP1 (Phosphatase And Tensin Homolog Pseudogene 1) is a Pseudogene. Diseases associated with PTENP1 include Prostate Disease and Renal Cell Carcinoma .\n4. PTENP1 was significantly downregulated in cervical cancer and low level of PTENP1 was closely related to poor prognosis. Functionally, PTENP1 modulated EGR1 level by decoying miR-27a-3p.\n5. PTENP1, the processed pseudogene of PTEN, is an important transcriptional and post-transcriptional regulator of PTEN. PTENP1 expression produces sense and antisense transcripts modulating PTEN expression, in conjunction with miRNAs. Due to the high sequence similarity between PTEN and the PTENP1 sense transcript, the transcripts possess common ...",
               "predicate": null
            }
         ],
         "row": 634,
         "id": 296200266819855442
      }
   ]
}